Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,response to copper ion (GO:0046688),0.9128558037983572,2.4190881953063816,0.0,0.0,0.0,8/20,0.13%,MT1G;MT1B;MT1X;MT1F;MT1E;MT1M;MT1H;MT1A
prerank,cellular response to copper ion (GO:0071280),0.9308632717190022,2.3345200151255443,0.0,0.0,0.0,8/16,0.13%,MT1G;MT1B;MT1X;MT1F;MT1E;MT1M;MT1H;MT1A
prerank,zinc ion homeostasis (GO:0055069),0.8251233737194575,2.330225568675795,0.0,0.0,0.0,8/28,0.13%,MT1G;MT1B;MT1X;MT1F;MT1E;MT1M;MT1H;MT1A
prerank,response to zinc ion (GO:0010043),0.8403618835699838,2.3202803794447457,0.0,0.0,0.0,8/25,0.13%,MT1G;MT1B;MT1X;MT1F;MT1E;MT1M;MT1H;MT1A
prerank,cellular zinc ion homeostasis (GO:0006882),0.828363499197186,2.3199704826335057,0.0,0.0,0.0,8/26,0.13%,MT1G;MT1B;MT1X;MT1F;MT1E;MT1M;MT1H;MT1A
prerank,response to cadmium ion (GO:0046686),0.8333324017446644,2.3116098560874843,0.0,0.0,0.0,9/26,0.81%,MT1G;MT1B;MT1X;MT1F;MT1E;MT1M;MT1H;MT1A;MAPK3
prerank,cellular response to cadmium ion (GO:0071276),0.8358800088251076,2.280577964012374,0.0,0.0,0.0,9/24,0.81%,MT1G;MT1B;MT1X;MT1F;MT1E;MT1M;MT1H;MT1A;MAPK3
prerank,cellular response to zinc ion (GO:0071294),0.9132974573789572,2.275739893657075,0.0,0.0,0.0,8/15,0.13%,MT1G;MT1B;MT1X;MT1F;MT1E;MT1M;MT1H;MT1A
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.7509594559158953,-2.0684837566414633,0.0,0.037250062962972584,0.03,9/17,10.60%,ATP1A2;CACNA1C;ATP1B1;ATP1A1;GJC1;GJD3;ATP1B2;PRKACA;GJA1
prerank,cellular potassium ion homeostasis (GO:0030007),-0.8348577423698664,-2.062510318872887,0.0,0.022011400841756526,0.036,8/13,9.45%,ATP1A2;KCNMA1;ATP1B1;ATP1B3;SLC12A2;ATP1A1;KCNJ2;ATP1B2
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.7788862370349801,-2.0461660759720894,0.0,0.02219953247288265,0.053,6/14,10.09%,ANK2;ATP1B1;ATP1B3;AKAP9;ATP1B2;ACTN2
prerank,regulation of NMDA receptor activity (GO:2000310),-0.6250612283878517,-2.0191009854457342,0.0,0.027373152328851062,0.084,19/32,22.22%,DLG2;LRRC7;GRIA4;GRIA2;GRIN2B;DLG4;RELN;SLC6A9;NLGN1;DLG3;ACTN2;EPHB2;DLG1;NEFL;OPRM1;DAPK1;GRIN1;CAMK2B;CAPN1
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.5366659578414884,-1.9689351118962082,0.0,0.056891005252539935,0.203,32/57,24.99%,DLG2;DLGAP1;LRRC7;GRIA4;GRIA2;GRIN2B;DLGAP2;SHISA9;DLG4;DLGAP4;NLGN2;RELN;SHISA6;AKAP9;NLGN1;DLG3;ACTN2;CACNG7;DLG1;NEFL;CACNG4;OPRM1;CACNG2;DAPK1;SHANK1;PRRT1;GRIN1;CAMK2B;CAPN1;CACNG3;CACNG8;CAMK2A
prerank,digestive tract development (GO:0048565),-0.6038378955705617,-1.9669554677922396,0.002544529262086514,0.04853796083054003,0.208,12/32,9.91%,FGFR2;CLMP;PKD1;GLI2;GLI3;RARB;PCSK5;KIT;SMO;COBL;NIPBL;SALL1
prerank,chondrocyte differentiation (GO:0002062),-0.6152322852023836,-1.9458836418007759,0.0,0.06030962574957465,0.281,20/32,29.17%,SULF1;NFIB;WNT5B;SOX5;SULF2;BMP4;OSR1;SLC39A14;CREB3L2;GPLD1;TGFB1;BMPR1B;CCN3;SOX6;BMPR2;EIF2AK3;RUNX2;SNX19;BMP2;HMGA2
prerank,cardiac muscle cell contraction (GO:0086003),-0.6748817215407585,-1.927361273002602,0.002325581395348837,0.07393573103256679,0.371,9/19,13.06%,FGF12;CACNA1C;CACNA1D;GSN;ATP1A1;KCNJ2;SCN1A;CAMK2D;CACNA1G
prerank,regulation of potassium ion transport (GO:0043266),-0.5879910733233606,-1.9190697412231215,0.0024330900243309003,0.07600517897495415,0.412,11/31,12.92%,ANK2;DPP6;ANK3;KCNIP4;CACNA1D;FHL1;KCNIP1;KCNIP3;ACTN2;DPP10;DLG1
prerank,regulation of cellular localization (GO:0060341),-0.5445680242771739,-1.9084251761422029,0.0,0.07946680098767483,0.454,20/46,21.05%,MAP2;ADCY5;GSN;EFNA5;DYNC1H1;PARD6G;FER;LRP5;CDK16;CSNK1E;DVL3;BRSK1;CAMK2D;STXBP4;KDM1A;TTL;DVL1;PARP1;PINK1;PPM1F
prerank,cardiac muscle cell action potential (GO:0086001),-0.5936889262113212,-1.9039041629241957,0.0,0.07501321219265276,0.462,9/30,8.73%,ANK2;ATP1A2;FGF12;CACNA1C;CACNA1D;ATP1B1;ATP1A1;KCNJ2;SCN1A
prerank,cellular transition metal ion homeostasis (GO:0046916),0.5479083584441802,1.9035287919276254,0.0,0.10573563224602761,0.572,22/91,12.09%,MT1G;MT1B;MT1X;MT1F;MT1E;MT1M;MT1H;MT1A;CAND1;HMOX2;SOD1;ABCG2;FBXL5;ATP6V0D1;ISCU;ARF1;GLRX3;ATP6AP1;SLC39A10;APP;PRNP;ACO1
prerank,eye morphogenesis (GO:0048592),-0.6779070494108175,-1.902702716479826,0.002188183807439825,0.07054936167229656,0.469,10/19,7.76%,TENM3;FBN1;COL5A1;COL5A2;EFEMP1;FBN2;NKD1;SKI;MFAP5;NIPBL
prerank,extracellular structure organization (GO:0043062),-0.42399859152429525,-1.8837554604857658,0.0,0.0876982834326394,0.567,83/204,21.06%,LAMA2;COL1A2;FBN1;COL4A5;ADAMTS12;ADAMTSL3;ADAMTS2;ITGA9;ADAM12;COL1A1;THSD4;SMOC1;TNR;COL4A6;COL8A1;ITGB8;COL3A1;COL11A1;COL22A1;MMP16;TGFBR1;COL5A1;COL4A3;ADAMTS6;COL5A2;ADAMTSL5;LAMC3;COL4A4;LOXL1;FBN2;NID2;JAM3;ADAMTS17;VCAN;MMP14;ADAMTS9;ATP7A;ITGB5;ADAM19;ADAMTS5;COL6A1;DDR1;HSPG2;ITGA5;COL8A2;MFAP5;SH3PXD2A;COL15A1;COL13A1;SPARC;ADAMTS1;COL6A2;ADAMTSL4;SMOC2;THBS1;VTN;CDH1;ITGA11;FN1;ADAMTS3;SLC39A8;ITGA8;COL23A1;COL6A3;ADAMTS10;SPP1;ITGB4;COL5A3;LAMA1;LAMB1;VIT;ITGA4;TGFBI;ADAMTS15;COL14A1;ADAMTS16;MMP2;LUM;PDGFA;ITGA1;ADAMTS20;COL16A1;COL18A1
prerank,regulation of smooth muscle cell migration (GO:0014910),-0.6617310722092732,-1.8804643864315613,0.0022522522522522522,0.08546551242586782,0.588,15/20,28.00%,IGF1;LRP1;PDGFRB;IGFBP5;NRP1;SORL1;VTN;S100A11;ACE;BMPR1A;PDGFA;NDRG4;SERPINE1;CCN4;TRIB1
prerank,mesonephric tubule development (GO:0072164),-0.7311148441100821,-1.878865855821013,0.0,0.08202539117099013,0.598,8/15,9.91%,ROBO2;FGFR2;PKD1;BMP7;BMP4;OSR1;FOXC1;SALL1
prerank,external encapsulating structure organization (GO:0045229),-0.41747283924819245,-1.8782174233607638,0.0,0.07725155103116473,0.598,82/205,21.06%,LAMA2;COL1A2;FBN1;COL4A5;ADAMTS12;ADAMTSL3;ADAMTS2;ITGA9;ADAM12;COL1A1;THSD4;SMOC1;TNR;COL4A6;COL8A1;ITGB8;COL3A1;COL11A1;COL22A1;MMP16;COL5A1;COL4A3;ADAMTS6;COL5A2;ADAMTSL5;LAMC3;COL4A4;LOXL1;FBN2;NID2;JAM3;ADAMTS17;VCAN;MMP14;ADAMTS9;ATP7A;ITGB5;ADAM19;ADAMTS5;COL6A1;DDR1;HSPG2;ITGA5;COL8A2;MFAP5;SH3PXD2A;COL15A1;COL13A1;SPARC;ADAMTS1;COL6A2;ADAMTSL4;SMOC2;THBS1;VTN;CDH1;ITGA11;FN1;ADAMTS3;SLC39A8;ITGA8;COL23A1;COL6A3;ADAMTS10;SPP1;ITGB4;COL5A3;LAMA1;LAMB1;VIT;ITGA4;TGFBI;ADAMTS15;COL14A1;ADAMTS16;MMP2;LUM;PDGFA;ITGA1;ADAMTS20;COL16A1;COL18A1
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.7713944219422888,-1.8774005593040524,0.0,0.07416812892984023,0.606,6/11,16.23%,DDX5;EGFR;BMP4;MAP2K2;TP53;TGFB1
prerank,regulation of cytoplasmic translation (GO:2000765),-0.7331552551355953,-1.874350765640002,0.0,0.07280694124581004,0.621,6/14,13.90%,CPEB4;CPEB1;CPEB2;YBX3;PKM;UNK
prerank,regulation of SMAD protein signal transduction (GO:0060390),-0.6521991601010181,-1.8678140974207047,0.0,0.07556950572392523,0.654,13/21,27.12%,BMP6;DAB2;TGFBR1;SMAD4;BMP4;NUP93;TGFB1;CCN3;WWTR1;BMPR1A;TGFB3;SLC2A10;SH2B1
prerank,embryonic digestive tract development (GO:0048566),-0.6615214640071562,-1.8676290310619268,0.002304147465437788,0.07196034890574247,0.654,8/18,9.91%,FGFR2;GLI2;GLI3;RARB;PCSK5;PDGFRA;NIPBL;SALL1
prerank,synaptic membrane adhesion (GO:0099560),-0.7284435343264984,-1.8652914336326638,0.0,0.07062998951420775,0.664,7/14,11.23%,LRRC4C;LRFN5;GPC6;NTNG1;PTPRS;PTPRF;LRRC4
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.7595301403382555,-1.859265300057094,0.0,0.07244778085911471,0.69,5/11,9.35%,DAB2;WNT5B;NKD1;CSNK1E;RSPO3
prerank,collagen fibril organization (GO:0030199),-0.4641268277098642,-1.856313906991507,0.0,0.07263516888695576,0.713,42/88,22.17%,COL1A2;COL4A5;ADAMTS2;COL1A1;COL4A6;COL8A1;COL3A1;COL11A1;PLOD2;COL25A1;COL22A1;TGFBR1;COL5A1;PLEC;COL4A3;COL5A2;COL4A4;LOXL1;COL12A1;ATP7A;COL6A1;COL8A2;P4HB;COL15A1;COL13A1;PLOD1;COL6A2;ADAMTS3;LOXL3;COL23A1;COL6A3;ITGB4;COL5A3;P4HA2;COL20A1;COL14A1;LUM;COL16A1;COL18A1;P3H1;LOX;CRTAP
prerank,negative regulation of growth (GO:0045926),0.5031995568804235,1.8511267231854776,0.0,0.21400082507210377,0.834,18/121,5.65%,MT1G;MT1B;MT1X;MT1F;MT1E;MT1M;MT1H;MT1A;CCDC85B;PTPRJ;FRZB;ST7L;RERG;PPT1;ING4;PPP2CA;SMARCA2;CDKN1A
prerank,membrane repolarization (GO:0086009),-0.7129641472905314,-1.8456246237342906,0.0,0.08084956847645185,0.762,6/15,9.45%,ATP1A2;ATP1B1;ATP1B3;ATP1A1;KCNJ2;ATP1B2
prerank,positive regulation of chemotaxis (GO:0050921),-0.5380862976608421,-1.8432555001312667,0.0,0.08005377167678834,0.769,19/43,22.30%,NTRK3;PDGFRB;NRP1;DSCAM;IL6R;P2RX4;F3;STX3;SMOC2;THBS1;LGMN;TGFB1;SEMA5A;MET;HSPB1;PPM1F;PRKD1;P2RY12;VEGFA
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),-0.6329872846696804,-1.8352526531274689,0.002352941176470588,0.0862655887032943,0.807,5/21,8.13%,ANK2;CACNA1D;SNTA1;FLNA;AKAP9
prerank,ureteric bud development (GO:0001657),-0.6878963194522627,-1.8331699873089438,0.002242152466367713,0.08578802379351261,0.817,8/17,9.91%,ROBO2;FGFR2;BMP7;BMP4;OSR1;GPC3;FOXC1;SALL1
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.50811955279026,1.8285534583595384,0.0,0.26781147741131744,0.914,54/110,19.90%,NCBP1;RPL30;RPL17;RPL23;RPL31;SMG8;RPL3;RPS21;PPP2CA;SMG1;RPL35A;RPS14;RPL8;RPL5;RPS12;RPS26;RPL37A;PYM1;RPL4;RPLP0;UPF2;RPS28;RPS24;RPS9;RPS23;RPL24;RPL34;RPS11;RPS3;RPS15A;RPL23A;RPL21;RPL35;DCP1A;UPF3B;RPL19;RPL38;RPL36;SMG6;RPSA;RPL26;RPS8;SMG5;RPL15;RPL10;RPL32;RPS2;EIF4G1;RPL27A;EIF3E;RPL7;RPL39;RPL14;SMG7
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.7825372957701888,1.8195603649839032,0.0019157088122605363,0.2778216385067276,0.942,6/11,14.46%,TNFAIP3;TIRAP;LYN;PJA2;MFHAS1;CYBA
prerank,outflow tract septum morphogenesis (GO:0003148),-0.6171028724532945,-1.8177834532841013,0.0,0.10167170865001822,0.867,11/24,9.78%,ROBO2;FGFR2;ROBO1;PARVA;NRP1;TGFBR2;SMAD4;BMP4;SMAD6;ACVR1;NRP2
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),-0.5708759023632992,-1.816544681163323,0.0026666666666666666,0.09972273909209588,0.872,11/30,13.06%,ANK2;FGF12;CACNA1C;CACNA1D;SNTA1;ATP1A1;GJC1;KCNJ2;SCN1A;GJA1;CACNA1G
prerank,receptor clustering (GO:0043113),-0.5901795796088634,-1.8101444622175968,0.004728132387706856,0.10392391303407099,0.887,10/27,12.92%,MAGI2;DLG2;LRRC7;NRXN1;DLG4;FLNA;NLGN1;DLG3;NRXN2;DLG1
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),-0.7032659557217402,-1.8060639355526542,0.008456659619450317,0.10556005134863881,0.898,10/13,27.12%,BMP6;DAB2;TGFBR1;SMAD4;BMP4;NUP93;TGFB1;BMPR1A;TGFB3;SH2B1
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),-0.5244492516595679,-1.8052240898092726,0.0025974025974025974,0.10300206804155296,0.899,20/43,26.36%,FOXP1;IGF1;PDGFRB;IGFBP5;IL6R;BMP4;ADAMTS1;THBS1;GJA1;IL18;RBPMS2;JUN;BMPR1A;DNMT1;STAT1;MMP2;CX3CL1;AKT1;MEF2D;CCN4
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.6687633042168278,-1.8017603120015417,0.0021141649048625794,0.1042591293949866,0.909,6/16,13.52%,IGF1;IGFBP5;IGFBP2;BMP5;IGFBP6;IGFBP4
prerank,cytoplasmic translation (GO:0002181),0.5123929938089773,1.792318686467091,0.0,0.3693703275303447,0.982,45/91,19.87%,RPL30;RPL17;RPL23;RPL31;RPL3;RPS21;RPL35A;RPS14;RPL8;RPL5;RPS12;RPS26;RPL37A;RPL4;EIF2B3;RPLP0;RPS28;RPS24;RPS9;RPS23;RPL24;RPL34;DRG2;RPS11;RPS3;RPS15A;RPL23A;RPL21;RPL35;EIF3M;RPL19;RPL38;RPL36;RPSA;RPL26;RPS8;RPL15;RPL10;RPL32;RPS2;RPL27A;FTSJ1;RPL7;RPL39;RPL14
prerank,regulation of cation transmembrane transport (GO:1904062),-0.5761469022258483,-1.7914015346428998,0.009876543209876543,0.11593335103983979,0.945,11/29,13.20%,DPP6;FGF12;KCNIP4;CACNA1D;SNTA1;KCNIP1;WNK1;KCNIP3;DPP10;DLG1;WNK3
prerank,bone morphogenesis (GO:0060349),-0.6920884810684066,-1.7850067581856706,0.008316008316008316,0.12152228332855472,0.954,8/14,19.93%,FGFR2;SKI;LRP5;CYP26B1;LRP6;BMPR1B;SFRP4;BMPR2
prerank,aorta development (GO:0035904),-0.694448728437281,-1.7713690198401761,0.002320185614849188,0.1385903015962448,0.971,6/14,5.49%,ROBO2;LRP1;ROBO1;PDGFRB;HECTD1;ADAMTS9
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.7359996956982167,1.7674328488378233,0.003780718336483932,0.46735438545381924,0.997,8/13,14.52%,SAE1;UBA1;UBA2;DESI2;DESI1;NAE1;ATG7;UBA6
prerank,melanocyte differentiation (GO:0030318),-0.7368784108011613,-1.765951309714468,0.002066115702479339,0.14466813969731038,0.978,4/11,5.42%,LRMDA;KIT;USP13;ENPP1
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.5113789409172868,1.7636439127314605,0.0,0.4576885731116567,0.998,43/87,19.87%,RPL30;RPL17;RPL23;RPL31;RPL3;RPS21;RPL35A;RPS14;RPL8;RPL5;RPS12;RPS26;RPL37A;RPL4;RPLP0;RPS28;RPS24;RPS9;RPS23;RPL24;RPL34;RPS11;RPS3;RPS15A;RPL23A;SEC61A2;RPL21;SRP9;RPL35;RPL19;RPL38;RPL36;RPSA;RPL26;RPS8;RPL15;RPL10;RPL32;RPS2;RPL27A;RPL7;RPL39;RPL14
prerank,cellular response to lectin (GO:1990858),0.4863503209984571,1.7569530997774392,0.0,0.4364652622496874,0.999,31/104,14.00%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;MAP3K7;TAB2;SRC;RPS6KA5;NRAS;PSMD11;PSMB4;FYN;PSMC1;EP300;PAK3;SYK;TAB3;RELA;LYN;PSMC2;PAK1;PSMD2;CREBBP;IKBKB;CHUK;PSMD14;PSMC6;PSMD1;PSMB1
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.4863503209984571,1.7569530997774392,0.0,0.4364652622496874,0.999,31/104,14.00%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;MAP3K7;TAB2;SRC;RPS6KA5;NRAS;PSMD11;PSMB4;FYN;PSMC1;EP300;PAK3;SYK;TAB3;RELA;LYN;PSMC2;PAK1;PSMD2;CREBBP;IKBKB;CHUK;PSMD14;PSMC6;PSMD1;PSMB1
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.48578321772361,1.7566323981327099,0.0,0.41378551968433486,0.999,31/105,14.00%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;MAP3K7;TAB2;SRC;RPS6KA5;NRAS;PSMD11;PSMB4;FYN;PSMC1;EP300;PAK3;SYK;TAB3;RELA;LYN;PSMC2;PAK1;PSMD2;CREBBP;IKBKB;CHUK;PSMD14;PSMC6;PSMD1;PSMB1
prerank,respiratory tube development (GO:0030323),-0.5631314842054821,-1.7562210608595228,0.002320185614849188,0.15895142497198267,0.985,12/28,23.37%,FGFR2;GLI2;PCSK5;FGF1;PDPN;BMP4;RBP4;LOXL3;CCDC39;BAG6;VEGFA;STRA6
prerank,cartilage development (GO:0051216),-0.5003733724624283,-1.7513502226739903,0.0,0.16335614247320687,0.989,17/49,17.75%,SULF1;NFIB;PKD1;ITGB8;WNT5B;SOX5;SULF2;BMP4;OSR1;ATP7A;SLC39A14;CREB3L2;DDRGK1;GPLD1;TGFB1;CCN3;SOX6
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.7665719904980832,1.7498765458934264,0.010101010101010102,0.42488629658772664,1.0,1/11,0.19%,RTP3
prerank,peptide biosynthetic process (GO:0043043),0.46923774423592046,1.7459676938877247,0.0,0.4213084328493992,1.0,62/153,19.87%,PCSK1;RPL30;MRPS33;RSL24D1;EEF1A1;RPL17;MRPL23;RPL23;MRPL24;RPL31;RPL3;RPS21;MRPL18;RPL35A;RPS14;RPL8;YARS2;RPL5;ABCF1;MRPS12;RPS12;HBS1L;RPS26;RPL37A;HARS1;RPL4;RPLP0;RPS28;RPS24;RPS9;RPS23;RPL24;RPL34;DMD;RPS11;MRPL52;RPS3;MRPS15;DHPS;RPS15A;RPL23A;RPL21;RPL35;HARS2;WARS1;RPL19;RPL38;RPL36;RPSA;RPL26;RPS8;RPL15;RPL10;RPL32;RPS2;EIF4G1;MRPL13;RPL27A;FURIN;RPL7;RPL39;RPL14
prerank,lung development (GO:0030324),-0.5354872594408736,-1.7422488519908679,0.0023584905660377358,0.17657094239342383,0.995,14/33,23.37%,FGFR2;PKD1;GLI2;ERRFI1;FGF1;PDPN;BMP4;RBP4;LOXL3;RCN3;CCDC39;BAG6;VEGFA;STRA6
prerank,regulation of smoothened signaling pathway (GO:0008589),-0.487723057557322,-1.7346931076888445,0.0025,0.1860025316909407,0.997,29/50,30.73%,FGFR2;ZIC1;GLI3;TULP3;IFT81;GLIS2;MGRN1;SMO;DCDC2;VCP;GPC3;BTRC;GAS1;WDR11;RORA;RACK1;INTU;EVC;HERC4;KCTD6;GLI1;PTCH1;SFRP1;SUFU;DLG5;TTC23;FUZ;PDCL;FBXL17
prerank,protein targeting to ER (GO:0045047),0.49106864481815427,1.734307028059341,0.0,0.45857319658307943,1.0,46/99,19.87%,RPL30;RPL17;RPL23;RPL31;RPL3;RPS21;RPL35A;RPS14;SGTB;RPL8;RPL5;SPCS3;RPS12;RPS26;RPL37A;RPL4;RPLP0;RPS28;RPS24;RPS9;RPS23;RPL24;RPL34;RPS11;SEC62;RPS3;RPS15A;SPCS2;RPL23A;RPL21;SRP9;RPL35;RPL19;RPL38;RPL36;RPSA;RPL26;RPS8;RPL15;RPL10;RPL32;RPS2;RPL27A;RPL7;RPL39;RPL14
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),0.4551032518941133,1.733803928508892,0.0,0.44041949299171834,1.0,87/168,21.53%,NCBP1;RPL30;RPL17;RPL23;PATL2;RPL31;SMG8;RPL3;RPS21;CNOT11;PPP2CA;ZFP36L1;SMG1;RPL35A;RPS14;RPL8;RPL5;CNOT2;RPS12;RPS26;RPL37A;PYM1;RPL4;CNOT7;RPLP0;EXOSC9;UPF2;XRN2;DXO;PATL1;RPS28;RPS24;RPS9;RPS23;RPL24;PAN3;RPL34;RPS11;RPS3;TUT7;PAN2;CNOT6;RPS15A;RPL23A;RPL21;RPL35;CNOT1;DCP1A;CNOT6L;TUT4;NBDY;UPF3B;PARN;CNOT10;LSM1;RPL19;RPL38;RPL36;SMG6;RPSA;RPL26;RPS8;SMG5;RPL15;RPL10;RPL32;RC3H1;RPS2;EIF4G1;DIS3L2;RPL27A;EIF3E;DCP1B;EXOSC7;RPL7;RPL39;RPL14;SMG7;AGO1;RPS27;CNOT8;CNOT4;RPS13;GSPT1;TENT2;MTPAP;RPL22
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.47662139706655693,1.7330178122435738,0.0014084507042253522,0.4248342003744076,1.0,16/107,8.25%,MT1G;MT1B;MT1X;MT1F;MT1E;MT1M;MT1H;MT1A;CXCL12;ATP2A2;SLC10A7;NPTN;HTR2A;ATP13A4;TRPV4;TMEM165
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.7457515458076411,-1.7318586300904528,0.010570824524312896,0.18805100328421295,0.997,4/10,8.13%,DLGAP1;DLGAP2;DLGAP4;AKAP9
prerank,establishment of endothelial barrier (GO:0061028),0.6044141989379074,1.7290843670196356,0.010050251256281407,0.4256871022134631,1.0,12/29,12.23%,PDE4D;PECAM1;MARVELD2;PPP1R16B;ICAM1;RAPGEF3;F11R;RAPGEF6;TJP1;RAB1A;ROBO4;RAP2C
prerank,response to cholesterol (GO:0070723),-0.6331002667564692,-1.7242488548267711,0.006564551422319475,0.20024205798559183,0.998,13/17,31.27%,GRAMD1B;TGFBR1;TGFBR2;SMO;GRAMD1C;GRAMD1A;LRP6;GPLD1;TGFB1;OSBPL7;PTCH1;PMVK;ABCA2
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),-0.4976875016858039,-1.7234394452119035,0.0,0.19756386699576572,0.998,16/44,14.22%,ANK2;KCNMA1;AKAP6;ATP1B1;WNK1;FLNA;ATP1B3;GABBR2;AKAP9;KCNJ2;ATP1B2;ACTN2;WNK4;KCNJ6;WNK3;ANO6
prerank,endodermal cell differentiation (GO:0035987),-0.5502528636991366,-1.720154688452589,0.002551020408163265,0.20092458204270058,0.998,14/31,19.90%,COL8A1;COL11A1;MMP14;COL12A1;ITGB5;COL6A1;ITGA5;CDC73;VTN;FN1;PAF1;LAMB1;ITGA4;MMP2
prerank,translation (GO:0006412),0.44458119079816444,1.7188790939302159,0.0,0.45696005966460274,1.0,80/208,19.87%,RPL30;MRPS2;MRPS33;RSL24D1;EEF1A1;RPL17;MRPL23;RPL23;MRPL24;FASTKD2;RPL31;RPL3;EEF1D;RPS21;MRPL18;FARS2;GARS1;RPL35A;RPS14;RPL8;YARS2;RPL5;IARS1;ABCF1;LARS2;MRPS12;RPS12;HBS1L;RPS26;RPL37A;HARS1;RPL4;RARS2;RPLP0;TSFM;RPS28;RPS24;RPS9;RPS23;RPL24;WARS2;RPL34;GTPBP2;DRG2;RPS11;MRPL52;RPS3;MRPS15;MRPS24;LARS1;DHPS;EEF1B2;RPS15A;RPL23A;RPL21;RPL35;MRPS28;GATB;HARS2;WARS1;MRPS34;RPL19;RPL38;RPL36;RPSA;IARS2;RPL26;RPS8;GFM2;RPL15;RPL10;RPL32;RPS2;EIF4G1;MRPL13;RPL27A;FTSJ1;RPL7;RPL39;RPL14
prerank,positive regulation of kinase activity (GO:0033674),-0.42180633627639685,-1.7187989193151658,0.0,0.19915778063734219,0.998,28/107,10.80%,ERBB4;NTRK3;FGFR2;PRKAG2;EGFR;LMO4;EPHA6;IQGAP1;PDGFRB;EPHB1;NTRK2;RASSF2;AXL;RYK;MAPT;EPHA7;PRKAG1;ROR1;KIT;RELN;DDR1;PDGFRA;RAD50;VAC14;EPHB4;MRE11;EPHB2;EPHA3
prerank,odontogenesis (GO:0042476),-0.5232303042569796,-1.7172031521739113,0.005420054200542005,0.1983788008215045,0.998,8/35,8.19%,FGFR2;COL1A2;EDA;GLI2;HDAC1;BMP4;OSR1;FOXC1
prerank,positive regulation of bone mineralization (GO:0030501),-0.5270094662283238,-1.7171101251836098,0.007334963325183374,0.1943164584993955,0.998,18/35,21.82%,BMP6;GPM6B;NELL1;BMP7;ADGRV1;BMP4;FBN2;OSR1;WNT4;ACVR1;KL;ANO6;TGFB1;BMPR1B;BMPR1A;BMPR2;CCN1;PKDCC
prerank,positive regulation of telomerase activity (GO:0051973),0.584043510673118,1.7157806197784335,0.0049586776859504135,0.4541300651202778,1.0,16/33,20.74%,MAP2K7;MAPK3;PNKP;GREM1;CCT2;MAP3K4;ACD;NEK7;TNKS;TCP1;DKC1;PARN;PARM1;NVL;PTGES3;HSP90AB1
prerank,regulation of cation channel activity (GO:2001257),-0.4304699048420573,-1.7144305148733217,0.0,0.1956722540553427,0.999,39/89,24.99%,DLG2;ANK2;ANK3;LRRC7;FGF12;GRIA4;GRIA2;AHNAK;CACNB4;GRIN2B;FGF14;SHISA9;DLG4;NLGN2;RELN;SHISA6;NLGN1;DLG3;PRKACA;ACTN2;CAMK2D;CACNG7;DLG1;VAMP2;NEFL;CACNG4;OPRM1;CACNG2;DAPK1;SELENON;SHANK1;PRRT1;GRIN1;CAMK2B;CAPN1;CACNG3;CACNG8;CACNB1;CAMK2A
prerank,actin filament polymerization (GO:0030041),-0.546113111033704,-1.7120711438098655,0.009708737864077669,0.196477150282879,0.999,10/29,7.49%,GSN;GAS7;SPIRE1;WASL;PSTPIP2;ARHGAP6;WASHC5;WASHC3;WASF1;COBL
prerank,positive regulation of gene silencing by miRNA (GO:2000637),-0.5407067577055081,-1.7093781804464323,0.0069124423963133645,0.19818007354156655,0.999,9/27,11.96%,DDX5;EGFR;PUM1;BMP4;PUM2;EIF4E2;MAP2K2;TP53;LIMD1
prerank,regulation of kinase activity (GO:0043549),-0.42887257963923914,-1.707437266239533,0.0,0.19847163500609458,0.999,27/89,10.80%,ERBB4;NTRK3;FGFR2;EGFR;LMO4;EPHA6;PDGFRB;EPHB1;NTRK2;AXL;RYK;MAPT;RBL2;EPHA7;PLCE1;ROR1;KIT;DDR1;PDGFRA;LDB1;RAD50;VAC14;CDKN1B;EPHB4;MRE11;EPHB2;EPHA3
prerank,positive regulation of immune effector process (GO:0002699),0.6010245418627469,1.7048735321859612,0.0068143100511073255,0.49441104723908097,1.0,3/27,2.03%,PCK1;PTPRJ;PTPRC
prerank,modified amino acid transport (GO:0072337),-0.6369510492153204,-1.7031384203414985,0.008421052631578947,0.20360812002631096,0.999,7/15,17.61%,SLC16A12;SLC6A13;PDPN;SLC25A32;CTNS;SLC19A1;SLC5A6
prerank,neurotransmitter uptake (GO:0001504),-0.7007059961973015,-1.7027214882431194,0.006072874493927126,0.2006319328387266,0.999,4/12,6.01%,ATP1A2;SNAP25;SLC1A3;GLUL
prerank,extracellular matrix organization (GO:0030198),-0.3688949326447626,-1.701668516765204,0.0,0.19891328387720675,0.999,107/276,22.40%,LAMA2;COL1A2;FBN1;COL4A5;ADAMTS12;ADAMTSL3;ADAMTS2;ITGA9;ADAM12;COL1A1;GSN;THSD4;SMOC1;TNR;GPM6B;COL4A6;COL8A1;TIMP2;ITGB8;COL3A1;CAPN2;COL11A1;PLOD2;COL25A1;COL22A1;MMP16;FLRT2;TGFBR1;COL5A1;PLEC;COL4A3;ADAMTS6;COL5A2;ADAMTSL5;LAMC3;COL4A4;LOXL1;FBN2;NID2;JAM3;ADAMTS17;VCAN;MMP14;ADAMTS9;COL12A1;ATP7A;ITGB5;ADAM19;ADAMTS5;COL6A1;DDR1;HSPG2;ITGA5;COL8A2;MFAP5;SH3PXD2A;P4HB;COL15A1;COL13A1;SPARC;ADAMTS1;PLOD1;COL6A2;ADAMTSL4;SMOC2;THBS1;VTN;CDH1;ITGA11;FN1;ADAMTS3;LOXL3;SCUBE1;SLC39A8;ITGA8;COL23A1;COL6A3;ADAMTS10;SPP1;QSOX1;ITGB4;COL5A3;TGFB1;LAMA1;LAMB1;VIT;P4HA2;ITGA4;TGFBI;ADAMTS15;COL20A1;COL14A1;ADAMTS16;MMP2;LUM;FLOT1;PDGFA;ITGA1;ADAMTS20;COL16A1;COL18A1;P3H1;SH3PXD2B;LOX;CRTAP;CAPN1;KLK2
prerank,negative regulation of transferase activity (GO:0051348),0.585592091179384,1.701617507573054,0.010309278350515464,0.4938930895964996,1.0,9/28,9.76%,PHPT1;CERS1;GSK3A;SRC;ERCC4;FBXO5;SMAD7;IRS2;PARK7
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.7520483475610112,1.7012150807080921,0.00945179584120983,0.4785893726961017,1.0,2/10,6.32%,SAG;GNB1
prerank,regulation of heart rate by cardiac conduction (GO:0086091),-0.5117536640008654,-1.6952902193262542,0.005319148936170213,0.20914862191764255,0.999,9/38,13.06%,ANK2;CTNNA3;CACNA1C;CACNA1D;AKAP9;KCNJ2;BIN1;CAMK2D;CACNA1G
prerank,regulation of hippo signaling (GO:0035330),-0.6206115585502189,-1.690649840982192,0.00646551724137931,0.21415320621030595,0.999,9/17,16.86%,WWC2;MAPK14;MOB3B;SCHIP1;CIT;VGLL4;LIMD1;NF2;SHANK2
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),-0.6393413953137156,-1.688904244275995,0.004395604395604396,0.21417813109065478,0.999,5/16,1.32%,ERBB4;FGFR2;TGFBR3;IGF1;AKAP6
prerank,heart development (GO:0007507),-0.39027952029543184,-1.687483704637944,0.0,0.21347519390901284,0.999,41/150,14.43%,ERBB4;NTRK3;TGFBR3;FGF12;CACNA1C;FBN1;AKAP13;PDLIM5;PKD1;MICAL2;GLI2;ADAP2;COL3A1;PCSK5;FLRT2;CXADR;TGFBR1;NCOA6;TGFBR2;BMP5;BMP7;PLCE1;PDLIM7;BMP4;OSR1;GPC3;NIPBL;CDKN1B;EPHB4;RBP4;FOXC1;ACVR1;SALL1;FN1;FOXC2;SCUBE1;MTHFD1;WDR11;PDLIM1;TCF25;PTK2
prerank,positive regulation of cell projection organization (GO:0031346),-0.40780533575729044,-1.6864474357820611,0.0,0.21196790878980407,0.999,44/115,18.67%,MAGI2;NTRK3;ROBO2;TENM3;LRRC7;PLXNA2;ROBO1;CUX1;DPYSL3;NTRK2;TIAM2;DLG4;TOX;PTK7;RHOA;ROR1;RELN;CBFA2T2;PLPPR5;STMN2;ARSB;ATP1B2;DVL3;EPHA3;CUX2;RIT2;GRIP1;IL1RAPL1;OBSL1;PLXND1;CAMK1;ROR2;SETX;ARHGDIA;PLXNB2;NGF;PLXNC1;RAPGEF2;ABL2;FZD4;DVL1;TWF2;SCARF1;SNX3
prerank,regulation of muscle contraction (GO:0006937),-0.5554577643987023,-1.6856975179433897,0.007246376811594203,0.21001041458856223,0.999,7/26,12.21%,ATP1A2;KCNB2;CHRM2;TPM1;PLCE1;KCNA1;SRI
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.6490973966916839,1.6841102690724288,0.0070921985815602835,0.55172751723554,1.0,3/19,6.50%,SLC5A7;APOE;RIC3
prerank,regulation of synapse assembly (GO:0051963),-0.4802361164552317,-1.6812262294226665,0.004842615012106538,0.21581732471313636,0.999,15/46,12.29%,ROBO2;LRFN5;GPC6;PDLIM5;NRXN1;GRID2;EPHB1;NLGN2;IL1RAPL2;SYNDIG1;CLSTN2;NLGN1;EPHB2;CUX2;IL1RAPL1
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),-0.5978478672498575,-1.6799075835406008,0.0069767441860465115,0.21522258600828598,0.999,8/20,9.45%,ATP1A2;KCNMA1;ATP1B1;ATP1B3;SLC12A2;ATP1A1;KCNJ2;ATP1B2
prerank,glutamate metabolic process (GO:0006536),0.6363272784271983,1.6798479993922584,0.012280701754385965,0.5597509570005403,1.0,7/19,6.17%,GCLC;ALDH5A1;GLS2;GLS;GOT2;GCLM;MTHFS
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.6576380159179105,1.678408229667704,0.007326007326007326,0.5499707374126964,1.0,6/18,6.71%,LRP8;RPS6KA4;CAMK1D;PRKD2;RPS6KA5;EPHA5
prerank,cotranslational protein targeting to membrane (GO:0006613),0.48534772961604994,1.6763666584511507,0.0014903129657228018,0.5439015167209754,1.0,43/91,19.87%,RPL30;RPL17;RPL23;RPL31;RPL3;RPS21;RPL35A;RPS14;RPL8;RPL5;RPS12;RPS26;RPL37A;RPL4;RPLP0;RPS28;RPS24;RPS9;RPS23;RPL24;RPL34;RPS11;SEC62;RPS3;RPS15A;RPL23A;RPL21;SRP9;RPL35;RPL19;RPL38;RPL36;RPSA;RPL26;RPS8;RPL15;RPL10;RPL32;RPS2;RPL27A;RPL7;RPL39;RPL14
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.6185484910555813,-1.676259421962588,0.002325581395348837,0.21949670150293266,1.0,4/17,1.33%,ANK2;ATP1A2;CACNA1C;CACNA1D
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.4949473877963357,1.6748082356762597,0.0,0.5360466224021382,1.0,27/74,14.75%,PSMB10;PSMC4;PSMB6;ELOC;PSMD8;PSMD5;PSMD12;STOX1;PSMD11;PSMB4;PSMC1;EP300;NOTCH1;PSMC2;PSMD2;CITED2;RBPJ;CREBBP;HIGD1A;ELOB;EGLN2;PSMD14;EPAS1;PSMC6;PSMD1;PSMB1;BACH1
prerank,neuron projection morphogenesis (GO:0048812),-0.39386655844859325,-1.6742532837897972,0.0,0.22051342634210994,1.0,38/137,11.06%,MAP2;FGFR2;CNTN4;DCLK1;ALCAM;ANK3;DCC;MAP1B;EPB41L3;CTNNA2;IQGAP1;NRCAM;GAS7;EPHB1;NBL1;NTNG1;SDC2;WASL;DLG4;RYK;CTNNB1;BMP7;GPM6A;ATP7A;DCDC2;MYO16;CTNND2;TAOK3;SHTN1;ROCK1;CTTN;DOCK10;NLGN1;BRSK1;SGK1;BTBD3;EPHB2;PLPPR4
prerank,respiratory system development (GO:0060541),-0.5218621867617117,-1.6731755939386705,0.004608294930875576,0.21942989339528843,1.0,13/32,24.63%,FGFR2;GLI2;FGF1;PDPN;BMP4;RBP4;LOXL3;SMCHD1;CCDC39;BAG6;VEGFA;STRA6;BASP1
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.5545440381082853,-1.6726347326293438,0.0048543689320388345,0.2174689338426278,1.0,12/26,14.04%,ANK2;CACNA1D;ATP1B1;FHL1;ATP1B3;WWP2;CAB39;AKAP9;ATP1B2;ACTN2;DLG1;VAMP2
prerank,regulation of B cell activation (GO:0050864),0.6141341646864438,1.6716931702436986,0.012259194395796848,0.5373827405518822,1.0,4/25,5.32%,TNFAIP3;FCGR2B;ZFP36L1;SAMSN1
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.6475375614042223,1.6704195469148455,0.003669724770642202,0.5286275700185371,1.0,8/18,12.07%,HRH4;GNAQ;RGS8;GNB1;RGS10;GNA11;PLCB1;AGRN
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.6203902280313425,1.6702880196070693,0.012237762237762238,0.514906413034328,1.0,4/22,2.51%,PHPT1;PTPRJ;SH2D1A;FCGR2B
prerank,potassium ion transport (GO:0006813),-0.3951785445945745,-1.6668443472970176,0.0,0.22695314653732668,1.0,23/120,12.75%,ATP1A2;KCNK2;SLC24A3;KCNQ3;KCNB2;HCN1;NALCN;KCNH7;KCNQ5;KCNMA1;SLC1A3;KCNC2;KCND2;ATP1B3;KCNH5;KCNK5;KCNJ2;KCNA1;SLC24A2;KCNK10;KCNJ6;SLC9A2;ABCC9
prerank,positive regulation of telomere capping (GO:1904355),0.6680857971948837,1.6643701251655172,0.0149812734082397,0.5310479600893414,1.0,6/17,11.69%,MAP2K7;MAPK3;PNKP;MAP3K4;NEK7;TNKS
prerank,regulation of cell communication (GO:0010646),-0.49943476090488875,-1.6643410793297952,0.005115089514066497,0.22952058997387143,1.0,16/35,25.33%,ANK2;CXADR;IGFBP7;SCG5;GRK5;GRK3;SOCS2;CAMK2D;ANXA1;SRI;GRK4;MTCH1;TBX18;GRK2;TSPYL2;GLRX2
prerank,regulation of telomerase activity (GO:0051972),0.5262071779762748,1.660700756012043,0.006289308176100629,0.5368116714029094,1.0,17/45,18.05%,MAP2K7;CERS1;MAPK3;PNKP;GREM1;SRC;CCT2;ERCC4;MAP3K4;ACD;NEK7;TNKS;TCP1;DKC1;PARN;SMG6;PARM1
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.6474529894835893,-1.6547813992990446,0.013015184381778741,0.24817249740266148,1.0,6/14,8.52%,KMT2A;AUTS2;CTNNB1;SMAD4;PAXIP1;SNW1
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.6255746258776708,-1.6518421700653996,0.021834061135371178,0.25095699695711576,1.0,7/15,15.55%,COL11A1;ADGRV1;KIT;PIEZO2;SCN1A;KCNA1;WHRN
prerank,positive regulation of histone methylation (GO:0031062),-0.5504864910342191,-1.6516828615183465,0.011389521640091117,0.24794181218830447,1.0,14/24,22.05%,OGT;KMT2A;AUTS2;CTNNB1;SMAD4;JARID2;TET1;PAXIP1;SNW1;MTF2;PAF1;RIF1;DNMT1;PHF1
prerank,central nervous system neuron differentiation (GO:0021953),-0.5043813163941935,-1.6477443010206483,0.0075,0.2532973355734553,1.0,9/33,5.67%,MAP2;GRID2;SPOCK1;NTRK2;TOX;RYK;MAPT;CTNNB1;ATP7A
prerank,connective tissue development (GO:0061448),-0.4970551683784035,-1.6450755619931015,0.007936507936507936,0.25602172676925955,1.0,11/35,13.84%,SULF1;PKD1;ITGB8;SOX5;SULF2;ATP7A;CREB3L2;SLC39A13;LRP5;DDRGK1;PGRMC2
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.47210723723906023,1.6437453472039116,0.0,0.6128164052437115,1.0,28/86,14.94%,ATF3;PSMB10;PSMC4;PSMB6;ELOC;PSMD8;PSMD5;PSMD12;KLF2;STOX1;PSMD11;PSMB4;PSMC1;EP300;PSMC2;PSMD2;CREBBP;HIGD1A;ELOB;EGLN2;PSMD14;EPAS1;DDIT3;PSMC6;PSMD1;PSMB1;BACH1;INO80
prerank,mesenchyme development (GO:0060485),-0.6185593339755113,-1.643012050229089,0.008714596949891068,0.25777043570377023,1.0,4/15,4.74%,FGFR2;TGFBR1;BMP7;BMP4
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),-0.5115312971139345,-1.641063122455172,0.004842615012106538,0.25876020611678957,1.0,8/29,10.53%,PKD1;IFNAR2;FER;STAT2;GHR;IL31RA;STAT6;SOCS2
prerank,positive regulation of biomineral tissue development (GO:0070169),-0.4854870044984616,-1.6406908803584586,0.01485148514851485,0.2561033451251991,1.0,19/40,21.82%,BMP6;GPM6B;NELL1;BMP7;ADGRV1;BMP4;FBN2;OSR1;WNT4;ACVR1;KL;ANO6;TGFB1;BMPR1B;BMPR1A;BMPR2;CEBPB;CCN1;PKDCC
prerank,ribosome assembly (GO:0042255),0.5239301207103163,1.6356622822946363,0.0110062893081761,0.6454229346933329,1.0,19/47,18.32%,MRPS2;MTERF3;RSL24D1;EIF2A;RPL3;RPS14;RPL5;MRPL20;RPLP0;RPS28;RRP7A;RPL24;DDX3X;EFL1;RPL23A;NPM1;EIF6;RPSA;RPL10
prerank,chordate embryonic development (GO:0043009),-0.4453930042605563,-1.6354365640987845,0.010810810810810811,0.2654826748468267,1.0,12/55,4.70%,FGFR2;SULF1;ARNT2;ALDH1A2;COL1A1;PKD1;PCSK5;TGFBR1;BMP5;BMP7;SULF2;FUT8
prerank,positive regulation of smooth muscle cell migration (GO:0014911),-0.6023662702363702,-1.634900915014972,0.011312217194570135,0.26336523227215597,1.0,7/17,9.69%,IGF1;DOCK5;PDGFRB;IGFBP5;NRP1;ADAMTS1;VTN
prerank,cAMP biosynthetic process (GO:0006171),-0.70331442882346,-1.6298908798937484,0.02032520325203252,0.2715586029490039,1.0,8/10,22.64%,ADCY5;ADCY2;ADCY1;ADCY9;ADCY7;ADCY3;ADCY8;ADCY4
prerank,renal system development (GO:0072001),-0.44586109732743306,-1.6262535537049247,0.005847953216374269,0.2771248604869707,1.0,25/52,24.84%,SULF1;GREB1L;PKD1;GLI2;PCSK5;TGFBR1;SULF2;BMP4;WNT4;RBP4;FOXC1;PYGO1;SALL1;ITGA8;ACE;TBX18;PYGO2;SIX1;STAT1;AGTR1;BAG6;VEGFA;STRA6;IFT88;PAX2
prerank,"phototransduction, visible light (GO:0007603)",0.6660433075699949,1.6255986229878712,0.020522388059701493,0.6913939523707441,1.0,4/14,8.84%,SAG;GNAQ;GNB1;GNA11
prerank,myotube cell development (GO:0014904),-0.702200420808872,-1.6235013873507131,0.02032520325203252,0.2810824226315362,1.0,5/10,18.72%,IGF1;SKI;CAV2;SELENON;SIX1
prerank,sulfation (GO:0051923),-0.6646043664220401,-1.6234828878287941,0.010460251046025104,0.2777638868038525,1.0,2/11,1.14%,UST;HS3ST5
prerank,heterotypic cell-cell adhesion (GO:0034113),-0.5271558565058275,-1.6226675760890992,0.018518518518518517,0.2765266218080987,1.0,5/25,6.53%,CTNNA3;PARVA;CXADR;JAM3;ITGA5
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.451376119178626,1.6226112653784877,0.00425531914893617,0.6937819920200018,1.0,31/94,14.28%,PSMB10;PSMC4;PSMB6;MAPK3;PSMD8;PSMD5;PSMD12;IL1R1;MAP3K7;TAB2;RPS6KA4;RPS6KA5;PSMD11;PSMB4;PSMC1;TAB3;RELA;PSMC2;PLCB1;PSMD2;UBE2V1;NOD1;TNIP2;IKBKB;CHUK;PSMD14;PSMC6;PSMD1;NFKBIA;PSMB1;MAP3K3
prerank,peptidyl-methionine modification (GO:0018206),0.6995968816850938,1.62187960549334,0.028901734104046242,0.6823190716612297,1.0,4/12,16.28%,NAA25;METAP2;METAP1;NAA15
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.4494772484047815,1.620537246895307,0.0,0.6759188234736015,1.0,33/109,14.00%,PSMB10;PSMC4;MAP2K7;PSMB6;MAPK3;PSMD8;PSMD5;PSMD12;MAP3K7;VAV3;TAB2;PPP3CB;PSMD11;PSMB4;PSMC1;MAPK8;SYK;LCP2;TAB3;PLCG1;RELA;LYN;PSMC2;PAK1;PSMD2;PPP3CA;PPP3R1;IKBKB;CHUK;PSMD14;PSMC6;PSMD1;PSMB1
prerank,regulation of potassium ion transmembrane transport (GO:1901379),-0.45266916355885245,-1.6194655839908074,0.005714285714285714,0.2812014557008714,1.0,17/54,12.92%,DPP6;KCNIP4;KCNMA1;AKAP6;CACNA1D;FHL1;KCNIP1;FLNA;KCNIP3;WWP2;CAB39;GABBR2;KCNJ2;BIN1;DPP10;KCNJ6;DLG1
prerank,negative regulation of protein catabolic process (GO:0042177),-0.4850360347343621,-1.617783706978926,0.009876543209876543,0.2821449448386394,1.0,13/40,9.26%,SNRNP70;EGFR;TIMP3;TIMP2;NELL1;FLNA;SIRT2;FMN2;ROCK1;PTPN3;IRAK3;BANP;AZIN1
prerank,membrane assembly (GO:0071709),-0.4899193437841384,-1.6161194092337867,0.0125,0.2833911094521933,1.0,12/34,12.29%,ANK3;NRXN1;ANXA2;NLGN2;UBXN2A;FLOT2;NLGN1;UBXN2B;TLCD2;NSFL1C;NRXN2;IL1RAPL1
prerank,nuclear migration (GO:0007097),-0.6405793511238818,-1.616041043404897,0.01511879049676026,0.28031185465903574,1.0,6/13,5.77%,SYNE2;CLMN;DYNC1H1;SYNE3;FBXW11;CEP120
prerank,regulation of protein metabolic process (GO:0051246),0.5235496922477887,1.6139403210965797,0.004709576138147566,0.6998480266372813,1.0,18/44,16.45%,KLF2;MAP2K5;SPOP;LTBP4;NEDD4L;APOE;WFS1;TMEM9;MAPK8;TRAF3;MDM2;SPOPL;APP;CHEK2;FAF1;VPS35;ODC1;FKBP1A
prerank,camera-type eye development (GO:0043010),-0.5323055940069831,-1.6125881237179802,0.00980392156862745,0.2857994275817583,1.0,6/25,6.85%,TENM3;CACNA1C;FBN1;EFEMP1;FBN2;SKI
prerank,ventricular cardiac muscle tissue development (GO:0003229),-0.5392198004757034,-1.6108770545447681,0.0182648401826484,0.2867753163799219,1.0,4/23,5.49%,FGFR2;TGFBR3;TPM1;ADAMTS9
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.5259707224183625,-1.6088107435577266,0.016241299303944315,0.2884492055081466,1.0,10/24,17.35%,CTNNA2;BOC;CDON;CTNNA1;MAPK14;CTNNB1;RBM4;CAMK1;OLFM2;CDC42
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.6369604434253844,-1.6075202045961237,0.018711018711018712,0.2883199043369211,1.0,7/12,13.20%,ANK3;ATP1B1;WNK1;ATP1B3;ATP1B2;WNK4;WNK3
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),-0.3718244361776349,-1.607022436448205,0.0,0.28651840544279267,1.0,36/159,12.31%,LRRC4C;TENM2;ROBO2;LRFN5;CNTN4;TENM3;ALCAM;SDK1;GPC6;ROBO1;CDH10;UNC5D;CNTN6;GRID2;KIRREL3;PKD1;NTNG1;CXADR;PTPRS;TGFBR2;DSCAM;CLDN11;IGSF11;PALLD;CDH11;SDK2;CDH7;NLGN1;ACVR1;MPZL2;CDH1;PTPRF;LRRC4;CDH4;IL1RAPL1;OBSL1
prerank,positive regulation of Rho protein signal transduction (GO:0035025),-0.5110836488567697,-1.6066675152815073,0.012285012285012284,0.28456310188058065,1.0,6/30,12.54%,LPAR1;ROBO1;AKAP13;COL3A1;PRAG1;GPR4
prerank,cellular sodium ion homeostasis (GO:0006883),-0.6228904233123207,-1.6064931013438262,0.01978021978021978,0.2819241607408135,1.0,6/15,9.45%,ATP1A2;ATP1B1;ATP1B3;SLC12A2;ATP1A1;ATP1B2
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.709124041427582,1.6050967885528236,0.026156941649899398,0.739169893752898,1.0,6/10,10.32%,DIP2A;DIP2B;SIRT1;SETD5;PARK7;PRKAA2
prerank,regulation of nucleocytoplasmic transport (GO:0046822),-0.6482954383951194,-1.6036853916694285,0.019867549668874173,0.28556029959556567,1.0,9/12,22.51%,KHDRBS1;PTPN14;BMP4;RBM4;SIRT7;TGFB1;AAAS;NEDD4;NUP214
prerank,Fc receptor signaling pathway (GO:0038093),0.44368935395886433,1.6025513323733824,0.0,0.7398395545511374,1.0,33/110,14.00%,PSMB10;PSMC4;MAP2K7;PSMB6;MAPK3;PSMD8;PSMD5;PSMD12;MAP3K7;VAV3;TAB2;PPP3CB;PSMD11;PSMB4;PSMC1;MAPK8;SYK;LCP2;TAB3;PLCG1;RELA;LYN;PSMC2;PAK1;PSMD2;PPP3CA;PPP3R1;IKBKB;CHUK;PSMD14;PSMC6;PSMD1;PSMB1
prerank,acyl-CoA biosynthetic process (GO:0071616),0.6310464040016723,1.6013626630864048,0.026929982046678635,0.7322303523960823,1.0,5/16,5.63%,SLC25A1;DIP2A;MLYCD;PPT1;ACAT1
prerank,regulation of biosynthetic process (GO:0009889),0.7012362545125989,1.600348180041966,0.017077798861480076,0.723814535320472,1.0,2/11,7.38%,PCK1;PIKFYVE
prerank,retina homeostasis (GO:0001895),0.5851132825492653,1.5989017978237474,0.014625228519195612,0.717978571226474,1.0,5/23,5.45%,SOD1;POC1B;POTEF;ACTB;B2M
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.6653785577336725,1.5982436623916878,0.033268101761252444,0.7080590310405319,1.0,6/13,16.29%,PTPRC;PTPRT;MGAT5;DOT1L;HES1;PIGU
prerank,cellular response to steroid hormone stimulus (GO:0071383),-0.5811834464228047,-1.5966341715919496,0.02832244008714597,0.30018826122862874,1.0,6/17,7.60%,ATP1A2;TFPI;BMP7;MED1;BMP4;ATP1A1
prerank,potassium ion transmembrane transport (GO:0071805),-0.3706863507889475,-1.5942611588267488,0.0,0.3032413134280084,1.0,36/135,19.95%,ATP1A2;KCNK2;SLC24A3;KCNQ3;KCNB2;HCN1;NALCN;KCNH7;KCNQ5;SLC1A3;KCNC2;KCND2;ATP1B1;ATP1B3;SLC12A2;KCNH5;ATP1A1;KCNK5;KCNJ2;KCNA1;ATP1B2;SLC24A2;KCNK10;KCNJ6;SLC9A2;ABCC9;SLC12A6;KCNJ13;KCNS3;SLC12A4;KCNQ4;ATP1A3;SLC12A9;KCNJ10;KCNA6;KCNA2
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.722202164030503,1.594116253290768,0.02404809619238477,0.719905304672507,1.0,4/10,4.52%,INSIG1;DERL2;SVIP;YOD1
prerank,protein import into mitochondrial matrix (GO:0030150),0.6091521972148594,1.5931633708651922,0.018148820326678767,0.7122062131812574,1.0,6/18,9.74%,TOMM20;ROMO1;TIMM17B;GRPEL2;TOMM40L;TIMM21
prerank,regulation of smooth muscle cell proliferation (GO:0048660),-0.4529328268181164,-1.5930221120092465,0.010666666666666666,0.30321117979012235,1.0,19/46,28.00%,FOXP1;IGF1;PDGFRB;IGFBP5;CTNNB1;IL6R;BMP4;OGN;THBS1;IL18;TCF7L2;RBPMS2;APOD;STAT1;CX3CL1;AKT1;NDRG4;CCN4;TRIB1
prerank,regulation of intracellular pH (GO:0051453),0.5487587479193097,1.5925443143132114,0.006700167504187605,0.7030320335308778,1.0,9/34,8.25%,SLC4A4;SLC4A5;SLC9A7;CA2;GPR89B;GPR89A;SLC9A6;SLC9A8;TMEM165
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.5585425978197194,-1.5908034125526194,0.016666666666666666,0.30600362329188596,1.0,6/19,12.92%,DLG2;LRRC7;PARD3B;CLIC4;DLG3;DLG1
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),-0.5664803880055879,-1.5901683359592858,0.01939655172413793,0.3045161912847626,1.0,6/19,7.87%,ERBB4;FGFR2;TGFBR3;TGFBR1;VGLL4;RBP4
prerank,dermatan sulfate biosynthetic process (GO:0030208),-0.6400269512737833,-1.5899248132968278,0.02553191489361702,0.3020508670562607,1.0,9/12,28.53%,UST;DSE;VCAN;CSPG4;DSEL;BGN;DCN;CSPG5;CHST12
prerank,T cell proliferation (GO:0042098),0.6609056124416361,1.5894780176939507,0.045283018867924525,0.7092598773818295,1.0,3/13,2.55%,CADM1;PIK3CG;PPP3CB
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.626184978692361,1.5892972219841237,0.03272727272727273,0.69809481540505,1.0,3/17,2.14%,PHPT1;PTPRJ;SH2D1A
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.5437565925748775,-1.5871654026742674,0.015555555555555555,0.30665821177696345,1.0,12/22,26.46%,KAT7;ERCC6;ELL;DDX39B;CDC73;BRD4;CCNT1;THOC5;CCNK;CDK12;THOC1;SUPT4H1
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),0.6021366495269828,1.5851704605687158,0.026881720430107527,0.7104262166443542,1.0,7/19,15.11%,KLF2;MAP2K5;PAX8;WFS1;MAPK8;APP;SLCO1C1
prerank,neural tube development (GO:0021915),-0.5909268878749451,-1.5848674231152127,0.02826086956521739,0.3102109701470627,1.0,6/15,17.28%,ALDH1A2;PKD1;ARL13B;DACT1;TGFB1;DVL1
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.5908439078209053,1.5834445828261343,0.029357798165137616,0.7090658423232922,1.0,7/20,10.32%,MAPK3;DIP2A;RUVBL2;RPS6KA4;RPS6KA5;DIP2B;PRKAA2
prerank,negative regulation of smoothened signaling pathway (GO:0045879),-0.5336505278284158,-1.5772817758012896,0.01805869074492099,0.32758554649572885,1.0,14/23,26.14%,GLI3;TULP3;GLIS2;MGRN1;ENPP1;VCP;GPC3;BTRC;RACK1;HERC4;KCTD6;PTCH1;GPR161;SUFU
prerank,metanephros development (GO:0001656),-0.5150192953381278,-1.5767223726369155,0.024752475247524754,0.3261457056509323,1.0,7/26,7.76%,ROBO2;PKD1;FOXD1;BMP7;BMP4;OSR1;NIPBL
prerank,Rap protein signal transduction (GO:0032486),0.6866178540066992,1.5750948662477053,0.024242424242424242,0.7469387663190434,1.0,4/10,12.23%,RAP2A;PLK2;RAPGEF3;RAP2C
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.7052734893300865,1.5745259155466427,0.03225806451612903,0.7377840792388168,1.0,2/10,2.51%,PTPRC;FCGR2B
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),-0.5173090608702016,-1.5706936894512142,0.0076726342710997444,0.3394386932587385,1.0,12/25,14.18%,ANK2;ANK3;ATP1B1;WNK1;ATP1B3;SLC6A9;AKAP9;ATP1B2;ACTN2;WNK4;WNK3;NDUFA4
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),-0.5204227919800961,-1.5684396589374507,0.02823529411764706,0.3425981520379569,1.0,13/25,26.46%,ELL;LDB1;CDC73;RNF168;RNF8;BRD4;NELFB;WDR43;EAF1;NELFA;CDK12;LARP7;SUPT4H1
prerank,regulation of keratinocyte proliferation (GO:0010837),-0.5413432452091679,-1.5676444739506867,0.02823529411764706,0.3418679673432446,1.0,6/22,5.85%,FGFR2;NOTCH2;MED1;KLF9;SRSF6;EPB41L4B
prerank,pyrimidine nucleobase metabolic process (GO:0006206),-0.6285879848480902,-1.5635023907540309,0.031914893617021274,0.3497709080145786,1.0,4/12,10.13%,DPYD;DPYSL3;CTPS1;ALDH6A1
prerank,membrane depolarization during action potential (GO:0086010),-0.4945854965877071,-1.5627610750519942,0.01639344262295082,0.3487553669984015,1.0,7/26,8.73%,ATP1A2;CACNA1C;CACNA1D;SCN8A;SCN3A;KCNJ2;SCN1A
prerank,muscle contraction (GO:0006936),-0.37406855063280336,-1.5620921343484477,0.0,0.3476370188803607,1.0,20/126,10.09%,SORBS1;CALD1;GNAO1;PABPN1;TMOD2;SNTA1;TPM1;VIM;TLN1;PXN;ROCK2;VCL;ITGB5;EDNRA;ROCK1;GLRA1;GJC1;SMTN;MYOF;ACTN2
prerank,positive regulation of tissue remodeling (GO:0034105),-0.6687946028558336,-1.5611129686324514,0.017578125,0.3472576934249975,1.0,4/10,17.90%,ROCK2;ROCK1;IL18;TMBIM1
prerank,oligosaccharide biosynthetic process (GO:0009312),-0.5443594110144296,-1.5610071990116245,0.011682242990654205,0.3444195082679527,1.0,8/20,17.89%,B4GALT1;FUT8;ST6GALNAC5;B3GALT5;ST3GAL4;B3GALT1;ST6GALNAC6;MPDU1
prerank,regulation of phospholipase C activity (GO:1900274),-0.5946515917658683,-1.5599079467497052,0.024553571428571428,0.34457535186170024,1.0,5/15,6.19%,NTRK3;BICD1;PDGFRB;KIT;PDGFRA
prerank,cellular response to metal ion (GO:0071248),0.4255363534021375,1.5598137384905162,0.00535475234270415,0.8152887987716083,1.0,11/123,1.88%,MT1G;MT1B;MT1X;MT1F;MT1E;MT1M;MT1H;MT1A;CPNE5;MAPK3;SLC25A24
prerank,heme catabolic process (GO:0042167),0.6411696812972983,1.5566359583800924,0.04330708661417323,0.8096459407083011,1.0,2/14,2.40%,HMOX2;ABCG2
prerank,porphyrin-containing compound catabolic process (GO:0006787),0.6411696812972983,1.5566359583800924,0.04330708661417323,0.8096459407083011,1.0,2/14,2.40%,HMOX2;ABCG2
prerank,regulation of smooth muscle contraction (GO:0006940),-0.5425175570978378,-1.5565183863143945,0.013953488372093023,0.35117039503859837,1.0,6/20,9.97%,KCNB2;CHRM2;PLCE1;CTTN;CHRM3;ZDHHC21
prerank,regulation of lipid catabolic process (GO:0050994),0.60211507962745,1.5563350761174688,0.0285204991087344,0.7991092020482964,1.0,1/19,0.14%,CIDEA
prerank,T cell receptor signaling pathway (GO:0050852),0.4182236592790201,1.555450741388843,0.004120879120879121,0.7921479928458813,1.0,37/138,15.09%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;PTPRJ;PDE4D;PTPRC;MAP3K7;TAB2;PRKD2;PSMD11;PSMB4;FYN;PSMC1;PAK3;SPPL3;LCP2;PRAM1;PLCG1;EIF2B3;RELA;RBCK1;INPP5D;PSMC2;PAK1;PSMD2;PIK3CD;IKBKB;CHUK;PSMD14;PSMC6;PSMD1;PSMB1;PAG1;DENND1B
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.5214663502612582,1.5554112679858476,0.033783783783783786,0.7805287635068721,1.0,8/33,11.92%,PHPT1;PTPRJ;SH2D1A;PRKD2;RELA;CD81;RPS3;PRNP
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.580808132271506,-1.5541053302200247,0.02914798206278027,0.3548162563038701,1.0,5/16,10.68%,ANK2;ATP1A2;CACNA1C;PRKACA;CAMK2D
prerank,cellular response to nerve growth factor stimulus (GO:1990090),-0.5528069747434788,-1.5535481181312167,0.033482142857142856,0.3533781653608552,1.0,7/22,7.58%,MAGI2;NTRK3;NTRK2;SH3GL2;MAPT;WASF1;STMN2
prerank,axonal fasciculation (GO:0007413),-0.635259927721141,-1.5491929800124098,0.03382663847780127,0.3636600239048747,1.0,4/12,10.80%,CNTN4;NRCAM;EPHB2;EPHA3
prerank,actin polymerization or depolymerization (GO:0008154),-0.4367124154612549,-1.5491601855374648,0.017142857142857144,0.3607518092658994,1.0,14/50,7.49%,SVIL;GSN;GAS7;MICAL2;SPIRE1;WASL;ABI1;MICAL3;PSTPIP2;ARHGAP6;WASHC5;WASHC3;WASF1;COBL
prerank,regulation of chemotaxis (GO:0050920),-0.47995376480513685,-1.5482700675231156,0.027848101265822784,0.3601585727051046,1.0,14/30,21.63%,PDGFRB;ADGRA2;EFNB2;P2RX4;PDGFRA;ZSWIM8;YTHDF1;STX3;THBS1;TGFB1;PTPN2;ZSWIM4;PPM1F;P2RY12
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.6418985191531188,1.5481559241134155,0.04734848484848485,0.8150244188916291,1.0,4/12,10.51%,BOD1;CHAMP1;CENPC;MIS12
prerank,dopamine metabolic process (GO:0042417),-0.5479604867446719,-1.5447215515418289,0.018433179723502304,0.36696770919955746,1.0,5/18,13.43%,MOXD1;SNCAIP;ATP7A;COMT;MAOB
prerank,glutathione biosynthetic process (GO:0006750),0.6847115502940876,1.540419102228164,0.03977272727272727,0.8521627674425326,1.0,5/11,13.17%,GCLC;GCLM;CNDP2;HAGH;GSS
prerank,regulation of ATP biosynthetic process (GO:2001169),-0.5679280702629546,-1.540370689760756,0.035940803382663845,0.3764926910706948,1.0,8/16,21.78%,PID1;PPARGC1A;VCP;PPARA;ATPSCKMT;PARP1;PINK1;FLCN
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.536434184966785,1.539529679440947,0.029565217391304348,0.8458821670418438,1.0,9/30,8.88%,CERS1;DACH1;CTC1;SRC;ERCC4;CDKN1A;HNRNPC;ACD;ACVRL1
prerank,cellular response to drug (GO:0035690),0.5544194187336542,1.5381179503340034,0.03783783783783784,0.8431517074372162,1.0,4/25,2.08%,CERS1;RBM22;RAP2A;ACER2
prerank,embryonic organ morphogenesis (GO:0048562),-0.44864587036725734,-1.53728592097299,0.02631578947368421,0.382341127690081,1.0,11/42,9.13%,FGFR2;FBN1;EFEMP1;FBN2;HOXA3;DYNC2I1;PDGFRA;MFAP5;NIPBL;RBP4;ACVR1
prerank,ganglion development (GO:0061548),-0.6453251188831932,-1.537173519034792,0.028225806451612902,0.3796436114003225,1.0,5/11,9.78%,NRP1;CTNNB1;UNC5C;SEMA3A;NRP2
prerank,hydrogen peroxide catabolic process (GO:0042744),-0.6368540070513204,-1.5367295980188713,0.05042016806722689,0.3780281161251933,1.0,7/11,30.50%,CAT;PRDX1;PRDX2;GPX1;PRDX3;PRDX4;PRDX5
prerank,nonribosomal peptide biosynthetic process (GO:0019184),0.6720187441719709,1.5360922105054267,0.030131826741996232,0.844379969423092,1.0,6/12,15.46%,GCLC;GCLM;CNDP2;HAGH;GSS;BDH2
prerank,dermatan sulfate metabolic process (GO:0030205),-0.6058037990588515,-1.5360340827507222,0.0425531914893617,0.377095781753767,1.0,9/13,28.53%,UST;DSE;VCAN;CSPG4;DSEL;BGN;DCN;CSPG5;CHST12
prerank,ceramide metabolic process (GO:0006672),0.4856869021452129,1.533187203519598,0.024350649350649352,0.8518118530587894,1.0,8/49,6.76%,CERS1;ACER2;SMPD4;ST6GALNAC3;CERS4;PPP2CA;SGMS1;PLPP1
prerank,positive regulation of ossification (GO:0045778),-0.4613956455136804,-1.5309909329717206,0.0196078431372549,0.3885153347293371,1.0,18/39,21.82%,BMP6;GPM6B;NELL1;BMP7;ADGRV1;BMP4;FBN2;OSR1;WNT4;ACVR1;KL;ANO6;TGFB1;BMPR1B;BMPR1A;BMPR2;CCN1;PKDCC
prerank,endoderm formation (GO:0001706),-0.4688296963321239,-1.5276116917083238,0.030927835051546393,0.3954614389355374,1.0,13/35,22.53%,COL8A1;COL11A1;MMP14;COL12A1;ITGB5;COL6A1;ITGA5;VTN;FN1;LAMB1;ITGA4;MMP2;DUSP1
prerank,cyclic purine nucleotide metabolic process (GO:0052652),-0.5223934430898679,-1.525358334448437,0.046255506607929514,0.39936582655453634,1.0,11/21,22.64%,ADCY5;ADCY2;ADCY1;ADCY9;ADCY7;GUCY1A1;NPR1;ADCY3;ADCY8;GUCY1B1;ADCY4
prerank,kidney development (GO:0001822),-0.4009142864197809,-1.5247661066203881,0.009174311926605505,0.3983076938384009,1.0,17/65,9.91%,ROBO2;SULF1;GREB1L;KANK2;PKD1;GLI2;PCSK5;TGFBR1;BMP7;SULF2;BMP4;OSR1;WNT4;NIPBL;FOXC1;PYGO1;SALL1
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.5674821644957749,1.524401121972131,0.03620689655172414,0.8973513607968835,1.0,7/22,10.57%,TNFAIP3;TIRAP;IFI35;RAB7B;WDFY1;LYN;MFHAS1
prerank,negative regulation of catalytic activity (GO:0043086),0.5512690740094645,1.5236609919051083,0.03041144901610018,0.8904012768801466,1.0,7/24,10.40%,PHPT1;CAND1;IFIT1;SIRT1;NOTCH1;PPP1R12A;CCAR2
prerank,amide biosynthetic process (GO:0043604),0.4826696658046764,1.5229391508725523,0.024429967426710098,0.8840654465548689,1.0,8/47,11.70%,PCSK1;CERS1;SMPD4;CERS4;SGMS1;DMD;SLC25A2;PAM
prerank,regulation of muscle cell differentiation (GO:0051147),-0.4769571295153466,-1.5226704274824066,0.0225,0.40160972382760424,1.0,13/31,17.35%,FGFR2;CTNNA2;BOC;CDON;CTNNA1;MAPK14;CTNNB1;RBM4;CAMK1;IGF2;MEGF10;CDK9;CDC42
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.5874021609709592,1.5222801668437131,0.04895104895104895,0.8767588376192545,1.0,7/20,8.20%,BBS12;CCT2;NDUFAF1;PFDN6;LONP1;PSMG1;TMEM35A
prerank,regulation of bone mineralization (GO:0030500),-0.42816529286557303,-1.52222073544867,0.013888888888888888,0.39989712159702484,1.0,24/55,22.34%,BMP6;GPM6B;NELL1;BMP7;ADGRV1;BMP4;FBN2;ENPP1;OSR1;WNT4;ANKH;ACVR1;KL;ECM1;ANO6;TGFB1;BMPR1B;BCOR;BMPR1A;BMPR2;TXLNG;CCN1;PKDCC;NOTUM
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.37879635263594563,1.5221836287973431,0.0,0.8661838087151948,1.0,74/306,14.74%,POLR2J;RPL30;MRPS33;NR4A2;RSL24D1;EEF1A1;POLR2B;RPL17;MRPL23;RPL23;MRPL24;RPL31;RPL3;EEF1D;RPS21;ING4;MRPL18;PAX8;ORC3;EXT2;APOE;RAD1;RPL35A;RPS14;RPL8;YARS2;RPL5;ABCF1;PWP1;MRPS12;RPS12;POLE;CDC45;HBS1L;RPS26;RPL37A;HARS1;ORC4;RPL4;POLD3;RPLP0;POLA1;TSFM;RPS28;RPS24;EIF4G2;TERT;RPS9;RPS23;RPL24;THRB;RPL34;GTPBP2;HUS1;RPS11;ORC2;MRPL52;RPS3;TOP3A;MRPS15;NBN;DHPS;HELB;RRAGC;ING5;PPP5C;EEF1B2;RPS15A;RPL23A;RPL21;RPL35;RMI1;BAZ2A;BRIP1
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.6847635949857858,1.5220857496809488,0.06297709923664122,0.8558188665043506,1.0,5/10,11.64%,MAPK3;GREM1;LYN;RNF13;NBR1
prerank,positive regulation of protein binding (GO:0032092),0.46665227268966347,1.5215651704873119,0.014240506329113924,0.84844497327523,1.0,16/56,11.27%,TRIB3;RALB;PIN1;TIAM1;HIPK2;PPP2CA;APOE;B2M;PPP2CB;BDNF;SPPL3;EPB41;AKTIP;CLDN5;TERT;APP
prerank,neuromuscular synaptic transmission (GO:0007274),0.592559515916254,1.5211208453075602,0.04247787610619469,0.8407697243507893,1.0,5/18,12.73%,SLC5A7;KIF1B;DTNA;TBC1D24;ERC1
prerank,histone H2B ubiquitination (GO:0033523),-0.6560076341771223,-1.5204940316238449,0.04893617021276596,0.4023882875656432,1.0,7/10,21.13%,WAC;UBE2E1;CDC73;RNF8;PAF1;RNF40;DTX3L
prerank,circulatory system development (GO:0072359),-0.36593764251043015,-1.519225307021965,0.0036363636363636364,0.40301139949546927,1.0,34/118,14.21%,ERBB4;NTRK3;FGF12;CACNA1C;FBN1;AKAP13;PDLIM5;PKD1;MICAL2;GLI2;ADAP2;COL3A1;NXN;PCSK5;CXADR;TGFBR1;NCOA6;TGFBR2;PLCE1;PDLIM7;OSR1;HSPG2;CDKN1B;RBP4;FOXC1;ACVR1;SALL1;FN1;STK11;FOXC2;MTHFD1;WDR11;PDLIM1;TCF25
prerank,regulation of cell cycle phase transition (GO:1901987),0.43421418710798754,1.519051573437462,0.008797653958944282,0.8434097903957442,1.0,25/91,14.00%,PSMB10;ERCC3;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;ANAPC2;NEK11;PSMD11;PSMB4;PSMC1;CDKN1A;FBXO5;ANAPC7;PSMC2;TFAP4;PSMD2;ANAPC11;ANAPC10;ANAPC4;PSMD14;PSMC6;PSMD1;PSMB1
prerank,pre-replicative complex assembly (GO:0036388),0.46087344349248477,1.5177937362933582,0.018376722817764167,0.8403249009534735,1.0,18/64,14.00%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;ORC3;PSMD11;PSMB4;PSMC1;ORC4;PSMC2;PSMD2;ORC2;PSMD14;PSMC6;PSMD1;PSMB1
prerank,regulation of blood circulation (GO:1903522),-0.4558323946263497,-1.517518514325083,0.02926829268292683,0.4053600323192107,1.0,20/34,40.01%,CELF2;TPM1;PER2;DMPK;CAMK2D;SRI;ACE;BDKRB2;AGTR1;TBX2;FXYD1;KCNQ1;KCNJ12;DES;S100A1;KCNMB4;CACNA1H;ACE2;AGT;KCNIP2
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),-0.5543670372361946,-1.5164673729012526,0.033707865168539325,0.4053673629098182,1.0,3/17,8.13%,ANK2;SNTA1;AKAP9
prerank,regulation of cardiac conduction (GO:1903779),-0.4218132273045587,-1.5160933502345062,0.014619883040935672,0.40355052840167216,1.0,13/54,10.32%,ANK2;ATP1A2;ITPR1;RYR3;ATP1B1;STIM1;TMEM65;ATP1B3;ATP1A1;TRPC1;ATP1B2;PRKACA;DMPK
prerank,regulation of nervous system process (GO:0031644),-0.5546569614698393,-1.516092765456908,0.04439252336448598,0.40065540797998217,1.0,6/18,8.13%,DLGAP1;HTR2C;DLGAP2;DLGAP4;ROCK2;AKAP9
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.527216617934423,1.5130424547334307,0.02905982905982906,0.8587677486366108,1.0,3/29,6.81%,CADM1;CYRIB;AP1G1
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.5904180860353498,1.5112939961715843,0.051188299817184646,0.8598922764837179,1.0,7/16,18.77%,NAA25;EP300;NAA35;CREBBP;NAA80;NAA15;NAA50
prerank,regulation of ERAD pathway (GO:1904292),-0.624179139960724,-1.509085410643946,0.05496828752642706,0.4198775495367446,1.0,9/11,26.05%,USP13;HERPUD1;TMEM259;USP19;RNFT1;BAG6;UBXN1;AQP11;RNF185
prerank,receptor signaling pathway via STAT (GO:0097696),-0.4945379299020042,-1.5081550051641508,0.03299492385786802,0.4197576942483432,1.0,7/25,10.53%,PKD1;IFNAR2;STAT2;GHR;IL31RA;STAT6;SOCS2
prerank,skin development (GO:0043588),-0.40649565739712323,-1.5076462207987062,0.008771929824561403,0.41847099115658676,1.0,12/65,6.02%,COL1A2;COL1A1;PKD1;COL3A1;ERRFI1;COL5A1;CLIC4;COL5A2;MED1;ATP7A;BCR;PIP5K1A
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.3978395064918145,1.5073660354155292,0.002677376171352075,0.874523213353784,1.0,38/163,14.50%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;PTPRJ;PDE4D;PTPRC;MAP3K7;VAV3;TAB2;PRKD2;PSMD11;PSMB4;FYN;PSMC1;PAK3;SYK;SPPL3;LCP2;PRAM1;PLCG1;EIF2B3;RELA;RBCK1;INPP5D;PSMC2;PAK1;PSMD2;PIK3CD;IKBKB;CHUK;PSMD14;PSMC6;PSMD1;PSMB1;PAG1
prerank,central nervous system neuron development (GO:0021954),-0.5884327848535853,-1.5072664029220455,0.039473684210526314,0.41682338943839103,1.0,9/15,29.32%,MAP2;NTRK2;MAPT;ATP7A;B4GALT6;RAPGEF2;LHX6;HSP90AA1;GBA2
prerank,regulation of T cell cytokine production (GO:0002724),0.6031668544148123,1.5067478121928062,0.05916030534351145,0.868480139783937,1.0,6/15,12.57%,MAP3K7;TNFRSF1B;B2M;SMAD7;TRPM4;CD55
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.5850792412350768,1.5056385316083891,0.04814814814814815,0.8650683255670979,1.0,2/17,6.81%,CADM1;AP1G1
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.4955531580773557,1.5046239383393674,0.026845637583892617,0.8611601932282352,1.0,13/38,18.84%,MIS18A;ASF1B;HJURP;RUVBL1;RSF1;CENPC;CABIN1;CENPP;RBBP4;CENPO;NPM1;ATRX;HAT1
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.5352447515170166,-1.5023424023174485,0.043478260869565216,0.4299826817567203,1.0,13/18,26.68%,RIMS1;NRXN1;DLG4;NLGN2;PRKCZ;RELN;NLGN1;CUX2;SHANK1;GRIN1;NLGN3;CHRNA7;STX1B
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.5347586071864477,-1.5017370306171416,0.041304347826086954,0.429111383624864,1.0,6/18,16.23%,DDX5;EGFR;BMP4;MAP2K2;TP53;TGFB1
prerank,regulation of mRNA processing (GO:0050684),0.5081034400125267,1.50079323588648,0.043327556325823226,0.8753797343315864,1.0,13/32,10.59%,NCBP1;KHDRBS3;AHCYL1;ZFP36L1;SF1;QKI;HNRNPK;CPSF4;SRSF10;CDK11B;YTHDC1;PAPOLA;SRPK2
prerank,hexose metabolic process (GO:0019318),0.49073778967251086,1.4977283244044828,0.03678929765886288,0.884963711219379,1.0,7/39,8.49%,PCK1;HECTD4;FUCA1;PPARD;OMA1;IRS2;GALM
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.6687414582429316,1.4975975234994068,0.0684931506849315,0.8761364028877053,1.0,3/10,13.00%,PRKAR1A;PRNP;CD274
prerank,cellular response to alcohol (GO:0097306),-0.43302133777996077,-1.4958414289188133,0.030534351145038167,0.4443102155160042,1.0,20/42,21.67%,ADCY5;GRAMD1B;ADCY2;CTNNA1;SPIDR;ADCY1;CTNNB1;KLF9;SMO;GLRA1;GRAMD1C;CDH1;ADCY7;GRAMD1A;LRP6;GPLD1;OSBPL7;BLM;ADCY3;ADCY8
prerank,positive regulation of receptor internalization (GO:0002092),-0.5195688372077201,-1.4949910042286605,0.02981651376146789,0.44395993408930584,1.0,2/22,1.74%,MAGI2;AHI1
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.5919955194171843,1.4929919668522693,0.05390334572490706,0.8952784002364454,1.0,2/16,6.81%,CADM1;AP1G1
prerank,negative regulation of hippo signaling (GO:0035331),-0.6088091094924258,-1.491893266169485,0.04294478527607362,0.45104304330554307,1.0,6/12,16.86%,WWC2;MAPK14;CIT;VGLL4;LIMD1;SHANK2
prerank,atrial cardiac muscle cell action potential (GO:0086014),-0.5882468227379334,-1.4917884988428296,0.05508474576271186,0.4484098488465217,1.0,4/13,10.60%,ANK2;CACNA1C;GJC1;GJA1
prerank,regulation of osteoblast differentiation (GO:0045667),-0.3847938286487817,-1.4914579370601493,0.012084592145015106,0.4465492396409682,1.0,22/82,11.96%,DDX5;BMP6;FGFR2;RANBP3L;IGF1;SMOC1;NELL1;BMP7;IL6R;BMP4;FBN2;CRIM1;WNT4;SKI;TMEM64;LRP5;SMAD6;ACVR1;PRKACA;CDK6;SEMA4D;LIMD1
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.4606540367886645,1.4910752112622057,0.03426791277258567,0.8978153220634806,1.0,5/53,6.74%,HRH4;MTNR1A;HTR1F;TSHR;HTR2A
prerank,inorganic anion transport (GO:0015698),-0.4133067311547567,-1.4909419473139525,0.016260162601626018,0.44529635773195875,1.0,20/53,27.13%,SLC4A10;CLIC4;SLC26A7;ENPP1;SLC13A4;GLRA1;CLCN6;ANO1;CLCN2;ANO6;SLC26A11;ENPP3;CLIC5;SLC5A5;ANO10;TTYH3;SLC25A30;SLC25A11;TTYH1;FXYD1
prerank,bone development (GO:0060348),-0.43715282794916904,-1.490343419367398,0.022900763358778626,0.4442753223205412,1.0,17/39,22.34%,FGFR2;RANBP3L;SULF1;AKAP13;SULF2;SKI;LRP5;GJA1;TP53;DYM;CYP26B1;LRP6;MBTPS2;SFRP4;P3H1;SH3PXD2B;NOTUM
prerank,negative regulation of epithelial cell proliferation (GO:0050680),-0.404658126800845,-1.4896397714800351,0.011428571428571429,0.44359963077335157,1.0,23/66,17.45%,FGFR2;TGFBR3;SULF1;ROBO1;NR2F2;NFIB;MCC;MTSS1;MED1;KLF9;NUPR1;XDH;SPARC;CDC73;THBS1;CDK6;AIMP1;CAV2;MAGED1;PEX2;TGFB1;ATP5IF1;SCG2
prerank,heterocycle biosynthetic process (GO:0018130),0.6102590864965972,1.4893572171629288,0.05783582089552239,0.899321093278374,1.0,2/14,0.85%,GPHN;MOCS3
prerank,dicarboxylic acid metabolic process (GO:0043648),0.4731796104555985,1.4885987206438338,0.0243161094224924,0.8944304874500768,1.0,9/52,6.17%,PCK1;ALDH1L1;GCLC;ALDH5A1;SDHAF3;ME3;GOT2;GCLM;MTHFS
prerank,synaptic vesicle cycle (GO:0099504),-0.4594732320671155,-1.4885544974582814,0.04030226700251889,0.4440541744240073,1.0,9/30,16.64%,RIMS1;SNAP25;PCLO;SYNDIG1;NLGN1;BRSK1;VAMP2;SYT7;STX1A
prerank,embryonic digit morphogenesis (GO:0042733),-0.5437581296792828,-1.4882656707356618,0.04555808656036447,0.4420122329496814,1.0,7/18,14.49%,GLI3;HDAC1;OSR1;MAP3K20;SALL1;TBX3;INTU
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.5142407341152819,1.487895147939048,0.03852889667250438,0.8899411367716636,1.0,4/32,6.03%,ROMO1;RPL30;RNASE6;FAM3A
prerank,mitochondrial fusion (GO:0008053),0.5719677500929566,1.4875405494919733,0.06390977443609022,0.8832296319193861,1.0,2/18,0.19%,THG1L;MIGA1
prerank,positive regulation of lipid metabolic process (GO:0045834),-0.5050535277521704,-1.4868410200488997,0.035555555555555556,0.4437012161789974,1.0,4/22,8.00%,ZBTB20;SORBS1;PPARA;CREBL2
prerank,NIK/NF-kappaB signaling (GO:0038061),0.431355137140035,1.48637530257113,0.01624815361890694,0.8813724933057742,1.0,22/72,14.87%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;MAP3K7;TIRAP;BIRC2;PSMD11;TNFRSF10B;PSMB4;PSMC1;RELA;PSMC2;PSMD2;CHUK;PSMD14;PSMC6;PSMD1;PSMB1;COPS8
prerank,neuron cell-cell adhesion (GO:0007158),-0.5749417569394217,-1.486302713747152,0.037694013303769404,0.4426653400052613,1.0,7/14,11.97%,NRXN3;CNTN4;NRXN1;NCAM2;NLGN2;NLGN1;NRXN2
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.6021696976064337,1.4850205102991576,0.051233396584440226,0.8804085007647229,1.0,5/15,9.76%,RPL23;RPL5;FBXO5;SMAD7;PARK7
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.4093803885116775,1.484325196172654,0.015427769985974754,0.8763259402594501,1.0,27/114,14.00%,PSMB10;PSMC4;PSMB6;EIF5A;PSMD8;PSMD5;PSMD12;BIRC2;PSMD11;PSMB4;TNFRSF1B;PSMC1;EDAR;TRAF5;ACTN4;TRAF3;RELA;PSMC2;PSMD2;CDIP1;IKBKB;CHUK;PSMD14;PSMC6;PSMD1;NFKBIA;PSMB1
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.5413697459044908,1.4839226594295647,0.05714285714285714,0.8700825368816025,1.0,8/24,15.25%,TNFAIP3;RAMP2;TEK;KRIT1;ICAM1;TNIP2;CDH5;GAS6
prerank,T cell activation involved in immune response (GO:0002286),0.6625509035012256,1.4827074777303582,0.05938697318007663,0.868646191420541,1.0,2/12,6.67%,LCP1;ICAM1
prerank,negative regulation of glycolytic process (GO:0045820),-0.6409984761775881,-1.4826989447665277,0.056451612903225805,0.44866199335504886,1.0,3/10,6.59%,HDAC4;NUPR1;PPARA
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),-0.6409984761775881,-1.4826989447665277,0.056451612903225805,0.44866199335504886,1.0,3/10,6.59%,HDAC4;NUPR1;PPARA
prerank,embryonic limb morphogenesis (GO:0030326),-0.4443959155770314,-1.4824980946664632,0.02610966057441253,0.446605679130306,1.0,14/34,15.42%,AFF3;CACNA1C;GLI3;CTNNB1;HDAC1;OSR1;MAP3K20;SKI;NIPBL;SALL1;TBX3;CYP26B1;INTU;LRP6
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.42825830479735005,1.4822319814047813,0.017341040462427744,0.8627805768271142,1.0,22/84,14.00%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;ANAPC2;PSMD11;PSMB4;PSMC1;FBXO5;ANAPC7;PSMC2;PSMD2;ANAPC11;ANAPC10;ANAPC4;CUL3;PSMD14;PSMC6;PSMD1;PSMB1
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),-0.5001781804965358,-1.4820336405407097,0.03333333333333333,0.4453531431340074,1.0,4/25,8.60%,ANK2;AKAP6;CEMIP;TRPC1
prerank,neuron development (GO:0048666),-0.34770032716391597,-1.4816287478982866,0.00390625,0.44367709673910943,1.0,42/141,17.07%,TENM2;MAP2;CNTN4;TENM3;PLP1;PBX1;PPP1R9A;MYT1L;GPM6B;GLI2;NTRK2;HDGFL3;SH3GL2;RASGRF1;RYK;MAPT;WNK1;ATP8A2;GPM6A;ATP7A;ERCC6;ROCK1;STMN2;ETV1;TDP2;NLGN1;CDK16;STX3;B4GALT6;GSK3B;DCX;UGDH;RAB11A;UNK;BICDL1;STMN1;SRRM4;RAPGEF2;EHD1;GPRIN3;PBX4;LAMB1
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.5144039950924584,-1.4781520017406398,0.05707762557077625,0.4519037197828107,1.0,6/20,10.68%,ANK2;ATP1A2;CACNA1C;ATP1B1;PRKACA;CAMK2D
prerank,7-methylguanosine RNA capping (GO:0009452),0.5046916799769853,1.4779127599299535,0.04690117252931323,0.872343307084366,1.0,6/31,8.79%,POLR2J;ERCC3;NCBP1;POLR2B;CCNH;GTF2H1
prerank,7-methylguanosine mRNA capping (GO:0006370),0.5046916799769853,1.4779127599299535,0.04690117252931323,0.872343307084366,1.0,6/31,8.79%,POLR2J;ERCC3;NCBP1;POLR2B;CCNH;GTF2H1
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.6013879229027174,1.4769466011713435,0.05818181818181818,0.8699182475539902,1.0,2/16,5.41%,PTPRC;CYRIB
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.44357499430549474,1.4766528296648063,0.018404907975460124,0.863617277634361,1.0,20/70,14.46%,PSMB10;PSMC4;PSMB6;MFSD6;PSMD8;PSMD5;PSMD12;PSMD11;PSMB4;PSMC1;B2M;PSMC2;PSMD2;IKBKB;CHUK;PSMD14;PSMC6;PSMD1;PSMB1;CYBA
prerank,regulation of cytokine production (GO:0001817),0.4023698033027814,1.4763124993239976,0.015235457063711912,0.8575405304977949,1.0,19/126,9.60%,CIDEA;CADM1;PIK3CG;PTPRC;SOD1;FCGR2B;RPS6KA4;HDAC9;BCL6B;RPS6KA5;TNFRSF1B;NPTN;RGCC;PPP1R11;TRAF3;CD47;POLA1;LYN;LURAP1
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.4878123595361855,1.4761280865491893,0.03459637561779242,0.8507960848543588,1.0,11/39,12.65%,TNFAIP3;RAMP2;TEK;KRIT1;ICAM1;RGCC;PLCG1;TNIP2;PRKCI;CDH5;ECSCR
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.5114515736951607,-1.4755749200359287,0.049528301886792456,0.4573250523857631,1.0,7/21,12.21%,ANK2;ATP1A2;CACNA1C;AKAP6;PRKACA;CAMK2D;SRI
prerank,cell morphogenesis involved in differentiation (GO:0000904),-0.3951663627112387,-1.4754652127381502,0.02046783625730994,0.4549022840629682,1.0,24/70,21.91%,TMEFF2;PARVA;NTNG1;NRP1;FER;LAMC3;RHOA;RILPL1;PXN;RELN;SRCIN1;RADIL;FN1;ILK;ARL13B;NTN4;UNK;ITGA8;LAMB1;ITGA4;PIK3R1;SIPA1L3;ATF4;RILPL2
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),-0.5092758510077487,-1.4753600437599155,0.03881278538812785,0.4523999067043749,1.0,7/23,9.05%,IGF1;AKAP6;MAPK14;EFNB2;MAML1;MMP14;NIBAN2
prerank,regulation of heart contraction (GO:0008016),-0.3652740589647094,-1.4750545812987286,0.010273972602739725,0.4507183267096602,1.0,20/90,12.75%,CELF2;ANK2;ATP1A2;ITPR1;RYR3;ATP1B1;STIM1;ASB3;TMEM65;TPM1;P2RX4;ATP1B3;ATP1A1;TRPC1;ATP1B2;PRKACA;DMPK;CAMK2D;SRI;ABCC9
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.5519535714419378,1.4746822734330067,0.05615942028985507,0.8509660564090101,1.0,8/20,12.21%,GNAQ;RGS8;GNB1;RGS10;GNA11;PLCB1;AGRN;LYPD1
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.5531540548883093,-1.4741867835531879,0.05217391304347826,0.450911205888364,1.0,7/16,18.55%,IGF1;AKAP6;ROCK2;ROCK1;CAMK2D;IL6ST;PARP1
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),-0.5520187167857433,-1.4726401854279307,0.0614406779661017,0.453078854407438,1.0,6/15,12.56%,FGFR2;TGFBR1;TGFBR2;PDGFRA;NIPBL;MTHFD1
prerank,establishment of mitotic spindle orientation (GO:0000132),-0.4883550674344447,-1.4723378799186684,0.04656319290465632,0.4513963957841002,1.0,8/23,20.02%,FBXW11;HTT;UBXN2B;GJA1;NSFL1C;DCTN1;NDE1;ZW10
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),-0.4574452917433935,-1.4720851709707654,0.02336448598130841,0.4495685872927959,1.0,5/31,4.07%,FGFR2;TGFBR3;TGFBR1;SMAD4;TPM1
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),-0.5210916765302989,-1.4719245430442176,0.06387665198237885,0.44747983494191074,1.0,2/17,1.32%,ANK3;AKAP6
prerank,metanephric mesenchyme development (GO:0072075),-0.6222497427116679,-1.470627243500197,0.054878048780487805,0.44899081847451955,1.0,6/10,24.84%,OSR1;WNT4;SIX1;STAT1;BASP1;PAX2
prerank,neurogenesis (GO:0022008),-0.4295109774638485,-1.470581241563664,0.024193548387096774,0.446514208233793,1.0,11/43,11.85%,LPAR1;SPOCK1;EPHB1;RYK;MAPT;CIT;ERCC6;TRAK1;CDK6;BTBD3;ANXA1
prerank,regulation of vascular endothelial growth factor production (GO:0010574),-0.4759469431346159,-1.470433778779336,0.049528301886792456,0.444336811658925,1.0,10/26,24.40%,SULF1;SULF2;CCBE1;IL6ST;RORA;TGFB1;SARS1;PTGS2;ATF4;EIF2AK3
prerank,snRNA metabolic process (GO:0016073),-0.536156963027279,-1.467465841664606,0.07036247334754797,0.4506244273142935,1.0,13/17,33.08%,INTS10;INTS8;MTREX;INTS11;RBM7;ZCCHC8;INTS7;TUT1;INTS12;INTS9;INTS3;MEPCE;INTS1
prerank,axonal transport of mitochondrion (GO:0019896),-0.6057574309742045,-1.4660667587884944,0.059574468085106386,0.45240236543919055,1.0,4/11,16.19%,MAPT;TRAK1;NEFL;ACTR10
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.5961821583224985,-1.4656273833234656,0.058823529411764705,0.45114810679465367,1.0,5/12,18.15%,RIMS1;UNC13C;UNC13B;SYT7;SYT2
prerank,negative regulation of developmental growth (GO:0048640),-0.45220194582287976,-1.4654313684996911,0.04187192118226601,0.44913851945349514,1.0,7/30,7.77%,MAP2;DCC;ULK2;WWC2;PTPRS;NKD1;CDKN1B
prerank,positive regulation of lipid localization (GO:1905954),-0.6094568073295848,-1.4651560947941715,0.056016597510373446,0.4477093846995794,1.0,4/11,14.25%,LRP1;NFKB1;IKBKE;VSTM2A
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.5076381164172801,1.4647427320887607,0.04695652173913043,0.9010719390944435,1.0,12/32,16.46%,MAP2K7;MAPK3;PNKP;CCT2;CCT5;MAP3K4;ACD;NEK7;TNKS;ATR;TCP1;PARN
prerank,regulation of telomere capping (GO:1904353),0.5356595438190476,1.4640884511056358,0.061371841155234655,0.8967484771501946,1.0,7/23,12.55%,MAP2K7;MAPK3;PNKP;MAP3K4;NEK7;TNKS;NBN
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.6215388873384688,-1.4637819095305695,0.06553911205073996,0.4494953186203267,1.0,5/11,30.08%,BIN1;CAMK2D;CACNA2D1;CACNB1;NOS1
prerank,striated muscle tissue development (GO:0014706),-0.46696747228386315,-1.4627665185872663,0.05176470588235294,0.4500708156899819,1.0,6/29,7.87%,SVIL;CFLAR;BMP5;BMP7;IGSF8;RBP4
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.3987290074643374,1.4624304767773173,0.011126564673157162,0.8990910364003571,1.0,35/124,14.38%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;FRZB;LEF1;MAP3K7;TIAM1;PPP3CB;AP2S1;PSMD11;PFN1;PSMB4;PSMC1;GNB1;CCDC88C;DAAM1;WNT5A;PSMC2;PLCB1;FZD9;FZD3;PSMD2;CELSR1;NLK;AGO4;PPP3CA;PPP3R1;PSMD14;PSMC6;PSMD1;PSMB1;AP2M1
prerank,iron ion transmembrane transport (GO:0034755),-0.6301001405930361,-1.4623825012883687,0.056112224448897796,0.44883889411552613,1.0,5/10,22.62%,SLC39A14;SCARA5;SLC39A8;SLC11A2;SLC25A28
prerank,protein localization to cell surface (GO:0034394),-0.481984151261583,-1.4619913006992902,0.05275779376498801,0.44766944080978227,1.0,13/26,23.94%,ANK2;CTNNB1;FLNA;JAM3;VCL;USP4;GGA2;MESD;PTPRU;GGA3;PRRT1;UNC50;EMP2
prerank,positive regulation of catalytic activity (GO:0043085),0.48490267466557674,1.4607464931236949,0.048494983277591976,0.9017016818422025,1.0,9/37,9.71%,MAPK3;SOD1;PSEN2;CIB1;MAPK8;CHTOP;YWHAB;SSBP1;MSH3
prerank,regulation of protein localization to centrosome (GO:1904779),-0.6363399317411742,-1.4603601967510857,0.0408997955010225,0.4506555938381968,1.0,5/10,16.53%,BICD1;UBXN2B;GSK3B;NSFL1C;CEP250
prerank,eye development (GO:0001654),-0.40402620788924365,-1.4601704013988783,0.02185792349726776,0.4489609657767593,1.0,21/54,21.64%,CACNA1C;FBN1;PBX1;SMOC1;COL5A1;COL5A2;EFEMP1;MEIS2;FBN2;SKI;NIPBL;RBP4;FOXC1;HIPK1;BMPR1B;PBX4;LAMA1;PBX2;SIPA1L3;SMG9;SH3PXD2B
prerank,skeletal muscle tissue development (GO:0007519),-0.45156561884328933,-1.4598955412069408,0.04597701149425287,0.4474353698051174,1.0,7/32,18.72%,SVIL;CFLAR;IGSF8;SKI;CAV2;SELENON;SIX1
prerank,positive regulation of biosynthetic process (GO:0009891),-0.4332422676394265,-1.4595382392638814,0.02512562814070352,0.44604608759772235,1.0,7/40,8.00%,ZBTB20;SORBS1;VIM;BMP4;PPARA;WNT4;CREBL2
prerank,stem cell differentiation (GO:0048863),-0.42950223464115667,-1.4594261907484825,0.0291005291005291,0.44405634621772877,1.0,14/39,17.68%,FGFR2;PUM1;UFL1;JARID2;KIT;GPM6A;OSR1;TP53;NELFB;LMBR1L;MTF2;LRP6;METTL5;ACE
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.5639958125546649,1.4588043879073291,0.07329842931937172,0.9055469249043374,1.0,4/19,5.71%,RAC2;CAMK1D;TIRAP;RIPOR2
prerank,plasma membrane invagination (GO:0099024),-0.4599548773359778,-1.4583333884182845,0.03333333333333333,0.4451531049047165,1.0,6/29,5.56%,GULP1;GSN;DOCK1;SPIRE1;RHOA;ARHGAP12
prerank,regulation of glucose import (GO:0046324),-0.45879965726944993,-1.4577597643167042,0.05673758865248227,0.44459542862786994,1.0,10/30,9.89%,SORBS1;PRKAG2;IGF1;PID1;OCLN;ENPP1;APPL2;AKT2;CREBL2;ARPP19
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.39762600950686877,1.4574287306706593,0.009655172413793104,0.9056760868172444,1.0,18/116,10.61%,GPR176;PRKAR1A;PTGER2;FCGR2B;PLK2;SRC;TSHR;INSL3;RAMP2;FYN;GNB1;RXFP1;SYK;PLCG1;LYN;RHBDF2;CD163;YES1
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.5681319196717816,-1.4566159844748685,0.07708779443254818,0.4456661967973701,1.0,7/13,15.77%,PLXNA2;NRP1;SEMA3A;NRP2;PLXND1;PLXNB2;PLXNC1
prerank,regulation of immune effector process (GO:0002697),0.4774926142370064,1.4556224892610723,0.043010752688172046,0.9089362847517961,1.0,6/41,12.57%,C1QB;C1QC;FCGR2B;PHB2;CD81;CD55
prerank,lung epithelium development (GO:0060428),-0.6191984528717764,-1.4544654021803143,0.06746031746031746,0.45012393558742275,1.0,4/10,14.41%,PKD1;ERRFI1;BMP4;RCN3
prerank,regulation of insulin receptor signaling pathway (GO:0046626),-0.4227946386778322,-1.4544557323603513,0.04120879120879121,0.44783280163559985,1.0,16/43,18.74%,SORBS1;OGT;TNS2;PID1;GKAP1;PRKCZ;ENPP1;SORL1;PRKCD;PIP4K2B;NUCKS1;GRB10;IGF2;PTPN2;TSC2;RPS6KB1
prerank,negative regulation of ATP metabolic process (GO:1903579),-0.5421454983436989,-1.4544165782506842,0.046052631578947366,0.4456693624738553,1.0,5/17,7.72%,HDAC4;PID1;NUPR1;PPARA;FIS1
prerank,embryonic skeletal system morphogenesis (GO:0048704),-0.4595659674988327,-1.4544014011359596,0.0399002493765586,0.4434473713800133,1.0,7/31,6.19%,FGFR2;TGFBR1;TGFBR2;HOXA3;OSR1;DYNC2I1;PDGFRA
prerank,regulation of metal ion transport (GO:0010959),-0.5356594095900796,-1.4527592765561108,0.06438631790744467,0.44626159879175414,1.0,9/16,22.10%,ANK2;STIM1;SLC30A10;IL16;SRI;DLG1;BCL2;CACNA2D1;CAMK2B
prerank,plasma membrane organization (GO:0007009),-0.3951276992575558,-1.4524386877319713,0.03283582089552239,0.44499401815699224,1.0,29/61,33.15%,ANK2;ANK3;EPB41L3;A4GALT;COL5A1;BIN1;BIN3;MYOF;PLSCR1;AHNAK2;TLCD2;SYT11;ABCD2;ANO6;SYT7;PACSIN1;ARV1;DEGS1;ANXA6;CLN3;SERP1;SPTBN1;SYTL4;ABCA7;PACSIN3;PLSCR4;CAVIN2;MICALL1;SMPD1
prerank,cellular response to hypoxia (GO:0071456),0.39460194131356563,1.4519307331919833,0.01783264746227709,0.9233448794278576,1.0,36/126,14.00%,PSMB10;PSMC4;PSMB6;ELOC;PSMD8;PSMD5;PSMD12;HIPK2;STOX1;ZFP36L1;PSMD11;SCN2A;PSMB4;PSMC1;EP300;CARD16;RGCC;SIRT1;MDM2;PSMC2;PSMD2;BAD;TERT;HYOU1;HP1BP3;CREBBP;HIGD1A;UBQLN1;ELOB;EGLN2;BNIP3L;PSMD14;EPAS1;PSMC6;PSMD1;PSMB1
prerank,cellular response to light stimulus (GO:0071482),0.439430571390193,1.4512969047466602,0.03179650238473768,0.9194826230447323,1.0,20/66,17.96%,GPR52;SAG;EIF2S1;RUVBL2;ERCC4;YY1;POLK;EP300;GNB1;USP47;CREBBP;BMF;INO80;TAF1;ATR;N4BP1;TMEM161A;USP28;NPM1;RPL26
prerank,metal ion export (GO:0070839),-0.4578136308243415,-1.4510728960188346,0.05089058524173028,0.4469270155193501,1.0,7/31,9.45%,ATP1A2;ATP1B1;ATP1B3;ATP7A;ATP1A1;KCNK5;ATP1B2
prerank,sphingolipid catabolic process (GO:0030149),0.5850267764143631,1.4504785567409049,0.0856610800744879,0.9166776330378892,1.0,3/15,3.22%,ACER2;SMPD4;PPT1
prerank,cardiac myofibril assembly (GO:0055003),-0.5499784947939725,-1.4502511294930407,0.06512605042016807,0.44726602115555875,1.0,3/15,12.31%,PDGFRB;PDGFRA;OBSL1
prerank,regulation of striated muscle contraction (GO:0006942),-0.4630933109892731,-1.4500881458251813,0.0625,0.44559678815920734,1.0,6/27,12.21%,ANK2;ATP1A2;ASB3;P2RX4;PRKACA;SRI
prerank,neuron projection fasciculation (GO:0106030),-0.6294399883900932,-1.449928169485892,0.059548254620123205,0.4437987924476926,1.0,4/10,19.13%,CNTN4;NRCAM;EPHB2;SEMA5A
prerank,cardiac muscle tissue development (GO:0048738),-0.4099101414900558,-1.4489943573934638,0.040214477211796246,0.44447627002272727,1.0,17/50,19.93%,NOTCH2;AKAP13;GJB6;BMP5;BMP7;SMAD4;MAML1;BMP4;ADAMTS9;RBP4;SIK1;GJA1;CACNA1G;SMAD5;TBX18;BMPR1A;BMPR2
prerank,import into cell (GO:0098657),-0.43198685609843357,-1.448805490485029,0.026737967914438502,0.44280652683821203,1.0,16/41,17.61%,ATP1A2;SNAP25;SLC1A3;SLC6A13;SLC47A1;LRRC8D;GLUL;SLC39A14;SLC22A4;SLC27A1;SLC12A6;SLC19A1;SLC16A2;LRSAM1;SLC12A4;SLC5A6
prerank,positive regulation of phospholipase C activity (GO:0010863),-0.42432483155663475,-1.4484038494710139,0.03694581280788178,0.4419074357861588,1.0,9/40,6.20%,NTRK3;LPAR1;EGFR;PDGFRB;NTRK2;KIT;ARHGAP6;PDGFRA;EDNRA
prerank,SNARE complex assembly (GO:0035493),-0.6177977110237798,-1.4483598372991253,0.06349206349206349,0.4399321204832622,1.0,6/10,29.10%,UVRAG;STXBP1;VAMP2;VAMP1;VAMP8;SNCA
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),-0.4739300907009348,-1.447853666663209,0.0585480093676815,0.4391264925021601,1.0,9/24,24.40%,SULF1;SULF2;CCBE1;IL6ST;RORA;TGFB1;PTGS2;ATF4;EIF2AK3
prerank,positive regulation of T-helper cell differentiation (GO:0045624),-0.5822780806862,-1.4478437362182972,0.05154639175257732,0.4370370149379528,1.0,6/14,17.46%,MALT1;PRKCZ;ANXA1;RARA;IL18;SOCS5
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.5042262197436936,1.4476084861254641,0.06654991243432574,0.9261824337843312,1.0,9/31,10.17%,TOMM20;ROMO1;TIMM17B;PEX1;PEX7;GRPEL2;TOMM40L;TIMM21;AIFM1
prerank,substrate adhesion-dependent cell spreading (GO:0034446),-0.4308529955115942,-1.4474693626961892,0.03183023872679045,0.436117925793399,1.0,17/46,20.03%,TMEFF2;PARVA;NTNG1;NRP1;FER;LAMC3;RHOA;PXN;SRCIN1;RADIL;FN1;ILK;NTN4;ITGA8;LAMB1;ITGA4;PIK3R1
prerank,carbohydrate biosynthetic process (GO:0016051),-0.4979411654825142,-1.4470155944839889,0.057007125890736345,0.435341969615312,1.0,8/21,17.89%,B4GALT1;FUT8;ST6GALNAC5;B3GALT5;ST3GAL4;B3GALT1;ST6GALNAC6;MPDU1
prerank,regulation of cellular amine metabolic process (GO:0033238),0.45687014103986867,1.4464162273550263,0.04590163934426229,0.9260264728721187,1.0,16/50,15.26%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;PSMD11;PSMB4;PSMC1;PSMC2;PSMD2;PSMD14;PSMC6;PSMD1;PSMB1;ODC1
prerank,presynapse assembly (GO:0099054),-0.5318991876210808,-1.4460298519460995,0.05934065934065934,0.43605523942437097,1.0,7/16,17.28%,LRRTM3;PCLO;NLGN2;NLGN1;IL1RAPL1;BSN;DVL1
prerank,organelle fusion (GO:0048284),0.5287635955362859,1.445837998989313,0.0659536541889483,0.9220542069699008,1.0,3/22,4.40%,THG1L;MIGA1;VPS11
prerank,estrogen metabolic process (GO:0008210),0.5891960780605974,1.4439675197761086,0.08231173380035026,0.9257074669025388,1.0,4/15,11.73%,SULT1A1;HSD17B11;CYP1B1;HSD17B4
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.44561637267961735,1.4438143966606922,0.046031746031746035,0.9193218152650006,1.0,17/55,14.00%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;PSMD11;PSMB4;PSMC1;USP47;PSMC2;PSMD2;PSMD14;PSMC6;PSMD1;AVEN;PSMB1
prerank,protein localization to membrane (GO:0072657),-0.3252886213053793,-1.4421897331394573,0.004784688995215311,0.445211730233264,1.0,56/187,18.37%,MAGI2;DLG2;ANK2;DPP6;ANK3;KCNB2;LRRC7;KCNIP4;EPB41L3;NRXN1;MAP7;RAB3C;ATP1B1;PACS2;DLG4;NLGN2;FLNA;KCNIP3;SYNE3;ROCK2;ATP1B3;FLOT2;RAB8B;PIP5K1A;ROCK1;TTC7B;NUP155;NLGN1;EZR;DLG3;TM9SF4;ACTN2;TTC7A;CDH1;DPP10;LRRC4;NRXN2;RAMP1;ARL5A;DLG1;MYADM;RAB11A;WNK3;WDR19;STXBP1;AP4M1;FYB1;LRP6;RAPGEF2;EHD1;RAB8A;EHD3;DVL1;ITGA4;FRMPD1;ZFYVE27
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.4841366168031928,1.4410950139559986,0.052980132450331126,0.9281519450153544,1.0,6/32,8.79%,ERCC3;MAPK3;POLR1C;CCNH;POLR1G;GTF2H1
prerank,positive regulation of potassium ion transport (GO:0043268),-0.4269670118345652,-1.4390798340024809,0.035897435897435895,0.45195577175575335,1.0,10/38,12.92%,ANK2;KCNMA1;AKAP6;FHL1;FLNA;GABBR2;KCNJ2;ACTN2;KCNJ6;DLG1
prerank,nerve growth factor signaling pathway (GO:0038180),-0.6433231134804988,-1.4385559131471966,0.06613226452905811,0.45142624448599294,1.0,1/10,0.01%,MAGI2
prerank,regulation of cell killing (GO:0031341),0.5736075048002874,1.4385365654634383,0.07276119402985075,0.9369294766579357,1.0,5/16,14.46%,MAPK8;ICAM1;WNT5A;CD55;CYBA
prerank,nervous system development (GO:0007399),-0.29495722161593374,-1.4374501151517731,0.0,0.452523950233197,1.0,112/429,17.97%,NAV3;ERBB4;ROBO2;NOTCH2;CNTN4;DCLK1;SDK1;LPAR1;FGF12;TEAD1;ROBO1;ZIC1;ADAM22;ARNT2;ALDH1A2;ZIC4;NRXN1;CNTN6;SPOCK1;GSN;KIRREL3;MYT1L;GPM6B;NRCAM;EFNA5;AHI1;ADAM23;PKD1;GLRB;ADGRA2;CHRM2;EPHB1;NBL1;HDAC4;TMOD2;MBP;SH3GL2;NELL1;TGFBR1;MOBP;DLG4;AXL;RYK;ZEB2;TRPC5;DNER;DSCAM;JARID2;ADGRV1;NLGN2;GLIS2;IL1RAPL2;GPM6A;CRIM1;SCN8A;GMFB;VCAN;RELN;SMO;ZIC5;ERCC6;IGSF8;LDB1;FEZ1;TRAK1;MOG;SDK2;CHRM3;NLGN1;FUT10;RBFOX3;BTBD3;CDH1;EPHB2;NUMBL;NR2C2;ZIC2;FN1;DCX;TBX3;NRXN2;ALDH3A2;ACVR1B;OBSL1;APBA1;ATXN1;DPF2;COX7B;FKTN;PLXND1;VLDLR;INTU;DACT1;ATN1;ARHGAP26;SRRM4;NINJ2;DCTN1;NGF;NPAS2;TGFB1;NHEJ1;NES;WWTR1;SZT2;SHANK2;DVL1;S100B;CYP51A1;SOX6;MYLIP;GFRA2
prerank,skeletal system development (GO:0001501),-0.33312453943337433,-1.4367562406039116,0.003861003861003861,0.4525610904311764,1.0,27/148,8.02%,BMP6;FGFR2;IGF1;COL1A2;SULF1;FBN1;AKAP13;COL1A1;PKD1;GLI2;ITGB8;PCSK5;MMP16;TGFBR1;SOX5;BMP5;BMP7;SULF2;VCAN;MMP14;NPR3;ATP7A;CREB3L2;CDH11;ANKH;RBP4;COL13A1
prerank,embryonic eye morphogenesis (GO:0048048),-0.6017083823501599,-1.4366984881487281,0.07430997876857749,0.4506108021547916,1.0,5/11,15.42%,FBN1;EFEMP1;FBN2;MFAP5;LRP6
prerank,tRNA metabolic process (GO:0006399),0.5572145000881937,1.4362214816621528,0.0784313725490196,0.9435802171891083,1.0,4/17,8.67%,THG1L;FARS2;YARS2;POP5
prerank,positive regulation of immune response (GO:0050778),0.43436736173361384,1.4357933071282936,0.041791044776119404,0.9388436851428404,1.0,9/64,14.46%,PCK1;PTPRC;FCGR2B;IFI35;SIRT1;CD81;POLR3F;POLR3B;CYBA
prerank,regulation of microtubule polymerization (GO:0031113),-0.4159370239330803,-1.4357455770135992,0.044444444444444446,0.4515521602463094,1.0,12/40,15.74%,NAV3;MAP2;EML2;MAPT;OCLN;STMN2;AKAP9;SLAIN2;CLIP3;STMN1;TUBB4A;DCTN1
prerank,negative regulation of lipid metabolic process (GO:0045833),0.5342211262430576,1.4344040288707294,0.07065217391304347,0.9398171040205688,1.0,2/22,6.15%,CIDEA;ASXL3
prerank,protein localization to plasma membrane (GO:0072659),-0.33768776906413267,-1.4333456678131662,0.015810276679841896,0.4568093718305481,1.0,39/129,16.80%,ANK2;DPP6;ANK3;KCNB2;KCNIP4;EPB41L3;MAP7;RAB3C;ATP1B1;PACS2;ASB3;FLNA;KCNIP3;ROCK2;ATP1B3;FLOT2;RAB8B;PIP5K1A;ROCK1;TTC7B;EZR;AFDN;ACTN2;TTC7A;CDH1;DPP10;RAMP1;DLG1;MYADM;RAB11A;WNK3;STXBP1;NECTIN3;FYB1;LRP6;RAPGEF2;EHD1;RAB8A;EHD3
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.4477963413716863,1.4329125798445146,0.05246422893481717,0.9419071775868623,1.0,15/53,14.00%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;PSMD11;PSMB4;PSMC1;PSMC2;PSMD2;PSMD14;PSMC6;PSMD1;PSMB1
prerank,cGMP-mediated signaling (GO:0019934),-0.5727362584950636,-1.429864888796211,0.07311827956989247,0.4654615994318108,1.0,3/13,1.83%,HTR2C;IRAG1;KCNC2
prerank,actin cytoskeleton reorganization (GO:0031532),-0.3895902347426485,-1.4297938552776905,0.029498525073746312,0.4635750671304476,1.0,19/63,13.71%,MCU;GSN;PARVA;AUTS2;NRP1;CXADR;CDC42BPB;PTK7;FER;RHOA;FLNA;NEDD9;KIT;PIP5K1A;CTTN;EZR;ANXA1;GRB2;MKLN1
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.5263536335956115,1.429699797985777,0.0846286701208981,0.9542772994008738,1.0,3/23,4.01%,SLC12A1;SLC9A7;CLCN3
prerank,acute inflammatory response (GO:0002526),-0.4826779330176998,-1.428983299144141,0.07093821510297482,0.46398853338249213,1.0,8/23,31.92%,IL6R;F3;LBP;PLSCR1;ANO6;CEBPB;IL22;CTNNBIP1
prerank,cellular response to BMP stimulus (GO:0071773),-0.3758461071909599,-1.4289027098897318,0.026470588235294117,0.4621508355187335,1.0,15/66,10.15%,DDX5;BMP6;TGFBR3;ADAMTS12;SMAD3;RGMA;BMP5;BMP7;SMAD4;BMP4;SMAD6;ZFYVE16;ACVR1;HIVEP1;RGMB
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.3885938159095812,1.4288205280914816,0.015172413793103448,0.9522594986472994,1.0,18/117,10.70%,GPR176;PRKAR1A;PTGER2;PLK2;SRC;TSHR;INSL3;RAMP2;FYN;GNB1;RXFP1;SYK;PLCG1;LYN;RHBDF2;CD163;YES1;CD81
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.556128842654399,-1.428671483365041,0.08609271523178808,0.46079819500272434,1.0,4/13,6.59%,PID1;PPARGC1A;VCP;PPARA
prerank,positive regulation of synapse assembly (GO:0051965),-0.46312410713513735,-1.4278263982119306,0.07780320366132723,0.46115327105985215,1.0,11/27,12.29%,NRXN1;GRID2;EPHB1;NLGN2;SYNDIG1;CLSTN2;NLGN1;EPHB2;CUX2;SEMA4D;IL1RAPL1
prerank,inositol lipid-mediated signaling (GO:0048017),-0.4021909889276749,-1.427636874246062,0.03287671232876712,0.4596172290129609,1.0,19/50,16.54%,IGF1;OGT;PDGFRB;ADAP2;PLCL2;RHOA;PLCE1;PIK3C2B;PIK3C3;PDGFRA;PLCD3;EZR;PLCB3;GAB2;PLCH1;PLCL1;NGF;EXOC1;PLCD1
prerank,cell-matrix adhesion (GO:0007160),-0.3594565370860987,-1.4267303201872128,0.03436426116838488,0.4601185857647647,1.0,25/95,14.06%,SORBS1;ITGBL1;ADAMTS12;PKD1;ITGB8;COL3A1;SGCE;NID2;PPFIA1;ADAMTS9;VCL;ITGB5;BCR;PIP5K1A;DDR1;CTTN;COL13A1;VTN;ACTN2;ITGA11;FN1;ILK;CD34;MKLN1;ITGA8
prerank,cellular response to interleukin-1 (GO:0071347),0.37968628982538943,1.426606609341021,0.0160857908847185,0.9591081895311921,1.0,34/143,14.28%,PSMB10;PSMC4;PSMB6;MAPK3;PSMD8;PSMD5;PSMD12;IL1R1;MAP3K7;TAB2;RPS6KA4;RPS6KA5;PSMD11;GBP3;PSMB4;PSMC1;TAB3;CCL25;RELA;CD47;PSMC2;PLCB1;PSMD2;UBE2V1;NOD1;TNIP2;IKBKB;CHUK;PSMD14;PSMC6;PSMD1;NFKBIA;PSMB1;MAP3K3
prerank,neuron projection extension (GO:1990138),-0.44397466117846185,-1.4263722690987108,0.05486284289276808,0.4591302949309079,1.0,10/32,9.78%,ALCAM;MAP1B;ULK2;IQGAP1;AUTS2;SH3GL2;NRP1;CTNNB1;SEMA3A;NRP2
prerank,regulation of humoral immune response (GO:0002920),0.46391734707692045,1.4260845963723037,0.051829268292682924,0.9550355969973141,1.0,6/44,12.57%,C1QB;C1QC;FCGR2B;PHB2;CD81;CD55
prerank,myeloid dendritic cell activation (GO:0001773),-0.5801427298910602,-1.425959263499138,0.07692307692307693,0.4584168129623462,1.0,3/12,9.65%,TGFBR2;CAMK4;DOCK2
prerank,positive regulation of cilium assembly (GO:0045724),-0.5205518792970321,-1.424555534107425,0.07191011235955057,0.4604235384547132,1.0,9/18,33.31%,TAPT1;CEP120;HTT;ENTR1;CCP110;FUZ;KCTD17;WRAP73;CROCC
prerank,inorganic cation transmembrane transport (GO:0098662),-0.30793160138187564,-1.4238020662806854,0.0,0.46081499246978924,1.0,53/268,14.22%,TRPM3;ATP1A2;KCNK2;SLC24A3;KCNQ3;KCNB2;CACNA1C;HCN1;NALCN;KCNH7;KCNQ5;SLC1A3;CACNA1D;RYR3;SLC6A13;KCNC2;PKD1;KCND2;ATP1B1;SLC41A1;TRPM6;TRPC5;SLC6A1;P2RX4;SCN8A;SCN3A;ATP1B3;SLC12A2;SLC39A14;SLC30A10;KCNH5;SLC6A9;ATP1A1;SLC6A12;SLC39A13;KCNK5;KCNJ2;TRPC1;SCN1A;KCNA1;SCARA5;SLC24A2;KCNK10;SLC30A4;ATP6V0A4;SLC9A2;ABCC9;ATP6V0C;CACNA1G;TMCO1;SLC39A8;SLC6A15;ANO6
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.40969735790355244,-1.4237990867763732,0.04289544235924933,0.45883358642374167,1.0,17/43,28.28%,DDX5;TEAD1;SMAD3;NFIB;BMP4;PPARA;TP53;TGFB1;JUN;NR3C1;NFATC4;GNL3;KLF5;ATOH8;GATA2;EGR1;FOXO3
prerank,Rho protein signal transduction (GO:0007266),-0.3874890547090933,-1.4237448131020558,0.037333333333333336,0.4570678164006517,1.0,25/53,26.98%,COL1A2;ARHGAP29;PDPN;RHOA;ROCK2;CTNNAL1;ARHGAP6;SHTN1;ROCK1;PLEKHG5;RHOJ;RHOB;ARHGDIA;CDC42EP5;CDC42EP1;CDC42;AGTR1;ARHGEF1;ARHGDIB;RHOU;EPS8L2;RIPOR1;ADRA2A;ADGRG1;CDC42EP2
prerank,acetyl-CoA metabolic process (GO:0006084),0.5618048652650562,1.423564472320567,0.10193321616871705,0.9632197409907921,1.0,5/15,9.95%,DIP2A;MLYCD;ACAT1;ACACB;HMGCS2
prerank,histone H2A acetylation (GO:0043968),0.5747105819537913,1.423214766935223,0.09108159392789374,0.9585560854393729,1.0,7/16,13.10%,ACTL6A;RUVBL2;DMAP1;RUVBL1;YEATS4;ING3;TRRAP
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.566748029745783,-1.4225125467816766,0.07021276595744681,0.4585250239341404,1.0,3/13,0.39%,ERBB4;FGFR2;TGFBR3
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.5377728433305147,-1.422466282231767,0.08275862068965517,0.4567755947729049,1.0,5/15,13.04%,DAB2;SNAP91;WASL;SCYL2;HIP1R
prerank,organophosphate biosynthetic process (GO:0090407),0.4738805658788311,1.4209382100582202,0.064891846921797,0.9651689438878782,1.0,9/37,12.02%,GPHN;MOCS3;PPIP5K2;GPAM;FITM2;TPI1;MBOAT1;AGPAT3;IP6K2
prerank,regulation of leukocyte migration (GO:0002685),0.5539105677300605,1.4201274293361381,0.10714285714285714,0.9630947770053486,1.0,4/16,11.04%,RAC2;HOXA7;CD81;RHOG
prerank,positive regulation of filopodium assembly (GO:0051491),-0.47702845453798537,-1.419386992803921,0.07110091743119266,0.4638512912283151,1.0,8/24,8.48%,TENM2;DPYSL3;NRP1;WASL;GPM6A;PLPPR5;NLGN1;DOCK11
prerank,cellular response to tumor necrosis factor (GO:0071356),0.3723462533958567,1.4185899352237046,0.01675257731958763,0.9654999047330338,1.0,36/175,14.00%,PSMB10;PSMC4;PSMB6;EIF5A;PSMD8;PSMD5;PSMD12;SMPD4;BIRC2;ZFP36L1;PSMD11;GBP3;PSMB4;TNFRSF1B;PSMC1;CIB1;EDAR;TRAF5;ACTN4;SIRT1;CCL25;ERBIN;TRAF3;RELA;PSMC2;PSMD2;NPNT;CDIP1;RPS3;IKBKB;CHUK;PSMD14;PSMC6;PSMD1;NFKBIA;PSMB1
prerank,activation of adenylate cyclase activity (GO:0007190),-0.43216374819003583,-1.4175541743962736,0.043701799485861184,0.4675475873703064,1.0,13/35,22.97%,ADCY5;LGR4;ADCY2;ADCY1;ADCY9;EDNRA;ADCY7;RAF1;LGR5;ADCY3;ADCY8;ADCY4;CAP1
prerank,positive regulation of interleukin-13 production (GO:0032736),-0.6120011294519805,-1.4168818958985443,0.07276507276507277,0.46756559805725606,1.0,3/10,13.39%,PRKCZ;RARA;IL18
prerank,positive regulation of neutrophil migration (GO:1902624),0.5587621806049755,1.4163300755029768,0.09403254972875226,0.9723345848796034,1.0,4/18,5.71%,RAC2;CAMK1D;TIRAP;RIPOR2
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.49256171822342387,1.4156229659167985,0.07413793103448275,0.9697061638998541,1.0,9/29,9.76%,TRIB3;PIN1;DCUN1D4;FBXO5;SMAD7;BMI1;AXIN1;MAGEC2;PARK7
prerank,transcription by RNA polymerase I (GO:0006360),0.46993502685507127,1.4150674314876208,0.0664451827242525,0.9663427327901307,1.0,6/34,8.79%,ERCC3;MAPK3;POLR1C;CCNH;POLR1G;GTF2H1
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),-0.422537642480785,-1.4149968639606747,0.059278350515463915,0.47085175314195366,1.0,14/37,15.12%,BICD1;PHLDB2;EFNA5;PHLDB1;CYLD;MAPT;ROCK1;STMN2;SKA2;GSK3B;EPHA3;TAOK1;TRIM36;STMN1
prerank,regulation of cellular component movement (GO:0051270),-0.4053071260221588,-1.4144363297339348,0.0453257790368272,0.4704654732478768,1.0,26/49,29.61%,ERBB4;TGFBR3;EGFR;TGFBR1;PDPN;RHOA;ROCK2;ROCK1;ZSWIM8;YTHDF1;CDK6;PRAG1;RAF1;ABL2;DIAPH1;ZSWIM4;CADM4;VEGFA;ERBB2;ZSWIM5;INPP5F;DAPK3;HDAC6;HBEGF;NRG4;ARAP1
prerank,positive regulation of RNA metabolic process (GO:0051254),-0.40624743785479084,-1.414271858360567,0.022613065326633167,0.46896766053446404,1.0,19/45,20.15%,DDX5;EGFR;BMP4;RIOK1;LIN28B;RIOK2;MAP2K2;NFKB1;TP53;POLR2A;ZC3H18;WDR43;SETX;SIRT7;TGFB1;HABP4;GRSF1;PIK3R1;SUPV3L1
prerank,positive regulation of muscle hypertrophy (GO:0014742),-0.5389197224740163,-1.4140485062726438,0.08686440677966102,0.4677574272542971,1.0,6/15,18.55%,IGF1;ROCK2;ROCK1;CAMK2D;IL6ST;PARP1
prerank,relaxation of muscle (GO:0090075),-0.5645943722628063,-1.4133652091666804,0.08114035087719298,0.4678856892234006,1.0,7/13,10.68%,ATP1A2;GSN;ATP1B1;P2RX4;ATP1A1;KCNJ2;CAMK2D
prerank,regulation of epidermal cell differentiation (GO:0045604),-0.4957175728876329,-1.4123363681328622,0.08296943231441048,0.4689242588320653,1.0,6/21,6.46%,ERRFI1;MAFG;BMP4;CBFB;ROCK2;ROCK1
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.5690140855301707,1.4122663847688879,0.08839779005524862,0.9765848363525204,1.0,4/17,5.71%,RAC2;CAMK1D;TIRAP;RIPOR2
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.42508630592434504,1.4118893570240292,0.0471841704718417,0.9723409100011774,1.0,19/67,14.46%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;PSMD11;PSMB4;PSMC1;B2M;PSMC2;PSMD2;IKBKB;CHUK;PSMD14;PSMC6;PSMD1;PSMB1;CYBA
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.4723221620706429,1.4105530206329284,0.07947019867549669,0.9738539790023157,1.0,9/33,10.93%,PIK3CG;ACER2;CIB1;NEXMIF;RET;SYK;EFNA1;LYN;CYP1B1
prerank,protein import into peroxisome membrane (GO:0045046),-0.48209513616816424,-1.410487247285999,0.08747044917257683,0.47240082941032374,1.0,13/22,30.45%,ACBD5;RAB8B;PEX14;FIS1;ALDH3A2;PXMP4;ABCD2;PEX2;PEX5;GDAP1;ABCD3;PEX26;PEX19
prerank,embryonic skeletal system development (GO:0048706),-0.4316515221383962,-1.410318803325735,0.0546448087431694,0.47101736427064983,1.0,9/35,7.87%,SULF1;COL1A1;PCSK5;SULF2;HOXA3;OSR1;DYNC2I1;PDGFRA;RBP4
prerank,regulation of lysosomal lumen pH (GO:0035751),0.599213290319131,1.410118266720266,0.08208955223880597,0.9697904554942348,1.0,4/12,8.25%,PPT1;TMEM9;ATP6AP2;TMEM165
prerank,sphingolipid metabolic process (GO:0006665),0.3869537928429453,1.4099756240694414,0.026170798898071626,0.9642841118778042,1.0,19/108,8.19%,SERINC1;CERS1;GLB1;ACER2;SMPD4;ST6GALNAC3;CERS4;PPT1;PRKD2;PPP2CA;ESYT2;SGMS1;KDSR;ELOVL6;CERKL;UGCG;PLPP1;TEX2;SGPP2
prerank,immunoglobulin mediated immune response (GO:0016064),0.6382090824678295,1.4099241309966144,0.10526315789473684,0.9581287436745973,1.0,2/10,10.70%,FCGR2B;CD81
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),-0.5788960070995504,-1.4095252304617225,0.07692307692307693,0.47154622091870935,1.0,4/12,5.92%,SORBS1;GKAP1;PRKCZ;SORL1
prerank,mesenchymal cell differentiation (GO:0048762),-0.3975129959621167,-1.4094470972158566,0.04054054054054054,0.46988605816781975,1.0,14/51,11.62%,DDX5;FGFR2;TGFBR3;RANBP3L;DDX17;TGFBR1;CTNNB1;BMP7;ROCK2;ROCK1;WNT4;FOXC1;GSK3B;LOXL3
prerank,glutamine family amino acid metabolic process (GO:0009064),0.4795319840364525,1.409376927362032,0.07106598984771574,0.9549014130221736,1.0,7/33,6.17%,GCLC;ALDH5A1;GLS2;GLS;GOT2;GCLM;MTHFS
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.5192606626558943,1.4084060161704162,0.07103825136612021,0.9543466245761693,1.0,9/25,15.69%,RPL23;PDCL3;PSME3IP1;HIPK2;RPL5;EFNA1;OPHN1;CSNK2A2;TAF1
prerank,protein polymerization (GO:0051258),-0.39523796518763576,-1.4081111777974045,0.030555555555555555,0.47185679732590086,1.0,14/55,9.09%,GSN;GAS7;HDGFL3;SPIRE1;WASL;MAPT;PSTPIP2;ARHGAP6;WASHC5;WASHC3;WASF1;COBL;CKAP5;RNF135
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),-0.37462857229721463,-1.4078112175018487,0.022222222222222223,0.4707414623507389,1.0,14/67,6.19%,ERBB4;FGFR2;EGFR;PDGFRB;ABI1;FER;PIBF1;EFEMP1;KIT;TEC;GHR;RELN;DDR1;PDGFRA
prerank,catecholamine metabolic process (GO:0006584),-0.5341998911332724,-1.4070658643429008,0.07676348547717843,0.4710291373510546,1.0,3/14,6.37%,SNCAIP;ATP7A;COMT
prerank,tRNA modification (GO:0006400),0.4283788094185264,1.4066313120064498,0.060126582278481014,0.9583880087542841,1.0,15/62,16.85%,THG1L;MOCS3;THUMPD1;TRMO;BCDIN3D;THUMPD2;PUS10;TRMT61B;ANKRD16;METTL2A;METTL2B;WDR4;SSB;NSUN6;CDKAL1
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),-0.6110283420698583,-1.405950149746325,0.08365019011406843,0.47251050887146323,1.0,3/10,9.11%,ATP1A2;VDAC1;BIN1
prerank,histone H4 acetylation (GO:0043967),0.44294081767961047,1.4046693247361148,0.07852564102564102,0.9640917523882486,1.0,16/47,14.04%,JADE3;ACTL6A;LEF1;RUVBL2;DMAP1;ING4;KANSL2;BEND3;EP300;RUVBL1;KANSL3;YEATS4;ING3;TRRAP;ING5;HCFC1
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),-0.4406889645654395,-1.4045640562872226,0.057279236276849645,0.474912648464565,1.0,13/31,26.45%,SYT9;SYT12;SYT11;CACNA1G;SYT4;STXBP1;SYT7;SCAMP5;STX1A;SYT2;ADRA2A;SYT10;SYT6
prerank,ribosomal large subunit assembly (GO:0000027),0.5172243071713237,1.4042774063733652,0.09540034071550256,0.9601630978918008,1.0,8/24,13.61%,RSL24D1;FASTKD2;RPL3;RPL5;MRPL20;RPLP0;RPL24;RPL23A
prerank,smooth muscle cell differentiation (GO:0051145),0.5966173202617199,1.4041956926378742,0.10486891385767791,0.9545335765129659,1.0,5/12,8.25%,MRTFA;MRTFB;HEY1;HEY2;EDNRB
prerank,calcium ion transport (GO:0006816),-0.34006197299145136,-1.4041358196613805,0.01858736059479554,0.47426947260897556,1.0,16/113,6.12%,TRPM3;ANK2;SLC24A3;CACNA1C;NALCN;ITPR1;CALCRL;STIM2;CACNA1D;RYR3;PKD1;STIM1;TRPM6;TRPC5;P2RX4;CACNA1B
prerank,positive regulation of interleukin-2 production (GO:0032743),0.49977052782110465,1.403345575149015,0.0899830220713073,0.9531751615821662,1.0,6/25,11.52%,PDE4D;PTPRC;MAP3K7;PRKD2;PNP;RPS3
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.5091388706661306,1.4029238629253615,0.08216783216783216,0.9496898990373255,1.0,2/23,6.81%,CADM1;AP1G1
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.6285529741039875,1.4029226098901024,0.10097087378640776,0.9437227338975236,1.0,2/10,3.42%,PTPRC;MAP2K5
prerank,retinoic acid metabolic process (GO:0042573),-0.548582997905249,-1.401945101759927,0.10738255033557047,0.47894771983419415,1.0,3/14,13.51%,ALDH1A2;SCPEP1;CYP26B1
prerank,regulation of programmed cell death (GO:0043067),0.37251471893099153,1.4015563813837788,0.015810276679841896,0.9458779553073934,1.0,28/161,12.04%,LRP8;CIDEA;MECOM;ACER2;GLS2;CHM;DNAJA3;PAX8;BIRC2;NME1;TNFRSF10B;SLK;TOX3;CASP6;WFS1;AKT1S1;CRADD;ACTN4;SIRT1;OMA1;PHLPP1;FBXO11;TARDBP;NAE1;CREBBP;RPS3;ACER3;BNIP3L
prerank,mitochondrial gene expression (GO:0140053),0.4558077028698843,1.4007628024186387,0.057283142389525366,0.9442054640567349,1.0,15/42,18.14%,MRPS2;MRPL23;FASTKD2;LARS2;MRPS12;HARS1;RARS2;MRPS15;MRPS24;TFAM;MRPS28;GATB;MRPS34;IARS2;GFM2
prerank,regulation of acute inflammatory response (GO:0002673),-0.503083325148728,-1.4007254414967674,0.07311320754716981,0.48080271846691003,1.0,3/18,16.65%,OSMR;IL6ST;PTGES
prerank,neuron fate commitment (GO:0048663),-0.553211953056492,-1.4004084115005082,0.09312638580931264,0.4798235029347883,1.0,2/14,3.29%,MYT1L;TGFBR1
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.43061099075082726,1.3985864981928589,0.058544303797468354,0.9515307502825134,1.0,24/60,20.78%,MAP2K7;MAPK3;PNKP;GREM1;CCT2;PRKD2;CCT5;MAP3K4;RGCC;ACD;NEK7;TNKS;ATR;TCP1;DKC1;PARN;PARM1;TNKS2;NVL;CCT8;RFC5;PTGES3;HSP90AB1;PDGFB
prerank,nucleoside phosphate catabolic process (GO:1901292),-0.5573286322113218,-1.3981107014750604,0.11885245901639344,0.48487209041678103,1.0,10/13,39.55%,ENPP1;ENTPD7;ENTPD5;ENPP3;ENTPD6;ITPA;ENTPD1;ENTPD2;SMPDL3A;ENTPD3
prerank,regulation of mRNA metabolic process (GO:1903311),0.6028383386335805,1.3977929134232472,0.12449799196787148,0.9502072400447342,1.0,7/11,21.70%,NCBP1;CDK11B;SRPK2;PTCD2;SAFB;DHX9;SLTM
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.4960718459107201,-1.397588787712927,0.08064516129032258,0.4845733298862884,1.0,8/21,19.90%,IGF1;IGFBP5;ADAMTS1;GJA1;JUN;BMPR1A;DNMT1;MMP2
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.5262223141659498,1.3973108557008953,0.09615384615384616,0.9472451673767598,1.0,6/20,11.73%,SLC25A1;PPT1;FITM2;FAR2;ACSL4;HSD17B4
prerank,response to X-ray (GO:0010165),-0.5579546865286337,-1.3972672672549435,0.07478632478632478,0.48366905762854584,1.0,7/14,20.02%,NIPBL;IKBIP;ANXA1;NUCKS1;MSH2;ATM;BLM
prerank,potassium ion import across plasma membrane (GO:1990573),-0.40333423311669714,-1.3967074939919166,0.07105263157894737,0.4833815206368884,1.0,20/41,27.26%,ATP1A2;ATP1B1;ATP1B3;SLC12A2;ATP1A1;KCNJ2;ATP1B2;KCNJ6;ABCC9;SLC12A6;KCNJ13;SLC12A4;ATP1A3;SLC12A9;KCNJ10;SLC12A7;KCNK9;HCN2;SLC12A8;SLC12A5
prerank,myoblast differentiation (GO:0045445),-0.5487786501516885,-1.3963579581762855,0.08917197452229299,0.48268688457744996,1.0,3/14,2.05%,DDX5;IGF1;DDX17
prerank,CENP-A containing nucleosome assembly (GO:0034080),0.4850448182797441,1.395674957144879,0.08202443280977312,0.9452626549346134,1.0,9/29,17.31%,MIS18A;HJURP;RUVBL1;RSF1;CENPC;CENPP;RBBP4;CENPO;NPM1
prerank,CENP-A containing chromatin organization (GO:0061641),0.4850448182797441,1.395674957144879,0.08202443280977312,0.9452626549346134,1.0,9/29,17.31%,MIS18A;HJURP;RUVBL1;RSF1;CENPC;CENPP;RBBP4;CENPO;NPM1
prerank,amino sugar metabolic process (GO:0006040),0.6004411987578843,1.3956633198426631,0.125,0.9396460230755471,1.0,4/10,13.42%,CSGALNACT1;EXTL2;SLC35A3;ST3GAL1
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.4167525688280945,1.3955451677782087,0.05417956656346749,0.9346979299337241,1.0,18/65,14.00%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;PSMD11;PSMB4;PSMC1;USP47;PSMC2;PSMD2;CHFR;PSMD14;PSMC6;PSMD1;AVEN;PSMB1
prerank,positive regulation of neuron projection development (GO:0010976),-0.35555717969919154,-1.3953774734440418,0.03812316715542522,0.4837486572827099,1.0,38/85,22.80%,MAGI2;NTRK3;TENM3;LRRC7;DPYSL3;NTRK2;BMP5;TOX;BMP7;PTK7;ROR1;RELN;CBFA2T2;PLPPR5;COBL;STMN2;ARSB;ATP1B2;EPHA3;CUX2;RIT2;CAMK1;VLDLR;ROR2;SETX;PLXNB2;RAPGEF2;ABL2;TWF2;SCARF1;SNX3;PACSIN1;CX3CL1;P3H1;PRKD1;DBNL;CAMK2B;SCN1B
prerank,base conversion or substitution editing (GO:0016553),0.6047754612997194,1.3951357456107405,0.09233791748526522,0.9315272978764952,1.0,3/11,15.66%,ADAR;ADARB2;ADARB1
prerank,chloride transport (GO:0006821),-0.36199301692211155,-1.394669135812794,0.029498525073746312,0.48387027953750206,1.0,35/74,27.26%,GABRB1;SLC4A10;SLC1A3;GLRB;GABRA2;ANO3;CLIC4;SLC6A1;SLC26A7;SLC12A2;GLRA3;GABRG2;GLRA1;CLCN6;ANO1;CLCN2;ANO6;SLC12A6;GABRA5;SLC12A4;GABRG3;CLIC5;ANO10;GABRA4;SLC12A9;GABRG1;SLC4A8;TTYH3;GABRA1;SLC12A7;TTYH1;FXYD1;LRRC8A;SLC12A8;SLC12A5
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.39962217273164286,1.3942710657643744,0.045655375552282766,0.9308152032410308,1.0,24/87,14.00%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;ZFP36L1;PSMD11;PSMB4;PSMC1;CDKN1A;RGCC;FBXO5;USP47;CDK4;WEE1;PSMC2;PSMD2;PSMD14;PSMC6;PSMD1;AVEN;APC;PSMB1
prerank,positive regulation of phosphatase activity (GO:0010922),-0.4935803354858067,-1.3942010426359852,0.06911447084233262,0.4834968721327721,1.0,2/21,1.84%,MAGI2;PDGFRB
prerank,regulation of histone methylation (GO:0031060),0.5959818583608313,1.3933144065114673,0.1050656660412758,0.9306599524393623,1.0,4/13,6.16%,CTCFL;AASS;TTLL12;CHTOP
prerank,nucleoside diphosphate metabolic process (GO:0009132),-0.5421819148719159,-1.3931634649269098,0.08196721311475409,0.4846454705869457,1.0,12/15,43.75%,ENTPD7;ENTPD5;ENTPD6;AK5;ENTPD1;ENTPD2;AK4;CMPK2;AK1;NME2;ENTPD3;AK7
prerank,atrial septum development (GO:0003283),-0.5553233807197269,-1.3922711117166504,0.09190371991247265,0.48547684487879134,1.0,2/13,0.30%,ANK2;NOTCH2
prerank,histone exchange (GO:0043486),0.46776876861454214,1.3916612183959378,0.06643356643356643,0.9344879175785896,1.0,12/37,17.31%,MIS18A;DMAP1;VPS72;HJURP;RUVBL1;RSF1;CENPC;ZNHIT1;CENPP;RBBP4;CENPO;NPM1
prerank,microtubule-based transport (GO:0099111),0.6135240405527398,1.390755679361016,0.10754716981132076,0.9340500407470076,1.0,2/12,2.17%,DYNC1I1;CABYR
prerank,regulation of mitotic cell cycle (GO:0007346),0.36100935857823285,1.3904767585886666,0.020330368487928845,0.9300112647624824,1.0,38/171,14.15%,DYNLT3;PSMB10;ERCC3;PSMC4;PSMB6;CKS2;PSMD8;PSMD5;PSMD12;TAL1;BRINP3;PIN1;ANAPC2;NEK11;TTLL12;PSMD11;PSMB4;PSMC1;CDK11B;FBXO5;SIRT1;ANAPC7;MDM2;PSMC2;TFAP4;PSMD2;NEK7;USP22;APP;ANAPC11;ANAPC10;ANAPC4;PSMD14;PSMC6;NEK6;PSMD1;PSMB1;RNF20
prerank,type I interferon signaling pathway (GO:0060337),0.45668374724889693,1.3903054607962393,0.07729468599033816,0.920348422643267,1.0,13/41,12.67%,IFITM2;IFIT1;XAF1;IFI35;IRF9;IFITM3;ADAR;IFITM1;IFNAR1;IFI27;IP6K2;TYK2;IRF2
prerank,cellular response to type I interferon (GO:0071357),0.45668374724889693,1.3903054607962393,0.07729468599033816,0.920348422643267,1.0,13/41,12.67%,IFITM2;IFIT1;XAF1;IFI35;IRF9;IFITM3;ADAR;IFITM1;IFNAR1;IFI27;IP6K2;TYK2;IRF2
prerank,neutral amino acid transport (GO:0015804),0.4968918840014617,1.3903005044876884,0.06825938566552901,0.9151692935166682,1.0,5/28,5.53%,SLC7A8;SLC1A1;SLC36A4;SLC3A2;SLC6A6
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),-0.418744082453437,-1.3885783602559516,0.06403940886699508,0.49442256230602244,1.0,7/35,3.73%,HTR2C;KSR1;AKAP6;IRAG1;ADCY2;ADCY1;NUDT4
prerank,histone ubiquitination (GO:0016574),-0.48905739158293526,-1.3881540848571026,0.08783783783783784,0.49371754624698266,1.0,12/21,25.71%,UBE2N;WAC;UBE2E1;CDC73;HUWE1;RNF8;PHC1;PAF1;RNF40;DTX3L;UBR2;UBE2B
prerank,regulation of defense response (GO:0031347),0.41341637744991283,1.387916720772732,0.05688622754491018,0.9231452278104396,1.0,17/76,11.89%,LRP8;PIK3AP1;IL1R1;SEMA7A;FCGR2B;TIRAP;BCL6B;BIRC2;SBNO2;APOE;SPATA2;WNT5A;TRAF3;RELA;PARK7;NLRP6;USP18
prerank,positive regulation of cell killing (GO:0031343),0.5864758376878755,1.3878411749885577,0.11560693641618497,0.9184407691130894,1.0,4/13,14.46%,MAPK8;SYK;WNT5A;CYBA
prerank,cellular response to fluid shear stress (GO:0071498),0.5985571707651185,1.386081710215957,0.1005586592178771,0.9229810053269394,1.0,3/12,3.90%,KLF2;MAP2K5;HDAC3
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.5055959367106477,-1.3857150602279453,0.10232558139534884,0.4993180718203891,1.0,11/18,24.78%,NRXN1;TSHZ3;NLGN2;RELN;NLGN1;CACNG7;CACNG4;CACNG2;NLGN3;CACNG3;CACNG8
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),-0.48997189234935395,-1.385675657549607,0.06787330316742081,0.49756720578160035,1.0,7/20,14.25%,ZC3H7A;PUM1;ZC3H7B;PUM2;TSN;AGO3;DICER1
prerank,negative regulation of interleukin-12 production (GO:0032695),-0.5422978103447247,-1.3851434427964342,0.07926829268292683,0.49730660039046964,1.0,3/14,9.33%,PIBF1;IRAK3;THBS1
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),0.600468145649892,1.3843899441034386,0.12062256809338522,0.9269126132910298,1.0,2/11,0.84%,TIMM29;ROMO1
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.4110937316340593,1.3842978051491914,0.048558421851289835,0.9223000253808951,1.0,18/70,14.00%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;TAL1;PSMD11;PSMB4;PSMC1;PSMC2;PSMD2;LMO2;N4BP2L2;PSMD14;PSMC6;PSMD1;PSMB1
prerank,regulation of aerobic respiration (GO:1903715),-0.5306235253535024,-1.383868833122826,0.07484407484407485,0.4994750089759268,1.0,7/15,24.90%,ATP7A;VCP;COX7A2L;SLC25A33;PINK1;NOP53;UQCC2
prerank,phagolysosome assembly (GO:0001845),0.5912246368004497,1.3827774089684028,0.11380597014925373,0.9259236721774541,1.0,4/12,8.22%,RAB7A;RAB7B;PIKFYVE;RAB14
prerank,cardiac muscle contraction (GO:0060048),-0.41313323558850795,-1.3827434216765655,0.06217616580310881,0.5009478440869832,1.0,4/34,4.07%,ATP1A2;GSN;ATP1B1;TPM1
prerank,positive regulation of cellular senescence (GO:2000774),0.6331207328882625,1.3825953772210142,0.12678936605316973,0.9218268658170685,1.0,3/10,7.73%,B2M;SIRT1;YPEL3
prerank,nucleoside triphosphate metabolic process (GO:0009141),-0.5318880360457146,-1.382343294500565,0.10199556541019955,0.5003617272932626,1.0,10/14,37.64%,ENPP1;ENPP3;AK3;AK5;ITPA;AK4;SMPDL3A;CMPK2;AK1;NME2
prerank,regulation of immunoglobulin production (GO:0002637),0.5148823311585426,1.3817337890881844,0.0944055944055944,0.9215055194772473,1.0,4/23,10.85%,PTPRC;FCGR2B;PHB2;GPI
prerank,relaxation of cardiac muscle (GO:0055119),-0.5564804851693365,-1.3803711266345298,0.10421286031042129,0.5045526754079931,1.0,7/13,10.68%,ATP1A2;GSN;ATP1B1;P2RX4;ATP1A1;KCNJ2;CAMK2D
prerank,cell-cell junction assembly (GO:0007043),-0.3688849385740345,-1.3790353876460926,0.043478260869565216,0.5066676871718885,1.0,28/63,23.00%,EPB41L3;CDH10;GJB6;CTNNA1;CTNNB1;RHOA;TLN1;CLDN11;JAM3;VCL;CTNND2;CDH11;TLN2;CDH7;GJC1;GJD3;ARVCF;GJA1;GJB2;WDR1;CTNND1;CDH9;CDH8;CDH19;CLDN12;FLCN;RHOC;DCHS1
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.4551612437133086,1.3787272703718803,0.08149405772495756,0.932560859237225,1.0,15/40,16.33%,RPL23;PDCL3;HIPK2;UBE3A;RPL5;FOXF2;AXIN1;DESI1;GNA12;RAD23A;XPO1;CSNK2A2;UBQLN4;TAF1;PTK2B
prerank,microvillus organization (GO:0032528),0.5623705988101702,1.3778881378172614,0.12162162162162163,0.9323121620219424,1.0,6/13,15.52%,RAP2A;MINK1;RAPGEF6;RAP2C;MAP4K4;FXYD5
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),-0.5745057450044533,-1.3778615484767462,0.10722100656455143,0.5085482216983283,1.0,2/12,1.68%,MAGI2;IQGAP1
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.46549318815283075,1.3776147267646417,0.07601351351351351,0.9287916750815002,1.0,12/35,16.46%,MAP2K7;MAPK3;PNKP;CCT2;CCT5;MAP3K4;ACD;NEK7;TNKS;ATR;TCP1;PARN
prerank,regulation of microtubule-based process (GO:0032886),-0.418845266803574,-1.3771794323734627,0.059278350515463915,0.5087807557125724,1.0,12/36,14.42%,BICD1;PHLDB2;EFNA5;PHLDB1;CYLD;MAPT;MACF1;ROCK1;GSK3B;EPHA3;TAOK1;TRIM36
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.5498177315734901,-1.3757791064995388,0.09611451942740286,0.511345804792901,1.0,4/13,9.97%,NFAT5;RHOA;IRAK1;ZDHHC21
prerank,negative regulation of DNA metabolic process (GO:0051053),0.49563449811611093,1.375642648042774,0.1057347670250896,0.9344100418486614,1.0,7/24,11.52%,ZRANB3;DACH1;ERCC4;CDKN1A;ACVRL1;MSH3;RPS3
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),-0.5642305865165568,-1.3755926309080704,0.08714596949891068,0.5101607620224905,1.0,4/12,16.23%,TMEFF2;AP2A1;SELENOS;TGFB1
prerank,dendrite morphogenesis (GO:0048813),-0.4103715381590521,-1.375589705388385,0.06053268765133172,0.50837169530941,1.0,11/35,10.62%,MAP2;CTNNA2;EPHB1;SDC2;WASL;DLG4;DCDC2;CTNND2;DOCK10;BTBD3;EPHB2
prerank,regulation of cellular pH (GO:0030641),0.48254943519928767,1.3751230528466734,0.08417508417508418,0.9325115907839578,1.0,7/29,10.69%,SLC4A4;SLC4A5;SLC9A7;CA2;SLC9A6;SLC9A8;ATP6AP1
prerank,defense response to Gram-positive bacterium (GO:0050830),0.4523187404009067,1.3750543595683244,0.08239095315024232,0.9281204102369643,1.0,6/40,7.66%,ROMO1;DMBT1;TIRAP;RNASE6;GBP4;PPP1R11
prerank,regulation of axonogenesis (GO:0050770),-0.3861564711149733,-1.3749877328465985,0.039886039886039885,0.5084898840102362,1.0,15/51,15.77%,LRRC4C;ROBO2;PLXNA2;ROBO1;NTRK2;TIAM2;RHOA;BRSK1;GSK3B;GDI1;PLXND1;ARHGDIA;PLXNB2;NGF;PLXNC1
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),0.5163064988193553,1.3749813528860544,0.10387323943661972,0.9236706267800749,1.0,6/20,9.12%,SEMA6A;SEMA6D;SEMA7A;SEMA3C;SEMA6B;SEMA4C
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),-0.5486676603427354,-1.3748628182805482,0.10602910602910603,0.5070491925215895,1.0,4/13,5.92%,SORBS1;GKAP1;PRKCZ;SORL1
prerank,regulation of stem cell differentiation (GO:2000736),0.3951709740778509,1.373948375597463,0.048411497730711045,0.9243250277064298,1.0,20/89,14.00%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;TAL1;OCIAD1;PSMD11;PSMB4;PSMC1;NOTCH1;PSMC2;PSMD2;LMO2;PSMD14;PSMC6;PSMD1;HES1;PSMB1
prerank,inner mitochondrial membrane organization (GO:0007007),0.43651784236663443,1.373496246751889,0.07269789983844911,0.9220013612779693,1.0,16/47,14.72%,TIMM29;ROMO1;ATP5F1E;UQCC3;ATP5MG;ATP5PF;ATP5MC2;IMMT;MAIP1;CHCHD6;CHCHD3;LETM1;DNAJC11;NDUFA13;MICOS10;ATP5F1C
prerank,positive regulation of phospholipase activity (GO:0010518),-0.4742454704675472,-1.3734503236735798,0.09292035398230089,0.5096703723832218,1.0,9/22,19.78%,NTRK3;FGFR2;PDGFRB;KIT;PDGFRA;ARL1;ARF4;ABL2;AGTR1
prerank,positive regulation of Ras protein signal transduction (GO:0046579),-0.37111606015133625,-1.3734226715018312,0.030303030303030304,0.5079554040405352,1.0,8/62,3.24%,NOTCH2;LPAR1;IGF1;ROBO1;AKAP13;COL3A1;AUTS2;RASGRF1
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.5695076690058293,1.373367875478206,0.12477396021699819,0.917950293077972,1.0,5/13,16.80%,KPNA3;NUP54;KPNA1;NUP35;KPNB1
prerank,response to organonitrogen compound (GO:0010243),-0.41396753676531917,-1.3726322035216774,0.06356968215158924,0.5086633558231701,1.0,11/38,17.58%,GLRB;KAT7;VCP;RHBDD1;GLRA3;HLCS;GLRA1;IRAK3;RCN3;RNF139;ERLEC1
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.4372056002208846,1.372511151508494,0.07704918032786885,0.9178386667861274,1.0,18/51,18.25%,MAP2K7;MAPK3;CTC1;PNKP;SRC;CCT2;CCT5;MAP3K4;HNRNPC;ACD;NEK7;TNKS;ATR;TCP1;PARN;SMG6;TNKS2;SMG5
prerank,regulation of transforming growth factor beta production (GO:0071634),-0.4956095158447712,-1.3718468572422249,0.08764044943820225,0.5092409701865638,1.0,6/18,11.71%,SMAD3;ITGB8;SMAD4;LTBP1;FN1;CD34
prerank,intracellular pH reduction (GO:0051452),0.4699041138135713,1.3711785398639313,0.06382978723404255,0.9200625601188333,1.0,11/33,14.80%,ATP6V1D;CLCN3;RAB7A;ATP6V0D1;TMEM9;GPR89B;GPR89A;ATP6V0E1;DMXL2;DMXL1;ATP6V1B2
prerank,negative regulation of TORC1 signaling (GO:1904262),-0.5417721117982206,-1.3710435754021384,0.09421841541755889,0.5099708210992427,1.0,7/13,17.23%,RNF152;DEPDC5;CASTOR2;STK11;ATM;SZT2;ITFG2
prerank,neuromuscular process controlling balance (GO:0050885),-0.5523612794391349,-1.370784969291267,0.09623430962343096,0.5090219157700915,1.0,2/12,1.35%,PCDH15;NRXN1
prerank,negative regulation of ion transport (GO:0043271),-0.44932219549775804,-1.3707134201537063,0.10416666666666667,0.5075054397269139,1.0,12/24,30.08%,GPM6B;WNK1;ACTN2;WNK4;SYT11;WNK3;NEDD4;ADRA2A;INPP5K;SNCA;PACSIN3;NOS1
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.4450139357539801,1.3706660345902095,0.061806656101426306,0.918046522515423,1.0,20/42,19.08%,ACTL6A;DMAP1;ACTB;SMARCA2;VPS72;ACTR8;HNRNPC;ACTR5;CHD3;CECR2;ZNHIT1;INO80;PBRM1;SMARCA4;RBBP4;SMARCAD1;CHD8;HDAC2;ACTR6;SMARCB1
prerank,positive regulation of axonogenesis (GO:0050772),-0.3974352178484725,-1.370276958477847,0.051490514905149054,0.5070083030208248,1.0,19/43,21.60%,ROBO2;PLXNA2;ROBO1;NTRK2;TIAM2;MAPT;MACF1;RHOA;SHTN1;SEMA4D;PLXND1;ARHGDIA;PLXNB2;NGF;PLXNC1;TWF2;ZFYVE27;SLITRK1;DBNL
prerank,regulation of establishment of planar polarity (GO:0090175),0.39046573447782584,1.3701916345858212,0.04769001490312966,0.9160232900595197,1.0,24/88,14.38%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;TIAM1;AP2S1;PSMD11;PFN1;PSMB4;PSMC1;DAAM1;WNT5A;PSMC2;FZD3;PSMD2;CELSR1;PSMD14;PSMC6;PSMD1;PSMB1;SPEF1;AP2M1
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.4147762784638849,1.3701602728424318,0.07219662058371736,0.911602535925765,1.0,17/61,14.00%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;PANK2;PSMD11;PSMB4;PSMC1;SIRT1;PSMC2;PSMD2;PSMD14;PSMC6;PSMD1;PSMB1
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.519331932472617,1.370122417689627,0.10669077757685352,0.907234830507857,1.0,5/19,4.52%,NDST3;CSGALNACT1;XYLT1;EXT2;HS6ST1
prerank,protein neddylation (GO:0045116),0.5710893147306468,1.3700430651982114,0.11753371868978806,0.9031493004696675,1.0,7/13,16.97%,RNF7;DCUN1D4;UBE2M;NAE1;UBE2F;DCUN1D2;DCUN1D1
prerank,protein acylation (GO:0043543),0.45483216147722966,1.3698309344335224,0.08928571428571429,0.8997365367128555,1.0,13/38,14.04%,ZDHHC17;ING4;ZDHHC13;EP300;ZDHHC14;CLOCK;SELENOK;ZDHHC15;CREBBP;NAA80;ZDHHC9;ING5;ZDHHC7
prerank,JNK cascade (GO:0007254),0.4483283604560845,1.369816511200535,0.07655502392344497,0.8954153421023825,1.0,11/40,12.14%,MAP2K7;MAP3K11;MAP3K7;TAB2;MAPK8;ARHGEF6;TAB3;MINK1;UBE2V1;NOD1;CRKL
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.3891417277798301,-1.3680801582254312,0.05012531328320802,0.5116885006390584,1.0,14/47,14.45%,DOCK5;EFNA5;DOCK1;FBLN1;NRP1;PDPN;FLNA;NEDD9;RREB1;P4HB;ILK;MYADM;PTK2;TRIOBP
prerank,BMP signaling pathway (GO:0030509),-0.36446855670971123,-1.3672303269365205,0.029585798816568046,0.512704767871209,1.0,14/62,10.15%,DDX5;BMP6;TGFBR3;SMAD3;RGMA;BMP5;BMP7;SMAD4;BMP4;SMAD6;ZFYVE16;ACVR1;HIVEP1;RGMB
prerank,protein localization to cell periphery (GO:1990778),-0.3218150212955419,-1.3669350739260453,0.01568627450980392,0.5117856365033945,1.0,38/133,16.80%,ANK2;DPP6;ANK3;KCNB2;KCNIP4;EPB41L3;MAP7;RAB3C;ATP1B1;PACS2;FLNA;KCNIP3;ROCK2;ATP1B3;FLOT2;RAB8B;PIP5K1A;ROCK1;TTC7B;EZR;ACTN2;TTC7A;CDH1;DPP10;RAMP1;DLG1;MYADM;RAB11A;WNK3;WDR19;STXBP1;AP4M1;FYB1;LRP6;RAPGEF2;EHD1;RAB8A;EHD3
prerank,embryonic appendage morphogenesis (GO:0035113),0.5912299944176171,1.36660141791565,0.1308411214953271,0.9078032716670512,1.0,1/12,0.04%,TBX4
prerank,peptidyl-tyrosine modification (GO:0018212),-0.37775655159807275,-1.3660401797339332,0.05962059620596206,0.5126497967009999,1.0,11/56,6.19%,ERBB4;FGFR2;EGFR;PDGFRB;ABI1;FER;EFEMP1;KIT;TEC;RELN;PDGFRA
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.47925748099338,1.3654094001934836,0.1076158940397351,0.9095499227651428,1.0,7/30,12.36%,NUDT14;ASGR1;ALG8;OST4;STT3B;MCFD2;MGAT5
prerank,regulation of stress fiber assembly (GO:0051492),-0.358632809208827,-1.3631914010307642,0.05194805194805195,0.5195739575022031,1.0,18/74,6.57%,TMEFF2;PHLDB2;LPAR1;CGNL1;WASF2;NRP1;ARHGEF10L;CCN2;TGFBR1;TPM1;ARHGAP28;RHOA;PXN;PPFIA1;ROCK2;ARHGAP6;ROCK1;PPM1E
prerank,regulation of neuron projection development (GO:0010975),-0.30968442153587566,-1.3620281088174813,0.008438818565400843,0.5212584568294268,1.0,55/163,22.10%,MAGI2;LRRC4C;NTRK3;TENM3;DCC;LPAR1;LRRC7;CTNNA2;PDLIM5;SPOCK1;DPYSL3;NTRK2;NTNG1;PTPRS;EFNB2;TOX;PTK7;ROR1;RELN;CBFA2T2;SEMA3A;SRCIN1;PLPPR5;STMN2;ARSB;ULK4;ATP1B2;BRSK1;GSK3B;PRAG1;EPHA3;DISC1;RIT2;IL1RAPL1;KIF1A;CAMK1;ROR2;SETX;PLXNB2;PTPRO;RAPGEF2;ABL2;TWF2;MYLIP;SCARF1;SNX3;NCS1;KNDC1;MAG;PAQR3;CX3CL1;P3H1;PRKD1;RTN4IP1;CAMK2B
prerank,signal release from synapse (GO:0099643),-0.4004621171954121,-1.3616890539730724,0.04736842105263158,0.520489123411881,1.0,14/43,17.28%,RIMS1;SNAP25;NRXN1;SYN2;PCLO;PTPRN2;SYN1;BRSK1;NRXN2;STXBP1;SNPH;VAMP2;STX1A;DVL1
prerank,cellular response to UV-A (GO:0071492),0.5886229598072003,1.3616858147713813,0.1337099811676083,0.9243190328928902,1.0,2/11,4.43%,CERS1;MME
prerank,positive regulation of wound healing (GO:0090303),-0.417630602678064,-1.3613025232866616,0.07598039215686274,0.519980777902117,1.0,18/36,33.10%,OCLN;PLPP3;RREB1;SMOC2;THBS1;VTN;FOXC2;ANXA1;PTK2;ST3GAL4;ENPP4;ADRA2A;DMTN;SERPINE1;HBEGF;MYLK;CLDN1;MTOR
prerank,epithelial cell-cell adhesion (GO:0090136),-0.5644258161549742,-1.3612611046036815,0.10021321961620469,0.5184145226958992,1.0,5/11,22.42%,KIT;VCL;ITGB5;CCN3;PLEKHA7
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.5429913337674108,1.3609500116795492,0.1274131274131274,0.9237454190760718,1.0,8/14,18.79%,ACD;TPP1;TERT;TNKS;TERF2IP;ATR;TNKS2;ATRX
prerank,positive regulation of viral life cycle (GO:1903902),-0.47199854371388955,-1.3607470139366398,0.09131403118040089,0.5182528075587962,1.0,8/22,21.10%,AXL;DDB1;P4HB;TSG101;CHMP2B;LGALS1;TRIM11;VPS4A
prerank,mammary gland development (GO:0030879),-0.46634411653011704,-1.360087860292768,0.08490566037735849,0.5184795992470955,1.0,8/21,26.13%,ERBB4;GLI2;WNT4;TBX3;PRLR;VEGFA;TGFB3;NOTCH4
prerank,neutrophil migration (GO:1990266),0.4226216810070543,1.3598144741558422,0.07272727272727272,0.9255432202344758,1.0,8/58,11.50%,PIK3CG;BSG;PECAM1;PPIB;SYK;PIKFYVE;CCL25;PIK3CD
prerank,regulation of gene expression by genetic imprinting (GO:0006349),0.5971285543393766,1.3597238832136904,0.14738805970149255,0.9216475655354566,1.0,2/10,6.24%,CTCFL;PCGF3
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),-0.3543932364209349,-1.3597237676987417,0.046012269938650305,0.51777290468588,1.0,19/75,13.93%,MAP2;FGFR2;CNTN4;ANK3;DCC;MAP1B;CTNNA2;NRCAM;NTNG1;SDC2;RYK;DCDC2;SHTN1;BRSK1;BTBD3;PLPPR4;AFG3L2;UNK;MAP1A
prerank,protein-DNA complex assembly (GO:0065004),0.3726042987548612,1.3587504008985016,0.05091937765205092,0.9222643604342656,1.0,24/116,14.00%,PSMB10;ERCC3;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;NAP1L4;ORC3;PSMD11;CCNH;PSMB4;PSMC1;ORC4;GTF2H1;RSF1;PSMC2;PSMD2;ORC2;PSMD14;PSMC6;PSMD1;BRD2;PSMB1
prerank,microvillus assembly (GO:0030033),0.5465928595157674,1.3586407976384223,0.13051823416506717,0.9184466963958652,1.0,6/14,15.52%,RAP2A;MINK1;RAPGEF6;RAP2C;MAP4K4;FXYD5
prerank,positive regulation of cartilage development (GO:0061036),-0.5099432997282867,-1.3577780565377835,0.09523809523809523,0.5220486220994521,1.0,9/17,28.26%,SOX5;TAPT1;BMP4;BMPR1B;SOX6;BMPR2;PKDCC;BMP2;MDK
prerank,'de novo' posttranslational protein folding (GO:0051084),0.46680611526065413,1.3550501951057066,0.09944751381215469,0.9327622816757799,1.0,12/30,17.98%,HSPA8;CCT2;DNAJB5;BAG1;HSPE1;SDF2;HSPA13;DNAJB14;HSPA14;GAK;ST13;UGGT1
prerank,activin receptor signaling pathway (GO:0032924),-0.5193208854230588,-1.354030940707683,0.11879049676025918,0.5318997651707248,1.0,4/15,12.18%,SMAD3;TGFBR1;ACVR1;ACVR1B
prerank,negative regulation of epithelial cell migration (GO:0010633),0.46073093825040423,1.3540245799313535,0.09917355371900827,0.9335695567889977,1.0,8/33,11.08%,PTPRR;PTPRG;PTPRM;EVL;APOE;KRIT1;ACVRL1;ADIPOR1
prerank,negative regulation of T cell mediated immunity (GO:0002710),0.5974459154562142,1.3539055575896726,0.13320463320463322,0.9298838820149405,1.0,2/11,7.28%,PTPRC;SMAD7
prerank,retrograde axonal transport (GO:0008090),-0.5053730521140771,-1.353282654194974,0.10950413223140495,0.5325534616086219,1.0,9/16,16.19%,DLG2;DYNC1H1;KIF1C;FBXW11;KIF1A;MAP1A;NEFL;KIF5A;ACTR10
prerank,positive regulation of cation transmembrane transport (GO:1904064),-0.3929449902944572,-1.3526376093546228,0.06068601583113457,0.5327228111148926,1.0,9/41,11.70%,ANK2;ANK3;KCNMA1;AKAP6;FLNA;GABBR2;KCNJ2;ACTN2;KCNJ6
prerank,AMP metabolic process (GO:0046033),-0.5226564077611148,-1.3523495421189704,0.1346153846153846,0.5318389885901001,1.0,11/13,42.67%,AMPD3;XDH;AK3;AMPD2;ADSS2;ADSL;AK4;NUDT2;NT5C1A;ADSS1;NT5E
prerank,macrophage activation involved in immune response (GO:0002281),0.5630767693004842,1.352234385210844,0.12172284644194757,0.9343395755182172,1.0,3/13,6.70%,IFI35;SBNO2;SYK
prerank,stress-activated MAPK cascade (GO:0051403),0.41319830662824325,1.3520821624533303,0.055384615384615386,0.9307220901777925,1.0,16/61,12.87%,MAP2K7;MAP3K11;MAPK3;MAP3K7;TAB2;ZFP36L1;MAPK8;ARHGEF6;TAB3;MINK1;UBE2V1;NOD1;CRKL;TNIP2;IKBKB;CHUK
prerank,neurotransmitter secretion (GO:0007269),-0.3943721587838532,-1.3516148295796746,0.05181347150259067,0.5325338913328191,1.0,14/44,17.28%,RIMS1;SNAP25;NRXN1;SYN2;PCLO;PTPRN2;SYN1;BRSK1;NRXN2;STXBP1;SNPH;VAMP2;STX1A;DVL1
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.39425729047545716,1.3512177029248962,0.06814814814814815,0.9309015004356495,1.0,19/79,10.48%,DYNC1I1;MFSD6;KIF18A;CAPZA2;FCGR2B;AP2S1;KIFAP3;RAB7A;DCTN2;CLTA;AP1G1;AP1S2;PIKFYVE;KIF15;DCTN3;ARF1;OSBPL1A;KIF2A;DYNLL1
prerank,negative regulation of lipid catabolic process (GO:0050995),0.5285791003075033,1.3509157508224716,0.11851851851851852,0.9281519122737655,1.0,1/17,0.14%,CIDEA
prerank,regulation of calcium ion transport (GO:0051924),-0.37226505838454865,-1.3504004449079436,0.05221932114882506,0.5345890357293486,1.0,21/54,30.08%,ANK2;STIM2;CACNA1D;STIM1;CTNNB1;P2RX4;IL16;SRI;WNK3;EFHB;BCL2;CACNA2D1;CAMK2B;TRPC6;CRACR2A;CAMK2A;ADRA2A;INPP5K;PACSIN3;MYLK;NOS1
prerank,centromere complex assembly (GO:0034508),0.4493967288858262,1.3502893771207056,0.1001727115716753,0.9272154897379404,1.0,11/36,17.31%,MIS18A;HJURP;RUVBL1;RSF1;CENPC;MIS12;POGZ;CENPP;RBBP4;CENPO;NPM1
prerank,vacuolar acidification (GO:0007035),0.5056551510118962,1.34926119057947,0.13082437275985664,0.9284631926325555,1.0,7/21,13.75%,PPT1;ATP6V0D1;TMEM9;ATP6AP2;ATP6V0E1;DMXL2;DMXL1
prerank,endocytic recycling (GO:0032456),0.4301171896232111,1.349226010442921,0.08925619834710743,0.9244942294858256,1.0,20/50,18.24%,VPS50;EHD4;VPS29;RAB7A;VPS26A;RAB11B;DENND1A;SNX17;RAB14;VPS53;EIPR1;ACAP2;CCDC93;ANKRD27;VPS35;DENND1B;ARF6;ANKRD50;SNX27;VPS26C
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.5520446794966554,-1.3491175926141858,0.1331923890063425,0.5368372273343784,1.0,4/12,12.92%,CTNNA3;CACNA1C;BIN1;DLG1
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.5026153412893373,-1.348927756986971,0.11389521640091116,0.5356558332804028,1.0,9/15,17.78%,WNT5B;GPC3;CSNK1E;RSPO3;ZNRF3;RNF213;DAAM2;DACT1;SFRP4
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.5276877063999367,1.34889939726362,0.1298932384341637,0.9219942044610168,1.0,2/18,4.13%,PCK1;ZFP36L1
prerank,sodium ion transport (GO:0006814),-0.3373252204925668,-1.3488004267604363,0.037162162162162164,0.5343345742800925,1.0,23/85,18.17%,ATP1A2;SLC24A3;HCN1;NALCN;SLC6A13;ATP1B1;SLC6A1;SCN8A;SCN3A;ATP1B3;SLC12A2;SLC6A9;SLC6A12;SCN1A;SLC24A2;SGK1;SLC9B2;SLC6A15;ANO6;NDUFA9;SLC5A6;SLC38A7;SLC5A5
prerank,cardiac muscle cell differentiation (GO:0055007),-0.47755873015208455,-1.3487031254434143,0.10633484162895927,0.5329679523312084,1.0,10/21,34.54%,AKAP13;CXADR;SIK1;ACVR1;KDM6B;VEGFA;MYH11;BMP2;CBY1;MYOCD
prerank,organic anion transport (GO:0015711),0.39695601771974187,1.3486119318030383,0.06782106782106782,0.9192481869838313,1.0,13/76,10.46%,SLC4A4;SLC4A5;ABCC4;SLC25A24;ABCG2;CA2;SLC52A2;CA4;SLC52A3;LRRC8C;SLC35A1;CYB5R4;SLC35B1
prerank,protein localization to cell junction (GO:1902414),-0.456595872694401,-1.3474768966964354,0.10849056603773585,0.5350570752814321,1.0,9/22,13.67%,CGNL1;PCLO;JAK1;DLG4;NLGN2;JAM3;NLGN1;KIF3A;BSN
prerank,peripheral nervous system development (GO:0007422),0.504748901547375,1.3471100717375661,0.14235500878734622,0.922864645540257,1.0,7/23,14.16%,GFRA3;BDNF;NFASC;PMP22;NF1;ARTN;ADGRG6
prerank,phosphatidylinositol dephosphorylation (GO:0046856),-0.4576364703335212,-1.3465030049534579,0.09803921568627451,0.5364208474327542,1.0,11/23,27.74%,MTMR7;PIP4P2;SACM1L;MTMR12;MTMR9;MTMR4;MTMR11;PIP4P1;INPP5F;OCRL;INPP5K
prerank,non-motile cilium assembly (GO:1905515),-0.4204254812145191,-1.3443818371389022,0.09024390243902439,0.5411730607212574,1.0,17/30,31.82%,PIBF1;TTC8;IFT57;CEP89;ARL13B;DISC1;DCTN1;CEP250;GORAB;TMEM80;IFT88;TOGARAM1;C2CD3;FUZ;TMEM216;BBS1;VANGL2
prerank,synaptic vesicle exocytosis (GO:0016079),-0.4009894265649096,-1.3439662033172277,0.05774278215223097,0.540838925947527,1.0,17/40,29.69%,RIMS1;SNAP25;PCLO;STX3;UNC13C;SNPH;UNC13B;VAMP2;SYT7;STX1A;SYT2;SNAP29;CPLX1;SYT10;STX1B;SNCA;CDK5
prerank,histone deacetylation (GO:0016575),-0.39757546813385697,-1.343957705397448,0.08533333333333333,0.5391629141762755,1.0,15/43,12.62%,PRDM5;MIER1;HDAC4;TBL1XR1;HDAC1;SIRT2;MORF4L2;PER2;MTA3;MIDEAS;MORF4L1;MTA1;TBL1X;PER1;RCOR3
prerank,regulation of adenylate cyclase activity (GO:0045761),-0.4589967118882585,-1.3435873266966458,0.10739856801909307,0.5387281125262308,1.0,5/22,7.83%,CACNA1C;CACNA1D;STIM1;ADGRV1;GABBR2
prerank,regulation of tissue remodeling (GO:0034103),-0.48392164028164364,-1.3433968286436968,0.12359550561797752,0.5375703609303519,1.0,7/18,30.88%,LEPR;IL18;SYT7;TGFB1;MDK;CEACAM1;FLT4
prerank,regulation of calcium-mediated signaling (GO:0050848),-0.4410539372301323,-1.3431308406313587,0.12121212121212122,0.5367692485972205,1.0,5/25,11.76%,ITPR1;MAPT;P2RX4;HTT;RIT2
prerank,branching involved in blood vessel morphogenesis (GO:0001569),-0.5276034271484807,-1.3431214052727898,0.1290983606557377,0.5351334569000703,1.0,3/13,3.91%,NRP1;TGFBR2;CTNNB1
prerank,positive regulation of nervous system development (GO:0051962),-0.3871748516460466,-1.342955524310354,0.07397959183673469,0.5339661939267545,1.0,13/42,12.29%,NRXN1;GRID2;EPHB1;NLGN2;SYNDIG1;CLSTN2;SPEN;NLGN1;SNW1;EPHB2;NUMBL;CUX2;IL1RAPL1
prerank,cardiac muscle tissue morphogenesis (GO:0055008),-0.4371740981287251,-1.3428449624980894,0.10218978102189781,0.532681440443081,1.0,3/29,4.07%,FGFR2;TGFBR3;TPM1
prerank,membrane lipid biosynthetic process (GO:0046467),0.41105890810751855,1.3427582944621737,0.08936825885978428,0.9411845739096592,1.0,17/58,16.13%,CERS1;ACER2;CERS4;PRKD2;SGMS1;KDSR;ELOVL6;PLPP1;SGPP2;HACD2;ACER3;SGPP1;SPNS2;ST8SIA6;CERT1;GBGT1;PPM1L
prerank,ceramide biosynthetic process (GO:0046513),0.43475016790552035,1.3427301486455891,0.08090614886731391,0.9371868169625955,1.0,5/40,5.24%,CERS1;SMPD4;ST6GALNAC3;CERS4;SGMS1
prerank,positive regulation of microtubule polymerization (GO:0031116),-0.42997882956747,-1.3421481966613191,0.10451306413301663,0.5330028006543179,1.0,12/28,28.01%,NAV3;MAPT;OCLN;AKAP9;SLAIN2;CKAP5;DCTN1;MET;GIT1;ARL2;TOGARAM1;MAPRE1
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.5461389773653046,1.3421276785941005,0.12637362637362637,0.93602794625976,1.0,3/15,8.70%,REEP1;ATL1;REEP3
prerank,myofibril assembly (GO:0030239),-0.3872066223588697,-1.3416065506311265,0.0671462829736211,0.5330159138794456,1.0,9/42,14.39%,CFLAR;PDGFRB;TMOD2;TPM1;PDGFRA;ACTN2;CSRP2;OBSL1;WDR1
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.502168411928508,-1.341410624088284,0.09287257019438445,0.5319173124621434,1.0,7/17,30.46%,AKAP13;ADCY9;ADRA1B;RAPGEF2;ADRA1A;ADRA2A;DRD2
prerank,mitotic metaphase plate congression (GO:0007080),0.4167347897949858,1.3412294671195717,0.08870967741935484,0.9364738140143108,1.0,11/51,12.83%,KIF18A;NUDC;BOD1;CHAMP1;DCTN2;CHMP1A;CDCA8;CENPC;CHMP2A;MIS12;CUL3
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.37404882365046654,-1.3403530509198858,0.06582278481012659,0.5336097173759157,1.0,8/49,7.05%,ERBB4;IGF1;PARP14;IL6R;PIBF1;KIT;GHR;IL31RA
prerank,ventricular septum morphogenesis (GO:0060412),-0.45035860083901524,-1.3403525606250288,0.11056511056511056,0.5320010136671871,1.0,7/27,4.74%,ROBO2;TGFBR3;ROBO1;TGFBR1;TGFBR2;SMAD4;BMP4
prerank,response to light stimulus (GO:0009416),0.4112006037302179,1.3400562953528918,0.09646302250803858,0.9384797329817913,1.0,9/55,10.40%,ERCC3;ZRANB3;MAP2K7;GPR52;ERCC4;MAPK8;CLOCK;SPRTN;CCAR2
prerank,protein targeting to mitochondrion (GO:0006626),0.4250405687643284,1.339956697914705,0.08082408874801902,0.9349216482135958,1.0,11/52,10.17%,TOMM20;TIMM29;ROMO1;IMMP2L;TIMM17B;TSPO;GRPEL2;TOMM40L;TIMM21;FBXO7;AIFM1
prerank,defense response to Gram-negative bacterium (GO:0050829),0.43476328797923314,1.3397920422576894,0.1035031847133758,0.9316454481234206,1.0,5/42,6.63%,ROMO1;RPL30;DMBT1;RNASE6;SELP
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),-0.5689241839974373,-1.3397892264857487,0.13664596273291926,0.5320577859631814,1.0,2/11,1.47%,ST18;GSN
prerank,positive regulation of ion transport (GO:0043270),-0.3827652133041698,-1.33973893245688,0.06218905472636816,0.5305718768851028,1.0,18/48,25.10%,ANK2;ANK3;STIM2;CACNA1D;FHL1;SNX4;P2RX4;ACTN2;DLG1;WNK3;ANO6;GPD1L;TRPC6;SCN1B;VAMP8;CRACR2A;CAMK2A;ADRA2A
prerank,positive regulation of osteoblast differentiation (GO:0045669),-0.3933566654231235,-1.3386972509687465,0.06635071090047394,0.5319100807127861,1.0,22/43,28.14%,BMP6;IGF1;NELL1;BMP7;IL6R;BMP4;FBN2;WNT4;LRP5;ACVR1;IL6ST;BMPR1B;WWTR1;BMPR1A;BMPR2;CCN1;PRKD1;YAP1;RUNX2;CCN4;LRP3;BMP2
prerank,regulation of protein dephosphorylation (GO:0035304),0.4471497934657472,1.338571753062391,0.09268292682926829,0.9337635124267507,1.0,15/37,15.43%,PIN1;TIPRL;PPP1R16B;CNEP1R1;YWHAB;CALM3;SPPL3;TSC1;MFHAS1;ANKLE2;PTBP1;CDH5;PTPA;PPP6R1;PPP1R8
prerank,anterograde trans-synaptic signaling (GO:0098916),-0.2911078181826364,-1.3382190966141174,0.02030456852791878,0.5318116180412449,1.0,56/224,17.50%,DLG2;DLGAP1;KCNQ3;PLP1;HTR2C;GABRB1;GRIA4;SNAP25;GRIA2;SLC1A3;NRXN1;CACNB4;AMPH;GRIN2B;GRM5;GLRB;CHRM2;KCND2;SYN2;MBP;GABRA2;DLG4;NLGN2;SLC6A1;CACNA1B;GLRA3;CAMK4;CHRM3;GABRG2;GLRA1;GABBR2;AKAP9;NLGN1;SYN1;KCNA1;PRKACA;HTR4;RIT2;NRXN2;PRKAR1B;APBA1;DLG1;UNC13C;CAMK1;BSN;HTR7;UNC13B;GRIK4;SLC12A6;LRP6;KIF5A;GABRA5;SLC12A4;NOVA1;GABRG3;HCRTR2
prerank,regulation of Ras protein signal transduction (GO:0046578),-0.3456637735418601,-1.3380911509677804,0.040123456790123455,0.530642063058298,1.0,21/86,16.71%,NOTCH2;IGF1;AKAP13;DENND4A;OGT;KANK2;RALGPS1;RASGRF1;PLCE1;ARFGAP1;BCR;STARD13;LZTR1;EPHB2;GRB2;ARHGDIA;MADD;RAF1;NGF;RASGEF1A;RABL3
prerank,T cell mediated immunity (GO:0002456),0.5660240539915322,1.3380506284298535,0.137524557956778,0.9322481478027386,1.0,4/13,20.22%,CADM1;CD55;CD46;BTN3A3
prerank,positive regulation of dendritic spine development (GO:0060999),0.5059556283454778,1.337645560045101,0.14629629629629629,0.9302690461011242,1.0,3/20,4.59%,LRP8;SHANK3;APOE
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.39457805132260926,1.3373985194782956,0.07750759878419453,0.9274693890219243,1.0,17/73,14.00%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;TAL1;PSMD11;PSMB4;PSMC1;PSMC2;PSMD2;LMO2;PSMD14;PSMC6;PSMD1;PSMB1
prerank,entrainment of circadian clock by photoperiod (GO:0043153),-0.4409684241530796,-1.3372192346501022,0.10648148148148148,0.5316834362345554,1.0,12/27,14.52%,PER2;PER3;CRY2;PML;BHLHE40;SIK1;MTA1;TP53;CRY1;PER1;RBM4;FBXL12
prerank,positive regulation of lipid biosynthetic process (GO:0046889),-0.42136578423878013,-1.3371787059094404,0.08447488584474885,0.5302807286691412,1.0,18/29,33.67%,ZBTB20;SORBS1;LPGAT1;PPARA;CREBL2;LDLR;SLC27A1;GPLD1;SREBF1;CTDNEP1;NR1H2;AKT1;SLC45A3;MFSD2A;SIRT4;MTOR;CHP1;MID1IP1
prerank,potassium ion homeostasis (GO:0055075),-0.458269929464547,-1.3364411429874665,0.11691542288557213,0.5308675058773291,1.0,12/23,19.52%,ATP1A2;KCNMA1;ATP1B1;ATP1B3;SLC12A2;ATP1A1;KCNJ2;ATP1B2;SLC12A6;SLC12A4;ATP1A3;SLC12A9
prerank,epithelium development (GO:0060429),-0.3271634658779471,-1.335844129370406,0.02666666666666667,0.5309561559306843,1.0,43/107,31.90%,FGFR2;ALDH1A2;AHI1;KANK2;PKD1;ERRFI1;ANXA4;OSR1;SMO;VDAC1;VCL;MEOX2;CPT1A;WNT4;SALL1;PTER;LOXL3;CD34;MTHFD1;TOLLIP;RCN3;DACT1;ANXA7;TGFB1;DVL1;SIX1;TAGLN2;STAT1;PGK1;VEGFA;PAX2;NDRG4;PTCH1;TBX2;TAGLN;CTSB;BMP2;PCNA;ALDOC;PIH1D1;GATA6;MFSD2A;FGF10
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.39520773390001995,1.335687001812443,0.0792507204610951,0.9326047986031194,1.0,24/80,15.69%,SURF4;VPS50;HEATR5B;PREPL;SNX8;VPS29;RAB7A;RAB7B;VPS26A;TBC1D10B;GOSR2;RAB6B;PIKFYVE;RAB6A;SNX1;VPS53;GCC2;RBSN;TBC1D14;ERC1;TRIM27;TBC1D23;VPS35;TRAPPC10
prerank,peptidyl-asparagine modification (GO:0018196),0.46971182963259717,1.335664296091037,0.12687813021702837,0.928789599150325,1.0,7/31,12.36%,NUDT14;ASGR1;ALG8;OST4;STT3B;MCFD2;MGAT5
prerank,response to hydroxyurea (GO:0072710),-0.5397692397480647,-1.3354720755886997,0.1366223908918406,0.5306238863270754,1.0,5/11,20.02%,SPIDR;KAT7;DDI2;RTF2;BLM
prerank,regulation of catabolic process (GO:0009894),0.5311156496265684,1.3354352614263858,0.12982456140350876,0.9261417706512259,1.0,10/18,19.50%,NEDD4L;TMEM9;MDM2;CHEK2;FAF1;ZDHHC7;ODC1;HPGD;CENATAC;FURIN
prerank,transition metal ion transport (GO:0000041),-0.4062991652225257,-1.335282436051684,0.09042553191489362,0.5296664543834763,1.0,15/35,30.35%,CP;TRPC5;ATP7A;SLC30A10;TRPC1;SLC31A1;SLC39A8;SLC31A2;COX17;SLC11A2;TRPC6;SLC30A5;TTYH1;TRPC3;ATOX1
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.5839283586983797,1.3340366117526075,0.1524008350730689,0.9292758168303901,1.0,4/11,10.58%,NCBP1;AHCYL1;ZFP36L1;PAPOLA
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),-0.42792808918490005,-1.3330947062708856,0.10268948655256724,0.5345033550894176,1.0,2/27,0.64%,LPAR1;HTR2C
prerank,response to metal ion (GO:0010038),0.40236690729777186,1.3327841076345375,0.06906906906906907,0.9318321792068749,1.0,14/67,14.95%,MT1X;MT1A;GPHN;AHCYL1;PPP2CA;NEDD4L;CALM3;PPP2CB;PAM;PPP3CA;SLC25A12;PPP5C;MT2A;HOMER1
prerank,acute-phase response (GO:0006953),-0.544260265973835,-1.3322804804996116,0.1286031042128603,0.535305586809772,1.0,5/12,29.14%,IL6R;LBP;PLSCR1;CEBPB;IL22
prerank,stabilization of membrane potential (GO:0030322),-0.5056413340581772,-1.3317063868746817,0.1383219954648526,0.5355338652363978,1.0,3/16,10.34%,KCNK2;KCNK5;KCNK10
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.5054234789254433,-1.3316219006172854,0.15876288659793814,0.5342568585516129,1.0,11/15,40.90%,IGF1;GHITM;AKT1;BCL2L1;GPX1;FXN;PRELID1;CLU;HGF;OPA1;PPIF
prerank,sensory perception of mechanical stimulus (GO:0050954),-0.3433872574796406,-1.331474866722724,0.060897435897435896,0.533120584992553,1.0,18/85,11.29%,PCDH15;EYA1;CACNA1D;COL1A1;EML2;COL11A1;COL4A3;ADGRV1;ROR1;CEMIP;P2RX4;PIEZO2;DCDC2;GSDME;NIPBL;TIMM9;ATP6V0A4;TBL1X
prerank,epithelial cell migration (GO:0010631),-0.39818453352681454,-1.3313116243179137,0.08488063660477453,0.5320719329616167,1.0,13/37,9.85%,FSTL1;KANK2;ADGRA2;NRP1;ZEB2;RHOA;KIT;PXN;ROCK1;DPP4;STARD13;FAP;PLEKHG5
prerank,regulation of B cell proliferation (GO:0030888),0.425892543648653,1.3311809603424576,0.10264900662251655,0.9361209645509463,1.0,7/44,10.70%,PTPRC;VAV3;FCGR2B;TIRAP;IRS2;LYN;CD81
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.32990405297853864,1.3310232220171534,0.01053864168618267,0.9331043067682935,1.0,102/341,18.09%,PSMB10;PSMC4;PSMB6;ELOC;GSK3A;RNF7;CBL;PSMD8;PSMD5;PSMD12;ARIH1;RNF149;ANAPC2;KLHL3;TNFAIP3;FEM1C;SPOP;UBXN11;UBA1;RFFL;BIRC2;PSMD11;NEDD4L;UBAP1;NHLRC1;RBBP6;PSMB4;PSMC1;UBE2I;RNF130;COP1;SIRT1;UBL7;CLOCK;RNF187;PPP1R11;TTC3;TRIM25;FBXO11;CRBN;ANAPC7;RBCK1;MDM2;RAD23A;PSMC2;UBE3D;PSMD2;RNF6;ZNRF1;FBXO7;RNF13;VPS37B;CHFR;SPOPL;UBQLN1;ANAPC11;IFI27;ANAPC10;PLAA;ANAPC4;FBXO8;RNF11;CUL3;PSMD14;USP33;UBE2R2;RNF146;RNF216;DDIT3;PSMC6;PSMD1;FAF1;APPBP2;PSMB1;RNF20;USP9X;TRIM3;UBA6;NHLRC3;UBE2G1;FBXO22;UBQLN4;RMND5A;RNF114;TAF1;PELI1;KLHL42;RNF128;RNF125;UBE2H;UFD1;UBQLN2;PSMA4;VPS37C;UBR3;ATXN3;CDC26;RNF215;RAD23B;KCTD10;AGAP3;VPS4B
prerank,cell chemotaxis (GO:0060326),-0.35703440133660747,-1.330690596669194,0.07365439093484419,0.5322648138894283,1.0,12/60,10.71%,LPAR1;PARVA;PDGFRB;EPHB1;NRP1;KIT;PIP5K1A;PRKCD;PDGFRA;CCR9;PLEKHG5;ACKR3
prerank,calcium ion transmembrane transport (GO:0070588),-0.3350097513421047,-1.3303747568893738,0.041666666666666664,0.5316148379709565,1.0,13/86,4.75%,TRPM3;SLC24A3;CACNA1C;NALCN;MCU;CACNA1D;GRIN2B;RYR3;PKD1;TRPM6;TRPC5;MICU2;P2RX4
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.38047072467166715,-1.3303421452186304,0.07323943661971831,0.5302353346463776,1.0,17/52,17.39%,CELF2;DDX5;DDX17;KHDRBS1;CELF4;KHDRBS2;RBMX;SRSF6;RBM15;RBFOX3;HNRNPA1;SMU1;RBM4;SRRM4;RBM7;NOVA1;RNPS1
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.5309191237724679,1.330322149639034,0.15682656826568267,0.9328816225008367,1.0,6/16,19.12%,ZC3H12D;ZFP36L1;TARDBP;MOV10;RC3H1;DHX36
prerank,regulation of epithelial cell proliferation (GO:0050678),-0.3489935806658645,-1.3303177309391512,0.05521472392638037,0.5288027404146988,1.0,14/85,5.85%,BMP6;FGFR2;TGFBR3;IGF1;EGFR;MCC;FGF1;BMP5;MTSS1;BMP4;NUPR1;OSR1;SRSF6;EPB41L4B
prerank,insulin secretion (GO:0030073),0.5128242085392286,1.3300492187437098,0.1378026070763501,0.9304975171550256,1.0,6/19,9.76%,SELENOT;RAB11B;RAB11FIP5;RAB11FIP2;CYB5R4;PARK7
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),-0.3984450734481254,-1.3292999157684937,0.082687338501292,0.5303873030606444,1.0,14/37,23.40%,MAPK14;APPL2;PPARA;IL17RA;ADCY7;PER1;SIRPA;ABCD2;PLD3;GBP5;APOD;CHID1;APPL1;IL17D
prerank,regulation of oxidative phosphorylation (GO:0002082),-0.49950435357104656,-1.3287966507146745,0.1425438596491228,0.530349445487972,1.0,11/16,40.90%,NUPR1;ATP7A;VCP;COX7A2L;SLC25A33;PINK1;UQCC2;AK4;PDE12;MLXIPL;PPIF
prerank,cellular metal ion homeostasis (GO:0006875),-0.32605472349255354,-1.326052952627869,0.03642384105960265,0.5368619616501283,1.0,17/102,10.32%,ANK2;ATP1A2;SLC24A3;HTR2C;KCNMA1;STIM2;ATP1B1;STIM1;SLC41A1;ATP13A5;ATP1B3;SLC12A2;ATP1A1;KCNJ2;ATP1B2;SLC24A2;DMPK
prerank,organelle organization (GO:0006996),0.32503403954213755,1.3251344261528402,0.00903954802259887,0.9514467058036208,1.0,67/388,11.15%,CIDEA;ROPN1;SURF4;FAM161B;CHCHD2;SEMA6A;SYNE1;SH3D19;SMPD4;TNFAIP3;LYSMD3;CYCS;KIFAP3;GORASP2;DNAJA3;SORT1;FITM2;CLASP2;GABPA;ZMYM4;MTFR1;LMAN2;ATL1;SIRT3;CFAP126;VPS11;APOE;PRPF40A;PLAAT3;RAB7A;PHB2;TMED4;SEC23IP;RAB43;CFL1;DST;PEX1;TRAPPC8;SSBP1;USP6NL;ARHGEF7;PEX7;CHMP1A;TRIP11;TTC17;LONP1;VMP1;TMED5;AGTPBP1;PIKFYVE;ODF2;TMED10;RAB14;FGD5;CDCA8;TMEM135;AUP1;RAB1A;GOLPH3L;PARK7;TRAPPC11;DOP1B;CHMP2A;TERT;TMED7;HPS3;NOS3
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.47065042201104035,1.3248534010936115,0.122040072859745,0.9490178031007864,1.0,10/25,17.73%,HSPA8;DNAJB5;BAG1;HSPE1;SDF2;HSPA13;DNAJB14;HSPA14;GAK;ST13
prerank,proteolysis (GO:0006508),0.3336099765168199,1.3246051958722729,0.026252983293556086,0.9463551242713282,1.0,31/252,9.39%,LRP8;CAPN8;PCSK1;LVRN;FBXL6;CELA1;PSMC4;PRCP;PSEN2;RSPRY1;DPP8;MME;MMP12;ATG4C;UBE3A;CASP6;METAP2;FBXW2;CNDP2;RET;SPCS3;PGPEP1;LONP1;NAPSA;SPPL3;ATG4B;DESI2;DESI1;TPP1;SPRTN;MDM2
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.4442862213044373,1.3245571697110852,0.11686143572621036,0.9427885618275249,1.0,7/34,6.45%,PTPRQ;PTPN18;DUSP7;PTPRJ;PTPRB;PTPN12;PTPRT
prerank,transport across blood-brain barrier (GO:0150104),-0.33350097270545476,-1.323753127569386,0.04892966360856269,0.5416605597518391,1.0,17/83,6.96%,ATP1A2;SLC24A3;LRP1;SLCO3A1;SLC2A13;SLC1A3;LEPR;SLC16A12;SLC6A13;SLC13A3;SLC7A2;SLC22A8;SLC6A1;SLC16A7;SLC1A5;SLC12A2;SLC6A9
prerank,positive regulation of actin nucleation (GO:0051127),-0.5560015050004847,-1.323604631902744,0.13043478260869565,0.540510080915738,1.0,4/11,13.84%,GSN;WASF2;WASF1;FCHSD2
prerank,dephosphorylation (GO:0016311),0.3489710032508894,1.3234588413347077,0.04144385026737968,0.9445286118071781,1.0,22/147,6.91%,PHPT1;PTPRR;PTPN18;PTPRG;DUSP7;PTPRJ;PTPRC;CTDSP1;PPP3CB;PNKP;PTPRM;PTPRB;DUSP12;PTPRE;PPP2CA;PLPP6;PTPN12;PXYLP1;SSH2;PTPRT;PLPP1;PPP2CB
prerank,positive regulation of glucose import (GO:0046326),-0.46219616278890563,-1.3233202379725721,0.10660980810234541,0.5398263737738792,1.0,11/21,25.65%,SORBS1;IGF1;OCLN;AKT2;CREBL2;ARPP19;PIK3R1;OSBPL8;APPL1;AKT1;CAPN10
prerank,positive regulation of hemostasis (GO:1900048),-0.5682637821267535,-1.3229318909539918,0.14137214137214138,0.5379780768410791,1.0,5/10,25.87%,THBS1;ST3GAL4;ENPP4;DMTN;SERPINE1
prerank,positive regulation of coagulation (GO:0050820),-0.5682637821267535,-1.3229318909539918,0.14137214137214138,0.5379780768410791,1.0,5/10,25.87%,THBS1;ST3GAL4;ENPP4;DMTN;SERPINE1
prerank,central nervous system projection neuron axonogenesis (GO:0021952),-0.5309154878989775,-1.3228629471408293,0.1422680412371134,0.536716092291473,1.0,5/12,16.69%,NFIB;GLI2;EPHB1;EPHB2;SZT2
prerank,cristae formation (GO:0042407),0.46820842166061505,1.3227181896180291,0.12607944732297063,0.9443863485139218,1.0,11/27,14.72%,ATP5F1E;UQCC3;ATP5MG;ATP5PF;ATP5MC2;IMMT;CHCHD6;CHCHD3;LETM1;DNAJC11;ATP5F1C
prerank,cardiac conduction system development (GO:0003161),-0.44240245452303595,-1.3226830026176493,0.11244019138755981,0.5357354819693082,1.0,10/24,19.14%,NOTCH2;GJB6;SMAD4;MAML1;BMP4;GJA1;CACNA1G;SMAD5;TBX18;BMPR1A
prerank,negative regulation of T cell differentiation (GO:0045581),-0.5681676057556682,-1.3226654912156135,0.1350210970464135,0.5343093804668807,1.0,2/10,4.74%,GLI3;BMP4
prerank,positive regulation of integrin activation (GO:0033625),0.5851998771906536,1.322351794701297,0.14971209213051823,0.9424962038362164,1.0,3/11,13.31%,SRC;RASIP1;PLEK
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),-0.5031740871557446,-1.3220728500305508,0.1210762331838565,0.5345905015088145,1.0,8/15,22.30%,P2RX4;SMOC2;LGMN;SEMA5A;MET;HSPB1;PRKD1;VEGFA
prerank,sodium ion transmembrane transport (GO:0035725),-0.3354994993240498,-1.3220267790147644,0.051194539249146756,0.5332712210114687,1.0,17/84,9.99%,ATP1A2;SLC24A3;HCN1;NALCN;SLC6A13;ATP1B1;SLC6A1;SCN8A;SCN3A;ATP1B3;SLC12A2;SLC6A9;ATP1A1;SLC6A12;SCN1A;ATP1B2;SLC24A2
prerank,regulation of cardiac muscle cell action potential (GO:0098901),-0.4347441884194577,-1.3218710759148886,0.09744779582366589,0.5322151320805039,1.0,7/25,12.92%,ANK2;CTNNA3;CACNA1C;CXADR;AKAP9;CAMK2D;DLG1
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.37002584282594847,1.3214623625278163,0.06599713055954089,0.9431945539516332,1.0,19/104,10.80%,TRIB3;RALB;EZH2;MTCP1;ACTB;RPTOR;SRC;CDC37;PPP2CA;CCNH;CIB1;CDKN1A;CALM3;SIRT1;GTF2H1;CCNG2;CSF1R;BCCIP;DDX3X
prerank,vascular transport (GO:0010232),-0.3365261341913053,-1.3212475897860185,0.0529595015576324,0.5325642516804281,1.0,17/81,6.96%,ATP1A2;SLC24A3;LRP1;SLCO3A1;SLC2A13;SLC1A3;LEPR;SLC16A12;SLC6A13;SLC13A3;SLC7A2;SLC22A8;SLC6A1;SLC16A7;SLC1A5;SLC12A2;SLC6A9
prerank,regulation of cellular senescence (GO:2000772),0.46626473431429627,1.3212083887292831,0.12975778546712802,0.9407109145282977,1.0,11/28,16.19%,B2M;FBXO5;SIRT1;YPEL3;ZKSCAN3;ING2;TERT;NEK6;YBX1;MAP3K3;RSL1D1
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.37634637811815813,1.32117011270484,0.07374631268436578,0.9372218362018877,1.0,20/87,13.08%,TTC19;IMMP2L;SDHAF3;NDUFAF1;NDUFAF5;UQCC3;NDUFB6;NDUFB4;NDUFA10;OMA1;NDUFA1;NDUFS2;TIMM21;AIFM1;NDUFB7;TIMMDC1;NDUFV3;NDUFA8;NDUFC2;NDUFA13
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.380055008261895,-1.3210603503984644,0.09375,0.5315986422914074,1.0,7/45,4.74%,BMP6;DAB2;TGFBR1;BMP5;BMP7;SMAD4;BMP4
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.4887736148774761,-1.320855841657211,0.13716814159292035,0.5307912191032428,1.0,4/17,19.44%,PLA2G4A;LPGAT1;CRLS1;LPCAT1
prerank,T cell activation (GO:0042110),0.3927732191887884,1.3205405979878049,0.0781010719754977,0.9367018162057312,1.0,11/69,11.89%,LCP1;JAG2;PIK3CG;PTPRC;PPP3CB;GPR89B;GPR89A;NLRC3;LFNG;PIK3CD;PPP3CA
prerank,axon extension (GO:0048675),-0.4426550248318448,-1.3204088835213383,0.11342592592592593,0.5306562818871755,1.0,7/23,9.78%,ALCAM;MAP1B;ULK2;AUTS2;NRP1;SEMA3A;NRP2
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),-0.38906796425024487,-1.320225686840203,0.08401084010840108,0.5297157936763417,1.0,6/40,3.36%,MAGI2;BICD1;DAB2;AHI1;ANXA2;WASL
prerank,myeloid cell differentiation (GO:0030099),0.4243722827506841,1.3202029400554653,0.1167192429022082,0.9349527560948815,1.0,8/47,10.57%,PRKX;SNRK;TAL1;TIRAP;HIPK2;RPS14;LYN;MFHAS1
prerank,chondroitin sulfate catabolic process (GO:0030207),-0.5228119167529667,-1.3201730247238728,0.13555555555555557,0.5284647862144299,1.0,9/13,28.06%,VCAN;HEXA;HEXB;ARSB;CSPG4;BGN;DCN;HYAL1;CSPG5
prerank,positive regulation of protein acetylation (GO:1901985),0.5522314008904075,1.320130725181222,0.16535433070866143,0.931685399763857,1.0,6/12,15.22%,DIP2A;DIP2B;RAPGEF3;PRKAA2;DDX3X;TERF2IP
prerank,sprouting angiogenesis (GO:0002040),-0.3720540504251372,-1.3200578156290634,0.07792207792207792,0.5273808776094133,1.0,14/51,10.86%,ROBO1;PARVA;ADGRA2;BMPER;NRP1;EFNB2;BMP4;PIK3R3;EPHB4;CCBE1;THBS1;RSPO3;OTULIN;RNF213
prerank,actomyosin structure organization (GO:0031032),-0.3423974027619573,-1.3200148665568587,0.05763688760806916,0.5260854581823742,1.0,19/75,14.39%,SORBS1;EPB41L3;TMOD2;EPB41L1;CDC42BPB;TPM1;RHOA;ROCK2;ITGB5;EPB41L4B;CIT;FRMD3;ROCK1;TNFAIP1;EPB41L2;ACTN2;CSRP2;PDLIM1;WDR1
prerank,innate immune response (GO:0045087),0.3406862353708072,1.31927175260481,0.04590570719602978,0.9324690842967631,1.0,40/217,14.46%,DMBT1;PIK3CG;CAPZA2;TRIM28;IFNLR1;IFITM2;SRC;IFIT1;TRIM8;RNASE6;FYN;PHB2;TRIM14;B2M;SYK;IFITM3;RNF187;ADAR;TRIM25;IFITM1;RELA;LYN;PJA2;MFHAS1;SRPK2;YES1;SERINC5;DDX3X;APP;SERINC3;PIK3CD;ANKHD1;IFI27;IKBKB;CHUK;NLRC5;ANKRD17;TRIM27;GCH1;CYBA
prerank,positive regulation of signal transduction (GO:0009967),-0.2908237427159074,-1.3182732977803477,0.010471204188481676,0.5297034205987151,1.0,55/238,14.71%,SORBS1;BMP6;NTRK3;FGFR2;RIMS1;IGF1;SULF1;ROBO1;SASH1;WLS;NRXN1;NRP1;FGF1;TGFBR1;DLG4;AXL;MACF1;SULF2;NLGN2;MAML1;FLNA;GKAP1;PRKCZ;RELN;SMO;F3;DCDC2;SORL1;SLC39A14;ITGA5;SKI;HTT;PTGIS;ZDHHC5;CDC73;NLGN1;SNW1;CCBE1;SMOC2;RSPO3;VTN;SALL1;CUX2;ILK;DISC1;ADAMTS3;LOXL3;ATP6V0C;LY86;GRB10;TRIM39;IL6ST;IGF2;CAV2;DACT1
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.5748308370927339,1.3176242017509285,0.15643564356435644,0.9368612879744148,1.0,4/11,10.32%,RGS2;GSK3A;NOTCH1;GLRX3
prerank,chromatin remodeling (GO:0006338),0.36990115588630035,1.3172788224473677,0.06358381502890173,0.9349081451405488,1.0,38/100,19.08%,ACTL6A;RUVBL2;ACTB;NUDT5;SMARCA2;ACTR8;HNRNPC;SIRT1;ACTR5;KDM6A;RUVBL1;KDM4D;RSF1;PAK1;ESR1;SMARCD1;CHD3;CECR2;HDAC5;KDM5C;DR1;HCFC1;BAZ2A;INO80;EZH1;PBRM1;TAF6L;TOP1;SMARCA4;RBBP4;SMARCAD1;NPM1;TADA2A;CHD8;KDM4C;HDAC2;ATRX;SMARCB1
prerank,positive regulation of blood coagulation (GO:0030194),-0.49090894783582806,-1.3171290373159412,0.12364425162689804,0.5315549160450425,1.0,7/17,25.87%,F3;THBS1;ANO6;ST3GAL4;ENPP4;DMTN;SERPINE1
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.5227680850139972,1.3167837396822986,0.15459882583170254,0.9337171941943297,1.0,6/15,16.15%,RUVBL2;CCT2;CCT5;RUVBL1;TCP1;DKC1
prerank,sequestering of extracellular ligand from receptor (GO:0035581),-0.5222156167169396,-1.3164873814367206,0.16288659793814433,0.531869579178005,1.0,6/13,10.98%,FBN1;FSTL1;NBL1;FBN2;LTBP1;GREM2
prerank,positive regulation of dephosphorylation (GO:0035306),0.46974901547171216,1.31641652661669,0.13089005235602094,0.9321163354269146,1.0,10/27,14.15%,PIN1;SRC;PPP1R16B;CNEP1R1;CALM3;SPPL3;ANKLE2;PTBP1;CDH5;PTPA
prerank,hematopoietic stem cell differentiation (GO:0060218),-0.5661983483000752,-1.3161835771188786,0.1315240083507307,0.5313882438730224,1.0,5/10,25.77%,UFL1;TP53;LMBR1L;ACE;SFRP1
prerank,diol metabolic process (GO:0034311),0.5028683712951099,1.3160477980452325,0.14432989690721648,0.930375830742632,1.0,7/19,14.25%,SPR;PTS;PLPP1;SGPP2;NOS3;SGPP1;GCH1
prerank,regulation of complement activation (GO:0030449),0.431715583403347,1.3157999300570153,0.13003095975232198,0.9280333491737841,1.0,5/40,12.57%,C1QB;C1QC;PHB2;CD81;CD55
prerank,regulation of cytoskeleton organization (GO:0051493),-0.31967621168558963,-1.3147555773574702,0.034482758620689655,0.5341409444235571,1.0,33/108,17.63%,BICD1;PHLDB2;LRP1;GPM6B;IQGAP1;EFNA5;PDGFRB;CAPN2;PHLDB1;CYLD;MAPT;CLIC4;RHOA;ROCK2;PRKCD;ROCK1;EZR;RND3;RHOBTB2;GSK3B;EPHA3;RHOB;RHOBTB1;HIP1R;TAOK1;PFDN2;TRIM36;PTK2;ARHGEF5;IQGAP2;NEXN;DIAPH1;TWF2
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.4199922956237766,-1.3139168547711206,0.10550458715596331,0.5350582409204524,1.0,9/29,9.75%,SMAD3;ZC3H7A;PUM1;ZC3H7B;PUM2;LIN28B;SRRT;HNRNPA2B1;AGO3
prerank,positive regulation of calcium ion transport (GO:0051928),-0.4018305477372642,-1.3138389028841122,0.09571788413098237,0.5338316507532213,1.0,5/36,4.75%,ANK2;STIM2;CACNA1D;PDGFRB;P2RX4
prerank,glutamate receptor signaling pathway (GO:0007215),-0.3893392837032083,-1.3135998419885286,0.08695652173913043,0.5331374631053022,1.0,6/37,1.54%,GRIA4;GRIA2;CPEB4;GRID2;GRIN2B;GRM5
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.3436924284851465,1.3126911912066965,0.044929396662387676,0.9396214438236274,1.0,40/184,14.94%,PSMB10;ERCC3;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;ANAPC2;ALMS1;NEK11;HAUS4;HAUS5;CEP41;TUBB;ZFP36L1;PSMD11;PSMB4;DCTN2;PSMC1;RGCC;FBXO5;ODF2;CEP164;ANAPC7;DCTN3;PSMC2;TFAP4;PSMD2;DYNLL1;ANAPC11;ANAPC10;ANAPC4;CUL3;PSMD14;PSMC6;NEK6;PSMD1;PSMB1;DYNC1I2;INO80
prerank,neuron projection development (GO:0031175),-0.29595151628039584,-1.3126608796755719,0.0311284046692607,0.534451018095217,1.0,48/168,17.35%,MAP2;CNTN4;DCLK1;PLP1;EPB41L3;PPP1R9A;GPM6B;GAS7;EPHB1;NBL1;HDGFL3;SH3GL2;RASGRF1;WASL;DLG4;RYK;MAPT;BMP7;ADGRV1;GPM6A;ATP7A;MYO16;CTNND2;TAOK3;SHTN1;ERCC6;ROCK1;CTTN;STMN2;DOCK10;NLGN1;CDK16;STX3;SGK1;GSK3B;EPHB2;RAB11A;TAOK1;DICER1;BICDL1;STMN1;WHRN;NGF;RAPGEF2;EHD1;GPRIN3;LAMB1;CDC42
prerank,sodium ion export across plasma membrane (GO:0036376),-0.526177778664674,-1.311820078184191,0.15283842794759825,0.535522567113985,1.0,5/13,9.45%,ATP1A2;ATP1B1;ATP1B3;ATP1A1;ATP1B2
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.37416135975884945,1.3114826834091424,0.07646176911544228,0.9419515159520856,1.0,11/88,5.30%,FBXL6;PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;PSMD11;PSMB4;FBXL5;PSMC1
prerank,granulocyte differentiation (GO:0030851),0.5102700950914323,1.311090801493874,0.1282952548330404,0.9405434801517674,1.0,5/18,8.52%,TAL1;LEF1;CDKN1A;EP300;CDK4
prerank,negative regulation of dephosphorylation (GO:0035305),0.5012526054532157,1.3105482343754122,0.14233576642335766,0.9397180262744634,1.0,6/18,15.43%,PPP1R36;PPP1R16B;YWHAB;MFHAS1;PTPA;PPP1R8
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),-0.5261960327296256,-1.3101949600143254,0.16198704103671707,0.5386379627896503,1.0,3/13,5.12%,GLI3;TGFBR2;CBFB
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",-0.4926350242720376,-1.3098031898723557,0.15856236786469344,0.5382748146858563,1.0,5/16,7.45%,DDX5;DDX17;CELF4;SRSF6;SRSF1
prerank,photoreceptor cell development (GO:0042461),-0.5018097144283327,-1.3094529497920753,0.1592356687898089,0.5379427110111968,1.0,6/14,31.53%,AHI1;DCX;TOPORS;VEGFA;RP1;MFSD2A
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.5526695204425461,-1.3093651940072402,0.14468085106382977,0.5367569991149985,1.0,7/11,24.53%,IGF1;GHR;TSC2;PIK3R1;GIGYF1;EIF2AK3;AKT1
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.49379379622096786,1.3091267011973018,0.1455223880597015,0.9433001222796089,1.0,7/21,11.52%,PTPRC;PRKCH;PRKD2;RELA;CD81;SLC39A10;RPS3
prerank,growth hormone receptor signaling pathway (GO:0060396),-0.5035283081800366,-1.309098278594919,0.15020576131687244,0.5362447912669915,1.0,8/14,25.88%,GHR;PXN;STAT6;SOCS2;PTK2;PIK3R1;PRLR;STAT5A
prerank,regulation of receptor internalization (GO:0002090),-0.3995671823686011,-1.3086774160799852,0.11029411764705882,0.536076741394711,1.0,3/35,3.56%,MAGI2;AHI1;DLG4
prerank,negative regulation of immune response (GO:0050777),0.3461039024572766,1.30834269716241,0.05326231691078562,0.9436198114437896,1.0,22/154,10.61%,GPR176;PRKAR1A;PTGER2;TNFAIP3;FCGR2B;PLK2;SRC;TSHR;INSL3;RAMP2;FYN;SAMSN1;GNB1;RXFP1;SYK;NLRC3;PLCG1;LYN;RHBDF2;CD163;TRAF3IP1;YES1
prerank,diterpenoid metabolic process (GO:0016101),-0.36455430593129223,-1.308183117169214,0.08430232558139535,0.5360567845630164,1.0,13/55,11.98%,GPC6;LRP1;ALDH1A1;SDC2;DHRS3;GPC3;HSPG2;ABCA4;NAPEPLD;RBP4;GPC5;RBP1;ALDH3A2
prerank,regulation of osteoblast proliferation (GO:0033688),-0.483338108872965,-1.3081625581991978,0.16059957173447537,0.5347670410417904,1.0,11/17,30.40%,FGFR2;NELL1;RHOA;NPR3;EIF2AK2;MN1;CCN1;PLXNB1;SFRP1;BMP2;TMEM119
prerank,purine ribonucleotide catabolic process (GO:0009154),0.49514435030998916,1.3080545520539641,0.15978456014362658,0.9415734987868175,1.0,7/21,12.02%,NUDT11;PDE4D;MLYCD;FITM2;ACAT1;PNP;NT5C2
prerank,negative regulation of interleukin-17 production (GO:0032700),0.5746704090918683,1.3079429478835536,0.16237623762376238,0.9386748995182025,1.0,3/10,13.40%,VSIR;PRNP;DDIT3
prerank,cell-cell junction organization (GO:0045216),-0.33364643461587284,-1.3067687313131826,0.04281345565749235,0.5374159558032933,1.0,33/79,24.41%,SDK1;CDH10;SMAD3;CTNNA1;CXADR;OCLN;TLN1;NLGN2;CTNND2;CDH11;SDK2;TLN2;CDH7;GJC1;ARVCF;AFDN;CDH1;CSK;CDH4;MYADM;CTNND1;NECTIN3;CADM2;TGFB1;CDH9;CDH8;CADM3;CDH19;FLCN;NECTIN2;DCHS1;TGFB3;PVR
prerank,negative regulation of peptidase activity (GO:0010466),-0.3707445098541555,-1.3059783654742187,0.09455587392550144,0.5382350468228501,1.0,5/47,1.97%,SPOCK3;LRP1;TIMP3;SPOCK1;TIMP2
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),-0.3053974089742088,-1.3058820731150875,0.026717557251908396,0.53713247675645,1.0,33/138,15.76%,ERBB4;NTRK3;FGFR2;EGFR;EPHA6;AHI1;PDGFRB;EPHB1;NTRK2;AXL;RYK;ABI1;FER;EPHA7;MTSS1;NEDD9;ROR1;KIT;DDR1;PDGFRA;FRK;IL31RA;EPHB4;EPHB2;EPHA3;PTPRF;ACVR1B;SHC3;IL6ST;ROR2;PTK2;PTPRU;NGF
prerank,lymphocyte proliferation (GO:0046651),0.4794294362946413,1.3058193824744504,0.14652014652014653,0.9456051366596513,1.0,3/22,2.55%,PIK3CG;PTPRC;PPP3CB
prerank,alanine transport (GO:0032328),0.5991146888501511,1.30552605148839,0.17073170731707318,0.9436235994204516,1.0,2/10,5.53%,SLC36A4;SLC6A6
prerank,negative regulation of macromolecule metabolic process (GO:0010605),-0.3007119169667262,-1.3046318008677291,0.0326530612244898,0.5393847883556359,1.0,43/182,16.23%,FOXP1;NOTCH2;SLC24A3;IGF1;ROBO1;ITGB8;SH3GL2;DLG4;MAPT;OCLN;PARP14;RBL2;HDAC1;TET1;BMP4;KDM4A;ROCK2;FLOT2;SMO;WWP2;WNT4;XDH;LDLR;MAP2K2;OPTN;SFMBT2;AGO3;LGMN;NDFIP1;NFKB1;REL;CD34;DDRGK1;MYADM;SETDB2;HINFP;RACK1;DICER1;PTPN22;ANXA7;RIN3;RBMS3;TGFB1
prerank,negative regulation of stress fiber assembly (GO:0051497),-0.43049315692318507,-1.3045689151573803,0.14878048780487804,0.5382223241413552,1.0,7/24,5.82%,TMEFF2;PHLDB2;CGNL1;WASF2;ARHGAP28;PPFIA1;ARHGAP6
prerank,negative regulation of response to wounding (GO:1903035),-0.4757372504288653,-1.304550427343973,0.13551401869158877,0.5369295660041203,1.0,8/19,28.26%,PTPRS;AJAP1;CERS2;CD109;GIT1;SERPINE1;INPP5F;MDK
prerank,DNA biosynthetic process (GO:0071897),0.5129930417974987,1.3042913078191003,0.16974169741697417,0.9461502405076567,1.0,5/16,10.58%,POLE;SIRT1;POLD3;POLA1;TERT
prerank,regulation of filopodium assembly (GO:0051489),-0.38618908272027386,-1.303997993617988,0.0906801007556675,0.5372813061195337,1.0,10/38,8.48%,TENM2;DPYSL3;NRP1;WASL;GPM6A;PRKCD;GAP43;PLPPR5;NLGN1;DOCK11
prerank,chromatin organization (GO:0006325),0.35381331467530375,1.303657304861102,0.06397774687065369,0.9458675379924776,1.0,43/132,19.08%,MECOM;EZH2;ACTL6A;RUVBL2;NUDT5;HDAC3;SMARCA2;SOX2;FAM50A;SIRT1;KDM6A;SETD5;RUVBL1;KDM4D;RSF1;PAK1;CHD1;ESR1;HP1BP3;PWWP3A;SMARCD1;HDAC5;KDM5C;DR1;HCFC1;BAZ2A;INO80;EZH1;PBRM1;TAF6L;TOP1;SMARCA4;TCF7L1;RBBP4;SETD2;SMARCAD1;NPM1;TADA2A;KDM4C;SAFB;HDAC2;ATRX;SMARCB1
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.5119322791027306,-1.3035644374613122,0.15301724137931033,0.5371289760792632,1.0,8/14,37.92%,SULF1;SULF2;THBS1;CREB3L1;FUZ;GPC1;SPRY4;SPRY1
prerank,RNA splicing (GO:0008380),0.3703301542527617,1.3033824228251465,0.05079825834542816,0.9437754127605874,1.0,33/95,17.92%,SNRPD2;NCBP1;PRPF3;SNRPD1;PPP2CA;PPIG;SRSF10;USB1;SFPQ;HNRNPC;IVNS1ABP;SMNDC1;SF3B3;SRSF4;YJU2;RSRC1;TARDBP;U2AF1;CCAR2;SRPK2;PTBP1;RRAGC;SRSF7;USP39;FUS;TCERG1;TRA2B;LSM1;NONO;SNRPA1;DHX8;DDX23;PRPF18
prerank,myotube differentiation (GO:0014902),-0.46673430719753334,-1.3033745840884141,0.133630289532294,0.5363440449368987,1.0,5/17,6.85%,IGF1;ADGRB3;ADAM12;ADAMTS5;SKI
prerank,spinal cord development (GO:0021510),-0.5241769129989808,-1.3032544966946324,0.16926503340757237,0.5353103047932322,1.0,5/12,17.21%,PKD1;GLI2;RELN;LOXL3;VIT
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.4692982089433852,1.3029551789617262,0.11551155115511551,0.9424751047364474,1.0,6/26,14.25%,ACER2;SPR;CYP1B1;NOS3;ACER3;GCH1
prerank,positive regulation of neurogenesis (GO:0050769),-0.34197406171294475,-1.3026139385207873,0.08306709265175719,0.5358782461848974,1.0,23/68,16.89%,ROBO2;PLXNA2;ROBO1;CUX1;NTRK2;TIAM2;CTNNB1;RHOA;SPEN;SNW1;SMARCD3;NUMBL;CUX2;DISC1;IL1RAPL1;OBSL1;PLXND1;ARHGDIA;KDM1A;PLXNB2;NGF;PLXNC1;OPRM1
prerank,regulation of innate immune response (GO:0045088),0.39953299193410574,1.3018558132048605,0.10558069381598793,0.9446933078828871,1.0,7/57,4.02%,LRP8;TNFAIP3;FCGR2B;TIRAP;CDC37;BIRC2;IFI35
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.5655709802597743,1.3012264461952112,0.1792452830188679,0.9442545377891878,1.0,2/11,1.58%,ATF3;ATF6
prerank,establishment of protein localization to membrane (GO:0090150),0.3967953209684742,1.3012122619169286,0.09494640122511486,0.9409739311941379,1.0,19/66,17.24%,RTP3;REEP1;GORASP2;CHM;RAB11B;ZDHHC14;PIKFYVE;ZDHHC15;ICMT;VPS37B;PRKCI;ZDHHC9;NPC1;ZDHHC7;PARD3;RAB3GAP1;BRAF;VPS37C;RTP4
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.3511688468049446,1.3010532257642264,0.06621621621621622,0.9384083394474482,1.0,31/145,14.00%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;ALMS1;HAUS4;HAUS5;CEP41;STOX1;TUBB;PSMD11;PSMB4;DCTN2;PSMC1;FBXO5;ODF2;USP47;CDK4;CEP164;DCTN3;PSMC2;PSMD2;DYNLL1;RAD51B;PSMD14;PSMC6;PSMD1;AVEN;PSMB1
prerank,regulation of presynapse organization (GO:0099174),-0.4754913902634938,-1.301038289361002,0.14655172413793102,0.5376077362412883,1.0,9/18,29.17%,LRFN5;GPC6;IL1RAPL2;IL1RAPL1;SLITRK1;GPC4;LRRC4B;SNCA;MDGA1
prerank,regulation of presynapse assembly (GO:1905606),-0.4754913902634938,-1.301038289361002,0.14655172413793102,0.5376077362412883,1.0,9/18,29.17%,LRFN5;GPC6;IL1RAPL2;IL1RAPL1;SLITRK1;GPC4;LRRC4B;SNCA;MDGA1
prerank,muscle organ development (GO:0007517),-0.3649005752965879,-1.3007205949317246,0.10802469135802469,0.5371426828123881,1.0,16/54,17.75%,LAMA2;IGF1;VAMP5;SGCE;FHL1;CHD2;MKX;SMTN;SPEG;ITGA11;LARGE1;SRI;FKTN;COL6A3;EVC;SOX6
prerank,positive regulation of cell division (GO:0051781),-0.38423207672937915,-1.2998919018701056,0.09615384615384616,0.5381442905978991,1.0,6/38,6.06%,FGFR2;SVIL;FGF1;RHOA;SIRT2;CIT
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.4728140390028265,1.2995845856625174,0.13253012048192772,0.942251340336204,1.0,3/25,4.48%,NDST3;CSGALNACT1;EXT2
prerank,endothelial cell development (GO:0001885),0.47731492668790165,1.2995657158038114,0.13035714285714287,0.9390122952051477,1.0,7/25,10.82%,PDE4D;PECAM1;MARVELD2;PPP1R16B;ICAM1;RAPGEF3;ROBO4
prerank,cellular response to growth factor stimulus (GO:0071363),-0.2986644481862091,-1.29825983050882,0.015503875968992248,0.5412436361833223,1.0,62/151,26.26%,MAGI2;BMP6;NTRK3;ADAMTS12;EGFR;SMAD3;IQGAP1;NTRK2;NRP1;TGFBR1;MAPK14;SOX5;TGFBR2;MAPT;CTNNB1;BMP7;SMAD4;SIRT2;MED1;BMP4;APPL2;WNT4;STMN2;CLEC3B;GAS1;FOXC1;ACVR1;LGMN;ANXA1;ACVR1B;MTSS2;PDCD5;DUSP22;RACK1;VSTM2A;SETX;RAPGEF2;TGFB1;BMPR1B;EHD1;NR3C1;TWF2;SOX6;RPS6KB1;BMPR1A;CPNE3;BMPR2;HSPB1;PRKD1;VEGFA;APPL1;ITGB1BP1;EMD;AKT1;KIDINS220;ERBB2;HYAL1;RUNX2;DSTYK;SFRP1;NR4A1;PDE2A
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.5646712196485122,1.2976019147317053,0.16666666666666666,0.9459371390648108,1.0,1/12,1.52%,IL1R1
prerank,Rac protein signal transduction (GO:0016601),0.49679853712800587,1.2975365158968977,0.16064981949458484,0.9429235849948455,1.0,10/18,20.98%,RAC2;TIAM1;RHOG;ELMO1;ABI2;CDH13;CYFIP1;HACE1;EPS8;RAC1
prerank,mitochondrial translation (GO:0032543),0.366916516025595,1.2974737766853075,0.08835904628330996,0.9399309583836993,1.0,19/104,12.45%,MRPS22;MRPS2;MRPS33;MRPL23;MRPL24;FASTKD2;MRPL18;MRPL38;LARS2;MRPS12;HARS1;RARS2;MRPL20;EARS2;TSFM;MRPL52;MRPS15;MRPS24;MRPL48
prerank,positive regulation of neuroinflammatory response (GO:0150078),-0.5470181492239395,-1.2966827248226573,0.14314928425357873,0.5443526649396745,1.0,3/12,13.42%,NUPR1;IL18;IL33
prerank,magnesium ion transport (GO:0015693),-0.5177810643534224,-1.296574602550563,0.1540130151843818,0.5433168089700562,1.0,6/12,22.63%,SLC41A1;NIPA2;MRS2;NIPAL2;MAGT1;NIPAL3
prerank,spindle assembly (GO:0051225),0.3921134628033589,1.2964209874004335,0.12480499219968799,0.9417832378712446,1.0,23/67,17.19%,ABRAXAS1;HAUS4;HAUS5;CLASP2;HDAC3;TUBGCP5;MZT1;STARD9;KIF2A;BCCIP;NEK7;RPS3;TNKS;KIF3B;CHEK2;NEK6;ARHGEF10;RCC1;INO80;STAG2;TUBGCP2;KPNB1;CLASP1
prerank,activation of protein kinase A activity (GO:0034199),-0.485047042153837,-1.295315775604463,0.14502164502164502,0.5455597586884021,1.0,11/16,22.64%,ADCY5;ADCY2;ADCY1;PRRC1;ADCY9;PRKACA;ADCY7;PRKAR1B;ADCY3;ADCY8;ADCY4
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.4802707668411984,-1.2949645884559733,0.14380530973451328,0.5451150542293258,1.0,2/17,1.84%,MAGI2;PDGFRB
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),-0.31398470317895466,-1.2948602609365605,0.03125,0.5440630114808338,1.0,29/108,16.69%,ST18;UACA;ROBO1;GSN;SMAD3;CFLAR;COL4A3;MAPT;MALT1;CASP8AP2;F3;VCP;XDH;FAM162A;FIS1;IFT57;ANP32B;GRAMD4;MAP3K5;CASP12;CTSD;HIP1R;PDCD5;RACK1;HSPD1;NGF;EGLN3;TRAF2;MTCH1
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),-0.3319517472229032,-1.2944531821238379,0.05865102639296188,0.5438012961335084,1.0,25/80,17.63%,TENM2;DPYSL3;WASF2;AUTS2;NRP1;WASL;OCLN;TAPT1;PLCE1;GPM6A;CEP120;HTT;PLPPR5;ACTR3;NLGN1;DOCK11;FAM98A;ENTR1;CCP110;CDC42EP5;CDC42EP1;PLEKHM1;ACTR2;CDC42;TWF2
prerank,regulation of T cell migration (GO:2000404),0.503504057596635,1.2944128773054968,0.15229357798165138,0.9481947929265938,1.0,5/18,15.24%,CXCL12;LRCH1;RIPOR2;APP;DOCK8
prerank,response to cAMP (GO:0051591),-0.390714847003348,-1.2942407395562916,0.12266666666666666,0.543108365977991,1.0,14/37,27.74%,HCN1;AKAP6;IGFBP5;AKAP9;EZR;RAPGEF2;SLC5A5;STAT1;DGKQ;DMTN;PDE2A;HCN2;KCNQ1;INPP5K
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.5753115371535327,1.2938065875738023,0.19144981412639406,0.9478185259609384,1.0,3/10,7.78%,TIRAP;IFI35;WDFY1
prerank,positive regulation of cell-substrate adhesion (GO:0010811),-0.34271551509146114,-1.293668411584225,0.0728862973760933,0.5433413357931667,1.0,27/67,29.30%,DOCK5;RSU1;DOCK1;PLEKHA2;NRP1;FLNA;NEDD9;RREB1;P4HB;CDK6;GSK3B;FN1;ILK;MYADM;TRIOBP;VIT;CDC42;CX3CL1;PPM1F;EMP2;DMTN;SFRP1;ARL2;CSPG5;MDK;MYOC;NDNF
prerank,receptor catabolic process (GO:0032801),-0.4323583478586584,-1.2934956678158944,0.1267605633802817,0.5424958301293027,1.0,13/24,20.31%,AP2B1;RNF43;AP2A2;AP2A1;ZNRF3;LGMN;GPRASP1;UVRAG;SNX25;VLDLR;TGFB1;MYLIP;NEDD4
prerank,anterior/posterior axis specification (GO:0009948),-0.4878623722749356,-1.293356956382587,0.1422319474835886,0.5416111626825192,1.0,3/15,11.62%,WLS;SKI;TBX3
prerank,RNA destabilization (GO:0050779),-0.4599113885086744,-1.2933329490893952,0.14977973568281938,0.5403778028081185,1.0,6/18,13.32%,PUM1;ROCK2;ROCK1;LIN28B;YTHDF1;ZC3H18
prerank,cellular modified amino acid biosynthetic process (GO:0042398),0.493377178522667,1.2932224815155526,0.15602836879432624,0.9475072088929122,1.0,7/20,13.17%,GCLC;GCLM;CNDP2;GATM;MTHFS;HAGH;GSS
prerank,secretion (GO:0046903),-0.4975577206449363,-1.292726928334957,0.17123287671232876,0.5408408131613817,1.0,4/14,16.75%,RIMS1;SLC22A4;SLC22A6;NPR1
prerank,triglyceride metabolic process (GO:0006641),0.4120949693717232,1.2925624533059188,0.1206896551724138,0.9474746281904857,1.0,7/48,7.30%,GPAM;FABP7;APOE;PLAAT3;LMF1;GPAT4;SIRT1
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.40186334117996336,1.2921150184106487,0.10566615620214395,0.9463798536818705,1.0,26/52,21.01%,PATL2;CNOT11;CNOT2;HBS1L;CNOT7;EXOSC9;PATL1;PAN3;NT5C3B;TUT7;PAN2;CNOT6;EXOSC1;CNOT1;DCP1A;CNOT6L;TUT4;PARN;CNOT10;LSM1;RC3H1;DCP1B;EXOSC7;CNOT8;DDX6;CNOT4
prerank,in utero embryonic development (GO:0001701),-0.4271752075472034,-1.291412297214659,0.12731481481481483,0.5432964448463324,1.0,11/25,24.53%,FGFR2;ARNT2;PKD1;TGFBR1;FUT8;HINFP;IGF2;FLCN;VEGFA;TGFB3;ZNF568
prerank,muscle cell migration (GO:0014812),-0.5573767774462034,-1.2911972751360643,0.14931237721021612,0.5426322542668728,1.0,8/10,28.89%,DDR1;ROCK1;MEGF10;CCN3;SIX1;AAMP;ITGB1BP1;ITGB3
prerank,membrane lipid catabolic process (GO:0046466),0.567112156494659,1.2907950039815648,0.1889763779527559,0.9495617136499053,1.0,3/10,10.93%,PPT1;FUCA1;CYP1B1
prerank,synapse organization (GO:0050808),-0.3099604072523425,-1.290761730355551,0.053231939163498096,0.5425262590935698,1.0,23/125,6.09%,LRRC4C;LRFN5;PDZRN3;ANK3;SDK1;GPC6;NRXN1;CACNB4;GRM5;KIRREL3;NRCAM;NTNG1;PPFIBP1;PTPRS;RYK;MAPT;DNER;DSCAM;NLGN2;SLC6A1;GPM6A;PPFIA1;CTNND2
prerank,neurotrophin signaling pathway (GO:0038179),-0.45454952494513506,-1.2905276596212811,0.15065502183406113,0.5418856536448151,1.0,9/21,26.28%,MAGI2;NTRK2;GRB2;NGF;RAPGEF2;ZFYVE27;CASP3;KIDINS220;DDIT4
prerank,regulation of intracellular protein transport (GO:0033157),0.44193958145299833,1.2905137444854073,0.15445859872611464,0.9476766267044379,1.0,7/32,11.87%,LCP1;PRR5L;ZFAND1;ICE1;RUFY3;GCC2;IFI27
prerank,regulation of hormone secretion (GO:0046883),-0.49024880160932727,-1.290201784268647,0.15203426124197003,0.5415774038300731,1.0,7/15,35.12%,SCG5;ANXA1;VAMP2;SNX6;EDN1;SOX11;EDN3
prerank,purine ribonucleotide transport (GO:0015868),0.5129969828670627,1.289653446273759,0.16258741258741258,0.9486220111266274,1.0,3/16,6.45%,ABCC4;SLC25A24;LRRC8C
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",-0.4226282648351621,-1.2895468969799473,0.13114754098360656,0.5421874116816393,1.0,14/25,26.46%,KAT7;ERCC6;ELL;LDB1;DDX39B;HTATSF1;CCNT1;WDR43;THOC5;CCNK;EAF1;THOC1;ZNF326;SUPT4H1
prerank,positive regulation of activated T cell proliferation (GO:0042104),-0.4695247930129871,-1.2895409368402486,0.13895216400911162,0.5409282260785139,1.0,4/18,14.13%,IGF1;IGFBP2;IL18;IGF2
prerank,regulation of activin receptor signaling pathway (GO:0032925),-0.49088749435209345,-1.2893772744298206,0.16844349680170576,0.5401180008851578,1.0,5/15,14.71%,MAGI2;SKI;ACVR1;ACVR1B;DACT1
prerank,synapse assembly (GO:0007416),-0.34418777223574354,-1.2890359726278076,0.08806818181818182,0.5399298876971038,1.0,24/67,17.28%,SDK1;NRXN1;GRID2;KIRREL3;LRRTM3;NRCAM;GABRA2;RYK;DNER;DSCAM;NLGN2;GPM6A;SDK2;GABRG2;NLGN1;CDH1;LRRC4;NRXN2;OBSL1;PLXND1;PLXNB2;LGI2;SHANK2;DVL1
prerank,androgen receptor signaling pathway (GO:0030521),-0.5332258989290067,-1.2884697216118612,0.16804979253112035,0.5403254199951804,1.0,3/11,4.49%,DDX5;DDX17;RNF14
prerank,DNA-dependent DNA replication (GO:0006261),0.35024803172172114,1.2882686160337644,0.08053691275167785,0.9521218487935977,1.0,27/128,14.00%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;PNKP;ORC3;PSMD11;PSMB4;PSMC1;SSBP1;POLE;CDC45;ORC4;POLD3;CDK2AP1;POLA1;PSMC2;PSMD2;SRPK2;ORC2;HELB;PSMD14;PSMC6;PSMD1;PSMB1
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.41764606593589093,1.287167225033098,0.12479740680713128,0.9544592125079538,1.0,10/46,10.17%,TOMM20;ROMO1;TIMM17B;RALA;TSPO;GRPEL2;TOMM40L;TIMM21;FBXO7;AIFM1
prerank,regulation of osteoclast differentiation (GO:0045670),-0.4016099618267302,-1.2871135528448554,0.1475,0.5429845534555502,1.0,12/33,35.43%,FBN1;CAMK4;UBASH3B;TCTA;CEBPB;PRXL2A;TLR3;GPR137B;TMEM178A;MAFB;MTOR;GPR137
prerank,cellular response to osmotic stress (GO:0071470),0.4850483718361145,1.2867408609476996,0.1438474870017331,0.9534267964684032,1.0,6/21,10.80%,OXSR1;ZFP36L1;SCN2A;ZFAND1;TRPV4;DDX3X
prerank,regulation of extracellular matrix disassembly (GO:0010715),-0.47699886596549385,-1.2866366247286736,0.1734475374732334,0.5430471791241998,1.0,5/15,9.67%,LRP1;PDPN;DDR1;DPP4;FAP
prerank,regulation of postsynapse organization (GO:0099175),0.45910641605001656,1.2861643312510942,0.15178571428571427,0.9529760640692327,1.0,12/28,16.30%,FCGR2B;SHANK3;CFL1;TANC2;WNT5A;ZDHHC15;PPFIA2;ABHD17B;HOMER1;VPS35;CDKL5;ABI2
prerank,regulation of insulin secretion (GO:0050796),-0.32020303845049813,-1.2861355302315292,0.0627062706270627,0.5431772950540926,1.0,25/101,16.68%,CACNA1C;ITPR1;SNAP25;ADCY5;MCU;CACNA1D;EFNA5;KCNC2;NLGN2;PER2;GLUD1;DPP4;ENSA;RBP4;LRP5;CDK16;STXBP4;TM7SF3;NNAT;PSMD9;SYT7;CCN3;TCF7L2;STX1A;KCNS3
prerank,protein heterooligomerization (GO:0051291),-0.467814715426516,-1.2856389135199602,0.15862068965517243,0.5433952419076951,1.0,3/17,1.93%,GRIN2B;KCNC2;PKD1
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.4719419333845452,-1.2847321170670305,0.1447084233261339,0.5448084443888555,1.0,7/18,15.37%,PABPN1;ENY2;POLDIP3;NXF1;NUP93;DDX19B;DDX19A
prerank,positive regulation of nuclear division (GO:0051785),-0.4291548856610484,-1.2846254814883384,0.16063348416289594,0.5438540260202807,1.0,4/25,7.88%,IGF1;PDGFRB;SIRT2;LRP5
prerank,pulmonary valve morphogenesis (GO:0003184),-0.4702104847116131,-1.2843046757912011,0.1368653421633554,0.5435032416729066,1.0,5/17,8.66%,ROBO2;NOTCH2;ROBO1;BMP4;SMAD6
prerank,mesonephros development (GO:0001823),-0.5344788563705015,-1.2834757006983875,0.17519685039370078,0.5446384949644975,1.0,4/11,5.59%,FGF1;BMP7;BMP4;OSR1
prerank,regulation of TORC1 signaling (GO:1903432),-0.3965957919036644,-1.2832016906961152,0.11320754716981132,0.5441461016455492,1.0,23/33,36.55%,RNF152;GPR137C;DEPDC5;KLHL22;CASTOR2;STK11;SEH1L;ATM;SZT2;ITFG2;FLCN;DGKQ;TELO2;LAMTOR5;SESN2;PIP4P1;GPR137B;SPAAR;PIH1D1;SMCR8;RRAGD;GPR137;RRAGA
prerank,protein acetylation (GO:0006473),0.44445377568194905,1.2831504797158608,0.15973377703826955,0.9643093681331355,1.0,12/30,18.84%,ING4;EP300;SIRT1;CLOCK;NAA35;ESCO1;CREBBP;NAA80;ING5;NAA15;NAA50;HAT1
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.537431065383789,1.28314600994382,0.1863468634686347,0.9611508723124669,1.0,5/13,14.70%,PTTG1IP;SIRT1;YJU2;MDM2;CD44
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.41662787170643634,-1.2825100600008081,0.15011037527593818,0.5449232695568186,1.0,12/26,25.65%,SORBS1;IGF1;OCLN;AKT2;CREBL2;ARPP19;CLIP3;PIK3R1;OSBPL8;APPL1;AKT1;CAPN10
prerank,bicellular tight junction assembly (GO:0070830),0.4082176261349298,1.282100457128611,0.14858096828046743,0.9630875877279106,1.0,11/46,14.49%,PECAM1;MARVELD2;RAMP2;F11R;ESAM;CLDN5;PRKCI;CDH5;APC;PATJ;PARD3
prerank,motor neuron axon guidance (GO:0008045),0.5180038544417903,1.2818369374889909,0.1750503018108652,0.9612496077009249,1.0,3/15,11.04%,RAC2;TMEFF1;RHOG
prerank,negative regulation of microtubule polymerization (GO:0031115),-0.521383757458795,-1.2816934513079916,0.14989293361884368,0.5459375166157808,1.0,6/12,15.56%,MAP2;EML2;STMN2;CLIP3;STMN1;TUBB4A
prerank,Golgi organization (GO:0007030),0.3574941481003629,1.281525205469872,0.07493188010899182,0.9596944523950386,1.0,22/112,10.97%,SURF4;SYNE1;LYSMD3;GORASP2;CLASP2;LMAN2;TMED4;SEC23IP;RAB43;TRAPPC8;USP6NL;ARHGEF7;GOSR2;TRIP11;VMP1;TMED5;TMED10;RAB1A;GOLPH3L;TRAPPC11;GCC2;TMED7
prerank,positive regulation of phagocytosis (GO:0050766),0.41035988818791286,1.2813178311716875,0.13449367088607594,0.9575205812817988,1.0,12/47,18.30%,PTPRJ;PTPRC;FCGR2B;CAMK1D;LMAN2;MERTK;CD47;CYBA;GAS6;CALR;RAB27A;MYO18A
prerank,cytokine-mediated signaling pathway (GO:0019221),0.30726689490606107,1.2807963376745026,0.015267175572519083,0.9568953167951912,1.0,90/532,14.00%,LRP8;CISH;LCP1;PSMB10;PSMC4;PSMB6;MAPK3;EIF5A;CBL;PSMD8;PSMD5;PSMD12;PTPRJ;IL1R1;HSPA8;MAP3K7;SOD1;TAB2;CXCL12;RPS6KA4;IFNLR1;IFITM2;CRLF1;SRC;IFIT1;TRIM8;RPS6KA5;BIRC2;XAF1;IFI35;PSMD11;IRF9;SOX2;PSMB4;FYN;TNFRSF1B;PSMC1;CFL1;B2M;RALA;EDAR;CDKN1A;UGCG;TRAF5;ICAM1;SYK;TALDO1;PIM1;ACTN4;ADIPOR2;SIRT1;IFITM3;IRS2;TAB3;ADAR;TRIM25;CCL25;RPLP0;IFITM1;TRAF3;RELA;CSF1R;SOD2;ARF1;INPP5D;IL10RB;PSMC2;PLCB1;PSMD2;PITPNA;IFNAR1;UBE2V1;ADIPOR1;CDIP1;NOD1;PIK3CD;IFI27;IP6K2;CRKL;TYK2;TNIP2;IKBKB;IRF2;CHUK;PSMD14;MID1;PSMC6;PSMD1;NFKBIA;PSMB1
prerank,artery development (GO:0060840),-0.42234863533460065,-1.2807177440802258,0.14549653579676675,0.5473200324863915,1.0,5/23,4.10%,ROBO2;ROBO1;NRP1;TGFBR1;HECTD1
prerank,water transport (GO:0006833),-0.5256537294570485,-1.279758408925766,0.17484008528784648,0.5488695747086006,1.0,3/12,24.93%,PDPN;AQP4;AQP11
prerank,positive regulation of B cell proliferation (GO:0030890),0.44837169555559964,1.2796616270855399,0.17926186291739896,0.9592565249283135,1.0,5/29,10.70%,PTPRC;VAV3;TIRAP;IRS2;CD81
prerank,regulation of Golgi organization (GO:1903358),0.5011541105295241,1.2796292071933915,0.1767857142857143,0.9562972765356595,1.0,6/17,11.02%,MAPK3;MYO5A;USP6NL;CAMSAP2;PDE4DIP;RBSN
prerank,negative regulation of lymphocyte activation (GO:0051250),0.4787399720812268,1.2794905391523885,0.18613138686131386,0.9538519090512869,1.0,3/21,5.32%,TNFAIP3;FCGR2B;SAMSN1
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),-0.35450103139441663,-1.2790689148731549,0.09919571045576407,0.549491817409976,1.0,12/56,10.91%,BMP6;LDLRAD4;DAB2;BMPER;TGFBR1;BMP5;BMP7;SMAD4;BMP4;SMAD6;ACVR1;SNX25
prerank,glycosaminoglycan biosynthetic process (GO:0006024),-0.3188387599315721,-1.2787720533498863,0.08860759493670886,0.5490737915536291,1.0,44/95,29.11%,UST;GPC6;HS3ST5;HS6ST2;DSE;SDC2;GLCE;B4GALT1;CEMIP;CHSY1;VCAN;OGN;HS3ST3A1;GPC3;HSPG2;HEXA;CSGALNACT2;CHST15;GPC5;B4GALT6;CHST11;SLC35D2;UGDH;CSPG4;ST3GAL4;PRELP;HS3ST3B1;DSEL;LUM;NDST2;B4GALT4;GPC4;SDC3;BGN;DCN;HYAL1;CHPF2;CHST2;XYLT2;CHST3;CSPG5;OMD;CHST12;B4GALT7
prerank,cellular response to organic cyclic compound (GO:0071407),-0.29796547418535013,-1.2785101654434285,0.036585365853658534,0.5485665271757342,1.0,42/141,22.88%,ATP1A2;GABRB1;HCN1;EGFR;ADCY5;AKAP6;RYR3;TFPI;ADCY2;IGFBP5;CTNNA1;SPIDR;ADCY1;CTNNB1;MED1;P2RX4;ROCK2;ATP1A1;GABRG2;AKAP9;EZR;CDH1;NCOA4;IL18;RORA;SPP1;CASP7;RAPGEF2;TGFB1;NR3C1;DIAPH1;ATP1A3;SLC5A5;MSN;RIOK3;SSH1;BLM;P2RY12;ADCY3;ADCY8;IMPACT;CASP3
prerank,protein heterotetramerization (GO:0051290),-0.49928527508916387,-1.2783869587247023,0.19369369369369369,0.5476448650661633,1.0,2/13,1.93%,GRIN2B;PKD1
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),-0.36244411282740724,-1.2769843484823817,0.1122715404699739,0.5502875406639728,1.0,13/51,7.23%,DCLK1;EPB41L3;GAS7;NBL1;SNX2;BMP7;GPM6A;ATP7A;MYO16;TAOK3;SHTN1;CTTN;WASF1
prerank,spliceosomal snRNP assembly (GO:0000387),0.4240196167237561,1.2766564338592419,0.1360759493670886,0.9642646014828296,1.0,7/38,8.83%,SNRPD2;PRPF31;PRPF3;SNRPD1;SRSF10;GEMIN5;COIL
prerank,positive regulation of cellular respiration (GO:1901857),0.5551360570814983,1.276229868094747,0.20643939393939395,0.963223372430108,1.0,5/11,9.96%,IFNLR1;ISCU;IL10RB;PARK7;IFNAR1
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.4085299892690616,1.2760959968503651,0.14026402640264027,0.9608170124300452,1.0,11/42,12.59%,FARS2;GARS1;YARS2;IARS1;LARS2;HARS1;NARS2;RARS2;EARS2;WARS2;LARS1
prerank,chromatin remodeling at centromere (GO:0031055),0.43930748496455796,1.2758589221736096,0.16869565217391305,0.9588364424517356,1.0,9/31,17.31%,MIS18A;HJURP;RUVBL1;RSF1;CENPC;CENPP;RBBP4;CENPO;NPM1
prerank,positive regulation of transporter activity (GO:0032411),-0.5084009713183774,-1.2756737036377341,0.1517094017094017,0.5525966517987524,1.0,4/13,13.20%,KMT2A;SGK1;RXRA;WNK3
prerank,regulation of mRNA catabolic process (GO:0061013),0.3504522374462251,1.2752443803438418,0.08683853459972862,0.9588510709051442,1.0,28/121,14.69%,PSMB10;PSMC4;PSMB6;PRR5L;PSMD8;PSMD5;PSMD12;HSPA8;ZFP36L1;PSMD11;PSMB4;PSMC1;FXR1;YWHAB;CNOT7;EXOSC9;PCID2;PSMC2;PSMD2;ZC3H14;XPO1;PSMD14;EXOSC1;PSMC6;PSMD1;PSMB1;CNOT1;DCP1A
prerank,sensory perception of sound (GO:0007605),-0.32484976900422435,-1.2745592107794756,0.07467532467532467,0.5546070317163172,1.0,17/88,11.29%,PCDH15;EYA1;CACNA1D;COL1A1;EML2;COL11A1;COL4A3;ADGRV1;ROR1;CEMIP;KIT;DCDC2;GSDME;NIPBL;TIMM9;ATP6V0A4;TBL1X
prerank,carbohydrate homeostasis (GO:0033500),0.3793582552242285,1.2745280963610692,0.1328358208955224,0.959127021591031,1.0,11/67,11.08%,PCK1;HECTD4;PYGL;SELENOT;WFS1;ADIPOR2;CYB5R4;PARK7;PRKAA2;BAD;ADIPOR1
prerank,protein prenylation (GO:0018342),0.5652718444936721,1.274521910773143,0.20185185185185187,0.9561309444560331,1.0,2/10,2.99%,CHML;CHM
prerank,regulation of primary metabolic process (GO:0080090),0.34699393966736475,1.274456322882024,0.08767123287671233,0.9534705205970502,1.0,31/126,14.00%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;GPAM;HMGCR;HDAC3;PSMD11;APOE;PSMB4;PSMC1;ELOVL6;PLPP1;PPARD;SC5D;IRS2;ACACB;PSMC2;PSMD2;IDI1;CREBBP;ADIPOR1;CARM1;LSS;SP1;PSMD14;PSMC6;PSMD1;PSMB1
prerank,regulation of cell-substrate junction assembly (GO:0090109),-0.4397486178241125,-1.2740597623225947,0.1542056074766355,0.5546988143675173,1.0,9/21,10.80%,GPM6B;EFNA5;MACF1;RHOA;ROCK2;VCL;ROCK1;LDB1;EPHA3
prerank,regulation of fat cell differentiation (GO:0045598),0.37306674935958295,1.2739801695949073,0.10708898944193061,0.9527760670091858,1.0,15/74,12.48%,CCDC85B;PTPRQ;TRIB3;FRZB;CCDC71L;BBS12;ZFP36L1;PPARD;TRIO;SIRT1;WNT5A;AAMDC;TRPM4;CARM1;WDFY2
prerank,positive regulation of regulated secretory pathway (GO:1903307),-0.45847414272530357,-1.2734399271604486,0.1688888888888889,0.5551922598292603,1.0,10/17,35.39%,NLGN1;CACNA1G;SYT4;SCAMP5;STX1A;SLC4A8;SYT10;RAB3D;CACNA1H;RAB3A
prerank,protein localization to organelle (GO:0033365),-0.30237728461528235,-1.2734207895508982,0.039711191335740074,0.5540090306163369,1.0,54/133,25.35%,ANK2;BICD1;TIA1;COL1A1;TULP3;BMP7;BMP4;WDR35;LMNA;TTC21B;SORL1;UBE2J2;CYB5A;DDX1;BANP;TOR1AIP1;OPTN;RPA1;TRAM1;DDRGK1;ALDH3A2;OBSL1;BBS9;TOLLIP;RAB11A;ARL1;TOPORS;VAMP2;TOR1B;BBS2;PAF1;TRAM2;CEP250;EHD1;STX1A;ZNF423;DVL1;IFT20;SCG3;SGTA;GBP5;SIX1;PAQR3;CNTLN;MTCH2;GBP2;CTDNEP1;EMD;RAB33B;SERP1;ARFRP1;RIPOR1;DNAJA1;SEC61B
prerank,odontogenesis of dentin-containing tooth (GO:0042475),-0.47834574310435646,-1.273310447456883,0.1570796460176991,0.5530945639052239,1.0,4/15,8.19%,EDA;GLI2;HDAC1;FOXC1
prerank,tight junction assembly (GO:0120192),0.4025857908304846,1.2730127660546788,0.1461794019933555,0.9542277924644144,1.0,12/49,14.49%,PECAM1;MARVELD2;RAMP2;F11R;ESAM;CLDN5;PRKCI;CDH5;LSR;APC;PATJ;PARD3
prerank,cellular response to sterol (GO:0036315),-0.506614221330325,-1.2725041459037245,0.17463617463617465,0.5540794913270878,1.0,9/13,19.50%,GRAMD1B;SMO;GRAMD1C;INSIG2;RORA;GRAMD1A;LRP6;GPLD1;OSBPL7
prerank,bicarbonate transport (GO:0015701),0.46243015482992783,1.2723105933200047,0.17089678510998307,0.954488363487978,1.0,5/25,9.58%,SLC4A4;SLC4A5;CA2;CA4;CYB5R4
prerank,cardiocyte differentiation (GO:0035051),-0.5720252045252971,-1.272281265671207,0.19675456389452334,0.5535897016696154,1.0,8/10,34.54%,AKAP13;SIK1;KDM6B;EEF1AKMT4-ECE2;BMP2;GATA6;CBY1;MYOCD
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.4796063830997265,1.2719536123574442,0.14928057553956833,0.9532192471975286,1.0,12/21,16.90%,CNOT11;CNOT2;CNOT7;PAN3;TUT7;PAN2;CNOT6;CNOT1;CNOT6L;TUT4;PARN;CNOT10
prerank,regulation of protein modification process (GO:0031399),0.39891376794198263,1.2715078940063758,0.14040561622464898,0.952418907108397,1.0,13/50,12.62%,ROPN1;PIN1;PPIB;PPP2CA;PPP1R16B;SPRED1;HPF1;CCDC88C;KDM4D;LYN;CCAR2;ATG7;CDH5
prerank,somite development (GO:0061053),-0.5323714173939774,-1.2710010997635917,0.19047619047619047,0.5559178549797965,1.0,4/11,12.56%,SMO;MEOX2;LOXL3;MTHFD1
prerank,N-terminal protein amino acid modification (GO:0031365),0.5128122856939434,1.2701998258483786,0.1814814814814815,0.9559385333754413,1.0,6/14,18.77%,METAP2;NAA35;METAP1;NTMT1;NAA15;NAA50
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.48802669966777834,-1.2698439259446537,0.18577981651376146,0.5579647349642931,1.0,5/14,13.20%,ANK3;ATP1B1;WNK1;WNK4;WNK3
prerank,regulation of endothelial cell chemotaxis (GO:2001026),-0.4753764636764518,-1.2697441344101892,0.16985138004246284,0.5570270193018512,1.0,9/15,21.58%,FGF1;P2RX4;SMOC2;THBS1;LGMN;SEMA5A;MET;HSPB1;PRKD1
prerank,positive regulation of ATP metabolic process (GO:1903580),-0.3942546140103461,-1.2696643407311787,0.12740384615384615,0.5559780477945123,1.0,7/32,6.59%,ZBTB20;IGF1;PID1;NUPR1;PPARGC1A;VCP;PPARA
prerank,ribosomal large subunit biogenesis (GO:0042273),0.3935908492476075,1.2693760137049075,0.15262321144674085,0.9569057647611278,1.0,24/54,21.15%,RSL24D1;RPL3;RRP15;RPL35A;RPL5;MRPL20;SNU13;RPLP0;RPL24;WDR12;PAK1IP1;LTO1;RPL23A;RSL1D1;NPM1;EIF6;RPL26;RPL10;NVL;RPL7;RPL14;MDN1;GTF3A;SDAD1
prerank,nucleic acid-templated transcription (GO:0097659),0.4061926286491311,1.269153457721462,0.13915857605177995,0.9550961672093684,1.0,10/42,14.55%,POLR2J;NR4A2;POLR2B;PAX8;PWP1;TERT;THRB;RRAGC;PPP5C;BAZ2A
prerank,nucleoside salvage (GO:0043174),0.5678689770391141,1.2690967881390056,0.19342359767891681,0.9524952395123507,1.0,3/10,9.50%,UPP1;UCK2;UPP2
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.415983197156527,-1.2684934326736463,0.14318706697459585,0.5581510453171366,1.0,6/26,8.44%,NAV3;MAPT;OCLN;STMN2;AKAP9;SLAIN2
prerank,renal filtration (GO:0097205),-0.5431919023240117,-1.2683261105942014,0.17932489451476794,0.5574804451175032,1.0,4/10,11.71%,SULF1;SULF2;TBC1D8B;CD34
prerank,L-amino acid transport (GO:0015807),0.45320603162967654,1.2676885615840805,0.17513134851138354,0.9561545239007014,1.0,8/28,13.69%,SLC7A8;SLC1A1;SLC36A4;SLC3A2;SLC1A2;SFXN1;SLC25A12;SLC38A5
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.5611972161840507,1.2676753428945258,0.199203187250996,0.9533205549240411,1.0,5/10,13.57%,PSMC4;PSMC2;ESR1;PSMC6;THRA
prerank,TOR signaling (GO:0031929),0.4498744509829906,1.2673341236107487,0.156794425087108,0.9520581284245263,1.0,4/26,4.89%,PRR5L;TIPRL;RPTOR;SMG1
prerank,ventricular septum development (GO:0003281),-0.3813582503847205,-1.2671475391187559,0.1306532663316583,0.5596066792505318,1.0,9/37,9.91%,ROBO2;TGFBR3;ROBO1;TGFBR1;TGFBR2;SMAD4;HECTD1;ACVR1;SALL1
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.5035704134470976,1.2671157639605801,0.16727941176470587,0.9502135840458047,1.0,6/17,14.70%,RFFL;PTTG1IP;SIRT1;YJU2;MDM2;CD44
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.5703955322993285,1.2670825909151762,0.206,0.9475050267840075,1.0,5/11,18.84%,ASF1B;CABIN1;RBBP4;ATRX;HAT1
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.455827448050883,-1.265439234057342,0.15991471215351813,0.5632442089621312,1.0,6/17,19.00%,CTNNA2;WASF2;GMFB;WASF1;FCHSD2;ARFIP2
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.5020731907747302,-1.2654195057182036,0.16025641025641027,0.5621009012310926,1.0,5/13,25.42%,CACNA1G;SYT4;SCAMP5;STX1A;SYT10
prerank,cellular protein-containing complex assembly (GO:0034622),0.33375932196553515,1.2650459792897577,0.07951482479784366,0.9541317713697002,1.0,33/159,14.60%,HIGD2A;IMMP2L;TIAM1;AP2S1;SRC;BBS12;CCT2;NDUFAF1;SMAD1;PSMD11;SGIP1;CLTA;PFDN6;LONP1;OMA1;PSMG1;AXIN1;PDE4DIP;TMEM35A;EIF4H;TBCEL;CENPC;AIFM1;CHMP2A;MIS12;DMD;HIGD1A;EIF4B;PICALM;POGZ;AP2M1;CYBA;PIK3C2A
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.5312506646644649,-1.265001091595707,0.1834319526627219,0.5620525334560681,1.0,4/11,9.13%,TGFBR3;TGFBR1;TGFBR2;ACVR1
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.4433628177340058,-1.2647836075693772,0.16666666666666666,0.5614677746808083,1.0,7/19,9.11%,IGF1;NTRK2;RTN1;FLOT2;SORL1;ROCK1;BIN1
prerank,extracellular matrix assembly (GO:0085029),-0.4316476416280925,-1.2641576327692958,0.1405152224824356,0.5619901852215423,1.0,11/23,24.78%,GPM6B;TNXB;NTNG1;ATP7A;NTN4;QSOX1;TGFB1;LAMB1;EFEMP2;EMILIN1;MYH11
prerank,muscle cell differentiation (GO:0042692),0.4311191805436248,1.2640937764302866,0.16086235489220563,0.9557335291895943,1.0,7/32,10.98%,SYNE1;MRTFA;MRTFB;TBX1;HEY2;SEMA4C;DMD
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.5567102538013227,1.2639198810187595,0.19672131147540983,0.9537319698840963,1.0,2/10,1.01%,RSC1A1;GSK3A
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),-0.4969109438269514,-1.2639166059373785,0.1774891774891775,0.5614585958520543,1.0,5/14,20.25%,UFL1;BCL2L11;TMEM33;DDRGK1;COPS5
prerank,neutrophil chemotaxis (GO:0030593),0.4003815979298812,1.2635467312752096,0.1298904538341158,0.9527150817055574,1.0,7/53,11.50%,PIK3CG;BSG;PPIB;SYK;PIKFYVE;CCL25;PIK3CD
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.5333588182275337,1.2634734580687992,0.2018181818181818,0.9502223970226028,1.0,2/12,1.42%,CBL;PTPRJ
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),-0.27469420414610096,-1.2632088969492057,0.014634146341463415,0.5622790129483028,1.0,79/248,17.36%,RNF220;BICC1;FGFR2;LRRK1;WLS;DAB2;EGFR;COL1A1;LGR4;ADGRA2;GLI3;IGFBP2;MCC;TBL1XR1;SMURF2;FZD6;CYLD;ZEB2;CTNNB1;WNK1;PTK7;HDAC1;PPM1B;NKD1;HECW1;VCP;SHISA6;GPC3;CTNND2;CSNK1A1;BTRC;DKK3;IGFBP6;TMEM64;PSMD4;PSMA2;CSNK1E;UBR5;GPC5;PSMA6;TLE1;DVL3;ZNRF3;CSNK1G2;OTULIN;XIAP;INVS;GSK3B;NFKB1;PSMD13;PSMA1;TBL1X;ILK;PSMF1;PSME4;STK11;DAAM2;LIMD1;PPM1A;SCYL2;USP34;SIAH2;IGFBP4;PSMA5;PSMD9;LMBR1L;CTNND1;DACT1;LRP6;PTPRU;PTPRO;RBMS3;TGFB1;TCF7L2;WWTR1;GPRC5B;FZD4;DVL1;PSMB3
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.4274213678119431,1.2630758972330105,0.14480408858603067,0.9492299196837249,1.0,7/34,11.11%,MT1G;SEMA6A;PRKD2;RAMP2;NOTCH1;RELA;FLT1
prerank,modification-dependent protein catabolic process (GO:0019941),0.330194841304319,1.2629002081885254,0.0561941251596424,0.9472576446067085,1.0,61/193,19.04%,ELOC;RNF7;CBL;ARIH1;RNF149;ANAPC2;KLHL3;FEM1C;UBA1;RFFL;PSMD11;NEDD4L;RBBP6;UBE2I;RNF130;LONP1;UBL7;PPP1R11;TTC3;TRIM25;FBXO11;ANAPC7;MDM2;PSMC2;RNF6;FBXO7;RNF13;CHFR;UBQLN1;ANAPC11;ANAPC10;ANAPC4;FBXO8;RNF11;CUL3;PSMD14;USP33;UBE2R2;RNF146;RNF20;UBA6;UBE2G1;FBXO22;UBQLN4;RNF114;TAF1;RNF128;RNF125;UBE2H;UFD1;UBQLN2;UBR3;ATXN3;CDC26;RNF215;KCTD10;NDFIP2;RC3H1;FBXW4;TRPC4AP;HACE1
prerank,rRNA processing (GO:0006364),0.3343637409174896,1.262793584456246,0.08723958333333333,0.9449657946495179,1.0,60/172,19.87%,RPL30;THUMPD1;UTP20;UTP18;RPL17;RPL23;RPL31;RPL3;DDX54;DDX10;RRP15;RPL35A;RPS14;RPL8;RPL5;RPL37A;RPL4;EMG1;SNU13;POP5;RPLP0;EXOSC9;XRN2;RPS28;RPS24;RRP7A;RPS9;RPL24;RPL34;DDX27;WDR12;SRFBP1;EXOSC1;UTP11;RPL23A;RPL21;RPL35;MPHOSPH6;HEATR1;DKC1;RSL1D1;PRKDC;RPL19;RPL38;EIF6;RPL36;DCAF13;RPL26;RPL15;RPL10;RPL32;RPS2;TFB1M;RPL27A;NOP58;NVL;EXOSC7;RPL7;RPL39;RPL14
prerank,phagosome-lysosome fusion (GO:0090385),0.5625431040446812,1.2627494199936853,0.19593345656192238,0.9424184150935667,1.0,3/10,7.38%,RAB7A;RAB7B;PIKFYVE
prerank,regulation of macrophage cytokine production (GO:0010935),0.529320545916589,1.2624328575768993,0.17790262172284643,0.9411045030284585,1.0,4/13,8.56%,SEMA7A;SIRT1;CUEDC2;WNT5A
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.46707587386776195,1.2623477717476896,0.18803418803418803,0.9387525802355808,1.0,4/23,5.71%,RAC2;CAMK1D;TIRAP;RIPOR2
prerank,negative regulation of inflammatory response (GO:0050728),0.3249923617403989,1.262296467310551,0.06582278481012659,0.9362559192892442,1.0,25/182,10.61%,GPR176;PRKAR1A;PTGER2;TNFAIP3;PLK2;SRC;TSHR;INSL3;RAMP2;APOE;TEK;FYN;TNFRSF1B;LPCAT3;GNB1;RXFP1;SYK;PPARD;NLRC3;PLCG1;LYN;RHBDF2;CD163;MFHAS1;YES1
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.39242599001471057,1.2622398089049163,0.1537190082644628,0.9338342239021433,1.0,21/52,20.96%,RAC2;GSK3A;SAE1;VPS11;MAPK8;YWHAB;BAD;PPP3R1;YWHAH;CSNK2A2;ATG13;YWHAQ;LEPROT;UBE2D3;USP36;SH3GLB1;YWHAE;FBXW7;YWHAZ;UBE2L3;TFDP2
prerank,peptide cross-linking (GO:0018149),-0.41481386881780813,-1.2613579252382794,0.14780600461893764,0.566508678074592,1.0,4/25,11.85%,COL3A1;THBS1;FN1;ANXA1
prerank,response to UV (GO:0009411),0.35210038698478985,1.2609233925937786,0.10666666666666667,0.9371291511125481,1.0,28/95,17.96%,ERCC3;ZRANB3;MAP2K7;EIF2S1;RUVBL2;SDF4;ERCC4;YY1;MAP3K4;POLK;EP300;MAPK8;USP47;RELA;SPRTN;CCAR2;CREBBP;BMF;INO80;TAF1;ATR;N4BP1;TMEM161A;USP28;NPM1;UVSSA;POLH;RPL26
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.5552849655707914,1.2608379451513378,0.1968503937007874,0.9348313860608782,1.0,4/10,9.20%,CSGALNACT1;XYLT1;PXYLP1;B3GAT2
prerank,regulation of pH (GO:0006885),0.5527870044390126,1.260818398193673,0.20114942528735633,0.9322415019217347,1.0,3/11,10.69%,SLC9A7;CLCN3;ATP6AP1
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.3683624420895047,1.2607683335589104,0.12296296296296297,0.9271423270627022,1.0,18/78,10.48%,DYNC1I1;KIF18A;CAPZA2;FCGR2B;AP2S1;KIFAP3;RAB7A;DCTN2;CLTA;AP1G1;AP1S2;PIKFYVE;KIF15;DCTN3;ARF1;OSBPL1A;KIF2A;DYNLL1
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.3683624420895047,1.2607683335589104,0.12296296296296297,0.9271423270627022,1.0,18/78,10.48%,DYNC1I1;KIF18A;CAPZA2;FCGR2B;AP2S1;KIFAP3;RAB7A;DCTN2;CLTA;AP1G1;AP1S2;PIKFYVE;KIF15;DCTN3;ARF1;OSBPL1A;KIF2A;DYNLL1
prerank,leukotriene biosynthetic process (GO:0019370),-0.49889923426393923,-1.260241480012046,0.20045558086560364,0.5683719641736615,1.0,3/14,13.80%,PLA2G4A;GGTA1;GGT5
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),-0.47275483074021996,-1.2599218793628406,0.17943107221006566,0.5680604771256418,1.0,9/17,25.91%,ROBO1;NRP1;EFNB2;PIK3R3;EPHB4;GPLD1;VEGFA;AKT1;NR4A1
prerank,camera-type eye morphogenesis (GO:0048593),-0.5345905603797703,-1.2595869239005935,0.1932059447983015,0.5677169645862324,1.0,6/10,30.06%,TENM3;SKI;LRP6;VEGFA;TBX2;KDM2B
prerank,positive regulation of JNK cascade (GO:0046330),0.3719227281829799,1.2595044706778253,0.12158054711246201,0.9303137415283944,1.0,14/70,11.27%,MAP3K11;FCGR2B;TIRAP;HIPK2;EDAR;TRAF5;AXIN1;MTURN;MINK1;TRAF3;PJA2;PLCB1;MFHAS1;APP
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),-0.3425413862434447,-1.2592444265089568,0.07407407407407407,0.5674485668014934,1.0,16/59,12.31%,ROBO2;CNTN4;TENM3;SDK1;ROBO1;CNTN6;KIRREL3;PKD1;DSCAM;IGSF11;PALLD;SDK2;MPZL2;CDH1;CDH4;OBSL1
prerank,regulation of extracellular matrix organization (GO:1903053),-0.47410762591272554,-1.2591506068183578,0.19162995594713655,0.5665244169676741,1.0,4/15,9.67%,LRP1;AEBP1;DDR1;FAP
prerank,negative regulation of innate immune response (GO:0045824),0.42611239452221306,1.259018861160923,0.16917922948073702,0.9298813742853398,1.0,9/34,13.09%,TNFAIP3;TTLL12;FAM3A;NLRC3;CNOT7;USP15;A2M;USP18;NLRC5
prerank,clathrin coat assembly (GO:0048268),0.5025926323669565,1.2589151493364088,0.18874773139745918,0.9277253462534988,1.0,5/15,14.60%,AP2S1;SGIP1;CLTA;PICALM;PIK3C2A
prerank,translational elongation (GO:0006414),0.35833364249047117,1.258852732567389,0.12534818941504178,0.9253249460390717,1.0,20/101,15.13%,MRPS22;MRPS2;MRPS33;EEF1A1;MRPL23;MRPL24;EEF1D;MRPL18;MRPL38;MRPS12;MRPL20;TSFM;GTPBP2;MRPL52;MRPS15;MRPS24;MRPL48;EEF1B2;MRPS28;MRPS35
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.48200029336354255,1.25835567028901,0.1843065693430657,0.9250099971324283,1.0,2/19,0.97%,LRP8;SS18L1
prerank,positive regulation of stress fiber assembly (GO:0051496),-0.3594007294119583,-1.2579172110974823,0.1368421052631579,0.5688887546048945,1.0,20/44,24.21%,LPAR1;NRP1;ARHGEF10L;CCN2;TGFBR1;TPM1;RHOA;PXN;ROCK2;PPM1E;FHOD1;NF2;ARHGEF5;CDC42;PPM1F;PFN2;ARHGEF15;RHOC;ITGB1BP1;TGFB3
prerank,copper ion transport (GO:0006825),-0.5291521838899945,-1.257705904695802,0.18448637316561844,0.568229944871454,1.0,7/11,23.25%,ATP7A;STEAP3;SLC31A1;SLC31A2;COX17;SLC11A2;STEAP2
prerank,acylglycerol biosynthetic process (GO:0046463),-0.43246707000795553,-1.257656548242387,0.16904761904761906,0.5671756281348921,1.0,6/23,7.97%,AGMO;PLA2G4A;LPGAT1;PLCE1;GK;LPIN1
prerank,protein insertion into ER membrane (GO:0045048),-0.37724193245881266,-1.2574959279527154,0.12437810945273632,0.5664361215760909,1.0,18/37,27.58%,UBE2J2;EMC7;CYB5A;CAMLG;TRAM1;ALDH3A2;VAMP2;TRAM2;STX1A;SGTA;BAG6;EMC1;EMC8;EMD;EMC9;SERP1;SEC61B;GET4
prerank,positive regulation of phosphorylation (GO:0042327),-0.2769676529555684,-1.2574172620385455,0.03636363636363636,0.5655025623583084,1.0,52/240,14.43%,ZBTB20;ERBB4;NTRK3;FGFR2;IGF1;SLCO3A1;DAB2;EGFR;LMO4;EPHA6;LEPR;EFNA5;PDGFRB;EPHB1;NTRK2;NRP1;FGF1;AXL;RYK;DSCAM;EPHA7;ROR1;BMP4;KIT;ROCK2;IL34;DDR1;PDGFRA;AKT2;PIK3R3;RAD50;VAC14;EPHB4;NIBAN1;PELI2;THBS1;MRE11;CCND3;DVL3;EPHB2;EPHA3;SEMA4D;ILK;PFKFB4;CLIP3;FNIP1;FAM20A;RALBP1;ROR2;IGF2;RACK1;PTK2
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.4513750509148772,1.2567339456555653,0.15358931552587646,0.9298571162287288,1.0,8/27,12.87%,MAP2K7;MAPK3;MAP3K7;MAPK8;CCDC88C;TNIP2;IKBKB;CHUK
prerank,digestive tract morphogenesis (GO:0048546),-0.4877188596634021,-1.2565889823539431,0.21333333333333335,0.5666876012647518,1.0,6/14,23.37%,FGFR2;PDGFRA;NIPBL;RBPMS2;GLI1;STRA6
prerank,positive regulation of binding (GO:0051099),0.36049640813250095,1.2563488886098881,0.1119186046511628,0.9291039268297453,1.0,18/84,11.27%,NCBP1;TRIB3;RALB;PIN1;TIAM1;HIPK2;NME1;APOE;B2M;CEBPG;SPPL3;TXN;EPB41;KDM4D;AKTIP;CLDN5;TERT;APP
prerank,ncRNA processing (GO:0034470),0.32852527084861466,1.256284166568078,0.08104575163398693,0.9268126765924247,1.0,67/200,20.27%,THG1L;RPL30;UTP20;UTP18;RPL17;RPL23;RPL31;RPL3;DDX54;DDX10;FARS2;SMAD1;RPL35A;RPS14;RPL8;RPL5;RPL37A;PUS10;ADAR;RPL4;EMG1;SNU13;POP5;RPLP0;EXOSC9;XRN2;RPS28;RPS24;RRP7A;RPS9;RPL24;RPL34;AGO4;DDX27;WDR12;TUT7;EXOSC1;UTP11;RPL23A;RPL21;RPL35;MPHOSPH6;HEATR1;SSB;TUT4;DKC1;INTS6;RPL19;RPL38;RPL36;DCAF13;RPL26;RPL15;RPL10;RPL32;RPS2;RPL27A;NOP58;NVL;EXOSC7;RPL7;RPL39;POP1;RPL14;AGO1;MDN1;INTS2
prerank,ATP transport (GO:0015867),0.5705491832831782,1.25616814781028,0.19557195571955718,0.9248073480657343,1.0,3/10,15.36%,SLC25A24;CD47;SLC25A42
prerank,peptidyl-serine phosphorylation (GO:0018105),0.331349492767702,1.2559878913451925,0.10119840213049268,0.923030068992262,1.0,37/153,15.84%,PCK1;PRKX;STK32A;PLK2;RPS6KA1;PRKCH;RPS6KA4;CAMK1D;HIPK2;PRKD2;RPS6KA5;PKN3;SMG1;MAPK8;CSNK1G3;SBK1;PIKFYVE;DCLK3;LATS2;PKN1;SRPK2;NLK;TNKS;PRKCI;MAST4;IKBKB;MAPK12;CHUK;TLK2;NEK6;CSNK2A2;MAP3K10;GAS6;DYRK2;TOP1;TAF1;ATR
prerank,positive regulation of neuroblast proliferation (GO:0002052),-0.5337937632072621,-1.2553471863067005,0.17365269461077845,0.5690572859758459,1.0,8/10,30.46%,CTNNB1;SMARCD3;DISC1;KDM1A;CX3CL1;VEGFA;CX3CR1;DRD2
prerank,nuclear export (GO:0051168),-0.32777978847687717,-1.2553072439982682,0.09404388714733543,0.5679795006144162,1.0,26/80,16.23%,RANBP3L;SRSF5;PKD1;SRSF11;CASC3;SRSF2;MALT1;SRSF6;XPO6;SRSF1;POLDIP3;DDX39B;NXF1;NUP155;NUP188;PHAX;LSG1;RANBP3;STRADA;HNRNPA1;ATXN1;THOC5;SLU7;CDC40;NUTF2;TGFB1
prerank,membrane repolarization during action potential (GO:0086011),-0.5051224655437698,-1.2552757112830557,0.19646799116997793,0.566901504925459,1.0,3/13,8.46%,ATP1B1;ATP1A1;KCNJ2
prerank,axon development (GO:0061564),-0.324024693857304,-1.2552576742837267,0.0990990990990991,0.5657977514672635,1.0,16/78,11.06%,FGFR2;CNTN4;ANK3;DCC;PLP1;MAP1B;CTNNA2;NRCAM;NTNG1;RYK;MAPT;SHTN1;GAP43;BRSK1;EPHB2;PLPPR4
prerank,regulation of Wnt signaling pathway (GO:0030111),-0.30464804085179764,-1.2552476219216915,0.07719298245614035,0.5646614453814054,1.0,30/108,14.71%,FGFR2;TRABD2B;SULF1;LRP1;WLS;NXN;CTNNB1;PTK7;MACF1;SULF2;RNF43;CBFB;NKD1;DCDC2;GPC3;CTNND2;VGLL4;BTRC;SKI;CDC73;RSPO3;TLE1;SALL1;OTULIN;DISC1;DAAM2;ATP6V0C;GRB10;RACK1;DACT1
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.30426904996335286,1.2542148698793483,0.03778040141676505,0.9283691370681164,1.0,101/366,18.81%,TBX4;ONECUT1;TRAPPC2;FOXN2;EZH2;ZFAT;HES6;EIF2A;GTF2IRD1;RPS6KA4;ATXN1L;RPS6KA5;ORC3;PPP2CA;SBNO2;MYBL2;SMARCA2;SOX2;RBBP6;SPIN1;EP300;RFX3;NFX1;MED23;TGFBRAP1;SRSF10;ACTR8;CDK11B;ZNF205;SFPQ;FBXO5;ACTR5;GEMIN5;DRAP1;CLOCK;PFDN5;NOTCH1;TSC1;SOX13;ACVRL1;RELA;NAB2;ESCO1;RNF6;UBE2V1;RYBP;ING2;CCAR2;ESR1;METAP1;NLK;HP1BP3;CREBBP;CARM1;NANOS3;APP;USP37;JMJD1C;SP1;MZF1;IRF2;CHD3;ERC1;NUP35;TRRAP;CHEK2;DDIT3;ANKRD17;ZKSCAN5;HCFC1;YBX1;RNF20;BAZ2A;NSD2;BACH1;FUS;TERF2IP;RBM4B;TFEB;TAF6L;APBB2;TCF7L1;TCF3;SOX17;WTIP;CYFIP1;MYT1;CALR;NONO;ZNF219;INSR;STAT3;FOXK2;RPL10;PATZ1;ZSCAN21;NCOA2;HINT1;YAF2;ATRX;MSL3
prerank,regulation of interleukin-2 production (GO:0032663),0.40236317273671407,1.2540610094713012,0.15883306320907617,0.9264940005252246,1.0,10/43,14.09%,PDE4D;PTPRC;MAP3K7;TNFAIP3;HDAC7;PRKD2;PNP;RPS3;PRNP;TRIM27
prerank,mitochondrion organization (GO:0007005),0.33021622101984416,1.2538230574883833,0.08638743455497382,0.9249593996742272,1.0,26/165,11.20%,THG1L;MIGA1;TOMM20;HIGD2A;CHCHD2;DNM3;IMMP2L;CYCS;DNAJA3;GABPA;MTFR1;SIRT3;PHB2;TIMM17B;TSPO;SSBP1;LONP1;AGTPBP1;OMA1;PARK7;FBXO7;AIFM1;TERT;NOS3;CHCHD3;HIGD1A
prerank,termination of RNA polymerase I transcription (GO:0006363),0.4306326389206208,1.253097796796944,0.1635434412265758,0.9256412021177656,1.0,5/30,8.79%,ERCC3;POLR1C;CCNH;POLR1G;GTF2H1
prerank,cellular response to UV (GO:0034644),0.3668880464309973,1.2530230853845665,0.12951807228915663,0.9234778773739908,1.0,23/76,17.96%,CERS1;EIF2S1;RUVBL2;MME;ERCC4;YY1;POLK;CDKN1A;EP300;CARD16;SIRT1;ACTR5;USP47;CREBBP;BMF;INO80;TAF1;ATR;N4BP1;TMEM161A;USP28;NPM1;RPL26
prerank,negative regulation of transmembrane transport (GO:0034763),0.5407647234183365,1.2528689842528777,0.2074688796680498,0.9215992862772391,1.0,3/10,12.75%,RSC1A1;IRS2;CTTNBP2NL
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.5259313676843661,1.2526149103485344,0.19813084112149532,0.9202208698009746,1.0,3/13,4.52%,DERL2;SVIP;YOD1
prerank,histone H2A ubiquitination (GO:0033522),-0.45415284771588477,-1.2515871919433035,0.17987152034261242,0.5738323161856829,1.0,11/17,32.70%,DDB1;DDB2;RNF168;RNF8;BCOR;DTX3L;UBR2;UBE2B;KDM2B;RING1;TRIM37
prerank,adenine nucleotide transport (GO:0051503),0.49167170929751625,1.251585463772674,0.19652173913043477,0.9220902298231652,1.0,3/17,6.45%,ABCC4;SLC25A24;LRRC8C
prerank,negative regulation of cell projection organization (GO:0031345),-0.3618379829324664,-1.2506073012348409,0.11918604651162791,0.5754288712530089,1.0,10/48,7.58%,DCC;LPAR1;SPOCK1;GRIN2B;DPYSL3;PTPRS;EFNB2;CBFA2T2;SEMA3A;STMN2
prerank,response to glucagon (GO:0033762),-0.4476708504301725,-1.2505931872414255,0.18,0.5742890814071892,1.0,8/19,12.02%,ADCY5;ADCY2;ADCY1;ADCY9;PRKACA;CRY1;ADCY7;PRKAR1B
prerank,negative regulation of neuron projection development (GO:0010977),-0.34876186107461604,-1.2503975681299135,0.11461318051575932,0.5736780973680339,1.0,16/56,15.44%,DCC;LPAR1;SPOCK1;DPYSL3;PTPRS;EFNB2;RHOA;CBFA2T2;SEMA3A;STMN2;NLGN1;BCL11A;PRAG1;GDI1;ARHGDIA;PTPRO
prerank,homeostasis of number of cells (GO:0048872),0.5345264139835127,1.2500310434331818,0.1996007984031936,0.9263393046462134,1.0,4/12,11.15%,OCIAD1;LPCAT3;NOTCH1;NOS3
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.5344117100311239,1.2499422754607767,0.20446096654275092,0.9241713442627508,1.0,3/12,9.50%,UPP1;UCK2;UPP2
prerank,epithelial cell morphogenesis (GO:0003382),-0.46646779368509833,-1.2498307204350239,0.19144602851323828,0.5742259182488046,1.0,7/17,21.91%,COL22A1;RILPL1;COL15A1;MET;SIPA1L3;COL18A1;RILPL2
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.3712569639093195,1.249099369795659,0.1346749226006192,0.9254838015240763,1.0,19/72,14.97%,ACER2;PLK2;HIPK2;ING4;CNOT11;CDKN1A;EP300;CRADD;CNOT2;RGCC;CNOT7;MDM2;TFAP4;CARM1;NBN;CNOT6;CHEK2;CNOT1;CNOT6L
prerank,regulation of histone acetylation (GO:0035065),0.413533776042092,1.2485445108402504,0.14991181657848324,0.9254122724725449,1.0,9/33,13.20%,MAPK3;RUVBL2;RPS6KA4;RPS6KA5;RAPGEF3;SETD5;PARK7;CTBP1;HDAC5
prerank,modulation of excitatory postsynaptic potential (GO:0098815),-0.4071704705050573,-1.2485104184691609,0.16299559471365638,0.5768321877427998,1.0,8/26,11.22%,RIMS1;NRXN1;DLG4;NLGN2;PRKCZ;RELN;NLGN1;CUX2
prerank,tRNA aminoacylation (GO:0043039),0.41094948896683464,1.24844330007356,0.1592775041050903,0.9234102731100798,1.0,13/37,17.80%,FARS2;GARS1;YARS2;IARS1;LARS2;HARS1;RARS2;WARS2;LARS1;GATB;HARS2;WARS1;IARS2
prerank,early endosome to Golgi transport (GO:0034498),0.547638869161366,1.2483054468498784,0.23007246376811594,0.9215719389014291,1.0,5/11,11.02%,SURF4;SNX8;RAB6A;SNX1;RBSN
prerank,axonogenesis (GO:0007409),-0.2760435901028564,-1.2481576835941603,0.047872340425531915,0.5766630560607549,1.0,60/237,13.93%,NRXN3;NCAM1;ROBO2;FGFR2;NOTCH2;CNTN4;ANK3;LAMA2;DCC;MAP1B;ROBO1;CTNNA2;UNC5D;NRXN1;CNTN6;EPHA6;TNR;ULK2;NRCAM;EFNA5;SEMA3D;GLI2;EPHB1;NTNG1;AUTS2;NRP1;EFNB2;RYK;DSCAM;EPHA7;PDLIM7;KIF5C;UNC5C;RELN;DAB1;SHTN1;PALLD;SEMA3A;FEZ1;NOTCH3;EPHB4;EZR;NIBAN2;NRP2;B4GALT6;SPTAN1;BRSK1;EPHB2;EPHA3;PLPPR4;SEMA4D;GAB2;GRB2;NTN4;SHC3;RANBP9;AFG3L2;GRB10;VLDLR;MAP1A
prerank,supramolecular fiber organization (GO:0097435),-0.2644330334960383,-1.2474872632280378,0.006622516556291391,0.5773429103666649,1.0,125/333,28.03%,COL1A2;COL4A5;ADAMTS2;PPP1R9A;COL1A1;GSN;TNXB;COL4A6;COL8A1;CGNL1;COL3A1;COL11A1;TMOD2;PLOD2;COL25A1;HDGFL3;COL22A1;TGFBR1;DYNC1H1;COL5A1;PLEC;COL4A3;CLIP4;SNCAIP;MAPT;SHROOM3;COL5A2;TPM1;VIM;RHOA;COL4A4;LOXL1;ARHGAP12;COL12A1;ATP7A;SORL1;COL6A1;TUBGCP4;HSPG2;COL8A2;STMN2;P4HB;COL15A1;COL13A1;PLOD1;COL6A2;SLAIN2;GGA2;RND3;CEP126;CKAP5;BACE1;RHOBTB2;BIN3;UBC;ADAMTS3;LOXL3;RHOB;CLIP3;TUBGCP6;RHOBTB1;INPPL1;DLG1;HIP1R;SIAH2;FIGNL2;COL23A1;TRIOBP;NEFL;STMN1;COL6A3;KATNAL1;ERMN;DCTN1;MYO1B;TPM4;ITGB4;COL5A3;GGA3;CDC42;P4HA2;TGFBI;COL20A1;COL14A1;LUM;MYO1F;ALDOA;COL16A1;TMOD1;COL18A1;WDR73;EFEMP2;P3H1;MYO19;LOX;GFAP;CRTAP;HOOK2;EMILIN1;RHOC;COL26A1;TPPP;STMN4;EMP2;ARHGAP17;KATNAL2;MYH11;ELMO2;COL9A2;TSPAN15;MFGE8;COL27A1;APH1B;STMN3;DPT;TPPP3;HIP1;DBN1;CDC42EP2;MYO5B;MPRIP;RHOH;BFSP2;CD151;MAP7D3
prerank,ERBB signaling pathway (GO:0038127),0.3759638747137231,1.246959299292076,0.14479638009049775,0.9250570748974668,1.0,10/64,8.78%,FAM83B;PTPRR;PTPN18;CBL;SRC;CDC37;RPS6KA5;PTPN12;PLCG1;ERBIN
prerank,positive regulation of heart contraction (GO:0045823),0.4780135553948018,1.246868711542421,0.20892857142857144,0.9231057656702429,1.0,3/19,3.95%,RGS2;GSK3A;ATP2A2
prerank,positive regulation of T cell cytokine production (GO:0002726),0.47355483919657415,1.246550324560089,0.19202898550724637,0.922089877271168,1.0,6/20,15.09%,IL1R1;MAP3K7;B2M;CD81;CD55;DENND1B
prerank,central nervous system development (GO:0007417),-0.2707836852263133,-1.245518235171364,0.021621621621621623,0.5816021102688316,1.0,34/250,6.38%,ROBO2;CNTN4;DCLK1;ZIC1;ADAM22;ARNT2;PBX1;ZIC4;CNTN6;SPOCK1;GSN;GRIN2B;NRCAM;AHI1;NFIB;ADAM23;PKD1;ADGRA2;AFF2;MBP;SH3GL2;NCOA6;TGFBR2;DNER;EPHA7;JARID2;MEIS2;GLIS2;IL1RAPL2;VCAN;RELN;SMO;ZIC5;HSPG2
prerank,positive regulation of cellular component movement (GO:0051272),0.45717011357546405,1.2454034488555785,0.19444444444444445,0.9247747774704029,1.0,5/24,9.31%,PHPT1;SPOCK2;ACTN4;CSF1R;LYN
prerank,lipid droplet organization (GO:0034389),0.46891651435884796,1.2452105234722837,0.1978798586572438,0.9232997299600254,1.0,3/22,9.48%,CIDEA;FITM2;AUP1
prerank,positive regulation of organelle organization (GO:0010638),-0.38363982247084333,-1.2450412308627674,0.1893939393939394,0.5816583363746259,1.0,11/32,13.51%,STX18;ANXA2;RAB3GAP2;PPARGC1A;AKT2;LMAN1;TMED9;GSK3B;UVRAG;ANXA1;PFDN2
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),-0.3836038678281069,-1.2449871924616103,0.15763546798029557,0.5806422130399634,1.0,11/34,17.35%,DOCK5;DOCK1;NRP1;FLNA;NEDD9;RREB1;P4HB;ILK;MYADM;TRIOBP;CDC42
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.476325610583571,1.2448463576093056,0.18650088809946713,0.9225422958675995,1.0,9/21,16.45%,TIPRL;BOD1;PPP1R16B;YWHAB;PPP1R11;MFHAS1;PTPA;PPP1R8;FKBP1A
prerank,positive regulation of cation channel activity (GO:2001259),-0.36955885393811116,-1.243905339178084,0.12121212121212122,0.5825279172874748,1.0,7/40,10.62%,ANK2;ANK3;AKAP6;RELN;HTT;ACTN2;EPHB2
prerank,regulation of BMP signaling pathway (GO:0030510),-0.32322102360358795,-1.2435745809853105,0.09912536443148688,0.582299756975908,1.0,26/73,21.42%,SULF1;FSTL1;FOXD1;NBL1;BMPER;SMURF2;SMAD4;VWC2L;BMP4;CRIM1;SORL1;SKI;HTRA3;SMAD6;XIAP;SPART;PCSK6;SMAD5;BMPR1B;RBPMS2;ZNF423;SFRP4;BMPR1A;BMPR2;TWSG1;CCN1
prerank,positive regulation of rRNA processing (GO:2000234),-0.5268921520394335,-1.2433635027736356,0.2033195020746888,0.5817435587636557,1.0,6/10,25.27%,RIOK1;RIOK2;WDR43;SIRT7;UTP15;BUD23
prerank,establishment of endothelial intestinal barrier (GO:0090557),0.5458886600324165,1.2430290611932324,0.20355731225296442,0.9279296999105104,1.0,5/11,12.23%,F11R;RAPGEF6;TJP1;RAB1A;RAP2C
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.5258177322183958,1.2426413877519724,0.21851851851851853,0.9273305682328407,1.0,4/13,6.27%,FCGR2B;MANF;WFS1;LPCAT3
prerank,regulation of lipid kinase activity (GO:0043550),-0.5285009987556932,-1.2419402731954212,0.2134387351778656,0.5845984316931321,1.0,6/11,30.75%,RBL2;PIK3R3;PIK3R1;RBL1;PIK3R2;WDR81
prerank,regulation of sequestering of calcium ion (GO:0051282),-0.4968732144106559,-1.2416295082999378,0.1910569105691057,0.5843675158478256,1.0,2/12,7.21%,ANK2;UBASH3B
prerank,protein localization to synapse (GO:0035418),-0.4966847462621044,-1.241026710749461,0.21304347826086956,0.5849079601579459,1.0,7/12,13.67%,NRXN1;PCLO;DLG4;NLGN2;NLGN1;NRXN2;BSN
prerank,wound healing (GO:0042060),-0.339964620112635,-1.2403497099090595,0.12394366197183099,0.5856250822786013,1.0,17/62,15.32%,IGF1;SMAD3;CFLAR;COL3A1;FGF1;TGFBR1;PLEC;TPM1;MACF1;EPB41L4B;PDGFRA;FUT10;MYOF;AHNAK2;SYT11;SYT7;RAF1
prerank,isotype switching (GO:0045190),-0.5417303025863476,-1.2400760501943382,0.21850393700787402,0.5852351190461225,1.0,8/10,43.87%,RNF168;RNF8;MSH2;HSPD1;MSH6;EXOSC3;BATF;LIG4
prerank,gene expression (GO:0010467),0.3061778018998688,1.2396701254241151,0.05983889528193326,0.9379729203972055,1.0,100/348,18.37%,POLR2J;NCBP1;RPL30;MRPS33;NR4A2;RSL24D1;EEF1A1;POLR2B;RPL17;MRPL23;RPL23;MRPL24;FASTKD2;RPL31;RPL3;RPS21;DDX54;MRPL18;PAX8;SMG1;HNRNPK;LMF1;RPL35A;CPSF4;RPS14;RPL8;CHTOP;YARS2;RPL5;ABCF1;NUP54;PWP1;MRPS12;RPS12;HBS1L;RPS26;RPL37A;NXT1;HARS1;NUP50;ADAR;YTHDC1;FYTTD1;RPL4;SRSF4;RPLP0;SARNP;UPF2;XRN2;RPS28;U2AF1;RPS24;DUSP11;RPS9;RPS23;RPL24;THRB;ADARB2;RPL34;RPS11;MRPL52;RPS3;MRPS15;DHPS;NUP35;RRAGC;PPP5C;TSPAN17;RPS15A;RPL23A;RPL21;RPL35;SRSF7;BAZ2A;HNRNPL;NDC1;ADARB1;SLBP;UPF3B;DKC1;U2AF2;HARS2;WDR33;WARS1;NUP160;RPL19;RPL38;HNRNPF;POM121;RPL36;SMG6;RPSA;DHX8;RPL26;RPS8;SMG5;CLP1;RPL15;RPL10;NUP42
prerank,photoperiodism (GO:0009648),-0.40364049960115106,-1.2393493976043473,0.16705882352941176,0.5862137097693312,1.0,12/28,14.52%,PER2;PER3;CRY2;PML;BHLHE40;SIK1;MTA1;TP53;CRY1;PER1;RBM4;FBXL12
prerank,mammary gland epithelium development (GO:0061180),-0.4888314700297288,-1.2389535666793734,0.21041666666666667,0.5862551963746575,1.0,3/14,7.03%,ERBB4;WNT4;AKT2
prerank,regulation of receptor binding (GO:1900120),0.5635651199844621,1.2387973915599084,0.21774193548387097,0.9393589573911063,1.0,3/10,7.11%,ATP2A2;B2M;BDNF
prerank,positive regulation of cell cycle process (GO:0090068),-0.31405379873374417,-1.238719720086681,0.09477124183006536,0.5858418993267507,1.0,17/91,15.16%,SVIL;IGF1;PDGFRB;DYNC1H1;RHOA;SIRT2;CEP120;CIT;MAP3K20;LRP5;UBXN2B;PLSCR1;NSFL1C;USP19;CENPV;IGF2;CEP295
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),-0.514303214723431,-1.2386359528022057,0.20568927789934355,0.58490124117112,1.0,3/12,4.40%,FOXP1;DAB2;HDAC1
prerank,ribosome biogenesis (GO:0042254),0.32311718049752364,1.2386295653392119,0.10243277848911651,0.937644933542138,1.0,62/187,19.87%,RPL30;UTP20;UTP18;RPL17;RPL23;EIF2A;RPL31;RPL3;DDX54;DDX10;RPL35A;RPS14;RPL8;RPL5;RPL37A;RPL4;EMG1;SNU13;POP5;RPLP0;EXOSC9;TSC1;XRN2;RPS28;RPS24;RRP7A;RPS9;RPL24;RPL34;LTV1;RBIS;DDX27;WDR12;PAK1IP1;XPO1;EXOSC1;UTP11;LTO1;RPL23A;RPL21;RPL35;MPHOSPH6;HEATR1;DKC1;RPL19;NPM1;RPL38;EIF6;RPL36;DCAF13;RPL26;RPL15;RPL10;RPL32;RPS2;RPL27A;NOP58;NVL;EXOSC7;RPL7;RPL39;RPL14
prerank,nuclear envelope organization (GO:0006998),-0.4309567477755713,-1.2384739302152934,0.19230769230769232,0.5841807448851829,1.0,13/20,26.03%,NUP155;TOR1AIP1;DMPK;NUP93;TOR1B;NEMP1;SUN1;VPS4A;CTDNEP1;EMD;LEMD2;TMEM170A;TMEM43
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.3991372377033934,-1.2384730562648685,0.16546762589928057,0.5830441762029336,1.0,11/30,20.30%,TGFBR3;SMAD3;FSTL1;SMURF2;SMAD4;DKK3;XIAP;PCSK6;TGFB1;SFRP4;TWSG1
prerank,negative regulation of MAPK cascade (GO:0043409),0.3532535690973582,1.2384569853006218,0.13126843657817108,0.9360644809168526,1.0,13/87,9.31%,RGS2;SEMA6A;PTPRR;DUSP7;PTPRJ;PIN1;PTPRC;PRDM15;APOE;SPRED1;CNKSR3;DAG1;LYN
prerank,leukocyte cell-cell adhesion (GO:0007159),0.4496541458445176,1.238314240509192,0.1919191919191919,0.9343114548018031,1.0,5/24,7.28%,PECAM1;SELP;ICAM1;SYK;F11R
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.302877864730465,-1.2380203625681958,0.0914826498422713,0.5832014553811208,1.0,33/104,19.95%,MAGI2;LDLRAD4;SMAD3;NBL1;BMPER;SMURF2;TGFBR1;TGFBR2;SMAD4;VWC2L;CRIM1;SORL1;PPARA;SKI;HTRA3;SMAD6;ACVR1;SPART;SNX25;UBC;PPM1A;SMAD5;MTMR4;TGFB1;BMPR1B;CCN3;RBPMS2;PRDM16;CD109;BMPR1A;STUB1;BMPR2;SPRED3
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),-0.4082879833939968,-1.2377515953752036,0.175,0.5827915315956123,1.0,4/26,2.15%,IGF1;AKAP6;FHL2;CAMTA1
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.5087472148457304,1.2372108981361212,0.21206581352833637,0.9367297068057965,1.0,3/13,10.12%,NCBP1;CPSF4;CPSF6
prerank,axon guidance (GO:0007411),-0.2766512720041939,-1.2369017361536805,0.05172413793103448,0.5840270683686252,1.0,52/201,13.66%,NRXN3;NCAM1;ROBO2;NOTCH2;CNTN4;ALCAM;LAMA2;DCC;PLXNA2;ROBO1;UNC5D;NRXN1;CNTN6;EPHA6;TNR;EFNA5;NFIB;SEMA3D;GLI2;EPHB1;NRP1;EFNB2;RYK;DSCAM;EPHA7;PDLIM7;KIF5C;UNC5C;RELN;SMO;DAB1;PALLD;SEMA3A;FEZ1;GAP43;NOTCH3;EPHB4;EZR;NIBAN2;NRP2;SPTAN1;EPHB2;EPHA3;SEMA4D;GAB2;GRB2;NTN4;SHC3;PLXND1;RANBP9;GRB10;VLDLR
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",-0.5207259170185854,-1.2363982260886734,0.20240480961923848,0.584249343193497,1.0,5/10,32.28%,APPL2;RAB31;ANO6;NCKAP1L;CD300A
prerank,protein deubiquitination (GO:0016579),0.31491789378327395,1.2358199776435117,0.09302325581395349,0.9405925844115693,1.0,59/242,14.94%,TOMM20;PSMB10;PSMC4;ABRAXAS1;PSMB6;PSMD8;PSMD5;PSMD12;ACTL6A;MAP3K7;TNFAIP3;ACTB;BIRC2;SMAD1;PSMD11;YOD1;OTUD1;PSMB4;YY1;SPATA2;PSMC1;EP300;ACTR8;SMAD7;ACTR5;DESI2;RUVBL1;USP47;ATXN7L3;TRAF3;MDM2;RAD23A;PSMC2;USP48;USP31;PSMD2;ESR1;OTUD3;USP22;USP15;USP37;NFRKB;USP18;TNIP2;OTUD5;PSMD14;TRRAP;USP33;BRCC3;PSMC6;PSMD1;APC;NFKBIA;PSMB1;HCFC1;MINDY2;USP9X;UCHL5;INO80
prerank,negative regulation of receptor binding (GO:1900121),0.5628633695743461,1.2354378953787726,0.23938223938223938,0.9397916627283562,1.0,2/10,5.45%,ATP2A2;B2M
prerank,DNA conformation change (GO:0071103),0.4804516496466121,1.2351835501817288,0.2222222222222222,0.9385232450149811,1.0,5/17,19.18%,ERCC3;TOP3A;TOP1;HAT1;TOP3B
prerank,ventricular cardiac muscle cell action potential (GO:0086005),-0.4482914439615997,-1.2343716334107282,0.20833333333333334,0.5888287164027336,1.0,2/17,2.50%,ANK2;SNTA1
prerank,negative regulation of viral entry into host cell (GO:0046597),0.52856217892141,1.233643050244162,0.19133574007220217,0.9428479424071674,1.0,4/12,8.83%,LY6E;IFITM2;IFITM3;IFITM1
prerank,diol biosynthetic process (GO:0034312),0.5090409349582509,1.2336259599155017,0.21505376344086022,0.940561245911732,1.0,4/15,14.25%,ACER2;SPR;ACER3;GCH1
prerank,regulation of sodium ion transport (GO:0002028),-0.3805541748672749,-1.233558090895238,0.17647058823529413,0.5899234114321471,1.0,12/34,13.92%,ANK3;FGF12;SNTA1;WNK1;P2RX4;ATP1A1;SIK1;WNK4;PER1;DLG1;WNK3;NKAIN4
prerank,chondroitin sulfate metabolic process (GO:0030204),-0.38630550789783513,-1.2334827247151048,0.16831683168316833,0.5889868512181768,1.0,20/30,29.30%,DSE;CHSY1;VCAN;HEXA;CSGALNACT2;CHST15;HEXB;ARSB;CHST11;UGDH;CSPG4;DSEL;BGN;DCN;HYAL1;CHPF2;CHST3;CSPG5;CHST12;NDNF
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.5298176570864069,1.2333903413908918,0.2300194931773879,0.9392267399251278,1.0,3/12,9.31%,MAPK3;CSF1R;LYN
prerank,neuron maturation (GO:0042551),-0.44832426185228214,-1.2331673577889297,0.18859649122807018,0.5886920935383114,1.0,12/18,34.83%,ADGRB3;B4GALT6;SRRM4;MTCH1;SCARF1;CX3CL1;EPHA8;PICK1;LGI4;CLN5;B4GALT5;C1QA
prerank,cholesterol biosynthetic process (GO:0006695),0.4193379650553889,1.2330853279975353,0.17089678510998307,0.9381634279283905,1.0,8/31,11.99%,EBP;INSIG1;HMGCR;PLPP6;SC5D;IDI1;NSDHL;LSS
prerank,positive regulation of cell adhesion (GO:0045785),0.3606202181068978,1.2329514641693313,0.14136904761904762,0.9364563249797593,1.0,13/74,11.89%,FRMD5;PTPRJ;CXCL12;PRKD2;CIB1;RET;SYK;MAGI1;SMAD7;CD47;CITED2;NPNT;PPP3CA
prerank,inner dynein arm assembly (GO:0036159),0.556957592980064,1.2329248132526216,0.23191094619666047,0.9342498545043436,1.0,1/10,1.21%,CFAP73
prerank,RNA transport (GO:0050658),-0.3250142051586239,-1.2329166011352914,0.10619469026548672,0.588257639465395,1.0,30/71,24.61%,SRSF5;SRSF11;CASC3;TGFBR2;SIDT1;SRSF2;KIF5C;SRSF6;SRSF1;POLDIP3;DDX39B;NXF1;NUP155;NUP188;CKAP5;HNRNPA2B1;SIDT2;HNRNPA1;THOC5;SLU7;CDC40;RTRAF;RNPS1;RAE1;FLOT1;NUP214;EIF4A3;NCBP2;THOC1;RBM8A
prerank,fluid transport (GO:0042044),-0.500263778620637,-1.2329164158842842,0.23060344827586207,0.5871307091215917,1.0,2/12,9.82%,PDPN;AQP4
prerank,protein K48-linked ubiquitination (GO:0070936),0.3808968571445049,1.2328497581962212,0.15698587127158556,0.9322164880624538,1.0,17/54,16.45%,KLHL3;TNFAIP3;RFFL;NEDD4L;UBE3A;RNF187;TTC3;RNF6;ZNRF1;IFI27;CUL3;UBE2R2;RNF146;RNF216;UBE2G1;PELI1;UBE2H
prerank,cellular response to nutrient levels (GO:0031669),0.3746287018071309,1.2326062729054195,0.16797488226059654,0.9309240785043497,1.0,21/62,21.13%,RALB;GAS2L1;MAP1LC3B;HSPA8;RPTOR;SIRT1;TSC1;PRKAA2;ATG7;RRAGC;USP33;ATG14;TFEB;ZFYVE1;ULK1;LAMP2;EIF4G1;XBP1;WDR45B;STK24;LRRK2
prerank,nitric oxide metabolic process (GO:0046209),0.4955889280593274,1.2324042706253513,0.2148014440433213,0.9294632534844929,1.0,4/14,14.25%,SPR;CYP1B1;NOS3;GCH1
prerank,spermatid development (GO:0007286),0.42626339973434124,1.2314209135616763,0.18294849023090587,0.9316114884797095,1.0,4/32,10.35%,SOX30;CIB1;CDYL;ING2
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),-0.3222038109442562,-1.230904009524318,0.1282798833819242,0.5916175044306914,1.0,33/71,31.42%,OTUD7A;ADAMTS12;CAPN2;NGLY1;DDB1;MALT1;VCP;RHBDD1;PSMA6;FAP;LGMN;CLPP;UBC;NEDD8;CTSO;DDI2;RNF123;HM13;CTSZ;STUB1;VPS4A;BAG6;OTUD7B;CTSK;CTSF;CLPX;CTSB;CTSC;HDAC6;CTSS;ZRANB1;FBXL17;PRPF19
prerank,positive regulation of cellular protein localization (GO:1903829),-0.32402208488140377,-1.2302639894721958,0.12654320987654322,0.5922807403050251,1.0,31/69,31.63%,BICD1;MAPT;KAT7;GNL3L;STX3;TM9SF4;GSK3B;DDRGK1;SYT11;ENTR1;MAP1A;TGFB1;CEP250;WWTR1;LIMK2;GPD1L;CARD10;GNL3;DTX3L;YAP1;LAMTOR5;EIF2AK3;AKT1;SESN2;SLC5A3;ABCA7;GPR137B;ORMDL3;PARP9;CDK5RAP3;PRKAA1
prerank,regulation of signal transduction (GO:0009966),-0.27760786407516985,-1.229808858686641,0.046296296296296294,0.5924103808477826,1.0,73/190,25.76%,NCAM1;FGFR2;SULF1;ZIC1;KCTD8;OGT;TULP3;IGFBP5;IGFBP2;PLCE1;IGFBP7;IFT81;PXN;CBFB;DHRS3;POFUT1;DCDC2;IRAK1;IGFBP6;UBASH3B;CASTOR2;GAS1;SNW1;RGS12;ACVR1;ELF1;RSPO3;GRK5;GRK3;PLSCR1;SOCS2;CSK;PRAG1;ILK;NUCKS1;IGFBP4;WDR11;FRRS1L;USP20;RORA;INTU;TMEM204;TGFB1;RGS20;PTPN2;GRK4;WWTR1;MTCH1;SOCS5;TSC2;FRMPD1;SNX3;TRIM5;SEMA5A;TMEM237;CX3CL1;DTX1;GLI1;PRKD1;GRK2;DOK5;DGKQ;IRAK2;ITGB1BP1;TSPYL2;RIC8B;LLGL1;TSPAN15;FOXL1;RGS4;GLRX2;PTCH1;GIT1
prerank,regulation of actin filament-based process (GO:0032970),-0.31917540238677466,-1.2297776075969051,0.12951807228915663,0.5913978627448364,1.0,20/70,15.35%,LRP1;GPM6B;IQGAP1;EFNA5;PDGFRB;RHOA;ROCK2;PRKCD;ROCK1;EZR;RND3;RHOBTB2;CNN2;EPHA3;RHOB;RHOBTB1;HIP1R;TAOK1;ARHGEF5;IQGAP2
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.518431847005824,-1.2296830076584901,0.20944558521560575,0.5905648243358561,1.0,5/11,15.87%,PDK1;PRKCD;MAP3K5;STK25;PRODH
prerank,V(D)J recombination (GO:0033151),0.5367063084463988,1.2295807549842148,0.22095238095238096,0.9372221552123009,1.0,4/11,16.75%,DCAF1;TCF3;XRCC4;PRKDC
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.2919613734815583,-1.2295579942965502,0.07420494699646643,0.58978838786151,1.0,29/121,14.13%,ERBB4;BMP6;IGF1;GRM5;EFNA5;NRP1;DLG4;PARP14;IL6R;NEDD9;PIBF1;KIT;TEC;GHR;RELN;IL34;ITGA5;IL31RA;SRCIN1;ACVR1;DLG3;VTN;TP53;SEMA4D;NOX4;CSPG4;IL18;IL6ST;IGF2
prerank,retinoid metabolic process (GO:0001523),-0.32462640070200804,-1.2294341160459474,0.11526479750778816,0.5890191545110244,1.0,14/71,10.87%,GPC6;LRP1;ALDH1A1;ALDH1A2;SDC2;DHRS3;GPC3;HSPG2;ABCA4;NAPEPLD;RBP4;SCPEP1;GPC5;RBP1
prerank,negative regulation of nervous system development (GO:0051961),-0.4451741698126843,-1.22937251339576,0.2202247191011236,0.5880696618115573,1.0,3/17,5.92%,ROBO2;APPL2;SORL1
prerank,regulation of microtubule-based movement (GO:0060632),-0.5169215551630423,-1.228974217038563,0.22844827586206898,0.587978309375132,1.0,2/11,5.89%,MAP2;TTC21B
prerank,modulation of chemical synaptic transmission (GO:0050804),-0.30245634390805465,-1.2287107716088792,0.0798611111111111,0.5875456929334529,1.0,21/107,8.70%,LRRC4C;ATP1A2;RIMS1;DLGAP1;DGKI;GRID2;GRM5;DLGAP2;DLG4;DLGAP4;SNCAIP;NLGN2;RELN;BCR;SLC12A2;CACNA1B;GRID1;CLSTN2;AKAP9;NLGN1;SYN1
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.5411392515649883,-1.2286407621224555,0.20042194092827004,0.586663607464202,1.0,6/10,20.31%,ATP1A2;OSR1;HECW1;CAMK2D;HECW2;NEDD4
prerank,cellular response to interleukin-12 (GO:0071349),0.39137685745754736,1.2281024825344016,0.16474464579901152,0.941258758543125,1.0,16/48,17.46%,LCP1;SOD1;CFL1;RALA;TALDO1;RPLP0;CD47;SOD2;ARF1;PLCB1;PITPNA;TYK2;TCP1;SNRPA1;HNRNPF;CAPZA1
prerank,protein K11-linked ubiquitination (GO:0070979),0.43517983812382194,1.2278889724693254,0.19148936170212766,0.9398947716142904,1.0,11/27,21.30%,ANAPC2;ANAPC13;ANAPC7;ANAPC11;ANAPC10;ANAPC4;UBE2H;CDC26;UBE2D3;UBE2L3;UBE2A
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.4269637444712358,1.2277507074615688,0.19824561403508772,0.9381023695695616,1.0,4/30,4.40%,RAC2;GSK3A;SAE1;VPS11
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.42649274714882335,1.2277261887191375,0.20327868852459016,0.9359026098532099,1.0,2/31,0.85%,GPHN;MOCS3
prerank,cellular response to heat (GO:0034605),-0.37476536481045936,-1.2276962168732448,0.16576086956521738,0.5882537891145585,1.0,12/35,19.24%,FGF1;MAPT;RBBP7;BAG3;VCP;THBS1;PRKACA;ANO1;HSF1;SLU7;CLPB;STUB1
prerank,negative regulation of phosphatase activity (GO:0010923),0.44855950490528895,1.2276009634880183,0.22638146167557932,0.9341555623858254,1.0,4/25,7.66%,PPP1R36;TIPRL;BOD1;PPP1R11
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.5082398137206542,-1.2274469515807453,0.2157676348547718,0.5878779407178165,1.0,6/11,20.62%,PARP4;PARP14;PARP6;PARP3;PARP12;PARP16
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.36412791485079055,-1.227008693218818,0.1597051597051597,0.5880068170520975,1.0,5/37,3.16%,TENM2;TENM3;ALCAM;GRID2;CXADR
prerank,I-kappaB phosphorylation (GO:0007252),0.5422969054033864,1.2267281874270872,0.21863117870722434,0.9356143235551073,1.0,3/10,12.87%,MAP3K7;ERC1;CHUK
prerank,plasma membrane repair (GO:0001778),-0.4776899471735294,-1.2262726282680352,0.21458333333333332,0.5889318825418948,1.0,9/13,37.42%,MYOF;AHNAK2;SYT11;SYT7;ANXA6;SYTL4;SMPD1;RAB3A;ARL8B
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.4938161504472233,1.2260267336746322,0.22672064777327935,0.9363174656709502,1.0,4/14,11.77%,CRAT;ACOX3;HSD17B4;ACOT8
prerank,ear morphogenesis (GO:0042471),-0.44345035034629415,-1.2259199166134438,0.20374707259953162,0.5888128404755378,1.0,5/20,10.62%,FGFR2;ZIC1;OSR1;NIPBL;EPHB2
prerank,regulation of spindle organization (GO:0090224),-0.4465045829120276,-1.224758732788446,0.21666666666666667,0.5909141235633458,1.0,6/18,20.58%,DYNC1H1;RNF4;PARP3;DCTN1;RAE1;MAP9
prerank,establishment of spindle localization (GO:0051293),0.5066993180325489,1.224595419834042,0.24452554744525548,0.9401590111947529,1.0,6/14,17.19%,CLASP2;CFL1;MAP4;ZBED3;KPNB1;CLASP1
prerank,histone monoubiquitination (GO:0010390),-0.4141746749905195,-1.2244820134827588,0.1975609756097561,0.5906099910000694,1.0,10/24,21.13%,WAC;UBE2E1;DDB1;DDB2;CDC73;RNF168;PAF1;BCOR;RNF40;DTX3L
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.42823592920630216,-1.2243955459983233,0.17987152034261242,0.589760323022738,1.0,9/21,28.33%,SIRT2;AATF;SLC30A10;PPARA;ABCD2;SIRT5;PINK1;PAX2;HDAC6
prerank,phosphatidylserine metabolic process (GO:0006658),0.4263193768575008,1.2239367690241538,0.18244406196213425,0.9406421517084321,1.0,7/32,12.52%,SERINC1;OSBPL10;PLAAT3;LPCAT3;MBOAT1;SERINC5;ABHD12
prerank,response to laminar fluid shear stress (GO:0034616),0.5439473746409675,1.223482724371235,0.22490706319702602,0.9403710667067747,1.0,3/10,7.28%,KLF2;MAP2K5;SMAD7
prerank,neurotransmitter biosynthetic process (GO:0042136),0.5098583215641781,1.2231778248531946,0.21933085501858737,0.9393776170068138,1.0,1/14,0.32%,SLC5A7
prerank,regulation of Rho protein signal transduction (GO:0035023),-0.3236118592326305,-1.223108809908634,0.1267605633802817,0.5921918625367529,1.0,23/72,22.06%,LPAR1;ROBO1;AKAP13;KANK2;COL3A1;NRP1;BCR;TNFAIP1;STARD13;PRAG1;RIT2;ABCA1;GPR4;RALBP1;ARHGDIA;STMN1;RAF1;ABL2;KCTD13;MET;ARHGDIB;FLCN;CCDC125
prerank,calcium-mediated signaling (GO:0019722),-0.3070823534178328,-1.2230816462532246,0.09584664536741214,0.5911906582978833,1.0,17/93,10.71%,ANK2;CACNA1C;EGFR;MCU;PPP1R9A;GRM5;ATP1B1;NUDT4;PLCE1;P2RX4;CHRM3;FIS1;CCR9;KSR2;PRKACA;DMPK;ACKR3
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.32572843066760476,1.2222179633377754,0.11081794195250659,0.9413293406158055,1.0,31/151,16.60%,PCSK1;GPHN;CERS1;MOCS3;ACER2;CERS4;PRKD2;LPCAT2;APOE;SGMS1;KDSR;ELOVL6;LPCAT3;GPAT4;PLPP1;SLC44A1;SGPP2;DMD;SLC25A2;HACD2;ACER3;PAM;CEPT1;SGPP1;GCH1;CSNK2A2;SPNS2;CERT1;AKR1A1;PPM1L;SLC44A2
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.3292805629818514,-1.2218926477357694,0.13774104683195593,0.5932578822272443,1.0,34/67,31.21%,SULF1;CYFIP2;DOCK1;WASF2;NRP1;MAPK14;AXL;ABI1;VAV2;RHOA;PXN;ROCK2;ROCK1;NRP2;PTK2;CDC42;SHB;PIK3R1;AAMP;HSPB1;PRKD1;VEGFA;ELMO2;VEGFB;HSP90AA1;NCKAP1L;MAPKAPK2;PGF;ITGB3;NCF2;PIK3R2;CLEC14A;FLT4;NCK1
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.38475787229360603,-1.221355550251485,0.15422885572139303,0.5937144313991587,1.0,10/31,18.58%,DLG2;LRRC7;PARD3B;RHOA;EZR;DLG3;DLG1;WDR1;CDC42;MSN
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.35772964907149374,1.220976033131477,0.14903129657228018,0.9444121722420469,1.0,22/80,13.52%,SURF4;ARF5;KIF18A;KIFAP3;LMAN2;COPG2;TMEM115;RAB6B;NAPA;RAB6A;KDELR2;TMED10;KIF15;RAB1A;GOLPH3L;KIF2A;TMED7;SCFD1;ARCN1;COPG1;KIF3B;COG3
prerank,sympathetic nervous system development (GO:0048485),-0.46433347359746835,-1.2209649791666277,0.22698072805139186,0.5937703037813514,1.0,4/15,9.78%,NRP1;CTNNB1;SEMA3A;NRP2
prerank,rRNA metabolic process (GO:0016072),0.32714237995225726,1.2207101375334917,0.1349206349206349,0.9433462973758567,1.0,53/160,19.87%,RPL30;UTP20;UTP18;RPL17;RPL23;RPL31;RPL3;DDX54;DDX10;RPL35A;RPS14;RPL8;RPL5;RPL37A;RPL4;EMG1;SNU13;POP5;RPLP0;EXOSC9;XRN2;RPS28;RPS24;RRP7A;RPS9;RPL24;RPL34;DDX27;WDR12;EXOSC1;UTP11;RPL23A;RPL21;RPL35;MPHOSPH6;HEATR1;DKC1;RPL19;RPL38;RPL36;DCAF13;RPL26;RPL15;RPL10;RPL32;RPS2;RPL27A;NOP58;NVL;EXOSC7;RPL7;RPL39;RPL14
prerank,positive regulation of autophagy (GO:0010508),0.3551486521037199,1.2205668776904897,0.14684287812041116,0.941743058728176,1.0,28/81,19.34%,GSK3A;ATF6;MAP3K7;PLK2;SVIP;TRIM8;EPM2A;PHB2;TRIM14;SIRT1;PARK7;FBXO7;PRKAA2;BAD;TMEM59;BNIP3L;TRIM27;SCOC;CAMKK2;PIK3C2A;TFEB;SESN3;BNIP3;ULK1;MID2;SH3GLB1;SESN1;LARP1
prerank,positive regulation of phospholipid transport (GO:2001140),0.541499273707942,1.2205020811663492,0.22928709055876687,0.9397584396354282,1.0,2/10,5.62%,APOE;DBI
prerank,contractile actin filament bundle assembly (GO:0030038),-0.46475478452045205,-1.220359264263191,0.18403547671840353,0.593232588660479,1.0,6/15,18.43%,SORBS1;RHOA;ITGB5;TNFAIP1;PDLIM1;KCTD13
prerank,stress fiber assembly (GO:0043149),-0.46475478452045205,-1.220359264263191,0.18403547671840353,0.593232588660479,1.0,6/15,18.43%,SORBS1;RHOA;ITGB5;TNFAIP1;PDLIM1;KCTD13
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.4548333894046735,-1.2203030112745155,0.22435897435897437,0.5923370667882525,1.0,9/16,19.28%,KMT2A;AUTS2;CTNNB1;SMAD4;PAXIP1;SNW1;KDM1A;BCOR;DNMT1
prerank,presynapse organization (GO:0099172),-0.5122827884754764,-1.2202688106695327,0.21887550200803213,0.5913586028663909,1.0,6/10,27.81%,LRRTM3;NLGN2;NLGN1;DVL1;NLGN3;FZD1
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.32055921058877684,1.2191278171998035,0.1189873417721519,0.9433750454548846,1.0,38/173,13.84%,BCAP29;DYNC1I1;TRAPPC2;MIA2;SPTB;CAPZA2;CNIH1;LMAN2;TMED4;COG5;DCTN2;GOPC;COPG2;TRAPPC8;TMEM115;GOSR2;F8;TRIP11;NAPA;TMED5;KDELR2;TMED10;DCTN3;RAB1A;NRBP1;TRAPPC11;DYNLL1;HYOU1;TMED7;SCFD1;TRAPPC6B;MCFD2;ARCN1;CD55;COPG1;CUL3;COG3;PROC
prerank,negative regulation of axonogenesis (GO:0050771),-0.39263940465984115,-1.2189008365171243,0.18475750577367206,0.5942228049848665,1.0,5/27,4.24%,MAP2;DCC;ULK2;PTPRS;RHOA
prerank,chemical synaptic transmission (GO:0007268),-0.261602054074087,-1.2187532837794692,0.03225806451612903,0.5935716554751935,1.0,70/284,17.50%,DLG2;RIMS1;DLGAP1;KCNQ3;PLP1;HTR2C;GABRB1;GRIA4;SNAP25;GRIA2;SLC1A3;NRXN1;CACNB4;AMPH;GRID2;GRIN2B;GRM5;GLRB;CHRM2;KCND2;SYN2;DLGAP2;MBP;GABRA2;DLG4;PTPRN2;NLGN2;SLC6A1;SHISA6;CACNA1B;GLRA3;CAMK4;GRID1;CHRM3;GABRG2;GLRA1;GABBR2;AKAP9;NLGN1;SYN1;KCNA1;PRKACA;BRSK1;HTR4;RIT2;NRXN2;PRKAR1B;APBA1;DLG1;UNC13C;CAMK1;BSN;STXBP1;HTR7;SNPH;FCHSD2;UNC13B;VAMP2;GRIK4;SLC12A6;LRP6;KIF5A;ERC2;GABRA5;STX1A;SLC12A4;NOVA1;GABRG3;DVL1;HCRTR2
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),0.4930980598418651,1.2187469926192818,0.22905027932960895,0.9428430549169058,1.0,3/14,10.12%,NCBP1;CPSF4;CPSF6
prerank,negative regulation of secretion by cell (GO:1903531),0.3964214473182664,1.218592185718744,0.19767441860465115,0.9413317325259981,1.0,7/38,10.01%,PNKD;HMGCR;APOE;TNFRSF1B;GRM7;NOTCH1;RHBDF2
prerank,negative regulation of cell motility (GO:2000146),-0.2978312530377127,-1.2184183546676215,0.10877192982456141,0.593437246155904,1.0,12/108,4.07%,MAGI2;NAV3;SPOCK3;LDLRAD4;TMEFF2;SULF1;ROBO1;DPYSL3;IGFBP5;FBLN1;CLIC4;TPM1
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.40794808080408396,1.2182297471849735,0.18181818181818182,0.9406499321581403,1.0,11/36,11.96%,LEF1;MAP3K7;PPP3CB;GNB1;WNT5A;PLCB1;FZD3;NLK;AGO4;PPP3CA;PPP3R1
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.39043824032683144,1.2179055016170797,0.17656765676567657,0.9397930854001971,1.0,15/46,17.46%,LCP1;SOD1;CFL1;RALA;TALDO1;RPLP0;SOD2;ARF1;PLCB1;PITPNA;TYK2;TCP1;SNRPA1;HNRNPF;CAPZA1
prerank,cellular response to cAMP (GO:0071320),-0.38941664724602865,-1.2169403648554793,0.17721518987341772,0.5965368769272671,1.0,12/30,27.74%,HCN1;AKAP6;IGFBP5;AKAP9;EZR;RAPGEF2;SLC5A5;DMTN;PDE2A;HCN2;KCNQ1;INPP5K
prerank,regulation of DNA recombination at telomere (GO:0072695),0.4545874148149434,1.2164362560769972,0.22761194029850745,0.9417468533247465,1.0,3/19,8.57%,POLR2J;POLR2B;ACD
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.4545874148149434,1.2164362560769972,0.22761194029850745,0.9417468533247465,1.0,3/19,8.57%,POLR2J;POLR2B;ACD
prerank,myoblast fusion (GO:0007520),-0.48972334122960776,-1.2164299961461549,0.24008810572687225,0.5968735314048921,1.0,3/12,6.00%,ADGRB3;ADAM12;ADAMTS5
prerank,stress granule assembly (GO:0034063),-0.4288577138545152,-1.2161543907636874,0.22453703703703703,0.5965471305238159,1.0,7/20,13.81%,BICD1;DYNC1H1;MAPT;OGFOD1;YTHDF1;G3BP1;ATXN2L
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.5495390376172195,1.2158126798262228,0.2231237322515213,0.9422029051375789,1.0,3/10,9.69%,HIPK2;ING4;TFAP4
prerank,positive regulation of Wnt signaling pathway (GO:0030177),-0.2827994859358711,-1.2155562998826175,0.06640625,0.5972007265345989,1.0,44/152,13.00%,RNF220;FGFR2;LRRK1;SULF1;WLS;EGFR;COL1A1;LGR4;ADGRA2;WNT5B;TBL1XR1;SMURF2;ZEB2;WNK1;PTK7;MACF1;SULF2;PPM1B;VCP;GPC3;SKI;CDC73;PSMD4;PSMA2;CSNK1E;UBR5;GPC5;RSPO3;PSMA6;SALL1;CSNK1G2;XIAP;NFKB1;PSMD13;PSMA1;TBL1X;ILK;PSMF1;DISC1;PSME4;DAAM2;PPM1A;ATP6V0C;USP34
prerank,regulation of actin filament depolymerization (GO:0030834),-0.5071421397199638,-1.2150171425509135,0.22391304347826088,0.5976759858008132,1.0,4/12,19.13%,PLEKHH2;LIMA1;WDR1;SEMA5A
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.48329479316445995,1.2146775123259923,0.213768115942029,0.9449674730736592,1.0,4/17,9.47%,CIB1;RET;SYK;PODXL
prerank,cardiac muscle cell membrane repolarization (GO:0099622),-0.5162571972376123,-1.214200269351575,0.23390557939914164,0.5988078371098723,1.0,3/11,8.46%,ATP1B1;ATP1A1;KCNJ2
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.4365350897428161,1.214038280954583,0.2120689655172414,0.9454351185804628,1.0,7/26,14.46%,TIRAP;IFI35;WDFY1;PJA2;MFHAS1;DDX3X;CYBA
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.41213908805646526,1.2131664309232384,0.18274111675126903,0.9470124191073024,1.0,9/31,16.30%,LRP8;SHANK3;CFL1;TANC2;EFNA1;ZDHHC15;PPFIA2;CAPRIN1;ABI2
prerank,glucose metabolic process (GO:0006006),0.3740323816789517,1.2130483288346576,0.18976897689768976,0.9453497275957561,1.0,9/58,8.49%,PCK1;HECTD4;SLC25A1;GOT2;TPI1;PPARD;OMA1;IRS2;GALM
prerank,nitric oxide biosynthetic process (GO:0006809),0.5006814635694867,1.2129493533500129,0.23104693140794225,0.9435977672411947,1.0,4/13,14.25%,SPR;CYP1B1;NOS3;GCH1
prerank,response to interleukin-4 (GO:0070670),0.5469606088560649,1.2129438836186028,0.2476007677543186,0.9414437948034686,1.0,1/10,2.03%,LEF1
prerank,negative regulation of viral process (GO:0048525),0.37220081376466546,1.212560100159167,0.19607843137254902,0.9409070103160413,1.0,10/57,10.59%,ILF3;BANF1;TRIM28;IFITM2;IFIT1;TRIM8;TRIM14;IFITM3;IFITM1;SRPK2
prerank,regulation of response to external stimulus (GO:0032101),0.3342705222645664,1.2124814715274237,0.1335149863760218,0.9390810478353598,1.0,21/121,12.57%,LRP8;SAG;PIK3AP1;IL1R1;SEMA7A;FCGR2B;TIRAP;BCL6B;BIRC2;SBNO2;SPATA2;METAP2;CYRIB;WNT5A;TRAF3;RELA;PARK7;METAP1;NLRP6;USP18;CD55
prerank,intracellular protein transmembrane transport (GO:0065002),0.3956133204114651,1.2120995331471112,0.18849840255591055,0.9384623338024366,1.0,10/42,11.48%,TOMM20;ROMO1;TIMM17B;PEX1;PEX7;GRPEL2;TOMM40L;TIMM21;AIFM1;SEC62
prerank,positive regulation of response to external stimulus (GO:0032103),-0.29008579720172756,-1.211912896428786,0.08267716535433071,0.6041061212156843,1.0,40/128,29.26%,BMP6;SASH1;PDGFRB;PUM1;PUM2;NAPEPLD;STX3;OPTN;THBS1;PLSCR1;IL16;IL17RA;POLR3C;GPR4;LY86;IL18;IL33;TNIP1;TGFB1;LRSAM1;GPRC5B;SCARF1;GBP5;RIOK3;AGTR1;SLC15A4;CX3CL1;SETD4;PPM1F;P2RY12;PLA2G7;TLR3;FEM1A;SERPINE1;PDE2A;CCN4;CD180;MDK;SNCA;POLR3G
prerank,cellular response to nitrogen compound (GO:1901699),-0.41818687511284647,-1.2118644836643593,0.21906693711967545,0.6031620820083942,1.0,13/20,39.91%,SPIDR;ROCK2;HSF1;DDI2;RTF2;RIOK3;BLM;DDX11;NSMCE3;ATP2B4;PDE12;TIMELESS;NR1H4
prerank,cellular protein localization (GO:0034613),0.30494488430573224,1.2118585090471146,0.09454545454545454,0.9372067099131265,1.0,62/285,13.52%,RTP3;REEP1;ARF5;RAP2A;TM9SF2;ARL5C;ARL4D;TM9SF3;EVI5L;RAB5C;TBC1D30;TBC1D8;ITSN1;SNX8;VPS29;TBC1D9;TMED4;VPS26A;SEC23IP;RAB43;CNTNAP2;TBC1D10B;TRAPPC8;LAMTOR1;USP6NL;RIC3;TBC1D4;RAB6B;NAPA;TMED5;IFT22;RABGAP1L;SNX17;HEY2;RAB6A;TMED10;RAB14;WNT5A;ACD;DNAJC27;TBC1D12;SNX1;ESAM;ARL5B;ARF1;RAB1A;ZDHHC15;CELSR1;TBC1D25;KIF13A;TMED7;DMD;SCFD1;RAB5B;RAB22A;ADPRH;ARCN1;TBC1D14;RRAGC;YWHAH;RABGAP1;COG3
prerank,pyruvate metabolic process (GO:0006090),0.3791876702074285,1.2114383728863378,0.18646616541353384,0.936734399458237,1.0,5/52,5.68%,PCK1;ENO4;BSG;ME3;TPI1
prerank,negative regulation of axon extension (GO:0030517),0.4166317245684083,1.2113616236189173,0.22240527182866557,0.9349345792572378,1.0,8/30,9.79%,SEMA6A;SEMA6D;SEMA7A;SEMA3C;DIP2B;SEMA6B;SEMA4C;RNF6
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.2954662439075777,1.2113500733158669,0.08263473053892216,0.9328738867954562,1.0,90/327,19.29%,TBX4;ONECUT1;TRAPPC2;FOXN2;EZH2;ZFAT;HES6;GTF2IRD1;RPS6KA4;ATXN1L;RPS6KA5;PPP2CA;SBNO2;MYBL2;SMARCA2;SOX2;SPIN1;EP300;RFX3;NFX1;MED23;TGFBRAP1;SRSF10;ACTR8;CDK11B;ZNF205;SFPQ;ACTN4;ACTR5;DRAP1;CLOCK;PFDN5;NOTCH1;SOX13;ACVRL1;RELA;NAB2;RNF6;UBE2V1;RYBP;ING2;CCAR2;ESR1;NLK;HP1BP3;CREBBP;CARM1;JMJD1C;SP1;MZF1;IRF2;CHD3;ERC1;NUP35;TRRAP;CHEK2;DDIT3;ZKSCAN5;HCFC1;YBX1;RNF20;BAZ2A;NSD2;BACH1;FUS;TERF2IP;TFEB;TAF6L;APBB2;TCF7L1;TCF3;SOX17;WTIP;MYT1;CALR;NONO;ZNF219;INSR;STAT3;FOXK2;PATZ1;ZSCAN21;NCOA2;HINT1;YAF2;ATRX;MSL3;TCF7;MYBL1;ACVR2B
prerank,regulation of T cell differentiation in thymus (GO:0033081),-0.48571458215141944,-1.210700641562486,0.23142250530785563,0.6054169620700445,1.0,4/13,6.99%,GLI2;TOX;BMP4;CAMK4
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.3439080789324237,-1.2099472754929792,0.14058355437665782,0.6064468240842977,1.0,14/48,14.45%,CUX1;DOCK5;DOCK1;NRP1;FLNA;NEDD9;RREB1;P4HB;CUX2;ILK;IL1RAPL1;OBSL1;MYADM;TRIOBP
prerank,regulation of melanin biosynthetic process (GO:0048021),-0.517186597215791,-1.2094486259785096,0.23408624229979466,0.6068065677953266,1.0,5/10,22.56%,ZEB2;ATP7A;CTNS;RAPGEF2;APPL1
prerank,Golgi to plasma membrane protein transport (GO:0043001),-0.37906581887377905,-1.209428664030279,0.195822454308094,0.6057925096109149,1.0,10/30,16.59%,ANK3;VAMP5;MACF1;RAB31;GGA2;OPTN;VAMP2;BBS2;GOLGA7;GGA3
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),-0.5157309772526162,-1.2086168275575313,0.2359081419624217,0.6068880452978529,1.0,5/10,20.51%,FGFR2;TGFBR2;LRP5;STAT1;PDGFA
prerank,regulation of neuron projection arborization (GO:0150011),-0.46548102042363165,-1.208006504093007,0.19646799116997793,0.6075616463699889,1.0,7/15,17.28%,NTNG1;DLG4;MACF1;DVL3;GRIP1;FZD4;DVL1
prerank,error-free translesion synthesis (GO:0070987),-0.41328297413415865,-1.2079773028595733,0.210412147505423,0.6065774497405179,1.0,7/22,14.27%,RFC1;RCHY1;VCP;RPA1;UBC;NPLOC4;POLDIP2
prerank,dendritic cell chemotaxis (GO:0002407),0.4898928252289705,1.207909436412361,0.23629489603024575,0.9457954735641939,1.0,2/14,10.53%,PIK3CG;TRPM4
prerank,plasma membrane bounded cell projection assembly (GO:0120031),-0.2604537379462016,-1.20751967825759,0.0427807486631016,0.6068445310884266,1.0,80/259,20.10%,GSN;PARVA;AHI1;PKD1;CC2D2A;EXOC3;NRP1;MTSS1;RILPL1;FLNA;PIBF1;IFT81;KIT;DZIP1;TTC8;WDR35;DYNC2I1;RAB8B;VCL;DCDC2;PIP5K1A;SHTN1;NUDCD3;CCDC66;CCDC57;CFAP20;EXOC6;TTC39C;IFT46;IFT52;ACTR3;CEP89;EZR;SPATA13;CEP126;IFT172;CEP20;ABLIM2;FGD1;ACTN2;IFT74;CFAP44;RP2;EMP1;ARL13B;DISC1;TTBK2;ABLIM3;KIF3A;DZIP1L;BBS9;RAB11A;WDR19;WDR11;ANO6;FGD4;INTU;RAB23;BBS2;PTPRO;CYS1;ARF4;EXOC7;EXOC1;RAPGEF2;PTPN23;CEP250;EHD1;RAB8A;EHD3;DYNLL2;ACTR2;IFT20;SNAP29;ARFIP2;BBS5;TMEM237;CCDC28B;TTLL3;ARHGEF4
prerank,protein deacetylation (GO:0006476),-0.3583027612895078,-1.2070151170104464,0.2041343669250646,0.6072354362852297,1.0,14/41,12.62%,PRDM5;MIER1;HDAC4;TBL1XR1;HDAC1;FLNA;SIRT2;MORF4L2;MTA3;MIDEAS;MORF4L1;MTA1;TBL1X;RCOR3
prerank,retinal metabolic process (GO:0042574),0.5142966555044926,1.2065700488055342,0.2656826568265683,0.9492987596293225,1.0,4/12,14.01%,RDH13;RDH11;CYP1B1;RDH10
prerank,regulation of fatty acid oxidation (GO:0046320),-0.4487599457906252,-1.2058231746414738,0.212253829321663,0.6095682303611717,1.0,4/16,6.59%,PRKAG2;PPARGC1A;APPL2;PPARA
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),-0.3780684592421267,-1.205576165271281,0.1855421686746988,0.6092228458188728,1.0,10/33,14.98%,KANK2;FHL1;RBL2;MYO16;CDC73;BRD7;CDK6;DLG1;DACT1;NACC2
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.43945852450272554,1.2055057157364848,0.21739130434782608,0.9517131933325256,1.0,6/24,13.40%,ATF3;ATF6;KLF2;NOTCH1;RBPJ;DDIT3
prerank,positive regulation of synaptic transmission (GO:0050806),-0.31621233244483304,-1.205481139581516,0.13994169096209913,0.6084236049560569,1.0,32/72,26.68%,RIMS1;NRXN1;GRIN2B;TSHZ3;ADCY1;DLG4;NLGN2;PRKCZ;RELN;CLSTN2;NLGN1;SLC24A2;LGMN;EPHB2;CACNG7;VAMP2;CACNG4;SHANK2;CACNG2;NFATC4;KCTD13;CLSTN3;FLOT1;ADRA1A;ADCY8;GRIN2D;NLGN3;CACNG3;MPP2;CACNG8;CHRNA7;STX1B
prerank,regulation of integrin activation (GO:0033623),0.48757049551019777,1.2053303863076374,0.23191094619666047,0.9503613792443973,1.0,4/15,13.31%,SRC;SELP;RASIP1;PLEK
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.4103842068978043,-1.2046865371697693,0.1960352422907489,0.6094756896703787,1.0,5/23,7.08%,TGFBR3;SMAD3;SMURF2;SMAD4;DKK3
prerank,endochondral bone morphogenesis (GO:0060350),-0.4951573994758571,-1.2044050868158354,0.22469635627530365,0.609242202384386,1.0,6/11,19.93%,BMP4;COL13A1;FOXC1;INPPL1;BMPR1B;BMPR2
prerank,regulation of oxidoreductase activity (GO:0051341),-0.47481192549280965,-1.204286145548461,0.23667377398720682,0.6084902041280487,1.0,8/13,42.59%,ATP7A;SZT2;ABL2;ECSIT;HDAC6;SIRT4;MT3;NOD2
prerank,negative regulation of cell population proliferation (GO:0008285),-0.25374635640444215,-1.2040865957388887,0.04827586206896552,0.6079970888155203,1.0,83/351,16.89%,MAGI2;ERBB4;ST18;TGFBR3;ALDH1A2;KANK2;CLMN;TNS2;IGFBP5;MCC;FBLN1;NELL1;PTPN14;COL4A3;BMP5;ABI1;CTNNB1;PDPN;MTSS1;ATP8A2;SIRT2;IGFBP7;BMP4;NUPR1;ZBTB7C;LMNA;PDS5B;OGN;APPL2;MYO16;PER2;VGLL4;FRK;PML;PODN;SKI;GSDME;IGFBP6;CDKN1B;RBP4;CDC73;ADAMTS1;SMAD6;NIBAN2;DLG3;CGRRF1;EIF2AK2;BRD7;FAP;CDK6;SPEG;CAMK2N1;DDAH1;TP53;NOX4;STK11;TBX3;WNT9A;P3H3;FKTN;PDCD5;NF2;ROR2;MAGED1;MED25;TOB1;NACC2;PEX2;RAF1;PTPRU;MN1;NGF;GPLD1;SLC16A2;RAPGEF2;TGFB1;RNF139;BMPR1B;CCN3;S100A11;PTPN2;SMYD2;OPRM1
prerank,negative regulation of reproductive process (GO:2000242),-0.44156697185674326,-1.2034966658653392,0.21171171171171171,0.6085602584778599,1.0,2/17,0.63%,IGF1;SULF1
prerank,negative regulation of lyase activity (GO:0051350),0.47667228650597343,1.2034494644544587,0.23465703971119134,0.9564133264305417,1.0,4/16,14.82%,PHPT1;EDNRB;PALM;GRM3
prerank,negative regulation of protein autophosphorylation (GO:0031953),-0.516372422364864,-1.2030532508082508,0.2545454545454545,0.6087432700090156,1.0,6/10,37.93%,ERRFI1;ENPP1;IMPACT;CAV1;CHP1;TESK1
prerank,positive regulation of cellular biosynthetic process (GO:0031328),-0.27434929276965586,-1.2025890778447947,0.07456140350877193,0.6089976594695639,1.0,46/166,19.13%,SORBS1;IGF1;PLD1;SAMD4A;EGFR;SMAD3;PDGFRB;GLI2;LPGAT1;ZEB2;KAT7;VIM;P2RX4;DDB1;PPARGC1A;ATP7A;LDB1;SLC6A9;AKT2;POLDIP3;LDLR;PRR16;EIF3C;YTHDF1;NIBAN1;SMOC2;THBS1;STN1;ARPP19;DDAH1;EEF2;RBM3;BRPF3;SLC27A1;ATAD5;IGF2;PLXNB2;GPLD1;PTPN2;METTL5;SREBF1;NAT10;PCIF1;UPF3A;RPS6KB1;CIRBP
prerank,pteridine-containing compound metabolic process (GO:0042558),0.5113568753005798,1.2019652891195074,0.24548736462093862,0.9605433465024376,1.0,4/13,14.25%,SPR;PTS;NOS3;GCH1
prerank,epithelial structure maintenance (GO:0010669),-0.51434208547059,-1.2015374591183052,0.2575452716297787,0.610599503892398,1.0,2/11,7.87%,CXADR;RBP4
prerank,negative regulation of BMP signaling pathway (GO:0030514),-0.33533667271712686,-1.201406058224724,0.16452442159383032,0.6099227481108944,1.0,14/51,10.98%,FBN1;FSTL1;NBL1;BMPER;SMURF2;SMAD4;VWC2L;CRIM1;SORL1;SKI;HTRA3;SMAD6;SPART;GREM2
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.45725036579039663,1.2011425065579389,0.23119266055045873,0.961841473110976,1.0,3/19,9.21%,PIK3AP1;TIRAP;RAB11FIP2
prerank,vasodilation (GO:0042311),0.5095869294296556,1.2001072472692034,0.2595419847328244,0.9640363155898224,1.0,4/13,11.15%,SOD1;KLF2;SOD2;NOS3
prerank,triglyceride homeostasis (GO:0070328),0.426640138253353,1.2000655795760415,0.22377622377622378,0.9620332404291013,1.0,5/26,11.85%,FITM2;APOE;SIRT1;PNPLA8;SCARB1
prerank,mitochondrial translational elongation (GO:0070125),0.3466227896581963,1.1999859098085612,0.17391304347826086,0.9602191725379495,1.0,14/88,12.45%,MRPS22;MRPS2;MRPS33;MRPL23;MRPL24;MRPL18;MRPL38;MRPS12;MRPL20;TSFM;MRPL52;MRPS15;MRPS24;MRPL48
prerank,regulation of phosphatase activity (GO:0010921),0.4270933753094524,1.1998226398442282,0.2098976109215017,0.9587382342853827,1.0,5/24,14.98%,PPP1R36;TIPRL;TSC1;PTPA;PPP6R1
prerank,sulfate transport (GO:0008272),-0.4632232785271917,-1.1993540560879419,0.24568965517241378,0.6144682406598526,1.0,6/14,26.06%,SLC26A7;SLC13A4;SLC26A2;SLC26A11;SLC25A30;SLC25A11
prerank,regulation of sequestering of triglyceride (GO:0010889),0.4792241175825496,1.1990065889728947,0.24187725631768953,0.9600743473598196,1.0,2/15,3.44%,CIDEA;FITM2
prerank,regulation of cell adhesion (GO:0030155),0.3257136725313878,1.1987194557640575,0.14384508990318118,0.9592495768907657,1.0,19/129,10.04%,PRKX;RAC2;FRMD5;PIK3CG;PTPRJ;CXCL12;SRC;PRKD2;CD164;PPP2CA;RIPOR2;RET;MINK1;EFNA1;ACVRL1;PLXNA4;LYN;PODXL;PPP1R12A
prerank,tRNA processing (GO:0008033),0.3639760019041729,1.198464078371329,0.1794871794871795,0.9581436134791701,1.0,20/61,19.86%,THG1L;THUMPD1;FARS2;CPSF4;TRMT10B;POP5;ANKRD16;PTCD1;WDR4;SSB;TSEN2;NSUN6;CDKAL1;TSEN15;CLP1;NSUN2;TRNT1;FTSJ1;URM1;POP1
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.523768146255738,1.1979960183490854,0.2544731610337972,0.9579971842865396,1.0,3/11,9.69%,HIPK2;ING4;TFAP4
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.3425768139697132,1.1979490466793623,0.17655786350148367,0.9561040035054661,1.0,18/85,9.79%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;TIAM1;AP2S1;PSMD11;PFN1;PSMB4;PSMC1;DAAM1;WNT5A;PSMC2;FZD3;PSMD2;CELSR1
prerank,nucleosome assembly (GO:0006334),0.4131082467726378,1.1966225314537071,0.23208191126279865,0.959587311552656,1.0,9/31,18.84%,ASF1B;NAP1L4;RSF1;CABIN1;BRD2;RBBP4;NPM1;ATRX;HAT1
prerank,regulation of cellular component size (GO:0032535),0.4162142006730807,1.1965898443838339,0.21911037891268534,0.9576213823081592,1.0,8/30,14.38%,PEX11G;VAV3;RPTOR;HP1BP3;RAB22A;PICALM;LARS1;AP2M1
prerank,negative regulation of amyloid-beta formation (GO:1902430),-0.43809321136695367,-1.196508743451732,0.23076923076923078,0.6212886046338257,1.0,6/17,9.11%,IGF1;NTRK2;RTN1;SORL1;ROCK1;BIN1
prerank,positive regulation of hormone secretion (GO:0046887),-0.4430268676538175,-1.196491575940523,0.2318840579710145,0.6202863890419551,1.0,8/17,35.29%,SNX4;SPP1;C1QTNF3;VAMP8;EDN1;SOX11;EDN3;HFE
prerank,regulation of cell migration (GO:0030334),-0.24638287686482696,-1.1964526001738152,0.007352941176470588,0.6193473081165916,1.0,76/382,14.16%,MAGI2;NAV3;ERBB4;NTRK3;LDLRAD4;TMEFF2;IGF1;SULF1;PLXNA2;ROBO1;CTNNA2;SASH1;DAB2;EGFR;LMO4;COL1A1;SYNE2;DPYSL3;PDGFRB;SEMA3D;NTNG1;IGFBP5;WNT5B;FGF1;TGFBR1;CLIC4;PDPN;TPM1;MACF1;FER;RHOA;FLNA;NEDD9;CEMIP;AMOTL2;KIT;MMP14;ROCK2;LMNA;NKD1;SMO;APPL2;VCL;F3;SORL1;PDGFRA;ROCK1;LDB1;PODN;SEMA3A;AKT2;PIK3R3;SRCIN1;DOCK10;ARSB;ULK4;SPATA13;ACVR1;THBS1;AFDN;SGK1;CDH1;EPHB2;SEMA4D;DDRGK1;ANXA1;TTBK2;RHOB;TBCCD1;MYADM;PLXND1;NF2;DUSP22;ATM;ROR2;RACK1
prerank,protein localization to cell-cell junction (GO:0150105),0.4781712950305266,1.1961791628928884,0.2349624060150376,0.9571480280777899,1.0,6/15,13.38%,ACTB;F11R;ARHGEF18;TJP1;CDH5;LSR
prerank,regulation of adaptive immune response (GO:0002819),0.47285982749365696,1.1958796067914348,0.25448028673835127,0.9564312545521321,1.0,4/18,14.09%,FCGR2B;SAMSN1;SIRT1;TRIM27
prerank,hyaluronan catabolic process (GO:0030214),-0.4429856807985146,-1.1957899188953867,0.2194513715710723,0.6201709543066167,1.0,9/18,33.38%,CEMIP;CEMIP2;HEXA;HEXB;TGFB1;GUSB;HYAL1;SLC9A1;CHP1
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),-0.31277057402241276,-1.195748891466771,0.14241486068111456,0.6192218258779858,1.0,12/74,4.04%,LDLRAD4;PHLDB2;DAB2;COL1A1;SMAD3;PHLDB1;TGFBR1;TGFBR2;BMP5;CTNNB1;PDPN;SMAD4
prerank,cellular response to chemical stress (GO:0062197),0.33782149450375804,1.1955487793418906,0.1842818428184282,0.9557669747190377,1.0,17/96,11.74%,CHCHD2;PRR5L;TXNRD2;SLC25A24;SOD1;EIF2S1;CYCS;STOX1;ZFAND1;LONP1;GPX7;TRPV4;SOD2;PARK7;PRKAA2;DDX3X;ATG7
prerank,phosphate-containing compound metabolic process (GO:0006796),0.31079615078940037,1.1955379557071402,0.1342534504391468,0.9537415789291568,1.0,30/198,12.18%,NUDT14;MAPK3;PIK3CG;PPIP5K2;NUDT11;PTPRC;PPP3CB;PNKP;PTPRB;DUSP12;NUDT5;PANK2;ACYP1;PLAAT3;CERKL;PXYLP1;PLPP1;PLCG1;INPP5D;PLCB1;PAK1;GPI;PGP;PFKFB3;PI4KA;PIK3CD;PPP3CA;INPP4B;IP6K2;PLAA
prerank,protein O-linked glycosylation via serine (GO:0018242),-0.507538005626987,-1.1954777478387284,0.22266401590457258,0.6189428453316105,1.0,7/10,39.46%,GALNT13;POGLUT3;POGLUT2;GALNT2;GALNT1;GALNT3;MGAT5B
prerank,interleukin-6-mediated signaling pathway (GO:0070102),-0.428808538447507,-1.1954653005309344,0.21348314606741572,0.6179167480978978,1.0,5/18,4.40%,ST18;JAK1;SMAD4;FER;IL6R
prerank,regulation of cardiac muscle cell contraction (GO:0086004),-0.38650314773916117,-1.1954563977301413,0.2191142191142191,0.6168941232744514,1.0,8/27,15.64%,ANK2;CTNNA3;CACNA1C;AKAP9;CAMK2D;SRI;DLG1;PDE4B
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.4764217318101521,1.1951054612116219,0.2277580071174377,0.9535009787007053,1.0,3/17,5.08%,SORT1;HDAC9;LMF1
prerank,response to reactive oxygen species (GO:0000302),0.3715551175812438,1.195054766817452,0.17767295597484276,0.9516462038856162,1.0,12/54,12.87%,MAPK3;ROMO1;TXNRD2;SOD1;APOE;FYN;MAPK8;SIRT1;SOD2;APTX;RPS3;CHUK
prerank,cellular response to hydroxyurea (GO:0072711),-0.5031831724464644,-1.1949669991849787,0.25,0.6172592461449784,1.0,7/10,38.96%,SPIDR;DDI2;RTF2;BLM;DDX11;NSMCE3;TIMELESS
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.40934463164278106,1.1947097945533955,0.2231833910034602,0.9510331793698501,1.0,9/33,15.25%,TNFAIP3;RAMP2;TEK;WFS1;KRIT1;ICAM1;TNIP2;CDH5;GAS6
prerank,protein modification by small protein removal (GO:0070646),0.30287665300478406,1.194017634523182,0.1329268292682927,0.9519372652636657,1.0,59/252,14.94%,TOMM20;PSMB10;PSMC4;ABRAXAS1;PSMB6;PSMD8;PSMD5;PSMD12;ACTL6A;MAP3K7;TNFAIP3;ACTB;BIRC2;SMAD1;PSMD11;YOD1;OTUD1;PSMB4;YY1;PSMC1;EP300;ACTR8;SMAD7;ACTR5;DESI2;DESI1;RUVBL1;USP47;TRAF3;MDM2;RAD23A;PSMC2;USP48;USP31;PSMD2;ESR1;OTUD3;USP22;USP15;COPS7B;USP37;NFRKB;USP18;TNIP2;OTUD5;PSMD14;TRRAP;USP33;BRCC3;PSMC6;PSMD1;APC;NFKBIA;PSMB1;HCFC1;USP9X;UCHL5;COPS8;INO80
prerank,apical protein localization (GO:0045176),0.5281400973929784,1.1933252863931856,0.2475442043222004,0.952872578953565,1.0,4/10,9.79%,ACTB;MAL;GOPC;CELSR1
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.5079466688057535,1.1932205020705047,0.27850467289719627,0.9512782266280265,1.0,5/13,18.08%,HEY1;HEY2;DDIT3;TAF1;SIN3A
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.41428122777072157,1.1928273845454165,0.21996615905245348,0.9508498484272538,1.0,10/30,16.78%,CXCL12;PTTG1IP;FBXO5;SIRT1;YJU2;MDM2;CCAR2;RPS3;CD44;TMEM161A
prerank,cardiac left ventricle morphogenesis (GO:0003214),0.5049853446145198,1.1925840500364229,0.2541436464088398,0.949836219776119,1.0,4/13,10.80%,GSK3A;HEY2;NOTCH1;RBPJ
prerank,nucleic acid metabolic process (GO:0090304),0.3572570522449017,1.1924311948726969,0.19428571428571428,0.9484460111270335,1.0,13/69,11.65%,POLR2J;NCBP1;POLR2B;HNRNPH2;DDX54;PCBP1;HNRNPK;HNRNPC;XRN2;DXO;EXD2;DUSP11;PTBP1
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.5206935322220676,1.1923439147678947,0.25146198830409355,0.9467838702678388,1.0,3/11,9.71%,ZRANB3;FBXO5;MSH3
prerank,histone acetylation (GO:0016573),0.35538217689389756,1.192240754145342,0.19054878048780488,0.9452519732933856,1.0,16/69,13.99%,JADE3;ACTL6A;LEF1;MAP3K7;RUVBL2;DMAP1;ING4;BEND3;EP300;RUVBL1;YEATS4;ING3;CREBBP;TRRAP;ING5;DR1
prerank,regulation of androgen receptor signaling pathway (GO:0060765),-0.37916706913972725,-1.1921759065199964,0.18072289156626506,0.623918091745798,1.0,5/30,4.49%,DDX5;FOXP1;DAB2;HDAC1;RNF14
prerank,negative regulation of signaling (GO:0023057),-0.3920379205094055,-1.1921499963541284,0.22048997772828507,0.6229437373682299,1.0,6/25,17.46%,UBASH3B;GLRA1;ACVR1;OPTN;OPRM1;SOCS5
prerank,sphingolipid biosynthetic process (GO:0030148),0.3535489300585879,1.1921119221956675,0.1723076923076923,0.9437553577980067,1.0,17/71,16.13%,CERS1;ACER2;SMPD4;CERS4;PRKD2;SGMS1;KDSR;ELOVL6;ST8SIA1;PLPP1;SGPP2;HACD2;ACER3;SGPP1;SPNS2;CERT1;PPM1L
prerank,regulation of neutrophil migration (GO:1902622),0.5163829240981822,1.1920818142670224,0.2490118577075099,0.9419065385399789,1.0,2/10,11.04%,RAC2;RHOG
prerank,positive regulation of protein secretion (GO:0050714),-0.3171180027842288,-1.191174920020553,0.14195583596214512,0.6245736174551971,1.0,27/69,28.10%,BMP6;IGF1;WLS;MCU;NLGN2;GLUD1;RBP4;EZR;PPID;TM7SF3;NNAT;UNC13B;PSMD9;EXOC1;TGFB1;PTPN23;TCF7L2;C1QTNF3;TGFB3;IER3IP1;CAPN10;APBB1;SYTL4;PPIA;AACS;LRRC8A;MYOM1
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.405442288825836,1.190911874438892,0.22776911076443057,0.944846356926386,1.0,11/35,15.57%,CBL;PPT1;SGIP1;HNRNPK;B2M;ARF1;PICALM;SMAP1;LDLRAP1;BMP2K;ARF6
prerank,tetrahydrobiopterin metabolic process (GO:0046146),0.5280019770262047,1.1907854114118126,0.24220183486238533,0.9433275497163386,1.0,4/11,14.25%,SPR;PTS;NOS3;GCH1
prerank,inorganic anion transmembrane transport (GO:0098661),-0.3193472465346054,-1.1907432215403624,0.16620498614958448,0.6248002985106201,1.0,32/63,27.26%,GABRB1;SLC1A3;GLRB;GABRA2;ANO3;SLC6A1;SLC12A2;SLC26A2;GLRA3;GABRG2;GLRA1;SLC25A3;ANO1;SLC20A1;ANO6;SLC12A6;GABRA5;SLC12A4;GABRG3;SLC5A6;SLC5A5;GABRA4;SLC12A9;GABRG1;SLC4A8;GABRA1;SLC12A7;SLC25A30;SLC25A11;LRRC8A;SLC12A8;SLC12A5
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.3241254720715051,1.1904936737887235,0.16997167138810199,0.9425390385351002,1.0,32/125,17.78%,DYNC1I1;EML1;KIF18A;NUDC;PLK2;CLASP2;NEK9;DCTN2;MAP4;CDCA8;CENPC;KIF2A;DYNLL1;BCCIP;MIS12;TNKS;XPO1;KIF3B;NEK6;PTPA;EFHC2;RCC1;DYNC1I2;CLIP1;CENPP;CENPO;SETD2;KPNB1;NUP160;CLASP1;RANGAP1;PAFAH1B1
prerank,mitochondrion morphogenesis (GO:0070584),-0.4951864501305749,-1.1903614901727484,0.26459143968871596,0.6247577308025082,1.0,3/11,7.72%,PID1;WASF1;FIS1
prerank,regulation of neuron migration (GO:2001222),-0.39864749116513143,-1.1898974990212163,0.2311212814645309,0.6249493688953563,1.0,14/26,25.81%,CTNNA2;COL3A1;NTNG1;SHTN1;SEMA3A;NIPBL;ULK4;PLXNB2;RAPGEF2;CX3CL1;NSMF;CAMK2B;CAMK2A;ADGRG1
prerank,body fluid secretion (GO:0007589),-0.45851945798462346,-1.1897691942129363,0.22121896162528218,0.6243036681876941,1.0,5/15,22.30%,ERBB4;SLC22A4;NPR1;PRLR;VEGFA
prerank,antibacterial humoral response (GO:0019731),0.47570302877971155,1.188994403797047,0.26765799256505574,0.946991435925166,1.0,2/16,4.65%,DMBT1;RNASE6
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.4170831841205383,1.1889590994740231,0.21837088388214904,0.9451684135646898,1.0,7/29,11.62%,ACSL5;SLC25A1;PPT1;HSD17B12;ELOVL6;ACSL4;HACD2
prerank,positive regulation of defense response to virus by host (GO:0002230),-0.39229403095309956,-1.1889589367403446,0.18660287081339713,0.6255226229638726,1.0,10/24,30.96%,TRAF3IP2;AIM2;PTPN22;MAVS;STAT1;DTX3L;HSP90AA1;ZC3H12A;TOMM70;PARP9
prerank,positive regulation of cellular protein metabolic process (GO:0032270),-0.29698953534790967,-1.1886753883162076,0.13804713804713806,0.6252781707951888,1.0,32/101,19.78%,PLD1;SAMD4A;OGT;CYFIP2;VIM;FBXW11;VGLL4;BTRC;IST1;POLDIP3;PRR16;EIF3C;YTHDF1;EZR;NIBAN1;THBS1;EEF2;RBM3;ASPSCR1;TBC1D10A;DACT1;PLXNB2;TGFB1;METTL5;NAT10;PCIF1;UPF3A;MSN;RPS6KB1;CIRBP;STUB1;AGTR1
prerank,positive regulation of macromolecule metabolic process (GO:0010604),-0.2465988319573049,-1.1885466523076131,0.03821656050955414,0.6245807647659438,1.0,63/348,13.65%,MAGI2;ANK2;BMP6;NTRK3;ANK3;RIMS1;SLC24A3;IGF1;ROBO1;GSN;SMAD3;AHI1;ITGB8;FOXD1;NTRK2;ANXA2;FGF1;TGFBR1;MAPK14;PID1;OCLN;MED26;BMP7;PRKAG1;MED1;BMP4;PPARGC1A;ROCK2;OSR1;SMO;F3;EPB41L4B;ADAM19;ROCK1;HOXA5;MPHOSPH8;FUBP3;PIK3R3;EZR;UBR5;TLE1;AGO3;AFDN;PLSCR1;GSK3B;GJA1;EPHB2;CAMK2N1;FN1;CUX2;TP53;FAM98A;CD34;DDRGK1;IFNGR1;RPS7;SNF8;SCYL2;PDCD5;SETDB2;IL33;HINFP;ATM
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.48043799977462054,1.187906518266597,0.24949290060851928,0.947654381296426,1.0,3/15,5.04%,SH3D19;APOE;TNFRSF1B
prerank,negative regulation of endopeptidase activity (GO:0010951),-0.33430128183861124,-1.1872520836301477,0.20911528150134048,0.6269425768690907,1.0,7/47,9.69%,SPOCK3;TIMP3;SPOCK1;TIMP2;SORL1;BIN1;VTN
prerank,regulation of keratinocyte differentiation (GO:0045616),-0.40072642170415473,-1.1869099984525602,0.22273781902552203,0.6268278079581449,1.0,7/24,8.19%,ERRFI1;MED1;CBFB;ROCK2;SRSF6;ROCK1;FOXC1
prerank,beta-catenin destruction complex disassembly (GO:1904886),-0.4169654612055388,-1.1863378692948232,0.2219679633867277,0.6273720346381859,1.0,11/21,31.78%,CTNNB1;CSNK1A1;DVL3;FZD2;GSK3B;LRP6;DVL1;AMER1;FZD1;PPP1CA;CAV1
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.45400589216921505,1.1858630551341942,0.26136363636363635,0.9542619293194908,1.0,8/18,18.22%,TEK;CYRIB;RIPOR2;KRIT1;RUFY3;CDH5;PTK2B;ARFGEF1
prerank,cellular protein metabolic process (GO:0044267),0.2900599055759952,1.1857105004393564,0.09703196347031963,0.9529272632442909,1.0,104/396,18.73%,RPL30;DMBT1;MRPS33;RSL24D1;EEF1A1;RPL17;MRPL23;RPL23;MRPL24;PSEN2;RPL31;RPL3;RPS21;MRPL18;DUSP12;CDH2;SEC11A;APOE;RPL35A;WFS1;PDIA6;VWA1;UBE2I;FBXW2;RPS14;RPL8;YARS2;RPL5;ABCF1;CSNK1G3;SPCS3;MRPS12;RPS12;HBS1L;NAPSA;RPS26;RPL37A;SPPL3;HARS1;OMA1;RPL4;MAGEC2;SLC35A1;RPLP0;PIGH;FBXO11;RPS28;UBE2M;ICMT;MBTPS1;RPS24;YES1;RPS9;RPS23;RPL24;RPL34;APP;RPS11;MRPL52;RPS3;PLAT;ST3GAL6;MRPS15;ADPRH;DHPS;CHEK2;ST3GAL1;RPS15A;SPCS2;RPL23A;RPL21;RPL35;PROC;MSRA;QPCT;UBE2G1;FBXO22;GAS6;APH1A;NTAQ1;CALU;HARS2;PRKDC;WARS1;YME1L1;LCMT1;MELTF;PRSS23;RPL19;RPL38;CKAP4;RPL36;RPSA;SEPHS1;MGAT4A;RPL26;RPS8;RPL15;RPL10;MIA3;UBE2D3;MSRB3;RPL32;RPS2
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.36258370901549347,-1.1852633884532484,0.21375921375921375,0.6293878525194885,1.0,13/34,23.83%,AMBRA1;PDGFRB;KIT;PDGFRA;PIK3R3;PIK3IP1;PTK2;TGFB1;PIK3R1;PRKD1;P2RY12;EPHA8;TNFAIP8L3
prerank,negative regulation of actin filament bundle assembly (GO:0032232),-0.3771743342047497,-1.1852066937162073,0.22113022113022113,0.6284904412863539,1.0,7/27,5.82%,TMEFF2;PHLDB2;CGNL1;WASF2;ARHGAP28;PPFIA1;ARHGAP6
prerank,DNA recombination (GO:0006310),-0.3592496756143067,-1.184897833944452,0.20050125313283207,0.6282624878754428,1.0,19/37,33.56%,TSN;RAD50;MRE11;RPA1;RAD51D;MSH2;BLM;SUPV3L1;RECQL;RTEL1;DMC1;RAD21;RPAIN;RHNO1;RAD54B;RAD51C;IGHMBP2;ERCC1;HMGB1
prerank,negative regulation of mitotic cell cycle (GO:0045930),-0.34256342075250507,-1.1848782433609375,0.18341708542713567,0.6272846100691053,1.0,13/45,8.36%,SMAD3;BRINP1;TOM1L2;CTNNB1;BMP7;ZWINT;BMP4;TRIM35;PTPN3;CDKN1B;GAS1;FOXC1;BRINP2
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.43079693914802647,1.1846600434399264,0.2703180212014134,0.9553234651724154,1.0,6/24,9.12%,SEMA6A;SEMA6D;SEMA7A;SEMA3C;SEMA6B;SEMA4C
prerank,negative regulation of establishment of protein localization (GO:1904950),-0.4985611784496705,-1.1846195260152534,0.2627450980392157,0.6270390255932513,1.0,7/10,31.58%,MAPT;WWP2;NDFIP1;SNX3;PPM1F;DNAJA1;TERF1
prerank,cellular response to glucagon stimulus (GO:0071377),-0.43646347764582044,-1.1843258652410154,0.23620309050772628,0.62682565158438,1.0,10/17,22.64%,ADCY5;ADCY2;ADCY1;ADCY9;PRKACA;ADCY7;PRKAR1B;ADCY3;ADCY8;ADCY4
prerank,tricarboxylic acid metabolic process (GO:0072350),-0.47445453058269305,-1.1838550480919532,0.25279642058165547,0.6271091259425928,1.0,8/12,33.60%,GLUD1;ACLY;IDH2;IDH3B;IDH3A;ASS1;SIRT4;IDH3G
prerank,regulation of neuroblast proliferation (GO:1902692),-0.4461843372844037,-1.1837250030818618,0.2457627118644068,0.6264433446908606,1.0,10/15,33.70%,TAFA1;CTNNB1;SMARCD3;DISC1;KDM1A;CX3CL1;VEGFA;CX3CR1;DRD2;PTN
prerank,T cell differentiation (GO:0030217),0.3914270653024175,1.1837162420034764,0.23366013071895425,0.9572629142049629,1.0,8/40,11.50%,JAG2;PTPRC;ZFP36L1;GPR89B;GPR89A;SOX13;LFNG;PIK3CD
prerank,sensory perception (GO:0007600),-0.3363619508890094,-1.1837147528555718,0.2020997375328084,0.625446978115188,1.0,14/45,26.66%,PCDH15;ADGRV1;P2RX4;TTC8;GNAL;WHRN;PTGES;OPRM1;KCNA2;TMEM150C;ADORA2A;NIPSNAP1;CHRNA7;TRPV2
prerank,positive regulation of histone acetylation (GO:0035066),0.4358186685174399,1.1836055273276893,0.2593984962406015,0.9557804120569949,1.0,4/23,3.78%,MAPK3;RUVBL2;RPS6KA4;RPS6KA5
prerank,regulation of protein neddylation (GO:2000434),0.5236768724231861,1.1835091570897058,0.26666666666666666,0.954193674051893,1.0,5/10,16.97%,DCUN1D4;RPL5;EPAS1;DCUN1D2;DCUN1D1
prerank,dicarboxylic acid transport (GO:0006835),-0.38308068067669354,-1.1833010185519424,0.22115384615384615,0.6255826415427782,1.0,9/28,15.92%,SLC1A3;SLC13A3;PDPN;SLC26A7;SLC25A13;SLC25A32;GJA1;SLC22A6;SLC19A1
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.4491235621690387,1.1832070164778687,0.25874125874125875,0.9534550363168459,1.0,6/20,10.80%,SMAD1;EP300;CARF;NOTCH1;RELA;RBPJ
prerank,natural killer cell mediated immunity (GO:0002228),0.4778691337033254,1.1827941788949516,0.2833333333333333,0.9531663603600942,1.0,2/15,6.48%,TUBB;CEBPG
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.33113758086467726,1.1825884675045744,0.18776671408250356,0.9520760111186574,1.0,18/93,11.77%,MAP3K11;FCGR2B;TIRAP;HIPK2;MAP3K4;EDAR;TRAF5;AXIN1;KLHDC10;MTURN;MINK1;TRAF3;SEMA4C;PJA2;PLCB1;MFHAS1;APP;RELL1
prerank,ether lipid biosynthetic process (GO:0008611),0.5240412071728742,1.1824405199749402,0.2646502835538752,0.9507693977697532,1.0,5/10,14.30%,LPCAT2;PEDS1;PEX7;AGPS;GNPAT
prerank,negative regulation of cation transmembrane transport (GO:1904063),-0.44006655597844163,-1.1822384802116632,0.23972602739726026,0.6273505783033964,1.0,5/18,14.70%,ATP1A2;CAB39;BIN1;CAMK2D;COMMD1
prerank,cellular response to glucose starvation (GO:0042149),-0.35335759439700065,-1.1822090758974395,0.1867007672634271,0.6264216177385031,1.0,21/41,31.63%,PRKAG2;CPEB4;PRKAG1;PIK3C3;SIK1;BRSK1;HNRNPA1;TP53;SZT2;ITFG2;ATF4;IMPACT;EIF2AK3;SESN2;PICK1;ZC3H12A;FOXO3;MYBBP1A;PRKAG3;TBL2;PRKAA1
prerank,cellular response to lipid (GO:0071396),-0.2649749076111819,-1.1819714148489269,0.07537688442211055,0.6261057214291221,1.0,46/191,18.87%,ATP1A2;EGFR;ADCY5;TFPI;PABPN1;ADCY2;WNT5B;BRINP1;ADCY1;MAPK14;PID1;AXL;PTK7;VIM;RHOA;MED1;ROCK2;LBP;IRAK1;ATP1A1;CDC73;BRINP2;SNW1;TRIM41;NFKB1;EPHA3;NCOA4;SIRPA;WNT9A;ATM;RORA;SETX;PAF1;PDE4B;GPLD1;SPP1;SELENOS;UPF1;DEFA6;ABL2;NR3C1;FZD4;TWF2;ATP1A3;MSN;CHMP5
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.2822838766305938,-1.1815005207585,0.10384615384615385,0.6263725645940452,1.0,25/128,10.15%,DDX5;BMP6;TGFBR3;COL1A2;SMAD3;COL3A1;SMURF2;TGFBR1;RGMA;TGFBR2;BMP5;BMP7;SMAD4;RHOA;BMP4;PRKCZ;PXN;APPL2;ITGB5;SKI;SMAD6;ZFYVE16;ACVR1;HIVEP1;RGMB
prerank,regulation of response to biotic stimulus (GO:0002831),0.417698152259901,1.1813859046073043,0.23214285714285715,0.95305698705092,1.0,4/28,3.83%,LRP8;FCGR2B;TIRAP;BIRC2
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),-0.4820193517384982,-1.181211441246172,0.25708502024291496,0.6251459598082982,1.0,3/12,2.15%,IGF1;AKAP6;CAMTA1
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.4820193517384982,-1.181211441246172,0.25708502024291496,0.6251459598082982,1.0,3/12,2.15%,IGF1;AKAP6;CAMTA1
prerank,cellular response to organonitrogen compound (GO:0071417),-0.2899529851636845,-1.1808519477706438,0.12040133779264214,0.6251335836885998,1.0,15/99,8.71%,GABRB1;HCN1;CPEB4;AKAP6;RYR3;CPEB1;CAPN2;IGFBP5;CTNNA1;CTNNB1;P2RX4;GABRG2;GLRA1;AKAP9;EZR
prerank,positive regulation of T cell differentiation (GO:0045582),0.39711118693327246,1.18010229133138,0.22789115646258504,0.9566005894365038,1.0,7/36,16.07%,PCK1;LEF1;VSIR;PNP;NKAP;BCL6;IL7
prerank,positive regulation of protein kinase activity (GO:0045860),0.3110932720298346,1.179729949988555,0.18840579710144928,0.9563379622562808,1.0,26/148,12.32%,LRP8;RALB;EZH2;PTPRC;MTCP1;TAB2;RPTOR;SRC;STOX1;PPP2CA;CIB1;CDKN1A;PAK3;CALM3;LCP2;AXIN1;MINK1;EFNA1;CSF1R;NAB2;PAK1;DDX3X;MMD;PRNP;STRADB;MAP4K4
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.30882695599915005,1.1794662993523293,0.14713541666666666,0.9554729810176097,1.0,32/166,13.57%,POLR2J;MAZ;ERCC3;MAPK3;NR4A2;POLR2B;POLR1C;GTF3C1;HDAC7;HDAC9;HDAC3;NR5A1;CCNH;MED23;PPARD;POLR1G;NOTCH1;NRBF2;GTF2H1;RSF1;NRBP1;TAF15;ESR1;THRB;RBPJ;GTF2A2;CREBBP;E2F3;TAF4B;TBP;HDAC5;THRA
prerank,bile acid biosynthetic process (GO:0006699),-0.3943605834778193,-1.1790868935998657,0.2323943661971831,0.6290928479618554,1.0,5/24,10.21%,OSBPL9;OSBPL6;CYP27A1;CYP7B1;OSBP
prerank,positive regulation of protein ubiquitination (GO:0031398),0.3421039929497232,1.1790313081558255,0.19672131147540983,0.9553568919903442,1.0,15/80,9.54%,GSK3A;TRIB3;PIN1;DCUN1D4;BIRC2;HDAC3;UBE3A;WFS1;PTTG1IP;SMAD7;BMI1;AXIN1;MAGEC2;SPRTN;MYCBP2
prerank,nuclear pore complex assembly (GO:0051292),-0.509069043319043,-1.1785773856769621,0.2732919254658385,0.6295047183699357,1.0,5/10,27.49%,NUP205;AHCTF1;NUP93;TMEM170A;NUP153
prerank,response to ATP (GO:0033198),-0.42903142361823077,-1.178460398875409,0.25892857142857145,0.6288171840881533,1.0,8/18,29.78%,RYR3;P2RX4;ABCC9;SSH1;P2RY12;DGKQ;TRPC3;P2RY1
prerank,nucleotide-excision repair (GO:0006289),0.32686678178806217,1.1769757620444823,0.19888734353268428,0.9622259111185452,1.0,17/101,11.27%,POLR2J;ERCC3;POLR2B;PNKP;CCNH;ERCC4;XRCC1;POLK;EP300;POLE;SIRT1;POLD3;GTF2H1;POLA1;RAD23A;COPS7B;HUS1
prerank,muscle cell development (GO:0055001),-0.37224393593396515,-1.1769126834698356,0.23786407766990292,0.6320321216551223,1.0,11/30,24.91%,ANK2;IGF1;CXADR;BIN1;MYOF;KDM1A;MEGF10;EFEMP2;VEGFA;MYH11;SGCZ
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.31289086297575286,1.1766485929442854,0.16164383561643836,0.9615975209550278,1.0,31/149,14.09%,MAP3K7;TAB2;PRKCH;RPS6KA4;TIRAP;TRIM8;PRKD2;RPS6KA5;RAB7B;TRIM14;CIB1;EP300;CARD16;TRAF5;CLOCK;TAB3;TRIM25;WNT5A;RELA;RBCK1;UBE2V1;RNF25;APP;NOD1;RPS3;PRKCI;IKBKB;ERC1;CHUK;NFKBIA;TRIM27
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),0.4921153751863249,1.1766042697738603,0.2889733840304182,0.9598675646311745,1.0,4/13,10.70%,INSIG1;TMEM30B;GCC2;CD81
prerank,positive regulation of hydrolase activity (GO:0051345),0.31319358253826446,1.1765229703022722,0.16151685393258428,0.9582793031203217,1.0,27/137,13.08%,EZH2;PIN1;EVI5L;TBC1D30;BCAR3;RGS8;MAPK8;USP6NL;ARHGEF7;CALM3;RAPGEF3;F11R;RGS10;RAP1GDS1;CCL25;RAPGEF6;DOCK9;ITGA6;RAB11FIP2;RPS3;PICALM;NF1;AGRN;MAP4K4;LARS1;MAPK12;NDUFA13
prerank,positive regulation of T cell migration (GO:2000406),0.4506067237862395,1.1762866717032456,0.24420677361853832,0.9572663058992525,1.0,5/20,15.24%,OXSR1;CXCL12;WNT5A;APP;DOCK8
prerank,positive regulation of cell aging (GO:0090343),0.5170200028407949,1.1761593065083036,0.2774451097804391,0.9559054231872103,1.0,3/11,7.73%,B2M;SIRT1;YPEL3
prerank,triglyceride biosynthetic process (GO:0019432),0.45723630052164654,1.1760230912242915,0.2773722627737226,0.9545680557505404,1.0,3/18,6.73%,PCK1;GPAM;GPAT4
prerank,granulocyte chemotaxis (GO:0071621),0.36928862954848685,1.1760031471846635,0.20404984423676012,0.9527409241854129,1.0,7/55,11.50%,PIK3CG;BSG;PPIB;SYK;PIKFYVE;CCL25;PIK3CD
prerank,phospholipid homeostasis (GO:0055091),-0.47983685661384423,-1.175956964667089,0.2622601279317697,0.6336291339354764,1.0,3/11,14.41%,TLCD2;ABCA1;RCN3
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),-0.282645095219237,-1.17520833627255,0.1444866920152091,0.6346872217075062,1.0,34/122,19.13%,SORBS1;IGF1;PLD1;SAMD4A;EGFR;PDGFRB;GLI2;KAT7;VIM;LDB1;SLC6A9;AKT2;POLDIP3;PRR16;EIF3C;YTHDF1;NIBAN1;SMOC2;THBS1;STN1;NFKB1;EEF2;RBM3;BRPF3;IL33;ATAD5;IGF2;PLXNB2;METTL5;NAT10;PCIF1;UPF3A;RPS6KB1;CIRBP
prerank,negative regulation of nuclear division (GO:0051784),-0.48261039893647195,-1.1744235718101108,0.27607361963190186,0.6358262903132936,1.0,3/11,4.74%,TOM1L2;BMP7;BMP4
prerank,motile cilium assembly (GO:0044458),-0.488990816388473,-1.1741884316155762,0.28193832599118945,0.6354871491862044,1.0,5/12,27.80%,SPATA6;BBOF1;BBS5;CCDC39;E2F4
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.4593622650874677,1.1740884233490618,0.2564102564102564,0.958601075247778,1.0,5/17,11.25%,SOD1;SFPQ;SIRT1;SOD2;UBQLN1
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.34012049638157144,1.1737804640657659,0.18825301204819278,0.9578872016338185,1.0,11/75,9.69%,RGS2;PRKAR1A;DUSP7;PTPRJ;CDK5RAP1;APOE;SIRT1;RASIP1;LATS2;LYN;TFAP4
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),-0.3742891619327817,-1.1735033644144268,0.23058252427184467,0.6364209840030741,1.0,9/31,14.71%,KANK2;FHL1;RBL2;MYO16;CDC73;BRD7;CDK6;DLG1;DACT1
prerank,regulation of secretion (GO:0051046),-0.47348056843266406,-1.1731341471325494,0.25,0.636512415545562,1.0,9/13,38.57%,SGK1;GPLD1;OAS2;KCNQ1;FGF10;POFUT2;EGF;ERBB3;OPRK1
prerank,negative regulation of B cell activation (GO:0050869),0.43336441996714703,1.173128964531184,0.2669039145907473,0.958553781697553,1.0,4/21,9.31%,TNFAIP3;FCGR2B;SAMSN1;LYN
prerank,positive regulation of GTPase activity (GO:0043547),0.3060861857436038,1.1730224143421188,0.1472972972972973,0.9570576520373654,1.0,46/188,15.63%,EZH2;PIN1;TIAM1;EVI5L;ARHGEF26;TBC1D30;BCAR3;TBC1D8;RALGAPA2;RGS8;TBC1D9;ARHGAP25;TBC1D10B;USP6NL;ARHGEF7;TBC1D4;RALGAPB;RAPGEF3;F11R;RABGAP1L;RGS10;RAP1GDS1;CCL25;RAPGEF6;DOCK9;ITGA6;TBC1D12;TSC1;RAB11FIP2;TBC1D25;DOCK7;RHOG;PICALM;NF1;AGRN;ADPRH;MAP4K4;LARS1;TBC1D14;RABGAP1;RALGAPA1;SYDE1;ARHGEF10;DOCK8;RAB3GAP1;CDKL5
prerank,pharyngeal system development (GO:0060037),-0.45558637800177126,-1.1722807297087905,0.2565217391304348,0.637850041713418,1.0,4/15,4.74%,TGFBR1;BMP5;BMP7;BMP4
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),-0.3985323791676384,-1.1722564794824117,0.24942263279445728,0.6369169665391965,1.0,4/22,5.44%,MBP;WNK1;BMP7;FLOT2
prerank,negative regulation of phosphorylation (GO:0042326),-0.2964512307708063,-1.1721231502812792,0.14556962025316456,0.6363494650135527,1.0,17/85,8.75%,NTRK3;PTPN13;HDAC4;SH3GL2;FBLN1;PID1;MAPT;OCLN;BMP7;PLPP3;BMP4;NUPR1;ROCK1;PPARA;XDH;CDKN1B;NIBAN1
prerank,protein polyubiquitination (GO:0000209),0.2934356099304901,1.172090139257635,0.12876052948255115,0.9588825666425199,1.0,73/297,16.67%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;ARIH1;ANAPC2;KLHL3;TNFAIP3;SPOP;RFFL;BIRC2;PSMD11;NEDD4L;ANKRD39;NHLRC1;RBBP6;PSMB4;FBXL5;UBE3A;ANAPC13;TRIM14;PSMC1;FBXW2;TRAF5;RNF187;LMO7;UBE2V2;FBXO32;TTC3;AKTIP;FBXO11;TRAF3;ANAPC7;RBCK1;MDM2;PSMC2;UBE3D;PSMD2;RNF6;ZNRF1;FBXO7;UBE2V1;CHFR;ANAPC11;TNKS;IFI27;ANAPC10;ANAPC4;CUL3;PSMD14;UBE2R2;RNF146;RNF216;PSMC6;PSMD1;PSMB1;TRIM27;RNF20;TRIM3;NHLRC3;UBE2G1;FBXO22;RMND5A;RNF114;TAF1;PELI1;KLHL42;RNF125;UBE2H;PSMA4;FBXL20
prerank,positive regulation of histone modification (GO:0031058),0.40285741094458327,1.1714258601689658,0.25549915397631134,0.959843250076218,1.0,8/33,11.22%,MAPK3;RUVBL2;RPS6KA4;RPS6KA5;CHTOP;AKAP8L;ING2;CTBP1
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),-0.4034107465229943,-1.1713697076275496,0.2483221476510067,0.6374911313777066,1.0,11/21,30.46%,TOX;CTNNB1;SMARCD3;DISC1;KDM1A;NES;CX3CL1;VEGFA;CX3CR1;MDK;DRD2
prerank,protein oxidation (GO:0018158),-0.4924925266259784,-1.1711896738575642,0.2702127659574468,0.6369953919080802,1.0,5/11,25.72%,LOXL1;SUMF1;LOXL3;LOX;PRDX3
prerank,neurotransmitter transport (GO:0006836),-0.3034049280300435,-1.1708482154097564,0.1834319526627219,0.636918752545999,1.0,19/73,14.04%,ATP1A2;RIMS1;SNAP25;SLC1A3;NRXN1;SYN2;GABRA2;PTPRN2;PPFIA1;GLUL;SYN1;BRSK1;NRXN2;APBA1;STXBP1;SNPH;UNC13B;SLC6A15;VAMP2
prerank,protein transport (GO:0015031),0.2891141411807777,1.1704495954446985,0.13348946135831383,0.9619531779002048,1.0,67/332,13.25%,ARF5;MIA2;ZDHHC17;ARL5C;ARL4D;EVI5L;PPT1;PREPL;RAB5C;TBC1D30;TBC1D8;ATP6V1D;SLC10A7;SNX8;VPS29;RAMP2;APOE;RAB7A;TBC1D9;TMED4;VPS26A;SEC23IP;RAB43;RAB11B;ATP6V0D1;COPG2;TBC1D10B;USP6NL;TBC1D4;RAB6B;CHMP1A;VMP1;NAPA;TMED5;IFT22;RABGAP1L;SNX17;RAB6A;TMED10;RAB14;ATP6V0E1;ACD;DNAJC27;TBC1D12;SNX1;ARL5B;ARF1;RAB1A;GOLPH3L;GCC2;CHMP2A;TBC1D25;PPY;KIF13A;ATP6AP1;TMED7;SCFD1;RAB5B;RAB22A;ADPRH;ARCN1;COPG1;TBC1D14;SCAMP1;YWHAH;KIF3B;RABGAP1
prerank,negative regulation of sequestering of calcium ion (GO:0051283),-0.38921932217626753,-1.1702284979760778,0.23933649289099526,0.6376814377964899,1.0,4/24,6.94%,HTR2C;ITPR1;RYR3;ERO1A
prerank,regulation of peptide hormone secretion (GO:0090276),-0.313107903310255,-1.169581324047056,0.18,0.6384893604747018,1.0,9/67,7.25%,HTR2C;CACNA1C;ITPR1;SNAP25;CACNA1D;KCNC2;PER2;DPP4;ENSA
prerank,positive regulation of actin filament bundle assembly (GO:0032233),-0.327648088554726,-1.169386346624136,0.162534435261708,0.6380391818060902,1.0,22/51,24.21%,LPAR1;NRP1;ARHGEF10L;CCN2;TGFBR1;TPM1;RHOA;PXN;ROCK2;PPM1E;SYNPO2;FHOD1;NF2;ARHGEF5;CDC42;CX3CL1;PPM1F;PFN2;ARHGEF15;RHOC;ITGB1BP1;TGFB3
prerank,sphingosine metabolic process (GO:0006670),0.4647820747565622,1.169266353419961,0.24456521739130435,0.9651024576182258,1.0,5/17,13.88%,ACER2;PLPP1;SGPP2;ACER3;SGPP1
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.29082790202105263,1.1691602992276309,0.12440191387559808,0.9636241208404156,1.0,80/314,18.05%,FBXL6;PSMB10;PSMC4;PSMB6;GSK3A;PSMD8;PSMD5;PSMD12;ANAPC2;DERL2;FEM1C;SPOP;UBXN11;RFFL;BIRC2;PSMD11;NEDD4L;YOD1;NHLRC1;PSMB4;FBXL5;WFS1;PSMC1;FAM8A1;SGTB;COP1;FBXO5;SIRT1;CLOCK;RNF187;TRIM25;CRBN;ANAPC7;RBCK1;MDM2;RAD23A;AUP1;PSMC2;UBE3D;PSMD2;ZNRF1;RHBDD2;ERLIN2;STT3B;SPOPL;UBQLN1;ANAPC11;IFI27;ANAPC10;PLAA;ANAPC4;CUL3;PSMD14;RNF216;DDIT3;PSMC6;PSMD1;FAF1;APPBP2;PSMB1;TRIM3;NHLRC3;UBE2G1;RMND5A;DNAJC10;TAF1;PELI1;KLHL42;UFD1;UBQLN2;PSMA4;FBXL20;DNAJB14;UBR3;ATXN3;CDC26;RAD23B;UBXN4;KCTD10;AGAP3
prerank,cellular response to radiation (GO:0071478),0.3792567120730185,1.1690771991742375,0.2408026755852843,0.9620930710156494,1.0,8/40,11.27%,GPR52;EEF1D;RAD1;CDKN1A;SIRT1;CLOCK;KDM4D;HUS1
prerank,response to cytokine (GO:0034097),-0.2668323384489619,-1.168528809486261,0.10666666666666667,0.6395701832889198,1.0,30/141,13.88%,AFF3;NFAT5;PTPN13;ALDH1A2;TIMP3;AKAP6;SMAD3;DPYSL3;TIMP2;COL3A1;HDAC4;PTPN14;OSMR;PID1;IFNAR2;RHOA;IL6R;PML;IRAK1;KLHL20;IRAK3;EIF2AK2;PLSCR1;REL;IKBKE;ANXA1;IL1RAPL1;RELB;GGT5;IL6ST
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),0.5336776530188806,1.1685157739888439,0.28316831683168314,0.96255900133919,1.0,4/10,11.27%,SHANK3;NETO1;NPTN;APP
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),-0.34596982582071384,-1.1680382198481616,0.22531645569620254,0.6398693246412539,1.0,8/40,4.04%,DAB2;COL1A1;SMAD3;TGFBR1;TGFBR2;CTNNB1;PDPN;SMAD4
prerank,negative regulation of bone remodeling (GO:0046851),0.497656696794499,1.1670308297097687,0.283495145631068,0.9667345205450872,1.0,3/11,10.95%,TNFAIP3;GREM1;P2RX7
prerank,positive regulation of lipid catabolic process (GO:0050996),-0.420376690969433,-1.1667756312441966,0.22705314009661837,0.6423848026357347,1.0,5/19,13.86%,ABHD5;PRKCD;PPARA;AKT2;ABCD2
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.4994918167293892,1.166766445583778,0.28598130841121494,0.965882714829326,1.0,3/13,6.39%,PRPF31;PRPF3;SRSF10
prerank,regulation of interleukin-8 production (GO:0032677),0.3455494078119375,1.1666557561777342,0.218562874251497,0.9644646073092686,1.0,11/69,13.40%,PTPRC;TIRAP;MAP2K5;PRKD2;SYK;RELA;RAB1A;PARK7;NOD1;MAPKBP1;DDIT3
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),-0.3025419213203844,-1.1665941403119287,0.16091954022988506,0.6419016252789658,1.0,19/76,16.83%,UACA;NFAT5;SASH1;EGFR;CYLD;RASSF2;BMP7;RHOA;PPM1B;IRAK1;EZR;EIF2AK2;ILK;PPM1A;NR3C2;DLG1;PTPN22;CCN3;RTKN2
prerank,aminoglycan biosynthetic process (GO:0006023),-0.3330935954828125,-1.1663462826576259,0.1839080459770115,0.6415684687992678,1.0,18/49,21.73%,GPC6;HS3ST5;HS6ST2;SDC2;HS3ST3A1;GPC3;HSPG2;HEXA;GPC5;SLC35D2;UGDH;B3GALT5;B3GALNT1;HS3ST3B1;B3GALT1;NDST2;GPC4;SDC3
prerank,B cell mediated immunity (GO:0019724),0.5110562969481822,1.1662337993636582,0.3069679849340866,0.9644416144859811,1.0,1/10,2.51%,FCGR2B
prerank,response to histamine (GO:0034776),-0.5079185694242709,-1.165619248162006,0.27037773359840955,0.6425605329704318,1.0,3/10,17.49%,GABRB1;GABRG2;DIAPH1
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.429927370576502,1.1651950195551322,0.2570921985815603,0.9668319108899958,1.0,6/23,13.08%,TIMM29;ROMO1;BAD;MAIP1;BMF;NDUFA13
prerank,cilium assembly (GO:0060271),-0.2438440668016369,-1.165046453891848,0.06060606060606061,0.6432046272247438,1.0,83/296,19.87%,GSN;PARVA;AHI1;PKD1;CC2D2A;EXOC3;DYNC1H1;RILPL1;FLNA;PIBF1;IFT81;DZIP1;TTC8;WDR35;NINL;SPATA6;DYNC2I1;RAB8B;DCDC2;TTC21B;NUDCD3;CCDC66;CCDC57;CFAP20;EXOC6;TTC39C;IFT46;CEP57;IFT57;IFT52;AKAP9;CEP70;ACTR3;CEP89;CSNK1E;CEP152;CEP126;IFT172;CKAP5;CEP20;PRKACA;IFT74;CFAP44;RP2;DCX;ARL13B;DISC1;TTBK2;ABLIM3;KIF3A;DZIP1L;BBS9;RAB11A;WDR19;WDR11;INTU;RAB23;CCP110;BBS2;TUBB4A;CYS1;DCTN1;ARF4;EXOC7;EXOC1;PTPN23;CEP250;EHD1;BBOF1;RAB8A;EHD3;GORAB;DYNLL2;ACTR2;IFT20;NDE1;TUBA1A;SNAP29;BBS5;TMEM237;TMEM80;CCDC28B;TTLL3
prerank,protein kinase B signaling (GO:0043491),-0.3961664437577214,-1.16489124226463,0.2546728971962617,0.6426309830361411,1.0,9/23,24.84%,IGF1;SIRT2;PIK3R3;SETX;TGFB1;TSC2;THEM4;AKT1;PAX2
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.4134390083595238,1.1642406073349312,0.25565217391304346,0.9688075249668437,1.0,9/29,11.12%,GPAM;SRARP;VPS11;CNOT2;AXIN1;PAK1;WBP2;ESR1;CARM1
prerank,response to interferon-alpha (GO:0035455),0.46528780366827527,1.1625946456663756,0.2631578947368421,0.9737587066010179,1.0,6/16,9.96%,IFITM2;RO60;IFITM3;ADAR;IFITM1;IFNAR1
prerank,regulation of DNA repair (GO:0006282),-0.3416212220557695,-1.16181370348876,0.20194647201946472,0.65016034137615,1.0,18/44,19.32%,EYA2;EYA1;EGFR;UBE2N;KAT7;DEK;ERCC6;PML;UBR5;RNF168;RNF8;WRNIP1;SIRT7;NPAS2;USP1;CDK9;BABAM1;SMCHD1
prerank,peptidyl-serine modification (GO:0018209),0.30414829749415384,1.1615639152421635,0.18072289156626506,0.9762097602412471,1.0,37/166,15.84%,PCK1;PRKX;STK32A;PLK2;RPS6KA1;PRKCH;RPS6KA4;CAMK1D;HIPK2;PRKD2;RPS6KA5;PKN3;SMG1;HPF1;MAPK8;CSNK1G3;SBK1;DCLK3;LATS2;PKN1;SRPK2;TNKS;PRKCI;MAST4;IKBKB;MAPK12;CHUK;TLK2;NEK6;CSNK2A2;NTMT1;MAP3K10;GAS6;DYRK2;TOP1;TAF1;ATR
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.46104138385147,1.1615207343860376,0.29963235294117646,0.9745466191110425,1.0,2/16,2.28%,GSK3A;PRCP
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),-0.48741313343325826,-1.1614943881188298,0.27755905511811024,0.6500719455185019,1.0,1/11,4.87%,MALT1
prerank,regulation of cartilage development (GO:0061035),-0.42875598435453804,-1.1613011377046019,0.28051391862955033,0.6495994782790369,1.0,11/18,37.28%,SOX5;TAPT1;BMP4;BMPR1B;SOX6;BMPR2;BMP2;MDK;PTHLH;WNT11;KAT2A
prerank,glycogen metabolic process (GO:0005977),-0.370376704135314,-1.1612120481343133,0.23113207547169812,0.6488466928148208,1.0,12/27,19.40%,PRKAG2;PYGB;AGL;PER2;PGM1;PHKA2;GSK3B;GYS1;PYGM;PGM2;GAA;PHKG2
prerank,regulation of AMPA receptor activity (GO:2000311),-0.38059126744745275,-1.16103973503487,0.2506265664160401,0.6483412983607697,1.0,13/25,24.78%,SHISA9;NLGN2;RELN;SHISA6;NLGN1;CACNG7;CACNG4;CACNG2;SHANK1;PRRT1;NLGN3;CACNG3;CACNG8
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),-0.24272382014424246,-1.1607194830730156,0.03676470588235294,0.6482544961468761,1.0,73/390,11.20%,ERBB4;SORBS1;NTRK3;FGFR2;IGF1;SULF1;HNRNPH1;TIA1;EGFR;EPHA6;COL1A1;GRIN2B;EFNA5;AHI1;PDGFRB;CYFIP2;COL4A6;AP2B1;EPHB1;NTRK2;DOCK1;WASF2;SDC2;NRP1;FLRT2;FGF1;WASL;MAPK14;AXL;EFNB2;RYK;ABI1;SULF2;VAV2;FER;EPHA7;RHOA;MTSS1;AP2A2;SIRT2;NEDD9;ROR1;KIT;ATP6V1E1;GHR;PXN;ROCK2;ARPC1A;ATP6V0B;SLC39A14;DDR1;PDGFRA;ROCK1;FRK;AKT2;IL31RA;PIK3R3;UBASH3B;EPHB4;CEP57;AP2A1;FOXC1;ACTR3;ARPC1B;NRP2;SOCS2;GSK3B;EPHB2;KL;EPHA3;HNRNPA1;TCIRG1;ATP6V0A4
prerank,regulation of cardiac muscle contraction (GO:0055117),0.39381807421761067,1.1604313588914432,0.26136363636363635,0.9771828394267112,1.0,6/34,7.28%,RGS2;PIK3CG;PDE4D;ATP2A2;CALM3;SMAD7
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.381521751672138,-1.1601531843033912,0.26570048309178745,0.6486962184283517,1.0,5/27,10.68%,ANK2;AHNAK;CACNB4;PRKACA;CAMK2D
prerank,energy derivation by oxidation of organic compounds (GO:0015980),-0.38920013321506,-1.159966384968245,0.26450116009280744,0.6482431855596349,1.0,5/24,5.65%,LEPR;PID1;COQ10B;PPARGC1A;SLC25A13
prerank,negative regulation of viral life cycle (GO:1903901),0.4766978159272759,1.159900184405728,0.2831541218637993,0.977579175540121,1.0,4/15,8.83%,LY6E;IFITM2;IFITM3;IFITM1
prerank,regulation of cell differentiation (GO:0045595),0.3104825326457458,1.159595425437478,0.17310252996005326,0.9770426300459799,1.0,26/148,12.06%,SPOCK2;PTPRQ;TIAM1;OCIAD1;RPS6KA1;GREM1;LTBP4;CLASP2;BCL6B;BIRC2;PPP2CA;ZFP36L1;HEY1;CDK5RAP1;SINHCAF;SLC6A6;TBX1;BDNF;SMAD7;HEY2;DAG1;TRPS1;CREBBP;PA2G4;PTBP1;NF1
prerank,negative regulation of cell communication (GO:0010648),-0.4061432264814711,-1.159534527187466,0.2719298245614035,0.6484073891638406,1.0,5/21,17.46%,UBASH3B;GLRA1;ACVR1;OPRM1;SOCS5
prerank,positive regulation of telomere maintenance (GO:0032206),0.39830148226561196,1.1591647176161852,0.2636986301369863,0.9769841342302893,1.0,7/31,12.55%,MAP2K7;MAPK3;PNKP;MAP3K4;NEK7;TNKS;NBN
prerank,integrin-mediated signaling pathway (GO:0007229),-0.2982715225714421,-1.1590433833889968,0.18541033434650456,0.6488177495542141,1.0,16/73,11.33%,ITGBL1;DAB2;ITGB8;DOCK1;COL3A1;FBLN1;NRP1;PLPP3;NEDD9;TEC;ITGB5;ITGA5;ADAMTS1;ITGA11;FN1;ILK
prerank,regulation of trophoblast cell migration (GO:1901163),-0.4395267640971119,-1.1589270370178764,0.27546296296296297,0.6481647778561683,1.0,5/14,22.30%,SMURF2;GJA1;ACVR1B;ARHGDIB;VEGFA
prerank,regulation of vasoconstriction (GO:0019229),-0.37238800155566376,-1.1588046972100443,0.24178403755868544,0.6475171972670026,1.0,15/27,38.43%,PER2;ADRA1B;CHRM3;ZDHHC21;ACE;BDKRB2;AGTR1;BMPR2;ADRA1A;CAV1;TBXA2R;KCNMB4;ADM;ACE2;AGT
prerank,response to insulin (GO:0032868),0.3375098016270271,1.1587009934847596,0.21915820029027577,0.9770756248588304,1.0,17/80,13.20%,PCK1;GSK3A;TRIB3;INSIG1;SORT1;HDAC9;ZFP36L1;MYO5A;TBC1D4;SIRT1;IRS2;EPM2AIP1;TSC1;RHOQ;ZBED3;PRKCI;HDAC5
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.4759616490358295,1.1583255981213418,0.29136690647482016,0.9767922043636368,1.0,6/15,15.42%,ARPC3;ARPC5L;ARPC4;ARPC5;TRIM27;WHAMM
prerank,regulation of urine volume (GO:0035809),-0.5000618970791242,-1.157399397242508,0.2665330661322645,0.6505068900714073,1.0,7/10,46.41%,NPR3;NPR1;INPP5K;ADCY6;ADM;HYAL2;HAS2
prerank,regulation of JNK cascade (GO:0046328),0.32016763963028694,1.1571375998370843,0.22097902097902097,0.9798934601957263,1.0,19/101,12.32%,MAP3K11;MECOM;RAP2A;FCGR2B;TIRAP;HIPK2;HDAC3;EDAR;TRAF5;AXIN1;MTURN;MINK1;PHLPP1;TRAF3;PJA2;PLCB1;MFHAS1;APP;MAP4K4
prerank,replicative senescence (GO:0090399),0.48845423014565675,1.1570761660598676,0.30623818525519847,0.9783237206983696,1.0,5/12,15.84%,ROMO1;MME;TERT;CHEK2;ATR
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),-0.46628125814119614,-1.1568804077459758,0.2975206611570248,0.650908202917222,1.0,3/12,7.03%,SORBS1;IGF1;AKT2
prerank,smooth muscle contraction (GO:0006939),-0.44779156760601646,-1.156371199842957,0.259825327510917,0.6513882062664792,1.0,8/14,29.87%,ROCK2;EDNRA;ROCK1;SMTN;BDKRB2;ADRA1A;MYH11;MYLK
prerank,glucose transmembrane transport (GO:1904659),0.45758353112210703,1.1561695525155018,0.27124773960216997,0.9801649541915718,1.0,3/18,8.35%,SORT1;PPARD;SLC2A1
prerank,interleukin-35-mediated signaling pathway (GO:0070757),-0.4811589416845687,-1.156066726377724,0.2908704883227176,0.6512268355461037,1.0,3/11,19.51%,JAK1;IL6ST;STAT1
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.4419609283883987,1.155932297145036,0.2846299810246679,0.9793560429831758,1.0,7/18,16.46%,RUVBL2;CCT2;CCT5;RUVBL1;TCP1;DKC1;PARN
prerank,cation transmembrane transport (GO:0098655),-0.3379939715854316,-1.1558555295973605,0.23224043715846995,0.6508117174885318,1.0,7/44,7.66%,TRPM3;ATP1A2;SLC7A2;ATP1B1;TRPM6;SLC6A9;SFXN2
prerank,peroxisome organization (GO:0007031),0.4249876881523905,1.155560760192927,0.27162629757785467,0.9789416466129943,1.0,8/25,17.11%,PEX11G;PLAAT3;PEX1;PEX7;TMEM135;ACOT8;DNM1L;LONP2
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.3438056769962349,1.1549731238560457,0.22748091603053436,0.9794921060232978,1.0,10/72,8.79%,POLR2J;ERCC3;POLR2B;CCNH;ERCC4;XRCC1;POLK;EP300;POLD3;GTF2H1
prerank,defense response to bacterium (GO:0042742),0.32206960195720974,1.1548547223369665,0.21081830790568654,0.9781480083061137,1.0,11/105,9.48%,ROMO1;RPL30;DMBT1;TIRAP;RNASE6;STAB1;GBP4;SELP;SYK;PPP1R11;RAB1A
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.3164926985256722,1.1545103254466438,0.21203438395415472,0.977743246042278,1.0,22/113,13.81%,LCP1;ERCC3;PSMC4;TAL1;SLF1;TIRAP;SRC;ERCC4;ICE1;SYK;GTF2H1;RASIP1;PSMC2;PARK7;ESR1;DDX3X;RPS3;BMF;CDH5;PLEK;PSMC6;FAF1
prerank,iron ion homeostasis (GO:0055072),0.35466157329631315,1.1540533675606521,0.25697503671071953,0.9778586629247035,1.0,12/58,12.09%,CAND1;HMOX2;SOD1;ABCG2;FBXL5;ATP6V0D1;B2M;ISCU;GLRX3;ATP6AP1;PICALM;ACO1
prerank,purine ribonucleotide biosynthetic process (GO:0009152),-0.32777924830453237,-1.154008334030172,0.2074468085106383,0.6548774642010653,1.0,20/48,22.64%,ADCY5;AMPD3;ADCY2;ADCY1;ADCY9;DCAKD;SLC26A2;SLC35B3;PANK3;ADCY7;GMPS;GUCY1A1;PAPSS2;NPR1;ACOT7;AK5;ADCY3;ADCY8;GUCY1B1;ADCY4
prerank,regulation of ion transmembrane transport (GO:0034765),-0.3553629369279039,-1.1525213992477596,0.2552083333333333,0.6581689359326821,1.0,12/33,20.31%,AKAP6;WNK1;WWP2;CHRM3;AKAP9;KCNJ2;KCNJ6;WNK3;ANO6;KCNJ13;KCNJ10;NEDD4
prerank,negative regulation of fat cell differentiation (GO:0045599),0.3932643228550181,1.1521037589330718,0.27335640138408307,0.9839838882753891,1.0,6/34,8.56%,CCDC85B;TRIB3;BBS12;TRIO;SIRT1;WNT5A
prerank,cAMP metabolic process (GO:0046058),-0.46056232901760696,-1.1515415288314632,0.29273504273504275,0.6598932089847177,1.0,8/13,22.64%,ADCY5;ADCY2;ADCY1;ADCY9;ADCY7;ADCY3;ADCY8;ADCY4
prerank,protein dephosphorylation (GO:0006470),0.3079351713102708,1.1515100603181452,0.20943134535367544,0.984654600561832,1.0,19/135,6.91%,PHPT1;PTPRR;PTPN18;PTPRG;DUSP7;PTPRJ;PTPRC;CTDSP1;PPP3CB;PTPRM;PPP2R2D;PTPRB;DUSP12;PTPRE;PPP2CA;PTPN12;SSH2;PTPRT;PPP2CB
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.47218706318391734,1.151505153381925,0.2821011673151751,0.9828597366189405,1.0,4/14,11.52%,PRKD2;RELA;CD81;RPS3
prerank,regulation of ATP metabolic process (GO:1903578),-0.3143853636563418,-1.1514937906056324,0.20857142857142857,0.6590380203348603,1.0,23/54,24.95%,PRKAG2;OGT;PRKAG1;ATP7A;NUP205;NUP155;FIS1;NUP188;NUP88;NUP93;SEH1L;COX7A2L;ATP5IF1;NUP85;AAAS;RAE1;SLC25A33;PINK1;NUP37;NUP214;PGAM1;UQCC2;SEC13
prerank,artery morphogenesis (GO:0048844),-0.3647216247637082,-1.1514053032779217,0.2457831325301205,0.6582745399353722,1.0,6/30,5.49%,LRP1;PDGFRB;NRP1;TGFBR1;BMP4;ADAMTS9
prerank,peptide metabolic process (GO:0006518),0.3374864872855986,1.1512217091812171,0.22767857142857142,0.9822387150827208,1.0,10/75,9.07%,PCSK1;LVRN;SOD1;PSEN2;MME;SEC11A;SPCS3;SPPL3;TPP1;CARNMT1
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.46087851443920524,1.1510907219067132,0.283363802559415,0.9809955844442647,1.0,3/14,4.58%,MAP3K7;TIRAP;TNFRSF10B
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),-0.469227463210363,-1.1506331588943284,0.2800829875518672,0.6594416810180208,1.0,6/12,35.41%,WNK1;PPARA;AKT1;MDK;ASS1;SKAP1
prerank,monocarboxylic acid transport (GO:0015718),-0.3206875002722255,-1.1502677778817576,0.2131578947368421,0.6594732093395606,1.0,14/51,19.20%,SLCO3A1;SLC16A12;SLC6A13;SLC16A7;SLC6A12;RXRA;SLC27A1;NCOA1;SLC16A11;STARD5;ATP8B1;SLC16A2;SLC5A6;SLC16A9
prerank,rRNA transcription (GO:0009303),0.4503208161450051,1.1500930039215032,0.30386740331491713,0.9833461141115277,1.0,4/17,6.79%,GTF3C1;SPIN1;GTF3C5;POLR1G
prerank,T cell differentiation in thymus (GO:0033077),0.4737313036903119,1.1498536060865796,0.2959558823529412,0.9824907803963042,1.0,2/14,4.13%,PTPRC;ZFP36L1
prerank,positive regulation of dendrite development (GO:1900006),0.5085331235432733,1.1497787049662413,0.3204868154158215,0.981000958298363,1.0,1/10,0.02%,LRP8
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.4389259762208359,1.1496780941186482,0.31095406360424027,0.9795946759982507,1.0,4/20,6.18%,PIN1;PPIB;PPIG;PPIL3
prerank,regulation of catecholamine secretion (GO:0050433),-0.36398878509738025,-1.1493771047931522,0.2400932400932401,0.6609750854001646,1.0,13/29,30.46%,SYT9;SYT12;SYT11;SYT4;SYT7;STX1A;SYT2;KCNA2;GRK2;SYT10;SYT6;SNCA;DRD2
prerank,engulfment of apoptotic cell (GO:0043652),0.45989380819743564,1.1489188484012716,0.27734375,0.9809154898235841,1.0,2/15,0.45%,RAC2;XKR8
prerank,glutathione derivative metabolic process (GO:1901685),-0.401957244716729,-1.148862870343133,0.28125,0.6604372042731766,1.0,12/20,40.23%,GSTT1;GSTZ1;ESD;GSTA4;GSTM1;HPGDS;MGST1;GSTA3;GSTM2;MGST3;GSTM5;GSTO1
prerank,glutathione derivative biosynthetic process (GO:1901687),-0.401957244716729,-1.148862870343133,0.28125,0.6604372042731766,1.0,12/20,40.23%,GSTT1;GSTZ1;ESD;GSTA4;GSTM1;HPGDS;MGST1;GSTA3;GSTM2;MGST3;GSTM5;GSTO1
prerank,negative regulation of interleukin-10 production (GO:0032693),0.4510546165367909,1.148772087898133,0.3061594202898551,0.9797197850095961,1.0,3/16,13.00%,FCGR2B;VSIR;CD274
prerank,negative regulation of cell migration (GO:0030336),-0.268642059519936,-1.1484695752835787,0.16182572614107885,0.660557112228311,1.0,14/137,4.07%,MAGI2;NAV3;LDLRAD4;TMEFF2;PHLDB2;SULF1;LRP1;ROBO1;DPYSL3;COL3A1;IGFBP5;MCC;CLIC4;TPM1
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.34407455058543085,1.148319488163856,0.23867069486404835,0.9797216751059424,1.0,8/62,9.35%,POLR2J;ERCC3;NCBP1;ELOC;POLR2B;CCNH;GTF2H1;PCID2
prerank,regulation of double-strand break repair (GO:2000779),-0.3503242358333984,-1.1480831284360526,0.25761772853185594,0.660653358128984,1.0,11/39,17.14%,SPIRE1;SPIDR;FMN2;DEK;PML;UBR5;MGMT;RNF169;KDM1A;SIRT7;ACTR2
prerank,response to exogenous dsRNA (GO:0043330),0.4500959610116877,1.1480142571376994,0.2738301559792028,0.9792170963336299,1.0,3/18,4.17%,RALB;IFIT1;SLC3A2
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),-0.3202364863410045,-1.1479815136424008,0.25064599483204136,0.6599430421174651,1.0,20/52,24.75%,SORBS1;LRP1;EGFR;ZDHHC5;STX3;DPP10;EPHB2;EPHA3;CLIP3;DLG1;WNK3;RACK1;CNST;ZDHHC8;PIK3R1;NKD2;CLN3;PLS1;AKT1;SPTBN1
prerank,response to chemokine (GO:1990868),0.48567442762942126,1.1478578202057266,0.29944547134935307,0.9780474167023184,1.0,4/13,5.71%,OXSR1;CXCL12;LRCH1;RIPOR2
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),-0.3639645950483606,-1.1474890066897863,0.2644230769230769,0.6602573660186889,1.0,11/28,18.74%,TNS2;PID1;PRKCZ;ENPP1;APPL2;PRKCD;PIP4K2B;GRB10;PTPN2;TSC2;RPS6KB1
prerank,neuron migration (GO:0001764),-0.32273919737445167,-1.1471059174877678,0.23177083333333334,0.6603519705371605,1.0,11/48,6.81%,MAP1B;SPOCK1;NRCAM;NTRK2;AUTS2;NRP1;DNER;GPM6A;RELN;DCDC2;SEMA3A
prerank,negative regulation of cellular protein catabolic process (GO:1903363),-0.4932817745258814,-1.1470769072161744,0.3076923076923077,0.6594499171954202,1.0,2/10,3.01%,ANXA2;NELL1
prerank,intestinal absorption (GO:0050892),0.48177107785652273,1.1470737713282324,0.30694980694980695,0.9794281405387342,1.0,2/13,7.28%,UGCG;F11R
prerank,positive regulation of growth (GO:0045927),0.3482392258693799,1.1468728786037465,0.22580645161290322,0.9784493464592473,1.0,12/64,10.80%,NCBP1;DERL2;RPS6KA1;RPTOR;WFS1;CIB1;USP47;EXOSC9;LGI1;PLCB1;EIF4G2;DDX3X
prerank,smooth muscle tissue development (GO:0048745),-0.4841095887351017,-1.1467912295648264,0.3008130081300813,0.6592661216638543,1.0,6/10,29.87%,BMP4;SMO;EFEMP2;STRA6;PTCH1;MYLK
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),-0.2956483275523484,-1.1467577783226002,0.1804733727810651,0.6584145011723859,1.0,16/75,9.33%,SULF1;COL4A3;CTNNB1;GTF2I;ROCK2;HSPG2;ROCK1;HOXA5;PML;WNT4;SPARC;ADAMTS1;FOXC1;THBS2;NIBAN2;THBS1
prerank,positive regulation of response to stimulus (GO:0048584),0.3811143945120704,1.1464679463996594,0.2795341098169717,0.9782979092466565,1.0,7/40,9.37%,FCGR2B;B2M;FXR1;SIRT1;YPEL3;WNT5A;BCLAF1
prerank,anterograde axonal transport (GO:0008089),-0.34226065484645396,-1.1462340555331343,0.22597402597402597,0.6589479286693436,1.0,12/37,15.75%,DLG2;AP3B1;KIF5C;KIF1C;TRAK1;AP3S2;RAB27B;KIF3A;KIF1A;MAP1A;NEFL;KIF5A
prerank,postsynaptic membrane organization (GO:0001941),0.4574734147759393,1.1458930187835161,0.28909090909090907,0.9788009775959188,1.0,4/17,4.59%,GPHN;SHANK3;DNAJA3;APOE
prerank,regulation of vacuole organization (GO:0044088),0.44042239392671034,1.145819798098775,0.26958105646630237,0.9773699849445747,1.0,7/20,16.57%,ENO4;PIKFYVE;TBC1D12;ADPRH;TBC1D14;LAPTM4B;UBQLN2
prerank,negative regulation of RNA splicing (GO:0033119),0.44034099991852665,1.145761706463015,0.2901023890784983,0.9758268201556057,1.0,7/19,16.18%,SFSWAP;SRSF10;RPS26;SRSF4;PTBP1;SRSF7;U2AF2
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.3912726297542372,1.1453576118539566,0.27212020033388984,0.9758047348227009,1.0,7/31,9.48%,TRIB3;PIN1;DCUN1D4;BMI1;AXIN1;MAGEC2;RAB1A
prerank,exit from mitosis (GO:0010458),0.49184682682357855,1.1451949394754466,0.2828096118299446,0.9747357336323603,1.0,3/12,10.22%,PPP2R2D;CLASP2;CHMP2A
prerank,prostanoid biosynthetic process (GO:0046457),-0.42972450435993415,-1.1449534322951158,0.2989247311827957,0.6616221979263062,1.0,5/15,19.91%,PLA2G4A;PTGDS;PTGIS;PTGES;PTGS2
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.354654506966195,1.1448445932219533,0.2562111801242236,0.9744094204619512,1.0,14/56,13.49%,RPTOR;STOX1;PHB2;RGCC;FBXO5;CDK4;ANAPC7;PLCB1;DDX3X;RAD51B;ANAPC11;ANAPC4;CUL3;ANKRD17
prerank,cellular component maintenance (GO:0043954),0.4912687520162231,1.1447971843527789,0.31647940074906367,0.9728776256520445,1.0,5/12,17.55%,FYN;PRNP;ITGA3;MTMR2;INSR
prerank,monosaccharide transmembrane transport (GO:0015749),-0.4253550393094999,-1.144467318797771,0.2811791383219955,0.6619505917755995,1.0,7/16,36.94%,SLC2A12;SLC2A10;SLC50A1;SLC5A3;SLC45A3;SLC2A8;SLC2A9
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.33960233139803697,1.1439164029649507,0.2544642857142857,0.9746579904415668,1.0,8/64,9.35%,POLR2J;ERCC3;NCBP1;ELOC;POLR2B;CCNH;GTF2H1;PCID2
prerank,release of sequestered calcium ion into cytosol (GO:0051209),-0.3798580761062196,-1.1439066820008001,0.25879396984924624,0.6624617874685238,1.0,4/26,6.94%,HTR2C;ITPR1;RYR3;ERO1A
prerank,proteoglycan biosynthetic process (GO:0030166),0.3889746961288584,1.143784499739396,0.27257799671592775,0.9734519172946601,1.0,6/31,9.20%,NDST3;CSGALNACT1;XYLT1;EXT2;PXYLP1;B3GAT2
prerank,response to estrogen (GO:0043627),0.3905474980897026,1.1434845801698463,0.2677966101694915,0.9728920600983044,1.0,6/31,10.45%,ARID5A;EP300;TRIM25;CITED2;WBP2;ESR1
prerank,"DNA-templated transcription, termination (GO:0006353)",0.34047657373837525,1.142629448419974,0.24702380952380953,0.9745987367023463,1.0,17/68,18.64%,MAZ;ERCC3;NCBP1;POLR1C;CCNH;CPSF4;POLR1G;GTF2H1;PAPOLA;TBP;SCAF8;SLBP;WDR33;TAF1D;CLP1;POLR3K;SNRPD3
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.34512817279607005,1.1421880804460287,0.25696594427244585,0.9729415516853666,1.0,14/56,13.08%,NDUFAF1;NDUFAF5;NDUFB6;NDUFB4;NDUFA10;NDUFA1;NDUFS2;TIMM21;NDUFB7;TIMMDC1;NDUFV3;NDUFA8;NDUFC2;NDUFA13
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.34512817279607005,1.1421880804460287,0.25696594427244585,0.9729415516853666,1.0,14/56,13.08%,NDUFAF1;NDUFAF5;NDUFB6;NDUFB4;NDUFA10;NDUFA1;NDUFS2;TIMM21;NDUFB7;TIMMDC1;NDUFV3;NDUFA8;NDUFC2;NDUFA13
prerank,chloride transmembrane transport (GO:1902476),-0.32277102427756993,-1.1420600995325134,0.24870466321243523,0.6667592525309629,1.0,25/48,27.26%,GABRB1;SLC1A3;GLRB;GABRA2;ANO3;SLC6A1;SLC12A2;GLRA3;GABRG2;GLRA1;ANO1;ANO6;SLC12A6;GABRA5;SLC12A4;GABRG3;GABRA4;SLC12A9;GABRG1;SLC4A8;GABRA1;SLC12A7;LRRC8A;SLC12A8;SLC12A5
prerank,negative regulation of metabolic process (GO:0009892),-0.31834586332992815,-1.1419397403530263,0.21657754010695188,0.6661315717096988,1.0,21/54,24.50%,NRDC;ALDH1A1;LGR4;PLCL2;IP6K1;NPR3;ADAMTS5;ARRDC3;FIS1;ACOT11;STK11;FOXC2;RHEB;PLCL1;ZNF423;NOVA1;TFE3;ATF4;FLCN;CCDC3;NR1H2
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.34581328841230363,-1.1419159717610419,0.23809523809523808,0.6652345367018078,1.0,12/33,28.28%,TEAD1;SMAD3;TP53;TGFB1;JUN;NR3C1;GNL3;KLF5;ATOH8;GATA2;EGR1;FOXO3
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.4821951041394176,1.141545451828985,0.3171171171171171,0.9703238719799611,1.0,4/12,12.83%,ANAPC7;ANAPC11;ANAPC4;CUL3
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.4821951041394176,1.141545451828985,0.3171171171171171,0.9703238719799611,1.0,4/12,12.83%,ANAPC7;ANAPC11;ANAPC4;CUL3
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.4821951041394176,1.141545451828985,0.3171171171171171,0.9703238719799611,1.0,4/12,12.83%,ANAPC7;ANAPC11;ANAPC4;CUL3
prerank,myeloid cell activation involved in immune response (GO:0002275),0.4429038803380217,1.1404724446723928,0.29294755877034356,0.9730422276331849,1.0,3/18,6.70%,IFI35;SBNO2;SYK
prerank,hematopoietic stem cell proliferation (GO:0071425),0.4990542441020624,1.1400657033057346,0.318,0.9729763511698093,1.0,2/11,8.56%,MECOM;WNT5A
prerank,retinol metabolic process (GO:0042572),0.4652210961479869,1.1396332664981539,0.30978260869565216,0.9729835551866638,1.0,4/14,14.01%,RETSAT;RDH11;CYP1B1;RDH10
prerank,fatty acid elongation (GO:0030497),-0.4443557586361048,-1.1395784444883215,0.31721470019342357,0.6706805652360256,1.0,4/13,7.28%,HACD3;HACD1;HACD4;TECR
prerank,secondary alcohol biosynthetic process (GO:1902653),0.39132608840103394,1.138959256182376,0.272108843537415,0.9738365560085245,1.0,7/30,11.99%,EBP;INSIG1;HMGCR;PLPP6;IDI1;NSDHL;LSS
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.41793196315242986,1.1389158864627653,0.2909090909090909,0.9723350294529473,1.0,3/22,5.45%,MAP3K7;CYRIB;B2M
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.37736209664273584,-1.1388325094018308,0.25415676959619954,0.6718416730081107,1.0,8/26,11.86%,FOXP1;DAB2;KANK2;HDAC1;CRY2;CNOT9;CRY1;PER1
prerank,neural crest cell development (GO:0014032),0.3608990820979972,1.1386468176225368,0.26540284360189575,0.9717320097463504,1.0,8/44,9.12%,SEMA6A;SEMA6D;SEMA7A;CDH2;SEMA3C;TBX1;SEMA6B;SEMA4C
prerank,dendritic cell migration (GO:0036336),0.4489653118251666,1.1385894543270847,0.2953271028037383,0.9702707602815326,1.0,2/16,10.53%,PIK3CG;TRPM4
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.29288064080714016,-1.1382757928270275,0.2254335260115607,0.6724187747723913,1.0,20/73,16.69%,ROBO1;SMAD3;CFLAR;COL4A3;MAPT;CASP8AP2;F3;VCP;XDH;FAM162A;IFT57;ANP32B;CASP12;HIP1R;RACK1;HSPD1;NGF;EGLN3;TRAF2;MTCH1
prerank,regulation of type I interferon production (GO:0032479),0.3315286043007284,1.1381947208424472,0.24887556221889057,0.970191502825788,1.0,19/84,13.47%,LRRFIP1;PIN1;TNFAIP3;POLR1C;TIRAP;EP300;TRIM25;TRAF3;RELA;POLA1;TRAF3IP1;CREBBP;POLR3F;OTUD5;DTX4;NLRP4;NLRC5;RNF216;POLR3B
prerank,negative regulation of smooth muscle cell migration (GO:0014912),-0.44684417194958703,-1.138101772553554,0.28289473684210525,0.6719547547135745,1.0,3/14,4.07%,LRP1;IGFBP5;TPM1
prerank,protein localization to chromosome (GO:0034502),0.38455650111900286,1.1380821318577312,0.28960817717206133,0.9689448277578963,1.0,12/34,18.79%,SLF1;BOD1;ACD;TPP1;ESR1;TNKS;TERF2IP;ATR;SLF2;XRCC4;TNKS2;ATRX
prerank,regulation of amyloid-beta formation (GO:1902003),-0.34148887906188596,-1.1380253324571892,0.2566137566137566,0.6712131142478543,1.0,11/34,12.55%,IGF1;SLC2A13;LRRTM3;NTRK2;RTN1;ROCK2;SORL1;ROCK1;BIN1;IFNGR1;GSAP
prerank,histone modification (GO:0016570),-0.27285210937241605,-1.1376720172141632,0.17725752508361203,0.6712185707446015,1.0,31/109,16.66%,EYA2;EYA1;PRDM5;MIER1;HDAC4;NSD3;TBL1XR1;UBE2N;UFL1;HDAC1;SIRT2;KDM4A;PHF20;MORF4L2;PRKCD;ENY2;MTA3;HLCS;MIDEAS;MORF4L1;HUWE1;EHMT2;MTA1;TBL1X;RCOR3;PHC1;MAP3K12;SIRT7;SGF29;TAF6;USP16
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),-0.4480634363256093,-1.1376048330840907,0.30616740088105726,0.6704364462397094,1.0,8/14,27.57%,LPIN1;CHKA;SLC27A1;ETNK2;PCYT2;LPIN2;CHKB;LPIN3
prerank,positive regulation of protein localization to cell periphery (GO:1904377),-0.3178890831246611,-1.137073778136507,0.2506811989100817,0.6709888221970265,1.0,13/52,13.20%,SORBS1;LRP1;EGFR;ZDHHC5;EPB41L2;STX3;EFCAB7;DPP10;EPHB2;EPHA3;CLIP3;DLG1;WNK3
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.4381692908725195,1.1369211996468274,0.29942418426103645,0.9718957702119404,1.0,5/19,11.20%,AEN;HIPK2;EP300;SIRT1;CDIP1
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.29719641499927735,1.1368120919385405,0.2304635761589404,0.9706035888464246,1.0,33/161,14.00%,PSMB10;PSMC4;PSMB6;GSK3A;PSMD8;PSMD5;PSMD12;FRZB;RUVBL2;GREM1;TPBG;PSMD11;APOE;SOX2;PSMB4;PSMC1;CCDC88C;PFDN5;AXIN1;WNT5A;SOX13;LATS2;PSMC2;PSMD2;TMEM131L;TLE4;CUL3;PSMD14;DDIT3;PSMC6;PSMD1;APC;PSMB1
prerank,positive regulation of endothelial cell migration (GO:0010595),-0.2891946325291166,-1.136487632535806,0.20754716981132076,0.6717266765305565,1.0,31/84,25.88%,FOXP1;ANXA3;SASH1;NRP1;FGF1;MAPK14;PLPP3;BMP4;P2RX4;ROCK2;SPARC;SMOC2;THBS1;NRP2;LGMN;FOXC2;RHOB;GPLD1;TGFB1;SEMA5A;MET;BMPR2;AAMP;HSPB1;PRKD1;VEGFA;ITGB1BP1;AKT1;ATOH8;GATA2;STAT5A
prerank,positive regulation of histone deacetylation (GO:0031065),0.4895690908081107,1.1361360360962844,0.3278985507246377,0.9716532506900669,1.0,4/12,11.22%,PRKD2;AKAP8L;ING2;CTBP1
prerank,response to peptide hormone (GO:0043434),0.3711022970014018,1.1357016485406504,0.28640776699029125,0.9717497658207761,1.0,10/43,11.54%,PCK1;SORT1;SRC;ZFP36L1;SIRT1;EPM2AIP1;EIF2B3;TSC1;ZBED3;GNAI1
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.3440753523276658,1.1356354099468056,0.2661764705882353,0.9703494531491769,1.0,12/62,10.96%,TXNDC12;CXCL12;BCL2L2;SRC;PTTG1IP;SIRT1;SOD2;MDM2;PARK7;CCAR2;DDX3X;HYOU1
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),-0.328737508808622,-1.1351738159581657,0.2689295039164491,0.6743142206588132,1.0,18/46,21.78%,NRDC;ALDH1A1;LGR4;PLCL2;IP6K1;NPR3;ADAMTS5;ARRDC3;ACOT11;STK11;FOXC2;RHEB;PLCL1;ZNF423;NOVA1;TFE3;ATF4;FLCN
prerank,icosanoid biosynthetic process (GO:0046456),-0.48976144762206864,-1.1349074832492847,0.3078556263269639,0.6740241795198084,1.0,1/10,1.27%,PLA2G4A
prerank,regulation of protein binding (GO:0043393),0.3136037414740753,1.1348519006045439,0.23504867872044508,0.9718673448085872,1.0,24/114,13.20%,TRIB3;RALB;PIN1;TIAM1;BTBD1;ACTB;PSME3IP1;HIPK2;IFIT1;PPP2CA;B2M;CDKN1A;MAPK8;CARD16;SPPL3;EPB41;AKTIP;PARK7;CLDN5;TERT;APP;LDLRAP1;USP33;HDAC5
prerank,positive regulation of intracellular protein transport (GO:0090316),0.30641979500061484,1.134838579128238,0.20713305898491083,0.9702671653471775,1.0,19/144,7.75%,RAC2;GSK3A;PRR5L;RBM22;TRIM28;SAE1;DMAP1;TCAF1;HDAC3;VPS11;FYN;ZFAND1;CIB1;MAPK8;ICE1;YWHAB;RAPGEF3;TMEM30B;RUFY3
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.398150745207777,-1.1343768041686302,0.2737556561085973,0.6745763374285115,1.0,6/20,17.31%,LBP;IRAK1;IL18;PTPN22;TGFB1;MTDH
prerank,negative regulation of cytokine production (GO:0001818),0.2988254755073379,1.1342391783758095,0.22005208333333334,0.9708802233423286,1.0,27/163,13.40%,CIDEA;PIN1;LEF1;PTPRC;TNFAIP3;FCGR2B;RPS6KA4;MAP2K5;HDAC7;HDAC9;RPS6KA5;NPTN;RGCC;PPP1R11;NLRC3;CUEDC2;TRIM25;CD84;VSIR;TRAF3IP1;PRNP;OTUD5;MAPKBP1;CD274;NLRC5;RNF216;DDIT3
prerank,cholesterol metabolic process (GO:0008203),0.3345884473392373,1.134225459926302,0.25522388059701495,0.9692825109232287,1.0,13/68,12.68%,EBP;INSIG1;HMGCR;PLPP6;APOE;SOAT1;PPARD;SNX17;OSBPL1A;IDI1;NSDHL;LSS;LDLRAP1
prerank,actin filament bundle assembly (GO:0051017),-0.35842304865486524,-1.1341371666593156,0.2755905511811024,0.6742610936317232,1.0,13/33,26.91%,CALD1;PAWR;DPYSL3;LIMA1;NEDD9;EZR;BAIAP2L1;MYO1B;ADD2;PLS1;DMTN;FAM107A;MICAL1
prerank,transport along microtubule (GO:0010970),0.48842663284666527,1.134127027750308,0.30952380952380953,0.9679891300366985,1.0,6/13,14.75%,DYNC1I1;COPG2;APP;SPG11;COPG1;DYNC1I2
prerank,establishment of protein localization to plasma membrane (GO:0061951),-0.33748852145202746,-1.1341171208957832,0.2601626016260163,0.6733559307658288,1.0,13/36,16.59%,ANK3;VAMP5;MACF1;RILPL1;RAB31;GGA2;OPTN;AFDN;VAMP2;BBS2;NECTIN3;GOLGA7;GGA3
prerank,pulmonary valve development (GO:0003177),-0.40844383164840226,-1.134071049664125,0.29540481400437635,0.6725316758677572,1.0,5/18,8.66%,ROBO2;NOTCH2;ROBO1;BMP4;SMAD6
prerank,phosphatidylinositol-mediated signaling (GO:0048015),-0.3028910028273717,-1.1337916623348812,0.2347560975609756,0.6723515822201416,1.0,20/69,16.54%,IGF1;OGT;PDGFRB;PLCL2;RHOA;PLCE1;PIK3C2B;SIRT2;PIK3C3;MYO16;PDGFRA;PLCD3;EZR;PLCB3;GAB2;PLCH1;PLCL1;NGF;EXOC1;PLCD1
prerank,positive regulation of lipid storage (GO:0010884),0.4245079739893065,1.1336633718556839,0.28547008547008546,0.9682137530380898,1.0,2/21,3.44%,CIDEA;FITM2
prerank,defense response to symbiont (GO:0140546),0.3209480027047374,1.1336390437520067,0.2619718309859155,0.9666731539748367,1.0,19/92,13.09%,PTPRC;IFNLR1;IFITM2;IFIT1;RNASE6;MLKL;IFITM3;CNOT7;IFITM1;RELA;NCBP3;SERINC5;SERINC3;ATG7;IFI27;BNIP3L;AGBL5;IRF2;NLRC5
prerank,negative regulation of cell differentiation (GO:0045596),-0.2592327744486204,-1.1335363662004574,0.14666666666666667,0.6721353275869325,1.0,38/181,14.13%,LDLRAD4;CNTN4;RANBP3L;ADAMTS12;EGFR;SMAD3;TGFBR1;COL5A1;BMP5;COL5A2;BMP7;ADGRV1;SIRT2;EFEMP1;MED1;BMP4;MEIS2;CRIM1;ENPP1;OSR1;PPARA;SKI;XDH;TMEM64;LRP5;ABCA5;CDC73;SMAD6;ANP32B;CDK6;SEMA4D;TBX3;LIMD1;ABCA1;NELFB;WNT9A;RORA;IGF2
prerank,inner ear morphogenesis (GO:0042472),-0.38753633546326083,-1.1333844733079521,0.2608695652173913,0.6715885288544583,1.0,6/22,18.72%,FGFR2;ZIC1;TTC39C;EPHB2;TBX18;SIX1
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.37374343254455816,1.1330984433409919,0.2757475083056478,0.9671613905778558,1.0,8/39,12.02%,CISH;PIK3CG;PIK3C2G;EFR3B;SMG1;PI4KA;PIK3CD;IP6K2
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.4318124253091067,1.132882506111615,0.2791519434628975,0.9664542035101458,1.0,5/21,4.52%,NDST3;XYLT1;SGSH;EXT2;HS6ST1
prerank,regulation of defense response to virus (GO:0050688),0.46366854182627465,1.1326564938524533,0.30727272727272725,0.9657524453983974,1.0,6/14,16.99%,TNFAIP3;IFNLR1;TRAF3;TRAF3IP1;RNF216;ZMPSTE24
prerank,positive regulation of smoothened signaling pathway (GO:0045880),-0.39730769333379123,-1.132278706585322,0.2817551963048499,0.6737046705452174,1.0,13/21,38.63%,SMO;DCDC2;EVC;GLI1;SFRP1;DLG5;TTC23;PDCL;KIF7;GAS8;ULK3;STK36;RAB34
prerank,regulation of protein localization to cell surface (GO:2000008),0.3855142891286389,1.1322693345091341,0.28171334431630973,0.965597592884591,1.0,8/33,8.20%,NEDD4L;RAB11B;GOPC;LEPROTL1;RIC3;BDNF;RAB11FIP5;TMEM35A
prerank,small GTPase mediated signal transduction (GO:0007264),0.31553208463837645,1.132019936626727,0.22687861271676302,0.9649803233058132,1.0,24/103,12.98%,RALB;TRIM28;TIAM1;PLK2;NUCB2;RERG;NRAS;RRAD;RASGRP3;RALA;CDKN1A;KRIT1;GNB1;GRAP;CCDC88C;ARHGEF18;RAPGEF5;RAPGEF6;PARK7;NF1;CRKL;G3BP2;RIT1;RRAGC
prerank,regulation of steroid metabolic process (GO:0019218),0.4152733830201364,1.1318217502956684,0.2874354561101549,0.9641416350179559,1.0,4/23,6.46%,PANK2;NR5A1;APOE;LAMTOR1
prerank,glucose homeostasis (GO:0042593),0.32715004139367476,1.1317164532306019,0.25181950509461426,0.9629096131708891,1.0,12/83,11.08%,PCK1;HECTD4;PYGL;SELENOT;WFS1;ADIPOR2;SIRT1;CYB5R4;PARK7;PRKAA2;BAD;ADIPOR1
prerank,regulation of cell-cell adhesion (GO:0022407),0.3734440553851665,1.131572196952362,0.2687074829931973,0.961910488090587,1.0,9/39,10.27%,PTPRR;PTPRG;SRC;MAGI1;SMAD7;MINK1;CD47;PODXL;CITED2
prerank,natural killer cell activation (GO:0030101),-0.38242257420596537,-1.1315572945330548,0.28735632183908044,0.674773388349206,1.0,8/23,22.17%,PBX1;AXL;TOX;KAT7;ELF4;RABL3;PRDX1;BAG6
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.3502481963796742,1.1314074472084055,0.27967479674796747,0.9609646012658525,1.0,10/54,12.41%,PRCP;PRKD2;APOE;RGCC;SIRT1;PLCG1;ACVRL1;NOS3;NF1;SP1
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.3392664608232659,-1.1304700613652467,0.2846715328467153,0.676966308544734,1.0,14/37,25.06%,IGF1;IGFBP5;TPM1;TAFA5;CDKN1B;ADAMTS1;GJA1;JUN;BMPR1A;DNMT1;MMP2;EFEMP2;TGFB3;MEF2D
prerank,regulation of collagen biosynthetic process (GO:0032965),-0.40679419675145584,-1.1301709993551465,0.28741092636579574,0.6768954979179531,1.0,7/19,24.21%,VIM;BMP4;WNT4;TGFB1;EMILIN1;CREB3L1;TGFB3
prerank,B cell differentiation (GO:0030183),0.36311681256197054,1.1301412974944878,0.2805071315372425,0.9642337588498097,1.0,6/46,10.07%,DCAF1;PTPRJ;PTPRC;HDAC9;CEBPG;KLF6
prerank,metal ion homeostasis (GO:0055065),0.37678301063917424,1.1301167678899677,0.29252782193958665,0.9627232833932746,1.0,4/40,5.19%,SLC12A1;SLC7A8;TMTC2;WFS1
prerank,basement membrane organization (GO:0071711),-0.44024774677537215,-1.1296792815357641,0.29958677685950413,0.6773039098775039,1.0,5/14,17.07%,NTNG1;FLRT2;NID2;NTN4;LAMB1
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.29294952444596767,-1.129560988102375,0.2166172106824926,0.6766613259879468,1.0,16/79,10.48%,SULF1;ADAMTS12;NBL1;BMPER;SMURF2;SMAD4;SULF2;VWC2L;CRIM1;SORL1;SKI;HTRA3;SMAD6;NIBAN2;THBS1;SPART
prerank,regulation of cell motility (GO:2000145),-0.271854808581172,-1.1295518332768413,0.2,0.6757367630567175,1.0,35/121,17.49%,ERBB4;SPOCK3;PLXNA2;EGFR;LMO4;FBLN1;FGF1;MACF1;RHOA;FLNA;AMOTL2;ROCK2;LMNA;ROCK1;LDB1;CFAP20;AKT2;SRCIN1;DOCK10;CAVIN1;SPATA13;CDK6;SGK1;PRAG1;TTBK2;RHOB;TBCCD1;PLXND1;PLXNB2;RAF1;PLXNC1;TGFB1;ABL2;NEXN;DIAPH1
prerank,cellular response to ketone (GO:1901655),0.37944516639864595,1.129452193557933,0.27318718381112983,0.9636742763382324,1.0,4/35,6.32%,PCK1;PTGER2;SRC;GNB1
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.2893570059419073,-1.1293545035265222,0.20909090909090908,0.6753642179238712,1.0,24/86,21.78%,BMP6;SULF1;DAB2;FOXD1;TGFBR1;BMP5;ZEB2;BMP7;SMAD4;BMP4;SNW1;ACVR1;THBS1;NUP93;STK11;ACVR1B;TGFB1;BMPR1B;ZNF423;BMPR1A;BMPR2;TWSG1;CCN1;FLCN
prerank,liver development (GO:0001889),0.384921748134504,1.1290479340320438,0.2887096774193548,0.9636573913505981,1.0,6/32,13.38%,PCK1;GFER;CEBPG;CITED2;NF1;LSR
prerank,organic cation transport (GO:0015695),0.4274918932167784,1.1287291471444534,0.298932384341637,0.9632610028907143,1.0,3/20,7.94%,SLC5A7;SLC44A1;SLC25A26
prerank,blood vessel morphogenesis (GO:0048514),0.3475623995734578,1.1287035921571673,0.2909090909090909,0.9617770423616024,1.0,13/54,12.06%,SLC1A1;CDH2;EGFL7;RAMP2;TBX1;SYK;SMAD7;HEY2;RASIP1;RBPJ;CYP1B1;FLT1;NF1
prerank,DNA repair (GO:0006281),0.28156588220766054,1.128702026767676,0.18996415770609318,0.9602037509410338,1.0,69/284,17.81%,ERCC3;ZRANB3;ABRAXAS1;RAD18;TRIM28;ALKBH2;PNKP;ERCC4;RAD1;HPF1;XRCC1;CIB1;TENT4A;POLK;APLF;MAPK8;TDG;ACTR8;POLE;PMS2;SIRT1;ACTR5;DCLRE1B;UBE2V2;EYA3;POLD3;USP47;MLH1;PMS1;GTF2H1;SPRTN;POLA1;RAD23A;RFWD3;EXD2;MSH3;PARK7;UBE2V1;ASCC3;RAD51B;SMUG1;APTX;HUS1;KMT5B;PWWP3A;NBN;DOT1L;TRRAP;MPG;BRCC3;PPP5C;CHEK2;FANCL;NSD2;BRIP1;BACH1;INO80;FTO;ATR;ENDOV;WDR33;XRCC4;SETD2;PRKDC;ATXN3;NPM1;DCLRE1C;POLH;RAD23B
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.45241512995908606,1.128594632372283,0.31053604436229204,0.9590700387814602,1.0,5/17,10.76%,SOD1;APOE;LPCAT3;MBTPS1;ERLIN2
prerank,regulation of phagocytosis (GO:0050764),0.3532082010468868,1.1284890315663871,0.26851851851851855,0.9579445088636962,1.0,12/53,17.51%,PTPRC;FCGR2B;CAMK1D;LMAN2;SYK;MERTK;CD47;SCARB1;CYBA;GAS6;CALR;RAB27A
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.39236492653145194,-1.1280297456639414,0.28743961352657005,0.67819514059867,1.0,4/22,6.92%,ANK2;AKAP6;ATP1B1;HTT
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.5059074259225405,1.1279591678233665,0.3204633204633205,0.9583939606615313,1.0,2/10,8.56%,OXSR1;WNT5A
prerank,gastrulation (GO:0007369),-0.4253689550069246,-1.127948914959568,0.2925170068027211,0.6774685451188006,1.0,3/15,12.24%,GPC3;LRP5;UGDH
prerank,regulation of apoptotic signaling pathway (GO:2001233),0.3844662693196907,1.1278598682210226,0.27580645161290324,0.9572033850226269,1.0,10/36,15.61%,MAZ;NR4A2;SGMS1;CRADD;BDNF;RPS3;PTPMT1;ING5;CSNK2A2;TPD52L1
prerank,ERBB2 signaling pathway (GO:0038128),0.38924636062409745,1.1276975921453558,0.28125,0.9562643701872249,1.0,6/31,8.78%,PTPRR;PTPN18;SRC;CDC37;PTPN12;ERBIN
prerank,proteasomal protein catabolic process (GO:0010498),0.2898094645110763,1.1273332635699118,0.21548387096774194,0.9560598839424351,1.0,45/201,15.39%,PSMB10;PSMC4;PSMB6;GSK3A;PSMD8;PSMD5;PSMD12;FEM1C;SPOP;UBXN11;RFFL;BIRC2;PSMD11;NEDD4L;NHLRC1;PSMB4;PSMC1;COP1;SIRT1;CLOCK;RNF187;CRBN;RBCK1;MDM2;RAD23A;PSMC2;UBE3D;PSMD2;ZNRF1;SPOPL;IFI27;PLAA;CUL3;PSMD14;RNF216;DDIT3;PSMC6;PSMD1;FAF1;APPBP2;PSMB1;TRIM3;NHLRC3;UBE2G1;RMND5A
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.4250473812528609,1.1272115954737272,0.31866197183098594,0.9549483764344565,1.0,4/21,7.72%,OSBPL10;PLAAT3;LPCAT3;MBOAT1
prerank,COPII-coated vesicle cargo loading (GO:0090110),-0.4497362349704704,-1.1255431499835833,0.3270042194092827,0.6832219671248179,1.0,5/14,16.96%,SEC31A;SEC24D;SEC23A;SEC24C;SEC24A
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.29954351666076107,-1.1254812432806418,0.2638888888888889,0.6824183980447303,1.0,15/63,17.45%,IGF1;CFLAR;TGFBR1;CYLD;BMP4;PML;HTT;ACVR1;THBS1;DEPTOR;SIAH2;MADD;TRAF2;TCF7L2;SCG2
prerank,mitochondrial translational termination (GO:0070126),0.32809140941238474,1.125480861130652,0.2679083094555874,0.9598858346702903,1.0,13/88,12.45%,MRPS22;MRPS2;MRPS33;MRPL23;MRPL24;MRPL18;MRPL38;MRPS12;MRPL20;MRPL52;MRPS15;MRPS24;MRPL48
prerank,cell junction assembly (GO:0034329),-0.2802527924618938,-1.1253596119501323,0.1978021978021978,0.6818015385671321,1.0,41/100,23.54%,SDK1;CDH10;NRXN1;KIRREL3;NRCAM;RYK;DNER;DSCAM;RHOA;TLN1;NLGN2;FLNA;GPM6A;CTNND2;CDH11;SDK2;TLN2;CDH7;GJC1;NLGN1;ARVCF;CDH1;FN1;ILK;NRXN2;OBSL1;PLXND1;CTNND1;SHANK2;CDC42;CDH9;CDH8;CDH19;SLITRK1;DBNL;FLCN;FLNC;DCHS1;NLGN3;FARP1;RAB29
prerank,keratan sulfate biosynthetic process (GO:0018146),-0.37720081944512057,-1.125136238915798,0.29411764705882354,0.681492392114651,1.0,15/26,38.13%,B4GALT1;OGN;B4GALT6;SLC35D2;ST3GAL4;PRELP;LUM;B4GALT4;CHST2;OMD;B4GALT3;B4GALT2;B4GALT5;FMOD;CHST1
prerank,negative regulation of ATPase activity (GO:0032780),0.44831640017375946,1.125116857579052,0.31608133086876156,0.9597368958501167,1.0,3/16,8.86%,IFIT1;SIRT1;TSC1
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.46752369459647103,1.1247889242740505,0.30018083182640143,0.9593942464627,1.0,5/15,14.70%,PTTG1IP;SIRT1;MDM2;ING2;CD44
prerank,regulation of axon guidance (GO:1902667),-0.4800185090985849,-1.124534170765339,0.3425531914893617,0.6822146660239807,1.0,6/10,25.48%,NRP1;ZSWIM8;YTHDF1;ZSWIM4;VEGFA;ZSWIM5
prerank,positive regulation of cell communication (GO:0010647),-0.3626450723297713,-1.124501178965312,0.29357798165137616,0.6813577556549613,1.0,9/28,18.91%,ANK3;RIMS1;WLS;DLG4;CLSTN2;ILK;PTPN23;KCTD13;CLSTN3
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.3990060673752095,1.1239130474715815,0.2922297297297297,0.9613513385745965,1.0,7/26,16.11%,RRM2B;ALG6;TPI1;ALG8;ST8SIA6;RRM1;GBGT1
prerank,blood vessel endothelial cell migration (GO:0043534),-0.38998461790785033,-1.1237959650758353,0.2942477876106195,0.6823036722746503,1.0,10/22,25.91%,ROBO1;NRP1;EFNB2;PIK3R3;EPHB4;GPLD1;VEGFA;EMP2;AKT1;NR4A1
prerank,regulation of supramolecular fiber organization (GO:1902903),-0.38434358625092757,-1.1233403153241162,0.32175925925925924,0.6825979713371126,1.0,5/22,3.74%,MAP2;MAP1B;AEBP1;AKAP13;MAPT
prerank,regulation of actin filament-based movement (GO:1903115),-0.49002014229895546,-1.122932374092422,0.30985915492957744,0.6827829244061715,1.0,4/10,15.64%,ANK2;PDPN;SRI;PDE4B
prerank,regulation of axon extension (GO:0030516),-0.33602986638191473,-1.1222392905440557,0.2701298701298701,0.6837802845148861,1.0,8/37,6.89%,MAP2;NRCAM;PTPRS;MAPT;MACF1;SHTN1;SEMA3A;CTTN
prerank,oligodendrocyte development (GO:0014003),-0.4327412581342082,-1.1214329192482453,0.32112068965517243,0.6850841696059762,1.0,10/15,33.89%,PLP1;B4GALT6;TPPP;CNTNAP1;EIF2B5;EIF2B2;EIF2B4;MYRF;B4GALT5;NSUN5
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.34559521146419825,1.1211154486314092,0.3042121684867395,0.9704479529894617,1.0,17/54,17.96%,PLK2;CNOT11;CDKN1A;EP300;CRADD;CNOT2;RGCC;CNOT7;MDM2;CARM1;CNOT6;CHEK2;CNOT1;CNOT6L;CNOT10;BAX;RPL26
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.3200313914582085,-1.1205192807872058,0.25668449197860965,0.686699498399277,1.0,7/46,5.33%,ATP1A2;DGKI;NRXN1;GRM5;TSHZ3;NLGN2;RELN
prerank,actin filament bundle organization (GO:0061572),-0.34792818360235694,-1.1202265692124933,0.3010204081632653,0.686621855233445,1.0,5/33,4.60%,CALD1;PAWR;DPYSL3;LIMA1;NEDD9
prerank,regulation of secretion by cell (GO:1903530),-0.3094889406226319,-1.1201392447650174,0.266304347826087,0.685934600240568,1.0,27/54,35.93%,RIMS1;RAB3C;SNCAIP;RAB8B;SCG5;SYN1;STXBP5;ANXA1;VAMP2;RAB8A;RHBDF1;P3H1;CPLX1;VAMP8;LLGL1;CAMK2A;RAB13;DNAJC1;KCNMB4;RAB3D;LGI3;RAB21;LLGL2;RAB3B;CPLANE2;RAB3A;CPLX2
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.38258095345389737,-1.1200543658777935,0.3157894736842105,0.6851846277258135,1.0,4/23,5.00%,ERBB4;PIBF1;KIT;GHR
prerank,negative regulation of immune system process (GO:0002683),0.4532024447770213,1.1199079622512766,0.3228200371057514,0.973521479310873,1.0,3/16,9.31%,FCGR2B;HOXA7;LYN
prerank,regulation of interleukin-1 production (GO:0032652),-0.42985594457016185,-1.1198773011022047,0.3282275711159737,0.6847653503939101,1.0,3/15,12.80%,FOXP1;ANXA1;SIRPA
prerank,sodium ion homeostasis (GO:0055078),-0.38695289352325113,-1.1196743900625723,0.31422018348623854,0.6843932228558469,1.0,6/21,9.45%,ATP1A2;ATP1B1;ATP1B3;SLC12A2;ATP1A1;ATP1B2
prerank,cytosolic transport (GO:0016482),0.3124232176682128,1.1195351963253362,0.2573426573426573,0.9733723126171582,1.0,35/108,18.89%,VPS50;HEATR5B;SORT1;PREPL;VPS29;RAB7A;VPS26A;TBC1D10B;GOSR2;AP1G1;RAB6B;PIKFYVE;RAB6A;RAB14;AKTIP;SNX1;VPS53;GCC2;DOP1B;RBSN;MYO1D;ERC1;TRIM27;ANKRD27;TBC1D23;CORO7;VPS35;HOOK3;SNX16;BECN1;GAK;KIF16B;HEATR5A;GOSR1;EVI5
prerank,skeletal muscle organ development (GO:0060538),-0.3700676136565896,-1.1194735084999081,0.2619589977220957,0.6840067891538877,1.0,7/26,24.63%,SVIL;CFLAR;IGSF8;LARGE1;SIX1;STRA6;BASP1
prerank,response to alcohol (GO:0097305),-0.35962186428163123,-1.1192678791198354,0.2702702702702703,0.6836611703595973,1.0,5/27,7.73%,TGFBR3;GRIN2B;TGFBR1;TGFBR2;GLRA1
prerank,positive regulation of cellular amide metabolic process (GO:0034250),-0.28797045964493406,-1.1188502238282767,0.2147239263803681,0.6838892828340787,1.0,26/80,19.13%,PLD1;SLC2A13;SAMD4A;LRRTM3;VIM;ROCK2;PRKCD;POLDIP3;PRR16;EIF3C;YTHDF1;NIBAN1;THBS1;SMPD3;EEF2;RBM3;IFNGR1;GSAP;RACK1;PLXNB2;METTL5;NAT10;PCIF1;UPF3A;RPS6KB1;CIRBP
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),-0.4302348671151542,-1.1187033045368326,0.3125,0.6833632353361184,1.0,10/15,28.53%,UST;DSE;VCAN;CSGALNACT2;CSPG4;DSEL;BGN;DCN;CSPG5;CHST12
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.327821889980057,1.1186122976692006,0.2834067547723935,0.9754039106602392,1.0,13/72,11.82%,MAZ;PIK3CG;CBL;PIK3AP1;SRC;TEK;SELP;SIRT1;IRS2;LYN;FLT1;PIK3CD;PIK3R5
prerank,ameboidal-type cell migration (GO:0001667),0.3503871878668629,1.1186090131974873,0.304552590266876,0.9738607487259121,1.0,10/51,9.74%,SEMA6A;SEMA6D;SEMA7A;PKN3;SEMA3C;TBX1;AMOTL1;SEMA6B;SEMA4C;PKN1
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.34731795280387767,1.1181011875299252,0.30064308681672025,0.9742878158771777,1.0,8/50,10.50%,ACTB;STOX1;CDC37;CCNH;CDKN1A;GTF2H1;CCNG2;BCCIP
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.4912812488149538,1.117983955986639,0.33805668016194335,0.9732059510797113,1.0,1/10,0.88%,SEMA6A
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.4014369224056266,1.1179031514471323,0.30318257956448913,0.9719897753869537,1.0,9/27,17.21%,SLC7A8;SLC1A1;SLC36A4;SLC3A2;SLC1A2;SLC25A12;SLC38A5;SLC25A38;SLC7A5
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.4563674316919729,-1.117541607103534,0.3368869936034115,0.685728370456881,1.0,4/12,8.17%,DOCK5;IGFBP5;TPM1;ADAMTS1
prerank,organic acid transport (GO:0015849),-0.2789347189868083,-1.1173813827933343,0.2251655629139073,0.6852134325622457,1.0,23/94,17.61%,SLC7A11;ACSL1;SLC6A13;SLC13A3;SLC7A2;PDPN;LRRC8D;SLC26A7;SLC7A14;SLC1A5;SLC6A12;SLC25A32;RXRA;SLC27A1;SLC6A15;NCOA1;SLC25A47;SLC22A6;STARD5;ATP8B1;SLC19A1;SLC16A10;SLC5A6
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.34525781532311234,-1.1170317807815862,0.29802955665024633,0.6853258045840748,1.0,10/32,15.56%,NAV3;MAP2;EML2;HDGFL3;STMN2;TTBK2;CLIP3;TAOK1;STMN1;TUBB4A
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.3845601013227733,1.11699799756207,0.30318257956448913,0.973949511545555,1.0,8/30,13.61%,TNFAIP3;RFFL;TNFRSF10B;ICAM1;PARK7;DDX3X;NOS3;FAIM
prerank,positive regulation of lyase activity (GO:0051349),-0.4334777368467593,-1.1166090575918506,0.3393258426966292,0.6856199373994083,1.0,3/14,3.09%,CACNA1C;CACNA1D;STIM1
prerank,aerobic electron transport chain (GO:0019646),0.33697766393873,1.1165068474369404,0.299079754601227,0.9742551982845227,1.0,19/68,14.40%,CYCS;NDUFAF1;UQCC3;NDUFB6;NDUFB4;COX6B1;NDUFA10;NDUFA1;NDUFS2;COX5A;SDHA;NDUFB7;COX15;UQCRB;NDUFV3;NDUFA8;NDUFC2;NDUFA13;COX10
prerank,positive regulation of transferase activity (GO:0051347),0.2967072378917108,1.1163449821420077,0.24833110814419226,0.9733014697607855,1.0,28/142,11.69%,SERINC1;MAP2K7;MAPK3;GSK3A;TRIB3;PIN1;PNKP;GREM1;CCT2;DCUN1D4;TEK;MAP3K4;UBE2I;DBI;RET;EPHA5;BMI1;AXIN1;MAGEC2;EPM2AIP1;ACD;MERTK;CSF1R;TIE1;SERINC5;NEK7;FLT1;TNKS
prerank,regulation of glucose transmembrane transport (GO:0010827),0.4344063741596654,1.1161479257666167,0.325497287522604,0.9724775575918321,1.0,3/18,8.35%,RSC1A1;TRIB3;SLC2A1
prerank,regulation of gluconeogenesis (GO:0006111),-0.36486607211230787,-1.1160736305204506,0.27419354838709675,0.6862102507953775,1.0,14/27,23.90%,OGT;DDB1;PPARGC1A;SIK1;ARPP19;CRY1;SIRT7;SELENOS;USP7;PTPN2;ZNF692;DGKQ;CLK2;C1QTNF3
prerank,intracellular protein transport (GO:0006886),0.2798287259096606,1.1158826046059804,0.21983273596176822,0.9720130245586206,1.0,62/304,13.25%,SURF4;ARF5;ARL5C;ARL4D;EVI5L;RAB5C;CDC37;TBC1D30;TBC1D8;SNX8;MMP12;VPS29;RAB7A;TBC1D9;PHB2;TMED4;VPS26A;SEC23IP;RAB43;TBC1D10B;PTTG1IP;USP6NL;TBC1D4;SYK;RAB6B;NAPA;TMED5;NXT1;IFT22;RABGAP1L;SNX17;RAB6A;NUP50;DESI1;TMED10;RAB14;ACD;XPO5;RANBP17;DNAJC27;TBC1D12;SNX1;ARL5B;ARF1;AP4S1;RAB1A;CCHCR1;TBC1D25;KIF13A;MAIP1;TMED7;SCFD1;RAB5B;RAB22A;STRADB;ADPRH;ARCN1;E2F3;TBC1D14;XPO1;YWHAH;RABGAP1
prerank,organelle fission (GO:0048285),0.4127357730162032,1.115833140183717,0.3216168717047452,0.9706608602736876,1.0,7/24,17.28%,PEX11G;DNM3;MTFR1;ACOT8;MIEF1;DNM1L;CORO1C
prerank,endomembrane system organization (GO:0010256),0.29069462654612316,1.115647371402034,0.24025974025974026,0.9698449990433073,1.0,29/178,10.19%,SURF4;SYNE1;SMPD4;LYSMD3;GORASP2;EXOC8;CLASP2;LEMD3;LMAN2;ATL1;VPS11;TMED4;SEC23IP;RAB43;SYNGR2;TRAPPC8;LAMTOR1;USP6NL;ARHGEF7;TRIP11;VMP1;TMED5;TMED10;REEP3;AKTIP;RAB1A;GOLPH3L;TRAPPC11;DOP1B
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.3741631778852351,1.115478699311339,0.2996688741721854,0.9689644075573397,1.0,4/38,4.40%,RAC2;GSK3A;SAE1;VPS11
prerank,positive regulation of locomotion (GO:0040017),0.40011359655092776,1.115408499987652,0.30185497470489037,0.967720608661505,1.0,2/27,0.42%,PHPT1;SPOCK2
prerank,smoothened signaling pathway (GO:0007224),-0.34284480464372585,-1.1152909823475692,0.29770992366412213,0.6875131756559006,1.0,8/32,11.86%,GLI2;GLI3;CC2D2A;SMO;EVC2;HIPK1;ARL13B;TTBK2
prerank,regulation of glycolytic process (GO:0006110),-0.30023350612015287,-1.1150467829471666,0.24024024024024024,0.6872304930780632,1.0,14/68,11.55%,ZBTB20;PRKAG2;IGF1;OGT;HDAC4;PRKAG1;NUPR1;NUP205;PPARA;NUP155;NUP188;PFKFB4;NUP88;NUP93
prerank,defense response to virus (GO:0051607),0.3119742133871917,1.1149765163790761,0.27977839335180055,0.9678181247698294,1.0,20/100,13.09%,PTPRC;IFNLR1;IFITM2;IFIT1;RNASE6;MLKL;PHB2;IFITM3;CNOT7;IFITM1;RELA;NCBP3;SERINC5;SERINC3;ATG7;IFI27;BNIP3L;AGBL5;IRF2;NLRC5
prerank,positive regulation of interferon-gamma production (GO:0032729),0.35995557630333325,1.114875918429079,0.2992,0.9666626687620864,1.0,4/48,6.48%,IL1R1;PDE4D;CYRIB;CEBPG
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),-0.3271807126303937,-1.1148207926539928,0.26666666666666666,0.6869304574089352,1.0,18/38,37.05%,SMAD3;P2RX4;ROCK2;PTGIS;DDAH1;CD34;SIRPA;PTGS2;AKT1;HSP90AA1;CX3CR1;DDAH2;ZC3H12A;ASS1;CAV1;EDN1;CLU;ATP2B4
prerank,positive regulation of cell differentiation (GO:0045597),-0.2410148985421221,-1.1148049979717873,0.13043478260869565,0.6860449756040126,1.0,36/237,8.36%,BMP6;RANBP3L;IGF1;CTNNA2;DAB2;COL1A1;SMAD3;NRCAM;BOC;NBL1;CDON;NELL1;CTNNA1;CCN2;BRINP1;TGFBR1;MEDAG;MAPK14;SOX5;TGFBR2;CTNNB1;PDPN;BMP7;SMAD4;RHOA;IL6R;BMP4;ZEB1;FBN2;HOXA5;WNT4;TMEM64;LRP5;CREBL2;FOXC1;BRINP2
prerank,embryonic organ development (GO:0048568),-0.3051104168109824,-1.1140655340259156,0.24846625766871167,0.6872583939811726,1.0,24/61,21.82%,FGFR2;TEAD1;PBX1;GLI2;GLI3;KMT2A;RARB;PCSK5;TGFBR2;KIT;COBL;RBP4;COL13A1;SALL1;TEAD3;TGFB1;NES;PBX4;BMPR1A;TEAD2;PBX2;PDGFA;ATF4;PKDCC
prerank,detection of mechanical stimulus (GO:0050982),-0.401235396619319,-1.1134413291374035,0.3036876355748373,0.6880281875324017,1.0,3/19,5.60%,PKD1;CTNNB1;PIEZO2
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.33796787666025346,1.1131440295440493,0.26435045317220546,0.9716918048317159,1.0,14/70,10.61%,MAPK3;ARPC3;VAV3;FCGR2B;ACTB;SRC;ARPC4;FYN;SYK;PLCG1;LYN;PAK1;WIPF3;YES1
prerank,dopaminergic neuron differentiation (GO:0071542),0.43071603524160096,1.112509413903328,0.326605504587156,0.9725995476102041,1.0,2/19,3.05%,NR4A2;MANF
prerank,cell cycle checkpoint signaling (GO:0000075),0.47306875896651085,1.1122173163706437,0.3253493013972056,0.9721767978363399,1.0,4/12,10.98%,PLK2;PRCC;WEE1;CHFR
prerank,renal water homeostasis (GO:0003091),-0.3768047144447633,-1.112035901746965,0.3163972286374134,0.690958947168224,1.0,9/23,13.00%,ADCY5;ADCY2;ADCY1;ADCY9;PRKACA;AQP4;ADCY7;PRKAR1B;RAB11A
prerank,cytoplasmic translational initiation (GO:0002183),0.4270028046292772,1.1117876898269616,0.32558139534883723,0.9722680415839993,1.0,9/17,18.94%,MCTS1;EIF2B3;EIF4H;EIF4B;EIF5;EIF3M;EIF2S2;EIF3A;EIF4G1
prerank,cytoskeleton organization (GO:0007010),-0.2703189281802086,-1.1115919278378432,0.20938628158844766,0.6912795599393966,1.0,55/114,28.81%,EPB41L3;MICAL2;PCLO;PDZD8;ARHGAP10;CDC42BPB;TPM1;RHOA;PLCE1;NEDD9;SYNE3;MICAL3;ZMYM6;PALLD;KLHL20;RND3;BIN1;FGD1;RHOBTB2;RANBP10;CNN2;SPRYD3;PAK5;LIMD1;RHOB;OBSL1;SIPA1;RHOBTB1;RANBP9;FGD4;PPP2R3C;BRWD1;STRIP2;DIAPH1;FMNL2;ARAP3;DIAPH3;CAPZB;PACSIN1;SIPA1L3;ZMYM3;CCL13;NECTIN2;RHOC;RHOU;MAST3;CNTNAP1;DMTN;FGD3;MICAL1;RHOH;CSPG5;MDK;BRWD3;AJUBA
prerank,positive regulation of response to biotic stimulus (GO:0002833),-0.33406341802297945,-1.1115083720631564,0.2570694087403599,0.6906037716048188,1.0,10/38,20.12%,BMP6;SASH1;PUM1;PUM2;PLSCR1;POLR3C;LY86;GBP5;RIOK3;SLC15A4
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.3319203076965369,1.1112378453861076,0.2591508052708638,0.9728072526700124,1.0,14/73,10.61%,MAPK3;ARPC3;VAV3;FCGR2B;ACTB;SRC;ARPC4;FYN;SYK;PLCG1;LYN;PAK1;WIPF3;YES1
prerank,epithelial to mesenchymal transition (GO:0001837),-0.31628956817269993,-1.1111065242988114,0.24119241192411925,0.690825329838369,1.0,12/47,11.62%,DDX5;TGFBR3;DDX17;TGFBR1;CTNNB1;BMP7;ROCK2;ROCK1;WNT4;GSK3B;LOXL3;TBX3
prerank,negative regulation of cellular senescence (GO:2000773),0.4633688005948672,1.1108067724655668,0.34026465028355385,0.9729057071285617,1.0,6/13,14.28%,FBXO5;SIRT1;ZKSCAN3;TERT;YBX1;MAP3K3
prerank,hyaluronan metabolic process (GO:0030212),-0.378890984722743,-1.1107710375891668,0.2961165048543689,0.6907984459805583,1.0,17/23,52.53%,CEMIP;CEMIP2;HEXA;HEXB;TGFB1;GUSB;HYAL1;SLC9A1;CHP1;HAS1;HYAL2;LYVE1;HAS2;HMMR;HAS3;HYAL3;STAB2
prerank,heart process (GO:0003015),0.453271355029051,1.1107488100395666,0.34629629629629627,0.9716407133858052,1.0,2/14,4.94%,SOD1;FYN
prerank,regulation of viral genome replication (GO:0045069),0.33472819275835314,1.110506252099959,0.291350531107739,0.9710608519814614,1.0,12/56,12.53%,ILF3;BANF1;IFITM2;IFIT1;IFITM3;ADAR;CNOT7;IFITM1;RAD23A;SRPK2;DDX3X;TMEM39A
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.3350768177027672,1.1104867536599543,0.2674591381872214,0.9696339721670606,1.0,14/71,10.61%,MAPK3;ARPC3;VAV3;FCGR2B;ACTB;SRC;ARPC4;FYN;SYK;PLCG1;LYN;PAK1;WIPF3;YES1
prerank,homologous chromosome pairing at meiosis (GO:0007129),-0.3458572381032165,-1.1103743837484812,0.2892768079800499,0.6910460021339482,1.0,24/29,64.48%,SIRT7;BAG6;RAD21;PRDM9;P3H4;TERB1;MEI4;FANCD2;ZCWPW1;TEX11;REC8;TRIP13;SYCE2;MAJIN;MEIOB;TEX12;STAG3;IHO1;SYCP2;RAD21L1;RNF212B;ANKRD31;HORMAD1;TERB2
prerank,negative regulation of sprouting angiogenesis (GO:1903671),0.4892792006214296,1.1103089787560458,0.328740157480315,0.9687867794115873,1.0,2/11,2.84%,SEMA6A;KLF2
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.4387048838111476,-1.109950434077537,0.32150313152400833,0.6912839700933707,1.0,3/13,7.03%,SORBS1;IGF1;AKT2
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.41247472462975593,1.1089403883080684,0.3176470588235294,0.9724029372788612,1.0,3/22,4.90%,PSMB10;PSMB6;PSMB4
prerank,regulation of transport (GO:0051049),0.3677337606382874,1.1086338830907247,0.3036912751677852,0.9720324955510603,1.0,6/36,11.58%,RSC1A1;ACTB;ICA1;EPB41;MBTPS1;SCFD1
prerank,pyroptosis (GO:0070269),-0.4200976659205119,-1.1085225671184205,0.33186813186813185,0.6944734160380281,1.0,9/15,51.24%,GSDME;AIM2;GSDMD;APIP;CASP8;ZBP1;CASP1;TREM2;NLRC4
prerank,positive regulation of MAPK cascade (GO:0043410),-0.24408353054573667,-1.1084897842604002,0.1875,0.6936368682128615,1.0,30/245,7.09%,ERBB4;NTRK3;FGFR2;NOTCH2;LPAR1;IGF1;HTR2C;ROBO1;EGFR;KSR1;IQGAP1;PDGFRB;NTRK2;BMPER;NRP1;CCN2;FGF1;RYK;ROR1;KIT;PRKCZ;ROCK2;IL34;TAOK3;PDGFRA;ROCK1;SLC30A10;ADRA1B;IRAK1;GSDME
prerank,peptidyl-proline modification (GO:0018208),0.4035309052673964,1.1084416717488792,0.3230240549828179,0.9712665302185836,1.0,5/25,6.18%,PIN1;PPIB;PPIG;P3H2;PPIL3
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.4086559255985507,1.1084093500840457,0.3321492007104796,0.9699116212470967,1.0,5/23,13.87%,PLAAT3;LPCAT3;MBOAT1;PNPLA8;ABHD4
prerank,tRNA methylation (GO:0030488),0.37410318161534395,1.1083470754008833,0.3247863247863248,0.9686221221495103,1.0,6/34,11.84%,TRMO;BCDIN3D;THUMPD2;TRMT61B;METTL2A;METTL2B
prerank,nuclear membrane disassembly (GO:0051081),0.45142880139313346,1.1078844739326275,0.326171875,0.9689493001457001,1.0,4/14,13.66%,NEK9;CNEP1R1;AKAP8L;NEK6
prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.37136052799434505,-1.1078402557708704,0.29711751662971175,0.6945646769741828,1.0,9/25,21.42%,SULF1;FOXD1;SMAD4;BMP4;BMPR1B;ZNF423;BMPR1A;BMPR2;CCN1
prerank,negative regulation of cell cycle (GO:0045786),-0.2899139729931526,-1.1077355119851993,0.25892857142857145,0.6939124112730125,1.0,16/73,12.51%,NR2F2;SMAD3;BRINP1;BMP7;BMP4;TRIM35;NUPR1;PTPN3;CDKN1B;GAS1;FOXC1;BRINP2;CDK6;CAMK2N1;RHOB;SIPA1
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.3011940621440875,-1.1075528930512701,0.2613333333333333,0.6935118755919788,1.0,11/57,13.88%,ERBB4;IGF1;PARP14;IL6R;PIBF1;KIT;GHR;IL31RA;NF2;IL18;IL6ST
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.3505365853759448,1.1073614885279808,0.296849087893864,0.9693671000982766,1.0,7/46,9.31%,SEMA6A;PTPRR;PIN1;PTPRC;SPRED1;CNKSR3;LYN
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),-0.440953529527442,-1.107292162854848,0.3274336283185841,0.6933029825207012,1.0,10/13,52.13%,B3GALT5;B3GALNT1;B3GALT1;B3GALT2;B3GNT9;B3GNT3;B3GNT8;GAL3ST3;B3GNT6;B4GAT1
prerank,ethanol metabolic process (GO:0006067),-0.4509848744623385,-1.1070149305129557,0.33760683760683763,0.6931507061788869,1.0,6/12,32.01%,ALDH1A1;ACSS2;ALDH2;ADH5;ACSS1;ADH1A
prerank,regulation of cell projection organization (GO:0031344),-0.4394096346433307,-1.1069296704406735,0.3471615720524017,0.6925051660957149,1.0,4/13,15.51%,NTNG1;MACF1;SEMA4D;ERMN
prerank,lymphocyte differentiation (GO:0030098),0.33427436410778244,1.1068386296493822,0.31045241809672386,0.9699166900261061,1.0,11/68,11.50%,DCAF1;JAG2;PTPRJ;PTPRC;HDAC9;GPR89B;GPR89A;CEBPG;LFNG;KLF6;PIK3CD
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.3091350128143262,1.1067885281355179,0.28317373461012313,0.9686253344466804,1.0,15/102,9.89%,PCK1;PRKAR1A;GSK3A;TRIB3;NR4A2;INSIG1;SRC;HDAC9;ZFP36L1;TSHR;MYO5A;TBC1D4;IRS2;RELA;RHOQ
prerank,regulation of protein localization to nucleus (GO:1900180),-0.3209098591884878,-1.1055495869959688,0.27925531914893614,0.6954551876024079,1.0,18/43,24.65%,CTNNA1;KAT7;BMP4;ILRUN;GLUL;GSK3B;TGFB1;WWTR1;LIMK2;CARD10;DTX3L;FLCN;YAP1;LAMTOR5;EIF2AK3;OTUD7B;AKT1;SESN2
prerank,response to amino acid (GO:0043200),-0.3496205911357402,-1.1054020607911477,0.3171355498721228,0.6949905805040024,1.0,6/31,7.73%,CPEB4;CPEB1;GLRB;CAPN2;GLRA3;GLRA1
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.32825103000676387,1.1053972060785755,0.28270676691729324,0.972463194618488,1.0,16/73,14.62%,CTCFL;EZH2;EED;POLR1C;ACTB;EP300;TDG;POLR1G;BMI1;WBP2;TBP;HDAC5;PPHLN1;TRIM27;TASOR;AEBP2
prerank,regulation of transmembrane transport (GO:0034762),0.37389960446184456,1.1050773859992096,0.33166666666666667,0.9721777391681445,1.0,5/31,8.35%,TRIB3;ACTB;NEDD4L;PIM1;SLC2A1
prerank,negative regulation of cellular process (GO:0048523),-0.22513421112198248,-1.1049922894111783,0.07954545454545454,0.6952200150096879,1.0,178/521,27.86%,MAGI2;ERBB4;ST18;TGFBR3;PLXNA2;ADAM22;ALDH1A2;SMAD3;KANK2;CLMN;VPS13C;TNS2;FBLN1;FHL1;CCN2;PTPN14;BRINP1;PACRG;COL4A3;BMP5;ABI1;CTNNB1;PDPN;BMP7;SMAD4;DSCAM;RBBP7;ATP8A2;SIRT2;IGFBP7;BMP4;NUPR1;ZBTB7C;LMNA;PDS5B;ENPP1;PIP4P2;APPL2;SRSF6;MYO16;VGLL4;FRK;PML;PODN;SKI;GSDME;IGFBP6;CDKN1B;CDC73;ADAMTS1;NDUFS3;SMAD6;ANP32B;NIBAN2;DLG3;SERTAD2;CGRRF1;EIF2AK2;BRD7;CDK6;PLSCR1;SPEG;GJA1;EPHB2;CAMK2N1;DDAH1;TP53;SEMA4D;NOX4;STK11;CD34;RHOB;ACVR1B;SYT11;SIPA1;TNFRSF21;SIRPA;WNT9A;P3H3;FKTN;PDCD5;PLXND1;NF2;ROR2;RACK1;DUS2;ARHGDIA;TOB1;NACC2;PLXNB2;SIRT7;RAF1;PTPRU;NGF;PLXNC1;GPLD1;CBLL1;NPAS2;RAPGEF2;TAF6;TGFB1;RNF139;CCN3;S100A11;PTPN2;NPR1;SMYD2;OPRM1;SFRP4;TSC2;CRYAB;RNF167;SNX3;ORC6;SUZ12;MDM4;SEMA5A;ATF5;TGFBI;BMPR2;BLM;DNAJB2;ITGA1;PARP16;BCL2;CCN5;TMEM109;COL18A1;ADRA1A;P3H1;CCN1;PRKD1;ARHGDIB;FLCN;IFIT3;HGS;MNT;IMPACT;EMILIN1;DUSP1;TBRG1;KLF10;UBR2;OSGIN2;ANXA6;ITGB1BP1;TSPYL2;BST2;VAMP8;TGFB3;EIF2AK3;BTG2;PLXNB1;NR1H2;SESN2;AQP11;HYAL1;SFRP1;ADGRG1;APBB1;NR4A1;NOTCH4;CCN4;ZBTB17;DLG5;TEX15;VHL;PLXNA1;DCBLD2;CELF1;RBM5;SH3BP4;FGFBP1;INHBA;CHERP;KLF11;DACT3;NME6
prerank,aortic valve morphogenesis (GO:0003180),-0.345201859240528,-1.1045452754545002,0.27296587926509186,0.695492832404453,1.0,6/30,8.66%,ROBO2;ROBO1;BMP4;ROCK2;ROCK1;SMAD6
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),-0.4566531697776708,-1.1044624158995713,0.33974358974358976,0.6947986629068074,1.0,1/11,1.32%,AKAP6
prerank,glutathione metabolic process (GO:0006749),0.36652457194979166,1.1044541460473696,0.3140096618357488,0.9729415565278022,1.0,7/38,13.17%,GCLC;SOD1;GCLM;CNDP2;PARK7;HAGH;GSS
prerank,cell junction organization (GO:0034330),-0.2888282012785566,-1.1038163237909222,0.284375,0.6957570737307205,1.0,15/71,7.34%,SDK1;GRM5;SMAD3;PPFIBP1;CXADR;MAPT;OCLN;RHOA;NLGN2;SLC6A1;FLNA;PPFIA1;RAB8B;CTNND2;SDK2
prerank,regulation of protein-containing complex assembly (GO:0043254),0.30279274869635486,1.103768797165698,0.29022988505747127,0.974110241471585,1.0,23/110,14.33%,RALB;TAL1;SLF1;HSPA8;TIRAP;SRC;SVIP;APOE;EP300;ICE1;SELP;SYK;NAPA;HJURP;PARK7;TRAF3IP1;DDX3X;RPS3;BMF;CDH5;FAF1;HCFC1;AIDA
prerank,regulation of dephosphorylation (GO:0035303),0.44255484603897377,1.1037302185928293,0.36007462686567165,0.9727604912391498,1.0,7/15,19.90%,SRC;PPP1R16B;MTMR2;SMG6;SMG5;IGBP1;SMG7
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.3741274091852316,1.10323597850996,0.3106457242582897,0.9732347186885907,1.0,12/31,20.96%,GSK3A;MAPK8;YWHAB;ZNF205;BAD;PPP3R1;YWHAH;YWHAQ;BAX;YWHAE;YWHAZ;TFDP2
prerank,regulation of calcium ion transmembrane transport (GO:1903169),-0.37770015158709763,-1.1032094904128331,0.3091334894613583,0.6964910435853777,1.0,4/23,10.68%,ANK2;ATP1A2;UBASH3B;CAMK2D
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.3339379231049349,1.1031000615103774,0.3147286821705426,0.9723011602845663,1.0,19/69,14.40%,CYCS;NDUFAF1;UQCC3;NDUFB6;NDUFB4;COX6B1;NDUFA10;NDUFA1;NDUFS2;COX5A;SDHA;NDUFB7;COX15;UQCRB;NDUFV3;NDUFA8;NDUFC2;NDUFA13;COX10
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.4138191627081884,-1.1030436800516172,0.3133047210300429,0.6960345333161125,1.0,7/16,19.18%,APPL2;PPARA;ADCY7;SIRPA;ABCD2;APOD;CHID1
prerank,regulation of lipid biosynthetic process (GO:0046890),0.38000717461495437,1.1030167688828618,0.33772652388797364,0.9711502652222662,1.0,8/32,11.08%,PCK1;FITM2;NR5A1;APOE;ASXL3;ADIPOR2;PRKAA2;ADIPOR1
prerank,amyloid precursor protein metabolic process (GO:0042982),0.43103661730048204,1.1029615974531657,0.3397548161120841,0.9698799459130862,1.0,5/18,15.68%,PSEN2;TMCC2;APOE;LDLRAP1;APH1A
prerank,regulation of blood coagulation (GO:0030193),-0.35752477079544853,-1.1026733692229513,0.30024213075060535,0.6961530633004223,1.0,10/27,25.87%,TFPI;THBS1;FAP;VTN;EPHB2;CD34;ST3GAL4;ENPP4;DMTN;SERPINE1
prerank,regulation of mitotic nuclear division (GO:0007088),-0.3020037862626883,-1.1025988302810605,0.27350427350427353,0.6954770619915133,1.0,11/55,15.46%,IGF1;PDGFRB;TOM1L2;BMP7;CUL9;BMP4;LRP5;OBSL1;IGF2;CAV2;TOM1L1
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.2783326787243472,1.1017723935977166,0.24231242312423124,0.9729021711685141,1.0,43/234,14.09%,LRP8;MAP3K7;TAB2;PRKCH;RPS6KA4;CAMK1D;TIRAP;HIPK2;TRIM8;PRKD2;RPS6KA5;RAB7B;PHB2;TRIM14;CIB1;EP300;CARD16;CEBPG;TRAF5;EPHA5;RGCC;CLOCK;TAB3;TRIM25;WNT5A;RELA;RBCK1;PARK7;BUD31;UBE2V1;ESR1;RNF25;APP;NOD1;RPS3;PRKCI;IKBKB;ERC1;CHUK;HDAC5;DDIT3;NFKBIA;TRIM27
prerank,protein polyglutamylation (GO:0018095),0.4776621951553756,1.1010355829843697,0.3420523138832998,0.9741022449443372,1.0,2/11,3.12%,TTLL1;CEP41
prerank,autophagosome maturation (GO:0097352),0.37572237588284707,1.1009959684576014,0.3086003372681282,0.9728196160233917,1.0,12/32,18.88%,MAP1LC3B;ATP2A2;VMP1;EPG5;TECPR1;UBQLN1;ATG14;GABARAPL1;VPS33A;GABARAP;CALM1;LAMP2
prerank,nucleocytoplasmic transport (GO:0006913),0.35947276573761927,1.100993969087795,0.2995008319467554,0.9713806674666812,1.0,7/40,9.26%,SNRPD2;NCBP1;SNRPD1;BACH2;NXT1;GEMIN5;RSRC1
prerank,aminoglycan metabolic process (GO:0006022),0.4998518911874067,1.1004699768545647,0.34911242603550297,0.9718675641213046,1.0,2/10,9.20%,XYLT1;B3GAT2
prerank,histone methylation (GO:0016571),0.386617811803492,1.100267969855973,0.32642487046632124,0.9711825752515058,1.0,5/26,11.12%,CTCFL;EZH2;SMYD3;CREBBP;CARM1
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.47716875620212035,1.1001427817226812,0.3483606557377049,0.9702550697798427,1.0,1/11,1.14%,SAG
prerank,protein trimerization (GO:0070206),0.4535619908108872,1.0997513339781675,0.3435114503816794,0.9687450669504729,1.0,3/14,8.22%,SIGMAR1;MLKL;SLC1A2
prerank,protein homotrimerization (GO:0070207),0.4535619908108872,1.0997513339781675,0.3435114503816794,0.9687450669504729,1.0,3/14,8.22%,SIGMAR1;MLKL;SLC1A2
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),0.43870498419103454,1.0994355386535482,0.33707865168539325,0.9685166603184674,1.0,4/16,6.85%,ATP5F1E;ATP5MG;ATP5PF;ATP5MC2
prerank,negative regulation of locomotion (GO:0040013),0.46345387235804086,1.0992526722664009,0.37969924812030076,0.9677355580935877,1.0,2/12,2.02%,FRMD5;PIN1
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.31043382426434457,1.0991552483563922,0.296875,0.9666482917868549,1.0,17/93,11.27%,PDE4D;MTCP1;RPTOR;STOX1;BCAR3;PRKD2;CNKSR3;RAPGEF3;BDNF;SMAD7;TXN;AXIN1;PAK1;PARK7;DOCK7;DMD;APP
prerank,adrenergic receptor signaling pathway (GO:0071875),-0.38778619955354604,-1.0990414002762332,0.3544857768052516,0.7045217243583062,1.0,5/20,9.97%,AKAP13;ADCY9;ADRA1B;LMBRD2;ZDHHC21
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),-0.30843712941983736,-1.099029498780327,0.28254847645429365,0.7036408345151398,1.0,15/56,18.70%,ANK3;SON;SPIRE1;RHOA;ROCK2;CIT;ROCK1;IST1;BIN3;RHOB;MITD1;TRIM36;STMN1;JTB;SNX18
prerank,regulation of mRNA stability (GO:0043488),0.29557277071392,1.0988763345437491,0.27445652173913043,0.9662927367692546,1.0,32/145,16.61%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;HSPA8;ZFP36L1;PSMD11;PSMB4;PSMC1;FXR1;YWHAB;EXOSC9;PCID2;PSMC2;PSMD2;TAF15;ZC3H14;XPO1;PSMD14;EXOSC1;PSMC6;PSMD1;PSMB1;YBX1;DCP1A;FUS;NOCT;FTO;PARN;PSMA4
prerank,glycogen catabolic process (GO:0005980),-0.4181529499408714,-1.0987176216743073,0.32142857142857145,0.7036069873232771,1.0,7/15,19.40%,PYGB;AGL;PHKA2;PYGM;PGM2;GAA;PHKG2
prerank,regulation of anatomical structure morphogenesis (GO:0022603),-0.2595047985018866,-1.0985419622530923,0.23104693140794225,0.7031390770011025,1.0,17/118,5.85%,LRRC4C;FGFR2;PHLDB2;ADGRB3;PDLIM5;EFNA5;ADGRA2;PDZD8;BMPER;SDC2;PHLDB1;PID1;MAPT;CTNNB1;STAT2;ZMYM6;HECW1
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),-0.4672977481236495,-1.098426640761601,0.348643006263048,0.7025552945251723,1.0,2/11,3.17%,ANK3;JAK1
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.43687702242322984,1.098419539229556,0.3439153439153439,0.9666456114534159,1.0,4/17,14.59%,BOD1;CHAMP1;MIS12;MTBP
prerank,positive regulation of cell-cell adhesion (GO:0022409),-0.32193189237305114,-1.0982392105669863,0.28969359331476324,0.7021750902271168,1.0,12/41,20.69%,ANK3;JAK1;BMP7;PLPP3;ADAM19;AFDN;DENND6A;PTPRU;MEGF10;PTPN23;FLOT1;CX3CL1
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.406531797571573,-1.0978455102374165,0.3310344827586207,0.7023955717015858,1.0,8/17,22.16%,SULF1;FSTL1;XIAP;PCSK6;TMEM204;SFRP4;TWSG1;DOK5
prerank,negative regulation of protein transport (GO:0051224),0.3883176031099427,1.0977606809768194,0.32116788321167883,0.9677171520988445,1.0,3/25,4.59%,RSC1A1;HMGCR;APOE
prerank,thyroid hormone generation (GO:0006590),-0.4719922697234463,-1.097524576309178,0.3598326359832636,0.7023491308884289,1.0,3/10,24.76%,CPQ;SLC5A5;CTSK
prerank,regulation of T cell chemotaxis (GO:0010819),0.4859018191794102,1.0974665201622495,0.36328125,0.9674375917925816,1.0,2/11,8.56%,OXSR1;WNT5A
prerank,negative regulation of cell junction assembly (GO:1901889),-0.3668958373348562,-1.097340078259551,0.31654676258992803,0.7020123427436814,1.0,9/25,18.52%,ROBO2;PHLDB2;ROCK2;ARHGAP6;ROCK1;THBS1;DUSP22;ACE;APOD
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.3751241754043847,1.0972986381363026,0.3142857142857143,0.9666023455865042,1.0,9/32,14.76%,ACER2;SRC;CLASP2;MMP12;NEXMIF;ACVRL1;HOXA7;MAP4K4;SEMA3E
prerank,regulation of cytoplasmic transport (GO:1903649),0.477749459619701,1.0969459476018149,0.34235976789168276,0.966515333755841,1.0,2/11,3.25%,MAPK3;SRC
prerank,cilium organization (GO:0044782),-0.2392871020113689,-1.0969204959370817,0.17333333333333334,0.7023284097382176,1.0,58/209,17.47%,GSN;PARVA;AHI1;PKD1;CC2D2A;EXOC3;RILPL1;FLNA;PIBF1;IFT81;DZIP1;TTC8;WDR35;DYNC2I1;RAB8B;DCDC2;NUDCD3;CCDC66;CCDC57;CFAP20;EXOC6;TTC39C;IFT46;IFT52;ACTR3;CEP89;CEP126;IFT172;CEP20;IFT74;CFAP44;RP2;ARL13B;DISC1;TTBK2;ABLIM3;KIF3A;DZIP1L;BBS9;RAB11A;WDR19;WDR11;INTU;RAB23;CCP110;BBS2;CYS1;ARF4;EXOC7;EXOC1;PTPN23;CEP250;EHD1;RAB8A;EHD3;DYNLL2;ACTR2;IFT20
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.3346181260353897,1.0968385334111594,0.29742033383915023,0.9655325359232966,1.0,13/60,11.53%,TRIM28;LEF1;CCNC;CDKN1A;MED23;MED12;HEY2;MED15;CDK4;RELA;CSF1R;AGO4;MED4
prerank,negative regulation of biomineral tissue development (GO:0070168),0.4125092270067351,1.0967353172333678,0.34900542495479203,0.9645141587358895,1.0,8/21,16.33%,GREM1;HEY1;HEY2;NOTCH1;TRPM4;NOS3;GAS6;PTK2B
prerank,positive regulation of interleukin-8 production (GO:0032757),0.34458299163582495,1.0965865673950232,0.3106796116504854,0.9636231610316274,1.0,8/49,13.40%,TIRAP;PRKD2;SYK;RELA;RAB1A;PARK7;NOD1;DDIT3
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),-0.4038142413266015,-1.0964379408815779,0.3392857142857143,0.7027325997731476,1.0,2/17,2.80%,PLA2G4A;LPGAT1
prerank,response to ethanol (GO:0045471),0.4541368554578985,1.0963244370249035,0.35526315789473684,0.96317619287679,1.0,3/14,4.49%,SOD1;GOT2;SDF4
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.3957911656955386,1.0961425098558089,0.34440559440559443,0.9624309323244279,1.0,2/24,1.75%,PRKAR1A;PDE4D
prerank,manganese ion transport (GO:0006828),-0.4220927537889654,-1.0959235850143219,0.35181236673773986,0.7033062283925372,1.0,7/14,22.45%,TRPC5;SLC39A14;SLC30A10;TRPC1;SLC39A8;SLC11A2;TRPC6
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.3970084282852995,1.0956046638076002,0.33810375670840787,0.9630900327064893,1.0,4/23,6.61%,DYNC1I1;TUBB;KIF1B;CCDC88C
prerank,actin nucleation (GO:0045010),0.420385153663308,1.095374044102079,0.3298059964726631,0.9625352323563469,1.0,7/21,15.42%,ARPC3;ARPC5L;ARPC4;ARPC5;TRIM27;LMOD1;WHAMM
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.42303047769485785,1.0946390130522277,0.3471502590673575,0.9638453666174648,1.0,7/19,17.77%,PTPRJ;PTPRC;SELP;PRNP;ADGRL1;BCAP31;RYR2
prerank,triglyceride catabolic process (GO:0019433),0.4163713399583236,1.0946139347767323,0.3409090909090909,0.9625575770679855,1.0,1/19,3.33%,FABP7
prerank,post-translational protein modification (GO:0043687),0.27155713454103736,1.0946051560298335,0.24260355029585798,0.961196187104663,1.0,57/332,14.00%,CISH;PSMB10;PSMC4;PSMB6;CAND1;ELOC;RNF7;PSMD8;PSMD5;PSMD12;KLHL5;KLHL3;FEM1C;CHML;BTBD1;CHM;CDH2;PSMD11;NEURL2;PTP4A2;APOE;PSMB4;FBXL5;WFS1;RAB11B;PSMC1;PDIA6;VWA1;FBXW2;DCAF6;COP1;LMO7;KLHL2;FBXO32;FBXO11;ESCO1;RAB1A;PSMC2;PSMD2;FBXO7;UBE2M;ICMT;MBTPS1;NAE1;STT3B;COPS7B;APP;ELOB;CUL3;DCAF10;PSMD14;EPAS1;UBE2F;PSMC6;PSMD1;PROC;PSMB1
prerank,branching morphogenesis of an epithelial tube (GO:0048754),-0.3234296315153324,-1.0945634847980765,0.2868020304568528,0.7061231065913723,1.0,8/39,9.91%,PKD1;GLI2;NRP1;TGFBR2;CTNNB1;BMP4;LRP5;SALL1
prerank,actin crosslink formation (GO:0051764),0.46076007247348244,1.094367264680102,0.34854014598540145,0.9607100991881781,1.0,2/12,1.76%,LCP1;GAS2L1
prerank,monocarboxylic acid metabolic process (GO:0032787),-0.2579880890513907,-1.093734106575393,0.2600732600732601,0.7076440327091286,1.0,29/117,17.61%,IGF1;ALDH1A2;ME1;ABAT;MCCC2;VDAC1;PER2;CPT1A;PPARA;HLCS;PCCB;PDHX;DLD;SCPEP1;ACOT11;CKB;LDHB;CPT1C;ALDH4A1;ACADSB;MSMO1;CYP26B1;GGT5;PCCA;GLO1;ACSF2;ACOT7;AASDH;SLC5A6
prerank,regulation of neuroinflammatory response (GO:0150077),-0.3951441265978799,-1.093324286317303,0.32842105263157895,0.7079224412704497,1.0,5/19,19.91%,IGF1;NUPR1;IL18;IL33;PTGS2
prerank,protein kinase A signaling (GO:0010737),0.47293389651168083,1.0930544502662434,0.36996336996337,0.9640286748029708,1.0,1/12,0.56%,LCP1
prerank,regulation of phospholipase activity (GO:0010517),-0.4705781312583764,-1.0928550801681474,0.37067209775967414,0.7084082317657907,1.0,2/10,0.70%,FGFR2;LRP1
prerank,heme biosynthetic process (GO:0006783),0.4101335374435467,1.092552887478376,0.35714285714285715,0.9644792656694131,1.0,9/22,18.59%,ABCB10;ABCG2;TSPO;COX15;COX10;SLC25A38;ALAS1;FECH;NFE2L1
prerank,negative regulation of cell aging (GO:0090344),0.43213036967356777,1.0920902841324513,0.3580705009276438,0.9647422700402993,1.0,6/16,14.28%,FBXO5;SIRT1;ZKSCAN3;TERT;YBX1;MAP3K3
prerank,transcription by RNA polymerase III (GO:0006383),0.38619904533871013,1.0918142185051094,0.3251318101933216,0.9643085324448153,1.0,9/27,18.56%,GTF3C1;ICE1;GTF3C5;RO60;IVNS1ABP;TBP;GTF3C2;POLR3K;POLR3GL
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),-0.42389176755136837,-1.091729813344428,0.33905579399141633,0.7106806406611011,1.0,7/14,26.73%,FLNA;LOXL3;PRKD1;ITGB1BP1;EMP2;DMTN;SLC2A10
prerank,establishment of spindle orientation (GO:0051294),-0.3454164446930607,-1.0916333787920316,0.3099273607748184,0.7100571119565791,1.0,9/28,24.02%,FBXW11;HTT;UBXN2B;GJA1;NSFL1C;DCTN1;NDE1;ZW10;LLGL1
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.3215866837511918,1.0915257918680108,0.3020030816640986,0.9639500788126601,1.0,7/72,4.99%,POLR2J;MAPK3;NCBP1;CBL;POLR2B;SHCBP1;SPRED1
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),0.48810862558194745,1.0914788040993966,0.3861788617886179,0.9627416762925849,1.0,4/10,16.15%,CCT2;CCT5;TCP1;DKC1
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.39405835122815563,1.091417924992104,0.343205574912892,0.9615950030562037,1.0,6/26,9.90%,FYN;SIRT1;TXN;SOD2;PARK7;FBXO7
prerank,inositol phosphate biosynthetic process (GO:0032958),0.48204324981592805,1.0910905575335197,0.3579136690647482,0.9614204378614092,1.0,3/11,16.52%,PPIP5K2;IP6K2;ITPKB
prerank,ketone body metabolic process (GO:1902224),-0.470175576138586,-1.0910375395529088,0.3622881355932203,0.7107684017013319,1.0,4/10,11.04%,OXCT1;HMGCLL1;ACSS3;HMGCL
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.31851522304571844,1.0910114342421848,0.29210134128166915,0.9603783518650036,1.0,17/76,13.89%,TNFAIP3;NWD1;MAP2K5;SIRT1;NLRC3;MTURN;ERBIN;TRAF3;RBCK1;NFKBIL1;CYP1B1;G3BP2;CHUK;NLRC5;DDIT3;FAF1;NFKBIA
prerank,activation of protein kinase activity (GO:0032147),-0.2719950845715251,-1.0907800506268337,0.24758842443729903,0.7105944419276942,1.0,40/106,25.13%,NTRK3;IGF1;ADCY5;ADCY2;FGF1;ADCY1;TGFBR2;PRRC1;PIBF1;MALT1;ADCY9;GHR;TAOK3;PRKCD;IRAK1;PRKACA;STRADA;STK11;ADCY7;PAK5;PRKAR1B;TAOK1;IL18;TOM1L1;TRAF2;CARD10;PINK1;CARD14;PRLR;OSBPL8;ADCY3;ADCY8;VEGFA;ADCY4;ITGB1BP1;EMP2;NRK;AKT1;ADRA2A;TLR3
prerank,epithelial cell differentiation (GO:0030855),-0.27714600756686714,-1.090668933357032,0.2698412698412698,0.7100073595716403,1.0,35/88,30.99%,ERBB4;FGFR2;DAB2;FSTL1;MAF;HDAC1;BMP4;ANXA4;VDAC1;CPT1A;AKT2;PTER;ANXA1;SCUBE1;TOLLIP;ANXA7;SIX1;TAGLN2;FZD7;PGK1;PCK2;GLI1;KDM6B;VEGFA;AKT1;BASP1;PAX2;TAGLN;E2F4;CTSB;PCNA;SCRIB;ALDOC;PIH1D1;GATA6
prerank,intraciliary retrograde transport (GO:0035721),-0.4408318910168524,-1.0906353500180883,0.3407707910750507,0.7092010829273383,1.0,6/12,27.66%,WDR35;DYNC2I1;TTC21B;WDR19;DYNLT2B;DYNC2I2
prerank,positive regulation of axon extension (GO:0045773),-0.3737524577831886,-1.0904883569708401,0.3325526932084309,0.708692089910972,1.0,10/22,22.30%,NRP1;MAPT;MACF1;DSCAM;SHTN1;TWF2;ZFYVE27;SEMA5A;DBNL;VEGFA
prerank,actin filament depolymerization (GO:0030042),-0.45325621860172216,-1.0903550365526942,0.3562753036437247,0.7081871913516138,1.0,5/11,17.63%,GSN;MICAL2;MICAL3;WDR1;TWF2
prerank,defense response to tumor cell (GO:0002357),-0.4807030414012712,-1.0899463205199043,0.3594080338266385,0.7084586275985412,1.0,8/10,48.44%,RBMS3;DAPK1;PRDX2;ABI3;PLK5;LAPTM5;SPI1;DLEC1
prerank,peptidyl-lysine acetylation (GO:0018394),0.48941946187906304,1.0890790005107702,0.3680297397769517,0.9660194076531002,1.0,4/10,11.07%,EP300;SIRT1;ESCO1;CREBBP
prerank,regulation of coagulation (GO:0050818),-0.45646459081467855,-1.0890253679743058,0.3649193548387097,0.7100467775211676,1.0,2/11,10.62%,HS3ST5;EPHB2
prerank,positive regulation of Notch signaling pathway (GO:0045747),0.35581975047806486,1.089016964074109,0.3472,0.9648810260300559,1.0,9/39,12.23%,JAG2;TM2D3;SRC;EP300;NOTCH1;RBPJ;CREBBP;NOS3;PRKCI
prerank,regulation of lipid metabolic process (GO:0019216),0.3125450378616482,1.0886676662700163,0.32390381895332393,0.9648327137455662,1.0,18/88,13.15%,PCK1;GPAM;HMGCR;HDAC3;PANK2;ELOVL6;PLPP1;PPARD;SC5D;IRS2;ACACB;IDI1;CREBBP;ADIPOR1;CARM1;LSS;SP1;NPC2
prerank,positive regulation of protein metabolic process (GO:0051247),0.30373999845900623,1.088391838830653,0.32,0.9644480241277323,1.0,20/110,13.89%,GSK3A;ABCB10;TNFAIP3;PLK2;KLF2;MAP2K5;NEDD4L;APOE;RAB7A;WFS1;MAPK8;AXIN1;WNT5A;RAB1A;APP;ATG7;EGLN2;NDUFA13;APC;NFKBIA
prerank,negative regulation of cellular protein localization (GO:1903828),-0.32921107043403963,-1.0883693691013785,0.30930232558139537,0.7110419769824037,1.0,12/34,14.70%,GPM6B;CTNNA1;MAPT;ROCK2;ILRUN;UBXN2B;ACTN2;GSK3B;NSFL1C;TTBK2;MAP1A;COMMD1
prerank,leukotriene metabolic process (GO:0006691),-0.3902267910540634,-1.0882837861060763,0.335632183908046,0.7104257541867423,1.0,14/19,55.80%,PLA2G4A;GGT5;MAPKAPK2;ABCC10;MGST3;ALOX12;LTA4H;PTGR1;GGT1;PLA2G5;ALOX5AP;MGST2;ALOX5;DPEP1
prerank,Golgi to plasma membrane transport (GO:0006893),-0.30777902079347536,-1.0881807897656997,0.29213483146067415,0.7097942356993417,1.0,16/47,16.59%,ANK3;ARFGEF2;VAMP5;MACF1;RAB31;EXOC6;GGA2;OPTN;OSBPL5;VPS35L;VAMP2;COMMD1;BBS2;GOLGA7;EXOC1;GGA3
prerank,negative regulation of coagulation (GO:0050819),-0.4205511268869077,-1.0881730024378884,0.35384615384615387,0.7089458088127365,1.0,4/14,11.71%,HS3ST5;TFPI;VTN;CD34
prerank,oligosaccharide metabolic process (GO:0009311),-0.31531479290797093,-1.0881032509040505,0.3050397877984085,0.7082687331255992,1.0,13/46,18.89%,AMY1A;AMY1B;AMY1C;B4GALT1;FUT8;ST6GALNAC5;B3GALT5;ST3GAL4;ST6GAL2;B3GALT1;ST6GALNAC6;MPDU1;ST8SIA2
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.40385100206647967,1.087949945746487,0.34205933682373474,0.964630042139369,1.0,6/23,11.62%,ACSL5;HSD17B12;ELOVL6;FAR2;ACSL4;HACD2
prerank,positive regulation of developmental growth (GO:0048639),0.3445390632499825,1.0878286621902398,0.32838283828382836,0.9637254380836351,1.0,9/49,12.18%,CPNE5;SEMA7A;PPIB;NEDD4L;BDNF;RUFY3;PLCB1;AGRN;PLAA
prerank,intestinal lipid absorption (GO:0098856),-0.45001675157952764,-1.0878023131347825,0.3724279835390947,0.7082597105073447,1.0,2/11,8.09%,LIMA1;LDLR
prerank,negative regulation of cilium assembly (GO:1902018),0.45987188202152074,1.087623154859992,0.36435643564356435,0.9630881262505651,1.0,3/12,7.53%,EVI5L;TBC1D30;MAP4
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.3130160743867798,1.087092531830856,0.2906110283159464,0.9636135746249022,1.0,9/87,5.97%,POLR2J;MAPK3;NCBP1;CBL;POLR2B;SHCBP1;ZFP36L1;SPRED1;TBX1
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),-0.4360824059153705,-1.087074927233745,0.33047210300429186,0.7094367068804124,1.0,4/12,15.74%,BICD1;NINL;KIF3A;DCTN1
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.38125319133830915,1.0867700510607288,0.3184931506849315,0.9633952632940844,1.0,5/29,11.52%,LPCAT2;PLAAT3;DBI;LPCAT3;PNPLA8
prerank,regulation of cholesterol esterification (GO:0010872),0.48692728724567247,1.0860763391603312,0.36553030303030304,0.964500858903159,1.0,2/10,6.46%,APOE;LAMTOR1
prerank,negative regulation of viral genome replication (GO:0045071),0.357440819719227,1.0860026172269521,0.34974533106960953,0.9634412278834519,1.0,7/40,10.59%,ILF3;BANF1;IFITM2;IFIT1;IFITM3;IFITM1;SRPK2
prerank,negative regulation of proteolysis (GO:0045861),-0.33517524425725836,-1.0858512465636465,0.35128205128205126,0.7118803372077879,1.0,7/34,12.39%,TIMP3;TIMP2;ROCK1;PTPN3;GAS1;CAMK2N1;ECM1
prerank,negative regulation of double-strand break repair (GO:2000780),-0.3461296675961696,-1.085771867668757,0.3422982885085575,0.711232211409523,1.0,21/30,44.30%,ERCC6;UBR5;SHLD1;RNF169;HSF1;RIF1;SMCHD1;SHLD2;HMGA2;OTUB1;POLQ;TWIST1;OGG1;CYREN;FANCB;CGAS;MAD2L2;NUDT16L1;RMI2;TFIP11;PARPBP
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.4686504893493387,-1.0857161235149895,0.3776824034334764,0.7105203456255669,1.0,5/10,38.77%,CBFB;NCKAP1L;HMGB1;ZBTB7B;SH3RF1
prerank,negative regulation of angiogenesis (GO:0016525),-0.2730169554676764,-1.0855380073064291,0.27300613496932513,0.7101601142300865,1.0,17/84,9.33%,SULF1;COL4A3;CTNNB1;GTF2I;ROCK2;ADAMTS9;SLC12A2;HSPG2;ROCK1;HOXA5;PML;SPARC;ADAMTS1;FOXC1;THBS2;NIBAN2;THBS1
prerank,response to calcium ion (GO:0051592),-0.27342477391797293,-1.0855295959068874,0.2923076923076923,0.709311255891198,1.0,26/102,15.96%,KCNMA1;CPNE8;RYR3;IQGAP1;SEC31A;STIM1;ADCY1;CLIC4;ADGRV1;SLC25A13;ANXA11;SYT9;NLGN1;TRPC1;THBS1;LGMN;CAMK2D;SYT12;SYT11;SYT4;RASGRP2;CPNE2;SYT7;GPLD1;PEF1;D2HGDH
prerank,phagosome maturation (GO:0090382),0.3699848863251103,1.0854884397313689,0.3394648829431438,0.9638806977184535,1.0,7/35,8.45%,ATP6V1D;RAB7A;RAB43;ATP6V0D1;PIKFYVE;RAB14;ATP6V0E1
prerank,peroxisomal membrane transport (GO:0015919),-0.352680908179413,-1.0854592386752802,0.3375,0.7086417629625951,1.0,10/27,18.06%,ACBD5;RAB8B;PEX14;FIS1;ALDH3A2;PXMP4;ABCD2;PEX2;PEX5;PEX6
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.4662341392155824,1.0853989567853366,0.378698224852071,0.9628692726688475,1.0,4/11,11.90%,NEDD4L;GOPC;LEPROTL1;PICALM
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.35765714444610835,1.0853373260453583,0.3261231281198003,0.961753005194137,1.0,11/38,13.08%,NDUFAF1;NDUFB6;NDUFB4;NDUFA10;NDUFA1;NDUFS2;NDUFB7;NDUFV3;NDUFA8;NDUFC2;NDUFA13
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.3704407867654248,1.085095799786526,0.35075885328836426,0.9612861411906138,1.0,8/32,16.58%,CDK17;NPAT;CDC45;FBXO5;POLA1;BACH1;ID2;CDK14
prerank,negative regulation of cartilage development (GO:0061037),-0.43100108550224314,-1.085060851975531,0.38613861386138615,0.7088246532505516,1.0,4/13,12.87%,ADAMTS12;TGFBR1;EFEMP1;WNT9A
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.2874811001036364,1.0849708625498198,0.29517241379310344,0.9603860912588993,1.0,38/158,16.60%,ZDHHC17;JMJD8;MAP3K7;TAB2;PLK2;EEF1D;TIRAP;TRIM8;BIRC2;ZDHHC13;TNFRSF10B;TMED4;TRIM14;EDAR;GPR89A;CARD16;TRAF5;TAB3;TRIM25;RELA;RBCK1;LURAP1;UBE2V1;NOD1;TNIP2;IKBKB;CHUK;PPP5C;ANKRD17;NEK6;ATP2C1;TRIM27;MAP3K3;S100A13;TERF2IP;PELI1;FKBP1A;SLC44A2
prerank,cellular response to interleukin-7 (GO:0098761),0.42631933680844003,1.084765308385836,0.37832699619771865,0.9584599502721721,1.0,6/17,18.41%,CISH;IRS2;SMARCA4;IL7;STAT3;IRS1
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.42631933680844003,1.084765308385836,0.37832699619771865,0.9584599502721721,1.0,6/17,18.41%,CISH;IRS2;SMARCA4;IL7;STAT3;IRS1
prerank,positive regulation of epithelial cell proliferation (GO:0050679),-0.2653968094440113,-1.0843587703144577,0.2476780185758514,0.7099286414665262,1.0,14/113,5.83%,BMP6;FGFR2;NOTCH2;IGF1;EGFR;NRP1;FGF1;TGFBR1;BMP5;BMP4;RREB1;OSR1;SRSF6;F3
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.2912278707766558,1.0842051866348452,0.29906542056074764,0.9592089526902094,1.0,28/138,13.99%,POLR2J;MAZ;ERCC3;NR4A2;POLR2B;HDAC7;HDAC9;HDAC3;NR5A1;CCNH;MED23;PPARD;NOTCH1;NRBF2;GTF2H1;NRBP1;TAF15;ESR1;THRB;RBPJ;GTF2A2;CREBBP;E2F3;TAF4B;TBP;HDAC5;THRA;DR1
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.31634601366293635,1.0841165784072146,0.3333333333333333,0.9582049445064156,1.0,15/76,11.39%,GSK3A;SAE1;DCUN1D4;BIRC2;HDAC3;UBE3A;WFS1;PTTG1IP;SMAD7;UBA2;AXIN1;SPRTN;MYCBP2;UBQLN1;PIAS1
prerank,glycosaminoglycan catabolic process (GO:0006027),-0.3030176752038916,-1.0838478207490316,0.338368580060423,0.71050417383264,1.0,23/55,25.36%,GPC6;SDC2;CEMIP;VCAN;OGN;GPC3;CEMIP2;HSPG2;HEXA;HEXB;ARSB;GPC5;CSPG4;PRELP;TGFB1;GNS;LUM;GUSB;GPC4;SDC3;BGN;DCN;HYAL1
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.43912360036177245,-1.0836816343188216,0.3640256959314775,0.7101190361666231,1.0,9/12,52.13%,B3GALT5;B3GALNT1;B3GALT1;B3GALT2;B3GNT9;B3GNT3;B3GNT8;B3GNT6;B4GAT1
prerank,neural crest cell migration (GO:0001755),0.3580605738932352,1.083429815832872,0.3234323432343234,0.9592821229528946,1.0,7/36,9.12%,SEMA6A;SEMA6D;SEMA7A;SEMA3C;TBX1;SEMA6B;SEMA4C
prerank,epidermis development (GO:0008544),-0.29679463486627816,-1.0833969124876726,0.313953488372093,0.7100720982238837,1.0,8/56,11.98%,FGFR2;SVEP1;CCN2;HDAC1;FLOT2;PLOD1;EMP1;ALDH3A2
prerank,sterol biosynthetic process (GO:0016126),0.3638229857750209,1.0831780159967226,0.32669983416252074,0.9588720044250384,1.0,8/33,11.99%,EBP;INSIG1;HMGCR;PLPP6;SC5D;IDI1;NSDHL;LSS
prerank,regulation of calcium ion import (GO:0090279),0.4070098367711293,1.083001975457307,0.3378839590443686,0.9582728785923958,1.0,6/21,17.22%,PSEN2;CXCL12;FYN;PRNP;TRIM27;SLC30A1
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),-0.3133936794726692,-1.082866283570865,0.29973474801061006,0.7105738582114749,1.0,21/46,23.53%,ZIC1;SMAD3;KHDRBS1;FLNA;BAG3;PRKCD;UBR5;ANP32B;EFCAB7;CDH1;GSK3B;TP53;CAMK1;TGFB1;TCF7L2;MAVS;PIK3R1;NEDD4;NRDE2;EMD;NCBP2
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.3486276433794243,-1.0826031955953717,0.32917705735660846,0.7104454609699787,1.0,10/27,23.83%,AMBRA1;PDGFRB;KIT;PDGFRA;PTK2;TGFB1;PRKD1;P2RY12;EPHA8;TNFAIP8L3
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.3492833017457935,-1.0823918189153978,0.30969267139479906,0.7101157571620546,1.0,19/29,44.38%,CYLD;PML;THBS1;TRAF2;PPP2R1B;LTBR;TNFSF12;SFRP1;BCL10;INHBA;BID;CAV1;DEDD2;GPER1;HTRA2;AGT;HYAL2;G0S2;PYCARD
prerank,regulation of GTPase activity (GO:0043087),0.2810312374818889,1.0820814143698325,0.28608582574772434,0.9601849703805756,1.0,32/177,12.59%,EZH2;PIN1;SOD1;VAV3;EVI5L;CHN2;TBC1D30;BCAR3;PRKG1;LRCH1;RGS8;TBC1D10B;USP6NL;ARHGEF7;EPHA5;RAPGEF3;F11R;RGS10;RAP1GDS1;FGD5;CCL25;RAPGEF6;DOCK9;ITGA6;RASIP1;PLXNA4;RAB11FIP2;PICALM;NF1;AGRN;MAP4K4;LARS1
prerank,positive regulation of cyclase activity (GO:0031281),-0.417995251782046,-1.0820073102362473,0.35462555066079293,0.7103635775141308,1.0,4/14,3.50%,CACNA1C;CACNA1D;STIM1;MAPK14
prerank,calcium ion transmembrane import into cytosol (GO:0097553),-0.3178603814087065,-1.0819599844700427,0.3147208121827411,0.7096407219880075,1.0,4/41,1.57%,HTR2C;ITPR1;GRIN2B;RYR3
prerank,vesicle coating (GO:0006901),0.33053176791730776,1.0816807231988168,0.3323397913561848,0.9577264688995983,1.0,15/61,15.69%,TRAPPC2;CNIH1;ANKRD28;SEC23IP;GOSR2;F8;NAPA;TMED10;RAB1A;SCFD1;TRAPPC6B;MCFD2;CUL3;PPP6R1;TRAPPC10
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.33053176791730776,1.0816807231988168,0.3323397913561848,0.9577264688995983,1.0,15/61,15.69%,TRAPPC2;CNIH1;ANKRD28;SEC23IP;GOSR2;F8;NAPA;TMED10;RAB1A;SCFD1;TRAPPC6B;MCFD2;CUL3;PPP6R1;TRAPPC10
prerank,COPII vesicle coating (GO:0048208),0.33053176791730776,1.0816807231988168,0.3323397913561848,0.9577264688995983,1.0,15/61,15.69%,TRAPPC2;CNIH1;ANKRD28;SEC23IP;GOSR2;F8;NAPA;TMED10;RAB1A;SCFD1;TRAPPC6B;MCFD2;CUL3;PPP6R1;TRAPPC10
prerank,brain development (GO:0007420),-0.25908695048269653,-1.0816581986806186,0.2537878787878788,0.7095441408488093,1.0,58/136,31.53%,ROBO2;CNTN4;ZIC1;CTNNA2;ARNT2;PBX1;GRIN2B;NFIB;AFF2;NCOA6;TGFBR2;EPHA7;MEIS2;FBXW11;RELN;HSPG2;NIPBL;SMARCA1;ZIC2;ATXN1;SCYL2;NNAT;CTNS;CIC;BBS2;PLXNB2;RAPGEF2;NES;PBX4;SOX6;APOD;BPTF;PBX2;SMG9;GRIN2D;GRIN1;BAG6;IER3IP1;PCDH18;PAX2;NDRG4;PTCH1;ADGRG1;DDIT4;CX3CR1;POU6F1;EEF1AKMT4-ECE2;UTP3;AATK;SLC6A17;QARS1;MDGA1;TMX2;CLN5;COL4A1;CDK5RAP3;VPS51;MFSD2A
prerank,glycine transport (GO:0015816),0.48079813955966477,1.0816545309659962,0.38132295719844356,0.956522999324199,1.0,3/10,16.37%,SLC7A8;SLC38A5;SLC25A38
prerank,regulation of neurotransmitter transport (GO:0051588),-0.3999578362975011,-1.0815996753577557,0.33774834437086093,0.7088458630546155,1.0,6/16,24.99%,RIMS1;SNCAIP;SYN1;FLOT1;CPLX1;CAMK2A
prerank,"synaptic transmission, GABAergic (GO:0051932)",-0.4757042969260755,-1.0810424290274319,0.38289205702647655,0.7095316304287306,1.0,7/10,24.45%,GABRA2;GABRG2;GABRA5;GABRG3;GABRA4;GABRG1;GABRA1
prerank,2-oxoglutarate metabolic process (GO:0006103),-0.4326414379444043,-1.0806563725283522,0.3487858719646799,0.7097010478943507,1.0,7/13,21.65%,IDH2;PHYH;ADHFE1;D2HGDH;GPT2;L2HGDH;GOT1
prerank,"wound healing, spreading of cells (GO:0044319)",-0.36596774247161723,-1.0805008047842954,0.33490566037735847,0.7092934223424815,1.0,7/24,6.53%,TMEFF2;COL5A1;PDPN;RHOA;FLNA;DDR1;ITGA5
prerank,Ras protein signal transduction (GO:0007265),0.2870575970009612,1.0804665274552523,0.30578512396694213,0.9594603981024196,1.0,38/137,16.91%,RAC2;RALB;TRIM28;RAP2A;TIAM1;PLK2;RERG;NRAS;CFL1;RASGRP3;RALA;CDKN1A;GNB1;GRAP;RAPGEF3;GNA12;RAPGEF6;PARK7;CELSR1;RHOG;NF1;CDC42EP3;CRKL;G3BP2;RAP2C;MYO9B;RIT1;EPS8L1;RGL2;ELMO1;GNA13;MRAS;ABI2;CDH13;SHC1;KPNB1;CYFIP1;USP28
prerank,positive regulation of collagen biosynthetic process (GO:0032967),-0.4093155611076922,-1.080419498479069,0.352112676056338,0.708665366605128,1.0,6/16,24.21%,VIM;BMP4;WNT4;TGFB1;CREB3L1;TGFB3
prerank,negative regulation of multicellular organismal process (GO:0051241),0.2792804042159203,1.079767503584463,0.3042362002567394,0.9606205570159492,1.0,28/199,11.15%,CIDEA;RGS2;PTPRR;GSK3A;PTPRG;FCGR2B;RPS6KA4;HDAC9;HMGCR;RPS6KA5;EVL;PPP2CA;HEY1;SPRED1;NPTN;RGCC;SMAD7;HEY2;PPP1R11;RAB11FIP5;NOTCH1;EFNA1;NOVA2;HOXA7;DOCK7;RBPJ;ADIPOR1;NOS3
prerank,bile acid metabolic process (GO:0008206),-0.34936575319226926,-1.0797130703420579,0.34375,0.7097184381123411,1.0,5/27,10.21%,OSBPL9;OSBPL6;CYP27A1;CYP7B1;OSBP
prerank,regulation of dendrite extension (GO:1903859),0.41245096910171614,1.0796982190602578,0.35150375939849626,0.959576433190738,1.0,2/18,4.22%,CPNE5;NEDD4L
prerank,central nervous system myelination (GO:0022010),-0.4525966847986074,-1.0788650910129034,0.3531827515400411,0.7112337770311307,1.0,8/11,38.33%,PLP1;B4GALT6;CNTNAP1;ABCA2;MYRF;B4GALT5;CLU;SOX10
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.47173139268380176,-1.0781807638049754,0.3824175824175824,0.7122528207937847,1.0,1/10,0.36%,ANK3
prerank,regulation of Notch signaling pathway (GO:0008593),0.31581631724148507,1.077530515124716,0.31555555555555553,0.9660538068611912,1.0,14/76,12.23%,JAG2;TM2D3;SRC;HEY1;EGFL7;EP300;TSPEAR;NOTCH1;LFNG;BEND6;RBPJ;CREBBP;NOS3;PRKCI
prerank,energy reserve metabolic process (GO:0006112),-0.38935622451457164,-1.0773625120245551,0.367032967032967,0.7136979582988059,1.0,8/19,25.00%,PRKAG2;LEPR;PID1;GSK3B;PYGM;PHKG2;GFPT1;GFPT2
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.31121388185089205,1.0773133723822264,0.31976744186046513,0.9655295716085445,1.0,23/88,13.65%,SH3D19;HSPA8;SORT1;EXOC8;EXOC6B;GOPC;MYO5A;CLTA;DTNBP1;AP1G1;AP1S2;NAPA;RAB14;ARF1;AP4S1;RABEP1;DOP1B;CHMP2A;CLVS1;APP;SCFD1;SCAMP1;CCDC93
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),-0.39786615133546094,-1.0773006862934094,0.35023041474654376,0.7130130309842674,1.0,6/17,25.96%,EGFR;PKD1;CCND3;CCNYL1;AKT1;SPDYA
prerank,ribosomal small subunit assembly (GO:0000028),0.43653080273789235,1.077244625385948,0.3860640301318267,0.964486740452223,1.0,7/16,21.79%,RPS14;RPS28;RRP7A;PRKDC;RPSA;RPS27;RPS5
prerank,negative regulation of cellular catabolic process (GO:0031330),-0.292435907828834,-1.0770092868864118,0.31351351351351353,0.7129986527603625,1.0,12/63,8.12%,TIMP3;LEPR;TIMP2;NELL1;SIRT2;NUPR1;KDM4A;KLHL22;SORL1;ROCK1;PTPN3;GOLGA2
prerank,cellular protein modification process (GO:0006464),0.2515512644844473,1.0768435791787088,0.22141372141372143,0.9646760942003897,1.0,203/983,17.11%,CISH;PHPT1;PSMB10;PSMC4;JMJD4;PSMB6;MAP3K11;MAPK3;SNRK;CAND1;ELOC;PTPRR;PTPN18;GSK3A;PTPRG;ILF3;RNF7;DUSP7;PSMD8;PSMD5;PSMD12;PTPRJ;CDK17;KLHL5;OXSR1;PTPRC;CDK19;KLHL3;CTDSP1;FEM1C;CHML;PPP3CB;PLK2;NEK11;PTPRM;BTBD1;PRKCH;RPS6KA4;ENGASE;CHM;HIPK2;PTPRB;MEX3B;PRKG1;DUSP12;PRKD2;RPS6KA5;PTPRE;PPP2CA;CDH2;PSMD11;MAP3K9;NEURL2;SIRT3;PTP4A2;APOE;PKN3;PSMB4;PTPN12;FYN;FBXL5;METAP2;WFS1;RAB11B;PSMC1;PDIA6;VWA1;UBE2I;FBXW2;DCAF6;MAPK8;UGCG;COP1;RET;SSH2;PTPRT;PAK3;ST8SIA1;CSNK1G3;SIK3;SYK;CDK11B;PPP2CB;PIM1;SIRT1;ATG4B;LMO7;KLHL2;FBXO32;PEAK1;MINK1;SLC35A1;SERP2;CDK4;MERTK;ACVRL1;PIGH;FBXO11;LATS2;CDKL4;LYN;RAB1A;NRBP1;PSMC2;ERG;PKN1;PAK1;PSMD2;PARK7;FBXO7;PIGT;UBE2M;PPP1R12A;NIM1K;ICMT;MBTPS1;DUSP11;PRKAA2;ACVR2A;SRPK2;YES1;NAE1;METAP1;SETD3;NLK;STT3B;NEK7;CTBP1;COPS7B;APP;PIK3CD;ELOB;TNKS;ATG7;PPP3CA;PLAT;ST3GAL6;STRADB;TYK2;ADPRH;PRKCI;MAP4K4;MAPK6;IKBKB;CTTNBP2NL;NAA80;CUL3;CHUK;DCAF10;PSMD14;EPAS1;UBE2F;PPP5C;CHEK2;ST3GAL1;PSMC6;TLK2;COG3;NPC1;NEK6;PSMD1;BRD2;PGGT1B;PROC;PSMB1;PTPRA;ST6GALNAC2;MSRA;B3GALNT2;CAMKK2;ST8SIA6;QPCT;COPS8;BMP2K;KLHL11;FBXO22;GAS6;DYRK2;CDKL5;PPP2R3A;TAF1;MAN2A1;NTAQ1;BRAF;PPM1L;MTMR2;CALU;KLHL42;PIGU;PTK2B;PIK3R4;CDK14;PSMA4;KLHL13;WNK2;FBXL20;PRKDC;DCUN1D1;LCMT1;MELTF;PRSS23;PPP2R5A;TIPARP
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.3678769969952562,-1.0767788871458996,0.32456140350877194,0.7127431950431622,1.0,5/22,7.69%,NRDC;TIMP3;TIMP2;ROCK1;PTPN3
prerank,phospholipid dephosphorylation (GO:0046839),-0.32700775641088836,-1.076738373055206,0.3389830508474576,0.712006693430581,1.0,17/37,27.74%,PLPPR1;PLPP3;MTMR7;PIP4P2;SACM1L;PLPPR5;MTMR12;PLPPR4;MTMR9;MTMR4;MTMR11;PLPP5;EPHX2;PIP4P1;INPP5F;OCRL;INPP5K
prerank,positive regulation of cellular process (GO:0048522),0.25631856018069604,1.0762532728654957,0.24668141592920353,0.9653896926784736,1.0,96/565,15.25%,FRMD5;MAZ;RAD18;ROMO1;NCBP1;PTPRJ;TAL1;EZH2;LEF1;ACER2;TIAM1;RPL23;DERL2;FCGR2B;CXCL12;RPS6KA1;RPTOR;CAMK1D;GREM1;CRLF1;STOX1;MCTS1;TBC1D8;PRKD2;ZFP36L1;TSHR;LMAN2;CSPP1;SLC35F6;MEIS1;TNFRSF1B;SINHCAF;CIB1;SLC6A6;MAPK8;TBX1;FXR1;CHTOP;FBXO5;ACTN4;SIRT1;RNF187;IRS2;NOTCH1;USP47;CNOT7;CDK4;WNT5A;TJP1;MERTK;EXOSC9;ACACB;RELA;CD47;CSF1R;LGI1;LYN;BCLAF1;MDM2;RAD23A;PAK1;CLDN5;CITED2;PRKAA2;EIF4G2;ESM1;TRPM4;SRPK2;RPS9;CD81;DDX3X;P2RX7;RHOG;FLT1;PA2G4;ACER3;PPP3CA;CRKL;DHPS;DOT1L;CUL3;TENM4;CNOT6;ANKRD17;RPS15A;FAF1;APC;HES1;HCFC1;CYBA;PARD3;INO80;CNOT6L;S100A13;VEGFC;GAS6
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.42090457919571067,1.0755706458515386,0.3694852941176471,0.9666008706973025,1.0,5/18,11.62%,ACSL5;HSD17B12;ELOVL6;ACSL4;HACD2
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.3225378248313229,1.0753746579984846,0.3338391502276176,0.9660585913015562,1.0,11/69,9.76%,FOXQ1;SOD1;CRLF1;PPT1;APOE;TOX3;WFS1;BDNF;SOD2;FZD9;PARK7
prerank,endothelial cell proliferation (GO:0001935),0.4175003590672356,1.0752990395298345,0.3817204301075269,0.9650391931041219,1.0,3/17,8.88%,PRKX;TEK;ACVRL1
prerank,regulation of viral entry into host cell (GO:0046596),0.37770341679033176,1.0752732206097606,0.36363636363636365,0.963830624480393,1.0,6/30,8.83%,LY6E;IFITM2;TRIM14;IFITM3;TRIM25;IFITM1
prerank,hemopoiesis (GO:0030097),0.3061673306928881,1.0748058497418336,0.3411764705882353,0.964118211445714,1.0,12/87,9.17%,PRKX;MECOM;SNRK;TAL1;PTPRC;TIRAP;CD164;TEK;MEIS1;BMI1;WNT5A;CSF1R
prerank,T cell migration (GO:0072678),0.4483223673067599,1.073842397701713,0.34579439252336447,0.9662470361609579,1.0,2/13,11.50%,PIK3CG;PIK3CD
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.3430955501196553,1.0733065328932347,0.3534201954397394,0.9668763753830876,1.0,12/45,17.75%,FAM83B;CBL;SRC;RPS6KA5;PLCG1;ERBIN;PIK3C2A;BRAF;PTK2B;SHC1;PTPN11;KIF16B
prerank,ribonucleoprotein complex assembly (GO:0022618),0.2899757514791567,1.073044246717275,0.32705248990578734,0.9665228753286352,1.0,38/132,18.64%,SNRPD2;NCBP1;RSL24D1;RPL3;SNRPD1;MCTS1;SF1;RPS14;RPL5;SRSF10;GEMIN5;YTHDC1;MRPL20;EIF4H;RPLP0;COIL;RPS28;CPSF6;RRP7A;SRPK2;RPL24;EIF4B;STRAP;RPL23A;USP39;EIF5;PRKDC;RPL38;EIF2S2;EIF6;EIF3A;RPSA;DDX23;PRPF18;LUC7L2;CLP1;RPL10;SNRPD3
prerank,dendritic cell differentiation (GO:0097028),-0.36613396571765433,-1.0730141298850537,0.35629453681710216,0.7216581552287952,1.0,3/22,6.99%,TGFBR2;AXL;CAMK4
prerank,skeletal system morphogenesis (GO:0048705),-0.31786340261206086,-1.0728489840797546,0.34375,0.7212778829444391,1.0,16/42,23.69%,FGFR2;TGFBR1;FBN2;HOXA3;DYNC2I1;PDGFRA;SKI;LRP5;CYP26B1;LRP6;SFRP4;HOXC4;SIX1;HOXB3;HOXC9;RAB33B
prerank,neuronal action potential (GO:0019228),-0.36368353452365265,-1.072825087404441,0.3395348837209302,0.7204923104690872,1.0,6/22,13.06%,ANK3;SCN8A;SCN3A;SCN1A;KCNA1;CACNA1G
prerank,aggrephagy (GO:0035973),-0.3599820579003157,-1.072430532890671,0.32914572864321606,0.7207289313062611,1.0,8/27,11.40%,WDFY3;ACBD5;UBE2N;DYNC1H1;DYNC1LI2;VIM;UBC;ARL13B
prerank,alpha-amino acid metabolic process (GO:1901605),-0.3115772352194424,-1.0723195924875408,0.3451086956521739,0.7201678839508032,1.0,23/45,30.71%,ASPA;SRR;SLC25A13;ATP7A;GLUL;GLUD1;MTHFR;DDAH1;NOX4;MTHFD1;NAALAD2;KYAT1;GPT2;GOT1;ASPG;KYAT3;RIMKLB;OAT;MTRR;DDAH2;ALDH18A1;ASS1;RIMKLA
prerank,lipid biosynthetic process (GO:0008610),0.31589174573368534,1.0719194591086088,0.3524355300859599,0.969214289960602,1.0,13/77,12.28%,ACSL5;MLYCD;GPAM;FITM2;HMGCR;GPAT4;MBOAT1;AGPS;PRKAA2;AGPAT3;PAM;LSS;PDSS2
prerank,protein homooligomerization (GO:0051260),0.2923523469003658,1.0718675139971796,0.3278008298755187,0.9681432005830193,1.0,18/114,12.24%,THG1L;RS1;GLS;EHD4;SIGMAR1;ATL1;MLKL;B2M;BEND3;SSBP1;SLC1A2;ACACB;SOD2;TRMT61B;CHMP2A;TRPM4;G3BP2;LETM1
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),-0.2850759949511647,-1.0718487214695178,0.2975206611570248,0.7206300866327178,1.0,25/65,23.37%,LDLRAD4;FBN1;SMAD3;SMURF2;TGFBR1;TGFBR2;FBN2;PPARA;SKI;HTRA3;SMAD6;LTBP1;SNX25;UBC;PPM1A;MTMR4;TGFB1;PRDM16;CD109;STUB1;SPRED3;SNX6;ASPN;EMILIN1;NRROS
prerank,heart looping (GO:0001947),-0.31753772424392934,-1.071738105181944,0.3333333333333333,0.7200477999309354,1.0,10/39,25.89%,AHI1;MICAL2;TGFBR2;SMO;TBX3;SETDB2;BBS5;CCDC39;NDRG4;TBX2
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.31261622989826454,1.0716818865738234,0.35131195335276966,0.9675436013101806,1.0,17/73,15.96%,MTCP1;RPTOR;STOX1;BCAR3;PRKD2;RAPGEF3;BDNF;TXN;AXIN1;PAK1;PARK7;DOCK7;APP;CD44;TERF2IP;GAS6;BRAF
prerank,positive regulation of ERAD pathway (GO:1904294),-0.42740886127534206,-1.07163264051768,0.36423841059602646,0.7194922093086714,1.0,8/13,26.05%,USP13;HERPUD1;TMEM259;RNFT1;SGTA;BAG6;NFE2L2;RNF185
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),-0.3203669318325534,-1.0715417909468754,0.3168044077134986,0.7189086444009543,1.0,10/39,13.20%,ANK3;FGF12;FGF14;WNK1;OSR1;HECW1;PTPN3;WNK4;CAMK2D;WNK3
prerank,fat-soluble vitamin metabolic process (GO:0006775),-0.3659683149318177,-1.0715253696373706,0.3380281690140845,0.7181097372018052,1.0,5/22,25.15%,ALDH1A2;LGMN;RBP1;PIAS4;CUBN
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.3978002361414565,-1.0713780983117833,0.36043956043956044,0.7177150901435799,1.0,3/16,7.01%,NFAT5;RHOA;IRAK1
prerank,histone H3 acetylation (GO:0043966),0.349336348766195,1.071064685875469,0.35073409461663946,0.9684004446595903,1.0,5/40,3.39%,JADE3;LEF1;MAP3K7;PHF14;ING4
prerank,myeloid cell development (GO:0061515),-0.3870283391542165,-1.070552222296252,0.35909090909090907,0.719167757629752,1.0,4/18,4.76%,FOXP1;ANXA2;MED1;KIT
prerank,protein K63-linked deubiquitination (GO:0070536),0.3703455474864625,1.0702839392036658,0.37094017094017095,0.9698468116159255,1.0,9/31,13.29%,ABRAXAS1;TNFAIP3;YOD1;OTUD1;SPATA2;OTUD5;PSMD14;USP33;BRCC3
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),-0.2789756339819298,-1.070136210998624,0.33126934984520123,0.7194921999235192,1.0,23/72,17.54%,CFLAR;JAK1;CYLD;AXL;IFNAR2;CBFB;IRAK1;TAX1BP1;IRAK3;BIRC3;ELF1;OTULIN;VRK2;HIPK1;IFNGR1;CLIP3;IKBKG;RACK1;MADD;TRAF2;PTPN2;RNF31;IFNGR2
prerank,cellular response to gamma radiation (GO:0071480),-0.3978674392341015,-1.0700423673096895,0.35205183585313177,0.7188723561650648,1.0,8/17,23.08%,MAP3K20;TP53;HSF1;ATM;KDM1A;CRYAB;TMEM109;YAP1
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.4248116968385043,1.0697372233542852,0.3905109489051095,0.9705053508773678,1.0,2/18,5.93%,CABYR;RFX3
prerank,negative regulation of cellular component movement (GO:0051271),-0.40676595961763695,-1.0697131417951797,0.3412526997840173,0.7189320309641316,1.0,3/15,2.87%,SPOCK3;TGFBR3;FBLN1
prerank,RNA modification (GO:0009451),0.3390259272720701,1.0693421623154127,0.36217948717948717,0.970676713250614,1.0,15/54,19.84%,THG1L;THUMPD1;BCDIN3D;ADAR;ANKRD16;WDR4;SSB;ADARB1;NSUN6;PARN;CDKAL1;NSUN2;TFB1M;FTSJ1;URM1
prerank,transcription preinitiation complex assembly (GO:0070897),0.4557090235696856,1.0690260956176163,0.379110251450677,0.9704939522202423,1.0,5/12,15.69%,BDP1;GTF2A2;TBP;DR1;TAF1
prerank,protein methylation (GO:0006479),0.34899598775440177,1.0688550689895546,0.34782608695652173,0.9697914782859691,1.0,9/40,14.58%,CTCFL;EZH2;PRMT3;RAB6A;ICMT;SETD3;CARM1;ETFBKMT;NTMT1
prerank,translational termination (GO:0006415),0.30769360297969783,1.0685476266212215,0.3300561797752809,0.9696583568199951,1.0,13/95,12.45%,MRPS22;MRPS2;MRPS33;MRPL23;MRPL24;MRPL18;MRPL38;MRPS12;MRPL20;MRPL52;MRPS15;MRPS24;MRPL48
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.3266192130763864,1.0681349149172956,0.36431784107946025,0.9698562924358182,1.0,13/59,11.53%,TRIM28;LEF1;CCNC;CDKN1A;MED23;MED12;MED15;CDK4;RELA;CSF1R;BCLAF1;AGO4;MED4
prerank,regulation of cellular protein metabolic process (GO:0032268),0.3399973004320202,1.0681163115568721,0.3579277864992151,0.9686488543922676,1.0,17/47,20.44%,EIF2A;APOE;GEMIN5;EDNRB;TSC1;METAP1;NANOS3;APP;NFKBIA;VPS35;RBM4B;CYFIP1;RPL10;EIF4G1;NR1H3;EIF4E;MTPN
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),0.4593399596567994,1.068056687534016,0.3786407766990291,0.9675724577524315,1.0,3/11,11.50%,SIRT1;LYN;PIK3CD
prerank,protein phosphorylation (GO:0006468),0.25611697525859667,1.0678207905503878,0.28747203579418346,0.9671087619744375,1.0,103/479,16.75%,PCK1;PRKX;STK32A;MAP3K11;MAPK3;SNRK;GSK3A;ILF3;CDK17;OXSR1;MAP3K7;CDK19;PPP3CB;PLK2;NEK11;RPS6KA1;PRKCH;RPS6KA4;CAMK1D;HIPK2;SRC;MEX3B;PRKG1;PRKD2;RPS6KA5;MAP3K9;TEK;CCNH;PKN3;SMG1;FYN;SLK;MAPK8;RET;PAK3;CSNK1G3;SIK3;SYK;CDK11B;SBK1;PIM1;SMAD7;PEAK1;MINK1;CDK4;DCLK3;MERTK;GTF2H1;ACVRL1;LATS2;CDKL4;CSF1R;LYN;NRBP1;ERG;PKN1;PAK1;NIM1K;PRKAA2;ACVR2A;SRPK2;NLK;NEK7;FLT1;USP15;CTBP1;APP;PIK3CD;TNKS;STRADB;TYK2;PRKCI;MAST4;MAP4K4;MAPK6;IKBKB;MAPK12;ERC1;CHUK;CHEK2;TLK2;NEK6;BRD2;MAP2K6;MAP3K3;CSNK2A2;CAMKK2;MAP3K10;COPS8;BMP2K;GAS6;DYRK2;CDKL5;TOP1;TAF1;ATR;BRAF;ABI2;PTK2B;PIK3R4;CDK14;WNK2;PRKDC
prerank,neuropeptide signaling pathway (GO:0007218),-0.28982464150948,-1.0677748131631064,0.32075471698113206,0.7234657984388948,1.0,10/58,17.50%,SORCS1;GLRB;SORCS3;SORL1;GLRA3;GLRA1;GPR37;RAPGEF2;OPRM1;HCRTR2
prerank,fatty acid transmembrane transport (GO:1902001),-0.3824619255410216,-1.0677140769333757,0.36682242990654207,0.7228091993046276,1.0,6/19,14.84%,PRKAG2;CPT1A;PRKAB2;SLC27A1;ABCD2;CPT2
prerank,phospholipid transport (GO:0015914),0.33296935409358663,1.0674531200081856,0.33900928792569657,0.9671576221225411,1.0,12/52,13.90%,ATP8A1;ATP11A;APOE;PRELID3B;TMEM30B;PRELID2;PITPNA;SCARB1;ATP11C;NPC2;OSBPL2;ATP10A
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.41351432659739096,1.067327438188111,0.3929203539823009,0.966371897135642,1.0,4/18,9.65%,GSK3A;SLC35F6;ZNF205;FZD9
prerank,cellular response to increased oxygen levels (GO:0036295),0.4744250300176522,1.0671787905511925,0.3945841392649903,0.9656512315036268,1.0,6/11,22.61%,ATP6V0D1;ATP6AP1;ATG7;ATP6V1A;FAS;FOXO1
prerank,cellular response to exogenous dsRNA (GO:0071360),0.46388872891432553,1.0670913747328936,0.36617100371747213,0.9646854913410117,1.0,2/12,3.70%,RALB;IFIT1
prerank,activation of GTPase activity (GO:0090630),0.305074052010762,1.0670125386374631,0.3564213564213564,0.9637281947843463,1.0,24/89,14.63%,TIAM1;EVI5L;ARHGEF26;TBC1D30;TBC1D8;RALGAPA2;TBC1D9;ARHGAP25;TBC1D10B;USP6NL;TBC1D4;RALGAPB;RABGAP1L;TBC1D12;TSC1;TBC1D25;DOCK7;RHOG;ADPRH;TBC1D14;RABGAP1;RALGAPA1;SYDE1;ARHGEF10
prerank,negative regulation of osteoblast differentiation (GO:0045668),-0.33918012220468025,-1.0666885464215579,0.35658914728682173,0.7248463685745604,1.0,9/31,11.96%,RANBP3L;CRIM1;SKI;TMEM64;LRP5;SMAD6;CDK6;SEMA4D;LIMD1
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.4884852044668356,1.0666527581612155,0.3782771535580524,0.9624904419867697,1.0,4/10,15.61%,ALKBH2;ASCC3;MPG;FTO
prerank,DNA dealkylation (GO:0035510),0.4884852044668356,1.0666527581612155,0.3782771535580524,0.9624904419867697,1.0,4/10,15.61%,ALKBH2;ASCC3;MPG;FTO
prerank,mRNA splice site selection (GO:0006376),-0.3333646569033314,-1.066404933588428,0.32857142857142857,0.7248159192848493,1.0,6/30,7.45%,CELF2;SRSF5;CELF4;PSIP1;SRSF6;SRSF1
prerank,negative regulation of chemotaxis (GO:0050922),0.36810001420660926,1.06612955291105,0.3747870528109029,0.9631602109303921,1.0,7/31,9.12%,SEMA6A;SEMA6D;SEMA7A;SEMA3C;SEMA6B;NOTCH1;SEMA4C
prerank,protein insertion into membrane (GO:0051205),0.36077086132653535,1.065814515964931,0.375,0.9630060720001373,1.0,2/32,0.33%,RTP3;REEP1
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.45095294478907155,1.0653516116392443,0.3727810650887574,0.9633270908018542,1.0,3/12,13.66%,NEK9;CNEP1R1;NEK6
prerank,ATP synthesis coupled proton transport (GO:0015986),0.4168879020702386,1.065340192103347,0.3789868667917448,0.9621236610505708,1.0,4/17,6.85%,ATP5F1E;ATP5MG;ATP5PF;ATP5MC2
prerank,sphingoid metabolic process (GO:0046519),0.45296617460558136,1.064368306078938,0.3982142857142857,0.9641511215035767,1.0,4/12,13.88%,KDSR;PLPP1;SGPP2;SGPP1
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.32759783101440726,1.0642776676739956,0.3637747336377473,0.9632290262616999,1.0,5/57,6.77%,HRH4;MTNR1A;HTR1F;INSL3;GRM7
prerank,determination of bilateral symmetry (GO:0009855),0.3919143464290631,1.0641070829575474,0.3741258741258741,0.9625776918495567,1.0,5/24,17.83%,TBX1;NOTCH1;CITED2;KIF3B;BBS7
prerank,regulation of endothelial cell proliferation (GO:0001936),0.30299250176060555,1.0639060007426457,0.3551829268292683,0.9620380579500781,1.0,16/88,12.06%,PTPRM;PDCL3;PRKD2;NRAS;PPP1R16B;EGFL7;APOE;TEK;KRIT1;RGCC;SIRT1;WNT5A;ACVRL1;TIE1;PIK3CD;NF1
prerank,positive regulation of protein maturation (GO:1903319),-0.44130598209454447,-1.0638138891601683,0.3801295896328294,0.7311771980758881,1.0,6/11,44.72%,RHBDD1;CCBE1;NKD2;SOX4;BAG2;ADAM8
prerank,metal ion transport (GO:0030001),-0.26668368106447865,-1.0637285426590954,0.32094594594594594,0.7305842510992934,1.0,16/86,13.46%,CACNA1C;ITPR1;CALCRL;CACNA1D;RYR3;SLC41A1;TRPC5;NIPA2;MRS2;CACNA1B;TRPC1;NDFIP1;CACNG7;RAMP1;NIPAL2;SLC39A8
prerank,embryonic heart tube morphogenesis (GO:0003143),-0.30659058422260443,-1.0635076049003733,0.33676092544987146,0.7303676337080245,1.0,7/43,13.21%,AHI1;MICAL2;TGFBR2;SMO;ACVR1;TBX3;SETDB2
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.3540064600748949,1.063148804167236,0.3760539629005059,0.963407598248018,1.0,6/39,6.54%,PTPN18;CBL;PTPRJ;PTPN12;EPS15L1;ARHGEF7
prerank,negative regulation of endothelial cell migration (GO:0010596),0.35328010653683467,1.0631423177045616,0.3572621035058431,0.9621958100915159,1.0,6/36,8.88%,PTPRM;APOE;KRIT1;RGCC;NOTCH1;ACVRL1
prerank,male meiosis I (GO:0007141),0.42276780107999506,1.0629011822005514,0.38698010849909587,0.9617706734994675,1.0,16/16,57.77%,ING2;FOXJ3;ZSCAN21;MYBL1;BRDT;BTBD18;MEIOC;DNMT3L;CCNA1;MOV10L1;FOXJ2;SLC25A31;DDX4;TDRD9;SYCP3;HSF2BP
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.2739552603058902,1.062816167679111,0.3359273670557717,0.9608191040861783,1.0,35/186,14.00%,SOX30;PSMB10;PSMC4;PSMB6;GSK3A;PSMD8;PSMD5;PSMD12;FRZB;RUVBL2;GREM1;TPBG;PSMD11;APOE;SOX2;PSMB4;PSMC1;CCDC88C;PFDN5;AXIN1;WNT5A;SOX13;LATS2;PSMC2;PSMD2;TMEM131L;NLK;TLE4;CUL3;PSMD14;DDIT3;PSMC6;PSMD1;APC;PSMB1
prerank,cellular protein catabolic process (GO:0044257),-0.2873143599211779,-1.0627346708527028,0.3064516129032258,0.7316495879534519,1.0,18/59,17.85%,ADAMTS12;AP2B1;CAPN2;AP2A2;AFG1L;MALT1;AP2A1;PSMA6;FAP;LGMN;CLPP;TCIRG1;CTSO;SIAH2;VLDLR;RNF123;CTSZ;MYLIP
prerank,programmed necrotic cell death (GO:0097300),0.4163530751688011,1.0622090325905404,0.3701754385964912,0.9616610104384135,1.0,5/18,16.21%,MLKL;TRPM7;ALKBH7;ITPK1;DNM1L
prerank,cholesterol efflux (GO:0033344),0.40585634564150064,1.0617231694192228,0.3769633507853403,0.9621418553982646,1.0,5/20,13.55%,APOE;SOAT1;SCARB1;NPC2;NPC1
prerank,negative regulation of chondrocyte differentiation (GO:0032331),-0.4133023986837076,-1.0613868974090503,0.3838383838383838,0.7345282351313389,1.0,3/14,4.71%,ADAMTS12;TGFBR1;EFEMP1
prerank,amyloid fibril formation (GO:1990000),-0.2940691190206,-1.0611504432709158,0.3468208092485549,0.7343914191457346,1.0,14/51,25.76%,GSN;SNCAIP;MAPT;SORL1;HSPG2;GGA2;BACE1;UBC;SIAH2;GGA3;TGFBI;TSPAN15;MFGE8;APH1B
prerank,regulation of postsynaptic membrane potential (GO:0060078),-0.33132239820679366,-1.0608584154026868,0.33248730964467005,0.7343945501418113,1.0,16/34,24.53%,GRID2;GRIN2B;GABRA2;GABRG2;GLRA1;GSK3B;GABRA5;GABRG3;GABRA4;GRIN2D;GRIN1;GABRG1;NLGN3;MPP2;GABRA1;AKT1
prerank,positive regulation of cell cycle (GO:0045787),-0.28521995257822663,-1.060804712493988,0.34310850439882695,0.7337081475822455,1.0,17/62,16.40%,FGFR2;EGFR;PKD1;MEIS2;NUPR1;CCDC57;CDKN1B;SMOC2;CCND3;LGMN;TBX3;RARA;HSF1;USP19;LRP6;TTL;CCPG1
prerank,regulation of cellular response to stress (GO:0080135),0.2966730829986367,1.0607702194471056,0.3599439775910364,0.9641597058976982,1.0,34/115,19.38%,ATF3;MAPK3;CHCHD2;HSPA8;RPTOR;MANF;SMG1;AKT1S1;EP300;BAG1;NUP54;SIRT1;NUP50;ING2;CCAR2;CREBBP;FKBP4;NUP35;NEK6;CORO2B;NDC1;CAMK2G;ATR;RSL1D1;HIKESHI;NUP160;NPM1;POM121;NUP42;NUAK1;EIF4G1;YWHAE;NUP133;HSPB8
prerank,positive regulation of lymphocyte migration (GO:2000403),0.45156695288848164,1.0601391088233676,0.38740458015267176,0.9651134822059638,1.0,4/12,17.42%,CXCL12;APP;DOCK8;JAM2
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.44408159138306463,1.0596532008212063,0.3903345724907063,0.965583478914376,1.0,2/13,2.91%,UTP20;RPS21
prerank,positive regulation of protein phosphorylation (GO:0001934),0.2585960826517573,1.0596375290967461,0.31030444964871196,0.9644124340997822,1.0,52/348,12.55%,LRP8;GDF1;MAPK3;RALB;PTPRJ;LIMCH1;RAP2A;PIN1;PTPRC;MTCP1;PECAM1;TAB2;RPTOR;RPS6KA4;SRC;STOX1;BCAR3;PRKD2;RPS6KA5;HDAC3;TEK;NPTN;CIB1;CDKN1A;TBX1;FXR1;CALM3;RAPGEF3;BDNF;SIRT1;TXN;LCP2;AXIN1;EFNA1;AKTIP;ACVRL1;CDK2AP1;CSF1R;LYN;PAK1;PARK7;DOCK7;ACVR2A;CD81;DDX3X;APP;MMD;PRNP;CRKL;RAP2C;WDFY2;NBN
prerank,ion homeostasis (GO:0050801),0.37022573398111674,1.059511012032919,0.35494880546075086,0.9635963802120813,1.0,4/30,4.22%,SLC4A4;SLC4A5;KLHL3;NEDD4L
prerank,positive regulation of proteolysis (GO:0045862),-0.29199839301987646,-1.059427239006827,0.34759358288770054,0.7366596719886898,1.0,23/55,30.30%,NRDC;OGT;CYFIP2;FBXW11;RHBDD1;BTRC;IST1;CCBE1;TBC1D10A;RCN3;TNIP1;GPLD1;TANK;ATP5IF1;STUB1;PINK1;NKD2;ADRA2A;PERP;ZC3H12A;CTSC;PACSIN3;FGFR4
prerank,phosphatidylglycerol metabolic process (GO:0046471),-0.3548294203702363,-1.0592616499807461,0.3552941176470588,0.7362596406574022,1.0,7/24,19.44%,PLA2G4A;LPGAT1;CDS2;SLC27A1;CRLS1;PGS1;LPCAT1
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.42092507176065913,1.0592535436862822,0.38022813688212925,0.9632849743451649,1.0,2/16,0.93%,NCBP1;RBMXL1
prerank,positive regulation of dendrite extension (GO:1903861),0.41414556940845343,1.0585363579512985,0.37714285714285717,0.964593018787896,1.0,2/17,4.22%,CPNE5;NEDD4L
prerank,presynaptic endocytosis (GO:0140238),-0.3523004752263578,-1.0583941380985809,0.3794749403341289,0.7377336196082387,1.0,10/24,23.10%,AMPH;NLGN2;STON2;NLGN1;STON1;VAMP2;STX1A;SYT2;PACSIN1;NLGN3
prerank,cellular response to organic substance (GO:0071310),-0.2550244532548011,-1.0582574892246353,0.3007246376811594,0.7372696979499305,1.0,33/116,19.93%,ROBO2;NFAT5;PTPN13;AKAP6;SMAD3;DPYSL3;IGFBP5;PTPN14;TGFBR1;PID1;TGFBR2;CTNNB1;RHOA;GHR;CLEC3B;ACVR1;SOCS2;ACVR1B;RAMP1;IL1RAPL1;IL18;NCOA1;RACK1;TGFB1;BMPR1B;PTPN23;PTPN2;CDK9;TWF2;RPS6KB1;BMPR1A;CPNE3;BMPR2
prerank,cellular response to glucose stimulus (GO:0071333),0.37152778609347786,1.0579905215403982,0.38353765323992994,0.965272268744665,1.0,6/30,10.32%,PCK1;SELENOT;RAB11B;RAB11FIP5;RAB11FIP2;PRKAA2
prerank,regulation of endopeptidase activity (GO:0052548),-0.28857521873458514,-1.0575991759936065,0.35,0.7383334941011698,1.0,8/59,9.69%,SPOCK3;NRDC;TIMP3;SPOCK1;TIMP2;HDAC1;BIRC3;VTN
prerank,regulation of leukocyte chemotaxis (GO:0002688),0.4091129161526717,1.0575786995911438,0.37985865724381623,0.965464053398731,1.0,4/18,16.33%,CAMK1D;LYN;MTUS1;PTK2B
prerank,regulation of inclusion body assembly (GO:0090083),-0.44781850933619904,-1.057490549209411,0.3903966597077244,0.7378116967873793,1.0,9/11,49.67%,SNCAIP;SACS;DNAJB2;BAG5;DNAJA4;DNAJB1;HSPA1A;HSPA1B;HSPA2
prerank,regulation of fibroblast migration (GO:0010762),0.4089141649847035,1.0573605246757576,0.3857677902621723,0.9650234108412522,1.0,4/20,8.47%,PRR5L;RFFL;ARHGEF7;GNA12
prerank,axonal transport (GO:0098930),0.35139675817090227,1.0573461669397095,0.38193343898573695,0.9638587997556395,1.0,10/36,14.02%,SOD1;KIF1B;AP3S1;DST;DTNBP1;TMEM108;AP3M2;KIF3B;AP3M1;SNAPIN
prerank,mitotic spindle organization (GO:0007052),0.2792833187728843,1.0569515198256845,0.36569148936170215,0.9640619335193866,1.0,36/153,17.78%,ABRAXAS1;DYNC1I1;EML1;KIF18A;NUDC;PLK2;CLASP2;NEK9;DCTN2;MAP4;CDCA8;CENPC;MZT1;KIF2A;DYNLL1;BCCIP;MIS12;TNKS;XPO1;KIF3B;CHEK2;NEK6;PTPA;EFHC2;ARHGEF10;RCC1;DYNC1I2;CLIP1;CENPP;CENPO;STAG2;KPNB1;NUP160;CLASP1;RANGAP1;PAFAH1B1
prerank,proteasome assembly (GO:0043248),0.44888525072227053,1.0568390667252254,0.3875968992248062,0.9632190904668284,1.0,3/11,7.67%,PSMD5;PSMD11;PSMG1
prerank,action potential (GO:0001508),-0.30311783519359997,-1.0566534232167808,0.33238636363636365,0.7392512842517686,1.0,10/44,13.06%,ANK3;AKAP6;KCND2;SCN8A;SCN3A;KCNJ2;SCN1A;KCNA1;SRI;CACNA1G
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.3925779445169026,1.0566188296936883,0.3961937716262976,0.9627492352262634,1.0,4/21,9.48%,RPL23;RPL5;FBXO5;RAB1A
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.3990157710907385,1.056507061303652,0.38392857142857145,0.96191698320656,1.0,11/20,20.81%,CNOT7;AGO4;HELZ;CNOT6;CNOT1;MOV10;WTIP;EIF6;AGO1;CNOT8;TNRC6A
prerank,protein deacylation (GO:0035601),0.38752012734396213,1.0563040283859038,0.40350877192982454,0.9613497596392021,1.0,5/23,7.30%,PPT1;HDAC7;HDAC3;SIRT3;SIRT1
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.38572196261991293,1.055620378533886,0.3912280701754386,0.9624244718736646,1.0,9/24,18.59%,ABCB10;ABCG2;TSPO;COX15;COX10;SLC25A38;ALAS1;FECH;NFE2L1
prerank,proteoglycan metabolic process (GO:0006029),-0.3487789795731301,-1.054497297375851,0.38498789346246975,0.7443477493829084,1.0,6/26,10.38%,IGF1;SULF1;ADAMTS12;SULF2;CSGALNACT2;CHST11
prerank,positive regulation of protein catabolic process (GO:0045732),0.3054158035752629,1.0543577588469795,0.395738203957382,0.9655539640745965,1.0,17/84,13.85%,GSK3A;SH3D19;TNFAIP3;PLK2;NEDD4L;VPS11;APOE;RAB7A;TNFRSF1B;PTTG1IP;AXIN1;WNT5A;ATG7;EGLN2;NDUFA13;FAF1;APC
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.36731334121309345,-1.0542565994057596,0.37723214285714285,0.7433390003268989,1.0,2/21,0.72%,EYA2;EYA1
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),-0.36731334121309345,-1.0542565994057596,0.37723214285714285,0.7433390003268989,1.0,2/21,0.72%,EYA2;EYA1
prerank,positive regulation of JUN kinase activity (GO:0043507),0.38522127146268176,1.0539557399844384,0.3833922261484099,0.9657600203167841,1.0,6/23,14.82%,MAP3K11;MAP3K7;MAP3K4;PAK1;RPS3;MAP3K10
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.36644068080666997,1.053775295653333,0.3853658536585366,0.9639805317088318,1.0,5/29,11.77%,MLYCD;DBI;ACAT1;GPAT4;ACOT8
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.36644068080666997,1.053775295653333,0.3853658536585366,0.9639805317088318,1.0,5/29,11.77%,MLYCD;DBI;ACAT1;GPAT4;ACOT8
prerank,monocarboxylic acid biosynthetic process (GO:0072330),-0.2883951503651746,-1.0535505980579551,0.3457142857142857,0.7444387950213527,1.0,9/59,10.59%,ALDH1A2;OSBPL9;OSBPL6;CYP27A1;SRR;CYP7B1;PER2;OSBP;ACLY
prerank,positive regulation of RNA splicing (GO:0033120),0.36513982093755026,1.0529809002131738,0.37300177619893427,0.9655175813413637,1.0,4/29,6.86%,NCBP1;RBMXL1;RBM22;RBM20
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),0.45221987254846274,1.052684485164475,0.3903846153846154,0.9653288397725069,1.0,4/12,17.55%,JMJD4;FYCO1;BNIP3;INSR
prerank,sphingoid biosynthetic process (GO:0046520),0.46578334325214465,1.0526177408360855,0.4227188081936685,0.9631697445510435,1.0,2/11,11.63%,ACER2;ACER3
prerank,sphingosine biosynthetic process (GO:0046512),0.46578334325214465,1.0526177408360855,0.4227188081936685,0.9631697445510435,1.0,2/11,11.63%,ACER2;ACER3
prerank,histone H4-K5 acetylation (GO:0043981),0.42354935988880216,1.0522997417034914,0.39165009940357853,0.9618409882954526,1.0,5/15,14.04%,JADE3;ING4;KANSL2;KANSL3;HCFC1
prerank,histone H4-K8 acetylation (GO:0043982),0.42354935988880216,1.0522997417034914,0.39165009940357853,0.9618409882954526,1.0,5/15,14.04%,JADE3;ING4;KANSL2;KANSL3;HCFC1
prerank,regulation of centrosome duplication (GO:0010824),0.36482450583881443,1.0522154315724392,0.40036563071297987,0.9609469183942068,1.0,5/29,10.22%,ALMS1;PLK2;CHMP1A;SIRT1;CHMP2A
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.43067634319317843,1.0521433245290206,0.4024822695035461,0.9600001629962454,1.0,2/14,8.56%,OXSR1;WNT5A
prerank,regulation of platelet aggregation (GO:0090330),0.4152799288708117,1.0518181427975977,0.3977485928705441,0.9598958959388465,1.0,4/17,9.31%,PRKG1;SYK;F11R;LYN
prerank,positive regulation of cell growth (GO:0030307),0.29872053528087666,1.051751224856504,0.36524300441826213,0.9589404625940806,1.0,15/96,10.80%,CPNE5;NCBP1;SEMA7A;DERL2;RPS6KA1;RPTOR;NEDD4L;CIB1;BDNF;RUFY3;USP47;EXOSC9;LGI1;EIF4G2;DDX3X
prerank,negative regulation of protein depolymerization (GO:1901880),-0.3489992024357945,-1.051616334487879,0.3947990543735225,0.7488813134467315,1.0,7/24,13.07%,NAV3;PLEKHH2;HDGFL3;LIMA1;STMN2;TTBK2;TAOK1
prerank,cellular iron ion homeostasis (GO:0006879),0.3250084439890353,1.0516040785906355,0.3724035608308605,0.9582273072586105,1.0,10/55,12.09%,CAND1;HMOX2;SOD1;ABCG2;FBXL5;ATP6V0D1;ISCU;GLRX3;ATP6AP1;ACO1
prerank,membrane fusion (GO:0061025),-0.3220933866263819,-1.051258752600162,0.3704600484261501,0.749029716097968,1.0,12/33,22.63%,RIMS1;UBXN2A;UBXN2B;HUWE1;MYOF;NSFL1C;DNM1;VAMP2;USO1;SNAP29;VPS33B;GCA
prerank,telomere capping (GO:0016233),0.407547706071365,1.0511342974292581,0.3850574712643678,0.9586160243539529,1.0,7/16,17.41%,CTC1;DCLRE1B;ACD;NBN;TERF2IP;PRKDC;DCLRE1C
prerank,RNA catabolic process (GO:0006401),0.3356098876011802,1.0509054460070386,0.3706070287539936,0.958263477100818,1.0,7/46,11.25%,ZC3H12D;NCBP1;NUDT12;RNASE6;XRN2;DXO;AGO4
prerank,inflammatory response (GO:0006954),0.27278606713140024,1.0509027018861927,0.3515527950310559,0.9571023313833207,1.0,21/195,13.20%,HRH4;PTGER2;PIK3CG;TACR1;FCGR2B;HDAC9;LY75;NFX1;ABCF1;F11R;CCL25;RELA;CSF1R;PJA2;IL10RB;MFHAS1;NOD1;PIK3CD;IKBKB;CHUK;HDAC5
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.38003554836318076,1.0505482887168605,0.4028268551236749,0.9571944844074861,1.0,7/24,13.83%,MAP3K7;TNFAIP3;TAB2;TAB3;UBE2V1;NOD1;MAP2K6
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.3836318329966035,1.0499099424963256,0.39404553415061294,0.9582258935900194,1.0,6/24,11.69%,CTC1;SRC;ERCC4;HNRNPC;ACD;TNKS
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),-0.4638911789371448,-1.0498482357961927,0.41237113402061853,0.7520882633183504,1.0,6/10,20.31%,OSR1;HECW1;CAMK2D;COMMD1;HECW2;NEDD4
prerank,telomere organization (GO:0032200),0.33941911468445773,1.0497700434417112,0.3893653516295026,0.9575188130733047,1.0,13/43,16.75%,CTC1;ERCC4;DCLRE1B;POLD3;ACD;TERT;HUS1;NBN;DOT1L;LTO1;TERF2IP;ATR;PRKDC
prerank,negative regulation of cellular component organization (GO:0051129),-0.2793995155519104,-1.0497582234176117,0.3068181818181818,0.7514767457319471,1.0,24/74,22.32%,BMP6;TMEFF2;WASL;PRKCZ;SORL1;IRAK3;FAP;GSK3B;EPHA3;HSF1;SYT11;SACS;SCAMP5;RAF1;LRSAM1;PEX5;CDC42;CRYAB;RIOK3;DNAJB2;RTEL1;PRKD1;VEGFA;IMPACT
prerank,determination of left/right symmetry (GO:0007368),0.35480476089191626,1.0496004878686316,0.39865996649916247,0.9569473362259706,1.0,6/36,13.20%,RFX3;TBX1;NOTCH1;CITED2;DAND5;KIF3B
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.36921040348714,1.0495839823157813,0.39896373056994816,0.9558511960930752,1.0,4/27,7.75%,MAP3K7;TAB2;TIRAP;TAB3
prerank,regulation of intracellular transport (GO:0032386),-0.30983268211287474,-1.0494319161480368,0.36597938144329895,0.7514745231386076,1.0,16/38,29.14%,MAP2;DYNC1H1;ATP9A;TTC21B;GAS1;RBM4;ATPSCKMT;RINT1;RNF139;CRYAB;AAAS;NUP214;DYNLT2B;CAPN10;INPP5F;NEFH
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.24252649147144312,1.0492659954653223,0.27318548387096775,0.9557378949983566,1.0,268/1646,14.92%,TBX4;SOX30;LRRFIP1;DBX2;ATF3;IRX1;PRKAR1A;TOX4;MAZ;ZBTB42;CTCFL;MAP2K7;FOXQ1;CCDC85B;GCLC;DACH1;MECOM;SIM1;ELOC;SS18L1;ARID5A;ONECUT1;ILF3;KLF8;TRAPPC2;L3MBTL4;FOXN2;TRIB3;TFCP2;NR4A2;CDK17;MTERF3;TAL1;EZH2;ACTL6A;ATF6;TRIM28;ZFAT;HSPA8;LEF1;HES6;CIPC;EED;CTDSP1;RUVBL2;PPP3CB;BTAF1;GTF2IRD1;RPS6KA1;DMAP1;PHF14;RPS6KA4;KLF2;CCNC;HIPK2;ATXN1L;ELK3;ING4;PAX8;ZHX3;ZBTB24;ZBTB33;HDAC9;GABPA;BCL6B;BACH2;RPS6KA5;BCL11B;SMAD1;HDAC3;ZKSCAN1;PHF5A;PPP2CA;PRDM15;SBNO2;HNRNPAB;HEY1;NR5A1;RLF;ZBTB41;APOE;CCNH;IRF9;MYBL2;FLI1;BBX;SMARCA2;SOX2;MEIS1;HNRNPK;YY1;PHB2;GMEB2;TOX3;ZNF83;KDM3A;KDM2A;SPIN1;ZNF740;USF2;UBE2I;ZSCAN2;CDKN1A;NPAT;IRF2BPL;EP300;VEZF1;RFX3;TBX1;ZNF260;NFX1;MED23;CARF;RET;PCGF3;TGFBRAP1;SRSF10;CEBPG;CALCOCO1;CNOT2;FOXF2;ACTR8;MAMLD1;PPARD;MED12;CDK11B;CHMP1A;ZNF205;SFPQ;CDC45;FBXO5;UXT;SMAD7;SIRT1;ACTR5;DRAP1;CLOCK;RNF187;ZNF3;PFDN5;HEY2;AXIN1;SETD5;ZBTB14;NOTCH1;CAND2;RUVBL1;USP47;CNOT7;WNT5A;LCORL;ATXN7L3;ATAD2;GTF2H1;ZXDC;SOX13;ACVRL1;RSF1;RELA;SOD2;JUND;NAB2;POLA1;HOXA7;PCID2;BCLAF1;MDM2;RAI1;PLCB1;PIAS2;TFAP4;ERG;PKN1;RNF6;TRPS1;TSFM;ZKSCAN3;KLF6;UBE2V1;CIR1;TAF15;CITED2;YEATS4;RYBP;ING2;PBXIP1;CHD1;WBP2;CCAR2;MGA;HIC2;ESR1;SETD3;RBPJ;NLK;DACH2;RHOG;HP1BP3;CREBBP;USP22;CARM1;CTBP1;PIAS1;NFIC;MED4;PA2G4;POLR3F;JMJD1C;HDGF;PICALM;LANCL2;ILF2;E2F3;SP1;IKBKB;MZF1;SMARCD1;MDFIC;IRF2;CHD3;ERC1;NUP35;CHUK;PITHD1;ACTA2;ZBTB45;ZSCAN12;RRP8;YWHAH;NDUFA13;TRRAP;TGIF1;CTBP2;HDAC5;ING5;EPAS1;EDRF1;CHEK2;DDIT3;SP110;THRA;ZKSCAN5;BRD2;CREBRF;HES1;KDM5C;HCFC1;YBX1;GRHL1;SP8;RNF20;SIX5;PHF8;PURG;NCOA7;BAZ2A;NSD2;CAMKK2;AEBP2;E2F6;TMPRSS6;BRIP1;BACH1;MAP3K10;PHF10;FUS;TSHZ1;TFAM
prerank,methylguanosine-cap decapping (GO:0110156),0.4680620908375087,1.0487139174082172,0.4168260038240918,0.9564406974638248,1.0,5/10,19.40%,PATL2;PATL1;DCP1A;LSM1;DCP1B
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.36600777429541786,-1.0484473341138003,0.38979118329466356,0.75334509950652,1.0,7/20,23.35%,IGF1;FOXC1;NIBAN2;DDRGK1;TGFB1;GTF2B;LAMTOR5
prerank,regulation of neuron apoptotic process (GO:0043523),0.29663745803033276,1.0481426631228798,0.36427566807313644,0.9572750380839917,1.0,19/96,12.23%,FOXQ1;SOD1;CRLF1;PPT1;SIGMAR1;APOE;TOX3;WFS1;AKT1S1;BDNF;SOD2;FZD9;PARK7;SRPK2;NAE1;EGLN2;PRNP;NF1;PRKCI
prerank,MAPK cascade (GO:0000165),0.2589007901026906,1.0479208252301124,0.32929782082324455,0.9568117884480872,1.0,55/295,14.57%,GFRA3;PSMB10;PSMC4;MAP2K7;PSMB6;MAPK3;DUSP7;PSMD8;SPTB;PSMD5;PSMD12;MAP3K7;SHANK3;NRAS;ZFP36L1;PSMD11;TEK;PSMB4;FYN;SPRED1;PSMC1;RASGRP3;MAPK8;RET;FGF13;YWHAB;IRS2;MINK1;PSMC2;PAK1;PSMD2;ICMT;RASA2;NF1;TNIP2;MAP4K4;IKBKB;ARTN;MAPK12;PDE6D;CUL3;CHUK;ZDHHC9;NRG2;PSMD14;PPP5C;PSMC6;PSMD1;RGL2;PSMB1;PTPRA;MAP3K3;RGL3;GFRA1;CAMKK2
prerank,negative regulation of cell development (GO:0010721),-0.34213510979180617,-1.047134646633322,0.40399002493765584,0.7561921118512346,1.0,5/25,10.56%,IGF1;FBN1;APPL2;SORL1;GSK3B
prerank,inorganic cation import across plasma membrane (GO:0098659),-0.2736858191277199,-1.0461308894047718,0.36363636363636365,0.7582278695291323,1.0,28/75,27.26%,ATP1A2;ATP1B1;SLC6A1;ATP1B3;SLC12A2;SLC39A14;ATP1A1;KCNJ2;ATP1B2;SLC24A2;KCNJ6;SLC9A2;ABCC9;SLC39A8;SLC12A6;KCNJ13;SLC12A4;ATP1A3;SLC12A9;KCNJ10;SLC39A6;CACNA2D1;SLC12A7;KCNK9;HCN2;TRPV2;SLC12A8;SLC12A5
prerank,negative regulation of protein polymerization (GO:0032272),-0.343764896407598,-1.046125651287151,0.3883495145631068,0.7573860961861584,1.0,13/27,21.72%,MAP2;EML2;PRKCD;STMN2;CLIP3;MYADM;HIP1R;KANK4;STMN1;TUBB4A;TWF2;SSH1;PFN2
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),-0.45233953813842115,-1.046009367501926,0.42943548387096775,0.7568389172035453,1.0,7/10,31.21%,SIRT2;BAG3;JUN;IMPACT;VHL;HIF1AN;NCK1
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),-0.3374304700238824,-1.0459786163723441,0.37438423645320196,0.756079415781507,1.0,10/27,18.74%,TNS2;PID1;PRKCZ;ENPP1;PRKCD;PIP4K2B;GRB10;PTPN2;TSC2;RPS6KB1
prerank,response to UV-B (GO:0010224),0.44417171698395097,1.0459382884548063,0.4003831417624521,0.9624077861884193,1.0,3/12,9.03%,MME;CDKN1A;RELA
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.44568877648591065,1.0457129119203168,0.39878542510121456,0.9620415045517765,1.0,3/13,10.92%,TDG;UPP2;SMUG1
prerank,regulation of protein transport (GO:0051223),0.3696064962429655,1.0454922937928832,0.39649122807017545,0.9616333667571669,1.0,5/27,11.58%,LCP1;HSPA8;STXBP5L;RHBDF2;SCFD1
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.3002534073788653,1.045486997805496,0.40441176470588236,0.9604885026361706,1.0,17/83,14.75%,CDK17;PLK2;CCNH;CDKN1A;NPAT;POLE;CDC45;FBXO5;CDK4;LATS2;POLA1;USP37;E2F3;CUL3;PHF8;RCC1;BACH1
prerank,positive regulation of protein polymerization (GO:0032273),-0.27729524083069,-1.0451194694445363,0.35777126099706746,0.7575893604359493,1.0,25/65,28.01%,NAV3;MAPT;OCLN;FER;CTTN;AKAP9;SLAIN2;BIN1;BAIAP2L1;FCHSD2;CDC42EP5;DCTN1;CDC42EP1;MET;PINK1;PFN2;TPPP;HSP90AA1;TPPP3;TTBK1;CDC42EP2;NCKAP1L;ARL2;TOGARAM1;MAPRE1
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.42278620131097533,1.044827366048623,0.4084249084249084,0.9615065652168132,1.0,4/15,13.09%,TTLL12;CNOT7;USP18;NLRC5
prerank,regulation of dendrite morphogenesis (GO:0048814),-0.3231511162898575,-1.0447466898595394,0.3791348600508906,0.7577679985779835,1.0,14/32,20.84%,ADGRB3;CUX1;SDC2;HECW1;GSK3B;CUX2;SEMA4D;IL1RAPL1;OBSL1;RAPGEF2;HECW2;KNDC1;NEDD4;NSMF
prerank,negative regulation of protein metabolic process (GO:0051248),-0.3001256458168578,-1.0446055797183362,0.3609625668449198,0.7573051946230671,1.0,18/48,19.07%,EGFR;FLNA;SIRT2;FLOT2;FMN2;ROCK1;IRAK3;LDLR;BANP;AZIN1;EIF2AK1;NFKB1;VBP1;PFDN2;CYP51A1;CRYAB;SNX3;MDM4
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.2514279131087127,1.0444190225350547,0.34994337485843713,0.9617032639104363,1.0,56/417,10.43%,CCDC85B;GCLC;DACH1;MECOM;ARID5A;ILF3;L3MBTL4;TRIB3;MTERF3;EZH2;TRIM28;HSPA8;LEF1;CIPC;EED;BTAF1;DMAP1;ELK3;ING4;ZHX3;ZBTB33;HDAC9;RPS6KA5;HDAC3;SBNO2;HEY1;SMARCA2;PHB2;UBE2I;RFX3;PPARD;CHMP1A;SFPQ;SIRT1;CLOCK;PFDN5;HEY2;ZBTB14;NOTCH1;USP47;CNOT7;WNT5A;SOX13;RSF1;RELA;HOXA7;BCLAF1;MDM2;PLCB1;TFAP4;ZKSCAN3;CIR1;CITED2;PBXIP1;CCAR2;HIC2
prerank,positive regulation of B cell activation (GO:0050871),0.33049253748769597,1.044372765684642,0.4,0.9606867565096971,1.0,8/50,12.21%,PTPRC;VAV3;TIRAP;SYK;IRS2;CD81;KMT5B;TNIP2
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.3687600866214351,1.0438032052151902,0.3916083916083916,0.961391571823211,1.0,8/28,13.83%,MAP3K7;TNFAIP3;TAB2;TAB3;RELA;UBE2V1;NOD1;MAP2K6
prerank,cellular response to estradiol stimulus (GO:0071392),0.40627375593194814,1.0431058338881047,0.39965095986038396,0.9625679756148714,1.0,3/18,10.45%,RUVBL2;CCDC62;ESR1
prerank,regulation of DNA-dependent DNA replication (GO:0090329),-0.41967974412803066,-1.042697769981826,0.42250530785562634,0.7618179492552032,1.0,4/12,20.02%,KAT7;WRNIP1;METTL4;BLM
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.42496826884324623,1.0424818613823226,0.43257443082311736,0.9635079345419981,1.0,6/14,16.18%,SFSWAP;SRSF10;SRSF4;PTBP1;SRSF7;U2AF2
prerank,morphogenesis of an epithelium (GO:0002009),0.3733138477846244,1.042433776080709,0.4028268551236749,0.9625277695191433,1.0,5/25,10.61%,PRKX;ACTB;DAG1;LIN7C;TRAF3IP1
prerank,heart trabecula morphogenesis (GO:0061384),-0.3843124732231764,-1.0422421183237736,0.394273127753304,0.7623135827974363,1.0,5/18,7.87%,TGFBR3;TGFBR1;BMP5;BMP7;RBP4
prerank,positive regulation of gene expression (GO:0010628),-0.21573550267844518,-1.0421370455698613,0.3402061855670103,0.7617992674507399,1.0,83/442,15.15%,ANK2;DDX5;BMP6;NTRK3;ANK3;RIMS1;SLC24A3;IGF1;ROBO1;PLD1;SAMD4A;EGFR;GSN;SMAD3;ITGB8;FOXD1;NTRK2;FGF1;TGFBR1;MAPK14;PID1;OCLN;MED26;BMP7;VIM;ELAVL4;PRKAG1;MED1;BMP4;PPARGC1A;ROCK2;OSR1;SMO;F3;EPB41L4B;ADAM19;DEK;ERCC6;ROCK1;HOXA5;FUBP3;PLA2R1;PIK3R3;POLDIP3;PRR16;EIF3C;MAP2K2;YTHDF1;EZR;NIBAN1;UBR5;THBS1;EIF2AK2;TLE1;AGO3;AFDN;PLSCR1;GSK3B;GJA1;EPHB2;CAMK2N1;EEF2;FN1;CUX2;TP53;FAM98A;CD34;DDRGK1;RBM3;IFNGR1;RPS7;SNF8;PDCD5;POLR2A;IL33;HINFP;ATM;DDX21;VSTM2A;SETX;PTPN22;SCAMP5;PLXNB2
prerank,mismatch repair (GO:0006298),0.3724951778704684,1.0417729781498224,0.40341880341880343,0.9635479297149744,1.0,6/27,9.71%,TDG;PMS2;POLD3;MLH1;PMS1;MSH3
prerank,negative regulation of DNA binding (GO:0043392),0.36474742725389475,1.041592741848354,0.4228855721393035,0.9629999229952981,1.0,7/28,13.89%,LEF1;HEY1;HEY2;RSF1;TFAP4;TNKS;NFKBIA
prerank,regulation of peptidase activity (GO:0052547),-0.3682758388540929,-1.0415069281498845,0.37969094922737306,0.762722628302713,1.0,5/19,19.93%,NRDC;HDAC1;ECM1;RCN3;PINK1
prerank,mitotic cytokinesis (GO:0000281),-0.29912478025237393,-1.041430046631332,0.37662337662337664,0.7620830234543563,1.0,18/47,29.16%,ANK3;SON;ROCK2;CIT;ROCK1;KLHDC8B;RHOB;MITD1;TRIM36;STMN1;JTB;SNX18;RHOC;SPTBN1;CNTROB;RAB35;EFHC1;RTKN
prerank,cardiac ventricle morphogenesis (GO:0003208),-0.3067776584488055,-1.0412220355793937,0.3870967741935484,0.7618336920216124,1.0,5/41,4.74%,FGFR2;TGFBR3;TGFBR2;TPM1;BMP4
prerank,regulation of ion transmembrane transporter activity (GO:0032412),-0.3069899597123152,-1.0410326707660398,0.3850415512465374,0.7615547477915224,1.0,7/39,7.69%,ANK2;FGF12;CACNA1D;FHL1;WWP2;CHRM3;PTPN3
prerank,protein ADP-ribosylation (GO:0006471),-0.3447018297579438,-1.0407460060135638,0.37844611528822053,0.7615501462332601,1.0,13/28,21.51%,PARP4;ZC3HAV1;PARP14;SIRT2;PARP6;PARP3;ART3;ARF4;PARP12;PARP1;SIRT5;PARP16;PARP2
prerank,nuclear membrane organization (GO:0071763),-0.3681175508740474,-1.0404580817289604,0.41037735849056606,0.7615254875266961,1.0,13/19,35.37%,UBXN2A;UBXN2B;TOR1AIP1;NSFL1C;TOR1B;DCTN1;NEMP1;VPS4A;EMD;TMEM43;TOR1A;GPER1;CHMP7
prerank,canonical Wnt signaling pathway (GO:0060070),-0.27701965271873485,-1.0404211747199672,0.36607142857142855,0.7607855239912477,1.0,20/68,17.78%,WNT5B;FZD6;RYK;CTNNB1;PLPP3;DIXDC1;CSNK1A1;WNT4;LRP5;CSNK1E;DVL3;FZD2;GSK3B;WNT9A;SCYL2;LRP6;TCF7L2;FZD4;DVL1;SFRP4
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.34330766904902704,1.04040674254393,0.3983606557377049,0.9657691654434053,1.0,9/36,16.16%,EZH2;EED;UXT;BMI1;RYBP;MGA;APAF1;E2F6;RBBP4
prerank,negative chemotaxis (GO:0050919),0.3552001201158409,1.0403189891197469,0.40640809443507586,0.9649368012193408,1.0,6/33,9.12%,SEMA6A;SEMA6D;SEMA7A;SEMA3C;SEMA6B;SEMA4C
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.3465439223554818,1.0399754891198651,0.40604026845637586,0.9649889982844481,1.0,13/37,18.51%,EIF5A;SOD1;SFPQ;BCLAF1;BAD;RPS3;BMF;DDIT3;DNM1L;BECN1;BCAP31;BAX;FBH1
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.3525242070400762,1.039523755198473,0.4174917491749175,0.9654128723080306,1.0,6/33,8.88%,MAP2K5;APOE;MMRN2;RGCC;NOTCH1;ACVRL1
prerank,regulation of rRNA processing (GO:2000232),-0.39017187596844644,-1.0392815665317754,0.40397350993377484,0.763208313148059,1.0,8/16,32.22%,RIOK1;RIOK2;WDR43;SIRT7;UTP15;BUD23;KAT2B;YTHDF2
prerank,positive regulation of mRNA metabolic process (GO:1903313),0.43453838368340403,1.0392731570530866,0.4141048824593128,0.9651360785730099,1.0,6/13,20.76%,PRR5L;CNOT7;CNOT1;MOV10;RC3H1;CNOT8
prerank,nitrogen compound transport (GO:0071705),0.27597821208024986,1.0387232860205187,0.38639455782312926,0.9658039095081328,1.0,14/141,7.90%,SLC18A1;SLC5A7;SLC7A8;ABCG2;PPT1;SLC3A2;SLC52A2;RAMP2;RAB7A;SLC52A3;SLC6A6;CHMP1A;TMEM30B;SLC44A1
prerank,cAMP-mediated signaling (GO:0019933),-0.3442783936527632,-1.0382552974279553,0.3995381062355658,0.7652494729536773,1.0,4/24,3.20%,KSR1;AKAP6;ADCY2;ADCY1
prerank,protein maturation (GO:0051604),-0.2563004792288296,-1.0381150349686632,0.3704918032786885,0.7648424868164921,1.0,33/95,25.94%,AEBP1;OGT;PCSK2;PCSK5;MMP16;MMP14;F3;SORL1;ADAM19;CCS;BACE1;NAA40;ADAMTS3;CPM;NNAT;AFG3L2;PCSK6;NFU1;DDI2;MMS19;HSPD1;PITRM1;ISCA1;STUB1;CASP2;NAA60;CPXM2;CIAO1;CLN3;TSPAN15;PTCH1;APH1B;CPXM1
prerank,signal peptide processing (GO:0006465),0.45552060436854375,1.0379384621479153,0.4397810218978102,0.9673561081677889,1.0,4/11,13.54%,SEC11A;SPCS3;SPPL3;SPCS2
prerank,activation of phospholipase C activity (GO:0007202),-0.33069973819752674,-1.0377087227024446,0.3706293706293706,0.7651261467835621,1.0,5/29,6.20%,LPAR1;EGFR;NTRK2;ARHGAP6;EDNRA
prerank,neural tube closure (GO:0001843),-0.3135556531000784,-1.037587890836967,0.37745098039215685,0.764632981853189,1.0,17/34,31.82%,LMO4;SKI;COBL;MTHFR;DVL3;MTHFD1;PLXNB2;LRP6;TGFB1;DVL1;TSC2;PAX2;BCL10;FUZ;KDM2B;SCRIB;VANGL2
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.3875203280398324,-1.0373742981970804,0.3894736842105263,0.7643885660930752,1.0,4/16,6.19%,PDGFRB;NRP1;FER;PDGFRA
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),-0.4495208464844827,-1.0370626848393445,0.4342379958246347,0.7643945639658449,1.0,3/10,15.42%,RYK;CTNNB1;LRP6
prerank,positive regulation of TORC1 signaling (GO:1904263),-0.3887348515071163,-1.0368310993004886,0.42616033755274263,0.7641906856343161,1.0,12/16,36.55%,GPR137C;KLHL22;SEH1L;FLCN;TELO2;LAMTOR5;PIP4P1;GPR137B;PIH1D1;RRAGD;GPR137;RRAGA
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.24790686020774086,1.0366033151772458,0.36924803591470257,0.970634762469734,1.0,94/497,16.14%,CCDC85B;GCLC;DACH1;MECOM;GSK3A;ARID5A;ILF3;L3MBTL4;TRIB3;MTERF3;EZH2;TRIM28;HSPA8;LEF1;CIPC;PATL2;EED;BTAF1;DMAP1;ELK3;ING4;ZHX3;ZBTB33;HDAC9;RPS6KA5;HDAC3;SBNO2;HEY1;SMARCA2;PHB2;UBE2I;DBI;CDKN1A;RFX3;FXR1;PAIP2B;PPARD;CHMP1A;SFPQ;SIRT1;CLOCK;PFDN5;HEY2;ZBTB14;NOTCH1;USP47;CNOT7;WNT5A;TSC1;SOX13;ACVRL1;RSF1;RELA;HOXA7;BCLAF1;MDM2;PLCB1;TFAP4;ZKSCAN3;CIR1;CITED2;PBXIP1;CCAR2;HIC2;DDX3X;RBPJ;NANOS3;CTBP1;RPS3;PA2G4;LANCL2;MDFIC;NDUFA13;CTBP2;HDAC5;DDIT3;THRA;HES1;KDM5C;YBX1;CNOT1;CAPRIN1;TMPRSS6;MAP3K10;PHF10;GAS6;NKAP;BCL6;TRIM33;ATR;SMARCA4;ID2;HEYL;ZBTB18
prerank,eosinophil chemotaxis (GO:0048245),-0.39644058997195347,-1.0365943243015052,0.40772532188841204,0.7632068666544207,1.0,3/14,22.13%,SCG2;CX3CL1;CCL13
prerank,eosinophil migration (GO:0072677),-0.39644058997195347,-1.0365943243015052,0.40772532188841204,0.7632068666544207,1.0,3/14,22.13%,SCG2;CX3CL1;CCL13
prerank,negative regulation of heart contraction (GO:0045822),0.4433401800075724,1.0360565596934672,0.40594059405940597,0.9713066234342731,1.0,2/11,1.75%,PIK3CG;PDE4D
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.4037154527752552,1.035229105720469,0.42857142857142855,0.9730726718139708,1.0,4/18,8.04%,GSK3A;HDAC3;BDNF;NOTCH1
prerank,cellular calcium ion homeostasis (GO:0006874),-0.24648746330293175,-1.0348710644924317,0.3713235294117647,0.7672527754725138,1.0,24/133,14.53%,ANK2;SLC24A3;HTR2C;STIM2;MCU;PDZD8;ATP1B1;PACS2;STIM1;ATP13A5;TRPC5;MICU2;PML;HERPUD1;TRPC1;PRKACA;SLC24A2;DMPK;CAMK2D;CCL14;TMCO1;AFG3L2;SLC35G1;CAV2
prerank,sarcomere organization (GO:0045214),-0.3394329339063031,-1.034676560515582,0.4063926940639269,0.7669366244255393,1.0,4/27,14.39%,TPM1;ACTN2;CSRP2;WDR1
prerank,positive regulation of brown fat cell differentiation (GO:0090336),-0.4075194492991947,-1.0346298943659977,0.3991683991683992,0.7662272002495918,1.0,7/13,20.94%,BMP7;RREB1;NAPEPLD;VSTM2A;SIX1;PTGS2;TFE3
prerank,regulation of sprouting angiogenesis (GO:1903670),0.3559042747873933,1.034498385185799,0.4134453781512605,0.9744262820860069,1.0,5/33,4.06%,SEMA6A;JMJD8;KLF2;SMAD1;PPP1R16B
prerank,DNA damage checkpoint signaling (GO:0000077),0.36284221218389545,1.034284591422582,0.41047297297297297,0.9739810567859738,1.0,10/28,16.91%,TIPRL;RAD1;CLOCK;HUS1;NBN;DOT1L;CHEK2;BRIP1;ATR;USP28
prerank,carnitine shuttle (GO:0006853),-0.4276794731933821,-1.0342641884819113,0.4271047227926078,0.7664260595071066,1.0,4/11,14.84%,PRKAG2;CPT1A;PRKAB2;CPT2
prerank,regulation of dopamine secretion (GO:0014059),-0.34265998714985096,-1.0340272644126156,0.3761904761904762,0.7663127118491581,1.0,11/25,30.46%,SYT9;SYT12;SYT11;SYT4;SYT7;SYT2;KCNA2;SYT10;SYT6;SNCA;DRD2
prerank,protein K63-linked ubiquitination (GO:0070534),-0.3046763986966011,-1.0340226861070765,0.40669856459330145,0.7654893478208248,1.0,17/41,26.40%,RNF152;UBE2N;HECTD1;WWP2;RNF4;RNF135;RNF168;RNF8;TRAF3IP2;TRAF2;TRIM5;STUB1;NEDD4;ARIH2;UBE2B;UBE2E2;UBE2S
prerank,epithelial tube morphogenesis (GO:0060562),0.3590519342841716,1.0338661127178013,0.4058219178082192,0.974304628386349,1.0,7/32,9.75%,PRKX;PRKD2;ACVRL1;RASIP1;CSF1R;PODXL;PAK1
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.3464162081211393,1.0338505501308153,0.3964110929853181,0.9732172796380985,1.0,9/35,13.91%,PTPRC;OCIAD1;NOTCH1;IL10RB;NLK;CYP1B1;ADIPOR1;DOT1L;HES1
prerank,negative regulation of apoptotic process (GO:0043066),0.2503533633735677,1.0337546907821953,0.3857302118171683,0.9724090682353959,1.0,63/444,12.44%,CIDEA;HIGD2A;MAZ;FOXQ1;GCLC;MAPK3;CBL;NR4A2;LEF1;SOD1;PSEN2;PLK2;RPS6KA1;PRKCH;BCL2L2;GREM1;CRLF1;PPT1;SRC;MAP2K5;BIRC2;HDAC3;APOE;TEK;CIAPIN1;HNRNPK;PHB2;TOX3;WFS1;CFL1;CIB1;MAPK8;TBX1;CARD16;BAG1;SFPQ;PIM1;BDNF;SIRT1;NAA35;NOTCH1;USP47;WNT5A;TJP1;MERTK;RELA;SOD2;PCID2;FZD9;FZD3;PARK7;TMBIM4;CITED2;PRKAA2;DDX3X;HIGD1A;ANKLE2;PA2G4;BNIP3L;PRKCI;MAP4K4;IKBKB;API5
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.31391545692842626,1.0335748708694465,0.4143302180685358,0.9718630781465387,1.0,19/63,17.96%,PLK2;CNOT11;CDKN1A;EP300;CRADD;CNOT2;RGCC;CNOT7;MDM2;RFWD3;CARM1;CNOT6;CHEK2;CNOT1;CNOT6L;PRKDC;CNOT10;BAX;RPL26
prerank,cellular response to catecholamine stimulus (GO:0071870),0.38272277242331443,1.0335258768569908,0.42226148409893993,0.9709044326669344,1.0,3/23,6.32%,MAPK3;GABPA;GNB1
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.4523304200361879,1.033172273922268,0.42915811088295686,0.9709572520219674,1.0,4/11,16.15%,CCT2;CCT5;TCP1;DKC1
prerank,regulation of apoptotic process (GO:0042981),0.24516033970079018,1.0328580581808797,0.38329764453961457,0.9708045246913951,1.0,106/676,13.89%,LRP8;CIDEA;HIGD2A;ERCC3;GCLC;MAP3K11;CBL;ATF6;FRZB;LEF1;ACER2;TIAM1;SOD1;VAV3;PSEN2;PLK2;RPS6KA1;BCL2L2;GLS2;CHM;GREM1;DNAJA3;ARHGEF26;PPT1;SRC;MCF2L;ING4;PAX8;BIRC2;NME1;HDAC3;ITSN1;SIGMAR1;TNFRSF10B;TEK;CIAPIN1;HNRNPK;SLK;PHB2;TOX3;CASP6;WFS1;CFL1;CIB1;AKT1S1;MAPK8;BAG1;ARHGEF6;CRADD;ARHGEF7;PIM1;TRIO;ACTN4;SIRT1;OMA1;NAA35;ARHGEF18;USP47;WNT5A;ITGA6;TJP1;PHLPP1;FBXO11;LATS2;RELA;PCID2;BCLAF1;FZD9;TFAP4;PARK7;TARDBP;AIFM1;TMBIM4;CITED2;RYBP;PRKAA2;ING3;CCAR2;BAD;NAE1;DDX3X;CYP1B1;CREBBP;HIGD1A;ANKLE2;RPS3;PA2G4;ATG7;EGLN2;BMF;IP6K2;BNIP3L;NF1;PRKCI;MAP4K4;IKBKB;API5;ERC1;ING5;UTP11;DIABLO;AVEN;FAF1;PROC;APC;NFKBIA
prerank,gluconeogenesis (GO:0006094),0.3447170920059635,1.0328441215964113,0.4178082191780822,0.9697192995434988,1.0,4/39,5.68%,PCK1;SLC25A1;GOT2;TPI1
prerank,positive regulation of lamellipodium assembly (GO:0010592),-0.3472842779527088,-1.0326394392948233,0.3786848072562358,0.7684550026065083,1.0,10/24,20.89%,WASF2;AUTS2;OCLN;PLCE1;ACTR3;ACTR2;CDC42;TWF2;PIK3R1;ARPC2
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.4384380354837394,1.03259509326875,0.43148148148148147,0.9694130676436032,1.0,3/12,10.58%,BCDIN3D;ESR1;TERT
prerank,regulation of centriole replication (GO:0046599),0.4040340216134992,1.0325605912420945,0.43622920517560076,0.9684005581676846,1.0,2/17,2.58%,ALMS1;PLK2
prerank,gas transport (GO:0015669),0.46914366839610977,1.03209302780857,0.453027139874739,0.9688048384213781,1.0,1/10,3.99%,CA2
prerank,response to organophosphorus (GO:0046683),-0.38196409221422384,-1.0320720348822578,0.4,0.7693285829988468,1.0,9/16,40.77%,P2RX4;ABCC9;STAT1;DGKQ;TRIM16;TRPC3;TYMS;RFC3;VGF
prerank,negative regulation of response to external stimulus (GO:0032102),-0.2539581288331148,-1.031956787726062,0.37943262411347517,0.7688015465241336,1.0,23/105,17.92%,LRFN5;CTNNA2;GRID2;PTPRS;PPM1B;SIRT2;ILRUN;PRKCD;PPARA;PTGIS;IRAK3;TRAFD1;OTULIN;SIRPA;RORA;SELENOS;AJAP1;CCN3;PTPN2;ENPP3;CERS2;TNFAIP6;CD109
prerank,ncRNA catabolic process (GO:0034661),-0.33677210438741145,-1.0318911306402059,0.42857142857142855,0.7681494163739735,1.0,15/28,35.07%,LIN28B;EXOSC10;SND1;DIS3L;MTREX;DIS3;TRIR;RBM7;ZCCHC8;EXOSC8;EXOSC2;DEDD2;EXOSC3;EXOSC5;TENT4B
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.2837040643937754,-1.0317805853760769,0.3982808022922636,0.7676358206233981,1.0,13/57,13.37%,UACA;GRIN2B;CYFIP2;MALT1;FIS1;LGMN;GRAMD4;MAP3K5;CTSD;AIM2;USP50;PDCD5;TBC1D10A
prerank,protein localization to nucleus (GO:0034504),-0.25355334505024485,-1.0316748462454204,0.34951456310679613,0.7671184459262941,1.0,49/102,32.77%,COL1A1;TOR1AIP2;BMP7;IPO9;BMP4;LMNA;TNPO3;APPL2;PML;NUP155;NUP188;BANP;TOR1AIP1;IPO11;NUP88;NUP93;TNPO2;TOPORS;TAF8;TOR1B;FAM53C;PAF1;NUTF2;DVL1;IPO13;TSC2;NUP85;SIX1;NUP214;APPL1;TBRG1;GBP2;CTDNEP1;PPP1R10;AKT1;NOP53;SEC13;SUPT7L;RPF2;ARL2;NUP153;ABCA7;BCL3;NXT2;RPAIN;RAN;TOR1A;EIF4ENIF1;HEATR3
prerank,regulation of TOR signaling (GO:0032006),0.3083318172408599,1.0315718593142462,0.4024024024024024,0.9694534781906173,1.0,15/67,15.25%,GSK3A;RPTOR;RFFL;HDAC3;EPM2A;AKT1S1;LAMTOR1;SIRT1;GNA12;TSC1;PRKAA2;LARS1;RRAGC;TMEM127;GAS6
prerank,nucleotide-sugar metabolic process (GO:0009225),0.43880153664077526,1.031446540081663,0.4220532319391635,0.9687735645623207,1.0,4/12,12.61%,CSGALNACT1;EXTL2;UGP2;SLC35A3
prerank,positive regulation of inflammatory response (GO:0050729),-0.262606777615883,-1.0309449553756143,0.3862928348909657,0.7682941541340088,1.0,26/86,29.10%,OSMR;SNX4;NUPR1;LBP;NAPEPLD;IL16;IL17RA;GPR4;IL18;IL33;IL6ST;TNIP1;GPRC5B;AGTR1;CX3CL1;SETD4;PLA2G7;VAMP8;TLR3;FEM1A;SERPINE1;PDE2A;CCN4;KARS1;MDK;SNCA
prerank,regulation of purine nucleotide metabolic process (GO:1900542),-0.303601838934824,-1.0309242926212732,0.370757180156658,0.7675294627765503,1.0,16/41,22.88%,PRKAG2;OGT;PRKAG1;NUP205;NUP155;NUP188;NUP88;NUP93;SEH1L;LACC1;NUP85;AAAS;RAE1;NUP37;NUP214;PGAM1
prerank,Notch signaling involved in heart development (GO:0061314),0.4525139025274387,1.030865829329039,0.4126984126984127,0.9695761939302053,1.0,5/11,16.10%,HEY1;HEY2;NOTCH1;RBPJ;HEYL
prerank,negative regulation of MAP kinase activity (GO:0043407),0.3291200041918739,1.0308117552502463,0.4035656401944895,0.9686280800330733,1.0,4/44,4.59%,RGS2;DUSP7;PTPRJ;APOE
prerank,regulation of axon regeneration (GO:0048679),-0.4076215624488311,-1.0306996842533307,0.42084168336673344,0.7673113139864731,1.0,5/12,33.70%,PTPRS;CERS2;SCARF1;INPP5F;PTN
prerank,synaptic vesicle endocytosis (GO:0048488),-0.3196024893694038,-1.030375177127357,0.3856041131105398,0.7673773553990868,1.0,13/33,19.98%,DNAJC6;AMPH;SNAP91;NLGN2;STON2;NLGN1;STON1;DNM1;VAMP2;STX1A;ITSN2;SYT2;PACSIN1
prerank,cellular component assembly (GO:0022607),-0.22169742928258512,-1.0301623494707985,0.28901734104046245,0.7671428115098106,1.0,61/253,20.02%,CALD1;ANK3;RIMS1;TEAD1;PAWR;GSN;PARVA;DPYSL3;GPM6B;LRRTM3;KMT2A;PCLO;LIMA1;WASL;DLG4;WIPF1;OCLN;RHOA;NLGN2;FLNA;NEDD9;PPARGC1A;TAPBP;TUBGCP4;PEX14;PML;WASF1;DARS1;YTHDF1;NLGN1;EZR;PPID;TLCD2;RHOJ;DCX;TP53;ILK;STK25;BAIAP2L1;RANBP9;IKBKG;AFG3L2;WDR19;BSN;VAMP2;MYO1B;QSOX1;TGFB1;TRAF2;DVL1;CDC42;CARD10;CLDN14;ADD2;ZFYVE27;MDM4;TEAD2;SHANK1;SPG7;TTLL3;ZW10
prerank,acidic amino acid transport (GO:0015800),-0.3773611286602435,-1.0301501540222857,0.40969162995594716,0.7663607809617087,1.0,6/17,10.60%,SLC1A3;SLC6A13;LRRC8D;SLC6A1;SLC25A13;GJA1
prerank,endothelial tube morphogenesis (GO:0061154),-0.4352198061159318,-1.0300112032132904,0.4233128834355828,0.7659336341652654,1.0,5/10,12.11%,CTNNB1;RHOA;BMP4;STARD13;RHOB
prerank,innate immune response in mucosa (GO:0002227),-0.44520260467473693,-1.0299475216966796,0.4190064794816415,0.7652867393048083,1.0,2/10,16.05%,RNASE3;DEFA6
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.24085484803994633,1.029875431680634,0.3630769230769231,0.9705157218077902,1.0,191/1082,14.94%,SOX30;ATF3;MAZ;CTCFL;MAP2K7;MAPK3;MECOM;CHCHD2;SS18L1;ONECUT1;EIF5A;ILF3;TFCP2;NR4A2;TAL1;ATF6;TRIM28;PIN1;LEF1;RUVBL2;PPP3CB;RPS6KA1;RPTOR;RPS6KA4;KLF2;MRTFA;CCNC;GREM1;PCBP1;HIPK2;ELK3;MAP2K5;PAX8;GABPA;PRKD2;RPS6KA5;BCL11B;MRTFB;SMAD1;HDAC3;PHF5A;PRDM15;SBNO2;HNRNPAB;HEY1;NR5A1;RLF;MMP12;APOE;CCDC62;PRDM4;MYBL2;FLI1;SMARCA2;SOX2;MEIS1;YY1;TOX3;KDM3A;SPIN1;USF2;IER2;NPAT;IRF2BPL;EP300;VEZF1;DCAF6;RFX3;TBX1;ICE1;ASXL3;RET;CEBPG;CALCOCO1;FOXF2;PPARD;MED12;RGCC;SFPQ;SMAD7;SIRT1;DRAP1;PAXBP1;CLOCK;TET3;RNF187;HEY2;LMO7;AXIN1;NOTCH1;CAND2;GLMP;WNT5A;ITGA6;ATXN7L3;ATAD2;GTF2H1;ZXDC;ACVRL1;RSF1;RELA;JUND;HOXA7;PCID2;BCLAF1;RAI1;ECD;PLCB1;TFAP4;ERG;PARK7;RNF6;KANSL3;AKAP8L;RHOQ;ZKSCAN3;PPP1R12A;KLF6;LMO2;UBE2V1;TAF15;CITED2;YEATS4;RYBP;ING2;WBP2;ESR1;ACVR2A;CD81;SETD3;THRB;DDX3X;RBPJ;RHOG;CREBBP;USP22;APP;NFIC;ZBED3;MED4;ATAD2B;ZBED4;TNKS;PPP3CA;PICALM;PPP3R1;AGRN;ILF2;TNIP2;E2F3;SP1;IKBKB;SS18;MZF1;SMARCD1;MDFIC;IRF2;DOT1L;CHUK;PITHD1;ACTA2;YWHAH;NLRC5;CTBP2;HDAC5;ING5;EPAS1;EDRF1;CHEK2;DDIT3;POGZ;THRA;SSBP4;CREBRF;NFKBIA;HES1;DR1;HCFC1;YBX1;GRHL1;RNF20;PHF8;NCOA7;HEATR1;CAMKK2;SCAF8;TMPRSS6;CRTC3;PHF10;TFAM;INO80
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.24280722392054926,1.0295565280186725,0.37995824634655534,0.970442714359255,1.0,140/834,14.06%,SOX30;ATF3;CTCFL;MAPK3;CHCHD2;SS18L1;ONECUT1;EIF5A;TFCP2;NR4A2;TAL1;ATF6;PIN1;LEF1;RUVBL2;PPP3CB;RPS6KA1;RPS6KA4;KLF2;MRTFA;CCNC;GREM1;PCBP1;HIPK2;ELK3;MAP2K5;PAX8;GABPA;PRKD2;RPS6KA5;BCL11B;MRTFB;SMAD1;HDAC3;PRDM15;SBNO2;HEY1;NR5A1;RLF;MMP12;CCDC62;PRDM4;MYBL2;SMARCA2;SOX2;MEIS1;YY1;TOX3;USF2;IER2;NPAT;IRF2BPL;EP300;VEZF1;DCAF6;RFX3;TBX1;ASXL3;CEBPG;CALCOCO1;FOXF2;PPARD;MED12;RGCC;SFPQ;SMAD7;SIRT1;DRAP1;PAXBP1;CLOCK;TET3;HEY2;LMO7;NOTCH1;GLMP;WNT5A;ITGA6;ATAD2;ACVRL1;RSF1;RELA;JUND;HOXA7;BCLAF1;ECD;ERG;PARK7;KANSL3;AKAP8L;RHOQ;PPP1R12A;KLF6;LMO2;CITED2;YEATS4;WBP2;ESR1;ACVR2A;TERT;CD81;SETD3;THRB;DDX3X;RBPJ;CREBBP;APP;NFIC;ZBED3;MED4;ATAD2B;ZBED4;TNKS;PPP3CA;PPP3R1;AGRN;TNIP2;E2F3;SP1;IKBKB;SS18;MZF1;SMARCD1;IRF2;DOT1L;CHUK;NLRC5;CTBP2;HDAC5;EPAS1;DDIT3;POGZ;THRA;SSBP4;CREBRF;NFKBIA;HES1;DR1;HCFC1;YBX1;GRHL1
prerank,cellular response to oxidative stress (GO:0034599),0.2825757638539469,1.0292085854682875,0.3978638184245661,0.9704587431548606,1.0,16/118,10.32%,MAPK3;ROMO1;CHCHD2;PRR5L;TXNRD2;SLC25A24;SOD1;EIF2S1;CYCS;ZFAND1;MAPK8;LONP1;GPX7;SOD2;PARK7;PRKAA2
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.4068149966129876,-1.028700972358874,0.40589569160997735,0.7678786308067135,1.0,3/14,7.78%,PUM1;PUM2;ZDHHC5
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.31216244463156045,1.0282880409398893,0.40428790199081166,0.9723367470508449,1.0,13/59,13.89%,MAP3K7;TAB2;BIRC2;TAB3;NLRC3;RELA;RBCK1;NFKBIL1;IKBKB;ERC1;CHUK;FAIM;NFKBIA
prerank,negative regulation of interleukin-2 production (GO:0032703),0.3974714675119845,1.028255665718702,0.4359430604982206,0.9713439609142722,1.0,3/18,3.58%,PTPRC;TNFAIP3;HDAC7
prerank,maintenance of blood-brain barrier (GO:0035633),0.35459538430800597,1.028171616782345,0.4166666666666667,0.9705013998453483,1.0,10/30,13.38%,SLC1A1;PECAM1;ACTB;F11R;TJP1;ESAM;CLDN5;DMD;CDH5;LSR
prerank,regulation of lamellipodium organization (GO:1902743),-0.40038493540923425,-1.0273615749858402,0.4251101321585903,0.770772268099436,1.0,6/14,25.42%,PDPN;FER;CDC42;TWF2;CAPZB;DMTN
prerank,regulation of epithelial cell migration (GO:0010632),0.32278915123051,1.027331357112599,0.40993788819875776,0.9721928692255567,1.0,7/51,4.76%,PTPRR;PTPRG;SRC;CLASP2;EVL;INSL3;PFN1
prerank,negative regulation of interferon-beta production (GO:0032688),-0.4433877934783795,-1.0271943740098994,0.4444444444444444,0.7704183663314871,1.0,5/10,13.01%,PTPRS;PPM1B;REL;SIRPA;RELB
prerank,ephrin receptor signaling pathway (GO:0048013),0.3004177215903248,1.0270573336961075,0.4006024096385542,0.9720539954586731,1.0,17/82,10.61%,ARPC3;TIAM1;VAV3;PSEN2;AP2S1;ACTB;SRC;ITSN1;ARPC4;FYN;PAK3;ARHGEF7;EPHA5;EFNA1;LYN;PAK1;YES1
prerank,tRNA wobble base modification (GO:0002097),0.4210219538332285,1.0267836314765066,0.4266409266409266,0.9718655971087914,1.0,1/14,0.85%,MOCS3
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.44543951143180915,1.0266153749646663,0.43570057581573896,0.9713011324947853,1.0,2/13,6.81%,SYK;AP1G1
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.40925145244014605,-1.0265789816230884,0.4166666666666667,0.7713159448016299,1.0,4/12,33.41%,IL18;IL17D;CD80;PAEP
prerank,regulation of cell growth (GO:0001558),0.26634127308159167,1.026527570438234,0.41002570694087404,0.9704862048201256,1.0,29/204,12.38%,CISH;CCDC85B;NCBP1;PTPRJ;FRZB;ST7L;DERL2;RPS6KA1;RPTOR;RERG;PPT1;LTBP4;PPP2CA;SMARCA2;CIB1;CDKN1A;LAMTOR1;CDK11B;SIRT1;USP47;EXOSC9;ACVRL1;LGI1;EIF4G2;CCAR2;DDX3X;EGLN2;IP6K2;EI24
prerank,long-chain fatty acid transport (GO:0015909),-0.32260922232066064,-1.0261925764147333,0.41578947368421054,0.7715736461840221,1.0,7/30,14.84%,PRKAG2;ACSL1;CPT1A;PRKAB2;SLC27A1;ABCD2;CPT2
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.41212779843735,-1.025970066835914,0.4394904458598726,0.7713115783018927,1.0,6/13,26.46%,RNF168;RNF8;NELFB;NELFA;LARP7;SUPT4H1
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.31865832132813965,1.0258924050280496,0.3939873417721519,0.9714757861071811,1.0,8/50,10.80%,RPS6KA1;SRC;MAP2K5;RFFL;CARD16;USP47;PARK7;DDX3X
prerank,receptor-mediated endocytosis (GO:0006898),-0.2435790020344786,-1.0256685220179442,0.3948339483394834,0.7713051901325101,1.0,31/132,14.60%,DNAJC6;LRP1;DAB2;CALCRL;AP2B1;SNAP91;AP2A2;PDLIM7;SORL1;LRP1B;HSPG2;CTTN;WASF1;GPR107;RAB31;AP2A1;SPARC;LDLR;GRK3;ACKR3;IGF2R;RAMP1;GRB2;HIP1R;DNM1;M6PR;DNAJC13;VLDLR;FCHSD2;CAV2;LMBR1L
prerank,fatty acid transport (GO:0015908),0.41090717121932674,1.025357918503028,0.4204946996466431,0.9721519935610603,1.0,3/17,6.77%,GOT2;APOE;PPARD
prerank,ncRNA transcription (GO:0098781),0.43121811403858934,1.0251662497485041,0.4153846153846154,0.9716754594823555,1.0,3/13,6.79%,GTF3C1;SPIN1;POLR1G
prerank,cellular response to insulin stimulus (GO:0032869),0.2802441163120664,1.0251383634912896,0.4005235602094241,0.9706606325408488,1.0,33/124,18.41%,PCK1;GSK3A;TRIB3;INSIG1;BCAR3;HDAC9;ATP6V1D;ZFP36L1;ATP6V0D1;MYO5A;AP3S1;TBC1D4;IRS2;ATP6V0E1;RHOQ;ATP6AP1;PRKCI;GRB14;HDAC5;APC;ZDHHC7;DENND4C;PIK3C2A;ATP6V1B2;NAMPT;SHC1;PRKDC;BAIAP2;INSR;C2CD5;SYAP1;ATP6V1A;IRS1
prerank,lysine metabolic process (GO:0006553),0.4351605816528006,1.02502843698451,0.4318181818181818,0.9688076395167096,1.0,3/12,15.27%,AASS;PHYKPL;SLC25A21
prerank,lysine catabolic process (GO:0006554),0.4351605816528006,1.02502843698451,0.4318181818181818,0.9688076395167096,1.0,3/12,15.27%,AASS;PHYKPL;SLC25A21
prerank,mRNA processing (GO:0006397),0.25536520481399694,1.0249386753504452,0.4345738295318127,0.9679731859008013,1.0,46/287,10.99%,POLR2J;ERCC3;SNRPD2;NCBP1;RBM22;HSPA8;POLR2B;PRPF31;PRPF3;SNRPD1;HNRNPH2;PCBP1;PHF5A;SF1;CCNH;PRPF40A;HNRNPK;CPSF4;CHTOP;PPIL3;PLRG1;SRSF10;SNRNP27;PRCC;SFPQ;HNRNPC;GEMIN5;SMNDC1;YTHDC1;SF3B3;SRSF4;DNAJC8;SNU13;NOVA2;SARNP;GTF2H1;PRMT9;SF3A1;RSRC1;AKAP8L;BUD31;SYF2;U2AF1;CPSF6;PAPOLA;EFTUD2
prerank,negative regulation of T cell proliferation (GO:0042130),0.3580525127040916,1.0246256154752302,0.4414715719063545,0.9678869910247376,1.0,3/28,13.00%,PRKAR1A;PRNP;CD274
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.3771841136911053,-1.024058964536487,0.4322429906542056,0.7749857146919047,1.0,2/17,1.05%,BMP6;SASH1
prerank,negative regulation of osteoclast differentiation (GO:0045671),-0.36868588073886227,-1.0240283470996479,0.4442013129102845,0.7742501239786367,1.0,7/18,35.43%,FBN1;TCTA;TLR3;GPR137B;TMEM178A;MAFB;GPR137
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.4413126332276156,1.023997965449332,0.4524714828897338,0.9688357172915218,1.0,3/12,10.76%,TRIB3;SIRT1;ERLIN2
prerank,DNA integrity checkpoint signaling (GO:0031570),0.3477627942982482,1.0236213735759339,0.4358974358974359,0.9688993246699662,1.0,11/36,16.91%,TIPRL;RAD1;CDC45;CLOCK;HUS1;NBN;DOT1L;CHEK2;BRIP1;ATR;USP28
prerank,cellular response to interleukin-6 (GO:0071354),-0.3319097231883794,-1.023459684000125,0.4014423076923077,0.7751019203849425,1.0,8/26,10.66%,ST18;JAK1;PID1;SMAD4;FER;IL6R;PTGIS;NFKB1
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.35055721505396875,1.0234344607078354,0.4118673647469459,0.9683928705851877,1.0,9/29,15.69%,COG5;COPG2;GOSR2;RAB6B;NAPA;RAB6A;COPG1;COG3;TRAPPC10
prerank,negative regulation of vascular permeability (GO:0043116),0.4457928731699733,1.02334848742217,0.43366336633663366,0.9676146673929067,1.0,3/12,9.84%,PTPRJ;RAMP2;CLDN5
prerank,response to interleukin-6 (GO:0070741),0.46984887570992667,1.023214294924173,0.42911153119092627,0.9669362153441584,1.0,4/10,11.91%,SBNO2;PTPRT;RELA;ST3GAL6
prerank,lipoprotein catabolic process (GO:0042159),0.455706097713913,1.0231966049356547,0.4381338742393509,0.9659115461031264,1.0,2/11,4.59%,PPT1;APOE
prerank,negative regulation of RNA metabolic process (GO:0051253),0.39677351331708977,1.0231950776623642,0.4275618374558304,0.9648362012070871,1.0,4/18,11.65%,RPS26;ESR1;TERT;PTBP1
prerank,regulation of vasculature development (GO:1901342),-0.3418341548057625,-1.0231519521600174,0.43781094527363185,0.7751945886192284,1.0,12/26,37.62%,ADGRA2;BMPER;CTNNB1;PLXND1;EMP2;ERBB2;SFRP1;EGLN1;HTATIP2;ETS1;EPHA2;VASH1
prerank,aromatic amino acid family catabolic process (GO:0009074),-0.3860414718100018,-1.0227025495362612,0.41648106904231624,0.775701229207437,1.0,4/15,25.24%,GSTZ1;KYAT1;QDPR;FAH
prerank,striated muscle cell development (GO:0055002),0.41154553948730727,1.0226250642158115,0.411214953271028,0.9656018400410203,1.0,2/14,4.82%,PGM5;FLII
prerank,mitochondrion distribution (GO:0048311),-0.4088926892882988,-1.0224065340168107,0.4322033898305085,0.7757500191815381,1.0,3/12,10.29%,MAPT;TRAK1;ARMC1
prerank,sulfur compound biosynthetic process (GO:0044272),-0.25147646232846227,-1.0222730541749665,0.4265232974910394,0.7753041884660461,1.0,42/104,28.53%,UST;DSE;GLCE;B4GALT1;CHSY1;VCAN;OGN;SLC26A2;SLC35B3;CSGALNACT2;GGTA1;CHST15;GSTT1;B4GALT6;CHST11;GSTZ1;SLC35D2;UGDH;CSPG4;GGT5;ST3GAL4;PAPSS2;PRELP;DSEL;ESD;LUM;B4GALT4;GSTA4;GSTM1;CDO1;BGN;DCN;CHPF2;CHST2;OPLAH;CHAC2;HPGDS;CHST3;MGST1;CSPG5;OMD;CHST12
prerank,negative regulation of calcium ion transport (GO:0051926),-0.395929600018201,-1.0222418395344612,0.43683083511777304,0.7745633807889425,1.0,1/15,0.15%,ATP1A2
prerank,regulation of lymphocyte migration (GO:2000401),-0.43526473786289294,-1.0221616928619703,0.44509803921568625,0.7739504858180166,1.0,3/10,24.53%,WASL;MSN;AKT1
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.3757499317034912,1.0220941587701495,0.4456140350877193,0.9662275474422893,1.0,3/22,4.99%,EIF5A;RPL23;SPRED1
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.23705135872398897,1.0218665069010742,0.39134808853118713,0.9658935031352794,1.0,294/1668,16.22%,TBX4;SOX30;LRRFIP1;DBX2;ATF3;IRX1;PRKAR1A;TOX4;MAZ;ZBTB42;CTCFL;DCAF1;FOXQ1;DACH1;MAPK3;MECOM;CHCHD2;AASS;SIM1;ELOC;SS18L1;ARID5A;ONECUT1;EIF5A;KLF8;TRIB3;TFCP2;NR4A2;TAL1;EZH2;ACTL6A;ATF6;TRIM28;PIN1;LEF1;HES6;RPL23;EED;CTDSP1;RUVBL2;JAZF1;PPP3CB;GTF2IRD1;RPS6KA1;DMAP1;PHF14;RPS6KA4;KLF2;MRTFA;CCNC;GREM1;DNAJA3;PCBP1;HIPK2;ELK3;MAP2K5;PAX8;ZHX3;ZBTB24;ZBTB33;HDAC9;GABPA;BCL6B;BACH2;PRKD2;RPS6KA5;BCL11B;MRTFB;SMAD1;HDAC3;ZKSCAN1;PRDM15;SBNO2;HEY1;NEDD4L;NR5A1;RLF;MMP12;ZBTB41;APOE;CCNH;IRF9;CCDC62;PRDM4;MYBL2;FLI1;BBX;SMARCA2;SOX2;MEIS1;HNRNPK;YY1;GMEB2;TOX3;ZNF83;WFS1;KDM3A;KDM2A;VPS72;ZNF740;USF2;IER2;UBE2I;ZSCAN2;CDKN1A;NPAT;IRF2BPL;BEND3;EP300;VEZF1;DCAF6;RFX3;RPS14;TBX1;ZNF260;NFX1;MED23;CARF;ASXL3;PCGF3;CEBPG;CALCOCO1;CNOT2;FOXF2;MAMLD1;PPARD;MED12;RGCC;ZNF205;SFPQ;UXT;SMAD7;SIRT1;BMI1;DRAP1;PAXBP1;CLOCK;TET3;ZNF3;HEY2;LMO7;ZBTB14;NOTCH1;MED15;SAP130;EDNRB;GLMP;RUVBL1;CDK4;WNT5A;ITGA6;LCORL;ATXN7L3;ATAD2;EFNA1;GTF2H1;ZXDC;SOX13;ACVRL1;RSF1;RELA;CSF1R;SOD2;JUND;HOXA7;BCLAF1;MDM2;RAI1;ECD;PIAS2;TFAP4;ERG;PKN1;PARK7;TRPS1;KANSL3;AKAP8L;BUD31;RHOQ;ZKSCAN3;PPP1R12A;KLF6;LMO2;CIR1;CITED2;YEATS4;CHD1;WBP2;MGA;HIC2;ESR1;ACVR2A;CD81;SETD3;THRB;DDX3X;RBPJ;DACH2;CREBBP;CTBP1;AGO4;APP;PIAS1;ORC2;NFIC;ZBED3;MED4;ATAD2B;ZBED4;TNKS;JMJD1C;HDGF;IFI27;PPP3CA;PPP3R1;AGRN;TNIP2;N4BP2L2;E2F3;SP1;IKBKB;SS18;MZF1;SMARCD1;IRF2;CHD3;DOT1L;CHUK;ZBTB45;ZSCAN12;NLRC5;TGIF1;CTBP2;HDAC5;EPAS1;DDIT3;SP110;POGZ;THRA;SSBP4;ZKSCAN5;BRD2;CREBRF;NFKBIA;HES1;DR1;HCFC1;YBX1;GRHL1;TRIM27;SP8;SIX5;PHF8;PURG;USP9X;NCOA7;CNOT1;AEBP2;E2F6;TMPRSS6;BRIP1;BACH1;CRTC3;PHF10;FUS;TSHZ1;INO80;EZH1;PRDM10;TCF20;ZFP62;MOV10;TFEB;TAF6L;NKAP;TCERG1;NAMPT;FOXJ3;TAF1;ELK4;BCL6;WIZ;TRIM33;AKIRIN1;SMARCA4;ID2;ZNF483;TCF7L1;TCF3;HEYL;TSHZ2;ZBTB18;PURB;TAF3
prerank,positive regulation of macrophage differentiation (GO:0045651),-0.43336212209972624,-1.0216102915757677,0.4543524416135881,0.7745962699660327,1.0,3/11,16.23%,IL34;HSF1;TGFB1
prerank,regulation of lamellipodium assembly (GO:0010591),-0.3130631622141679,-1.0215750847382614,0.4117647058823529,0.7738728235312602,1.0,12/34,20.89%,WASF2;AUTS2;OCLN;FER;PLCE1;ACTR3;ACTR2;CDC42;TWF2;CAPZB;PIK3R1;ARPC2
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.41348691727142256,1.0215316511435115,0.44802867383512546,0.9647930885255526,1.0,4/15,14.50%,ZFP36L1;CNOT7;NANOS3;CNOT1
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.41348691727142256,1.0215316511435115,0.44802867383512546,0.9647930885255526,1.0,4/15,14.50%,ZFP36L1;CNOT7;NANOS3;CNOT1
prerank,negative regulation of fibroblast proliferation (GO:0048147),-0.3675763290561037,-1.0214161717866979,0.4139433551198257,0.7735228066713558,1.0,10/18,33.75%,SKI;CDC73;TP53;MED25;PEX2;EMD;SFRP1;B4GALT7;CD300A;TRIM32
prerank,negative regulation of catabolic process (GO:0009895),-0.29173091535726,-1.021267596678439,0.4021164021164021,0.7731248609496875,1.0,10/47,9.26%,EGFR;HDAC4;FLNA;SIRT2;NUPR1;FMN2;PPARA;IRAK3;BANP;AZIN1
prerank,kinetochore organization (GO:0051383),0.4228451076883539,1.0212542166504235,0.44509803921568625,0.9645700167356329,1.0,3/13,13.56%,CENPC;MIS12;POGZ
prerank,endothelial cell migration (GO:0043542),-0.30515606846236054,-1.021151277750909,0.42782152230971127,0.772629337853169,1.0,18/37,26.43%,FSTL1;ADGRA2;NRP1;RHOA;PXN;DPP4;STARD13;FAP;PLEKHG5;PLXND1;CCN3;SCG2;STAT1;TNFSF12;VEGFA;EMP2;NR4A1;RAB13
prerank,regulation of mesenchymal cell proliferation (GO:0010464),-0.41739471958278745,-1.0206946978166318,0.4410058027079304,0.7731878390658002,1.0,3/11,7.88%,FGFR2;TGFBR2;LRP5
prerank,regulation of glycogen biosynthetic process (GO:0005979),-0.33012451014894845,-1.02049560437424,0.4292237442922374,0.7729334820015548,1.0,7/24,15.93%,SORBS1;IGF1;ENPP1;AKT2;GSK3B;IGF2;SELENOS
prerank,regulation of transcription by RNA polymerase I (GO:0006356),-0.3713240207187971,-1.0201816957338627,0.4364406779661017,0.7729905180556818,1.0,8/18,25.56%,FLNA;WDR43;SIRT7;ATF4;UTP15;EIF2AK3;ERBB2;POLR2K
prerank,very long-chain fatty acid metabolic process (GO:0000038),-0.31883519580647757,-1.020135424973563,0.40232558139534885,0.7723082900108358,1.0,7/30,15.09%,ACSL1;HACD3;HACD1;HACD4;TECR;ABCD2;PEX2
prerank,regulation of protein kinase C signaling (GO:0090036),-0.39775787130560314,-1.0198558701686256,0.4342379958246347,0.77227975601841,1.0,10/14,39.85%,ADGRV1;ULK4;MYADM;GPD1L;ADRA1A;VEGFA;FLT4;WNT11;CD40;SPHK2
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.24377154869227724,1.0197537568049821,0.4144144144144144,0.9684852509489079,1.0,83/509,14.28%,RAC2;MAZ;PIK3CG;CBL;TRIB3;ZDHHC17;PIK3AP1;JMJD8;PTPRJ;PTPRC;MAP3K7;RPL23;TAB2;PLK2;RPTOR;EEF1D;TIRAP;SRC;BCAR3;TRIM8;PRKD2;BIRC2;HDAC3;IFI35;ZDHHC13;TNFRSF10B;TEK;SOX2;FYN;PHB2;TMED4;TRIM14;EDAR;GPR89A;EP300;TBX1;CARD16;RET;LAMTOR1;TRAF5;SELP;ACTN4;SIRT1;TXN;IRS2;VWF;TAB3;TRIM25;WNT5A;RELA;RBCK1;LYN;BCLAF1;LURAP1;PARK7;UBE2V1;RNF13;ESR1;BAD;MFHAS1;DDX3X;RHOG;FLT1;USP15;APP;NOD1;PIK3CD;RPS3;PIK3R5;BMF;TNIP2;IKBKB;LARS1;CHUK;RRAGC;NRG2;PPP5C;DDIT3;ANKRD17;NEK6;ATP2C1;TRIM27;MAP3K3
prerank,UV-damage excision repair (GO:0070914),0.4330081963610023,1.0196409806094107,0.44510978043912175,0.9677830679496795,1.0,5/12,14.94%,SIRT1;ACTR5;POLD3;POLA1;INO80
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.4438413021958255,1.0196389367715983,0.43920145190562615,0.9667163682166723,1.0,3/11,11.25%,FYN;PARK7;UBQLN1
prerank,COPII-coated vesicle budding (GO:0090114),0.30775451872882825,1.0195205806150696,0.4107946026986507,0.9660408644324144,1.0,13/68,12.83%,TRAPPC2;CNIH1;ANKRD28;SEC23IP;GOSR2;F8;NAPA;TMED10;RAB1A;SCFD1;TRAPPC6B;MCFD2;CUL3
prerank,protein O-linked glycosylation (GO:0006493),-0.25376097911053164,-1.0194028095955652,0.3927392739273927,0.7726683918093838,1.0,19/96,17.34%,GALNT13;GXYLT2;OGT;PLOD2;TMTC4;TET1;POFUT1;TRAK1;PLOD1;TMTC1;DPM1;RXYLT1;XXYLT1;LARGE1;FKTN;ST3GAL4;GALNT14;GALNTL6;POGLUT3
prerank,negative regulation of binding (GO:0051100),0.2941876894923338,1.0192312394333958,0.40634005763688763,0.9658951263467177,1.0,13/81,9.76%,RALB;PIN1;LEF1;BTAF1;ACTB;PSME3IP1;IFIT1;CDKN1A;MAPK8;CARD16;RSF1;TFAP4;PARK7
prerank,response to prostaglandin E (GO:0034695),0.4622621482382378,1.0191628844400114,0.458,0.9650752721710152,1.0,2/10,6.32%,PTGER2;GNB1
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.41492369148840214,1.0191257402809843,0.4359925788497217,0.9641096355944916,1.0,4/15,19.55%,APOE;SCARB1;PLTP;ABCG1
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.4476077466914707,1.0190260848068542,0.42996108949416345,0.9633687718755788,1.0,4/11,16.57%,PCBP1;NOVA2;PCBP3;ZNF445
prerank,regulation of cellular biosynthetic process (GO:0031326),0.357021969070145,1.0187746563109603,0.43717728055077454,0.9631614972962916,1.0,7/28,11.08%,FITM2;TNFRSF1B;ADIPOR2;SIRT1;CD47;PRKAA2;ADIPOR1
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.26128824752219026,1.0183964728529693,0.42028985507246375,0.9633329448630393,1.0,40/208,14.28%,ZDHHC17;JMJD8;MAP3K7;TNFAIP3;TAB2;PLK2;EEF1D;TIRAP;TRIM8;BIRC2;ZDHHC13;TNFRSF10B;TMED4;TRIM14;EDAR;GPR89A;CARD16;TRAF5;SIRT1;TAB3;NLRC3;TRIM25;WNT5A;TRAF3;RELA;RBCK1;LURAP1;UBE2V1;ESR1;NOD1;TNIP2;IKBKB;MAPKBP1;CHUK;PPP5C;ANKRD17;NEK6;ATP2C1;TRIM27;MAP3K3
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.37354901352204284,1.0181138975880157,0.423407917383821,0.9631611508978902,1.0,7/22,16.45%,TIPRL;BOD1;PPP1R11;MGAT5;IKBKB;PTPA;FKBP1A
prerank,cellular response to cytokine stimulus (GO:0071345),0.24703115298100808,1.0180767318256074,0.42350332594235035,0.9622248744353467,1.0,55/416,13.08%,LRP8;MT1X;PTPN18;GSK3A;CBL;PTPRJ;IL1R1;HSPA8;OXSR1;LEF1;SMPD4;CXCL12;IFNLR1;IFITM2;CRLF1;LRCH1;IFIT1;SBNO2;ZFP36L1;GBP3;MME;SOX2;PTPN12;FYN;TNFRSF1B;CIB1;CDKN1A;RIPOR2;MAPK8;GBP4;PTPRT;ICAM1;SYK;RO60;PIM1;SIRT1;CCL25;WNT5A;ERBIN;RELA;CD47;CSF1R;INPP5D;IL10RB;IFNAR1;NPNT;PIK3CD;RPS3;ST3GAL6;CRKL;TYK2;IKBKB;LDLRAP1;CHUK;NDUFA13
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.35449338944976283,1.0180694923355895,0.423785594639866,0.9611919046692456,1.0,13/29,20.89%,HBS1L;CNOT7;EXOSC9;PATL1;NT5C3B;CNOT6;EXOSC1;DCP1A;LSM1;DCP1B;EXOSC7;CNOT8;DDX6
prerank,regulation of chromatin binding (GO:0035561),0.4539698668859755,1.0174240768512797,0.45124282982791586,0.9620970563189701,1.0,2/10,8.54%,BTAF1;KDM4D
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.43795428398031305,1.0173399970298698,0.4381139489194499,0.9613242504721395,1.0,5/12,17.12%,EZH2;KLF2;CTBP2;CNOT1;CALR
prerank,neutrophil activation involved in immune response (GO:0002283),0.24722758884988694,1.01730381988552,0.4212860310421286,0.9603890971506787,1.0,72/428,14.81%,SURF4;IMPDH1;CAND1;ATP8A1;PSMD12;PTPRJ;HMOX2;EEF1A1;GLB1;HSPA8;PTPRC;GYG1;PRCP;PECAM1;PTGES2;SVIP;RAB5C;CCT2;PTPRB;PYGL;NRAS;TUBB;ATP6V1D;PSMD11;ATP11A;MME;RAB7A;TNFRSF1B;B2M;FUCA1;LAMTOR1;SYK;STOM;ATP6AP2;RAB6A;RAB14;CD47;NFASC;PSMC2;PSMD2;HRNR;MGAM;DYNLL1;PNP;VAT1;DDX3X;GPI;RHOG;PA2G4;ATG7;RAB5B;HGSNAT;ILF2;RAP2C;GM2A;GALNS;CD55;OSTF1;SCAMP1;NDUFC2;PSMD14;NPC2;ARPC5;PSMD1;ERP44;CD93;PSMB1;APAF1;CYBA;QPCT;CD44;NHLRC3
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.25772108379973424,1.0172429453237262,0.44471445929526127,0.9595185465997722,1.0,53/241,16.18%,POLR2J;SNRPD2;NCBP1;RBM22;HSPA8;POLR2B;PRPF31;PRPF3;SNRPD1;HNRNPH2;PCBP1;PHF5A;SF1;PRPF40A;HNRNPK;CPSF4;PPIL3;PLRG1;SRSF10;SNRNP27;PRCC;SFPQ;HNRNPC;GEMIN5;SMNDC1;YTHDC1;SF3B3;SRSF4;DNAJC8;SNU13;NOVA2;SF3A1;RSRC1;BUD31;SYF2;U2AF1;PAPOLA;EFTUD2;PTBP1;RBM10;YBX1;SRSF7;SNRPA;USP39;FUS;RBM4B;SF3B6;HNRNPL;TRA2B;GTF2F2;RBM41;UPF3B;U2AF2
prerank,negative regulation of protein kinase activity (GO:0006469),0.2890063111857923,1.0170907736690362,0.41509433962264153,0.958955423911848,1.0,11/88,7.80%,PTPRQ;TRIB3;PTPRC;GNAQ;PTPRB;SPRED1;CDKN1A;AKT1S1;DTNBP1;PTPRT;ADAR
prerank,transepithelial transport (GO:0070633),0.41231416598453663,1.016919069422408,0.455743879472693,0.9584460447073221,1.0,3/15,8.22%,SLC1A1;ABCG2;SLC1A2
prerank,response to UV-A (GO:0070141),0.4208314768514333,1.0168380499247656,0.4681647940074906,0.9576645803062478,1.0,2/14,4.43%,CERS1;MME
prerank,nucleotide biosynthetic process (GO:0009165),0.39087761112578356,1.0166883608823802,0.41952983725135623,0.9570993723669711,1.0,9/18,20.58%,RRM2B;PRPS1L1;PRPS1;PNP;RRM1;NMNAT1;HPRT1;GART;PPAT
prerank,negative regulation of DNA recombination (GO:0045910),0.3286256143271991,1.016572250285984,0.43448275862068964,0.9564820557055712,1.0,8/43,15.32%,POLR2J;ZRANB3;POLR2B;ACD;MSH3;HELB;TERF2IP;UBQLN4
prerank,neuromuscular junction development (GO:0007528),-0.34191935321761674,-1.0165242885012176,0.42962962962962964,0.7797724574769501,1.0,4/24,2.47%,PDZRN3;ANK3;CACNB4;PPFIBP1
prerank,mesenchyme morphogenesis (GO:0072132),0.40321636127391625,1.0163860389405164,0.437847866419295,0.9560643854546752,1.0,5/17,16.10%,HEY1;NOTCH1;ACVRL1;NOS3;HEYL
prerank,maintenance of protein localization in organelle (GO:0072595),-0.3685850671497622,-1.0163326459596183,0.41309255079006774,0.779539875088819,1.0,10/19,28.78%,TAPT1;PML;TOPORS;TAF8;PINK1;HK2;AKT1;SUPT7L;ARL2;BCL3
prerank,anion transport (GO:0006820),-0.3190593847301577,-1.0163115775115408,0.4292929292929293,0.7788003499086975,1.0,9/33,15.92%,SLC13A3;LRRC8D;SLC26A7;LRRC8B;VDAC1;SLC13A4;SLC22A6;SLC4A2;SLC19A1
prerank,tRNA wobble uridine modification (GO:0002098),0.41165105685118153,1.0162132226251885,0.4514285714285714,0.9555884866669532,1.0,2/14,8.03%,MOCS3;ELP1
prerank,regulation of protein acetylation (GO:1901983),0.4309656831122981,1.0161784980771649,0.4574898785425101,0.9546627260945144,1.0,5/12,15.22%,RAPGEF3;SIRT1;PARK7;DDX3X;TERF2IP
prerank,snRNA processing (GO:0016180),-0.37174176342305165,-1.0159951415080584,0.4182590233545648,0.7789001542068552,1.0,10/16,37.25%,INTS10;INTS8;INTS11;INTS7;TUT1;INTS12;INTS9;INTS3;INTS1;TOE1
prerank,stem cell development (GO:0048864),0.40855730884465935,1.0159822011450579,0.4426229508196721,0.9542532907781841,1.0,2/16,4.12%,PTPRC;CDH2
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.4099070818684077,1.0159344992266381,0.4438202247191011,0.9533859796753542,1.0,14/14,59.05%,ATP6AP1;CSF1;POU4F2;IFNG;IL12B;IL23R;TNF;IL23A;OCSTAMP;TNFSF11;CCR1;POU4F1;TRAF6;TYROBP
prerank,sulfur amino acid metabolic process (GO:0000096),0.37409216451440475,1.015902110650886,0.4512820512820513,0.9524675478446467,1.0,2/24,2.94%,GCLC;MTR
prerank,B cell activation (GO:0042113),0.3056726066608216,1.0157269768173978,0.4107692307692308,0.9520137659573441,1.0,9/68,13.20%,DCAF1;PTPRJ;PTPRC;HDAC9;PHB2;CEBPG;KLF6;PIK3CD;HDAC5
prerank,ion transport (GO:0006811),-0.24765836381863487,-1.015637917576007,0.4109090909090909,0.7791251723145526,1.0,23/111,14.68%,TRPM3;SLC24A3;GABRB1;SLC1A3;GLRB;WNK1;SLC26A7;PIEZO2;VDAC1;SLC12A2;SLC26A2;GLRA1;SLC24A2;WNK4;ANO1;LASP1;SLC20A1;SLC9A2;CTNS;ANO6;SLC26A11;SLC12A6;SLC4A2
prerank,regulation of gastrulation (GO:0010470),-0.39197827984604444,-1.0152455947191001,0.4365256124721604,0.7794246639804836,1.0,3/14,5.59%,PHLDB2;PHLDB1;OSR1
prerank,sensory perception of chemical stimulus (GO:0007606),-0.3897362659161039,-1.0151639306217153,0.43897216274089934,0.7788661225925029,1.0,6/15,33.92%,GNAL;ADCY3;SYT10;SLC24A4;DRD2;MKKS
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),-0.3825326199955565,-1.015014851489764,0.4514038876889849,0.7784618136525979,1.0,4/16,9.91%,FOXD1;FGF1;BMP4;SALL1
prerank,positive regulation of signaling (GO:0023056),-0.30618770970629977,-1.014838285971146,0.4180929095354523,0.7781225430334286,1.0,19/37,35.12%,RIMS1;WLS;ANXA2;DLG4;CLSTN2;ILK;PTPN23;KCTD13;CLSTN3;RAB29;INPP5F;CD80;SNCA;SCRIB;CDKN2AIP;NMU;EDN1;SOX11;EDN3
prerank,cellular response to calcium ion (GO:0071277),-0.26825409477179,-1.0146055882390812,0.425,0.777992706208751,1.0,17/67,15.88%,CPNE8;RYR3;IQGAP1;ADCY1;CLIC4;ADGRV1;SYT9;NLGN1;LGMN;CAMK2D;SYT12;SYT11;SYT4;RASGRP2;CPNE2;SYT7;GPLD1
prerank,cell part morphogenesis (GO:0032990),-0.41126307695421505,-1.014200380204532,0.42857142857142855,0.7783349225701268,1.0,3/13,7.72%,PID1;WASF1;FIS1
prerank,regulation of epithelial cell differentiation (GO:0030856),0.4029055591422126,1.0141017173995062,0.44716981132075473,0.956094585294342,1.0,1/17,0.25%,PRKX
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),-0.2882730132345182,-1.0136828420564012,0.4375,0.7789987784554292,1.0,8/48,12.21%,ANK2;AKAP6;CEMIP;UBASH3B;TRPC1;PRKACA;CAMK2D;SRI
prerank,negative regulation of mRNA processing (GO:0050686),0.40641348801550287,1.0136068771489164,0.4635879218472469,0.9566042777716329,1.0,6/15,16.18%,SFSWAP;SRSF10;SRSF4;PTBP1;SRSF7;U2AF2
prerank,positive regulation of nervous system process (GO:0031646),-0.36906852271803336,-1.0132227463534744,0.44042553191489364,0.7795136291762736,1.0,7/18,23.54%,RIMS1;NLGN2;UNC13B;DICER1;ATPSCKMT;TPPP;RNF10
prerank,regulation of establishment of protein localization (GO:0070201),-0.39981339485500944,-1.0130022866494,0.4504310344827586,0.7793306367145093,1.0,4/13,15.16%,SPIDR;CEP120;CTSD;CEP295
prerank,regulation of protein phosphorylation (GO:0001932),0.2563700497149551,1.0129478399884524,0.4476067270375162,0.9576541807394071,1.0,42/256,12.62%,ROPN1;ATF3;MAPK3;PRR5L;RALB;LIMCH1;RAP2A;PIN1;SOD1;PECAM1;SMG8;PDCL3;HDAC3;PPP2CA;TEK;FYN;NPTN;CIB1;TBX1;FXR1;CCDC88C;SIRT1;AXIN1;KDM4D;EFNA1;AKTIP;CDK2AP1;MOB1B;CSF1R;LYN;PAK1;PARK7;AKAP8L;TARDBP;ACVR2A;TRAF3IP1;APP;ZBED3;PRNP;CRKL;WDFY2;CDH5
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.45657146011200594,1.0129080656997431,0.4609375,0.956758544964104,1.0,3/10,10.93%,ACER2;NEXMIF;CYP1B1
prerank,transcription by RNA polymerase II (GO:0006366),-0.21634736781015126,-1.0128681611092356,0.3767123287671233,0.7788684332006538,1.0,87/305,20.07%,DDX5;NOTCH2;TEAD1;GLIS3;PRRX1;PABPN1;RARB;MAF;TBL1XR1;CCN2;ELP4;SOX5;MED26;RPRD1B;MAML1;HDAC1;GTF2I;MED1;PPARGC1A;CBFB;RREB1;POU2F1;ZBTB1;RBMX;DEK;ERCC6;PPARA;ELL;PIR;NOTCH3;CSTF3;MED17;RNGTT;CDC73;PHAX;SNW1;SRRT;GTF2A1;ELP2;RXRA;SYMPK;NFKB1;NR2C2;ESRRA;TBL1X;RARA;CDK7;NELFB;NR3C2;CCNT1;CSTF2;NFYA;ELOA;POLR2A;SNAPC3;DDX21;TAF8;RORA;SETX;INTS10;INTS8;CCNK;PAF1;TEAD3;MLLT1;INTS11;TAF6;CTDP1;RPAP1;WWTR1;NR3C1;CDK9;GTF2E2;EAF1;MAML2;TAF5L;TAF12;KLF13;PARP1;COPS2;MED20;NR2F1;NELFA;CDK12;TEAD2;CPSF3;NABP2
prerank,regulation of G0 to G1 transition (GO:0070316),0.32924243165366457,1.0127600426903223,0.43993506493506496,0.9561904741092458,1.0,9/38,16.16%,EZH2;EED;UXT;BMI1;RYBP;MGA;APAF1;E2F6;RBBP4
prerank,negative regulation of cell adhesion (GO:0007162),-0.2628410605963709,-1.0125054493184151,0.4619883040935672,0.7790642874035525,1.0,34/72,28.34%,PLXNA2;ADAM22;SPOCK1;FBLN1;DSCAM;RHOA;JAM3;CDH1;EPHB2;SEMA4D;SIPA1;PLXND1;NF2;PTK2;ARHGDIA;PLXNB2;PTPRO;PLXNC1;CBLL1;TGFB1;FZD4;SEMA5A;TGFBI;FZD7;CX3CL1;ARHGDIB;DUSP1;ITGB1BP1;PLXNB1;DMTN;SERPINE1;PLXNA1;MDK;LPXN
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.3483630997605619,1.0125012178117885,0.4206081081081081,0.9559567087520617,1.0,14/31,20.89%,HBS1L;CNOT7;EXOSC9;PATL1;NT5C3B;CNOT6;EXOSC1;DCP1A;LSM1;DIS3L2;DCP1B;EXOSC7;CNOT8;DDX6
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.40588397861426484,1.0122802927685195,0.45871559633027525,0.9556495018919334,1.0,2/15,3.56%,AMDHD2;EXTL2
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.4390819557077441,-1.0121199644683785,0.4639175257731959,0.7786174518228445,1.0,3/10,12.99%,MBP;WNK1;MYADM
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.4390819557077441,-1.0121199644683785,0.4639175257731959,0.7786174518228445,1.0,3/10,12.99%,MBP;WNK1;MYADM
prerank,double-strand break repair (GO:0006302),0.2677927755538572,1.0119994694793668,0.4295125164690382,0.9554819281079858,1.0,34/158,14.94%,ABRAXAS1;ZSWIM7;ERCC4;YY1;HPF1;XRCC1;KDM2A;CIB1;TENT4A;APLF;MAPK8;ACTR8;SFPQ;ACTR5;DCLRE1B;UBE2V2;EYA3;KDM4D;POLA1;SEM1;RFWD3;EXD2;RAD51B;APTX;HUS1;NBN;PSMD14;BRCC3;PPP5C;CHEK2;RMI1;NSD2;BRIP1;INO80
prerank,positive regulation of viral process (GO:0048524),0.3070959425074369,1.0117370395553247,0.43597560975609756,0.9552554907816394,1.0,12/60,12.66%,POLR2J;POLR2B;IFIT1;RAB7A;ADAR;CNOT7;RSF1;RAD23A;SRPK2;DDX3X;TMEM39A;MDFIC
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.34542779546870694,1.0112555237410172,0.42857142857142855,0.95582477140831,1.0,11/33,18.41%,PIK3CG;PIK3C2G;ZFP36L1;HTR2A;PIK3CD;PIK3R5;NF1;PIK3C2A;PLEKHA1;NYAP2;IRS1
prerank,gland development (GO:0048732),-0.2739156355151531,-1.0110731968132054,0.43243243243243246,0.780720466063312,1.0,12/59,11.85%,FGFR2;TGFBR3;GLI2;TGFBR1;ZBTB1;WNT4;DKK3;COBL;EZR;SALL1;TBX3;ANXA1
prerank,activation of protein kinase B activity (GO:0032148),-0.3233239271053768,-1.0109867033668967,0.43953488372093025,0.780140323735739,1.0,3/29,3.14%,NTRK3;IGF1;FGF1
prerank,membrane organization (GO:0061024),-0.22483596738840791,-1.0108637848178166,0.39,0.7796905029002723,1.0,81/227,26.09%,ANK2;ANK3;RIMS1;DNAJC6;DAB2;EGFR;AMPH;STX18;CHRM2;AP2B1;A4GALT;SH3GL2;TOR1AIP2;STAM2;WASL;AP2A2;STON2;UBXN2A;ARPC1A;CTTN;NUP155;SYT9;AP2A1;LDLR;ACTR3;PLEKHA8;UBXN2B;TOR1AIP1;BIN1;HUWE1;MYOF;TMEM33;DMPK;IGF2R;TLCD2;UBC;NUP93;NSFL1C;MITD1;GRB2;MYADM;HIP1R;EPN1;DNM1;M6PR;VAMP2;TOR1B;USO1;NEMP1;MTCH1;FZD4;ACTR2;SUN1;CHMP2B;SYT2;SNX3;CHMP5;SNAP29;GLTP;STAM;ARPC2;VPS4A;CNTN2;HGS;VPS33B;GCA;COX18;CTDNEP1;EMD;VAPB;CLN3;VAMP8;LEMD2;SERP1;TMEM170A;SPTBN1;SGCZ;PICK1;FNBP1;TMEM43;SYP
prerank,positive regulation of protein import (GO:1904591),-0.31849241038453585,-1.01083965068141,0.44221105527638194,0.7789524916619431,1.0,13/30,20.03%,ZIC1;SMAD3;FLNA;BAG3;PRKCD;UBR5;EFCAB7;CDH1;PDCD5;ARHGEF5;TGFB1;MAVS;PIK3R1
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.35728562054389934,1.0105112189706904,0.43470790378006874,0.9570748533883361,1.0,5/27,9.20%,CSGALNACT1;XYLT1;CHSY3;PXYLP1;B3GAT2
prerank,monocyte differentiation (GO:0030224),0.45163177606832194,1.0102281297987228,0.4619883040935672,0.9569655092472973,1.0,1/10,0.07%,MT1G
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.2834089450984254,1.0101723250270835,0.45569620253164556,0.9561555317483916,1.0,16/100,11.82%,MAZ;MAPK3;PIK3CG;CBL;PIK3AP1;SRC;PPP1R16B;TEK;SELP;SIRT1;IRS2;NLRC3;LYN;FLT1;PIK3CD;PIK3R5
prerank,vitamin D metabolic process (GO:0042359),-0.39685665342741816,-1.0099388287614892,0.4409282700421941,0.7807359133038119,1.0,4/13,33.90%,LGMN;PIAS4;CUBN;CYP2R1
prerank,termination of RNA polymerase II transcription (GO:0006369),0.34075198772991905,1.0092233548202043,0.4343598055105348,0.9581207220436763,1.0,9/33,18.64%,MAZ;NCBP1;CPSF4;PAPOLA;SCAF8;SLBP;WDR33;CLP1;SNRPD3
prerank,calcium ion import (GO:0070509),-0.3252684581274203,-1.0091332082994449,0.40425531914893614,0.7821294772963587,1.0,8/28,15.66%,CACNA1C;MCU;CACNA1D;MICU2;CACNA1B;CACNA1G;AFG3L2;MCUR1
prerank,lamellipodium organization (GO:0097581),-0.32614853389653314,-1.009106209400473,0.4321608040201005,0.7814073135822754,1.0,12/29,21.63%,SNX2;KIT;VCL;CTTN;WASF1;SPATA13;ABLIM2;ABLIM3;PTPRO;ARFIP2;ARHGEF4;P2RY12
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.36190991768086767,1.008758261880515,0.4353982300884956,0.9585595106918163,1.0,7/26,13.83%,MAP3K7;TNFAIP3;TAB2;TAB3;UBE2V1;NOD1;MAP2K6
prerank,negative regulation of amyloid fibril formation (GO:1905907),0.43994587100344074,1.0086314304497896,0.4635514018691589,0.9579412189169297,1.0,3/12,7.51%,APOE;PFDN6;PFDN5
prerank,primary alcohol metabolic process (GO:0034308),-0.3284264535023584,-1.0085680560923271,0.4295942720763723,0.7820700734558513,1.0,5/25,11.98%,IGF1;DHRS3;NAPEPLD;RBP4;ALDH3A2
prerank,negative regulation of viral release from host cell (GO:1902187),0.4283710349826019,1.008370967501763,0.450281425891182,0.9577092837034351,1.0,2/13,3.72%,TRIM28;TRIM8
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.40116999600396447,1.0083140615178683,0.44029850746268656,0.9568777955667354,1.0,2/16,6.48%,TUBB;CEBPG
prerank,focal adhesion assembly (GO:0048041),-0.35608814836279734,-1.0081252133372105,0.43427230046948356,0.7824553065696755,1.0,5/21,10.09%,SORBS1;BCR;PIP5K1A;CTTN;ACTN2
prerank,positive regulation of protein modification process (GO:0031401),0.2595001310100332,1.0078062836334196,0.4546684709066306,0.9574428421164033,1.0,43/203,15.37%,MAPK3;RALB;LIMCH1;RAP2A;PIN1;PECAM1;SVIP;HDAC3;PPP1R16B;TEK;NPTN;CIB1;TBX1;FXR1;CNEP1R1;CALM3;RAPGEF3;SIRT1;SPPL3;TXN;AXIN1;EFNA1;AKTIP;CDK2AP1;CSF1R;LYN;PAK1;ACVR2A;DDX3X;ANKLE2;APP;PTBP1;ATG7;CRKL;WDFY2;CDH5;PTPA;CAMKK2;VEGFC;TERF2IP;GAS6;ATG14;RAB3GAP1
prerank,positive regulation of cellular catabolic process (GO:0031331),0.270625438231137,1.0077437083901755,0.4320652173913043,0.9566402553374563,1.0,39/132,18.85%,SLC4A4;GSK3A;PRR5L;ATF6;SH3D19;PLK2;SVIP;TRIM8;VPS11;APOE;TNFRSF1B;TRIM14;PTTG1IP;IRS2;CNOT7;DXO;PRKAA2;BAD;P2RX7;PFKFB3;APP;TMEM59;FAF1;TRIM27;CNOT1;PIK3C2A;VPS35;DAGLB;MOV10;TFEB;BNIP3;ADAM9;INSR;IRS1;RDX;RC3H1;ULK1;MID2;SH3GLB1
prerank,regulation of cellular respiration (GO:0043457),0.39326394198759773,1.0076965734131158,0.4456140350877193,0.9557655482998556,1.0,3/17,9.96%,IFNLR1;IL10RB;IFNAR1
prerank,regulation of monocyte differentiation (GO:0045655),-0.398169023640489,-1.0074467771539006,0.4594594594594595,0.7835380967866378,1.0,3/14,9.85%,FOXP1;IL34;CDK6
prerank,regulation of endothelial cell migration (GO:0010594),-0.2567254503943337,-1.0071825130088554,0.45,0.783505914315709,1.0,18/85,12.11%,FOXP1;ANXA3;SASH1;NR2F2;BMPER;NRP1;FGF1;BMP4;ROCK2;ADAMTS9;GLUL;SPARC;SMOC2;THBS1;NRP2;RHOJ;FOXC2;RHOB
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.4098125981864892,1.0070406365564315,0.45542635658914726,0.9568307870405113,1.0,2/14,6.21%,RFFL;CARD16
prerank,regulation of cellular amide metabolic process (GO:0034248),0.34710482931847075,1.0065902516867866,0.42524916943521596,0.9572835048237017,1.0,14/32,20.79%,EIF2A;GEMIN5;TMED10;TSC1;METAP1;NANOS3;APP;PICALM;RBM4B;CYFIP1;RPL10;EIF4E;MTPN;SAMD8
prerank,positive regulation of secretion (GO:0051047),-0.42039251069134764,-1.0065371911698735,0.45473684210526316,0.7844609168050026,1.0,2/11,16.75%,GPLD1;NPR1
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),-0.30075943155148105,-1.0059404008287545,0.43467336683417085,0.7853637688841892,1.0,21/40,40.90%,IGF1;FAM162A;BCL2L11;TP53;GHITM;PDCD5;PINK1;AKT1;BCL2L1;GPX1;BID;FXN;PRELID1;GPER1;PLSCR3;CLU;HGF;BBC3;PLAUR;OPA1;PPIF
prerank,sterol metabolic process (GO:0016125),0.30833514663618805,1.0059396747910607,0.4567901234567901,0.9583382263275609,1.0,11/60,12.68%,EBP;INSIG1;HMGCR;APOE;SOAT1;PPARD;SC5D;OSBPL1A;NSDHL;CYP1B1;LDLRAP1
prerank,regulation of macromolecule metabolic process (GO:0060255),0.2639497169701225,1.0055199064857767,0.4281984334203655,0.9586423685639983,1.0,25/170,9.91%,CAVIN4;PIN1;PTPRC;SORT1;PCBP1;STOX1;ZFP36L1;HNRNPAB;APOE;PRDM4;SOX2;HNRNPK;TRIM14;NPAT;LAMTOR1;RO60;BMI1;RNF187;KDM6A;CDK4;TOB2;NOVA2;ARF1;MARF1;TARDBP
prerank,fatty acid beta-oxidation (GO:0006635),0.314355206220136,1.00532860285908,0.43506493506493504,0.9582326172324058,1.0,12/51,16.59%,CRAT;ACOX3;ACAT1;PPARD;ETFA;HSD17B4;ACOT8;BDH2;ECHDC1;ECHS1;ACAA2;ACADL
prerank,negative regulation of response to stimulus (GO:0048585),0.3024066999146311,1.0051196324215137,0.43661971830985913,0.9578503946385856,1.0,13/60,14.28%,FCGR2B;MAP2K5;WFS1;LPCAT3;FBXO5;SIRT1;LYN;ZKSCAN3;TERT;MCTP1;HHIP;YBX1;MAP3K3
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.3497946396287726,1.0050785149232448,0.46045694200351495,0.9569608384180976,1.0,9/32,14.60%,MAP2K5;HDAC7;HDAC9;CIB1;MMRN2;NOTCH1;HDAC5;MAP3K3;PIK3C2A
prerank,establishment of vesicle localization (GO:0051650),-0.36210024553322806,-1.0049770134179943,0.461864406779661,0.7872704461025283,1.0,7/18,16.97%,KIF5C;CCDC186;SYT11;RAB11A;IKBKG;KIF5A;LIMK2
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.426340949515007,1.0048857319031383,0.4624277456647399,0.956504696074065,1.0,3/12,8.19%,PCGF3;YTHDC1;CDYL
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.3812328301069312,1.0046795770803896,0.44565217391304346,0.9561805462788381,1.0,3/20,11.01%,GSK3A;EP300;PGP
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.4230083292549386,1.0044322766346077,0.43830570902394106,0.9559225241756935,1.0,2/12,6.88%,PDE4D;CALM3
prerank,positive regulation of stem cell differentiation (GO:2000738),-0.3686531685457206,-1.004370602007733,0.4444444444444444,0.788108271852599,1.0,3/16,17.75%,SOX5;FOXC1;SOX6
prerank,negative regulation of B cell proliferation (GO:0030889),0.42677191253342095,1.004185463345507,0.45155038759689925,0.9557019953865448,1.0,2/11,9.31%,FCGR2B;LYN
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.31418948860337065,1.0040473121441176,0.47163695299837927,0.9551345180669829,1.0,6/48,7.30%,AEN;BCL2L2;HIPK2;TNFRSF1B;EP300;SIRT1
prerank,aerobic respiration (GO:0009060),0.374103859780309,1.004011367147959,0.4391891891891892,0.9542504875873756,1.0,3/20,4.37%,ME3;MTFR1;SIRT3
prerank,endosome organization (GO:0007032),0.32734936367850764,1.0038019705914598,0.4504201680672269,0.9538925714903957,1.0,14/41,19.19%,EXOC8;CLCN3;VPS11;TMEM9;LAMTOR1;AKTIP;RAB22A;LAPTM4B;HOOK3;VPS18;CORO1C;RAB27A;ALS2;PI4K2B
prerank,regulation of isotype switching (GO:0045191),-0.40002584114986384,-1.0036620837530192,0.4646017699115044,0.7892687079229572,1.0,5/14,20.12%,PAXIP1;SHLD1;PARP3;RIF1;SLC15A4
prerank,neutrophil degranulation (GO:0043312),0.24405525158726837,1.0034131095801238,0.4576837416481069,0.9540968809980175,1.0,71/425,14.81%,SURF4;IMPDH1;CAND1;ATP8A1;PSMD12;PTPRJ;HMOX2;EEF1A1;GLB1;HSPA8;PTPRC;GYG1;PRCP;PECAM1;PTGES2;SVIP;RAB5C;CCT2;PTPRB;PYGL;NRAS;TUBB;ATP6V1D;PSMD11;ATP11A;MME;RAB7A;TNFRSF1B;B2M;FUCA1;LAMTOR1;STOM;ATP6AP2;RAB6A;RAB14;CD47;NFASC;PSMC2;PSMD2;HRNR;MGAM;DYNLL1;PNP;VAT1;DDX3X;GPI;RHOG;PA2G4;ATG7;RAB5B;HGSNAT;ILF2;RAP2C;GM2A;GALNS;CD55;OSTF1;SCAMP1;NDUFC2;PSMD14;NPC2;ARPC5;PSMD1;ERP44;CD93;PSMB1;APAF1;CYBA;QPCT;CD44;NHLRC3
prerank,anterograde synaptic vesicle transport (GO:0048490),0.4056809172501717,1.0031938959324451,0.45863309352517984,0.9528317402309385,1.0,6/15,16.44%,AP3S1;DTNBP1;AP3M2;AP3M1;SNAPIN;BLOC1S5
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.4056809172501717,1.0031938959324451,0.45863309352517984,0.9528317402309385,1.0,6/15,16.44%,AP3S1;DTNBP1;AP3M2;AP3M1;SNAPIN;BLOC1S5
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.23444600984730268,1.0030193183921843,0.4731404958677686,0.9523902201725262,1.0,143/807,16.22%,SOX30;LRRFIP1;ATF3;IRX1;MAZ;DCAF1;CCDC85B;GCLC;DACH1;MECOM;AASS;ARID5A;ILF3;KLF8;L3MBTL4;TRIB3;NR4A2;MTERF3;EZH2;TRIM28;HSPA8;LEF1;CIPC;RPL23;EED;JAZF1;BTAF1;GTF2IRD1;DMAP1;KLF2;DNAJA3;ELK3;ING4;MAP2K5;ZHX3;ZBTB33;HDAC9;BCL6B;RPS6KA5;HDAC3;SBNO2;HEY1;NEDD4L;SMARCA2;SOX2;YY1;PHB2;WFS1;KDM2A;VPS72;UBE2I;IRF2BPL;BEND3;EP300;RFX3;RPS14;NFX1;CNOT2;PPARD;CHMP1A;ZNF205;SFPQ;UXT;SMAD7;SIRT1;BMI1;DRAP1;CLOCK;ZNF3;PFDN5;HEY2;ZBTB14;NOTCH1;SAP130;EDNRB;USP47;CNOT7;WNT5A;EFNA1;SOX13;RSF1;RELA;NAB2;HOXA7;BCLAF1;MDM2;PLCB1;TFAP4;TRPS1;ZKSCAN3;CIR1;CITED2;PBXIP1;CCAR2;HIC2;ESR1;THRB;RBPJ;CREBBP;CTBP1;ORC2;NFIC;PA2G4;HDGF;IFI27;LANCL2;N4BP2L2;MZF1;MDFIC;IRF2;CHD3;NDUFA13;TGIF1;CTBP2;HDAC5;DDIT3;THRA;HES1;KDM5C;DR1;HCFC1;TRIM27;USP9X;CNOT1;E2F6;TMPRSS6;BACH1;MAP3K10;PHF10;EZH1;GAS6;NKAP;TCERG1;TAF1;ELK4;BCL6;TRIM33;SMARCA4;ID2;TCF3;HEYL;ZBTB18;TAF3
prerank,negative regulation of signaling receptor activity (GO:2000272),-0.3238769144997583,-1.002734932824416,0.4549763033175355,0.7910542911133045,1.0,8/25,21.12%,ERRFI1;PPARA;SLC6A9;EPHB2;ZGPAT;TSG101;SOCS5;SNX6
prerank,regulation of actin cytoskeleton organization (GO:0032956),-0.2527697452476756,-1.0027134945613476,0.43506493506493504,0.7903072927931005,1.0,22/87,15.35%,NOTCH2;LRP1;GPM6B;IQGAP1;EFNA5;PDGFRB;RHOA;ROCK2;PRKCD;PDGFRA;ROCK1;EZR;RND3;RHOBTB2;EPHA3;RHOB;RHOBTB1;HIP1R;TAOK1;ARHGDIA;ARHGEF5;IQGAP2
prerank,positive regulation of protein dephosphorylation (GO:0035307),-0.31592660870503275,-1.0025229032589873,0.46958637469586373,0.7900496146788724,1.0,3/32,2.15%,MAGI2;PDGFRB;CAMTA1
prerank,regulation of nervous system development (GO:0051960),0.3329491969927499,1.0025137141725702,0.44901315789473684,0.9529100612789518,1.0,9/37,16.10%,HES6;HEY1;TNFRSF1B;HEY2;PRUNE1;DOCK7;TENM4;HES1;HEYL
prerank,regulation of DNA biosynthetic process (GO:2000278),0.3524326284211225,1.0023640074622464,0.4453924914675768,0.9523351215714754,1.0,6/27,11.69%,DACH1;PRKD2;CDKN1A;RGCC;ACVRL1;TNKS
prerank,phosphorylation (GO:0016310),0.24434751886258446,1.0022727778963068,0.48853211009174313,0.9516385091579844,1.0,81/385,16.75%,MAP3K11;MAPK3;SNRK;GSK3A;ILF3;PIK3CG;CDK17;DGKB;OXSR1;CDK19;PPP3CB;PLK2;NEK11;PNKP;PRKCH;RPS6KA4;HIPK2;MEX3B;PRKG1;PRKD2;RPS6KA5;PANK2;MAP3K9;PKN3;FYN;CERKL;MAPK8;RET;PAK3;SIK3;SYK;CDK11B;PIM1;PEAK1;MINK1;CDK4;MERTK;ACVRL1;LATS2;CDKL4;LYN;NRBP1;ERG;PKN1;PAK1;NIM1K;PRKAA2;ACVR2A;SRPK2;NLK;NEK7;CTBP1;APP;PI4KA;PIK3CD;STRADB;TYK2;PRKCI;MAP4K4;MAPK6;IKBKB;CHUK;CHEK2;TLK2;NEK6;BRD2;CAMKK2;COPS8;BMP2K;GAS6;DYRK2;CDKL5;TOP1;TAF1;CERK;BRAF;PTK2B;PIK3R4;CDK14;WNK2;PRKDC
prerank,synaptic vesicle recycling (GO:0036465),-0.31420484623811784,-1.0022127664672873,0.42105263157894735,0.7900950512526886,1.0,10/31,19.98%,AMPH;NLGN2;STON2;NLGN1;STON1;VAMP2;SYT7;STX1A;SYT2;PACSIN1
prerank,regulation of trans-synaptic signaling (GO:0099177),0.3426704833626183,1.0018549910141399,0.4395973154362416,0.9519392274724768,1.0,4/33,3.01%,LRP8;CACNA1A;GRIK5;GRIK2
prerank,embryonic axis specification (GO:0000578),-0.383445806994712,-1.0015101908152413,0.448512585812357,0.7913167382931977,1.0,3/15,11.62%,COBL;SMAD6;TBX3
prerank,glucan catabolic process (GO:0009251),-0.37883340234776874,-1.0013425667853588,0.45263157894736844,0.7909853049211572,1.0,7/15,19.40%,PYGB;AGL;PHKA2;PYGM;PGM2;GAA;PHKG2
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),-0.4043060420209479,-1.0011849636974417,0.47780126849894294,0.7905991690137744,1.0,3/13,6.59%,NFIB;BMP4;PPARA
prerank,positive regulation of vascular permeability (GO:0043117),-0.41089384714991334,-1.000823242209496,0.47368421052631576,0.7908030336468933,1.0,2/12,3.92%,BMP6;OCLN
prerank,cellular response to chemokine (GO:1990869),0.3212688233958224,1.0007937036895247,0.46236559139784944,0.9541701129143706,1.0,5/46,8.51%,OXSR1;CXCL12;LRCH1;RIPOR2;CCL25
prerank,apical junction assembly (GO:0043297),0.3069071774721733,1.000444380534564,0.46485623003194887,0.9542507060337594,1.0,11/53,14.49%,PECAM1;MARVELD2;RAMP2;F11R;ESAM;CLDN5;PRKCI;CDH5;APC;PATJ;PARD3
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.41401860399581575,-1.000336933009907,0.4584221748400853,0.7913560662167038,1.0,7/11,45.25%,CAMK4;MAVS;TICAM1;TYROBP;ITGB2;SPI1;ITGAM
prerank,regulation of fatty acid metabolic process (GO:0019217),0.39750181229187587,1.0002053388112622,0.4953789279112754,0.9540285205559218,1.0,5/17,11.08%,PANK2;PPARD;ADIPOR2;PRKAA2;ADIPOR1
prerank,regulation of hydrolase activity (GO:0051336),0.29503498560628966,1.0001363881904062,0.44052863436123346,0.9532535008345667,1.0,12/71,8.96%,CFAP73;SOD1;VAV3;CHN2;PRKG1;TBC1D10B;TDG;EPHA5;FGD5;RAPGEF6;RASIP1;PLXNA4
prerank,cardiac muscle cell development (GO:0055013),-0.350746955484038,-1.000054843602832,0.44097995545657015,0.7913413469622845,1.0,4/20,6.19%,PDLIM5;PDGFRB;CXADR;PDGFRA
prerank,apoptotic process (GO:0006915),0.25700065576729686,0.9998020391384688,0.4502551020408163,0.9533338525935796,1.0,36/203,14.82%,ERCC3;SEMA6A;BNIPL;AHCYL1;MAP3K7;FASTKD2;MAL;MAGI3;ING4;PPP2CA;TNFRSF10B;SCN2A;CASP6;CIB1;EP300;TBX1;FXR1;ARHGEF6;BCL2L13;PPARD;CDK11B;BCLAF1;MDM2;AIFM1;BAD;NAE1;CDIP1;APP;IFI27;BMF;RRAGC;DIABLO;NFKBIA;ELMO1;APAF1;MAP3K10
prerank,cellular response to interleukin-4 (GO:0071353),0.4436862595607172,0.9995882880404721,0.46946564885496184,0.9530360026369505,1.0,1/10,2.03%,LEF1
prerank,microtubule anchoring (GO:0034453),0.42533630625180585,0.9995478408339872,0.484629294755877,0.9521806558617544,1.0,6/12,17.19%,CLASP2;DAG1;GCC2;BCCIP;BICD2;CLASP1
prerank,cellular response to peptide (GO:1901653),0.31104393918937046,0.9995341394311752,0.4657534246575342,0.9512564334907215,1.0,11/56,11.92%,CACNA1A;RPL23;FCGR2B;SRC;ZFP36L1;FYN;ICAM1;MDM2;APP;NOD1;PRNP
prerank,sensory perception of light stimulus (GO:0050953),-0.2500806728127509,-0.9995128177727463,0.45425867507886436,0.7919974035318094,1.0,9/87,6.49%,PCDH15;SLC4A10;COL1A1;EML2;COL11A1;ADGRV1;EFEMP1;DHRS3;DNAJC19
prerank,negative regulation of wound healing (GO:0061045),-0.32101626262004,-0.999444350888826,0.4228855721393035,0.7914030641190377,1.0,7/28,17.92%,PHLDB2;TFPI;SLC12A2;VTN;CD34;AJAP1;CD109
prerank,membrane depolarization (GO:0051899),-0.30510012920135776,-0.999415427651109,0.42482100238663484,0.7907054522969695,1.0,10/32,17.73%,CACNB4;P2RX4;SCN8A;SCN3A;CACNA1B;SCN1A;CACNA1G;CACNG4;ATP5IF1;CACNG2
prerank,positive regulation of programmed cell death (GO:0043068),0.252392667916359,0.9993083466155419,0.4795031055900621,0.9509309788340738,1.0,54/272,16.60%,ERCC3;MAP3K11;ATF6;FRZB;TIAM1;SOD1;VAV3;PSEN2;ARHGEF26;MCF2L;ING4;ITSN1;TNFRSF10B;MAPK8;ARHGEF6;CRADD;ARHGEF7;SYK;TRIO;SIRT1;OMA1;ARHGEF18;ITGA6;LATS2;BCLAF1;FZD9;TFAP4;AIFM1;RYBP;ING3;CCAR2;BAD;DDX3X;CYP1B1;ATG7;BMF;IP6K2;BNIP3L;NF1;ING5;UTP11;DIABLO;FAF1;APC;PTPA;APAF1;MAP3K10;GNA13;APH1A;BCL6;DNM1L;BNIP3;QRICH1;RASGRF2
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.42335477105237657,-0.9990230307750269,0.4547244094488189,0.790989905581531,1.0,3/11,15.12%,NRP1;SIRT2;STMN1
prerank,peptide hormone secretion (GO:0030072),0.3579918372565684,0.9988310262307797,0.46994535519125685,0.9514454241227348,1.0,4/26,9.76%,LTBP4;RAB1A;CYB5R4;PARK7
prerank,regulation of macroautophagy (GO:0016241),0.28363070953673314,0.9987396405893455,0.46799431009957326,0.9507489568041801,1.0,32/105,19.34%,MAP3K7;RPTOR;EXOC8;ATP6V1D;EPM2A;SMG1;VPS26A;ATP6V0D1;MAPK8;LAMTOR1;SIRT1;ATP6V0E1;TSC1;TBC1D25;PRKAA2;UBQLN1;BNIP3L;RRAGC;SCOC;ATP6V1B2;VPS35;ATG13;SESN3;BNIP3;UBQLN2;ATP6V1A;USP36;ULK1;SH3GLB1;LZTS1;SESN1;LARP1
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),-0.324992422946187,-0.9983916421934341,0.44776119402985076,0.7919261828475457,1.0,10/26,26.95%,LGR4;FLOT2;APPL2;IRAK3;BIRC3;FLOT1;GPR108;APPL1;TLR3;LRRC14
prerank,vasculature development (GO:0001944),-0.36280654534969103,-0.9983016821514225,0.4592274678111588,0.791389144305693,1.0,7/16,26.13%,PDGFRB;ERRFI1;PDGFRA;STK11;BMPR2;STRA6;NOTCH4
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.3822923960350374,0.9980852972394552,0.4802158273381295,0.9517854201349493,1.0,4/19,8.57%,CTC1;SRC;HNRNPC;ACD
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.39201036411131157,0.9978789318283479,0.4691588785046729,0.9514394863619356,1.0,4/18,10.81%,STOX1;FBXO5;CDK4;RAD51B
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.3349362014346748,0.9977194520619268,0.43812709030100333,0.9509760370879254,1.0,7/35,9.12%,SEMA6A;SEMA6D;SEMA7A;SEMA3C;SEMA6B;PLXNA4;SEMA4C
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),-0.2572217692519501,-0.9975005395642377,0.45768025078369906,0.7927740147241428,1.0,17/76,25.10%,LPAR1;HTR2C;GRM5;CHRM2;PLCE1;ADRA1B;ACTN2;ANO1;GPR4;OPRM1;GNA14;AGTR1;ADRA1A;P2RY12;CMKLR1;LPAR6;ADRA2A
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.4155274130860496,-0.9971380736997213,0.4688128772635815,0.7929994126969189,1.0,1/12,5.55%,ZBTB1
prerank,microtubule polymerization or depolymerization (GO:0031109),0.3685160023803166,0.9970909330803487,0.46503496503496505,0.9518790283160408,1.0,5/24,9.66%,KIF18A;PIN1;FGF13;TRPV4;KIF2A
prerank,regulation of interferon-gamma production (GO:0032649),0.2998120646828428,0.99708090668137,0.47049924357034795,0.9509487692844631,1.0,11/71,15.25%,IL1R1;PDE4D;CYRIB;CEBPG;CD47;VSIR;PRNP;CD274;DDIT3;TRIM27;GAS6
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.3309596433222857,0.9969440565826481,0.4483333333333333,0.9503877788067596,1.0,7/38,12.23%,LRP8;PTPRC;EFNA1;CSF1R;APP;PRNP;RAP2C
prerank,protein targeting to peroxisome (GO:0006625),-0.321498188464379,-0.9965844595088158,0.4578005115089514,0.7937055798112842,1.0,10/29,18.06%,ACBD5;RAB8B;PEX14;FIS1;ALDH3A2;PXMP4;ABCD2;PEX2;PEX5;PEX6
prerank,cytosolic calcium ion transport (GO:0060401),-0.32584793255653943,-0.9965308591702344,0.45176470588235296,0.7930473265169088,1.0,10/28,22.26%,CACNA1C;MCU;MICU2;AFG3L2;SLC35G1;MCUR1;ADRA1A;MCUB;CACNA2D1;ATP2B3
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.27714517299737873,0.9962128536997196,0.47406340057636887,0.951689678230068,1.0,16/101,11.82%,PIK3CG;RALB;EZH2;MTCP1;RPTOR;SRC;PPP2CA;CIB1;RGCC;CALM3;SIRT1;WNT5A;CSF1R;DDX3X;FLT1;PIK3R5
prerank,"transcription, DNA-templated (GO:0006351)",0.2549114769666633,0.9960422187489798,0.46532156368221944,0.9512448551993078,1.0,41/207,16.22%,POLR2J;ERCC3;NCBP1;ELOC;NR4A2;POLR2B;POLR1C;GTF3C1;PAX8;CCNH;IRF9;GMEB2;NFX1;GTF3C5;PWP1;RO60;TRIP11;IVNS1ABP;DRAP1;GTF2H1;RSF1;TAF15;THRB;GTF2A2;NFIC;MED4;ELOB;TSC22D1;TAF4B;TBP;RRAGC;RNMT;PPP5C;THRA;BAZ2A;TFAM;NOCT;TAF1;GTF3C2;GTF2F2;TAF3
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),-0.35247879255693393,-0.996029034414376,0.4488888888888889,0.7928545990654794,1.0,2/20,0.57%,ZBTB20;IGF1
prerank,positive regulation of glycolytic process (GO:0045821),-0.35247879255693393,-0.996029034414376,0.4488888888888889,0.7928545990654794,1.0,2/20,0.57%,ZBTB20;IGF1
prerank,response to hydrogen peroxide (GO:0042542),0.3192624312285536,0.9957245431222987,0.473257698541329,0.9512186124801133,1.0,9/45,11.52%,SOD1;TNFAIP3;FYN;SIRT1;RELA;PARK7;CYP1B1;APTX;RPS3
prerank,regulation of execution phase of apoptosis (GO:1900117),0.4302674685627814,0.9955740772070327,0.4826923076923077,0.9507458137936927,1.0,1/11,0.14%,CIDEA
prerank,positive regulation of cell motility (GO:2000147),0.2568826812782463,0.9955367283919793,0.4655612244897959,0.9499185046198996,1.0,31/205,12.62%,PHPT1;SPOCK2;MAZ;SEMA6A;SEMA6D;SEMA7A;LEF1;TIAM1;PECAM1;CXCL12;SEMA3C;CIB1;RET;SEMA6B;ACTN4;RUFY3;NOTCH1;ITGA6;TJP1;SEMA4C;CSF1R;SOD2;PODXL;PAK1;VSIR;FLT1;PIK3CD;PPP3CA;MAP4K4;MGAT5;CDH5
prerank,regulation of cholesterol transport (GO:0032374),-0.34188047313790293,-0.9954073324995024,0.44575471698113206,0.79376942648,1.0,5/20,12.78%,LRP1;OSBPL6;ABCA5;NFKB1;TTC39B
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.2847048172237363,0.9953786510523696,0.4846715328467153,0.9494488781415613,1.0,14/86,12.23%,LRP8;PTPRJ;PTPRC;PECAM1;PDCL3;SRC;FYN;SAMSN1;CNOT7;EFNA1;CD81;APP;PRNP;RAP2C
prerank,cell cycle G1/S phase transition (GO:0044843),0.3003976599568376,0.9953245228887286,0.47058823529411764,0.9486647615316111,1.0,12/61,14.65%,MAP3K11;PLK2;CCNH;CDKN1A;POLE;CDK4;LATS2;USP37;E2F3;CUL3;PHF8;RCC1
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.3774593285243315,0.9952006360859235,0.46059544658493873,0.9480932091052685,1.0,7/20,17.08%,RSC1A1;RHOQ;PICALM;TMEM59;AP2M1;LZTFL1;PPP2R5A
prerank,lipid catabolic process (GO:0016042),0.38878016142172966,0.9949627730614079,0.4527972027972028,0.9478366906339218,1.0,2/18,4.71%,PPT1;PLAAT3
prerank,regulation of amyloid fibril formation (GO:1905906),0.409469919866581,0.9939449459628097,0.48713235294117646,0.9499425204744758,1.0,4/15,11.27%,APOE;PFDN6;PFDN5;APP
prerank,secondary palate development (GO:0062009),-0.3810607550942873,-0.9938832078750083,0.48036951501154734,0.797176678517001,1.0,3/14,4.04%,TGFBR3;TGFBR2;SMAD4
prerank,regulation of programmed necrotic cell death (GO:0062098),-0.3507988431624131,-0.9938256403937537,0.4517543859649123,0.7965526559513922,1.0,6/20,8.63%,CFLAR;OGT;CYLD;NUPR1;FLOT2;BIRC3
prerank,positive regulation of translational initiation (GO:0045948),-0.35388756530798077,-0.9937080522969486,0.4444444444444444,0.7960928574955917,1.0,9/18,33.10%,KHDRBS1;YTHDF1;HABP4;RPS6KB1;EIF2B5;RPS6KB2;POLR2G;YTHDF2;MTOR
prerank,actin filament organization (GO:0007015),-0.2316241640243027,-0.99356184718028,0.45348837209302323,0.7957458435004131,1.0,32/151,15.85%,SVIL;MCU;PPP1R9A;GSN;DPYSL3;CGNL1;TMOD2;SPIRE1;WASL;SHROOM3;ABI1;TPM1;RHOA;FLNA;NEDD9;GAS2;ARHGAP12;COBL;RND3;RHOBTB2;BIN3;FHOD1;RHOB;BAIAP2L1;RHOBTB1;INPPL1;DLG1;HIP1R;TRIOBP;ERMN;MYO1B;TPM4
prerank,peptidyl-glutamic acid modification (GO:0018200),0.35794963779814154,0.9933329365543059,0.46221441124780316,0.9509040151107092,1.0,6/24,13.49%,TTLL1;CEP41;AGTPBP1;AGBL5;NAA80;TTLL7
prerank,regulation of dendrite development (GO:0050773),0.3231220815141912,0.9932167272602587,0.4630541871921182,0.9503279609331999,1.0,6/37,9.64%,LRP8;RAP2A;CAMK1D;NEDD4L;CAMSAP2;ZDHHC15
prerank,"base-excision repair, gap-filling (GO:0006287)",0.33619839794973055,0.9931757840206619,0.4812925170068027,0.9495113093377362,1.0,7/35,13.19%,PNKP;XRCC1;TDG;POLE;POLD3;SMUG1;MPG
prerank,chemokine-mediated signaling pathway (GO:0070098),0.32468215282782475,0.9928597198411703,0.4599358974358974,0.9494898065399768,1.0,4/42,8.51%,OXSR1;CXCL12;CIB1;CCL25
prerank,establishment of mitotic spindle localization (GO:0040001),-0.31476059580509713,-0.9928483120882012,0.4694835680751174,0.7968813231841145,1.0,8/28,20.02%,FBXW11;HTT;UBXN2B;GJA1;NSFL1C;DCTN1;NDE1;ZW10
prerank,regulation of platelet activation (GO:0010543),0.3729527947492452,0.9926632159906137,0.4981751824817518,0.9491191462812619,1.0,6/21,13.31%,APOE;SELP;SYK;LYN;NOS3;PLEK
prerank,nucleoside phosphate biosynthetic process (GO:1901293),-0.3803435264400332,-0.992659404614106,0.47085201793721976,0.7966182402233094,1.0,9/14,37.64%,ME1;NMNAT2;NMNAT3;AK3;AK5;AK4;CMPK2;AK1;NME2
prerank,protein K48-linked deubiquitination (GO:0071108),0.3664953812382001,0.9926586600080759,0.44661921708185054,0.9481865285670662,1.0,9/23,17.17%,TNFAIP3;YOD1;OTUD3;USP37;OTUD5;USP33;MINDY2;OTUD4;ATXN3
prerank,pore complex assembly (GO:0046931),-0.3602158637536767,-0.9926428690692283,0.47139588100686497,0.7958829499603418,1.0,10/19,31.36%,NUP205;AFDN;AHCTF1;NUP93;ANO6;GSDMD;PLEKHA7;TMEM170A;NUP153;PDZD11
prerank,morphogenesis of an epithelial sheet (GO:0002011),-0.43173506076352103,-0.992091518078344,0.4728682170542636,0.7966806321358337,1.0,3/10,5.56%,BMP5;BMP7;ARHGAP12
prerank,neutrophil mediated immunity (GO:0002446),0.24109168056944263,0.9919844800418011,0.4911308203991131,0.9493214554285662,1.0,71/432,14.81%,SURF4;IMPDH1;CAND1;ATP8A1;PSMD12;PTPRJ;HMOX2;EEF1A1;GLB1;HSPA8;PTPRC;GYG1;PRCP;PECAM1;PTGES2;SVIP;RAB5C;CCT2;PTPRB;PYGL;NRAS;TUBB;ATP6V1D;PSMD11;ATP11A;MME;RAB7A;TNFRSF1B;B2M;FUCA1;LAMTOR1;STOM;ATP6AP2;RAB6A;RAB14;CD47;NFASC;PSMC2;PSMD2;HRNR;MGAM;DYNLL1;PNP;VAT1;DDX3X;GPI;RHOG;PA2G4;ATG7;RAB5B;HGSNAT;ILF2;RAP2C;GM2A;GALNS;CD55;OSTF1;SCAMP1;NDUFC2;PSMD14;NPC2;ARPC5;PSMD1;ERP44;CD93;PSMB1;APAF1;CYBA;QPCT;CD44;NHLRC3
prerank,rRNA methylation (GO:0031167),-0.3372553406133477,-0.9916276363550903,0.4659090909090909,0.7972144008996077,1.0,17/22,44.85%,METTL15;NSUN4;NSUN3;METTL5;BUD23;MTERF4;FTSJ3;NOP2;NSUN5;ZCCHC4;FBL;MRM1;FDXACB1;MRM2;MRM3;TRMT112;METTL16
prerank,positive regulation of chondrocyte differentiation (GO:0032332),-0.4324292059752521,-0.9916071481649348,0.47713717693836977,0.7965082125437439,1.0,4/10,21.82%,SOX5;BMPR1B;SOX6;PKDCC
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.3335853183502803,0.9914757731132741,0.4817880794701987,0.9498581868523963,1.0,13/37,16.68%,RPL23;PDCL3;HIPK2;RPL5;PARK7;RYBP;CCAR2;TLK2;GIPC1;CSNK2A2;UCHL5;TAF1;N4BP1
prerank,serine family amino acid catabolic process (GO:0009071),-0.42565047081549046,-0.990974748205237,0.4906054279749478,0.7975251902629154,1.0,8/10,51.25%,DLD;AMT;CBS;GCSH;THNSL2;SHMT2;GLDC;SHMT1
prerank,import into nucleus (GO:0051170),0.29574238148969334,0.9909134562812105,0.47865853658536583,0.9505185245329417,1.0,11/73,8.71%,SNRPD2;SNRPD1;BACH2;MMP12;PHB2;PTTG1IP;SYK;NXT1;GEMIN5;NUP50;RANBP17
prerank,epiboly involved in wound healing (GO:0090505),-0.3788299857882995,-0.990781232053785,0.47113163972286376,0.7973036845687081,1.0,5/16,6.18%,TMEFF2;PDPN;RHOA;FLNA;DDR1
prerank,positive regulation of lipid kinase activity (GO:0090218),-0.3133163174100314,-0.9907573475106632,0.46194225721784776,0.7965851956429715,1.0,10/29,23.83%,AMBRA1;PDGFRB;KIT;PDGFRA;PTK2;TGFB1;PRKD1;P2RY12;EPHA8;TNFAIP8L3
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.38290769148246684,0.9906090160922254,0.45471014492753625,0.9504609531237327,1.0,8/19,19.52%,GSK3A;PARK7;FBXO7;CSNK2A2;CAMKK2;DNM1L;USP36;FBXW7
prerank,regulation of carbohydrate catabolic process (GO:0043470),-0.2885946103549193,-0.9905241535681275,0.44473007712082263,0.7964133009853295,1.0,15/41,22.88%,PRKAG2;OGT;PRKAG1;NUP205;NUP155;NUP188;NUP88;NUP93;SEH1L;NUP85;AAAS;RAE1;NUP37;NUP214;PGAM1
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.38512676522996614,-0.9902283371432321,0.4843137254901961,0.7964390043383006,1.0,4/13,7.28%,HACD3;HACD1;HACD4;TECR
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.42812145130322016,0.9901055699275498,0.47580645161290325,0.9509958637058222,1.0,5/12,16.80%,ACTB;CELSR1;TRAF3IP1;ZDHHC7;LAMA5
prerank,cardiolipin metabolic process (GO:0032048),-0.3932201745041123,-0.989847261508148,0.5,0.7967394650431342,1.0,5/13,21.48%,PLA2G4A;SLC27A1;CRLS1;PGS1;PLA2G6
prerank,positive regulation of response to wounding (GO:1903036),-0.3362855785175379,-0.9898155642254877,0.48,0.7960472772421555,1.0,12/24,33.70%,OCLN;VTN;ANXA1;PTK2;SCARF1;ADRA2A;DMTN;MDK;HBEGF;MYLK;CLDN1;PTN
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.3585113585915495,0.9893465928402874,0.48180242634315423,0.9523214610621813,1.0,5/25,8.20%,PRPF3;SRSF10;SMNDC1;SF3B3;SRSF4
prerank,regulation of protein catabolic process (GO:0042176),0.2798954174384563,0.9892997817452597,0.48180494905385735,0.9514866135052428,1.0,19/99,13.85%,GSK3A;EEF1A1;PIN1;TNFAIP3;PLK2;HMGCR;NEDD4L;RAB7A;TMEM9;AXIN1;SF3B3;WNT5A;MDM2;ATG7;EGLN2;NDUFA13;CHEK2;FAF1;APC
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.3018912749452995,0.9892511640512803,0.4679186228482003,0.9506902713868782,1.0,16/53,17.81%,PSME3IP1;APOE;FOXF2;DESI1;GNA12;RAD23A;PSMC2;OPHN1;ECSCR;XPO1;PSMD14;PSMC6;UCHL5;UBQLN4;TMTC3;RAD23B
prerank,peptidyl-lysine modification (GO:0018205),-0.24595697375517298,-0.9892414585352489,0.47440273037542663,0.796864396586701,1.0,38/99,23.28%,EYA1;HDAC4;PLOD2;LOXL1;SIRT2;SENP3;ATP7A;NUP205;NUP155;NUP188;IFIH1;PLOD1;USPL1;BCL11A;NUP88;NUP93;LOXL3;P3H3;NNAT;SEH1L;TOPORS;PIAS3;SIRT7;ATPSCKMT;SENP7;EEF1AKMT1;STX1A;NUP85;AAAS;NSMCE2;RAE1;SIRT5;PIAS4;NUP37;LOX;VPS33B;NUP214;METTL21A
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),-0.3416379678343541,-0.989139883652212,0.45368171021377673,0.7963699279401466,1.0,5/22,15.64%,AHNAK;CACNB4;SRI;GNB5;PDE4B
prerank,negative regulation of neuron death (GO:1901215),0.2823560173187892,0.989098927183225,0.4956268221574344,0.9502206008849129,1.0,13/93,9.90%,FOXQ1;SOD1;CRLF1;PPT1;APOE;TNFRSF1B;TOX3;WFS1;BDNF;SOD2;FZD9;PARK7;FBXO7
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),-0.3083592380687363,-0.9889538039891308,0.43669250645994834,0.7960792697647322,1.0,4/32,8.60%,AKAP6;CEMIP;P2RX4;TRPC1
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.3128664114981456,0.9888736099186068,0.46405228758169936,0.9499564138050305,1.0,9/44,15.25%,RPS6KA1;SRC;MAP2K5;CARD16;USP47;PCID2;DDX3X;CD44;GAS6
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.422025707258892,-0.988862755364461,0.4685598377281947,0.7955527370069091,1.0,2/10,7.08%,WNK1;DPP4
prerank,regulation of cellular protein localization (GO:1903827),-0.2856214379486569,-0.9887937259794983,0.4720670391061452,0.794979325092768,1.0,11/45,9.77%,MAP2;GPC6;SPIDR;MAPT;CTNNB1;VCP;GPC3;CCDC66;CSNK1E;GPC5;DVL3
prerank,detection of visible light (GO:0009584),0.39430700118069895,0.9885724403143961,0.46950092421441775,0.9498531846561894,1.0,2/16,8.84%,GNAQ;GNA11
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.39277898302186187,-0.9885648738477465,0.4946695095948827,0.7948387420506605,1.0,4/13,19.95%,DDX5;PLA2R1;ATM;SPRED3
prerank,blood vessel diameter maintenance (GO:0097746),0.3376877373973266,0.9884394784818875,0.4565587734241908,0.9492603639526528,1.0,6/34,11.15%,GCLC;KLF2;GCLM;EDNRB;KCNMB2;NOS3
prerank,positive regulation of glucose metabolic process (GO:0010907),-0.38809785775593975,-0.9882463508981405,0.4509394572025052,0.7949417875728626,1.0,9/14,30.05%,DDB1;PPARGC1A;AKT2;ARPP19;GPLD1;PTPN2;AKT1;NNMT;SLC45A3
prerank,chemical homeostasis (GO:0048878),0.3023974467691356,0.9881303957083172,0.4727838258164852,0.9492224282403392,1.0,10/61,11.52%,SLC4A4;SLC4A5;KLHL3;FITM2;NEDD4L;ACOX3;USF2;IRS2;DDX3X;PNPLA8
prerank,negative regulation of inclusion body assembly (GO:0090084),-0.439547169871508,-0.9880728397435454,0.5,0.7946430462564644,1.0,8/10,49.67%,SORL1;SACS;DNAJB2;DNAJA4;DNAJB1;HSPA1A;HSPA1B;HSPA2
prerank,DNA strand elongation (GO:0022616),0.3793486013589374,0.9880049646874796,0.4797047970479705,0.9486769668401124,1.0,5/18,12.55%,DCLRE1B;POLD3;POLA1;TERT;NBN
prerank,positive regulation of protein localization to Cajal body (GO:1904871),0.42522653426662466,0.9876066359240316,0.47305389221556887,0.9479192568091629,1.0,4/11,16.15%,CCT2;CCT5;TCP1;DKC1
prerank,regulation of protein localization to Cajal body (GO:1904869),0.42522653426662466,0.9876066359240316,0.47305389221556887,0.9479192568091629,1.0,4/11,16.15%,CCT2;CCT5;TCP1;DKC1
prerank,glycine metabolic process (GO:0006544),-0.399607608355803,-0.9876052970116382,0.4551569506726457,0.7952047542998459,1.0,8/12,51.25%,DLD;RIDA;AMT;GCSH;SHMT2;GCAT;GLDC;SHMT1
prerank,protein-containing complex assembly (GO:0065003),0.24937203948823936,0.9875327894473254,0.49031476997578693,0.9472483620773922,1.0,57/259,16.83%,SH3BGR;CAND1;TRAPPC2;CAPZA2;LEF1;TIAM1;CNIH1;CXCL12;KIFAP3;SKAP2;NDUFAF1;ANKRD28;SEC23IP;EP300;KPNA3;GOSR2;F8;MAGI1;NAPA;GEMIN5;AXIN1;PDE4DIP;TMED10;CAND2;SLC2A1;RUVBL1;MDM2;RAB1A;TFAP4;BAD;TERT;P2RX7;DMD;CREBBP;TLE4;SCFD1;ELOB;TRAPPC6B;PICALM;MCFD2;HGSNAT;CUL3;TRRAP;APC;HES1;AP2M1;PARD3;PPP6R1;TRAPPC10;SMARCA4;TCF7L1;DNM1L;PTK2B;TUBGCP2;LIN7A;DNAJB14;CD2AP
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.2674760800908885,0.9873849206398664,0.4985835694050991,0.9467416797019039,1.0,30/129,14.00%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;PIN1;PRDM15;PSMD11;PSMB4;PSMC1;TMEM9;CSNK1G3;ATP6AP2;AXIN1;RUVBL1;USP47;PSMC2;FZD9;PSMD2;CCAR2;TRPM4;DDX3X;ZBED3;TNKS;PSMD14;RNF146;PSMC6;PSMD1;PSMB1
prerank,cation transport (GO:0006812),-0.22738194602284267,-0.987273162597311,0.48660714285714285,0.795351566839746,1.0,44/167,23.76%,TRPM3;ATP1A2;KCNB2;KCNMA1;ATP1B1;SLC41A1;TRPM6;SLC47A1;SCN8A;SCN3A;PIEZO2;SLC12A2;SLC6A9;KCNK5;KCNJ2;SCN1A;KCNA1;SLC22A4;SGK1;ANO1;NDFIP1;KCNJ6;SLC9B2;ABCC9;ANO6;KCNJ13;NDUFA9;KCNS3;KCNQ4;SLC5A6;SLC38A7;SLC5A5;ANO10;KCNJ10;KCNA6;KCNA2;SLC11A2;GRIN1;SLC22A18;TRPC6;MCOLN1;KCNC1;PANX1;CLN3
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.3328610087803559,-0.9872542743410825,0.47044334975369456,0.7946398713010477,1.0,14/23,41.86%,DDB1;DDB2;UBC;PARP1;XPC;COPS2;COPS5;COPS7A;COPS6;RBX1;XPA;GPS1;UBA52;CETN2
prerank,protein import (GO:0017038),-0.2532754773258844,-0.9870125618521058,0.4934210526315789,0.7945188020313725,1.0,41/84,32.77%,ACBD5;IPO9;TNPO3;RAB8B;APPL2;PEX14;HSPA4;NUP155;FIS1;NUP188;IPO11;NUP88;NUP93;ALDH3A2;TNPO2;PXMP4;ABCD2;FAM53C;PEX2;NUTF2;PEX5;IPO13;TSC2;NUP85;GDAP1;NUP214;APPL1;PPP1R10;AKT1;SEC13;SAMM50;ABCD3;HSP90AA1;NUP153;NXT2;PEX26;PEX19;RPAIN;RAN;EIF4ENIF1;HEATR3
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.30200491168995347,-0.9867397353647258,0.423728813559322,0.7944552140987665,1.0,11/35,19.51%,SULF1;NR2F2;COL4A3;XDH;SPARC;THBS1;AIMP1;CAV2;ATP5IF1;SCG2;STAT1
prerank,mitochondrial fission (GO:0000266),0.39677585056516623,0.9864768922667939,0.4772313296903461,0.9484787981141001,1.0,2/16,3.85%,DNM3;MTFR1
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.41267435153189214,0.986171869718719,0.4803001876172608,0.9484649831850587,1.0,4/14,12.65%,RGCC;PLCG1;PRKCI;ECSCR
prerank,membrane lipid metabolic process (GO:0006643),0.3669807024418233,0.9860341869142093,0.479646017699115,0.94796303437201,1.0,5/22,11.91%,SERINC1;CERKL;TEX2;CYP1B1;ST3GAL6
prerank,dendrite self-avoidance (GO:0070593),-0.3702395114241916,-0.9860065576569859,0.4819532908704883,0.7956208983869837,1.0,4/16,6.72%,CNTN4;CNTN6;DSCAM;PALLD
prerank,mitochondrial transport (GO:0006839),0.30913535563747646,0.9859070733522761,0.49608763693270735,0.947398220600238,1.0,8/53,10.66%,TOMM20;ABCB10;SLC25A24;TIMM17B;TSPO;FBXO7;BAD;MAIP1
prerank,lipoprotein transport (GO:0042953),0.4451907578626173,0.9858814096353113,0.48507462686567165,0.9465669825106459,1.0,5/10,21.07%,ZDHHC17;VMP1;UNC119B;MIA3;PPARG
prerank,autophagosome assembly (GO:0000045),0.3110436020319088,0.9856134891723289,0.4852941176470588,0.946441802104239,1.0,19/52,18.80%,MAP1LC3B;ATP2A2;RAB7A;RAB43;TRAPPC8;VMP1;RAB1A;UBQLN1;ATG7;ATG16L1;ATG14;TMEM41B;GABARAPL1;ATG13;TP53INP2;UBQLN2;BECN1;GABARAP;ULK1
prerank,clathrin-dependent endocytosis (GO:0072583),-0.3208204466183134,-0.9854668641610447,0.5058823529411764,0.7963789835076776,1.0,6/26,7.94%,DNAJC6;AP2B1;SNAP91;AP2A2;GPR107;AP2A1
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.38210806886270365,0.9853752623392132,0.4869109947643979,0.9461745217265636,1.0,3/19,9.17%,MAPK3;CAMK1D;CSF1R
prerank,sodium ion import across plasma membrane (GO:0098719),0.38833386860951463,0.9848089677439898,0.47706422018348627,0.9469076109787006,1.0,3/17,10.53%,SLC9A7;SLC9A6;TRPM4
prerank,glycogen biosynthetic process (GO:0005978),0.41407692598730317,0.9848036151217596,0.4689922480620155,0.9450945708428298,1.0,4/12,15.56%,GYG1;NHLRC1;UGP2;PGM2L1
prerank,glucan biosynthetic process (GO:0009250),0.41407692598730317,0.9848036151217596,0.4689922480620155,0.9450945708428298,1.0,4/12,15.56%,GYG1;NHLRC1;UGP2;PGM2L1
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.40633212200785174,-0.9847635513020784,0.46963562753036436,0.797393046289434,1.0,2/12,2.73%,FOXP1;MBP
prerank,dicarboxylic acid catabolic process (GO:0043649),-0.39486958334995925,-0.984691601177969,0.4968944099378882,0.7968373523077318,1.0,4/13,7.04%,ASPA;DDO;GLUL;GLUD1
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.38640267611815954,0.984627621700592,0.46808510638297873,0.9446869542753512,1.0,3/18,4.40%,MAPK3;SRC;VPS11
prerank,peptidyl-threonine modification (GO:0018210),-0.261917300841374,-0.9846152454674179,0.48467966573816157,0.7962805667149723,1.0,17/66,14.50%,GALNT13;TGFBR1;TGFBR2;WNK1;CDC42BPB;ROCK2;CIT;PRKCD;HIPK3;ROCK1;ACVR1;GSK3B;CAMK2D;HIPK1;ACVR1B;WNK3;MAP3K12
prerank,Wnt signaling pathway (GO:0016055),-0.25146579499022437,-0.9845897500167956,0.49683544303797467,0.7955948848396134,1.0,26/92,18.67%,WLS;NXN;WNT5B;FZD6;RYK;CTNNB1;PLPP3;DIXDC1;CSNK1A1;BTRC;WNT4;LRP5;CSNK1E;DVL3;CSNK1G2;FZD2;GSK3B;UBC;WNT9A;USP34;LRP6;TCF7L2;FZD4;DVL1;SFRP4;SNX3
prerank,protein targeting (GO:0006605),0.27288296555573366,0.9845835979434262,0.487248322147651,0.9439070701776276,1.0,21/118,14.49%,RTP3;TOMM20;CHM;CDC37;TIMM17B;TSPO;PEX1;SPCS3;ZDHHC14;PIKFYVE;AP4S1;ZDHHC15;FBXO7;ICMT;VPS37B;PRKCI;ZDHHC9;SPCS2;GIPC1;ZDHHC7;PARD3
prerank,sensory perception of smell (GO:0007608),-0.4125305549694731,-0.9845591996086226,0.4899193548387097,0.7949394773824988,1.0,5/11,33.92%,ADCY3;SYT10;SLC24A4;DRD2;MKKS
prerank,long-term synaptic potentiation (GO:0060291),-0.33900545279927036,-0.9843621133674122,0.46993318485523383,0.7947644876363003,1.0,9/21,23.78%,GRIN2B;TSHZ3;PRKCZ;SLC24A2;VAMP2;SHANK2;NFATC4;GRIN2D;MPP2
prerank,regulation of cell junction assembly (GO:1901888),-0.32315334199623524,-0.9843229099086002,0.472289156626506,0.7941303889346688,1.0,6/27,9.54%,PDLIM5;OCLN;CBFB;ROCK2;ROCK1;PRKACA
prerank,acyl-CoA metabolic process (GO:0006637),0.3316312334887629,0.9840770906840216,0.46991869918699186,0.9445069603312759,1.0,6/35,11.77%,MLYCD;DBI;GPAT4;ACACB;HMGCS2;ACOT8
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.37536416257055777,0.9839588436128117,0.4838709677419355,0.9439342410796495,1.0,5/21,11.16%,FCGR2B;PRKCH;LYN;CD81;SLC39A10
prerank,atrial septum morphogenesis (GO:0060413),-0.42648976126630694,-0.9838916114100295,0.47950819672131145,0.7945567358124614,1.0,2/10,9.13%,NOTCH2;ACVR1
prerank,response to ionizing radiation (GO:0010212),0.29234290495236137,0.9837504409629534,0.4640625,0.943647749213735,1.0,11/70,9.53%,AEN;ABRAXAS1;EEF1D;RAD1;CDKN1A;COP1;SIRT1;CLOCK;EYA3;KDM4D;RFWD3
prerank,negative regulation of translation (GO:0017148),-0.2527237534943896,-0.9837220137413071,0.471875,0.7942650233714383,1.0,21/87,18.45%,SAMD4A;CPEB4;CPEB1;CPEB2;IGFBP5;PUM1;ROCK2;ROCK1;SYNCRIP;EIF4E2;YTHDF1;CNOT9;EIF2AK2;PUS7;RBM4;UNK;RACK1;TOB1;RNF139;PCIF1;DAPK1
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.32103859056514417,0.9834285022085015,0.4750830564784053,0.9436615581008017,1.0,6/41,9.17%,LRP8;SRC;FYN;BDNF;EFNA1;CSF1R
prerank,regulation of T cell mediated immunity (GO:0002709),0.42955509193231967,0.9832450445324269,0.4703476482617587,0.9432751834067109,1.0,2/10,10.53%,TNFRSF1B;TRPM4
prerank,Notch signaling pathway (GO:0007219),0.3003202059057226,0.9832305509036353,0.4947526236881559,0.9424119233348812,1.0,14/59,16.10%,SORBS2;JAG2;PSEN2;HEY1;EP300;HEY2;NOTCH1;RBPJ;CREBBP;DTX4;HES1;YBX1;APH1A;HEYL
prerank,protein stabilization (GO:0050821),0.2583949035582748,0.9831324627311894,0.4993548387096774,0.9418063835798723,1.0,37/168,16.43%,ZSWIM7;CDC37L1;PIN1;RPL23;GNAQ;PDCL3;CCT2;CDC37;PPIB;CCNH;CCT5;PFN1;PHB2;WFS1;CDKN1A;EP300;RPL5;BAG1;SMAD7;GLMP;EFNA1;TSC1;PARK7;OTUD3;NLK;ZBED3;TNIP2;USP33;CHEK2;COG3;HCFC1;USP9X;TAF1;WIZ;TCP1;NAA15;SOX17
prerank,protein import into nucleus (GO:0006606),0.3003031630431408,0.9823235620893934,0.5131375579598145,0.9433576853449788,1.0,18/66,17.67%,RPL23;MMP12;PHB2;KPNA3;PTTG1IP;NUP54;SYK;NXT1;NUP50;RANBP17;KPNA1;E2F3;NUP35;IPO8;HIKESHI;KPNB1;POM121;STAT3
prerank,regulation of feeding behavior (GO:0060259),-0.4128109350974614,-0.98199435497086,0.5010660980810234,0.7980789413610444,1.0,2/11,6.86%,LEPR;CFAP20
prerank,negative regulation of protein phosphorylation (GO:0001933),-0.23068362097389775,-0.981941674775977,0.4939759036144578,0.7974718468895997,1.0,48/150,22.41%,NTRK3;LDLRAD4;PRKAG2;PTPN13;DNAJC3;ERRFI1;SH3GL2;FBLN1;RASSF2;PID1;OCLN;PLPP3;SIRT2;PRKCZ;ENPP1;PRKCD;PPM1E;XDH;UBASH3B;SMAD6;NIBAN1;EPHB2;CAMK2N1;SNX25;SEMA4D;DEPTOR;SIRPA;MYADM;TAB1;RACK1;LRP6;TGFB1;WWTR1;RTRAF;DVL1;TSC2;GPD1L;PPP1R15B;SPRED3;PAQR3;CADM4;FKBP8;HSPB1;PPM1F;DBNDD2;DGKQ;IMPACT;EMILIN1
prerank,positive regulation by host of viral transcription (GO:0043923),0.4068794955881543,0.9819182376011757,0.4740882917466411,0.9436490853380199,1.0,6/15,15.97%,LEF1;EP300;TFAP4;CHD1;SP1;SMARCA4
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.4212489470151129,0.981891986974386,0.49416342412451364,0.9428332146160522,1.0,4/13,13.31%,SOD1;APOE;ERLIN2;PLEK
prerank,protein ubiquitination (GO:0016567),0.236720367384914,0.9816644423583928,0.5294771968854283,0.9425786961163728,1.0,96/471,16.75%,PSMB10;PSMC4;PSMB6;RAD18;CAND1;ELOC;RNF7;CBL;PSMD8;PSMD5;PSMD12;ARIH1;KLHL3;RNF38;SPOP;UBA1;BIRC2;PSMD11;NEDD4L;VPS11;NHLRC1;RBBP6;PSMB4;FBXL5;UBE3A;TRIM14;PSMC1;FBXW2;NFX1;SIRT1;RNF187;LMO7;UBE2V2;KLHL2;FBXO32;CAND2;TRIM25;AKTIP;FBXO11;CRBN;ANAPC7;RBCK1;MDM2;PJA2;RFWD3;MYCBP2;PSMC2;KLHL24;UBE3D;PSMD2;RNF6;ZNRF1;FBXO7;EIPR1;UBE2V1;RNF13;RNF25;CHFR;USP22;ANAPC11;ELOB;TNKS;DTX4;RNF11;CUL3;PSMD14;UBE2R2;EPAS1;RNF146;PSMC6;TSPAN17;PSMD1;PSMB1;TRIM27;RNF20;FANCL;USP9X;TRIM3;UBA6;NHLRC3;UBE2G1;FBXO22;RMND5A;RNF114;TAF1;TRIM33;KLHL7;PELI1;KLHL42;RNF125;UBE2H;PSMA4;KLHL13;VPS18;FBXL20;PRKDC
prerank,osteoclast differentiation (GO:0030316),-0.33562125910461005,-0.9814712684384682,0.47368421052631576,0.7979627117000393,1.0,3/22,3.50%,FOXP1;ANXA2;MAPK14
prerank,cellular polysaccharide catabolic process (GO:0044247),-0.3646132274865461,-0.9811436787492375,0.4861995753715499,0.7980905857018769,1.0,7/16,19.40%,PYGB;AGL;PHKA2;PYGM;PGM2;GAA;PHKG2
prerank,macroautophagy (GO:0016236),0.2657636498172257,0.9811054138976113,0.49653259361997226,0.9432587892114109,1.0,34/118,18.88%,TOMM20;MTERF3;MAP1LC3B;KLHL3;MTMR14;SRC;YOD1;ATG4B;EPG5;TECPR1;CHMP2A;PRKAA2;DYNLL1;VPS37B;UBQLN1;NBR1;ATG7;PLAA;EI24;CSNK2A2;ATG16L1;ATG14;GABARAPL1;ATG13;PIK3R4;ZFYVE1;VPS37C;BECN1;PIP4K2A;VPS33A;GABARAP;VPS4B;ULK1;LAMP2
prerank,regulation of cell division (GO:0051302),0.29014330472758887,0.9807794981354464,0.5109375,0.9433102147757656,1.0,8/72,6.88%,TAL1;PIN1;PLK2;PRDM15;CSPP1;PRPF40A;CIB1;CALM3
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.358112389146304,0.9806907424744186,0.4956521739130435,0.9426635861309516,1.0,8/24,16.16%,EZH2;EED;BMI1;PPHLN1;TRIM27;TASOR;AEBP2;RBBP4
prerank,determination of heart left/right asymmetry (GO:0061371),-0.2841544645261702,-0.9806872142458151,0.456359102244389,0.7985235557647845,1.0,10/42,25.89%,AHI1;MICAL2;TGFBR2;SMO;TBX3;SETDB2;BBS5;CCDC39;NDRG4;TBX2
prerank,regulation of ion transport (GO:0043269),-0.2525133061206122,-0.9806133534406478,0.4782608695652174,0.7979778511158826,1.0,22/76,21.12%,ANK3;WNK1;P2RX4;WWP2;ATP1A1;SYT9;KCNJ2;SIK1;KCNJ6;PER1;SYT12;SYT11;SYT4;NKAIN4;VAMP2;SYT7;KCNJ13;SYT2;KCNJ10;KCNA2;NEDD4;SNX6
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.3624989182356106,-0.980185671358668,0.4702127659574468,0.7984292266450385,1.0,2/17,3.00%,NTRK3;NRP1
prerank,detection of calcium ion (GO:0005513),0.41268198044821175,0.9801386020757514,0.4893203883495146,0.9433676735926227,1.0,5/13,18.82%,CALM3;KCNMB2;KCNMB3;RYR2;CALM1
prerank,regulation of immune response (GO:0050776),0.26669008109006775,0.9800188807892495,0.49936305732484076,0.9428287944634675,1.0,12/135,10.70%,LRP8;SH2D1A;FCGR2B;TIRAP;BIRC2;B2M;ICAM1;SYK;IFITM1;TRAF3;LYN;CD81
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.4140197129850625,0.9792596101125998,0.46577946768060835,0.9441399235680502,1.0,2/12,6.27%,SOAT1;LPCAT3
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.25809684178544723,0.9784394612061083,0.514745308310992,0.9456716826141959,1.0,18/150,11.82%,RAC2;MAZ;PIK3CG;TRIB3;PIK3AP1;PTPRJ;SRC;TEK;FYN;RET;TXN;IRS2;PARK7;ESR1;MFHAS1;RHOG;PIK3CD;PIK3R5
prerank,hexose biosynthetic process (GO:0019319),0.3218486775765761,0.9784114402090808,0.488135593220339,0.9448591315844519,1.0,4/42,5.68%,PCK1;SLC25A1;GOT2;TPI1
prerank,regulation of protein polymerization (GO:0032271),-0.3013462512764171,-0.9783509469205771,0.4844559585492228,0.802463449118373,1.0,17/35,29.32%,MAP2;MAPT;ARHGAP28;PLEKHG2;CTTN;FCHSD2;DBNL;PFN2;TPPP;HSP90AA1;TPPP3;DBN1;TTBK1;ARL2;HAX1;COTL1;GBA2
prerank,peptidyl-lysine dimethylation (GO:0018027),-0.3577623611889508,-0.978192892249951,0.47415730337078654,0.8021116630902625,1.0,7/18,20.71%,KMT2A;SETD7;EHMT2;KMT2B;SMYD2;KMT2D;SETD4
prerank,regulation of protein autophosphorylation (GO:0031952),-0.29616720926576035,-0.9779548311321669,0.49417249417249415,0.8019521983787179,1.0,14/36,22.49%,ERRFI1;RASSF2;EPHA7;ENPP1;RAD50;TNKS1BP1;MRE11;PPP2R5E;TOM1L1;PDGFD;PDGFA;VEGFA;IMPACT;PPP2R5D
prerank,regulation of viral transcription (GO:0046782),0.32021314657553873,0.9778498738386966,0.47417840375586856,0.9456234017899227,1.0,11/39,18.82%,POLR2J;POLR2B;TRIM14;IFITM3;RSF1;MDFIC;TRIM27;GTF2F2;UBP1;HEXIM1;MID2
prerank,calcium-ion regulated exocytosis (GO:0017156),-0.31584346098345095,-0.9771165417299194,0.4834123222748815,0.8034158662466561,1.0,11/27,26.45%,RIMS1;SYT9;SYT12;SYT11;SYT4;VAMP2;SYT7;SYT2;ARHGAP17;SYT10;SYT6
prerank,regulation of chondrocyte differentiation (GO:0032330),-0.3287132198817766,-0.9767301448985214,0.4945770065075922,0.8036898728165944,1.0,7/24,17.75%,ADAMTS12;TGFBR1;SOX5;EFEMP1;WNT9A;BMPR1B;SOX6
prerank,negative regulation of protein modification process (GO:0031400),0.2821393851411167,0.9766693064342542,0.48691860465116277,0.9481721517734709,1.0,27/79,17.28%,PRR5L;PNKP;PPP1R16B;XRCC1;CIB1;DBI;YWHAB;SIRT1;CDYL;LYN;PARK7;TARDBP;PRKAA2;MFHAS1;TRAF3IP1;DMD;ZBED3;PRNP;CRKL;PTPA;TERF2IP;ATG14;PPP1R8;DNAJC10;PRKDC;WARS1;CORO1C
prerank,spindle assembly checkpoint signaling (GO:0071173),-0.3455875173775536,-0.9765827437575495,0.48717948717948717,0.8018254435292835,1.0,14/20,49.42%,ZWINT;KLHL22;BUB3;ATM;ZW10;TEX14;MAD2L2;MAD2L1;BUB1B;TTK;IK;CENPF;KNTC1;TRIP13
prerank,mitotic spindle checkpoint signaling (GO:0071174),-0.3455875173775536,-0.9765827437575495,0.48717948717948717,0.8018254435292835,1.0,14/20,49.42%,ZWINT;KLHL22;BUB3;ATM;ZW10;TEX14;MAD2L2;MAD2L1;BUB1B;TTK;IK;CENPF;KNTC1;TRIP13
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),-0.3455875173775536,-0.9765827437575495,0.48717948717948717,0.8018254435292835,1.0,14/20,49.42%,ZWINT;KLHL22;BUB3;ATM;ZW10;TEX14;MAD2L2;MAD2L1;BUB1B;TTK;IK;CENPF;KNTC1;TRIP13
prerank,glucose import (GO:0046323),0.40336503890282893,0.9764411505349236,0.5142857142857142,0.9479643384293654,1.0,3/13,14.04%,SORT1;SLC2A1;ZDHHC7
prerank,cellular response to hydrogen peroxide (GO:0070301),0.33048176922299793,0.976100149003788,0.5,0.9481046488257614,1.0,7/33,11.52%,TNFAIP3;SIGMAR1;SIRT1;RELA;PARK7;CYP1B1;RPS3
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),-0.2657736858733874,-0.9757544796401364,0.5128939828080229,0.8033455813624408,1.0,14/66,12.92%,EGFR;KANK2;PKD1;FHL1;RBL2;APPL2;MYO16;CDC73;ADAMTS1;BRD7;CCND3;CDK6;ANXA1;DLG1
prerank,sensory perception of taste (GO:0050909),0.4381747426562893,0.9756125271730307,0.5188679245283019,0.948599835941939,1.0,10/10,56.21%,ASIC2;TAS1R3;GNAT3;TAS1R2;TAS1R1;ASIC3;CD36;ASIC1;PKD1L3;PKD2L1
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.38928586849422936,0.9748640398832937,0.4906015037593985,0.9498672751842518,1.0,4/15,15.56%,SYK;PNP;CD55;NKAP
prerank,amino acid import across plasma membrane (GO:0089718),0.3608568827706259,0.9746143662632653,0.49043478260869566,0.9496732385043457,1.0,5/24,8.22%,SLC7A8;SLC1A1;SLC3A2;SLC6A6;SLC1A2
prerank,glycosaminoglycan metabolic process (GO:0030203),0.3013523050583131,0.9746087311104924,0.4969040247678019,0.948800444537035,1.0,12/54,12.34%,XYLT1;SGSH;GLB1;EXT2;HS6ST1;PXYLP1;FUCA1;HS3ST2;B3GAT2;HGSNAT;AGRN;IDS
prerank,intraciliary transport involved in cilium assembly (GO:0035735),-0.29615447390028515,-0.9745290638990441,0.515,0.805890684103329,1.0,13/37,17.47%,IFT81;WDR35;DYNC2I1;TTC21B;IFT46;IFT57;IFT52;IFT172;IFT74;KIF3A;WDR19;DYNLL2;IFT20
prerank,organophosphate ester transport (GO:0015748),0.3519361192615706,0.9739954473506216,0.5025728987993139,0.9497197361467359,1.0,7/24,13.79%,PRELID3B;EPG5;PRELID2;PITPNA;SCARB1;NPC2;OSBPL2
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.39958278839192113,0.9739662766398559,0.4897579143389199,0.9489118731795612,1.0,1/15,0.77%,ZC3H12D
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.23594060913151996,0.9738823969518691,0.5565509518477044,0.9482560183666459,1.0,84/476,14.24%,MAZ;CTCFL;MAP2K7;MECOM;SS18L1;ILF3;TAL1;TRIM28;LEF1;PPP3CB;RPS6KA1;KLF2;HIPK2;PAX8;PHF5A;HNRNPAB;HEY1;RLF;APOE;FLI1;SMARCA2;SOX2;KDM3A;SPIN1;NPAT;EP300;RFX3;TBX1;RET;CALCOCO1;FOXF2;PPARD;MED12;CLOCK;RNF187;HEY2;AXIN1;NOTCH1;CAND2;WNT5A;ATXN7L3;ATAD2;GTF2H1;ZXDC;ACVRL1;RSF1;RELA;PCID2;RAI1;PLCB1;TFAP4;RNF6;ZKSCAN3;KLF6;UBE2V1;TAF15;CITED2;YEATS4;RYBP;ING2;WBP2;ESR1;SETD3;RHOG;CREBBP;USP22;MED4;PICALM;ILF2;SP1;IKBKB;MDFIC;CHUK;PITHD1;ACTA2;YWHAH;ING5;EDRF1;CHEK2;DDIT3;HES1;HCFC1;RNF20;PHF8
prerank,apoptotic cell clearance (GO:0043277),-0.3034433562349183,-0.9737276609059148,0.49417249417249415,0.8072560129270141,1.0,9/30,12.68%,XKR4;LRP1;TXNDC5;XKR6;THBS1;RHOBTB2;ANXA1;RARA;RHOBTB1
prerank,B cell receptor signaling pathway (GO:0050853),0.33312257828532765,0.9733557944198389,0.4957841483979764,0.9488580114058848,1.0,4/32,11.50%,PTPRC;VAV3;SYK;PIK3CD
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.3778036492663732,0.9733227588193898,0.47619047619047616,0.9480523739980667,1.0,4/17,10.56%,VEZF1;RFX3;TMEM100;BAD
prerank,negative regulation of cell growth (GO:0030308),0.2645550584427385,0.9731218731483006,0.5126835781041389,0.9477581364746014,1.0,20/121,13.08%,CCDC85B;GSK3A;PTPRJ;FRZB;ST7L;RERG;PPT1;PPP2CA;SMARCA2;CDKN1A;DIP2B;FGF13;SIRT1;ACVRL1;RNF6;CCAR2;DDX3X;IP6K2;EI24;NDUFA13
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.2507157791626961,-0.9727491947147631,0.5235294117647059,0.809046166667502,1.0,24/84,17.39%,CELF2;DDX5;TIA1;SON;DDX17;KHDRBS1;CELF4;KHDRBS2;RBM39;RBMX;SRSF6;RBM15;SNW1;RBFOX3;HNRNPA1;SMU1;RBM3;RBM4;DAZAP1;SRRM4;RBM7;NOVA1;SRPK1;RNPS1
prerank,cellular response to dsRNA (GO:0071359),0.3963130690286326,0.9726741729070664,0.49633699633699635,0.9481144210981655,1.0,2/15,3.70%,RALB;IFIT1
prerank,negative regulation of viral transcription (GO:0032897),0.4101993299558456,0.9726321051457857,0.5037174721189591,0.9473296098403627,1.0,6/13,18.82%,TRIM14;IFITM3;TRIM27;UBP1;HEXIM1;MID2
prerank,regulation of myoblast fusion (GO:1901739),-0.40272661423263956,-0.9725586962547565,0.49678800856531047,0.8088114521676911,1.0,4/11,20.46%,CFLAR;MAPK14;EHD1;FLOT1
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.38970272704771103,0.9723951624753413,0.5,0.9470946898890055,1.0,2/16,2.31%,RBM22;SFSWAP
prerank,regulation of protein processing (GO:0070613),-0.33846700870557117,-0.9722960607414924,0.48854961832061067,0.8087888871255633,1.0,6/21,23.76%,RHBDD1;GAS1;CCBE1;RNF139;NKD2;CLN3
prerank,positive regulation of mitochondrial translation (GO:0070131),0.40143003262951704,0.9721081166462661,0.49534450651769085,0.9470224587672998,1.0,2/14,8.85%,FASTKD2;NGRN
prerank,regulation of synapse organization (GO:0050807),-0.32559227728577356,-0.9720829869196969,0.49191685912240185,0.8085852130824848,1.0,10/26,29.18%,CTNNA2;PDLIM5;ARHGAP22;IL1RAPL1;NEDD4;CAMK2B;CLN3;SLITRK4;MDGA1;ABHD17A
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.3292402916034637,0.9718957752501882,0.5092748735244519,0.9467628023170712,1.0,9/35,11.76%,DDX54;SRC;UBE3A;KDM3A;CALCOCO1;PLPP1;WBP2;ESR1;EGLN2
prerank,limb development (GO:0060173),0.34436676292773866,0.9717914708912425,0.4974704890387858,0.9461822762833778,1.0,2/28,3.08%,TBX4;GREM1
prerank,positive regulation of cellular protein catabolic process (GO:1903364),0.385318515848323,0.9717163550743538,0.48392857142857143,0.9455206607581605,1.0,8/18,18.42%,VPS11;APOE;PTTG1IP;CD81;FAF1;VPS35;RNF128;RDX
prerank,glycerol metabolic process (GO:0006071),0.4429949845311687,0.9714602814754977,0.5028790786948176,0.9453900721877484,1.0,3/10,11.01%,TPI1;COQ2;PGP
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.2788076709365285,-0.9712297155479303,0.5014164305949008,0.8101551312883765,1.0,10/47,12.24%,PDGFRB;MAPK14;PID1;TGFBR2;MAPT;PRKCD;XDH;THBS1;TP53;GRB2
prerank,cell-substrate junction assembly (GO:0007044),-0.2950741298093051,-0.9709026278342794,0.48048780487804876,0.8102881611388592,1.0,7/33,11.11%,SORBS1;PLEC;BCR;PIP5K1A;CTTN;ACTN2;FN1
prerank,cardiac ventricle development (GO:0003231),0.3713747444638103,0.9708235589283988,0.483695652173913,0.9463614589692674,1.0,7/20,16.10%,HEY1;HEY2;NOTCH1;MATR3;DAND5;HES1;HEYL
prerank,cellular response to ATP (GO:0071318),-0.384356030111039,-0.9707815288913055,0.5319634703196348,0.8098727352097409,1.0,4/14,21.63%,RYR3;P2RX4;SSH1;P2RY12
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),-0.2936062888381578,-0.9707653716936971,0.5085995085995086,0.809169098634529,1.0,4/35,6.92%,MAGI2;PDGFRB;CRY2;HTT
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.42948117420965237,0.9704382976513108,0.5150905432595574,0.9466130050169665,1.0,1/12,0.61%,IMPDH1
prerank,tryptophan metabolic process (GO:0006568),-0.3963077550852042,-0.9703360370026107,0.5,0.8095392681200033,1.0,2/11,17.82%,ATP7A;KYAT1
prerank,anterior/posterior pattern specification (GO:0009952),-0.26289320937408683,-0.9703050787585512,0.5073313782991202,0.8088705596014487,1.0,9/53,8.39%,WLS;PCSK5;TGFBR1;HOXC6;HOXA3;HOXA5;SKI;LRP5;BHLHE40
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.3517481815493182,0.9702920223368832,0.5236363636363637,0.946185534283957,1.0,3/25,3.83%,EVI5L;TBC1D30;EVL
prerank,regulation of endocytosis (GO:0030100),-0.2601937146618054,-0.9700761769951948,0.5169491525423728,0.8087669584390779,1.0,22/61,21.58%,LRP1;DAB2;RUFY2;ARFGAP1;STON2;GPC3;ROCK1;ZFYVE16;STON1;EPHA3;RIT2;CLIP3;SYT11;HIP1R;SCAMP5;CBLL1;LRSAM1;ABL2;TSC2;PACSIN1;FLOT1;PRKD1
prerank,positive regulation of chromosome organization (GO:2001252),-0.37573551890635365,-0.970065503664892,0.49130434782608695,0.808045104310965,1.0,7/15,26.93%,PML;RAD50;MRE11;GNL3;RTEL1;PPP1R10;RAD21
prerank,positive regulation of DNA metabolic process (GO:0051054),-0.2676145951082168,-0.969980843606234,0.5,0.8075270751291943,1.0,19/61,19.32%,EYA2;EYA1;EGFR;PDGFRB;UBE2N;TOX;ERCC6;PML;RAD50;SMOC2;RNF168;MRE11;RNF8;PARP3;USP7;NPAS2;BABAM1;GNL3;SMCHD1
prerank,neuron projection organization (GO:0106027),-0.37177408862002026,-0.9696440230842728,0.5052854122621564,0.8077020044457051,1.0,9/15,26.56%,LGMN;GSK3B;ABCD2;MAP1A;DCTN1;ATP1A3;PLS1;PICK1;CHRNA7
prerank,regulation of chemokine production (GO:0032642),-0.29485381844828307,-0.9693608621871341,0.49214659685863876,0.8077688125533494,1.0,5/36,13.42%,FOXP1;IL6R;EIF2AK2;IL18;IL33
prerank,protein palmitoylation (GO:0018345),0.3379087546301955,0.9693106290970563,0.5033557046979866,0.9481408580429617,1.0,7/30,14.04%,ZDHHC17;ZDHHC13;ZDHHC14;SELENOK;ZDHHC15;ZDHHC9;ZDHHC7
prerank,negative regulation of protein binding (GO:0032091),0.28932572292409037,0.9689140198519293,0.4984894259818731,0.948365630131667,1.0,10/71,6.21%,RALB;PIN1;ACTB;PSME3IP1;IFIT1;ATP2A2;B2M;CDKN1A;MAPK8;CARD16
prerank,positive regulation of protein import into nucleus (GO:0042307),0.3393121502181658,0.968259778894532,0.5033670033670034,0.9493247282415552,1.0,4/28,3.90%,RBM22;TRIM28;DMAP1;HDAC3
prerank,positive regulation of cytokine production (GO:0001819),0.24165236628547265,0.9681804438639726,0.5468564650059312,0.9486650983786129,1.0,33/292,11.57%,LRRFIP1;CADM1;PIK3CG;IL1R1;PDE4D;PTPRC;MAP3K7;SOD1;POLR1C;TIRAP;PRKD2;RAB7B;CYRIB;EP300;CEBPG;SYK;RGCC;TMED10;WNT5A;RELA;CSF1R;RAB1A;PLCB1;LURAP1;PARK7;PNP;CYP1B1;CREBBP;APP;NOD1;PIK3CD;RPS3;POLR3F
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.24279865013995205,-0.9680748549619804,0.5251572327044025,0.8104078960867629,1.0,20/95,12.13%,LDLRAD4;TGFBR3;DAB2;SMAD3;SMURF2;TGFBR1;TGFBR2;ZEB2;SMAD4;PPARA;SKI;HTRA3;DKK3;SNW1;SMAD6;THBS1;SNX25;UBC;STK11;PPM1A
prerank,regulation of DNA binding (GO:0051101),0.313112310391475,0.9671549579236863,0.4928909952606635,0.9507604529335943,1.0,11/44,13.91%,LEF1;NME1;MAPK8;CEBPG;TXN;HJURP;RSF1;TFAP4;DOT1L;NFKBIA;HES1
prerank,positive regulation of DNA replication (GO:0045740),-0.35798733542661254,-0.9671135926863129,0.47391304347826085,0.8121813230943756,1.0,6/16,14.07%,EGFR;GLI2;KAT7;STN1;BRPF3;ATAD5
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.2429901599751272,0.9670311452421584,0.55,0.9502308074166433,1.0,56/264,16.18%,POLR2J;SNRPD2;NCBP1;RBM22;HSPA8;POLR2B;PRPF31;PRPF3;SNRPD1;HNRNPH2;PCBP1;PHF5A;SF1;PRPF40A;HNRNPK;CPSF4;PPIL3;PLRG1;SRSF10;SNRNP27;PRCC;SFPQ;HNRNPC;GEMIN5;SMNDC1;YTHDC1;SF3B3;SRSF4;DNAJC8;SNU13;NOVA2;COIL;SF3A1;RSRC1;BUD31;SYF2;U2AF1;PAPOLA;SRPK2;EFTUD2;PTBP1;RBM10;STRAP;YBX1;SRSF7;SNRPA;USP39;FUS;RBM4B;SF3B6;HNRNPL;TRA2B;GTF2F2;RBM41;UPF3B;U2AF2
prerank,T-helper cell differentiation (GO:0042093),-0.37749233240011704,-0.9668149105469265,0.5147058823529411,0.8122944965468728,1.0,2/14,5.67%,FOXP1;ATP7A
prerank,regulation of protein import into nucleus (GO:0042306),-0.2932699730533821,-0.9665724264987733,0.5025,0.8122246671273107,1.0,14/36,20.03%,ZIC1;SMAD3;FLNA;BMP4;BAG3;PRKCD;UBR5;EFCAB7;CDH1;RAB23;TGFB1;MAVS;APOD;PIK3R1
prerank,positive regulation of epithelial cell migration (GO:0010634),-0.24170874270028853,-0.9664270619517982,0.5358361774744027,0.8118805064239842,1.0,18/92,13.00%,FOXP1;ANXA3;SASH1;DOCK5;DOCK1;NRP1;FGF1;BMP4;RREB1;ROCK2;EPB41L4B;SPARC;SMOC2;THBS1;NRP2;FOXC2;RHOB;RAB11A
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),-0.27746197996434974,-0.9661065972445327,0.5014005602240896,0.8119699347908353,1.0,16/48,22.88%,PRKAG2;OGT;PRKAG1;NUP205;NUP155;NUP188;NUP88;NUP93;SEH1L;PRDM16;NUP85;AAAS;RAE1;NUP37;NUP214;PGAM1
prerank,mitotic recombination (GO:0006312),-0.37258861659325404,-0.9659810857387111,0.4978902953586498,0.8115668993120629,1.0,8/15,33.43%,SMC6;RAD50;TPRKB;RAD51D;NSMCE2;DMC1;RAD54B;ERCC1
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.39294966931261355,-0.9656748364401481,0.5281837160751566,0.8116338129797978,1.0,5/12,25.50%,RNF168;RNF8;NELFB;NELFA;LARP7
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),-0.3883545444781272,-0.9654947864285953,0.5161943319838057,0.8106384852127635,1.0,2/12,10.56%,FHL2;GSK3B
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),-0.3883545444781272,-0.9654947864285953,0.5161943319838057,0.8106384852127635,1.0,2/12,10.56%,FHL2;GSK3B
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.3730092935500381,0.9654346993692913,0.4874551971326165,0.9538671077150055,1.0,5/18,14.60%,HDAC7;HDAC9;CIB1;MAP3K3;PIK3C2A
prerank,regulation of protein kinase activity (GO:0045859),0.26495128150740255,0.9652329302750279,0.5272727272727272,0.9535860680279429,1.0,22/106,16.82%,TRIB3;PTPRC;SOD1;TAB2;GNAQ;SMG8;SPRED1;CDKN1A;AKT1S1;DTNBP1;SIRT1;LCP2;PARK7;MMD;NF1;RAP2C;TRIM27;CAMKK2;GAS6;PRKRIP1;PTK2B;WARS1
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.29636951647034154,0.9651532100242805,0.49765258215962443,0.952919693970944,1.0,12/52,13.86%,GSK3A;EXTL2;WFS1;ATP6V0D1;PDIA6;GOSR2;TPP1;HYOU1;HDGF;TATDN2;FKBP14;PDIA5
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.32941930887406523,0.9650399141583452,0.5176470588235295,0.9523665970034727,1.0,4/34,10.85%,PTPRC;PHB2;WNT5A;GPI
prerank,limb morphogenesis (GO:0035108),0.3687254152351713,0.9647771285135849,0.5187713310580204,0.9522556331268186,1.0,1/20,0.04%,TBX4
prerank,calcium import into the mitochondrion (GO:0036444),-0.4125559794507907,-0.9646869117063165,0.5050709939148073,0.8119969854485312,1.0,5/10,21.72%,MCU;MICU2;AFG3L2;MCUR1;MCUB
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.4293971408668854,0.9644899020181903,0.5076045627376425,0.9522308452667192,1.0,3/10,15.25%,CXCL12;LYN;GAS6
prerank,neuron remodeling (GO:0016322),-0.4113706631037188,-0.9643488519408706,0.5064102564102564,0.812167839913216,1.0,4/10,21.76%,ADGRB3;SCARF1;CX3CL1;EPHA8
prerank,intracellular lipid transport (GO:0032365),-0.3354120089941718,-0.9640894706682702,0.5124716553287982,0.8120997200319447,1.0,6/21,14.84%,PRKAG2;CPT1A;PLEKHA8;PRKAB2;ABCD2;CPT2
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.25763393313151245,0.9640503006405658,0.523936170212766,0.952603883156186,1.0,24/140,12.28%,RAC2;TIAM1;VAV3;ARHGEF26;CHN2;SRC;MCF2L;ITSN1;ARAP2;CYRIB;ARHGAP25;ARHGEF6;ARHGEF7;TRIO;ARHGEF18;MYO9A;FAM13A;RHOQ;OPHN1;ARHGAP39;RHOG;A2M;ARHGAP23;MYO9B
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.3588958136391643,0.963711415254794,0.5035714285714286,0.9527004631183906,1.0,3/22,10.53%,TNFRSF1B;WNT5A;TRPM4
prerank,regulation of organelle organization (GO:0033043),0.28337910631387747,0.9634514208682489,0.5059701492537313,0.9525521419364301,1.0,13/80,11.02%,SURF4;MAPK3;STOX1;VPS11;MYO5A;EP300;USP6NL;F11R;CAMSAP2;PDE4DIP;TJP1;TBC1D25;RBSN
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.25539292700326127,0.9631423448960986,0.550326797385621,0.9526344549310966,1.0,10/152,4.57%,MTNR1A;HTR1F;PTGER2;ADGRE1;ADGRL4;GNAQ;ADGRL3;TSHR;INSL3;RAMP2
prerank,positive regulation of DNA repair (GO:0045739),-0.28226554107419977,-0.9630356525930318,0.5226130653266332,0.8141450064511404,1.0,10/46,9.48%,EYA2;EYA1;EGFR;SPIRE1;SPIDR;UBE2N;FMN2;ERCC6;MGMT;RNF168
prerank,positive regulation of catabolic process (GO:0009896),0.2893238309865761,0.9628115434738739,0.49765258215962443,0.9527041545561262,1.0,12/65,13.85%,GSK3A;TNFAIP3;PLK2;NEDD4L;RAB7A;AXIN1;WNT5A;VSIR;ATG7;EGLN2;NDUFA13;APC
prerank,necroptotic process (GO:0070266),0.3863973043613674,0.962773798642525,0.5236363636363637,0.9519585491168818,1.0,4/16,16.21%,MLKL;TRPM7;ITPK1;DNM1L
prerank,aortic valve development (GO:0003176),-0.29148839101193347,-0.9626855283283483,0.4923469387755102,0.8143246979658773,1.0,6/34,8.66%,ROBO2;ROBO1;BMP4;ROCK2;ROCK1;SMAD6
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),-0.3366725612529456,-0.9626045451482576,0.47912087912087914,0.813791036852392,1.0,7/20,20.17%,GSN;PLA2R1;THBS1;ANO6;SFRP4;ITGA4;PIAS4
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.42718413471962424,0.9625323435955343,0.5125523012552301,0.9517625114795563,1.0,4/10,18.79%,SSBP1;INO80;WIZ;ATRX
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),-0.32563768752047806,-0.9621896942116153,0.49321266968325794,0.8140901343270023,1.0,2/23,0.57%,ZBTB20;IGF1
prerank,organelle assembly (GO:0070925),-0.2024139406875871,-0.9620240507702236,0.6896551724137931,0.8137768812442474,1.0,89/384,17.47%,BICD1;AMBRA1;GSN;ULK2;PARVA;AHI1;PKD1;CC2D2A;EXOC3;TMOD2;PACS2;STAM2;DYNC1H1;MAPT;RILPL1;FLNA;PIBF1;IFT81;DZIP1;TTC8;WDR35;UBXN2A;WIPI1;PIK3C3;DYNC2I1;RAB8B;DCDC2;TUBGCP4;NUDCD3;CCDC66;CCDC57;CFAP20;IST1;OGFOD1;EXOC6;TTC39C;IFT46;IFT52;GOLGA2;ACTR3;YTHDF1;CEP89;UBXN2B;CEP126;IFT172;CEP20;IFT74;CFAP44;RP2;ARL13B;DISC1;CD34;NSFL1C;TTBK2;ABLIM3;LIMD1;KIF3A;STX12;DZIP1L;TUBGCP6;BBS9;G3BP1;CCDC61;SNF8;CDS2;RAB11A;WDR19;WDR11;ATXN2L;INTU;RAB23;DHX29;CDS1;BBS2;TSG101;CYS1;ARF4;EXOC7;EXOC1;PTPN23;HPS4;CEP250;EHD1;RAB8A;EHD3;DYNLL2;ACTR2;CHMP2B;IFT20
prerank,regulation of cellular component biogenesis (GO:0044087),0.3195447471174635,0.9616537173722569,0.5248344370860927,0.9534320305182293,1.0,7/39,9.82%,HSPA8;VPS11;APOE;HJURP;NOTCH1;TJP1;TIE1
prerank,dendritic spine morphogenesis (GO:0060997),-0.3636061327689485,-0.961485362358296,0.5042918454935622,0.8145002759225909,1.0,6/15,10.62%,EPHB1;WASL;DLG4;CTNND2;DOCK10;EPHB2
prerank,regulation of focal adhesion assembly (GO:0051893),-0.26622706082873987,-0.9614365114852467,0.5145118733509235,0.8139134177108299,1.0,11/54,6.65%,PHLDB2;GPM6B;EFNA5;NRP1;MACF1;RHOA;ROCK2;VCL;ARHGAP6;ROCK1;LDB1
prerank,embryonic hemopoiesis (GO:0035162),-0.39759942887438043,-0.9609452392472435,0.5230460921843687,0.814479796025933,1.0,3/12,4.76%,KMT2A;TGFBR2;KIT
prerank,regulation of biomineral tissue development (GO:0070167),0.34518133903031967,0.9609044891844247,0.5208681135225376,0.9546837581166346,1.0,8/26,15.25%,HEY1;FBXO5;HEY2;NOTCH1;NOS3;NBR1;BMP2K;GAS6
prerank,regulation of angiogenesis (GO:0045765),-0.21724839040239483,-0.9603948743499338,0.5845410628019324,0.8152432771779283,1.0,33/192,12.39%,SULF1;ANXA3;SASH1;ADAM12;ITGB8;ADGRA2;BMPER;STIM1;FGF1;COL4A3;CTNNB1;GTF2I;ROCK2;F3;GLUL;CEMIP2;HSPG2;ROCK1;HOXA5;PML;PTGIS;SPARC;ADAMTS1;FOXC1;THBS2;NIBAN2;SMOC2;THBS1;HIPK1;RHOJ;CD34;RHOB;ECM1
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.2882849719051425,0.9603326263994155,0.5207006369426752,0.9554534914331951,1.0,7/63,13.00%,PTPRC;VAV3;TIRAP;IRS2;PNP;CD81;CD274
prerank,positive regulation of multicellular organismal process (GO:0051240),-0.20924938362795248,-0.9602570319299198,0.5517241379310345,0.81487355007944,1.0,52/308,13.61%,LRP1;DAB2;LEPR;COL1A1;SMAD3;ACSL1;OGT;FOXD1;SMURF2;EBF2;TGFBR1;DYNC1H1;SOX5;TGFBR2;SNX4;CTNNB1;PDPN;SMAD4;TAPT1;MED1;BMP4;GHR;PPARGC1A;RREB1;SMO;APPL2;SORL1;PER2;ROCK1;LBP;ADRA1B;PLA2R1;STAT6;LPIN1;FOXC1;PAXIP1;NLGN1;SHLD1;NIBAN2;ACVR1;KSR2;EIF2AK2;GJA1;NR2C2;PRKAB2;HSF1;ABCA1;ACVR1B;SLC27A1;IL18;IL33;GRB10
prerank,monoacylglycerol metabolic process (GO:0046462),-0.38063996897724267,-0.9600237149431198,0.5196687370600414,0.8147448496059816,1.0,1/13,1.27%,PLA2G4A
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.35548856111859106,0.9600148322573386,0.5399305555555556,0.9554698458816459,1.0,3/23,10.71%,SAG;METAP2;METAP1
prerank,acylglycerol metabolic process (GO:0006639),0.3213950929273724,0.9595754979734293,0.4976,0.9559187874551404,1.0,4/37,5.08%,DGKB;APOE;PLAAT3;LMF1
prerank,glycoprotein catabolic process (GO:0006516),-0.35096496356373774,-0.9593355852719709,0.5474613686534217,0.8157613824000116,1.0,3/17,5.49%,ADAMTS12;NGLY1;ADAMTS9
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),-0.2818539323893109,-0.958452207289288,0.4949238578680203,0.8173166960734496,1.0,16/38,27.76%,OTUD7A;PPM1B;TLE1;PER1;PPM1A;TRIM39;RORA;TNIP1;USP10;TANK;RIOK3;STAT1;OTUD7B;TRIM59;ZC3H12A;RHOH
prerank,regulation of neuron differentiation (GO:0045664),-0.24470942733715978,-0.9577820428416144,0.5432835820895522,0.8183210109191377,1.0,12/76,9.11%,CNTN4;NRCAM;NBL1;BRINP1;BMP7;RHOA;MED1;ZEB1;ROCK1;BRINP2;NLGN1;BIN1
prerank,regulation of DNA replication (GO:0006275),0.3005710810474752,0.9576945107270818,0.5235008103727715,0.9604557304445419,1.0,11/49,13.81%,CTC1;BCAR3;ORC3;PPP2CA;RBBP6;FBXO5;ACVRL1;ESCO1;USP37;ANKRD17;FAF1
prerank,response to molecule of bacterial origin (GO:0002237),0.28559252434428556,0.9574652377010385,0.5465465465465466,0.9602145117367359,1.0,13/69,16.05%,TNFAIP3;TAB2;FCGR2B;TIRAP;CYRIB;SELP;ERBIN;IFNAR1;NOS3;OTUD5;GCH1;NOCT;PELI1
prerank,amino acid transport (GO:0006865),0.30537373553640357,0.9574564995007174,0.5340557275541795,0.9593759661611307,1.0,5/49,5.53%,SLC7A8;SLC36A4;SLC25A44;SLC3A2;SLC6A6
prerank,regulation of regulated secretory pathway (GO:1903305),-0.289271197862675,-0.9572512178088848,0.49379652605459057,0.8189486116729923,1.0,8/34,14.55%,RIMS1;SYT9;SYN1;GSK3B;SYT12;SYT11;SYT4;SYT7
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.24567950474171643,0.9571232209617895,0.5771643663739021,0.9594207856353932,1.0,28/214,11.27%,MAP2K7;MAPK3;SEMA6A;PTPRR;ZDHHC17;SEMA7A;PIN1;PTPRC;TIRAP;PRKD2;APOE;TEK;PHB2;SPRED1;CIB1;ICAM1;SYK;HTR2A;CNKSR3;MTURN;NOTCH1;CCL25;CSF1R;LYN;MFHAS1;ATP6AP1;NPNT;APP
prerank,histone lysine demethylation (GO:0070076),0.3461920927384949,0.957046119443134,0.5238907849829352,0.9587718584259098,1.0,7/25,14.24%,KDM3A;KDM2A;KDM6A;KDM4D;JMJD1C;KDM5C;PHF8
prerank,negative regulation of mononuclear cell migration (GO:0071676),-0.39228503108166535,-0.9570383804718863,0.5274949083503055,0.8187653496267692,1.0,3/12,3.66%,NBL1;WASL;BMP5
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.3309810371456201,0.9569346222818449,0.5116666666666667,0.958206215287933,1.0,6/29,13.09%,TTLL12;CDC37;CNOT7;WNT5A;USP18;NLRC5
prerank,regulation of mitochondrial translation (GO:0070129),0.36242508947666324,0.9568528610548607,0.5072727272727273,0.9575776002807563,1.0,5/21,17.58%,FASTKD2;NGRN;TSFM;MTG2;RCC1L
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.3447628039794373,0.9568301920544655,0.5204262877442274,0.9567788080386306,1.0,3/25,10.80%,CBL;BCAR3;RBPJ
prerank,nuclear membrane reassembly (GO:0031468),-0.2663560871022786,-0.956047177961664,0.5261707988980716,0.8206775861606946,1.0,22/54,25.22%,SIRT2;PPP2R2A;UBXN2A;LMNA;NUP205;IST1;NUP155;NUP188;UBXN2B;AHCTF1;NUP93;NSFL1C;SEH1L;CHMP2B;NUP85;CC2D1B;NUP37;VPS4A;EMD;LEMD2;SEC13;LBR
prerank,blood circulation (GO:0008015),0.30582080379436466,0.9560300321442052,0.5201863354037267,0.9581941810410272,1.0,5/49,4.35%,GCLC;SOD1;CXCL12;TBC1D8;GCLM
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.24732688370739567,0.9560284175242516,0.5683930942895087,0.9573365425739959,1.0,36/190,13.40%,GSK3A;TRIB3;PTPRJ;PDE4D;TNFAIP3;BCL2L2;SRC;HDAC7;RFFL;IFI35;PRDM15;EPM2A;SPRED1;CYRIB;CIB1;AKT1S1;ARHGAP25;SIRT1;NLRC3;DAG1;PHLPP1;TSC1;RELA;LYN;MDM2;PRKAA2;ESR1;OTUD3;DDX3X;P2RX7;ADIPOR1;NF1;MAPKBP1;NDUFA13;PLEK;DDIT3
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),-0.3282215088478432,-0.9556600707250237,0.5178571428571429,0.8209869531726105,1.0,7/22,13.88%,IGF1;SMAD4;P2RX4;ROCK2;ROCK1;CAMK2D;IL6ST
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.3801763697720176,0.9552551822360525,0.5137111517367459,0.9586671286271808,1.0,1/16,1.01%,GSK3A
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),-0.26762184433703,-0.9545422937216584,0.538659793814433,0.8231606377144548,1.0,16/53,19.95%,EYA2;DDX5;EYA1;EGFR;UBE2N;PRKCD;ERCC6;PLA2R1;RNF168;RNF8;ATM;NACC2;NPAS2;BABAM1;SMCHD1;SPRED3
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.2988471965202967,-0.9544372519299134,0.535377358490566,0.8226945926570242,1.0,14/30,24.88%,OGT;WAC;FHIT;CAMLG;DDRGK1;TRIM39;MAP1A;USP7;SGTA;STYX;EIF3H;BAG6;UBXN1;NOP53
prerank,mature B cell differentiation involved in immune response (GO:0002313),-0.392114186933882,-0.9543582999782441,0.5421166306695464,0.8221590167047066,1.0,3/12,8.48%,NOTCH2;DOCK10;DOCK11
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.38512547318612594,0.9543527196581066,0.4869402985074627,0.9603334496908984,1.0,6/15,18.60%,GRM7;GRM3;HOMER1;DAGLB;GRM8;HOMER3
prerank,regulation of interleukin-12 production (GO:0032655),-0.2727897010396507,-0.9543036769770219,0.5365853658536586,0.8215822147567134,1.0,6/47,11.35%,FOXP1;MAPK14;PIBF1;IRAK3;THBS1;IL16
prerank,response to peptide (GO:1901652),0.3290042423203997,0.9542897154713921,0.5316666666666666,0.9596377652784346,1.0,7/33,11.92%,CACNA1A;MMP12;FYN;EIF2B3;ERBIN;GNAI1;PRNP
prerank,negative regulation of protein localization to nucleus (GO:1900181),-0.3454833242915199,-0.9542632632792349,0.5121951219512195,0.8209793472795237,1.0,12/18,35.82%,CTNNA1;ILRUN;GSK3B;RAB23;APOD;FLCN;CABP1;OTUD7B;SUFU;CHP1;POLR1A;LATS1
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.2851444179417977,0.9542563267713172,0.530920060331825,0.9588650618464348,1.0,13/72,7.51%,HSPA8;SHANK3;CLASP2;APOE;PFN1;CYRIB;CIB1;KANK3;PFDN6;FGF13;SSH2;CAMSAP2;PFDN5
prerank,protein modification by small protein conjugation (GO:0032446),0.2344228889725144,0.9537893799317582,0.5889929742388759,0.9593139029908864,1.0,79/361,17.51%,RAD18;MOCS3;CAND1;ELOC;RNF7;CBL;TRIM28;ARIH1;KLHL3;SAE1;RNF38;UFC1;UBA1;DCUN1D4;NEDD4L;VPS11;FBXL5;TRIM14;UBE2I;NFX1;NUP54;SIRT1;RNF187;UBA2;NUP50;LMO7;UBE2V2;KLHL2;FBXO32;CAND2;FBXO11;CRBN;ANAPC7;MDM2;PJA2;RFWD3;MYCBP2;KLHL24;PIAS2;RNF6;FBXO7;EIPR1;UBE2M;RNF25;TRPM4;NAE1;CHFR;ANAPC11;PIAS1;ELOB;ATG7;DTX4;CUL3;NUP35;UBE2R2;EPAS1;UBE2F;TSPAN17;TRIM27;RNF20;USP9X;UBA6;UBE2G1;NDC1;TRIM33;KLHL7;UBE2H;KLHL13;VPS18;PRKDC;DCUN1D2;NUP160;DCUN1D1;UBR3;MSL2;UVSSA;POM121;PEX13;RANGAP1
prerank,vasculogenesis (GO:0001570),0.3271732851723864,0.9533517525329068,0.5264957264957265,0.9597074173404497,1.0,6/32,8.94%,EGFL7;RAMP2;SPRED1;HEY2;NOTCH1;RASIP1
prerank,protein export from nucleus (GO:0006611),-0.3089226959706144,-0.953268927675698,0.5148514851485149,0.8228235959787465,1.0,8/27,16.23%,RANBP3L;PKD1;XPO6;DUSP16;RANBP3;STRADA;NUTF2;TGFB1
prerank,RNA 3'-end processing (GO:0031123),-0.249869664843867,-0.9526643761133505,0.5488505747126436,0.823668993262322,1.0,25/69,24.61%,SRSF5;SRSF11;PABPN1;CASC3;RPRD1B;SRSF2;SRSF6;LIN28B;SRSF1;POLDIP3;DDX39B;CSTF3;SYMPK;CSTF2;THOC5;SLU7;CDC40;RNPS1;CPSF3;SUPV3L1;EIF4A3;NCBP2;TUT1;THOC1;RBM8A
prerank,chromosome condensation (GO:0030261),0.31782677344962434,0.9523741900134154,0.5371900826446281,0.9616019748973228,1.0,7/36,14.34%,BANF1;TENT4A;CHMP1A;AKAP8L;AIFM1;PHF8;CSNK2A2
prerank,regulation of fibroblast proliferation (GO:0048145),-0.27156621862805425,-0.9521200339872857,0.5234375,0.8243527795880534,1.0,10/45,15.09%,IGF1;CTNNB1;PDGFRA;SKI;CDC73;CDK6;FN1;TP53;MED25;PEX2
prerank,regulation of interleukin-13 production (GO:0032656),-0.3785028472703349,-0.9520922454570664,0.5282608695652173,0.8236996033559827,1.0,4/13,13.39%,PRKCZ;RARA;TNFRSF21;IL18
prerank,positive regulation of heart rate (GO:0010460),0.3704077372666912,0.9515928203569441,0.5261194029850746,0.9629293830068872,1.0,3/17,10.53%,PDE4D;ATP2A2;TRPM4
prerank,mRNA export from nucleus (GO:0006406),-0.2331427963556702,-0.951397945550348,0.5876623376623377,0.8247607464484713,1.0,38/102,24.95%,SRSF5;SRSF11;PABPN1;CASC3;SRSF2;ALKBH5;SRSF6;NUP205;ENY2;SRSF1;POLDIP3;DDX39B;NXF1;NUP155;NUP188;HNRNPA2B1;SYMPK;NUP88;NUP93;DDX19B;SEH1L;THOC5;SLU7;DDX19A;CDC40;UPF1;RNPS1;NUP85;AAAS;RAE1;CPSF3;NUP37;NUP214;EIF4A3;NCBP2;THOC1;RBM8A;SEC13
prerank,cellular respiration (GO:0045333),0.314322805040445,0.9511180818588231,0.5317073170731708,0.9633900457130561,1.0,9/41,14.40%,CYCS;ME3;MTFR1;SIRT3;ETFA;SDHA;COX15;UQCRB;COX10
prerank,regulation of viral release from host cell (GO:1902186),0.35615462827300715,0.9507556203079487,0.5128205128205128,0.9635709380651327,1.0,5/21,10.51%,TRIM28;TRIM8;TRIM25;CHMP2A;VPS37B
prerank,regulation of protein localization to plasma membrane (GO:1903076),-0.24589382534347648,-0.9502182925563091,0.5769230769230769,0.8271074921393077,1.0,29/78,25.53%,SORBS1;LRP1;DAB2;EGFR;PID1;PPFIA1;MMP14;STX8;ZDHHC5;STX3;DPP10;EPHB2;EPHA3;CLIP3;DLG1;WNK3;TGFB1;TMBIM1;ZDHHC8;PIK3R1;VPS4A;APPL1;NKD2;CLN3;VAMP8;PLS1;AKT1;SPTBN1;BCL2L1
prerank,lipoprotein localization (GO:0044872),0.415727189405139,0.9499839639134128,0.5228519195612431,0.9648954820625353,1.0,2/11,7.14%,ZDHHC17;VMP1
prerank,positive regulation of positive chemotaxis (GO:0050927),-0.3693891399836727,-0.949890315809043,0.5249457700650759,0.827259322059043,1.0,7/15,27.69%,NTRK3;F3;IL16;SCG2;VEGFA;VEGFB;PGF
prerank,lysosome organization (GO:0007040),0.31842720144623804,0.949797224166827,0.5477386934673367,0.9645372336305156,1.0,15/36,21.13%,LAMTOR1;TMEM165;TPP1;AKTIP;ZKSCAN3;MBTPS1;CLVS1;SNAPIN;TFEB;HOOK3;VPS18;VPS33A;GRN;TPCN2;LRRK2
prerank,positive regulation of mRNA processing (GO:0050685),0.3505128354795583,0.9497186380307469,0.5071942446043165,0.9638803875320674,1.0,2/21,0.93%,NCBP1;RBMXL1
prerank,epidermal cell differentiation (GO:0009913),-0.28160906009481557,-0.9495845032488479,0.5494791666666666,0.8272963113033003,1.0,6/41,6.02%,CLIC4;CTNNB1;HDAC1;MED1;BCR;PIP5K1A
prerank,mitochondrial calcium ion homeostasis (GO:0051560),-0.3316419877199813,-0.9495720279510714,0.5125284738041003,0.826603603111772,1.0,8/21,23.29%,MCU;PDZD8;MICU2;FIS1;AFG3L2;MCUR1;MCUB;ANXA6
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.35804982351262393,-0.9492714450616805,0.5373134328358209,0.8266420994311355,1.0,2/16,2.05%,DDX5;DDX17
prerank,selective autophagy (GO:0061912),0.2943216624386703,0.9490849487659409,0.5294117647058824,0.964756718507013,1.0,16/56,15.94%,DYNC1I1;MAP1LC3B;KLHL3;UFC1;RAB7A;PHB2;AUP1;PARK7;UBE2V1;DYNLL1;UBQLN1;NBR1;LGALS8;DYNC1I2;ATG14;ATG13
prerank,heterochromatin organization (GO:0070828),0.3871731035916449,0.9488249327730386,0.5335892514395394,0.9646433524642791,1.0,4/14,15.04%,MECOM;SIRT1;HP1BP3;EZH1
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.4249902205860489,0.9485968567332806,0.5077220077220077,0.9643898403253107,1.0,3/10,10.09%,RAP2A;MYO9A;OPHN1
prerank,fructose 6-phosphate metabolic process (GO:0006002),-0.40846203506337797,-0.9483729999035877,0.5488069414316703,0.8282385758499673,1.0,5/10,31.61%,GFPT1;HK2;GFPT2;PFKM;PFKL
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.3481167010417059,0.9480732343435243,0.5220588235294118,0.9649523251197948,1.0,6/22,12.55%,RAP2A;GREM1;CALM3;DDX3X;RAP2C;NBN
prerank,regulation of protein localization to membrane (GO:1905475),-0.3044722984687829,-0.9480354590224048,0.5432692307692307,0.8284105844346095,1.0,12/28,24.75%,GPC6;GSN;MMP14;GPC3;STX8;GPC5;VPS4A;GPC4;APPL1;CLN3;VAMP8;SPTBN1
prerank,cognition (GO:0050890),-0.2779903618998186,-0.9476805392825013,0.5301507537688442,0.8286338698661255,1.0,20/42,35.67%,GRM5;SOBP;TTC8;NIPBL;CUX2;CTNS;ST3GAL4;MAGT1;CHMP2B;DGCR2;LINS1;STRA6;FAM107A;CHRNA7;SLC1A4;MFSD2A;JAKMIP1;NSUN5;SLC8A2;METTL23
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.3804114391448531,-0.9472731794388121,0.5337423312883436,0.8289697413071473,1.0,3/13,6.03%,SLC4A10;SHISA9;SHISA6
prerank,negative regulation of cytoskeleton organization (GO:0051494),0.32512046029141384,0.9471350400524686,0.5242070116861436,0.9666337999995804,1.0,8/29,14.33%,SHANK3;PFN1;CYRIB;KANK3;SSH2;TJP1;FKBP4;TWF1
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.31892869377568517,0.9470139682655497,0.5180921052631579,0.9660799445178572,1.0,2/33,4.13%,LEF1;ZFP36L1
prerank,protein modification process (GO:0036211),0.2760664445970314,0.9469528214306006,0.5535444947209653,0.9653944489765651,1.0,22/76,18.50%,DUSP12;UBE2I;FBXW2;CSNK1G3;SLC35A1;PIGH;FBXO11;UBE2M;ICMT;YES1;PLAT;ST3GAL6;ADPRH;ST3GAL1;MSRA;QPCT;FBXO22;NTAQ1;PRKDC;LCMT1;SEPHS1;UBE2D3
prerank,ERK1 and ERK2 cascade (GO:0070371),0.35539955520041455,0.9468420299048318,0.5364120781527532,0.9648675573026549,1.0,2/21,4.13%,MAPK3;ZFP36L1
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.3685564575268027,-0.9466172247308652,0.5145413870246085,0.829906054553151,1.0,4/14,18.55%,ERCC6;MMS19;ACTR2;PARP1
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.34782764943977024,0.9459561429584341,0.5337837837837838,0.9664493086376532,1.0,6/24,16.78%,CXCL12;SIRT1;ING2;CCAR2;CD44;TMEM161A
prerank,chondroitin sulfate biosynthetic process (GO:0030206),-0.3209860574873928,-0.9456341223258591,0.5305164319248826,0.831685587651388,1.0,13/21,28.53%,CHSY1;VCAN;CSGALNACT2;CHST15;CHST11;UGDH;CSPG4;BGN;DCN;CHPF2;CHST3;CSPG5;CHST12
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.36866154191831313,0.945010219173939,0.5420560747663551,0.9681709637924575,1.0,5/17,13.19%,KLHDC10;SEMA4C;LYN;RNF13;MID1
prerank,Golgi to lysosome transport (GO:0090160),0.41639756345760914,0.9446687121320057,0.5607843137254902,0.9682941653030451,1.0,3/11,11.02%,SORT1;AP1G1;RBSN
prerank,negative regulation by host of viral process (GO:0044793),-0.4109571992445667,-0.9445986472581231,0.539714867617108,0.8336280608704469,1.0,3/10,27.69%,CCNK;PSMC3;ZC3H12A
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.3365529934110721,-0.9444408830199138,0.517467248908297,0.8332868415575205,1.0,13/18,43.68%,COX16;COX19;COX17;COX18;PET100;COX20;COX14;BCS1L;COA5;SCO1;COA3;SURF1;FASTKD3
prerank,T cell homeostasis (GO:0043029),-0.39757320516766226,-0.9444008494218258,0.5345528455284553,0.8326571144046518,1.0,4/10,28.12%,PPP2R3C;AKT1;NCKAP1L;ZC3H8
prerank,multivesicular body assembly (GO:0036258),-0.3067680792580525,-0.9436805948492396,0.542997542997543,0.8338315933428605,1.0,10/30,22.03%,STAM2;IST1;SNF8;RAB11A;TSG101;CHMP2B;CHMP5;STAM;VPS4A;HGS
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.38819274229437534,-0.9435717094236868,0.5282608695652173,0.8334191859592823,1.0,4/12,18.87%,SNAP25;STX3;STX1A;SNAP29
prerank,maintenance of protein location in nucleus (GO:0051457),0.3501788053996759,0.9433727409986662,0.5545454545454546,0.9709986357698931,1.0,10/20,21.80%,SYNE1;ARL2BP;PARK7;TAF3;RANGAP1;MORC3;SP100;BBS4;SKP1;SUN2
prerank,positive regulation of neuron differentiation (GO:0045666),-0.2773128377498037,-0.943265866872478,0.5335051546391752,0.8335034959839801,1.0,9/40,16.72%,NRCAM;NBL1;BRINP1;RHOA;ZEB1;BRINP2;NGF;TCF4;GPRC5B
prerank,angiogenesis involved in wound healing (GO:0060055),0.4047963016190378,0.9432453451177003,0.5316698656429942,0.9704779313931499,1.0,2/11,7.27%,PRCP;ADIPOR2
prerank,regulation of ossification (GO:0030278),-0.2848492404852205,-0.943006034175549,0.5238095238095238,0.8334205038450906,1.0,14/36,28.26%,BMP4;CHSY1;ENPP1;ANKH;SMAD6;ACVR1;ECM1;LRP6;BMPR2;TXLNG;NOTUM;SFRP1;BMP2;MDK
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.39239200181987033,0.9428564846457542,0.54510556621881,0.9707226003671011,1.0,3/14,8.56%,SEMA7A;SIRT1;WNT5A
prerank,telomere maintenance via recombination (GO:0000722),-0.38843390444751147,-0.9423261835531117,0.5166666666666667,0.8344369736345375,1.0,5/11,19.18%,SMC6;RAD50;TPRKB;RAD51D;NSMCE2
prerank,negative regulation of epithelial cell differentiation (GO:0030857),-0.3656758944786078,-0.9422041243093975,0.5273109243697479,0.8340490316458503,1.0,3/14,6.98%,ZEB1;OSR1;XDH
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),-0.34047740581716723,-0.9418328505548662,0.5594405594405595,0.8342246875907651,1.0,4/20,9.33%,SULF1;SULF2;SMOC2;THBS1
prerank,maturation of SSU-rRNA (GO:0030490),-0.29300913768803066,-0.9416229668228677,0.5505050505050505,0.8340590499960261,1.0,18/34,28.35%,RIOK1;BMS1;RIOK2;UTP6;NOL11;DDX52;RPS16;UTP4;NAT10;NOB1;RIOK3;NOP14;WDR3;LSM6;RRP36;TSR2;NOL10;UTP3
prerank,regulation of gene expression (GO:0010468),0.2194745793714593,0.9414948829803697,0.7126436781609196,0.9736668415595288,1.0,164/903,16.10%,TBX4;MAZ;CTCFL;MAPK3;GSK3A;ONECUT1;CAVIN4;TRAPPC2;FOXN2;EZH2;ZFAT;DIP2A;PIN1;LEF1;PTPRC;HES6;RPL23;GTF2IRD1;RPS6KA4;PDCL3;NWD1;HNRNPH2;SORT1;PCBP1;ATXN1L;STOX1;GABPA;BCL6B;RPS6KA5;SMAD1;PPP2CA;SBNO2;ZFP36L1;HNRNPAB;HEY1;NR5A1;RAMP2;APOE;PRDM4;MYBL2;SMARCA2;SOX2;HNRNPK;YY1;TRIM14;FAM50A;SPIN1;NPAT;CPSF4;EP300;RFX3;MAPK8;TDG;DTNBP1;NFX1;MED23;RPL5;TGFBRAP1;SRSF10;CALCOCO1;ACTR8;RO60;RGCC;CDK11B;RBM20;ZNF205;SFPQ;SIRT1;BMI1;ACTR5;DRAP1;CLOCK;RNF187;PFDN5;KDM6A;HEY2;YTHDC1;NOTCH1;CNOT7;CDK4;WNT5A;TOB2;NOVA2;SOX13;ACVRL1;TRAF3;RELA;NAB2;LYN;MARF1;PARK7;RNF6;CLDN5;TARDBP;VSIR;UBE2V1;CITED2;RYBP;PRKAA2;ING2;CCAR2;ESR1;TERT;SRPK2;DDX3X;RBPJ;NLK;P2RX7;HP1BP3;CREBBP;CARM1;NOS3;MATR3;AGO4;APP;PIK3CD;RPS3;PTBP1;JMJD1C;PICALM;PCBP3;CRKL;SP1;MZF1;CDH5;IRF2;CHD3;ERC1;NUP35;ACTA2;TRRAP;HDAC5;CHEK2;DDIT3;POGZ;ZKSCAN5;HCFC1;YBX1;TRIM27;RNF20;BAZ2A;NSD2;BACH1;FUS;VPS35;PRDM10;TERF2IP;GAS6;ATG14;MOV10;HNRNPL;NOCT;TFEB;TAF6L;NKAP;TRA2B;APBB2;TAF1;BCL6;BRAF;TDRD7;ID2;TCF7L1;TCF3
prerank,keratan sulfate metabolic process (GO:0042339),-0.30512939346495205,-0.9414924537766955,0.5419664268585132,0.8337155212772625,1.0,11/31,20.24%,B4GALT1;OGN;HEXA;HEXB;B4GALT6;SLC35D2;ST3GAL4;PRELP;GNS;LUM;B4GALT4
prerank,cell differentiation in spinal cord (GO:0021515),0.41775026227497675,0.9414378945614362,0.5234375,0.9729777126009018,1.0,2/10,10.16%,SOX13;ZC4H2
prerank,regulation of autophagy (GO:0010506),0.24227781188031833,0.9408082462986075,0.5951776649746193,0.9737931849993665,1.0,57/216,18.94%,GSK3A;TRIB3;ATF6;EEF1A1;ACER2;TAB2;PLK2;RPTOR;EXOC8;SVIP;TRIM8;ATP6V1D;VPS29;VPS26A;ATP6V0D1;TRIM14;EP300;MAPK8;LAMTOR1;TAB3;DRAM2;ATP6V0E1;RASIP1;ZKSCAN3;PRKAA2;EIF4G2;BAD;CISD2;UBQLN1;BMF;TMEM59;TBC1D14;RRAGC;USP33;DDIT3;TLK2;TRIM27;CSNK2A2;PIK3C2A;ATP6V1B2;VPS35;TFEB;ATG13;DNM1L;BNIP3;UBQLN2;WDR41;DAPL1;PIP4K2A;STAT3;FOXK2;ATP6V1A;USP36;ULK1;MID2;SH3GLB1;EIF4G1
prerank,lipoprotein biosynthetic process (GO:0042158),0.4095615273111069,0.9404378283883099,0.5239852398523985,0.9739338025769778,1.0,3/11,11.74%,APOE;UGCG;ATG7
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),-0.4097755604695773,-0.9402758778217332,0.5679012345679012,0.8360938125274718,1.0,5/10,33.67%,LPGAT1;ABCD2;NR1H2;SLC45A3;MID1IP1
prerank,myeloid leukocyte differentiation (GO:0002573),0.28472642942832643,0.9401144727402696,0.5512048192771084,0.9739882799358052,1.0,8/65,9.17%,MT1G;LEF1;SBNO2;CDKN1A;EP300;SIRT1;CDK4;CSF1R
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.25697399650104696,0.9401008073873299,0.5759668508287292,0.9731701624771811,1.0,31/119,17.22%,CISH;PIK3CG;PIK3C2G;MTMR14;EFR3B;SMG1;PIKFYVE;RAB14;PIGH;ARF1;INPP5D;PIGB;PI4KA;PIK3CD;PIK3R5;PGAP2;INPP4B;IP6K2;SYNJ2;RUFY1;PIK3C2A;IMPA1;PIGN;MTMR2;PIGU;MBOAT7;PLEKHA1;ITPKB;PIK3R4;PIP4K2A;PLEKHA3
prerank,protein homotetramerization (GO:0051289),0.29620976206485616,0.9397903923078421,0.5518341307814992,0.9731775746022273,1.0,7/49,10.53%,THG1L;GLS;B2M;SSBP1;ACACB;SOD2;TRPM4
prerank,regulation of neurogenesis (GO:0050767),0.2930243156347095,0.9393837912114379,0.586053412462908,0.9734427774621304,1.0,12/55,16.22%,HES6;HEY1;MME;B2M;HEY2;NOTCH1;PRUNE1;DOCK7;FAIM;HES1;HEYL;HOOK3
prerank,negative regulation of gene expression (GO:0010629),0.23188091934276844,0.9390954796603415,0.6248506571087217,0.9734253703223302,1.0,61/302,17.21%,CIDEA;ZC3H12D;ILF3;EZH2;DIP2A;PATL2;EED;FCGR2B;RPS6KA4;STOX1;HDAC9;RPS6KA5;NUDT12;APOE;YY1;NPTN;FXR1;PAIP2B;RGCC;RPS26;SIRT1;BMI1;HEY2;PPP1R11;NOTCH1;CNOT7;TSC1;ACVRL1;DXO;PARK7;CLDN5;TARDBP;CITED2;PRKAA2;ESR1;TERT;DDX3X;NANOS3;AGO4;APP;RPS3;PTBP1;PICALM;CRKL;PPHLN1;YBX1;TRIM27;CNOT1;TASOR;CAPRIN1;AEBP2;MOV10;NOCT;TAF1;ID2;RBBP4;N4BP1;CNOT10;TIPARP;CALR;SLC7A5
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.33427046013557293,-0.9390919916390259,0.5290178571428571,0.8384181428585253,1.0,8/19,24.37%,ROBO1;XDH;CCBE1;SMOC2;ADAMTS3;JCAD;CADM4;DCN
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.2975438987056477,0.9385221907236627,0.5562805872756933,0.9741111673047124,1.0,10/48,14.60%,HDAC7;HDAC9;PRKD2;CIB1;SIRT1;PLCG1;NOS3;SP1;MAP3K3;PIK3C2A
prerank,regulation of Rac protein signal transduction (GO:0035020),-0.3559006424571819,-0.9382737100976712,0.5384615384615384,0.839779566415135,1.0,3/16,3.24%,OGT;AUTS2;RASGRF1
prerank,response to interferon-gamma (GO:0034341),0.2826207257874366,0.9382586835897844,0.5690690690690691,0.9739729511896706,1.0,8/67,9.09%,IFITM2;GBP3;GBP4;IFITM3;CCL25;WNT5A;IFITM1;CD47
prerank,cellular response to mechanical stimulus (GO:0071260),0.2983174014216794,0.9376300021338324,0.5375,0.9748452182898188,1.0,6/46,10.56%,MAPK3;TNFRSF10B;MAPK8;CRADD;F11R;BAD
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.3463535581130844,0.9375557752286106,0.5366300366300366,0.9741995523395508,1.0,6/22,13.91%,OCIAD1;NOTCH1;IL10RB;CYP1B1;MGAT5;HES1
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),0.3752688204239518,0.93736370164735,0.5352941176470588,0.9739077409997179,1.0,2/14,7.30%,PRKAR1A;SIRT1
prerank,regulation of embryonic development (GO:0045995),0.3204666430954835,0.9372238743416222,0.5562913907284768,0.9734453446816739,1.0,12/34,19.65%,CLASP2;CFL1;TDG;DAG1;RAB14;PLCB1;ZBED3;SOX17;CLASP1;INSR;DHX36;POGLUT1
prerank,entry into host (GO:0044409),0.3949255696582849,0.9362375178210115,0.5394495412844037,0.9753280995882636,1.0,2/13,3.25%,CBL;SRC
prerank,positive regulation of cell junction assembly (GO:1901890),-0.2573171396886412,-0.9362271720683074,0.5860215053763441,0.8443454922897706,1.0,12/56,12.29%,NRXN1;GRID2;EPHB1;NRP1;NLGN2;SYNDIG1;ROCK1;CLSTN2;NLGN1;EPHB2;CUX2;IL1RAPL1
prerank,positive regulation of cell migration (GO:0030335),0.23617752644620943,0.9351109254366894,0.6163215590742996,0.9775680787287562,1.0,39/253,12.62%,MAZ;SEMA6A;SEMA6D;SEMA7A;LEF1;PTPRC;TIAM1;PECAM1;CXCL12;SRC;CLASP2;INSL3;PFN1;SEMA3C;CIB1;RET;SEMA6B;ARHGEF7;FBXO5;ACTN4;RUFY3;NOTCH1;PLCG1;ITGA6;TJP1;SEMA4C;CSF1R;SOD2;PODXL;PAK1;VSIR;FLT1;PIK3CD;PPP3CA;CRKL;PLAA;MAP4K4;MGAT5;CDH5
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.34274695181373915,0.9350256514298316,0.5380622837370242,0.9769543049560918,1.0,6/22,13.44%,PSMC4;MED12;PSMC2;ESR1;MED4;PSMC6
prerank,response to growth factor (GO:0070848),-0.26920909679800775,-0.9345767380356164,0.5750636132315522,0.8478488254174114,1.0,26/41,36.63%,TGFBR1;TGFBR2;CTNNB1;ACVR1;ACVR1B;RACK1;BMPR1B;TWF2;RPS6KB1;BMPR1A;CPNE3;BMPR2;EMD;AKT1;ERBB2;SFRP1;HDAC6;TBC1D7;NOS1;GATA6;SPHK1;PLK5;MAPK7;EPHA2;URI1;HTRA2
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.3029912387396347,0.9344784251438328,0.5746031746031746,0.9775594460679939,1.0,8/43,15.25%,CIDEA;TNFAIP3;NLRC3;VSIR;NFKBIL1;CD274;TRIM27;GAS6
prerank,regulation of establishment of cell polarity (GO:2000114),0.36938242186960313,0.9342832586101324,0.5527831094049904,0.9772686027451755,1.0,7/16,18.22%,CYRIB;RIPOR2;KRIT1;RUFY3;CDH5;PTK2B;ARFGEF1
prerank,microtubule nucleation (GO:0007020),-0.3306868520241128,-0.9341556637555215,0.5379464285714286,0.8481934879618019,1.0,8/19,17.94%,TUBGCP4;CCDC57;GOLGA2;AKAP9;SLAIN2;TUBGCP6;RANBP9;NDE1
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),-0.37379001046281035,-0.9340953553476513,0.5518590998043053,0.8476238203899397,1.0,8/12,32.79%,WAC;TP53;SDE2;FBXO31;CDK2;RPS27L;CCND1;PLK5
prerank,regulation of mitochondrial depolarization (GO:0051900),0.4156655880216318,0.9339855631652133,0.5349716446124764,0.9772347461218652,1.0,2/10,9.65%,SRC;FZD9
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.3564388007603364,0.9337116742910114,0.5679245283018868,0.977187625128931,1.0,4/19,12.32%,PTPRJ;TEK;TSC1;MAP4K4
prerank,regulation of actin filament bundle assembly (GO:0032231),0.33239941815651997,0.9336926603546131,0.5493421052631579,0.9764029887947067,1.0,4/26,8.86%,ALMS1;SHANK3;PFN1;TSC1
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.3899918940374349,-0.9335598260406716,0.5655577299412916,0.8483375404699948,1.0,4/10,16.43%,PARP14;PIBF1;NF2;PTPN2
prerank,DNA packaging (GO:0006323),0.37294794875125736,0.9334518491878495,0.5422138836772983,0.976239312585269,1.0,4/16,18.84%,BANF1;AIFM1;RBBP4;HAT1
prerank,cellular response to arsenic-containing substance (GO:0071243),0.3749088051498424,0.9329020430200375,0.5569852941176471,0.9768888508252642,1.0,3/15,10.80%,ATF3;ZFAND1;DDX3X
prerank,platelet degranulation (GO:0002576),0.25833338666654604,0.9327986064022443,0.6042553191489362,0.9763384454520392,1.0,18/118,11.43%,ABCC4;CDC37L1;SOD1;PECAM1;MANF;NHLRC2;CYRIB;SELP;SELENOP;F8;ACTN4;VWF;LGALS3BP;LYN;GTPBP2;APP;A2M;OLA1
prerank,keratinocyte differentiation (GO:0030216),-0.3033656680478727,-0.932784705412598,0.6034912718204489,0.8496144270095555,1.0,5/29,11.85%,CLIC4;MED1;BCR;PIP5K1A;ANXA1
prerank,icosanoid secretion (GO:0032309),0.3989965055009477,0.932707572075614,0.5546875,0.9757593309288668,1.0,2/12,11.52%,ABCC4;PNPLA8
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.3545339267534308,-0.9324703886930625,0.5418502202643172,0.8496797693983179,1.0,3/15,8.46%,ATP1B1;ATP1A1;KCNJ2
prerank,regulation of MAP kinase activity (GO:0043405),0.2633280096254676,0.9323823805786552,0.5804093567251462,0.9757963590565533,1.0,6/92,1.51%,RGS2;PIK3CG;TRIB3;DUSP7;PTPRJ;EZH2
prerank,regulation of cell development (GO:0060284),0.3150366891974912,0.9321227163791322,0.5691318327974276,0.9756393547918952,1.0,10/36,16.10%,HES6;HDAC9;HEY1;CLOCK;HEY2;PRUNE1;DOCK7;HES1;FBXO22;HEYL
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.33138529641686254,-0.931886965121302,0.5760869565217391,0.8503462449339979,1.0,8/19,22.30%,BMP6;ADAM19;AFDN;DENND6A;PTPRU;FLOT1;PPM1F;VEGFA
prerank,regulation of protein secretion (GO:0050708),-0.2259243053369106,-0.9316115221687712,0.6402877697841727,0.8503052348854573,1.0,34/119,26.16%,BMP6;IGF1;CACNA1C;ITPR1;SNAP25;CACNA1D;KCNC2;SERGEF;SLC12A2;PER2;DPP4;ENSA;EZR;STXBP5;PPID;UNC13B;SYT7;EXOC1;TGFB1;STX1A;KCNS3;CYP51A1;ITPR2;RHBDF1;P3H1;LLGL1;TGFB3;IER3IP1;UQCC2;ADRA2A;PICK1;APBB1;SYTL4;PPIA
prerank,regulation of exit from mitosis (GO:0007096),0.3143377068780646,0.9315658302936506,0.5540308747855918,0.9763162064125128,1.0,7/38,12.42%,ANAPC2;PHB2;RGCC;ANAPC7;ANAPC11;ANAPC10;ANAPC4
prerank,calcium ion transport into cytosol (GO:0060402),-0.3290509335858405,-0.9314309072180923,0.5615212527964206,0.8500077520466991,1.0,2/21,1.54%,CACNA1C;GRIN2B
prerank,aspartate family amino acid metabolic process (GO:0009066),-0.3334497135333287,-0.9311159661354741,0.5647321428571429,0.8500425484389051,1.0,8/18,22.91%,ASPA;SLC25A13;MTHFR;MTHFD1;NAALAD2;SMS;GOT1;ASPG
prerank,alcohol catabolic process (GO:0046164),0.41147442661731176,0.9310453134144054,0.5517241379310345,0.976950685941663,1.0,2/10,7.62%,APOE;SNX17
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.34282469180538017,0.9308390109829515,0.5631970260223048,0.9758245092027412,1.0,9/23,20.96%,MAPK8;YWHAB;BAD;PPP3R1;YWHAH;YWHAQ;YWHAE;YWHAZ;TFDP2
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.34282469180538017,0.9308390109829515,0.5631970260223048,0.9758245092027412,1.0,9/23,20.96%,MAPK8;YWHAB;BAD;PPP3R1;YWHAH;YWHAQ;YWHAE;YWHAZ;TFDP2
prerank,reticulophagy (GO:0061709),-0.37824420236275014,-0.9305264887049028,0.5265306122448979,0.8508629925227624,1.0,4/12,14.47%,ULK2;UFL1;DDRGK1;TEX264
prerank,actin filament network formation (GO:0051639),0.4013388907854718,0.9304130360378245,0.5504761904761905,0.9761180408156735,1.0,1/11,0.56%,LCP1
prerank,regulation of mitochondrial fission (GO:0090140),-0.3116873887043604,-0.9299229973552632,0.5391923990498813,0.8516540304543668,1.0,5/24,7.72%,MCU;SPIRE1;MAPT;STAT2;FIS1
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.3165153147377126,0.9298795627747184,0.5461783439490446,0.976769904423718,1.0,6/33,12.90%,TAL1;ABCB10;RAB7B;MTURN;ACVR2A;PITHD1
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.2718911959430218,0.9293221107044712,0.5701078582434514,0.9774353721704967,1.0,11/78,10.50%,ACTB;CDC37;CDK5RAP1;CCNH;CDKN1A;RGCC;GTF2H1;LATS2;CCNG2;TFAP4;BCCIP
prerank,GTP metabolic process (GO:0046039),0.3815000983535348,0.9292079020102121,0.554561717352415,0.976902025596508,1.0,3/15,12.35%,IMPDH1;RHOQ;EFL1
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.4093656453474493,0.9291665465470356,0.5523255813953488,0.9761732322260069,1.0,2/10,8.36%,RUVBL2;RUVBL1
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),-0.31045929244065107,-0.9291502723902043,0.579185520361991,0.8529733790843186,1.0,9/26,21.67%,ADCY5;EFNA5;LRP5;CDK16;ANO1;STXBP4;GPLD1;PLA2G6;ADCY8
prerank,heart contraction (GO:0060047),-0.26779754759136143,-0.9289406216710882,0.5710526315789474,0.85275875190862,1.0,3/41,4.07%,ATP1A2;ATP1B1;TPM1
prerank,secondary alcohol metabolic process (GO:1902652),0.2989206642665305,0.9279829568062328,0.5763239875389408,0.9785761511861915,1.0,7/42,12.68%,EBP;APOE;SOAT1;PPARD;OSBPL1A;NSDHL;LDLRAP1
prerank,regulation of cell-matrix adhesion (GO:0001952),0.2772764388113169,0.9279768288499347,0.5705705705705706,0.9777561101273098,1.0,18/64,17.28%,LIMCH1;ACER2;SLK;CIB1;NEXMIF;PEAK1;MINK1;CCL25;TSC1;HOXA7;NF1;MAP4K4;PTPRA;SEMA3E;PTK2B;CDH13;CLASP1;CORO1C
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.27322087838496345,0.9276186733856389,0.5809248554913294,0.9779629900572891,1.0,21/69,19.57%,DERL2;YOD1;WFS1;FAM8A1;SGTB;TRIM25;AUP1;RHBDD2;ERLIN2;STT3B;UBQLN1;PSMC6;DNAJC10;UFD1;UBQLN2;DNAJB14;UBXN4;EDEM2;DNAJB9;DERL1;SEL1L
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),-0.21584775620294053,-0.9276124711781262,0.6925925925925925,0.8554637417107467,1.0,16/142,10.71%,ATP1A2;LPAR1;CACNA1C;ADCY5;SMAD3;DLG4;TRPC5;PLCE1;PDGFRA;EDNRA;ADRA1B;FIS1;CCR9;TRPC1;PRKACA;ACKR3
prerank,regulation of macrophage differentiation (GO:0045649),0.37495258848306906,0.9266540949660322,0.5540540540540541,0.9797897227487603,1.0,1/15,0.75%,C1QC
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.3689993776606145,0.9265453116475615,0.575591985428051,0.9792755656356992,1.0,5/17,14.40%,CYCS;COX6B1;COX5A;COX15;COX10
prerank,"phagocytosis, engulfment (GO:0006911)",0.30689574090116045,0.9264960718908561,0.5798319327731093,0.9785915316921218,1.0,4/36,5.90%,RAC2;XKR8;FCGR2B;ARHGAP25
prerank,positive regulation of apoptotic process (GO:0043065),0.2306867130263981,0.9264490839651103,0.6478365384615384,0.9778863664873051,1.0,58/293,16.60%,ERCC3;MAP3K11;ATF6;FRZB;TIAM1;SOD1;VAV3;PSEN2;ARHGEF26;MCF2L;ING4;ITSN1;TNFRSF10B;MAPK8;ARHGEF6;CRADD;ARHGEF7;TRIO;SIRT1;OMA1;ARHGEF18;ITGA6;LATS2;BCLAF1;FZD9;TFAP4;AIFM1;RYBP;ING3;CCAR2;BAD;SRPK2;DDX3X;CYP1B1;RPS3;ATG7;PRNP;BMF;IP6K2;BNIP3L;NF1;ING5;UTP11;DDIT3;DIABLO;FAF1;APC;PTPA;APAF1;MAP3K10;GNA13;TPD52L1;APH1A;BCL6;DNM1L;BNIP3;QRICH1;RASGRF2
prerank,regulation of cell cycle (GO:0051726),0.23089859831281934,0.9264446634123488,0.6597560975609756,0.9770748947708318,1.0,54/271,16.16%,DYNLT3;FBXL6;MECOM;CKS2;GAS2L1;PTPRC;RPL23;TTLL12;HIPK2;ING4;BIRC2;MYBL2;SOX2;CDKN1A;EP300;RGCC;CDK11B;CHMP1A;PRCC;FBXO5;SIRT1;NOTCH1;CDK4;TSC1;JUND;MDM2;RAD23A;FZD9;TFAP4;TARDBP;CITED2;EIF4G2;SRPK2;NEK7;NANOS3;CTBP1;WDR12;NBN;MAPK12;RRP8;ANKRD17;RPS15A;NEK6;MAP2K6;APC;HCFC1;RNF20;CSNK2A2;WHAMM;APBB2;ADARB1;HPGD;ID2;RBBP4
prerank,phosphatidylcholine metabolic process (GO:0046470),0.27198183252673563,0.9258909999484066,0.59375,0.9776978812197368,1.0,13/70,16.60%,LPCAT2;PLAAT3;DBI;LPCAT3;GPAT4;MBOAT1;SLC44A1;PNPLA8;CEPT1;ABHD4;CSNK2A2;MBOAT7;SLC44A2
prerank,snRNA transcription (GO:0009301),-0.24285192917750506,-0.9257935102182633,0.6231454005934718,0.8592746253187667,1.0,41/70,33.08%,RPRD1B;POU2F1;ELL;PHAX;SRRT;USPL1;GTF2A1;CDK7;CCNT1;POLR2A;SNAPC3;TAF8;INTS10;INTS8;CCNK;INTS11;TAF6;CDK9;GTF2E2;NABP2;GTF2B;INTS7;SNAPC4;NCBP2;TAF13;POLR2K;INTS12;GTF2E1;INTS9;TAF11;POLR2H;INTS3;ZC3H8;NABP1;POLR2G;POLR2F;POU2F2;POLR2C;TAF5;GTF2F1;INTS1
prerank,regulation of macrophage chemotaxis (GO:0010758),0.34693173564852303,0.925779615554048,0.5711678832116789,0.9771838162094114,1.0,5/21,16.33%,MAPK3;CSF1R;MTUS1;AKIRIN1;PTK2B
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.33561128303360044,0.9252977578310917,0.5370705244122965,0.9776057661516405,1.0,8/25,19.40%,SORT1;LEPROTL1;CHMP1A;CHMP2A;LAPTM4B;VPS4B;LEPROT;DENND10
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.30404352762110565,-0.9252940135636596,0.5639269406392694,0.8598234101319195,1.0,2/26,0.72%,EYA2;EYA1
prerank,regulation of cilium movement (GO:0003352),-0.4003703900051516,-0.9249931475798955,0.5694760820045558,0.859816953007553,1.0,9/10,56.06%,CCDC39;DNAH11;CFAP43;CFAP298;ODAD2;DRC1;CCDC65;CFAP206;CCDC40
prerank,regulation of fibrinolysis (GO:0051917),-0.37327234833699996,-0.924647309207567,0.5689277899343544,0.8599554450090785,1.0,2/13,9.67%,THBS1;FAP
prerank,regulation of exosomal secretion (GO:1903541),-0.32432185736927893,-0.924155416894136,0.5656108597285068,0.8604504644674184,1.0,7/19,22.03%,ATP9A;SMPD3;SNF8;TSG101;STAM;VPS4A;HGS
prerank,positive regulation of metabolic process (GO:0009893),0.2577351845089968,0.9240484897660997,0.5970149253731343,0.98015591912937,1.0,13/103,8.89%,ALMS1;UCP2;CAMK1D;HDAC3;TSHR;KDM3A;ELOVL6;BEND3;GATM;SYK;ADIPOR2;OMA1;ACACB
prerank,regulation of actomyosin structure organization (GO:0110020),-0.3660825569625499,-0.9239222742393935,0.5748898678414097,0.8602805931268288,1.0,5/13,17.35%,AKAP13;ROCK2;ROCK1;FHOD1;CDC42
prerank,positive regulation of viral transcription (GO:0050434),0.3297790758268022,0.9238816710925108,0.5570247933884298,0.9797993579070772,1.0,2/25,2.00%,POLR2J;POLR2B
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),-0.38598020652648,-0.9235560609427611,0.5643564356435643,0.8604317432631217,1.0,4/11,13.86%,MPV17L;SLC30A10;PPARA;ABCD2
prerank,regulation of necroptotic process (GO:0060544),-0.3196900049573307,-0.9231777902290091,0.5576036866359447,0.8606352502960238,1.0,6/23,8.63%,CFLAR;OGT;CYLD;FLOT2;YBX3;BIRC3
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.4009227051957688,0.9231589245670381,0.528957528957529,0.9809797210136237,1.0,4/10,17.41%,DCLRE1B;ACD;TERF2IP;DCLRE1C
prerank,nuclear body organization (GO:0030575),-0.3731700192161554,-0.9231043299381066,0.5425531914893617,0.8600928953071344,1.0,5/12,17.04%,AFF2;PML;USPL1;USP50;HABP4
prerank,positive regulation of protein localization to membrane (GO:1905477),-0.2286281114042087,-0.9230469731239737,0.6483870967741936,0.8595084837781212,1.0,18/98,13.20%,SORBS1;ANK3;LRP1;EGFR;CEMIP;AKT2;FIS1;ZDHHC5;STX3;EFCAB7;DPP10;EPHB2;EPHA3;TP53;CLIP3;DLG1;PDCD5;WNK3
prerank,positive regulation of endocytosis (GO:0045807),0.29618565334109237,0.923036748499231,0.5854037267080745,0.9804849059381577,1.0,7/45,5.45%,CBL;PPT1;NEDD4L;SGIP1;APOE;HNRNPK;B2M
prerank,positive regulation of fat cell differentiation (GO:0045600),0.2925563455346851,0.9229811169411832,0.5807504078303426,0.9798216043874769,1.0,10/47,12.48%,FRZB;CCDC71L;ZFP36L1;PPARD;PIM1;AAMDC;SOX13;TRPM4;CARM1;WDFY2
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.34470614954151924,-0.9228246532116806,0.6035634743875279,0.8593210431574445,1.0,8/17,27.58%,EMC7;CAMLG;SGTA;BAG6;EMC1;EMC8;EMC9;GET4
prerank,"base-excision repair, AP site formation (GO:0006285)",0.3563118866992007,0.922227434457156,0.591182364729459,0.9810424220942766,1.0,5/17,15.22%,TDG;ACD;SMUG1;MPG;TERF2IP
prerank,regulation of phosphorylation (GO:0042325),-0.22355400757030322,-0.9219272212639961,0.6678200692041523,0.8608461712346196,1.0,26/120,13.35%,PRKAG2;EGFR;GRM5;OGT;NRP1;BMP7;DSCAM;FER;PRKAG1;SIRT2;STAT2;BMP4;NUP205;ROCK1;LDB1;PML;NUP155;CDKN1B;NUP188;THBS1;FN1;ILK;NUP88;NUP93;FNIP1;SEH1L
prerank,RNA metabolic process (GO:0016070),-0.22158619529909543,-0.9219192797766944,0.6807692307692308,0.8601387700738605,1.0,30/127,15.32%,CELF2;RBMS1;BICD1;HNRNPH1;DDX17;PABPN1;ELAVL4;RBM39;RBMX;SYNCRIP;SNRNP40;DDX39B;RNGTT;DDX24;HNRNPA2B1;SIDT2;AGO3;HNRNPA1;RNASEH2B;RBM3;RBM4;ATXN1;TP53RK;SND1;POLR2A;DICER1;SETX;PABPC4;MTREX;RNASE3
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.25053054019258375,0.9216616003290098,0.6208333333333333,0.9816749155300035,1.0,9/110,6.34%,PTGER2;ADGRE1;ADGRL4;GNAQ;ADGRL3;TSHR;RAMP2;GNB1;RXFP1
prerank,regulation of myeloid cell differentiation (GO:0045637),-0.2475321687436543,-0.9215634586066314,0.6481994459833795,0.8602967617703499,1.0,11/62,9.85%,KMT2A;HDAC1;MEIS2;CBFB;HOXA5;CDC73;RBM15;THBS1;AGO3;RBBP5;CDK6
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.30493064872019904,0.9213188778517637,0.58,0.9817525115357467,1.0,5/37,8.79%,ERCC3;ERCC4;POLK;POLD3;GTF2H1
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.3820251843946472,-0.9208586558743947,0.5748373101952278,0.8613274687497792,1.0,7/11,26.50%,OGFOD1;P4HB;P4HTM;EGLN3;P4HA2;CRTAP;EGLN1
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.25018109102239555,0.9208236944415567,0.628808864265928,0.9822298090435154,1.0,30/136,16.22%,HES6;TNFAIP3;NWD1;MAP2K5;PHB2;WFS1;CEBPG;PIM1;SMAD7;SIRT1;NLRC3;MTURN;ERBIN;TRAF3;RBCK1;NFKBIL1;ESR1;CYP1B1;PRNP;CHUK;NLRC5;DDIT3;NFKBIA;HES1;MAP3K10;GAS6;TAF1;ID2;HEYL;TAF3
prerank,rRNA catabolic process (GO:0016075),-0.3500999742440594,-0.9206563723676164,0.5853658536585366,0.8611050801373586,1.0,9/16,34.82%,EXOSC10;DIS3L;DIS3;TRIR;EXOSC8;EXOSC2;DEDD2;EXOSC3;EXOSC5
prerank,negative regulation of lymphocyte migration (GO:2000402),0.40647632467627215,0.9206269939151257,0.5431861804222649,0.9819285812741826,1.0,2/10,5.71%,LRCH1;RIPOR2
prerank,microtubule polymerization (GO:0046785),-0.2969068161033235,-0.9204649066350037,0.5916870415647921,0.8608308507671193,1.0,10/28,13.34%,HDGFL3;MAPT;TUBGCP4;CCDC57;GOLGA2;AKAP9;SLAIN2;CKAP5;TUBGCP6;RANBP9
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.29209795889477813,0.9201886830704429,0.5594855305466238,0.9822683402900003,1.0,9/48,16.27%,PTPRC;TTLL12;RFFL;CARD16;CNOT7;USP18;NLRC5;GAS6;OTUD4
prerank,protein N-linked glycosylation (GO:0006487),0.27906173186049055,0.9201006498374878,0.582089552238806,0.9816961334671583,1.0,10/66,13.42%,NUDT14;ALG6;ASGR1;ALG8;TMEM165;OST4;STT3B;MCFD2;MGAT5;ST3GAL1
prerank,receptor metabolic process (GO:0043112),-0.25479757833239813,-0.9200288859131001,0.6088154269972452,0.8612049507104055,1.0,15/53,16.80%,LRP1;ARFGEF2;CALCRL;RAB31;GRK3;LGMN;ACKR3;UVRAG;SNX25;RAMP1;GRB2;DNM1;TGFB1;GRK4;EHD3
prerank,regulation of DNA damage checkpoint (GO:2000001),-0.396946623783511,-0.9196725852324501,0.583984375,0.8613812870302389,1.0,6/10,24.27%,DDX39B;CRY1;THOC5;WDR76;ETAA1;THOC1
prerank,regulation of membrane repolarization (GO:0060306),-0.3597108825702417,-0.9195867555291865,0.5695067264573991,0.8608556217522316,1.0,3/13,8.46%,AKAP6;AKAP9;KCNJ2
prerank,glycolipid metabolic process (GO:0006664),0.29419211838686044,0.9195310876810061,0.6179775280898876,0.9824052320274672,1.0,11/47,16.11%,GLB1;SMPD4;ST6GALNAC3;ESYT2;FUCA1;UGCG;ST3GAL6;GM2A;ST8SIA6;CERK;GBGT1
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.2961086683952221,-0.9194491986521283,0.5786924939467313,0.8604916879028115,1.0,4/30,5.33%,NOTCH2;IGF1;RASGRF1;RELN
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.24709430590445217,0.9193945731907486,0.654843110504775,0.9819148591160565,1.0,21/151,12.14%,MAP2K7;MAPK3;SEMA7A;PTPRC;TIRAP;PRKD2;APOE;TEK;PHB2;CIB1;ICAM1;HTR2A;MTURN;NOTCH1;CCL25;CSF1R;MFHAS1;ATP6AP1;NPNT;APP;CRKL
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.308200037744792,0.9187548781337312,0.5911413969335605,0.9827617659571402,1.0,7/35,9.17%,PHPT1;TEK;RAPGEF3;F11R;TJP1;ESAM;CSF1R
prerank,DNA duplex unwinding (GO:0032508),-0.2586153983000073,-0.9186142958129548,0.615819209039548,0.8618773260577454,1.0,17/50,22.64%,DDB1;DDX1;DDB2;RAD50;MRE11;RPA1;UBC;ANXA1;PURA;MCM9;PARP1;XPC;BLM;SUPV3L1;RECQL;RTEL1;MCM6
prerank,response to tumor necrosis factor (GO:0034612),0.2628332943225351,0.9184050692464328,0.5936599423631124,0.9829089824703985,1.0,13/91,12.87%,MAP2K7;SMPD4;ZFP36L1;GBP3;CIB1;SIRT1;CCL25;ERBIN;RELA;NPNT;RPS3;IKBKB;CHUK
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),-0.2718587050075674,-0.9183754596601029,0.5888324873096447,0.8617313475255923,1.0,12/36,22.53%,CYLD;TAOK3;EZR;PER1;SIRPA;DLG1;FKTN;DACT1;PTPN22;PINK1;SH3RF2;DUSP1
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),-0.24933505410935386,-0.918226863361856,0.6038251366120219,0.8613666505373664,1.0,16/55,19.93%,PDGFRB;MAPK14;PID1;TGFBR2;SIRT2;AATF;XDH;THBS1;TP53;GRB2;MPV17;ARF4;SIRT5;AGTR1;SLC25A33;PINK1
prerank,regulation of inflammatory response (GO:0050727),0.2390736483942119,0.9178411997390281,0.6649484536082474,0.9835663975157745,1.0,26/190,13.89%,PIK3AP1;IL1R1;SEMA7A;TNFAIP3;BCL6B;BIRC2;IFI35;SBNO2;APOE;TEK;TNFRSF1B;SPATA2;LPCAT3;PPARD;NLRC3;WNT5A;RELA;CD47;PARK7;MFHAS1;NLRP6;APP;USP18;CDH5;PROC;NFKBIA
prerank,positive regulation of sprouting angiogenesis (GO:1903672),-0.35486110096981505,-0.9177713706417443,0.5770114942528736,0.8618144994141146,1.0,5/15,10.64%,BMPER;FGF1;JAK1;ITGA5;PKM
prerank,negative regulation of type I interferon production (GO:0032480),-0.2702762909883858,-0.9175769273775011,0.6080402010050251,0.8615671781985477,1.0,12/40,13.01%,CYLD;PTPRS;PPM1B;ILRUN;TAX1BP1;IFIH1;RNF135;REL;IKBKE;NPLOC4;SIRPA;RELB
prerank,cellular response to amino acid stimulus (GO:0071230),-0.2859548403035327,-0.9170919783809246,0.5939086294416244,0.8620640092548484,1.0,6/33,7.73%,CPEB4;CPEB1;CAPN2;KLHL22;CASTOR2;GLRA1
prerank,cellular amino acid catabolic process (GO:0009063),0.26245611597269414,0.9170872584620036,0.6323119777158774,0.9847825378238282,1.0,8/87,5.63%,AASS;BCKDHB;ALDH5A1;SLC25A44;GLS2;GLS;GOT2;ACAT1
prerank,DNA metabolic process (GO:0006259),0.23004878894742076,0.9168156103167541,0.6703841387856257,0.984736993741857,1.0,50/270,16.84%,ERCC3;ZRANB3;RAD18;TRIM28;CTC1;PNKP;ORC3;ERCC4;RAD1;XRCC1;POLK;TDG;POLE;CDC45;LONP1;DCLRE1B;ORC4;UBE2V2;POLD3;ACD;GTF2H1;POLA1;EXD2;MSH3;PARK7;TERT;SRPK2;RAD51B;SMUG1;HUS1;ORC2;TOP3A;KMT5B;PWWP3A;NBN;DOT1L;HELB;TRRAP;MPG;LTO1;FANCL;BACH1;INO80;TERF2IP;TOP1;ATR;ENDOV;ZNF445;PRKDC;SMARCAD1
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),-0.3628888404578699,-0.9167498746227088,0.5723981900452488,0.8621856303134474,1.0,4/13,13.42%,IGF1;GOLGA2;RAMP1;IL33
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.2971727166606424,0.9162332302620738,0.6060606060606061,0.9854974693650956,1.0,9/48,12.95%,POLR1C;ACTB;EP300;POLR1G;ATAD2;WBP2;ATAD2B;SMARCD1;TBP
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.32534458300580266,0.9159728790086676,0.5874769797421732,0.9853836760218262,1.0,6/23,11.08%,HDAC7;IFI35;NLRC3;RELA;DDX3X;ADIPOR1
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.25824481555492274,0.9159268517461182,0.6088235294117647,0.9846880419078398,1.0,25/94,18.69%,TRIB3;BCL2L2;HIPK2;TNFRSF10B;SCN2A;TNFRSF1B;CDKN1A;SELENOK;AIFM1;BAD;DDX3X;CYP1B1;CUL3;RRP8;CHEK2;DDIT3;DIABLO;APAF1;DNAJC10;BNIP3;QRICH1;PRKDC;BAX;GSKIP;HINT1
prerank,regulation of vasculogenesis (GO:2001212),0.37813895478319326,0.9157351403012728,0.5804701627486437,0.9843887682391222,1.0,3/14,7.63%,HEY1;TMEM100;HEY2
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.3323679313797902,0.9153640988285887,0.573170731707317,0.9845329217876677,1.0,7/26,16.97%,FBXO5;ANAPC7;ANAPC11;ANAPC4;CUL3;NEK6;LCMT1
prerank,cellular response to retinoic acid (GO:0071300),-0.2722360117888047,-0.9152708951051856,0.6090225563909775,0.8650824994970886,1.0,12/42,17.63%,WNT5B;BRINP1;PTK7;BRINP2;SNW1;EPHA3;WNT9A;ATM;SETX;ABL2;FZD4;TWF2
prerank,steroid catabolic process (GO:0006706),0.4103893043230432,0.915029963942959,0.5884543761638734,0.9845560690443542,1.0,2/10,13.07%,HSD17B11;YWHAH
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),-0.39969896403230676,-0.9142843110666086,0.564,0.8668100732781128,1.0,6/10,22.26%,OGT;SIRT7;SELENOS;USP7;ZNF692;DGKQ
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.30825521117532984,0.9140916199630149,0.583916083916084,0.9861928504737736,1.0,2/33,3.56%,CBL;BCAR3
prerank,establishment of skin barrier (GO:0061436),0.36804761383453233,0.9140006478720174,0.555956678700361,0.9848183356456335,1.0,3/15,13.38%,UGCG;HRNR;LSR
prerank,regulation of water loss via skin (GO:0033561),0.36804761383453233,0.9140006478720174,0.555956678700361,0.9848183356456335,1.0,3/15,13.38%,UGCG;HRNR;LSR
prerank,regulation of RNA metabolic process (GO:0051252),-0.24815426712486618,-0.9137254130565349,0.628808864265928,0.8674650988426241,1.0,7/59,4.72%,HNRNPH1;SNRNP70;AHNAK;SON;AFF2;CLK4;MED1
prerank,positive regulation of superoxide anion generation (GO:0032930),0.3890183435761662,0.9135380631985538,0.5454545454545454,0.9852135039350837,1.0,2/13,6.70%,SOD1;SYK
prerank,regulation of cellular component organization (GO:0051128),0.2447405193097968,0.9132704781557635,0.6411682892906815,0.9851306652906431,1.0,20/135,11.90%,CISH;HSPA8;AP2S1;RPTOR;RAB5C;LTBP4;APOE;LAMTOR1;CDK11B;CAMSAP2;HJURP;SNX17;SETD5;WNT5A;TJP1;PARK7;OPHN1;EGLN2;RAB5B;PICALM
prerank,cellular response to starvation (GO:0009267),0.24438088743981382,0.9125283677509096,0.6446499339498019,0.9862534432023736,1.0,38/147,19.05%,MAPK3;RALB;GAS2L1;MAP1LC3B;HSPA8;EIF2S1;RPTOR;ATP6V1D;ATP6V0D1;XPR1;CDKN1A;MAPK8;LAMTOR1;SIRT1;ATP6V0E1;NIM1K;PRKAA2;ATG7;LARS1;RRAGC;RRP8;USP33;ATP6V1B2;ATG14;TFEB;GABARAPL1;KPTN;SESN3;PIK3R4;ZFYVE1;DAPL1;BECN1;ATP6V1A;GABARAP;SH3GLB1;LAMP2;NUAK1;SESN1
prerank,regulation of autophagosome assembly (GO:2000785),0.313511203095226,0.9124237011527256,0.6023489932885906,0.985735823399284,1.0,15/33,21.39%,RALB;PIKFYVE;TBC1D12;SCFD1;ADPRH;FEZ2;TMEM39A;TBC1D14;RAB3GAP1;UBQLN2;PIP4K2A;SH3GLB1;RAB5A;LRRK2;PIP4K2C
prerank,regulation of vesicle-mediated transport (GO:0060627),0.2619511494180526,0.912373964111313,0.6105417276720352,0.9850625574912472,1.0,16/91,11.90%,MAPK3;PTPRC;AP2S1;SRC;RAB5C;STXBP5L;RAB11B;RALA;SYK;SNX17;OPHN1;MBTPS1;SCFD1;RAB5B;SCARB1;PICALM
prerank,positive regulation of collagen metabolic process (GO:0010714),-0.3379727944757109,-0.9122268741580969,0.5853080568720379,0.8704272426827718,1.0,6/17,24.21%,VIM;BMP4;WNT4;TGFB1;CREB3L1;TGFB3
prerank,long-chain fatty acid import into cell (GO:0044539),-0.3868354635833455,-0.9120419160315291,0.5836909871244635,0.8701732739281625,1.0,3/10,18.74%,ACSL1;SLC27A1;RPS6KB1
prerank,membrane protein proteolysis (GO:0033619),0.3044268640221254,0.9118290580082533,0.5978090766823161,0.9857254545390778,1.0,12/37,18.20%,PSEN2;RET;NAPSA;SPPL3;DAG1;RELA;MBTPS1;TMPRSS6;APH1A;MYH9;ADAM9;SPPL2A
prerank,mucosal immune response (GO:0002385),0.3717860436140752,0.9116860074295979,0.582010582010582,0.9852980693955649,1.0,1/15,2.81%,IFNLR1
prerank,autophagosome organization (GO:1905037),0.28830557508901306,0.9114302796517526,0.6060606060606061,0.9851583271161258,1.0,18/50,18.80%,MAP1LC3B;ATP2A2;RAB7A;RAB43;VMP1;RAB1A;UBQLN1;ATG7;ATG16L1;ATG14;TMEM41B;GABARAPL1;ATG13;TP53INP2;UBQLN2;BECN1;GABARAP;ULK1
prerank,receptor recycling (GO:0001881),-0.38573775330121746,-0.9113608227675608,0.5539714867617108,0.871210440375416,1.0,8/10,37.77%,ARFGEF2;SORL1;EHD3;LMTK2;NSG1;PHETA1;PLEKHJ1;REP15
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.2169357053323276,0.911256187500897,0.7508055853920516,0.9848264341483306,1.0,99/572,16.22%,SOX30;LRRFIP1;ATF3;IRX1;MAZ;DCAF1;DACH1;AASS;ARID5A;KLF8;TRIB3;NR4A2;EZH2;RPL23;EED;JAZF1;GTF2IRD1;DMAP1;KLF2;DNAJA3;MAP2K5;HDAC9;BCL6B;HDAC3;HEY1;NEDD4L;SMARCA2;SOX2;YY1;WFS1;VPS72;UBE2I;IRF2BPL;BEND3;EP300;RPS14;NFX1;CNOT2;PPARD;ZNF205;SFPQ;UXT;SMAD7;SIRT1;BMI1;DRAP1;ZNF3;HEY2;NOTCH1;SAP130;EDNRB;EFNA1;SOX13;RELA;HOXA7;MDM2;TRPS1;ZKSCAN3;CIR1;CITED2;ESR1;THRB;RBPJ;CREBBP;CTBP1;ORC2;NFIC;HDGF;IFI27;N4BP2L2;MZF1;IRF2;CHD3;TGIF1;CTBP2;HDAC5;DDIT3;THRA;HES1;DR1;HCFC1;TRIM27;USP9X;CNOT1;E2F6;TMPRSS6;BACH1;EZH1;NKAP;TCERG1;TAF1;ELK4;BCL6;TRIM33;SMARCA4;ID2;TCF3;ZBTB18;TAF3
prerank,anion transmembrane transport (GO:0098656),0.276394148145999,0.9105026064508861,0.6113602391629297,0.9859816473981368,1.0,17/67,17.21%,SLC7A8;SLC1A1;SLC36A4;SLC25A1;SLC3A2;LRRC8C;SLC1A2;SLC35A1;SLC35B1;SFXN1;SLC25A12;SLC35A3;SLC38A5;SLC25A21;SLC25A42;SLC25A38;SLC7A5
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),-0.36971495397600396,-0.9102039761695376,0.5943204868154158,0.8726507513120001,1.0,2/12,2.87%,EFNA5;FBLN1
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),-0.36971495397600396,-0.9102039761695376,0.5943204868154158,0.8726507513120001,1.0,2/12,2.87%,EFNA5;FBLN1
prerank,water-soluble vitamin metabolic process (GO:0006767),0.26991842249408066,0.9099591062164788,0.6171171171171171,0.9865988277047226,1.0,8/68,8.35%,ALDH1L1;MTR;FLAD1;PANK2;SLC52A2;SLC52A3;MTHFS;SLC2A1
prerank,positive regulation of actin filament depolymerization (GO:0030836),-0.3880195042818566,-0.9099064364301531,0.5876494023904383,0.8726422688022979,1.0,3/10,19.13%,ACTN2;WDR1;SEMA5A
prerank,dendritic spine organization (GO:0097061),0.32635069176036574,0.9097764644275211,0.5889464594127807,0.9862747233766438,1.0,7/26,12.25%,DIP2A;SHANK3;FYN;PAK3;ARF1;PRNP;ITGA3
prerank,regulation of ERBB signaling pathway (GO:1901184),0.3636651274664146,0.9096956074252419,0.5783783783783784,0.9856942414070989,1.0,4/15,10.80%,PTPN18;PTPN12;RHBDF2;RBPJ
prerank,positive regulation of defense response (GO:0031349),-0.23280574725498962,-0.9095494357573243,0.6588628762541806,0.8728371690517136,1.0,28/89,29.26%,NAPEPLD;OPTN;PLSCR1;IL16;IL17RA;POLR3C;GPR4;IL18;IL33;TNIP1;NPAS2;LRSAM1;GPRC5B;GBP5;RIOK3;AGTR1;SLC15A4;CX3CL1;SETD4;PLA2G7;TLR3;FEM1A;SERPINE1;PDE2A;CCN4;MDK;SNCA;POLR3G
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.38619365900723734,0.9093138014090755,0.5689981096408318,0.9858855301351388,1.0,3/12,10.75%,GAS2L1;LMO2;THRB
prerank,transition metal ion homeostasis (GO:0055076),0.31745108243237713,0.9090134424629485,0.59375,0.9858732400686326,1.0,7/28,15.46%,HMOX2;FBXL5;B2M;PICALM;CUTC;TMPRSS6;BDH2
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),0.36003914937614395,0.9085589615103297,0.574108818011257,0.9862272946228129,1.0,4/16,14.25%,APOE;TERT;SCARB1;GCH1
prerank,positive regulation of cytoplasmic transport (GO:1903651),-0.3767786341953452,-0.9085167573449826,0.5782881002087683,0.8746992989691796,1.0,5/11,18.58%,DAB2;SORL1;EZR;PTPN23;MSN
prerank,protein lipidation (GO:0006497),0.2792616156217289,0.9085116582976597,0.6236722306525038,0.9855579637182174,1.0,14/59,16.29%,ZDHHC17;ZDHHC13;UGCG;ZDHHC14;SELENOK;PIGH;ZDHHC15;PIGB;ATG7;PGAP2;ZDHHC9;ZDHHC7;PIGN;PIGU
prerank,central nervous system neuron axonogenesis (GO:0021955),-0.3786264660594063,-0.9080654925291152,0.5893223819301848,0.8751706524492672,1.0,3/12,10.62%,EPHB1;B4GALT6;EPHB2
prerank,amino acid import (GO:0043090),-0.3144759801634275,-0.9076695955770535,0.5733634311512416,0.8753583333801922,1.0,6/21,9.28%,SLC1A3;SLC6A13;SLC47A1;SLC6A1;SFXN2;SLC22A4
prerank,phosphatidylinositol metabolic process (GO:0046488),-0.22262243494512599,-0.9076404085527504,0.6416382252559727,0.8746939988197409,1.0,23/109,15.31%,PTPN13;PLA2G4A;PDGFRB;PLEKHA2;LPGAT1;PIK3C2B;MTMR7;PIK3C3;PIP4P2;PIP5K1A;SACM1L;PIK3R3;VAC14;PLEKHA8;PIP4K2B;MTMR12;PLCB3;PITPNM3;INPPL1;SLC27A1;MTMR9;CDS1;MTMR4
prerank,negative regulation of cell-cell adhesion (GO:0022408),-0.275600295305228,-0.9075926359404963,0.6289156626506024,0.874096720015652,1.0,15/39,28.14%,BMP6;MBP;WNK1;PPARA;CDH1;MYADM;NF2;PTK2;TGFB1;PPM1F;VEGFA;AKT1;NOTCH4;AKNA;BMP2
prerank,regulation of MAPK cascade (GO:0043408),0.24178438814152664,0.9075184457182623,0.643048128342246,0.9872529612825036,1.0,26/157,12.32%,MAPK3;ZDHHC17;PTPRJ;PTPRC;GREM1;BCAR3;PRDM15;TEK;SOX2;SPRED1;TBX1;RET;LAMTOR1;PAK3;SYK;ATP6AP2;DAG1;MINK1;PHLPP1;LYN;PAK1;P2RX7;FLT1;NBR1;NF1;MAP4K4
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.3205763528934442,0.9073520044459384,0.6036789297658863,0.986894061766793,1.0,6/26,12.77%,TNFAIP3;CARD16;NLRC3;NFKBIL1;TRAF3IP1;MAPKBP1
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.30784095010201845,0.9070902062210652,0.5922818791946308,0.9867897210409556,1.0,9/35,16.87%,SLC25A1;PPT1;ACAT1;FAR2;HMGCS2;PAM;BDH2;HPGD;ACACA
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.31825819682015005,0.9067406499209791,0.592964824120603,0.9869187261429428,1.0,8/28,18.07%,SORT1;TNFRSF10B;CRADD;DDX3X;DIABLO;DELE1;BAX;GABARAP
prerank,regulation of protein kinase A signaling (GO:0010738),-0.31377398297057896,-0.9066885541482813,0.5868131868131868,0.8756512508279478,1.0,3/20,4.28%,AKAP6;AKAP12;ADGRV1
prerank,lipid modification (GO:0030258),0.30111981897094575,0.9066101594530076,0.5896147403685092,0.9864396934837549,1.0,6/37,8.19%,DGKB;PLPP6;LPCAT3;PLPP1;MBOAT1;SGPP2
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.329958245368283,0.9065173760000409,0.5775862068965517,0.9858791819396725,1.0,4/25,12.57%,MAP3K7;B2M;WNT5A;CD55
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.26459820444186516,0.9065019391057227,0.6523076923076923,0.9851302541477363,1.0,14/75,16.35%,PDCL3;PRKD2;NRAS;PPP1R16B;EGFL7;TEK;SIRT1;PLCG1;WNT5A;PIK3CD;SP1;VEGFC;ANG;CDH13
prerank,positive regulation of cellular component organization (GO:0051130),0.25002011730790624,0.9063266284164258,0.6349431818181818,0.9847777303739452,1.0,26/107,17.79%,SURF4;TAL1;SLF1;ANAPC2;SHANK3;TIRAP;NEDD4L;APOE;ICE1;SYK;RAPGEF3;PARK7;RPS3;BMF;CDH5;FAF1;ATP10A;ASAP1;ADGRL1;LRP4;BNIP3;SLF2;WARS1;INSR;TMEM30A;BAX
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.3887201660233519,0.9061998963953651,0.5730337078651685,0.9843232075609855,1.0,3/11,19.80%,SIRT1;HDAC2;XBP1
prerank,positive regulation of cytokinesis (GO:0032467),-0.2759162935798097,-0.9061514149803365,0.6059907834101382,0.8762757086341783,1.0,3/32,6.06%,SVIL;RHOA;CIT
prerank,negative regulation of defense response to virus (GO:0050687),-0.3873442156372886,-0.9057843042496688,0.5963855421686747,0.8764468837379868,1.0,2/10,5.90%,PPM1B;ILRUN
prerank,polarized epithelial cell differentiation (GO:0030859),0.38396236293526054,0.905364712555624,0.5680473372781065,0.9856665422128751,1.0,4/13,14.04%,RAP2A;MYO9A;OPHN1;ZDHHC7
prerank,primary neural tube formation (GO:0014020),-0.28421413076231494,-0.9050973700066747,0.6074074074074074,0.8774159870173304,1.0,9/30,17.83%,LMO4;SKI;COBL;MTHFR;MTHFD1;PLXNB2;LRP6;TGFB1;TSC2
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.33884773075425106,0.9049849534079022,0.5996343692870201,0.9850513303578508,1.0,3/21,8.79%,ERCC3;ERCC4;GTF2H1
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.33884773075425106,0.9049849534079022,0.5996343692870201,0.9850513303578508,1.0,3/21,8.79%,ERCC3;ERCC4;GTF2H1
prerank,negative regulation of defense response (GO:0031348),-0.23213870096134556,-0.9048460704000653,0.6697819314641744,0.8773148522554748,1.0,17/77,17.42%,LRFN5;PPM1B;SIRT2;ILRUN;PRKCD;PPARA;PTGIS;IRAK3;TRAFD1;OTULIN;SIRPA;RORA;SELENOS;CCN3;PTPN2;ENPP3;TNFAIP6
prerank,regulation of JUN kinase activity (GO:0043506),0.3085850705293031,0.9048249926147656,0.5851979345955249,0.9846980925641979,1.0,7/33,14.82%,MAP3K11;MAP3K7;MAP3K4;PAK1;RPS3;AIDA;MAP3K10
prerank,RNA processing (GO:0006396),0.2376326024774248,0.9041902761568846,0.666232073011734,0.9854618326896782,1.0,50/176,17.92%,SNRPD2;NCBP1;FASTKD2;PRPF3;SNRPD1;DDX54;PPP2CA;HNRNPK;PPIG;TENT4A;USB1;SFPQ;HNRNPC;IVNS1ABP;ADAR;SF3B3;SRSF4;YJU2;PRMT9;SF3A1;XRN2;RSRC1;AKAP8L;TARDBP;U2AF1;CPSF6;DUSP11;CCAR2;SRPK2;ADARB2;PTBP1;TUT7;RRAGC;SRSF7;USP39;FUS;TUT4;HNRNPL;TCERG1;ADARB1;TSEN2;DKC1;U2AF2;LSM1;NONO;SNRPA1;HNRNPF;DHX8;DDX23;PRPF18
prerank,branched-chain amino acid catabolic process (GO:0009083),0.34120571167193803,0.9038839232861751,0.5988909426987061,0.9846187067985581,1.0,3/20,5.63%,BCKDHB;SLC25A44;ACAT1
prerank,branched-chain amino acid metabolic process (GO:0009081),0.34120571167193803,0.9038839232861751,0.5988909426987061,0.9846187067985581,1.0,3/20,5.63%,BCKDHB;SLC25A44;ACAT1
prerank,regulation of translation (GO:0006417),0.2380057375217654,0.9038171659189903,0.7015503875968992,0.9839983377077672,1.0,56/173,21.42%,NCBP1;ILF3;PATL2;EIF2A;RPS6KA1;LARP4B;EIF3B;FXR1;RPL5;PAIP2B;GEMIN5;PYM1;CNOT7;EIF4H;TSC1;TSFM;EIF4G2;METAP1;DDX3X;NANOS3;APP;EIF4B;RPS3;YBX1;CNOT1;CAPRIN1;EIF5;RBM4B;UPF3B;LARP4;PRKDC;MTG2;CYFIP1;CNOT10;CALR;NPM1;EIF6;RPL26;RPL10;EIF4G1;MRPL13;DHX36;EIF3E;LARP1;MTIF2;METTL14;EIF4E;EIF1;MTPN;CNOT8;DDX6;TRAP1;EIF2AK4;GLE1;DHX9;GSPT1
prerank,response to gamma radiation (GO:0010332),-0.30449051089200724,-0.9038163716787088,0.6060606060606061,0.8790748609090697,1.0,15/24,40.93%,MAP3K20;TP53;HSF1;ATM;KDM1A;CRYAB;TMEM109;YAP1;PRKAA1;MEN1;DCUN1D3;TRIM13;HRAS;TSPYL5;FANCD2
prerank,tube closure (GO:0060606),-0.28166997428640667,-0.9037324748457621,0.6271604938271605,0.87856055360281,1.0,9/31,17.83%,LMO4;SKI;COBL;MTHFR;MTHFD1;PLXNB2;LRP6;TGFB1;TSC2
prerank,glycerophospholipid biosynthetic process (GO:0046474),-0.21150010279795534,-0.9036827704586642,0.7241379310344828,0.8779732499201583,1.0,48/172,22.56%,PTPN13;PLD1;PLA2G4A;PLEKHA2;AGPAT4;ABHD5;PIK3C2B;MTMR7;PIK3C3;AGPAT5;PIP5K1A;DGKH;SACM1L;PIK3R3;VAC14;LPIN1;PLEKHA8;PLSCR1;PIP4K2B;MTMR12;HDHD5;PITPNM3;CHKA;AGK;PCYT1B;INPPL1;CDS2;SLC27A1;ETNK2;MTMR9;CDS1;PTDSS2;CRLS1;MTMR4;PCYT2;PGS1;ABHD3;INPP4A;GPD1L;LPCAT1;CPNE3;PIK3R1;SBF1;BMX;LPIN2;DGKQ;PIP5K1B;CHKB
prerank,actin filament capping (GO:0051693),-0.3274399397486003,-0.9034692163994774,0.5883668903803132,0.8770493921668816,1.0,8/18,20.98%,SVIL;GSN;TRIOBP;ADD3;TWF2;ADD2;CAPZB;VILL
prerank,barbed-end actin filament capping (GO:0051016),-0.3274399397486003,-0.9034692163994774,0.5883668903803132,0.8770493921668816,1.0,8/18,20.98%,SVIL;GSN;TRIOBP;ADD3;TWF2;ADD2;CAPZB;VILL
prerank,phosphatidic acid biosynthetic process (GO:0006654),-0.26075230034114044,-0.9032757072653382,0.6385869565217391,0.8768219934677088,1.0,6/46,6.34%,PLD1;PLA2G4A;AGPAT4;ABHD5;AGPAT5;DGKH
prerank,UV protection (GO:0009650),-0.39644234280048557,-0.9030777233792482,0.6177062374245473,0.8766124446490142,1.0,3/10,8.37%,SCARA3;ERCC5;CAT
prerank,positive regulation of macroautophagy (GO:0016239),0.28166846126000555,0.9029442675957258,0.6204724409448819,0.9854460874339419,1.0,16/48,19.38%,RALB;MAP3K7;EPM2A;SIRT1;FYCO1;PRKAA2;BNIP3L;SCOC;RAB3GAP1;SESN3;BNIP3;PIP4K2A;SH3GLB1;SESN1;LARP1;HSPB8
prerank,epithelial cell development (GO:0002064),-0.316775912363759,-0.9028549718989692,0.5763440860215053,0.8764308134127627,1.0,2/20,4.42%,WNT5B;RILPL1
prerank,response to thyroid hormone (GO:0097066),0.37697762741918106,0.9024678025376611,0.5703564727954972,0.9859627152677612,1.0,3/13,10.75%,GAS2L1;LMO2;THRB
prerank,response to progesterone (GO:0032570),0.3573878679778684,0.9022850399766477,0.5981651376146789,0.9856332343925448,1.0,3/18,10.39%,SRC;UBE3A;WBP2
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.3323892183561901,0.9021553764871433,0.5899280575539568,0.9851860039929563,1.0,3/22,6.91%,DUSP7;PPP2CA;PPP2CB
prerank,mRNA destabilization (GO:0061157),0.3012399222063321,0.9021173839685747,0.5856905158069884,0.9845052999918956,1.0,12/38,20.12%,ZC3H12D;ZFP36L1;TARDBP;TUT7;CNOT1;TUT4;MOV10;FTO;RC3H1;DIS3L2;DHX36;METTL14
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),-0.2921275901519219,-0.9017270243279121,0.5933806146572104,0.8784106188166343,1.0,11/26,36.76%,SMAD3;P2RX4;DDAH1;PTGS2;AKT1;HSP90AA1;DDAH2;ASS1;EDN1;TMEM106A;CLU
prerank,regulation of tumor necrosis factor production (GO:0032680),0.2501763097384733,0.9016224636150566,0.6515775034293553,0.9850166855228145,1.0,12/112,11.27%,CIDEA;PTPRJ;PTPRC;TNFAIP3;TIRAP;SYK;NLRC3;WNT5A;CD47;VSIR;NFKBIL1;APP
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.25660167628946184,0.9016046114085403,0.6575539568345323,0.9842792878665607,1.0,14/95,13.00%,TNFAIP3;FCGR2B;TIRAP;SBNO2;TNFRSF1B;CYRIB;MAPK8;CARD16;WNT5A;RELA;NFKBIL1;PLAA;TNIP2;CD274
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.27890098007556235,-0.9014553074115613,0.6151898734177215,0.8784141171860871,1.0,4/32,8.60%,AKAP6;CEMIP;HTT;TRPC1
prerank,positive chemotaxis (GO:0050918),-0.3267960269434348,-0.901412971359188,0.5957894736842105,0.8778261643701648,1.0,10/17,32.41%,NRP1;SCG2;TSC2;SEMA5A;MET;CX3CL1;VEGFA;SCRIB;FGF10;FGF7
prerank,long-term memory (GO:0007616),-0.3186090444973527,-0.9013557435129467,0.5907079646017699,0.8772446633759571,1.0,6/19,19.80%,RASGRF1;CAMK4;LDLR;SGK1;NFATC4;SHANK1
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.32892564745178743,0.9013449653590869,0.5908319185059423,0.9841470218272053,1.0,4/24,9.76%,TXNDC12;WFS1;LPCAT3;PARK7
prerank,multivesicular body organization (GO:0036257),-0.2918764754494855,-0.9011288527053476,0.6320987654320988,0.8770925513697384,1.0,10/31,22.03%,STAM2;IST1;SNF8;RAB11A;TSG101;CHMP2B;CHMP5;STAM;VPS4A;HGS
prerank,regulation of amyloid-beta clearance (GO:1900221),-0.3358800395643914,-0.9009170685343572,0.6041666666666666,0.8769351974553284,1.0,5/16,17.61%,LRP1;HDAC1;ROCK1;IFNGR1;CYP51A1
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.31973548139493113,-0.9007282840543528,0.5704387990762124,0.8766684183857915,1.0,6/19,24.34%,ENPP1;SLC26A2;SLC35B3;PAPSS2;BPNT1;ABHD14B
prerank,histone H3 deacetylation (GO:0070932),0.36462949510549403,0.9005070594070469,0.5892193308550185,0.9854004422002164,1.0,4/15,7.30%,HDAC9;HDAC3;SFPQ;SIRT1
prerank,retinoic acid receptor signaling pathway (GO:0048384),-0.3823909137929415,-0.9005061712918891,0.6095444685466378,0.8764687390028014,1.0,4/10,11.95%,RARB;SNW1;RXRA;RARA
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),-0.34359326930590045,-0.9003772877774731,0.5792682926829268,0.8760512896923509,1.0,3/15,6.18%,EGFR;TEC;DDR1
prerank,regulation of myoblast differentiation (GO:0045661),0.30688839342290203,0.9002344127550013,0.5866209262435678,0.9853036047637046,1.0,5/32,9.59%,XKR8;ZFP36L1;RIPOR2;NOTCH1;PLCB1
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),-0.3330166210408079,-0.8996479263485988,0.6059225512528473,0.8770496050407591,1.0,7/17,19.51%,PBX1;MAML1;NOTCH3;SNW1;PLXND1;MAML2;STAT1
prerank,cytoplasmic microtubule organization (GO:0031122),0.2747935921093604,0.8995951603091681,0.6070336391437309,0.986164465706887,1.0,9/54,7.89%,TUBGCP5;SLK;CIB1;DST;CRIPT;CCDC88C;CLIP2;CAMSAP2;TRPV4
prerank,mitotic nuclear division (GO:0140014),0.2663917773852367,0.8993680672598294,0.6396396396396397,0.9859229737094907,1.0,17/71,17.19%,ABRAXAS1;KIF18A;PPP2R2D;CLASP2;CDCA8;MZT1;KIF2A;CHMP2A;BCCIP;MIS12;KIF3B;CHEK2;ARHGEF10;INO80;STAG2;KPNB1;CLASP1
prerank,regulated exocytosis (GO:0045055),0.23831322210972597,0.8993460021145263,0.6990801576872536,0.9852049295812064,1.0,25/173,11.43%,ABCC4;CDC37L1;SOD1;PECAM1;PPP3CB;MANF;SDF4;NHLRC2;RAB11B;SYNGR2;CYRIB;SELP;SELENOP;F8;ACTN4;VWF;RAB11FIP5;TMED10;LGALS3BP;RAB11FIP2;LYN;GTPBP2;APP;A2M;OLA1
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),-0.22866240586044495,-0.8993254918643914,0.7066246056782335,0.8771106615177421,1.0,34/85,26.76%,DAB2;HECTD1;RNF14;SIRT2;RCHY1;NUPR1;USP13;VCP;CSNK1A1;CSNK1E;GSK3B;TMEM259;DDRGK1;RACK1;RNFT1;RNF19B;KEAP1;DVL1;SOCS5;USP5;STUB1;OSBPL7;PSMC5;DNAJB2;PSMC3;ARIH2;SH3RF2;BAG6;NKD2;NOP53;RNF185;RNF144A;HSPBP1;DDA1
prerank,substrate-dependent cell migration (GO:0006929),0.3657072166009267,0.8993123372072277,0.5889328063241107,0.9845045778243526,1.0,5/14,16.83%,PTPRC;ITGA2;OPHN1;VEGFC;CD2AP
prerank,axoneme assembly (GO:0035082),-0.2870014408281235,-0.8988093572533639,0.594059405940594,0.8776495345472198,1.0,19/30,51.72%,DCX;SPAG1;TTLL3;CCDC39;CFAP74;RP1;TOGARAM1;SPAG16;GAS8;RSPH9;CFAP46;DNAAF3;LRGUK;DRC1;SPAG17;JHY;FOXJ1;CCDC65;DNAAF2
prerank,chromatin organization involved in regulation of transcription (GO:0034401),-0.35655083921952235,-0.8986439762704429,0.5850340136054422,0.8773307140028184,1.0,9/13,45.22%,SERTAD2;ARID1B;PADI2;SERTAD1;ZMIZ2;ELOF1;SPI1;CDCA4;CHEK1
prerank,gliogenesis (GO:0042063),-0.3430917903991919,-0.8982021797032353,0.5875831485587583,0.8776595069602365,1.0,4/15,11.85%,NFIB;RELN;CDK6;ANXA1
prerank,regulation of mitochondrial membrane potential (GO:0051881),-0.26448540944949983,-0.8977488694815821,0.6114130434782609,0.8780159225222196,1.0,15/40,26.65%,PID1;MAPT;VCP;AKT2;SPART;SLC25A36;ATP5IF1;SLC25A33;PINK1;BCL2;STOML2;AKT1;BCL2L1;PRDX3;RNF122
prerank,regulation of neural precursor cell proliferation (GO:2000177),-0.31008645716715955,-0.8975728519568059,0.6,0.8777302422559383,1.0,6/22,16.60%,TAFA1;TOX;APPL2;KDM1A;SLC16A2;NES
prerank,regulation of protein localization (GO:0032880),-0.2436724435038465,-0.8970707712680049,0.6863270777479893,0.8782292804844982,1.0,17/58,21.10%,MAP2;UFL1;CSNK1E;DVL3;AFDN;RAB9A;DZIP1L;CTSD;DLG1;CAMK1;RACK1;KDM1A;DVL1;PARP1;TRIM5;PPM1F;VPS4A
prerank,positive regulation of cell population proliferation (GO:0008284),0.2171271572350053,0.8970622606093348,0.7684449489216799,0.989525975679694,1.0,60/423,13.08%,MAZ;ROMO1;EZH2;LEF1;PTPRC;ACER2;TIAM1;RPL23;DERL2;PRKCH;GREM1;CRLF1;STOX1;MCTS1;TBC1D8;NME1;TSHR;SLC35F6;MEIS1;SINHCAF;CIB1;CDKN1A;TBX1;CHTOP;FBXO5;PIM1;SIRT1;BMI1;RNF187;IRS2;NOTCH1;CNOT7;CDK4;WNT5A;TJP1;RELA;CD47;CSF1R;LYN;MDM2;FZD9;PAK1;CLDN5;ESM1;TRPM4;BAD;TERT;SRPK2;RPS9;CD81;RBPJ;RHOG;FLT1;ACER3;CRKL;PRKCI;DHPS;DOT1L;CUL3;CNOT6
prerank,positive regulation of natural killer cell activation (GO:0032816),-0.35675015483104333,-0.8968368766367821,0.6057494866529775,0.8780498814442369,1.0,3/13,13.39%,AXL;ZBTB1;IL18
prerank,hepaticobiliary system development (GO:0061008),-0.3065109447402483,-0.8967834670568157,0.6067961165048543,0.8774724802322896,1.0,4/20,7.76%,TGFBR3;WNT4;COBL;NIPBL
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.2910448504289432,0.8965995735278686,0.6133768352365416,0.9899294577043596,1.0,19/45,20.74%,EIF2A;GEMIN5;YTHDC1;TSC1;METAP1;NANOS3;MATR3;APP;RBM4B;ATG14;TDRD7;LARP4;CYFIP1;RPL10;RC3H1;LARP1;EIF4E;MTPN;GCNT2
prerank,pyrimidine nucleoside metabolic process (GO:0006213),0.3758214043142007,0.8964514953725409,0.5922509225092251,0.9895236419050681,1.0,3/14,11.13%,UPP1;UPP2;ERH
prerank,regulation of response to oxidative stress (GO:1902882),0.38896597351910434,0.8961876029979859,0.5825049701789264,0.9894306242290501,1.0,2/11,10.96%,STOX1;MCTP1
prerank,lytic vacuole organization (GO:0080171),0.3025625711407356,0.8961345342918088,0.6115702479338843,0.9887634033612915,1.0,10/32,16.65%,LAMTOR1;TPP1;AKTIP;ZKSCAN3;MBTPS1;CLVS1;SNAPIN;TFEB;HOOK3;VPS18
prerank,regulation of cellular response to heat (GO:1900034),0.2653438010769796,0.8955841429140482,0.6296296296296297,0.9893861738828312,1.0,23/77,19.38%,MAPK3;HSPA8;RPTOR;AKT1S1;EP300;BAG1;NUP54;SIRT1;NUP50;CCAR2;CREBBP;FKBP4;NUP35;NDC1;CAMK2G;ATR;HIKESHI;NUP160;POM121;NUP42;YWHAE;NUP133;HSPB8
prerank,tRNA 5'-leader removal (GO:0001682),0.3697846174054293,0.8951433274639642,0.6059479553903345,0.9897273271637266,1.0,3/13,14.97%,RPP25L;POP5;SSB
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.34713763241267265,0.8946907044056678,0.6025408348457351,0.9900808207792621,1.0,5/18,12.83%,RIPOR2;SCAI;RASIP1;ITGA3;CUL3
prerank,mononuclear cell differentiation (GO:1903131),0.3257358201592289,0.8944237122352333,0.6129597197898424,0.9899734350289345,1.0,3/24,9.31%,MT1G;CSF1R;LYN
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.3345255682593883,0.8943990412376729,0.6098807495741057,0.9892619801031097,1.0,2/23,2.43%,SURF4;DERL2
prerank,intermediate filament organization (GO:0045109),-0.3322210656329329,-0.8943834289091921,0.6041666666666666,0.8825598518144887,1.0,10/17,44.05%,VIM;NEFL;GFAP;BFSP2;DES;PKP2;BFSP1;MTM1;DSP;TCHH
prerank,regulation of protein ubiquitination (GO:0031396),0.24837384212779237,0.8940076621878439,0.6620305980528511,0.9894594274426984,1.0,18/108,11.52%,GSK3A;TNFAIP3;PRMT3;BIRC2;HDAC3;UBE3A;WFS1;PTTG1IP;FOXF2;SMAD7;IVNS1ABP;AXIN1;SPRTN;MYCBP2;PARK7;SPOPL;UBQLN1;RPS3
prerank,regulation of small molecule metabolic process (GO:0062012),0.3150502436749425,0.8935556971815439,0.6006944444444444,0.9897756549603554,1.0,5/28,11.08%,MLYCD;PANK2;APOE;SIRT1;ADIPOR1
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.34240355060313166,0.893478497551659,0.6035087719298246,0.9892014098064565,1.0,4/20,10.76%,TRIB3;PRMT3;ASXL3;ERLIN2
prerank,skeletal muscle contraction (GO:0003009),0.34403869973366136,0.8934090183597203,0.605683836589698,0.9885896148735365,1.0,1/19,3.35%,STAC
prerank,negative regulation of platelet activation (GO:0010544),0.35340446327504293,0.892911699800506,0.5950266429840142,0.9890331283394704,1.0,6/16,20.78%,PRKG1;APOE;NOS3;CD9;THBD;PDGFB
prerank,L-glutamate transmembrane transport (GO:0015813),0.3961476804882147,0.8928085829401071,0.6033834586466166,0.9885318960216093,1.0,3/10,12.49%,SLC1A1;SLC1A2;SLC25A12
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",-0.31205135105734416,-0.8925560806192436,0.6111111111111112,0.8861659567068734,1.0,6/21,16.63%,MED13;MED1;MED17;PAXIP1;SETX;JUN
prerank,mitotic cell cycle phase transition (GO:0044772),0.22928965460239523,0.892479496702789,0.7191435768261965,0.9886011295347213,1.0,32/203,14.75%,FBXL6;ALMS1;PLK2;PPP2R2D;HAUS4;HAUS5;CEP41;CLASP2;TUBB;CCNH;DCTN2;CDKN1A;POLE;ODF2;CDK4;WEE1;LATS2;CCNG2;CEP164;ANAPC7;DCTN3;PLCB1;PPP1R12A;CHMP2A;DYNLL1;USP37;E2F3;CUL3;CHEK2;PHF8;RCC1;DYNC1I2
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.3581615547309226,-0.8922295742626939,0.5991379310344828,0.8862589162060202,1.0,5/12,28.89%,PPARA;ABCA5;ABCA1;NR1H2;ITGB3
prerank,chromatin assembly or disassembly (GO:0006333),-0.37269813077578995,-0.8920923080142518,0.611439842209073,0.8858843305184854,1.0,7/11,43.71%,TP53;MTA2;NOC2L;CDAN1;HIRIP3;SUV39H2;CHAF1A
prerank,sensory organ development (GO:0007423),0.27612652266131393,0.8919021521260112,0.6463022508038585,0.9892735641939506,1.0,5/51,4.88%,ATF6;HIPK2;PAX8;SOX2;MEIS1
prerank,negative regulation of neuron differentiation (GO:0045665),-0.3064341279480923,-0.8918437699932144,0.6355140186915887,0.8857826231751802,1.0,4/22,10.56%,CNTN4;BMP7;MED1;GSK3B
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),-0.26801077944716234,-0.8917192939114026,0.6492537313432836,0.8853387476720339,1.0,15/36,24.93%,OGT;WAC;FHIT;CAMLG;PSMF1;DDRGK1;TRIM39;MAP1A;USP7;EIF3H;BAG6;UBXN1;PRKCG;NOP53;AQP11
prerank,regulation of mast cell degranulation (GO:0043304),0.3646993808992321,0.8916238062584243,0.5810055865921788,0.9891860832731538,1.0,3/14,9.52%,SYK;LYN;CD84
prerank,regulation of histone modification (GO:0031056),0.37664093249731834,0.89139488242244,0.5920502092050209,0.9889789731664829,1.0,4/13,9.85%,HPF1;SETD5;PARK7;AKAP8L
prerank,response to lipid (GO:0033993),0.25240683825677174,0.8910960638746881,0.6585714285714286,0.988971874887417,1.0,12/105,12.24%,PCK1;ACER2;TAB2;TIRAP;PAQR8;SELP;PPARD;ERBIN;IFNAR1;ESR1;NOS3;OTUD5
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.25960214978833557,0.8910806787096154,0.6514032496307238,0.9882352835948833,1.0,13/75,14.04%,RGS2;SAG;RGS5;GNG7;METAP2;YWHAB;RGS3;PLCB1;METAP1;USP33;PLEK;RPGRIP1L;ZDHHC7
prerank,calcium ion homeostasis (GO:0055074),-0.22089341973745608,-0.8906908267504526,0.7566666666666667,0.8870712459054088,1.0,7/95,3.53%,ANK2;SLC24A3;HTR2C;STIM2;ATP1B1;STIM1;ATP13A5
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.2465286319888206,0.8903417954290295,0.6783216783216783,0.9893140494949049,1.0,29/124,16.84%,ROPN1;FAM161B;PTPRM;KIFAP3;MANF;CFAP126;APOE;CNTNAP2;DTNBP1;TMEM108;TTC17;MAP4;ODF2;CSF1R;LGI1;LYN;OPHN1;DOCK7;FRY;APP;TBC1D24;PLEK;SNAPIN;TBC1D23;LRP12;PLEKHA1;BLOC1S5;FRYL;CYFIP1
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.3402191256558319,0.8901520014457924,0.6007462686567164,0.9890198803423934,1.0,5/19,12.43%,PRKCH;F11R;TJP1;CLDN5;IKBKB
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.29255484129522347,0.8900714872646822,0.65814696485623,0.9884494451040282,1.0,5/41,10.27%,CIDEA;TNFAIP3;NLRC3;VSIR;NFKBIL1
prerank,snRNA transcription by RNA polymerase II (GO:0042795),-0.23425039654725063,-0.8899817050763343,0.7202380952380952,0.8879780009902982,1.0,40/69,33.08%,RPRD1B;POU2F1;ELL;PHAX;SRRT;GTF2A1;CDK7;CCNT1;POLR2A;SNAPC3;TAF8;INTS10;INTS8;CCNK;INTS11;TAF6;CDK9;GTF2E2;NABP2;GTF2B;INTS7;SNAPC4;NCBP2;TAF13;POLR2K;INTS12;GTF2E1;INTS9;TAF11;POLR2H;INTS3;ZC3H8;NABP1;POLR2G;POLR2F;POU2F2;POLR2C;TAF5;GTF2F1;INTS1
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.3260063775662367,0.8899772326764868,0.634315424610052,0.9879031710199369,1.0,4/24,8.15%,XRCC1;POLK;POLE;POLD3
prerank,positive regulation of acute inflammatory response (GO:0002675),-0.3494408121000261,-0.8898515462406709,0.5962343096234309,0.8875666903524421,1.0,3/14,19.91%,OSMR;IL6ST;PTGS2
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.3070773634490291,0.889566291136403,0.6137931034482759,0.9881478582484251,1.0,5/29,11.08%,PPP2CA;SPRED1;SMAD7;EFNA1;ADIPOR1
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.25473860157605877,0.8895347110094586,0.6755952380952381,0.9874744823281537,1.0,17/80,17.10%,CYCS;RPS6KA1;SRC;MAP2K5;SOX2;CARD16;SYK;SIRT1;USP47;BAD;DDX3X;NOD1;NDUFA13;CD44;GAS6;DELE1;BCAP31
prerank,cellular response to hexose stimulus (GO:0071331),0.3273936130043602,0.8894117386170218,0.600375234521576,0.9870210108548549,1.0,1/23,0.01%,PCK1
prerank,peptidyl-threonine phosphorylation (GO:0018107),-0.24265186948125206,-0.8893367530315299,0.6902173913043478,0.8880154230297823,1.0,16/59,14.50%,TGFBR1;TGFBR2;WNK1;CDC42BPB;ROCK2;CIT;PRKCD;HIPK3;ROCK1;ACVR1;GSK3B;CAMK2D;HIPK1;ACVR1B;WNK3;MAP3K12
prerank,positive regulation of DNA recombination (GO:0045911),-0.2920064394649662,-0.8890869275045699,0.6086956521739131,0.8879151986124778,1.0,7/27,19.21%,ERCC6;PAXIP1;SHLD1;MMS19;ACTR2;PARP1;RIF1
prerank,protein localization to phagophore assembly site (GO:0034497),-0.37255577208093416,-0.8889645315173783,0.6185344827586207,0.887494159028514,1.0,2/11,5.34%,PACS2;WIPI1
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.3987621487917203,0.8887873058857328,0.6129629629629629,0.9878206359100895,1.0,2/10,4.91%,PTPRJ;PTPN12
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.32075208992715876,0.8886816606247191,0.6222961730449251,0.9873148979658829,1.0,8/27,15.68%,GSK3A;FCGR2B;MBOAT1;FBXO7;EFHC2;HOMER1;VPS35;CAMK2G
prerank,cranial nerve development (GO:0021545),-0.3625260960270482,-0.8886720501382095,0.6157112526539278,0.8874823021603666,1.0,9/11,59.65%,SALL1;PAX2;TMEM126A;ERBB3;CHRNB2;TFAP2A;POU4F1;TIFAB;ISL1
prerank,amino acid transmembrane transport (GO:0003333),-0.25644036759722916,-0.8885890120261348,0.6558265582655827,0.8869933467651733,1.0,8/45,11.39%,SLC7A11;SLC6A13;SLC47A1;LRRC8D;SLC25A13;SFXN2;SLC22A4;SLC38A11
prerank,acylglycerol homeostasis (GO:0055090),0.3361446984356703,0.8885455260457358,0.631484794275492,0.9869131506321502,1.0,3/20,11.85%,APOE;PNPLA8;SCARB1
prerank,positive regulation of myoblast differentiation (GO:0045663),0.34772377480735317,0.8882578210588725,0.5879120879120879,0.9868158034508716,1.0,3/16,9.59%,XKR8;RIPOR2;PLCB1
prerank,amyloid-beta metabolic process (GO:0050435),0.34773103454444065,0.8882293341007054,0.6025878003696857,0.9861241302037618,1.0,2/16,4.43%,PSEN2;MME
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),-0.30040811560282116,-0.8881947794113114,0.6348837209302326,0.8872377168423605,1.0,9/24,22.41%,ITGA5;NIBAN2;VTN;GRB10;TMEM204;NEDD4;CADM4;HGS;EMILIN1
prerank,fat cell differentiation (GO:0045444),-0.24416028375517224,-0.8872219484282929,0.6703296703296703,0.8888205179254125,1.0,18/57,23.90%,WNT5B;OSBPL11;PID1;MED1;PPARGC1A;PER2;AKT2;SMAD6;CLIP3;BBS9;BBS2;TMEM120B;TCF7L2;PRDM16;ATF5;OSBPL8;TMEM120A;C1QTNF3
prerank,positive regulation of angiogenesis (GO:0045766),0.2519156155353205,0.8867182849095229,0.7036516853932584,0.9890571749747344,1.0,19/108,12.62%,JMJD8;PDCL3;HIPK2;PRKD2;SMAD1;RAMP2;TEK;RAPGEF3;SIRT1;PLCG1;WNT5A;TJP1;TIE1;CYP1B1;FLT1;NOS3;PIK3CD;SP1;CDH5
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.3569585781400855,0.8864789702362897,0.5942028985507246,0.988916406969991,1.0,5/16,18.51%,CXCL12;CCAR2;RPS3;TMEM161A;FBH1
prerank,erythrocyte differentiation (GO:0030218),0.28718338667234516,0.8863567730446296,0.6386292834890965,0.9884730073468078,1.0,7/44,10.57%,TAL1;ABCB10;HIPK2;RPS14;CEBPG;LYN;MFHAS1
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.37030220287284843,0.8862235760539949,0.598019801980198,0.9880470614478439,1.0,4/13,16.55%,PIK3AP1;EPG5;TNIP2;PIK3R4
prerank,negative regulation of signal transduction (GO:0009968),0.2235215631874273,0.8860331226201321,0.7558569667077681,0.9877188387875486,1.0,21/249,7.11%,SOX30;RGS2;MAZ;SEMA6A;PTPN18;GSK3A;NR4A2;PTPRJ;EZH2;FRZB;PTPRC;TNFAIP3;PTPRE;HEY1;EGFL7;PTPN12;MMRN2;CARD16;YWHAB;PTPRT;BDNF
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.3954773766936711,0.8858059003329156,0.6060606060606061,0.9875634781748384,1.0,3/11,12.03%,CYCS;UQCC3;UQCRB
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.2848800908308355,0.8854896717102262,0.629746835443038,0.9875680315708912,1.0,9/47,13.19%,MAPK3;RAP2A;GREM1;KLHDC10;PHLPP1;SEMA4C;NBR1;MAP4K4;MID1
prerank,axonemal dynein complex assembly (GO:0070286),0.3142153794493683,0.8854126060975768,0.625,0.9870137909061455,1.0,2/27,6.62%,CFAP73;DNAL1
prerank,positive regulation of developmental process (GO:0051094),0.23494452199814497,0.8851478295354374,0.7177097203728362,0.9869080603059253,1.0,23/164,12.16%,LRP8;ANAPC2;RPS6KA1;SHANK3;SRC;CLASP2;APOE;CFL1;SLC6A6;RALA;ARHGEF7;RAPGEF3;FBXO5;SIRT1;DAG1;DDHD1;WNT5A;PLCB1;ZDHHC15;TRPM4;ZBED3;PA2G4;KMT5B
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.29449143421871915,-0.885052221858586,0.6409090909090909,0.892461359987277,1.0,6/23,11.55%,DAB2;ZEB2;SMAD4;SNW1;THBS1;STK11
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.29449143421871915,-0.885052221858586,0.6409090909090909,0.892461359987277,1.0,6/23,11.55%,DAB2;ZEB2;SMAD4;SNW1;THBS1;STK11
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.262182295367737,0.8849128159930044,0.6617647058823529,0.9867148358885081,1.0,11/70,11.87%,GSK3A;BCL2L2;SORT1;TNFRSF10B;TNFRSF1B;CIB1;CRADD;BAD;DDX3X;P2RX7;IFI27
prerank,negative regulation of actin filament polymerization (GO:0030837),0.3264276995639786,0.8847743038268306,0.6223776223776224,0.986289032419855,1.0,4/22,6.40%,PFN1;CYRIB;KANK3;SSH2
prerank,protein auto-ADP-ribosylation (GO:0070213),-0.3558644285609043,-0.8844237253942187,0.6323529411764706,0.893239176776684,1.0,6/12,21.51%,PARP6;PARP3;PARP12;PARP1;PARP16;PARP2
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.28115908664799205,-0.884162619461667,0.6352941176470588,0.8931676143154427,1.0,14/30,27.39%,PARP14;PIBF1;PRKCZ;PRKCD;SRCIN1;SEMA4D;NF2;PTPN2;CADM4;SH3BP5;SH3BP5L;DMTN;SFRP1;INPP5F
prerank,regulation of chromatin organization (GO:1902275),0.35016794504816856,0.884102319270778,0.5925925925925926,0.9872176854670849,1.0,3/14,13.46%,HPF1;SETD5;TLK2
prerank,negative regulation of myotube differentiation (GO:0010832),0.38101240000137304,0.8840129012018425,0.618860510805501,0.9866894229813997,1.0,4/12,13.20%,HDAC3;BDNF;NOTCH1;HDAC5
prerank,negative regulation of blood pressure (GO:0045776),0.369312248437518,0.8834615573592096,0.6014625228519196,0.9873243685662014,1.0,2/13,11.15%,PRCP;NOS3
prerank,positive regulation of peptide hormone secretion (GO:0090277),-0.26075857121326695,-0.8833976508907889,0.6674937965260546,0.8942124915367847,1.0,9/39,16.42%,MCU;NLGN2;GLUD1;RBP4;AIMP1;TM7SF3;NNAT;PSMD9;TCF7L2
prerank,positive regulation of protein processing (GO:0010954),-0.3148494261042314,-0.8833527957915621,0.6077097505668935,0.8936030100676328,1.0,4/19,8.97%,GSN;RHBDD1;CLEC3B;CCBE1
prerank,positive regulation of neuron death (GO:1901216),-0.24869583201565099,-0.8833192054700698,0.6816901408450704,0.892982045059838,1.0,9/46,10.96%,GRIN2B;EFNB2;MAPT;CTNNB1;EPHA7;NUPR1;BACE1;GSK3B;MAP3K5
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.3379451523330415,0.8828108325058758,0.6126126126126126,0.9882113037773721,1.0,5/21,15.56%,TALDO1;RPIA;GPI;PGLS;PGM2L1
prerank,phosphatidylcholine catabolic process (GO:0034638),-0.3733724651906893,-0.8827792393490412,0.6238003838771593,0.8935201546483819,1.0,4/10,31.60%,PLA2G4A;PLA2G6;PLA2G7;PLA2G15
prerank,lipid droplet formation (GO:0140042),0.4017170473204263,0.8827003006732687,0.6121212121212121,0.9877208860269134,1.0,4/10,20.57%,FITM2;AUP1;ZFYVE1;BSCL2
prerank,global genome nucleotide-excision repair (GO:0070911),0.31357941354771507,0.8824036330496752,0.5934819897084048,0.9877128296248119,1.0,3/26,8.79%,ERCC3;ERCC4;GTF2H1
prerank,autophagy of nucleus (GO:0044804),-0.3316910930904047,-0.8822569589652037,0.6119402985074627,0.8939811006041916,1.0,2/16,5.34%,ULK2;WIPI1
prerank,generation of neurons (GO:0048699),0.2301286675201223,0.8820856202837787,0.7377260981912145,0.9877462725555372,1.0,23/190,10.54%,IRX1;EML1;NR4A2;PIN1;HES6;ASTN2;ADGRL3;HEY1;POMGNT2;IER2;MYEF2;FGF13;HEY2;WNT5A;ITM2C;NGRN;PRUNE1;FZD3;CELSR1;OPHN1;ACSL4;DOCK7;NAV1
prerank,regulation of lymphocyte activation (GO:0051249),0.37294413057124937,0.8819761680167527,0.6047904191616766,0.9872600876212457,1.0,12/12,62.73%,PAG1;SIT1;CD4;CD19;LCK;CRTAM;CCL5;THEMIS2;IKZF3;LAT;DCAF15;KAT2A
prerank,phosphatidic acid metabolic process (GO:0046473),-0.2524070515735165,-0.8817004809330449,0.6795580110497238,0.8945725563765983,1.0,6/48,6.34%,PLD1;PLA2G4A;AGPAT4;ABHD5;AGPAT5;DGKH
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.33670665369121155,0.8816752758728884,0.6412639405204461,0.9872544701069671,1.0,4/21,10.81%,STOX1;FBXO5;CDK4;RAD51B
prerank,zinc ion transport (GO:0006829),-0.30834157611365054,-0.8815369322827258,0.6198547215496368,0.8942628870823728,1.0,8/21,25.24%,SLC39A14;SLC30A10;SLC39A13;SLC30A4;SLC39A8;SLC39A7;SLC39A6;SLC30A5
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.38996938318063823,0.881442389884585,0.6165413533834586,0.9870660428621518,1.0,3/11,15.25%,CXCL12;MERTK;GAS6
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.3113449036126034,0.8814328932458253,0.6351118760757315,0.9863512314481869,1.0,8/28,17.79%,TRIB3;TNFRSF10B;SELENOK;AIFM1;DDIT3;DNAJC10;QRICH1;BAX
prerank,neuron differentiation (GO:0030182),0.23238981493470912,0.8812561091249345,0.7437582128777924,0.9860356489210029,1.0,17/165,10.10%,IRX1;ERCC3;NR4A2;PIN1;MANF;PPT1;HS6ST1;IER2;MYEF2;UGCG;EPHA5;WNT5A;ITM2C;NGRN;FZD3;OPHN1;ACSL4
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.339602380717169,0.8807669726261289,0.6368515205724508,0.9864542881120757,1.0,4/19,11.57%,RPTOR;ICE1;NAB2;POLR3F
prerank,cellular response to topologically incorrect protein (GO:0035967),-0.2804816823963602,-0.88060817116524,0.6565420560747663,0.8957597672027137,1.0,6/31,12.78%,PACRG;BAG3;RHBDD1;OPTN;HSF1;TM7SF3
prerank,negative regulation of stem cell differentiation (GO:2000737),0.3756309112455818,0.8805995235959826,0.5939278937381404,0.9861219095600956,1.0,3/12,13.91%,NOTCH1;N4BP2L2;HES1
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),-0.36743170402469727,-0.8802151947701714,0.6209850107066381,0.8959768932381662,1.0,3/11,10.09%,CAB39;BIN1;ACTN2
prerank,sulfur compound transport (GO:0072348),-0.2851629672529149,-0.8799473587983818,0.6709183673469388,0.8959002115513995,1.0,14/27,32.14%,SLC6A13;LRRC8D;SLC26A7;SLC13A4;SLC35F3;SLC27A1;SLC26A11;SLC5A6;SLC25A30;SLC19A2;SLC25A11;MGST1;SLC36A1;SLC25A19
prerank,positive regulation of peptidase activity (GO:0010952),-0.31267317642376435,-0.8798030813707981,0.6666666666666666,0.8955489600208865,1.0,11/20,34.71%,VCP;DDRGK1;RCN3;TANK;PINK1;APH1B;PSME2;PSME3;PSME1;PRELID1;PSENEN
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.21737531488212464,-0.8790583082779537,0.7788461538461539,0.896608583066056,1.0,35/96,24.95%,SRSF5;SRSF11;CASC3;SRSF2;ALKBH5;SRSF6;NUP205;SRSF1;POLDIP3;DDX39B;NXF1;NUP155;NUP188;HNRNPA2B1;SYMPK;NUP88;NUP93;DDX19B;SEH1L;THOC5;SLU7;CDC40;UPF1;RNPS1;NUP85;AAAS;RAE1;CPSF3;NUP37;NUP214;EIF4A3;NCBP2;THOC1;RBM8A;SEC13
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),-0.30948849289160013,-0.87901033932441,0.6233766233766234,0.8960262777913368,1.0,4/18,10.56%,RIMS1;NLGN1;SYN1;GSK3B
prerank,cellular biogenic amine catabolic process (GO:0042402),0.3885188440416349,0.8789743634385718,0.6171428571428571,0.9893123265004126,1.0,2/10,7.90%,SMOX;SLC44A1
prerank,regulation of interleukin-4 production (GO:0032673),0.3270132125460961,0.8788690119496323,0.6117021276595744,0.9888354481162165,1.0,4/21,17.21%,LEF1;SYK;DDIT3;SLC7A5
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.3839470332140402,0.8787894862348757,0.6025878003696857,0.9883050754244634,1.0,5/11,20.29%,SRC;ARHGEF7;CD44;CORO1C;ENPP2
prerank,positive regulation of triglyceride metabolic process (GO:0090208),-0.31794942401224713,-0.8780407959010176,0.621505376344086,0.8975438490838339,1.0,7/16,24.50%,ABHD5;LDLR;SLC27A1;GPLD1;SREBF1;CTDNEP1;NR1H2
prerank,positive regulation of reproductive process (GO:2000243),-0.2712481537328296,-0.8780381715094919,0.6727272727272727,0.8968463783508202,1.0,5/31,12.18%,SMURF2;SIRT2;LHFPL2;GLRA1;ACVR1B
prerank,cellular response to purine-containing compound (GO:0071415),-0.3838665857976322,-0.8780100245738266,0.6491228070175439,0.896216860045912,1.0,6/10,41.44%,RYR3;P2RY1;GSTM2;TRPM2;P2RY6;CASQ2
prerank,glycosphingolipid metabolic process (GO:0006687),0.28160136974973454,0.8778843344279595,0.64,0.9897229583670665,1.0,6/42,6.57%,GLB1;SMPD4;ST6GALNAC3;ESYT2;UGCG;ST8SIA1
prerank,response to purine-containing compound (GO:0014074),-0.32542099514460193,-0.8777252195103219,0.6510538641686182,0.8961659039890639,1.0,9/17,40.77%,P2RX4;ABCC9;STAT1;DGKQ;TRPC3;P2RY1;TRPM2;P2RY6;VGF
prerank,histone H4-K16 acetylation (GO:0043984),0.3360053321091652,0.8776617375955457,0.6064638783269962,0.9895243568345311,1.0,7/19,18.81%,JADE3;ING4;KANSL2;KANSL3;HCFC1;MSL2;MSL3
prerank,protein glycosylation (GO:0006486),-0.21083247102104677,-0.8776308521395956,0.8333333333333334,0.895675809425395,1.0,37/125,26.26%,MGAT4C;MAN1C1;OGT;PLOD2;B4GALT1;TET1;FUT8;POFUT1;TRAK1;PMM2;ALG9;GOLGA2;PLOD1;FUT10;DPM1;LARGE1;FKTN;B3GALT5;SLC39A8;ST3GAL4;B3GALNT1;MAGT1;ENTPD5;B3GALT1;ST8SIA2;ALG5;ALG10B;C1GALT1C1;ALG11;GFPT1;STT3A;GAL3ST1;SERP1;AQP11;GFPT2;ALG12;KRTCAP2
prerank,aorta morphogenesis (GO:0035909),0.3478603058184426,0.8773059252574176,0.6307977736549165,0.9896738780402997,1.0,5/17,10.80%,HEY1;TBX1;HEY2;ACVRL1;RBPJ
prerank,response to endoplasmic reticulum stress (GO:0034976),0.24184875010444493,0.8768205186694852,0.7060478199718706,0.9900975302174616,1.0,25/107,18.48%,ATF3;TRIB3;ATF6;EIF2S1;GORASP2;UFC1;ATP2A2;TNFRSF10B;WFS1;SELENOK;MBTPS1;AIFM1;HYOU1;UBQLN1;DDIT3;ERP44;DNAJC10;QRICH1;RASGRF2;TMTC3;BCAP31;BAX;DNAJB9;CCDC47;PDIA4
prerank,positive regulation of calcium ion import (GO:0090280),0.37657321926014864,0.876115609649402,0.6238185255198487,0.9910367133715774,1.0,1/12,2.58%,CXCL12
prerank,cellular response to oxygen-containing compound (GO:1901701),0.22041396069613975,0.876071743943807,0.792814371257485,0.9904121184438673,1.0,39/291,13.08%,CERS1;MAPK3;ROMO1;BRINP3;INSIG1;TNFAIP3;RUVBL2;ACTB;RPTOR;TIRAP;MTR;SBNO2;ZFP36L1;TSHR;CCDC62;TNFRSF1B;ZFAND1;MAPK8;TBX1;CARD16;RET;GNB1;LAMTOR1;RAPGEF3;WNT5A;RELA;LYN;NFKBIL1;ESR1;P2RX7;RPS3;IP6K2;PLAA;TNIP2;LARS1;CHUK;RRAGC;CD274;NDUFA13
prerank,synaptonemal complex assembly (GO:0007130),-0.33637476472175254,-0.8760337496691548,0.6289592760180995,0.8978614985639577,1.0,12/15,64.38%,BAG6;RAD21;P3H4;TEX11;REC8;TRIP13;SYCE2;TEX12;STAG3;SYCP2;RAD21L1;HORMAD1
prerank,synaptonemal complex organization (GO:0070193),-0.33637476472175254,-0.8760337496691548,0.6289592760180995,0.8978614985639577,1.0,12/15,64.38%,BAG6;RAD21;P3H4;TEX11;REC8;TRIP13;SYCE2;TEX12;STAG3;SYCP2;RAD21L1;HORMAD1
prerank,macrophage differentiation (GO:0030225),-0.34679330794746455,-0.875921790048757,0.6434599156118144,0.8974544860801474,1.0,5/13,22.30%,BMP4;IL31RA;CDC42;PARP1;VEGFA
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.32156265663344774,-0.8757655412628796,0.6556291390728477,0.8970953934360988,1.0,3/16,20.39%,CLDN11;CLDN14;CLDN12
prerank,response to interferon-beta (GO:0035456),0.3257158385641949,0.8757135781085514,0.6307692307692307,0.9905325375802254,1.0,5/22,13.08%,IFITM2;XAF1;IFITM3;IFITM1;NDUFA13
prerank,positive regulation of transport (GO:0051050),0.24794187257149386,0.8752443392525361,0.6772334293948127,0.9909365418508119,1.0,10/85,9.09%,GSK3A;FCGR2B;ACTB;CAMK1D;NEDD4L;LMAN2;APOE;ZNF205;MERTK;CD47
prerank,renal absorption (GO:0070293),-0.3736552187663662,-0.8752427269482284,0.6443514644351465,0.8975987629046419,1.0,3/10,10.22%,GSN;WNK4;SGK1
prerank,regulation of RNA splicing (GO:0043484),0.25986534424938035,0.8747183588910686,0.6742770167427702,0.9914496818419662,1.0,11/69,7.96%,KHDRBS3;RBM22;HNRNPH2;SF1;QKI;HNRNPK;FAM50A;SRSF10;RBM20;RPS26;YTHDC1
prerank,positive regulation of immunoglobulin production (GO:0002639),0.30125971409426405,0.8746110744929301,0.6588628762541806,0.9909608250201482,1.0,9/31,21.31%,PTPRC;PHB2;GPI;KMT5B;DNAJB9;TFRC;XBP1;KMT5C;STX4
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.26419654118911784,-0.8744573914656953,0.6778350515463918,0.8986941639273942,1.0,17/39,23.24%,RIOK1;RIOK2;NOL11;DDX52;RPS7;RPS16;RPS6;NOM1;UTP4;RPS17;NOB1;RIOK3;NOP14;WDR3;LSM6;METTL17;RRP36
prerank,cellular response to ionizing radiation (GO:0071479),-0.2520073769175461,-0.8742448443868421,0.7214854111405835,0.8984825968824529,1.0,19/47,23.20%,SPIDR;MAPK14;MAP3K20;NIPBL;TNKS1BP1;TP53;HSF1;NUCKS1;RHOB;GRB2;ATM;KDM1A;TANK;CRYAB;BLM;TMEM109;INTS7;YAP1;RAD9B
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.35918717515533183,0.8740123594505651,0.626641651031895,0.9916882492029576,1.0,2/13,5.79%,ALG6;ALG8
prerank,nucleotide catabolic process (GO:0009166),-0.32463270366411795,-0.8739333913737629,0.6255411255411255,0.8984590522182097,1.0,9/16,38.20%,VCP;XDH;DERA;NUDT3;ITPA;GPX1;GDA;NT5C;NT5C1A
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.2771795753175629,0.8735024839059137,0.6575121163166397,0.99218675639225,1.0,9/44,13.79%,EBP;INSIG1;HMGCR;SC5D;OSBPL1A;PARK7;HSD17B4;ACOT8;OSBPL2
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.29025218207397846,0.873491152030373,0.6851549755301795,0.9914714631016038,1.0,7/38,13.61%,TNFAIP3;RFFL;TNFRSF10B;ICAM1;DDX3X;NOS3;FAIM
prerank,aspartate family amino acid catabolic process (GO:0009068),0.3388598511392758,0.8733729072669566,0.6231884057971014,0.9909989879097796,1.0,3/19,9.70%,AASS;GOT2;PHYKPL
prerank,regulation of intracellular signal transduction (GO:1902531),0.2121567100808987,0.8733531920449363,0.8245412844036697,0.990303288540216,1.0,75/420,14.47%,RAC2;PRKAR1A;MAPK3;PIN1;TIAM1;VAV3;ARHGEF26;CHN2;HIPK2;MCF2L;RFFL;PRKD2;BIRC2;PPP1R16B;ITSN1;TEK;RAD1;SPRED1;SGMS1;ARAP2;EP300;ARHGAP25;RPL5;ARHGEF6;TRAF5;PAK3;ARHGEF7;TRIO;ATP6AP2;VWF;ARHGEF18;MINK1;GNA12;WNT5A;MYO9A;PHLPP1;TRAF3;RELA;LYN;MDM2;FAM13A;PJA2;TTC5;PAK1;RHOQ;OPHN1;TAF15;TMBIM4;PRKAA2;ING2;ARHGAP39;RHOG;HUS1;A2M;GNAI1;TOP3A;ARHGAP23;MYO9B;MAP4K4;PAK1IP1;TAF4B;NBN;CHD3;TBP;PTPMT1;RRAGC;ING5;DEPDC1B;CHEK2;MAP2K6;NFKBIA;ARHGAP15;CSNK2A2;RMI1;SYDE1
prerank,neuron projection regeneration (GO:0031102),0.3829903752489481,0.873315744559993,0.5777777777777777,0.9896554117198315,1.0,1/10,2.94%,MTR
prerank,regulation of wound healing (GO:0061041),-0.25877529946538513,-0.8729807552369301,0.6990291262135923,0.8998914559646506,1.0,16/42,31.78%,OCLN;SRSF6;VTN;EPHB2;ANXA1;PTK2;AJAP1;CD109;CADM4;ADRA2A;DMTN;SERPINE1;HBEGF;MYLK;CLDN1;CAV1
prerank,positive regulation of type 2 immune response (GO:0002830),-0.3368764901452147,-0.8727764590839512,0.6391304347826087,0.8996358718693308,1.0,3/14,13.39%,PRKCZ;RARA;IL18
prerank,positive regulation of lipid transport (GO:0032370),0.3741344300711029,0.8721343372685347,0.6076923076923076,0.9917228078456997,1.0,2/12,5.62%,APOE;DBI
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.29227690897833297,-0.8720225909093935,0.6460807600950119,0.9006279252298954,1.0,8/23,16.23%,PRKAG2;BMP7;CEMIP;CAB39;TNKS1BP1;WNK3;UBE2K;TGFB1
prerank,cell cycle G2/M phase transition (GO:0044839),0.23727784169748925,0.8720119935346089,0.7267683772538142,0.9913036843083752,1.0,17/129,10.48%,FBXL6;ALMS1;HAUS4;HAUS5;CEP41;TUBB;CCNH;DCTN2;CDKN1A;ODF2;WEE1;CEP164;DCTN3;PLCB1;AKAP8L;PPP1R12A;DYNLL1
prerank,gene silencing by miRNA (GO:0035195),-0.27440771429263916,-0.8718955587139319,0.6763285024154589,0.9002224744079781,1.0,8/32,14.25%,ZC3H7A;PUM1;ZC3H7B;PUM2;AGO3;RBM4;LIMD1;DICER1
prerank,interstrand cross-link repair (GO:0036297),-0.2411005175780436,-0.8716484532815437,0.7185792349726776,0.9000802789152167,1.0,34/53,45.06%,VCP;RNF168;RPA1;UBC;RNF8;NUCKS1;MCM9;FANCE;FAN1;USP1;ATRIP;SLX4;POLN;DCLRE1A;FAAP100;MSH6;FANCC;ERCC1;MUS81;FANCI;FAAP20;RPA3;XPA;FANCB;UBA52;FANCD2;FANCG;NEIL3;MCM8;RPA2;EXO5;RAD51;RAD51AP2;CENPX
prerank,sodium-independent organic anion transport (GO:0043252),-0.37219570724117057,-0.8714657972632885,0.6476578411405295,0.8997844949688216,1.0,1/10,0.94%,SLCO3A1
prerank,autophagy of mitochondrion (GO:0000422),0.291633488620477,0.8711861176280535,0.6582491582491582,0.9925055305921446,1.0,19/38,22.29%,MAP1LC3B;PHB2;FBXO7;CISD2;ATG7;ATG14;GABARAPL1;ATG13;BNIP3;BECN1;GABARAP;ULK1;WDR45B;ATG2B;FUNDC1;USP30;ATG12;SQSTM1;GABARAPL2
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.2864660014319185,0.871080094042439,0.6621848739495798,0.9920398006996008,1.0,5/39,8.79%,ERCC3;ERCC4;POLK;POLD3;GTF2H1
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.3291378397467402,0.8709470690839484,0.6321243523316062,0.9916119170676433,1.0,2/19,6.21%,TNFAIP3;CARD16
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.30663737513172895,0.8709467924872102,0.6468531468531469,0.9908768452240053,1.0,8/29,18.10%,UTP20;RPS21;RPS14;NGDN;HELB;HEATR1;DCAF13;RPS8
prerank,regulation of tube diameter (GO:0035296),0.366244594902041,0.8704702749495804,0.6428571428571429,0.9905437185267315,1.0,3/13,11.15%,GCLC;GCLM;NOS3
prerank,vascular process in circulatory system (GO:0003018),0.366244594902041,0.8704702749495804,0.6428571428571429,0.9905437185267315,1.0,3/13,11.15%,GCLC;GCLM;NOS3
prerank,negative regulation of developmental process (GO:0051093),-0.23440679075572,-0.8702923478588293,0.7359050445103857,0.9016052127749026,1.0,12/69,9.85%,DCC;NFIB;PTPRS;MAPT;BMP4;ROCK2;ROCK1;FOXC1;ANP32B;BCL11A;HUWE1;CDK6
prerank,peptide catabolic process (GO:0043171),0.32061467064201943,0.8701625887961978,0.6419965576592083,0.9905438920248578,1.0,1/23,0.22%,LVRN
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.3015344192705333,-0.8700565011641409,0.6194503171247357,0.9014197683571299,1.0,10/20,24.31%,BICD1;MGRN1;GRK3;RNF157;GPRASP1;CRY1;STMN1;MET;GRK2;APLP1
prerank,spliceosomal complex assembly (GO:0000245),0.2760913906653235,0.8691730469830407,0.6640378548895899,0.992193047108059,1.0,8/46,10.59%,SNRPD2;NCBP1;SNRPD1;SF1;SRSF10;YTHDC1;SF3A1;SRPK2
prerank,prostaglandin biosynthetic process (GO:0001516),-0.30991103592104485,-0.8691109678350587,0.6598639455782312,0.9028931148386669,1.0,3/18,7.23%,PLA2G4A;PTGDS;PTGIS
prerank,DNA geometric change (GO:0032392),-0.29098348923159584,-0.8687771251249881,0.6459770114942529,0.9029304722257715,1.0,10/24,21.24%,DDX1;RAD50;HNRNPA2B1;MRE11;ANXA1;MCM9;BLM;SUPV3L1;RECQL;RTEL1
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),-0.3431680869266499,-0.8685710988054575,0.6305309734513275,0.9026821123242228,1.0,3/13,13.37%,CYFIP2;LGMN;TBC1D10A
prerank,cellular response to DNA damage stimulus (GO:0006974),0.21376477605615476,0.8684483248308177,0.8092967818831943,0.9931941117580023,1.0,60/336,15.84%,ERCC3;ZRANB3;RAD18;MAPK3;TRIM28;SLF1;ACER2;VAV3;PNKP;BCL2L2;UBA1;ERCC4;RAD1;RBBP6;YY1;TNFRSF1B;HPF1;CIB1;POLK;CDKN1A;APLF;SIRT1;USP47;AKTIP;GTF2H1;SPRTN;POLA1;LYN;RFWD3;MSH3;PAK1;PARK7;ALKBH7;SUSD6;CHCHD6;RAD51B;APTX;HUS1;RPS3;KMT5B;PWWP3A;NBN;MAPK12;DOT1L;HELB;TRRAP;CHEK2;DDIT3;TLK2;MAP2K6;APC;FANCL;UBA6;BACH1;INO80;UBQLN4;DYRK2;TAF1;BCL6;ATR
prerank,mitochondrion localization (GO:0051646),-0.308573334468556,-0.8682064018195269,0.6600441501103753,0.9028008816099444,1.0,13/19,48.70%,TRAK1;NECTIN2;MFN1;ATCAY;MARK2;MSTO1;BRAT1;MUL1;TRAK2;MEF2A;MTM1;TLE6;HAP1
prerank,protein localization to condensed chromosome (GO:1903083),0.37378257565649864,0.8681941088078262,0.6171003717472119,0.9930491800022514,1.0,3/12,14.59%,CHAMP1;MIS12;MTBP
prerank,positive regulation of double-strand break repair (GO:2000781),-0.25857784187978444,-0.867753071792156,0.7066666666666667,0.9030888739122304,1.0,13/39,21.13%,SPIRE1;SPIDR;FMN2;ERCC6;SHLD1;MGMT;PARP3;MMS19;ACTR2;PARP1;RIF1;SMCHD1;DTX3L
prerank,serine family amino acid metabolic process (GO:0009069),0.3471350425939588,0.8672895440982538,0.6446124763705104,0.9944349580885404,1.0,1/16,0.78%,GCLC
prerank,positive regulation of ATPase activity (GO:0032781),-0.2557306304749275,-0.8672550463254164,0.7002583979328165,0.9035111548312947,1.0,8/41,9.90%,TOR1AIP2;ATP1B1;TPM1;DNAJC24;ATP1B3;TOR1AIP1;ATP1B2;PLSCR1
prerank,positive regulation of transmembrane transport (GO:0034764),0.37236647942722845,0.8668760852394294,0.6345454545454545,0.9946738485683335,1.0,5/13,17.58%,ACSL5;CA2;P2RX7;BRAF;C2CD5
prerank,N-glycan processing (GO:0006491),-0.31519439635735214,-0.866837599367756,0.648471615720524,0.9037317135927505,1.0,4/18,10.81%,MAN1C1;FUT8;GANC;MAN2A2
prerank,response to muscle stretch (GO:0035994),-0.32626544373149696,-0.8668159423987365,0.6644144144144144,0.9030887431761568,1.0,2/15,3.91%,GSN;CTNNB1
prerank,tRNA transport (GO:0051031),0.29371638718768317,0.8668136761493743,0.697560975609756,0.9940748381643469,1.0,11/35,19.26%,TOMM20;NUP54;NUP50;NUP35;YBX1;SSB;NDC1;NUP160;POM121;NUP42;NUP133
prerank,response to iron ion (GO:0010039),-0.3506794883118106,-0.8664552547951224,0.6268343815513627,0.9031817602625681,1.0,1/12,0.22%,BMP6
prerank,prostaglandin metabolic process (GO:0006693),-0.2819296729847927,-0.8664376681061148,0.6619718309859155,0.9025393292085805,1.0,8/26,27.59%,PLA2G4A;PTGDS;PTGIS;PTGES;PTGS2;GSTM1;TBXAS1;HPGDS
prerank,cellular response to inorganic substance (GO:0071241),-0.29909887411418484,-0.8658359702798301,0.6829268292682927,0.9031729281287404,1.0,11/21,38.99%,KCNC2;SPIDR;DDI2;RTF2;BLM;GUCY1B1;CDK2;DDX11;NSMCE3;TIMELESS;MT3
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.2858274290309712,0.8655354841785915,0.6824644549763034,0.9963714647249663,1.0,8/39,13.12%,DYNC1I1;MYO5A;ACTN4;TANC2;RAB1A;MYO1D;PPFIA2;MYO1E
prerank,cellular response to decreased oxygen levels (GO:0036294),0.2584435345666461,0.8654632949375933,0.6986301369863014,0.9958169494723342,1.0,16/65,13.25%,HIPK2;ZFP36L1;SCN2A;CARD16;RGCC;SIRT1;TSC1;MDM2;BAD;TERT;HYOU1;HP1BP3;UBQLN1;EGLN2;BNIP3L;EPAS1
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.28019538598932375,0.8653427139910319,0.6526655896607432,0.9953328352326501,1.0,8/40,10.35%,SMG1;FXR1;FBXO5;UBE2V2;BCLAF1;RFWD3;UBE2V1;ING2
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.37130708294393544,0.8648814780085333,0.616600790513834,0.995616991936433,1.0,4/12,16.15%,CCT2;CCT5;TCP1;DKC1
prerank,response to muramyl dipeptide (GO:0032495),-0.35392033465748507,-0.864788998759933,0.6252676659528907,0.9048010977840292,1.0,4/12,18.87%,VIM;TRIM41;PTPN22;CHMP5
prerank,carbohydrate derivative transport (GO:1901264),0.3324545888487601,0.8647241788404398,0.6441281138790036,0.9952860651644129,1.0,7/18,20.15%,SLC10A7;SLC29A1;SCARB1;NPC2;PLTP;ABCG1;SLC15A2
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.31677785638925365,0.8646971280314493,0.6592465753424658,0.9946164696348155,1.0,2/23,2.03%,CBL;PTPRC
prerank,positive regulation of calcium-mediated signaling (GO:0050850),-0.36339620487680274,-0.8646743080385355,0.630901287553648,0.9043624955999819,1.0,1/11,4.75%,P2RX4
prerank,regulation of brown fat cell differentiation (GO:0090335),-0.3226630812663799,-0.8646436531728516,0.6548117154811716,0.9037408639026286,1.0,8/16,21.78%,BMP7;RREB1;NAPEPLD;VSTM2A;SIX1;PTGS2;TFE3;FLCN
prerank,regulation of histone H3-K9 methylation (GO:0051570),-0.3725593056302354,-0.8645814964981701,0.6502057613168725,0.9031750724862381,1.0,4/10,19.28%,JARID2;KDM1A;RIF1;DNMT1
prerank,pyrimidine nucleoside catabolic process (GO:0046135),0.3845413550918636,0.8645687524997995,0.6329588014981273,0.9942140428032236,1.0,2/10,9.50%,UPP1;UPP2
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.2825959440439009,-0.8645115621152288,0.667458432304038,0.9026349959420183,1.0,9/25,33.26%,SMAD3;P2RX4;DDAH1;PTGS2;AKT1;HSP90AA1;DDAH2;ASS1;EDN1
prerank,cyclooxygenase pathway (GO:0019371),-0.36540880972799417,-0.8642133336293639,0.6388888888888888,0.9026138859942143,1.0,6/10,27.59%,PTGDS;PTGIS;PTGES;PTGS2;TBXAS1;HPGDS
prerank,positive regulation of protein sumoylation (GO:0033235),0.3864575270465621,0.8641175895620632,0.6276391554702495,0.9945768509704432,1.0,3/10,11.39%,SAE1;UBA2;PIAS1
prerank,regulation of microtubule depolymerization (GO:0031114),0.3119758144161813,0.8640150658818704,0.658578856152513,0.9940957687599765,1.0,6/25,7.89%,CLASP2;MAP1S;CIB1;FGF13;CAMSAP2;TRPV4
prerank,negative regulation of JNK cascade (GO:0046329),-0.2674255346102748,-0.8639134523427816,0.7044917257683215,0.9025945196396395,1.0,8/31,14.82%,CYLD;TAOK3;HIPK3;PER1;SIRPA;FKTN;DACT1;PTPN22
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),-0.3320015605427637,-0.8638981407605559,0.6363636363636364,0.9019569136766433,1.0,8/15,45.89%,IL17RA;GBP5;APPL1;IL17D;TICAM1;NOD2;MYD88;TLR4
prerank,regulation of protein-containing complex disassembly (GO:0043244),-0.3204506987265309,-0.8636939712099292,0.6554809843400448,0.9017654656930767,1.0,7/16,29.45%,OGFOD1;IRAK3;UPF1;CLN3;SHFL;HDAC6;MTRF1
prerank,mesenchymal to epithelial transition (GO:0060231),-0.3772966009388855,-0.8633177514762794,0.6652977412731006,0.9018953549680485,1.0,5/10,24.84%,BMP4;SALL1;FZD7;BASP1;PAX2
prerank,establishment of apical/basal cell polarity (GO:0035089),0.35983153913496924,0.8631517971640669,0.6460674157303371,0.995463300457184,1.0,4/14,14.26%,RAP2A;MYO9A;OPHN1;PATJ
prerank,C21-steroid hormone metabolic process (GO:0008207),0.3310391715403695,0.8629412181800397,0.6449912126537786,0.9952130936467126,1.0,3/20,15.93%,TSPO;STARD3NL;STARD3
prerank,lipid homeostasis (GO:0055088),0.26200338415736035,0.8627049903849128,0.7129485179407177,0.995028392902581,1.0,9/57,11.52%,FITM2;APOE;ACOX3;USF2;SIRT1;IRS2;PRKAA2;DDX3X;PNPLA8
prerank,protein-containing complex subunit organization (GO:0043933),0.23925141113057952,0.8626751738723706,0.7170868347338936,0.9943657251993971,1.0,27/109,17.73%,SH3BGR;CAPZA2;KIFAP3;SKAP2;NDUFAF1;KPNA3;NUP54;MAGI1;GEMIN5;SLC2A1;MDM2;TFAP4;CREBBP;ELOB;PICALM;NUP35;APC;HES1;PARD3;NDC1;DNM1L;PTK2B;TUBGCP2;LIN7A;CD2AP;CAPZA1;ST13
prerank,iron ion transport (GO:0006826),-0.24404616997037537,-0.8626624498258566,0.7351351351351352,0.9026154655233571,1.0,9/47,12.83%,CP;ATP6V1E1;ATP6V0B;SLC39A14;SCARA5;TCIRG1;ATP6V0A4;STEAP3;ATP6V0C
prerank,cellular amide metabolic process (GO:0043603),0.242554549729816,0.86238184662592,0.7399165507649513,0.9943206315310515,1.0,10/102,6.76%,ALDH1L1;MLYCD;PPP2CA;PANK2;MME;PLAAT3;DBI;MTHFS;GPAT4;PLPP1
prerank,cilium movement (GO:0003341),0.27762739352017285,0.8623790283431428,0.6908517350157729,0.9936024051251872,1.0,2/47,2.17%,CFAP73;CABYR
prerank,pinocytosis (GO:0006907),0.3902625763889818,0.8622988587571849,0.6365422396856582,0.9930767638252618,1.0,1/10,3.22%,PPT1
prerank,positive regulation of phosphate metabolic process (GO:0045937),-0.28708531280735744,-0.8620511041618316,0.6829268292682927,0.9032483797119186,1.0,5/25,11.33%,EGFR;NRP1;DSCAM;THBS1;ILK
prerank,detection of light stimulus involved in sensory perception (GO:0050962),-0.3638475799303971,-0.8620391506191944,0.6646586345381527,0.901917511282572,1.0,4/10,49.08%,CEP250;CACNA2D4;TULP1;CNGB1
prerank,detection of light stimulus involved in visual perception (GO:0050908),-0.3638475799303971,-0.8620391506191944,0.6646586345381527,0.901917511282572,1.0,4/10,49.08%,CEP250;CACNA2D4;TULP1;CNGB1
prerank,regulation of neuron death (GO:1901214),0.2480937816934734,0.8618613215564785,0.7163958641063516,0.9933631861605372,1.0,14/82,11.92%,SNCG;EIF2S1;FCGR2B;SIGMAR1;FYN;TNFRSF1B;AKT1S1;WNT5A;TSC1;PARK7;NAE1;EGLN2;PICALM;PRNP
prerank,RNA export from nucleus (GO:0006405),-0.21259734329851057,-0.8618083514269017,0.8096774193548387,0.9017150497596541,1.0,36/100,24.95%,SRSF5;SRSF11;CASC3;SRSF2;ALKBH5;SRSF6;NUP205;SRSF1;POLDIP3;DDX39B;NXF1;NUP155;NUP188;HNRNPA2B1;SYMPK;HNRNPA1;NUP88;NUP93;DDX19B;SEH1L;THOC5;SLU7;CDC40;UPF1;RNPS1;NUP85;AAAS;RAE1;CPSF3;NUP37;NUP214;EIF4A3;NCBP2;THOC1;RBM8A;SEC13
prerank,histone H3-K9 demethylation (GO:0033169),0.3781347705974111,0.8615518617998027,0.6266173752310537,0.9933520423498609,1.0,6/11,19.49%,KDM3A;KDM4D;JMJD1C;PHF8;KDM4C;KDM3B
prerank,positive regulation of establishment of protein localization (GO:1904951),0.3318708895948878,0.8610967544888495,0.6319702602230484,0.9936682696234155,1.0,5/18,16.15%,CCT2;CCT5;CORO2B;TCP1;DKC1
prerank,megakaryocyte differentiation (GO:0030219),0.37881141076284114,0.8606845634008422,0.6186131386861314,0.9938485650933746,1.0,1/11,1.49%,TAL1
prerank,pentose-phosphate shunt (GO:0006098),0.38035440643957774,0.8605846044889852,0.6285140562248996,0.9933616315438664,1.0,3/11,11.57%,TALDO1;RPIA;PGLS
prerank,negative regulation of ossification (GO:0030279),0.3121866137192398,0.8604917998961847,0.6522522522522523,0.9928542873633558,1.0,6/23,16.35%,GREM1;NOTCH1;TRPM4;RBPJ;PTK2B;LRP4
prerank,cortical actin cytoskeleton organization (GO:0030866),0.3252292366987301,0.8604369702488173,0.6389891696750902,0.9922520638389511,1.0,6/20,17.01%,LCP1;RHOQ;IKBKB;PLEK;ARF6;STRIP1
prerank,carboxylic acid metabolic process (GO:0019752),-0.2654264455174521,-0.8603718485722827,0.7131578947368421,0.9040934697997175,1.0,5/33,7.23%,PLA2G4A;DDO;GLUD1;CYB5A;PTGIS
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.2920604378350969,0.8601747641909373,0.6947723440134908,0.9921258006555064,1.0,8/33,11.12%,GPAM;EP300;AXIN1;PKN1;PARK7;RNF6;ESR1;CARM1
prerank,protein mannosylation (GO:0035268),0.32403014913209727,0.8601424419151262,0.6537102473498233,0.991478882993097,1.0,5/22,12.45%,TMTC2;POMGNT2;DPY19L4;DPY19L1;CRPPA
prerank,cholesterol homeostasis (GO:0042632),0.2601724136211954,0.8600825542884659,0.7113095238095238,0.9909098836305118,1.0,10/64,13.55%,INSIG1;HDAC9;APOE;SOAT1;LAMTOR1;SIRT1;SCARB1;LDLRAP1;NPC2;NPC1
prerank,mRNA 3'-end processing (GO:0031124),-0.22075213351165196,-0.8600261241949256,0.8096590909090909,0.9041198502608024,1.0,27/78,24.61%,SRSF5;SRSF11;PABPN1;CASC3;RPRD1B;SRSF2;SRSF6;SRSF1;POLDIP3;DDX39B;CSTF3;CDC73;SYMPK;CSTF2;THOC5;SLU7;PAF1;CDC40;RNPS1;GRSF1;CPSF3;PABPC1;EIF4A3;NCBP2;TUT1;THOC1;RBM8A
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.36315094659945657,0.8595926987747123,0.6788461538461539,0.9913121805195797,1.0,5/13,17.79%,BAD;BMF;BNIP3L;BNIP3;BAX
prerank,regulation of dendritic spine development (GO:0060998),0.33118484927410063,0.8595444679172921,0.6501831501831502,0.990710614035024,1.0,5/19,15.57%,SHANK3;APOE;TANC2;PPFIA2;ARF6
prerank,chromatin-mediated maintenance of transcription (GO:0048096),-0.35578388674794825,-0.8592193168892656,0.6593886462882096,0.9051239097244601,1.0,8/11,45.22%,SERTAD2;ARID1B;PADI2;SERTAD1;ZMIZ2;ELOF1;CDCA4;CHEK1
prerank,ether lipid metabolic process (GO:0046485),0.36090585413760234,0.8590862643200186,0.6321626617375231,0.9910238395698217,1.0,5/14,14.30%,PLAAT3;PEDS1;PEX7;AGPS;GNPAT
prerank,sterol homeostasis (GO:0055092),0.2588479521744483,0.8587162260883815,0.7083333333333334,0.9911273236146464,1.0,10/65,13.55%,INSIG1;HDAC9;APOE;SOAT1;LAMTOR1;SIRT1;SCARB1;LDLRAP1;NPC2;NPC1
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),-0.23568591008698767,-0.8584904391648643,0.7487046632124352,0.9060391085818342,1.0,15/55,21.96%,TGFBR1;CYLD;NUPR1;PML;GSDME;FIS1;BCL2L11;TP53;TRIM39;RACK1;TRAF2;TRAF7;BCL2;LTBR;TNFSF12
prerank,carboxylic acid transport (GO:0046942),0.26504846060353826,0.8583947190509346,0.6851851851851852,0.9911886996365381,1.0,5/55,5.53%,SLC7A8;SLC1A1;SLC36A4;SLC3A2;SLC6A6
prerank,regulation of leukocyte activation (GO:0002694),0.35735934035537287,0.8582040348940142,0.6413662239089184,0.9909309351455249,1.0,3/14,10.57%,LYN;PJA2;MFHAS1
prerank,protein sumoylation (GO:0016925),0.270418336242007,0.8581336656941729,0.6919504643962848,0.9903658477780471,1.0,16/49,19.26%,TRIM28;SAE1;UBE2I;NUP54;UBA2;NUP50;PIAS2;TRPM4;PIAS1;NUP35;NDC1;NUP160;POM121;RANGAP1;NUP42;NUP133
prerank,positive regulation of DNA binding (GO:0043388),-0.2649474471439467,-0.8580937575565755,0.7198177676537585,0.9061698989101707,1.0,7/31,16.23%,IGF1;SIRT2;SKI;FOXC1;NIBAN2;NGF;TGFB1
prerank,glycolytic process (GO:0006096),0.3088690668460397,0.8580777277334901,0.6706281833616299,0.989778021236444,1.0,3/28,10.85%,ENO4;TPI1;GPI
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.2755723662695498,0.858021300270328,0.6693548387096774,0.9892021520270973,1.0,7/42,9.29%,POLK;POLE;SIRT1;POLD3;TRIM25;SPRTN;POLA1
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.37610512872549523,0.857936659055099,0.6400778210116731,0.9886904750658667,1.0,3/10,8.04%,NEXMIF;RGCC;NOTCH1
prerank,protein localization to cilium (GO:0061512),0.28766172730455686,0.8579161109516452,0.6615905245346869,0.988034612350059,1.0,4/32,11.46%,ROPN1;ATP6V1D;RABEP1;IFT140
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),-0.20172643212099417,-0.8577810796870401,0.8674698795180723,0.9061607703371783,1.0,12/140,8.11%,LPAR1;HTR2C;CACNA1C;ADCY5;DLG4;PLCE1;P2RX4;PDGFRA;EDNRA;ADRA1B;FIS1;CCR9
prerank,Golgi inheritance (GO:0048313),-0.36086242322741263,-0.8575726211076902,0.6512605042016807,0.9059570365214514,1.0,2/11,11.61%,GOLGA2;STK25
prerank,response to steroid hormone (GO:0048545),0.29775574070294913,0.8574853736069414,0.6521035598705501,0.9883516493624531,1.0,3/31,5.00%,SOX30;PAQR8;UBE3A
prerank,regulation of translational initiation (GO:0006446),0.25672312213071413,0.8574762874777028,0.700152207001522,0.9876663309459446,1.0,8/63,11.42%,ATF3;NCBP1;EIF3B;PAIP2B;EIF4H;EIF4G2;DDX3X;EIF4B
prerank,endocrine system development (GO:0035270),-0.2956915609094206,-0.8574420665586355,0.6794582392776524,0.9055591347781419,1.0,5/21,9.91%,GLI2;TGFBR1;WNT4;DKK3;SALL1
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.37811342436578765,0.8573424431368727,0.6699801192842942,0.9872816318920173,1.0,2/11,8.56%,NR4A2;WNT5A
prerank,receptor internalization (GO:0031623),0.2788342196448783,0.8572770037302057,0.6865912762520194,0.9867321482624419,1.0,9/44,14.38%,SAG;DNM3;RAMP2;SYK;SNX1;CD81;PICALM;LDLRAP1;AP2M1
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.2514616340478339,0.8571366651891879,0.7305389221556886,0.9863473651350676,1.0,11/77,10.80%,MAZ;NR4A2;BCL2L2;SRC;SLC35F6;BDNF;ITGA6;RELA;FZD9;PARK7;DDX3X
prerank,regulation of chromosome segregation (GO:0051983),0.34813400322273375,0.8568154754523388,0.6611111111111111,0.9863654776864318,1.0,1/16,0.79%,RAD18
prerank,cardiac atrium morphogenesis (GO:0003209),-0.32009247197258284,-0.8566236077855058,0.6666666666666666,0.9065660567092907,1.0,1/16,0.30%,NOTCH2
prerank,histone H4 deacetylation (GO:0070933),-0.37102084966603355,-0.8563266924793045,0.6645702306079665,0.9065051586370467,1.0,3/10,4.58%,HDAC4;HDAC1;SIRT2
prerank,regulation of sodium ion transmembrane transport (GO:1902305),-0.2825549545941438,-0.856160203372166,0.6758793969849246,0.9061659505248288,1.0,7/27,17.83%,FGF12;SNTA1;PTPN3;CAMK2D;DLG1;COMMD1;GPD1L
prerank,mRNA transport (GO:0051028),-0.21092512031756663,-0.8558001259111966,0.8163265306122449,0.9062689860754078,1.0,36/101,24.95%,SRSF5;SRSF11;CASC3;SRSF2;KIF5C;ALKBH5;SRSF6;NUP205;SRSF1;POLDIP3;DDX39B;NXF1;NUP155;NUP188;HNRNPA2B1;SYMPK;NUP88;NUP93;DDX19B;SEH1L;THOC5;SLU7;CDC40;UPF1;RNPS1;NUP85;AAAS;RAE1;CPSF3;NUP37;NUP214;EIF4A3;NCBP2;THOC1;RBM8A;SEC13
prerank,substantia nigra development (GO:0021762),-0.25379180163868,-0.8553205178526205,0.7295285359801489,0.9065833053314903,1.0,8/37,10.06%,PLP1;MBP;RHOA;SIRT2;GLUD1;NDRG2;NDUFS3;CKB
prerank,mRNA catabolic process (GO:0006402),0.2725643555479274,0.8552138838554538,0.6908212560386473,0.9893006060283069,1.0,14/44,20.64%,ZC3H12D;NUDT12;EXOSC9;XRN2;DXO;AGO4;TUT7;TUT4;NBDY;CNOT10;RC3H1;DIS3L2;AGO1;ERN1
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),-0.3029805362314425,-0.8551462158684658,0.6960985626283368,0.9062751008806932,1.0,3/18,14.82%,WNK1;PPARA;PTPN22
prerank,homotypic cell-cell adhesion (GO:0034109),-0.2584231626892821,-0.8550114788279309,0.7189054726368159,0.905889131123438,1.0,10/39,13.72%,MEGF11;TLN1;FLNA;PLPP3;VCL;PDGFRA;UBASH3B;FN1;ILK;STXBP1
prerank,purine-containing compound salvage (GO:0043101),-0.3484840672025787,-0.8548299961492766,0.6539278131634819,0.9056037555018036,1.0,3/12,9.95%,AMPD3;DGUOK;ADK
prerank,positive regulation of myelination (GO:0031643),0.3679292826999902,0.8547578795399084,0.6626984126984127,0.9896073700866946,1.0,3/11,14.49%,TNFRSF1B;TENM4;PARD3
prerank,regulation of myotube differentiation (GO:0010830),0.3124149877054445,0.854741795199162,0.6684782608695652,0.9889446808755027,1.0,5/24,8.04%,HDAC9;HDAC3;ATP11A;BDNF;NOTCH1
prerank,vesicle transport along microtubule (GO:0047496),0.31703774088198844,0.8543705363326556,0.6618962432915921,0.9890995959757217,1.0,6/23,13.20%,DYNC1I1;KIFAP3;FYCO1;RAB1A;KIF13A;KIF3B
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),-0.30005677209119114,-0.8541166434884859,0.6704288939051919,0.9064215582590791,1.0,4/21,10.62%,CGNL1;ARHGAP12;LZTR1;EPHB2
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),-0.2999915076857744,-0.8540801808600881,0.678082191780822,0.9058240105359087,1.0,7/20,20.31%,OSR1;HECW1;CAB39;ACTN2;CAMK2D;HECW2;NEDD4
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.36185023712854714,0.854025217707894,0.625,0.9891675012376888,1.0,1/14,0.61%,IMPDH1
prerank,response to retinoic acid (GO:0032526),-0.23256489052713297,-0.8539980997801824,0.773841961852861,0.9053405651282349,1.0,15/59,17.63%,WNT5B;BRINP1;PTK7;RBP4;BRINP2;SNW1;RXRA;EPHA3;RARA;WNT9A;ATM;SETX;ABL2;FZD4;TWF2
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.3320748943995313,0.8538552765870195,0.6321428571428571,0.9888566849156603,1.0,3/18,9.29%,POLE;POLD3;POLA1
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.33687708829053536,-0.8538506671355168,0.6501079913606912,0.9049533698515972,1.0,5/14,28.75%,PAXIP1;SHLD1;RIF1;NECTIN2;SHLD2
prerank,response to glucose (GO:0009749),0.2750774720339777,0.8537411337130836,0.7072758037225042,0.9884195446150207,1.0,6/46,11.50%,PCK1;SELENOT;IRS2;EIF2B3;PRKAA2;ZBED3
prerank,nucleus organization (GO:0006997),0.27069914326944344,0.8536569695448007,0.7138211382113822,0.987915809234526,1.0,12/47,19.26%,SYNE1;LEMD3;NUP54;CHMP1A;REEP3;CHMP2A;NUP35;NDC1;VPS4B;USP36;PITPNB;NUP133
prerank,phagosome acidification (GO:0090383),0.309603258046935,0.85327856498982,0.6913793103448276,0.9880495917932195,1.0,4/26,8.45%,ATP6V1D;RAB7A;ATP6V0D1;ATP6V0E1
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.24912778397217328,0.8532101101529238,0.7155297532656023,0.9875190809526282,1.0,18/87,14.49%,CBL;MAP3K7;LRRC32;SRC;SMAD1;TGFBRAP1;F11R;SMAD7;SIRT1;ARHGEF18;ACVRL1;CLDN5;NLK;USP15;ZFYVE9;CDH5;USP9X;PARD3
prerank,establishment of epithelial cell polarity (GO:0090162),0.32987500914037515,0.8531780098684859,0.6660617059891107,0.9868983863490327,1.0,7/19,18.46%,RAP2A;MYO9A;OPHN1;PARD3;CLASP1;MYO18A;CYTH1
prerank,response to nutrient levels (GO:0031667),0.34195912142407126,0.8529022273935802,0.6660447761194029,0.9868154171636623,1.0,4/17,18.94%,RPTOR;PRKAA2;ULK1;EIF4G1
prerank,peptidyl-lysine trimethylation (GO:0018023),0.3042905540767299,0.8524594527153478,0.6800699300699301,0.9871260604843444,1.0,9/26,17.57%,BEND3;TET3;SETD5;SETD3;SETD1B;KMT5B;ETFBKMT;SETD2;TET2
prerank,alpha-amino acid catabolic process (GO:1901606),-0.2738073742604551,-0.851871126905056,0.6968911917098446,0.9083692968392145,1.0,10/29,25.95%,DDO;GSTZ1;ALDH4A1;ACADSB;PRODH;KYAT1;FAH;SARDH;HOGA1;MTRR
prerank,erythrocyte development (GO:0048821),0.3892311826918276,0.8515791839262501,0.6415094339622641,0.98838230251338,1.0,1/10,1.61%,ABCB10
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.3312315172925748,0.8512593398357506,0.6678700361010831,0.9883775635073009,1.0,5/17,20.22%,BACH2;CD55;STAT3;CD46;BTN3A3
prerank,protein depolymerization (GO:0051261),-0.27372923589508513,-0.8512579138017984,0.69377990430622,0.9089602768769834,1.0,8/27,17.63%,GSN;MICAL2;MICAL3;STMN2;CKAP5;WDR1;STMN1;TWF2
prerank,negative regulation of protein localization to membrane (GO:1905476),0.3105512871195546,0.8512262463782598,0.6701208981001727,0.9877488134085262,1.0,7/24,17.08%,RSC1A1;RHOQ;PICALM;TMEM59;AP2M1;LZTFL1;PPP2R5A
prerank,lipid phosphorylation (GO:0046834),-0.372692705937704,-0.8508298894037168,0.6993736951983298,0.9092619128877103,1.0,2/10,6.34%,DGKI;DGKH
prerank,nucleosome disassembly (GO:0006337),-0.33056943773434855,-0.8505419015019433,0.683371298405467,0.9085163117346895,1.0,4/14,22.05%,SET;SMARCD3;SMARCD2;SMARCC1
prerank,chromatin disassembly (GO:0031498),-0.33056943773434855,-0.8505419015019433,0.683371298405467,0.9085163117346895,1.0,4/14,22.05%,SET;SMARCD3;SMARCD2;SMARCC1
prerank,cellular response to alkaloid (GO:0071312),-0.31142726093042444,-0.8503894562903695,0.6594360086767896,0.9081760406582725,1.0,5/17,22.88%,RYR3;SPIDR;CASP7;BLM;CASP3
prerank,regulation of developmental growth (GO:0048638),-0.2738811735101031,-0.8503890543481628,0.7506112469437652,0.907506972370913,1.0,6/29,10.56%,IGF1;NRCAM;GHR;CTTN;NIPBL;GSK3B
prerank,nuclear transport (GO:0051169),0.33883899746778817,0.8503559795845443,0.6405109489051095,0.9890141603143997,1.0,4/16,12.89%,BANF1;NXT1;RSRC1;XPO1
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.35337592594230305,-0.8502241606685735,0.6535433070866141,0.9072112673095719,1.0,4/10,25.88%,GHR;STAT6;PRLR;STAT5A
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.3189325509042917,0.8497485864708338,0.6702127659574468,0.989680897230131,1.0,4/21,10.98%,PDE4D;CNKSR3;SMAD7;DMD
prerank,regulation of cellular catabolic process (GO:0031329),-0.226635465514874,-0.8496742547420286,0.7521367521367521,0.9076427192496772,1.0,20/62,21.21%,ITPR1;PSAP;DEPDC5;MAPT;NUPR1;USP13;ROCK1;PIP4K2B;ATM;MTMR4;KEAP1;USP10;DAPK2;RAB8A;ABL2;FBXL2;DAPK1;OSBPL7;HSPB1;KAT8
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.31839514403364594,0.8496612314775945,0.7021276595744681,0.9891635020253696,1.0,6/22,12.41%,GSK3A;EFNA1;RELA;LYN;PICALM;SP1
prerank,regulation of monooxygenase activity (GO:0032768),-0.2893325420846849,-0.8489977264022575,0.6815144766146993,0.9083829750930938,1.0,12/23,31.78%,EGFR;WASL;ZDHHC21;DDAH1;NOSIP;AKT1;HSP90AA1;DDAH2;CYGB;SNCA;POR;CAV1
prerank,protein-containing complex disassembly (GO:0032984),0.26101709578000204,0.8489018326497737,0.7403225806451613,0.9902188296548368,1.0,8/54,11.25%,MAP1LC3B;HSPA8;RPL23;AXIN1;PYM1;EPG5;TECPR1;UBQLN1
prerank,microglial cell activation (GO:0001774),-0.28806990479008515,-0.8487892351436885,0.6790697674418604,0.9081612563377052,1.0,13/21,50.18%,MAPT;IFNGR1;CX3CL1;CX3CR1;SNCA;C1QA;CLU;TYROBP;ITGB2;ITGAM;AGER;AIF1;TREM2
prerank,cortical cytoskeleton organization (GO:0030865),-0.2526906967360273,-0.8486208637232627,0.7142857142857143,0.9078393608886542,1.0,12/41,12.92%,EPB41L3;RHOA;ROCK2;ROCK1;NLGN1;EZR;RND3;RHOBTB2;FHOD1;RHOB;RHOBTB1;DLG1
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.28881939995853184,0.8485385908357524,0.69,0.9903453809169153,1.0,7/33,13.49%,EZH2;RPTOR;PHB2;RGCC;PLCB1;DDX3X;ANKRD17
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.3702074929607251,0.8481479177493279,0.6635859519408502,0.9905043915111972,1.0,2/12,9.31%,PTPRC;LYN
prerank,O-glycan processing (GO:0016266),-0.23124315865386502,-0.8478284262773952,0.7671232876712328,0.9087778674154818,1.0,9/54,22.24%,GALNT13;GXYLT2;POFUT1;XXYLT1;ST3GAL4;GALNT14;ST6GAL1;GALNT12;C1GALT1C1
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.3017812777187571,0.8473184270656341,0.6851520572450805,0.9916563155239517,1.0,4/26,8.31%,EEF1A1;ZFP36L1;PTPN12;PLCG1
prerank,negative regulation of macrophage activation (GO:0043031),0.3416696394571324,0.8471378997260446,0.6702317290552585,0.9913764358762438,1.0,2/16,2.51%,PTPRC;FCGR2B
prerank,mRNA metabolic process (GO:0016071),0.239303649019447,0.8471116554498984,0.7641242937853108,0.9907406106675086,1.0,24/90,17.29%,ZC3H12D;NCBP1;PRPF3;NUDT12;SFPQ;SRSF4;PRMT9;SF3A1;DXO;AKAP8L;U2AF1;CPSF6;AGO4;PTBP1;PCBP3;SRSF7;USP39;SSB;TCERG1;RNASE4;SLBP;U2AF2;CNOT10;NONO
prerank,cellular response to lipopolysaccharide (GO:0071222),-0.2070220257272683,-0.8470393152091518,0.8291814946619217,0.909727435539479,1.0,22/101,19.60%,PABPN1;MAPK14;AXL;VIM;RHOA;LBP;IRAK1;CDC73;TRIM41;NFKB1;SIRPA;IL18;PTPN22;PAF1;PDE4B;SELENOS;UPF1;DEFA6;TGFB1;MTDH;CHMP5;IRGM
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.36781196314753395,0.8470016753214921,0.6615969581749049,0.9902830826369577,1.0,3/12,15.93%,TSPO;STARD3NL;STARD3
prerank,regulation of viral life cycle (GO:1903900),-0.2997705130291032,-0.8467939513783179,0.684331797235023,0.9095774841306564,1.0,8/21,26.16%,HS3ST5;AXL;TSG101;TRIM5;VPS4A;NECTIN2;TRIM62;PPIA
prerank,protein autophosphorylation (GO:0046777),0.22475058887947624,0.8461070962980877,0.792,0.9915639397500263,1.0,18/157,9.75%,PRKX;MAP3K11;MAPK3;OXSR1;SRC;MEX3B;PRKD2;MAP3K9;TEK;SMG1;SLK;PIM1;PIKFYVE;PEAK1;MINK1;CSF1R;LYN;PAK1
prerank,mitotic spindle assembly (GO:0090307),0.27499969994332735,0.8457650772410401,0.7083333333333334,0.9916271157676086,1.0,11/42,17.19%,ABRAXAS1;CLASP2;MZT1;KIF2A;BCCIP;KIF3B;CHEK2;ARHGEF10;STAG2;KPNB1;CLASP1
prerank,error-prone translesion synthesis (GO:0042276),-0.28968268366084937,-0.8453321905513497,0.6832971800433839,0.9119346101886937,1.0,14/21,42.56%,RFC1;RPA1;UBC;PRIMPOL;RFC2;PCNA;POLE2;POLI;REV3L;RPA3;RFC3;MAD2L2;UBA52;RPA2
prerank,cell differentiation in hindbrain (GO:0021533),-0.35463814231092045,-0.8452735062028668,0.6666666666666666,0.9113909977602566,1.0,2/11,5.67%,GRID2;ATP7A
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),-0.27117480492155965,-0.8452479884414176,0.7258426966292135,0.9107787178466685,1.0,16/29,34.30%,RFC1;RAD50;TNKS1BP1;MRE11;RPA1;PPP6C;PPP6R3;RTEL1;TELO2;PPIA;HSP90AA1;CDK2;TERF1;TERF2;GAR1;TINF2
prerank,negative regulation of lipid storage (GO:0010888),-0.30635516754667336,-0.8451538590030937,0.6613272311212814,0.9103251666366661,1.0,8/19,28.89%,ABHD5;PPARA;ABCA1;TTC39B;PTPN2;OSBPL8;NR1H2;ITGB3
prerank,response to sterol (GO:0036314),-0.361850632255119,-0.8451159622669847,0.6582278481012658,0.9097236453760446,1.0,4/11,16.23%,TGFBR1;TGFBR2;RORA;TGFB1
prerank,adherens junction organization (GO:0034332),0.26861999678687476,0.8446069814626955,0.6944,0.9934172388016089,1.0,7/48,8.66%,CADM1;ACTB;CDH2;RAMP2;CDH12;SMAD7;TJP1
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),-0.3438044935184213,-0.8442969012651073,0.6631799163179917,0.9107138710097126,1.0,4/13,10.62%,ADCY1;RELN;LGMN;EPHB2
prerank,regulation of cell population proliferation (GO:0042127),0.19917435555068524,0.8436385703046929,0.9251054852320675,0.9948173121447373,1.0,79/691,11.39%,MAZ;ROMO1;JAG2;BNIPL;UTP20;PTPRJ;EZH2;FRZB;LEF1;ACER2;TIAM1;SHCBP1;RPL23;DERL2;IFNLR1;GREM1;DNAJA3;CRLF1;RERG;FABP7;ING4;STOX1;GNRH1;MCTS1;TBC1D8;BCL6B;BIRC2;NME1;CD164;IFI35;ZFP36L1;TSHR;SMARCA2;SLC35F6;MEIS1;SINHCAF;CIB1;TSPO;CDKN1A;P3H2;TBX1;CHTOP;TMEM115;PLPP1;RGCC;FBXO5;SIRT1;RNF187;IRS2;NOTCH1;CNOT7;CDK4;TJP1;IFITM1;TSC1;ACVRL1;RELA;CD47;CSF1R;SOD2;JUND;LYN;MDM2;TFAP4;PAK1;CLDN5;ESM1;TRPM4;SRPK2;RPS9;CD81;CYP1B1;RHOG;HP1BP3;FLT1;NOS3;CTBP1;APP;PIAS1
prerank,inositol phosphate metabolic process (GO:0043647),0.2719626429250511,0.8436089429348389,0.7079510703363915,0.9941874714690073,1.0,12/46,18.82%,PPIP5K2;NUDT11;PLCG1;INPP5D;PLCB1;INPP4B;IP6K2;ITPK1;IMPA1;ITPKB;MINPP1;CALM1
prerank,arachidonic acid metabolic process (GO:0019369),-0.25554181125131126,-0.8433777773229436,0.7416267942583732,0.9117974716428034,1.0,4/35,7.23%,PLA2G4A;PTGDS;EPHX1;PTGIS
prerank,ceramide catabolic process (GO:0046514),0.34864004550707206,0.8433718810256831,0.6575091575091575,0.994010335613529,1.0,3/14,12.29%,ACER2;ACER3;GM2A
prerank,Golgi localization (GO:0051645),-0.3474681592463829,-0.8429656014801568,0.6822033898305084,0.9119682192062452,1.0,5/11,24.83%,UVRAG;STK25;TBCCD1;CDC42;RIPOR1
prerank,genitalia development (GO:0048806),-0.33899432286309467,-0.8428435991020573,0.6967213114754098,0.9115368611320167,1.0,3/12,11.62%,PKD1;DNAJC19;TBX3
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.23591416882143765,0.8420595779599155,0.7691256830601093,0.9962027666063135,1.0,19/112,12.62%,CBL;MAP3K7;LRRC32;SRC;SMAD1;ZFP36L1;TGFBRAP1;F11R;SMAD7;SIRT1;ARHGEF18;WNT5A;ACVRL1;CLDN5;NLK;USP15;ZFYVE9;CRKL;CDH5
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.3626411875945176,-0.8418998711488701,0.6776859504132231,0.9120761239750323,1.0,5/10,17.85%,AP2B1;AP2A2;AP2A1;VLDLR;MYLIP
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.3626411875945176,-0.8418998711488701,0.6776859504132231,0.9120761239750323,1.0,5/10,17.85%,AP2B1;AP2A2;AP2A1;VLDLR;MYLIP
prerank,negative regulation of synaptic transmission (GO:0050805),0.30477162021121307,0.841733414261255,0.6961325966850829,0.9962116783537446,1.0,3/23,9.28%,PLK2;PNKD;ARF1
prerank,folic acid metabolic process (GO:0046655),0.3296714836044171,0.8416571867915837,0.6946428571428571,0.9956802804600839,1.0,2/18,6.17%,ALDH1L1;MTHFS
prerank,response to axon injury (GO:0048678),0.32334502713581714,0.841655101783383,0.6702898550724637,0.9949905608557584,1.0,2/18,2.94%,SOD1;MTR
prerank,positive regulation of cytoskeleton organization (GO:0051495),-0.22243970823478604,-0.841533538140798,0.8092307692307692,0.9121623750313161,1.0,18/76,21.72%,NTRK3;NRP1;DYNC1H1;FER;CTTN;BIN1;SYNPO2;BAIAP2L1;PFDN2;FCHSD2;WDR1;CDC42EP5;NES;CDC42EP1;CDC42;SEMA5A;CX3CL1;PFN2
prerank,regulation of response to stress (GO:0080134),0.3818453417567455,0.8411653253200133,0.6724806201550387,0.9953694932186614,1.0,3/10,18.94%,STOX1;CORO2B;EIF4G1
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.29827760170383383,0.8410243802434352,0.6863406408094435,0.9949891362184663,1.0,9/29,16.09%,LEF1;EP300;RUVBL1;TERT;CREBBP;TLE4;TRRAP;SMARCA4;TCF7L1
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.33050283761999305,0.8408575483992297,0.6724137931034483,0.9946617958739188,1.0,6/17,13.84%,F11R;CLDN5;PPP1R12A;IKBKB;CDH5;PROC
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.3545719983591261,0.8408043857560206,0.6621880998080614,0.9940947683630551,1.0,1/12,1.58%,ATF6
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.24450950090553403,0.8405596754440986,0.7484939759036144,0.9939251174894724,1.0,13/74,11.15%,TNFAIP3;SRC;MAP2K5;RFFL;TNFRSF10B;ICAM1;EYA3;ITGA6;RELA;PARK7;TERT;DDX3X;NOS3
prerank,cellular response to reactive oxygen species (GO:0034614),0.2559345960934853,0.840333792080808,0.7387944358578052,0.9937159440017467,1.0,10/59,12.87%,MAPK3;ROMO1;TNFAIP3;MAPK8;SIRT1;RELA;PARK7;CYP1B1;RPS3;CHUK
prerank,tRNA 5'-end processing (GO:0099116),0.33564561220519795,0.8402955211884513,0.6776556776556777,0.9931110193305294,1.0,3/15,14.97%,RPP25L;POP5;SSB
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.36657447225948275,0.8401732625718699,0.6759776536312849,0.9926777166520677,1.0,4/12,17.96%,SIRT1;ING2;CD44;RPL26
prerank,primary miRNA processing (GO:0031053),-0.3629708532511948,-0.840018587799254,0.714,0.9145389177261009,1.0,3/10,9.20%,SMAD3;SRRT;HNRNPA2B1
prerank,positive regulation of macrophage chemotaxis (GO:0010759),0.3469158846544148,0.8399492783461944,0.6591760299625468,0.9924931411368364,1.0,2/14,9.17%,MAPK3;CSF1R
prerank,positive regulation of viral genome replication (GO:0045070),0.2935834306206654,0.8398949427234573,0.6951219512195121,0.9919123422708624,1.0,7/29,12.53%,IFIT1;ADAR;CNOT7;RAD23A;SRPK2;DDX3X;TMEM39A
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),-0.24682786436201978,-0.8394857973943607,0.7613941018766756,0.9149095527502003,1.0,10/42,21.24%,SPIDR;ERCC6;SHLD1;MMS19;KDM1A;ACTR2;PARP1;RIF1;SMCHD1;RTEL1
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.3291871437819256,0.839176604578909,0.683111954459203,0.9927882404940765,1.0,3/17,9.19%,PRKG1;CDKN1A;SOD2
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",-0.3190434117559867,-0.83899442434373,0.700836820083682,0.9151902971738607,1.0,9/15,35.10%,NLGN2;NLGN1;STXBP1;ADRA1A;USP46;CLN3;DRD2;ZDHHC3;BAIAP3
prerank,regulation of interleukin-1 beta production (GO:0032651),-0.222338103158448,-0.8386934819996846,0.8176470588235294,0.9151233141966267,1.0,16/66,27.69%,FOXP1;IGF1;MALT1;AIM2;SIRPA;USP50;GBP5;GSDMD;CX3CL1;HSPB1;PANX1;GIT1;TRIM16;CX3CR1;EGR1;ZC3H12A
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.28686243060746025,0.8385618891927948,0.7035087719298245,0.993407145609882,1.0,8/32,16.91%,AEN;HIPK2;EP300;SIRT1;CDIP1;RRP8;DYRK2;USP28
prerank,positive regulation of stem cell proliferation (GO:2000648),0.32860061891625986,0.8385199626490487,0.6789473684210526,0.9928131014144812,1.0,3/17,12.29%,PTPRC;TERT;N4BP2L2
prerank,pattern recognition receptor signaling pathway (GO:0002221),-0.22588998317005932,-0.8383291772481277,0.7839335180055401,0.9151423768274887,1.0,20/56,30.99%,SFTPA2;SFTPA1;LBP;IRAK1;LGMN;UBC;TAB1;LACC1;IRAK4;IRAK2;CNPY3;CTSK;TLR3;BCL10;MAPKAPK2;CTSB;TIFA;CTSS;S100A1;TLR7
prerank,regulation of cell morphogenesis (GO:0022604),0.29550279329704404,0.8380179540707383,0.7032040472175379,0.9932196364677619,1.0,10/30,17.01%,SH3D19;FITM2;ZMYM4;CFL1;MYO9A;CD44;MOV10;LARP4;WTIP;STRIP1
prerank,placenta development (GO:0001890),0.3684866718788995,0.837918358877112,0.6791044776119403,0.9927293945135309,1.0,1/12,2.23%,SOD1
prerank,regulation of multicellular organism growth (GO:0040014),0.342901384386377,0.8374655831657251,0.6722846441947565,0.9930677405244457,1.0,3/15,11.27%,SOD1;PPIB;APP
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.3540712541965658,0.8372619133200697,0.6918489065606361,0.9928125139872365,1.0,1/12,0.88%,SEMA6A
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.26268743347861045,0.8371959647109403,0.7547169811320755,0.992277248221659,1.0,9/54,12.87%,TNFAIP3;RFFL;BIRC2;SPATA2;CARD16;SYK;RBCK1;IKBKB;CHUK
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.34495485500912354,0.8370102823728374,0.6789883268482491,0.9919753816898806,1.0,2/14,5.04%,PTPRC;TNFRSF1B
prerank,divalent inorganic cation homeostasis (GO:0072507),0.3105131710285268,0.8369166636810693,0.7032590051457976,0.9914908011451166,1.0,3/25,5.56%,TMTC2;WFS1;TRPM7
prerank,monocyte chemotaxis (GO:0002548),-0.2585600107603682,-0.8368471610955818,0.735897435897436,0.9174149015867948,1.0,6/32,22.13%,IL6R;ANXA1;CCL14;PTPRO;CX3CL1;CCL13
prerank,positive regulation of insulin secretion (GO:0032024),-0.25401948116766154,-0.8366533977774889,0.7382716049382716,0.9171494667673528,1.0,15/36,27.17%,MCU;NLGN2;GLUD1;RBP4;ANO1;TM7SF3;NNAT;PSMD9;GPLD1;TCF7L2;PLA2G6;ADCY8;CAPN10;AACS;LRRC8A
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.26865268743985743,-0.8364357213108937,0.7004950495049505,0.9169203543938268,1.0,5/27,14.92%,NFAT5;RHOA;IRAK1;SIRPA;HSPD1
prerank,homocysteine metabolic process (GO:0050667),-0.34635062234463965,-0.8363855430889765,0.7116182572614108,0.9163626490634565,1.0,2/11,11.53%,MTHFR;NOX4
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.34150547838689294,0.8362888035846102,0.6788461538461539,0.9921692340209963,1.0,5/16,18.68%,MLYCD;SIRT1;ADIPOR1;FOXK2;PDK3
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.3347462391035922,-0.8360438806281083,0.7015250544662309,0.9163970593444007,1.0,5/13,16.96%,BMP7;MED1;BMP4;NR3C2;NR3C1
prerank,negative regulation of programmed necrotic cell death (GO:0062099),-0.3525100911315355,-0.8357833935892116,0.6866666666666666,0.9162659727681078,1.0,3/11,8.63%,NUPR1;YBX3;BIRC3
prerank,fatty acid catabolic process (GO:0009062),-0.22507211582419084,-0.835445372051042,0.788135593220339,0.9162385070259207,1.0,25/67,31.60%,ACBD5;ECI2;PCCB;LPIN1;ALDH3A2;ABCD2;ACAD11;PCCA;CPT2;PEX2;PHYH;ABHD3;EHHADH;ACAD10;LPIN2;ECHDC2;NUDT7;ACAT2;ABCD3;ECI1;LPIN3;SLC27A4;PECR;MCEE;PLA2G15
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.2375043977546128,0.8353113991594998,0.7461212976022567,0.993636292683307,1.0,10/90,7.51%,ALMS1;UCP2;HDAC3;TSHR;KDM3A;ELOVL6;GATM;SYK;ADIPOR2;OMA1
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.3638954313946987,0.8352759235389419,0.6536964980544747,0.99303680442472,1.0,3/10,14.72%,ATP5MG;ATP5MC2;ATP5F1C
prerank,regulation of proteolysis (GO:0030162),-0.23521995962247788,-0.8351555664682763,0.7887700534759359,0.9161598092541147,1.0,20/48,31.78%,OGT;CYFIP2;FBXW11;BTRC;IST1;CAMK2N1;NEDD8;GSAP;TBC1D10A;RNF139;STUB1;BAG6;CLN3;AKT1;PERP;HDAC6;DNAJC1;CDK5;FGFR4;CAV1
prerank,response to nitric oxide (GO:0071731),0.3516966119782461,0.8351271658076302,0.6709558823529411,0.9927074025712844,1.0,2/13,7.36%,MTR;TXN
prerank,striated muscle contraction (GO:0006941),-0.23248803811414043,-0.8347412020827056,0.7902298850574713,0.9163064948875502,1.0,3/53,4.07%,ATP1A2;ATP1B1;TPM1
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.3113911903597628,0.8347123350961762,0.6929824561403509,0.9929078942480827,1.0,4/20,7.83%,ATP2A2;WFS1;RAP1GDS1;SELENOK
prerank,C4-dicarboxylate transport (GO:0015740),0.3400514776639296,0.8346029885013649,0.6660482374768089,0.9924508064761695,1.0,3/14,12.49%,SLC1A1;SLC1A2;SLC25A12
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.317727228730192,0.834402764188486,0.7027972027972028,0.9921884143462608,1.0,6/20,17.08%,RSC1A1;RHOQ;PICALM;TMEM59;AP2M1;PPP2R5A
prerank,myelination in peripheral nervous system (GO:0022011),0.34998195619307804,0.8343885816474879,0.6634615384615384,0.9915453405477208,1.0,5/13,14.63%,SOD1;NF1;ADGRG6;PARD3;ARHGEF10
prerank,eye photoreceptor cell differentiation (GO:0001754),-0.33861519806677765,-0.8341695533498555,0.6829787234042554,0.9167983513547545,1.0,3/12,7.34%,DSCAM;NKD1;SDK2
prerank,positive regulation of monooxygenase activity (GO:0032770),0.29717223590550607,0.8340606516769368,0.7314487632508834,0.9915504078899615,1.0,5/26,14.25%,APOE;PARK7;TERT;SCARB1;GCH1
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.26466053419881763,-0.8339232052559806,0.733502538071066,0.9159621935047358,1.0,16/32,33.24%,NUP205;NUP155;NUP188;NUP88;NUP93;SEH1L;NUP85;AAAS;RAE1;NUP37;NUP214;SEC13;NUP153;RAN;NUP43;NUP210
prerank,tRNA export from nucleus (GO:0006409),-0.26466053419881763,-0.8339232052559806,0.733502538071066,0.9159621935047358,1.0,16/32,33.24%,NUP205;NUP155;NUP188;NUP88;NUP93;SEH1L;NUP85;AAAS;RAE1;NUP37;NUP214;SEC13;NUP153;RAN;NUP43;NUP210
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.22672885226043626,0.8338842715007223,0.8229598893499308,0.991245092792466,1.0,16/128,10.48%,FBXL6;ALMS1;HAUS4;HAUS5;CEP41;TUBB;CCNH;DCTN2;CDKN1A;ODF2;WEE1;CEP164;DCTN3;PLCB1;PPP1R12A;DYNLL1
prerank,lipid translocation (GO:0034204),0.30986219616614125,0.8338410906275344,0.6909722222222222,0.990657944321117,1.0,7/21,18.55%,ATP8A1;ATP11A;TMEM30B;ATP11C;ATP10A;TMEM30A;ATP9B
prerank,glutamine family amino acid catabolic process (GO:0009065),0.35068390485730394,0.8337263144876165,0.6781818181818182,0.9902172731281987,1.0,3/13,11.15%,GLS2;GLS;NOS3
prerank,organelle disassembly (GO:1903008),-0.2603395860899262,-0.83369567121742,0.7092731829573935,0.9157372018040343,1.0,8/33,14.48%,ULK2;UFL1;VCP;GOLGA2;DDRGK1;MRRF;TEX264;EIF2D
prerank,purine-containing compound catabolic process (GO:0072523),-0.32816964570755774,-0.8334828580386762,0.6731601731601732,0.9155109124750686,1.0,2/13,6.98%,DPYD;XDH
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.31796672078322485,0.8329873648509034,0.6978021978021978,0.9911698020227686,1.0,5/18,13.91%,TNFRSF1B;NOTCH1;NF1;TENM4;HES1
prerank,positive regulation of chemokine production (GO:0032722),0.26300343129523,0.8326185723882601,0.7252032520325203,0.9912283468615233,1.0,6/44,11.27%,TIRAP;SYK;WNT5A;CSF1R;DDX3X;APP
prerank,cellular glucose homeostasis (GO:0001678),-0.2423677834206684,-0.8324506937660509,0.7794486215538847,0.9168680066552614,1.0,13/41,22.39%,ZBTB20;LRRC8D;PPARGC1A;SLC39A14;PRKACA;NUCKS1;UNC13B;RACK1;FOXK1;PIK3R1;PCK2;ADCY8;HK2
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.2711920822578061,0.8323269777248318,0.7156862745098039,0.9911686514318259,1.0,5/43,6.54%,CBL;PTPRJ;RAB7A;EPS15L1;ARHGEF7
prerank,atrioventricular valve development (GO:0003171),-0.3252986380263956,-0.8314200322613887,0.6993865030674846,0.9182085901512091,1.0,5/14,19.93%,TGFBR2;ACVR1;MDM4;BMPR1A;BMPR2
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),-0.32418175893612317,-0.8313447487820459,0.7117903930131004,0.9176980107465089,1.0,6/14,30.88%,NRP1;FOXC1;VEGFA;VEGFB;PGF;FLT4
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.27915937330390966,0.8313038922536099,0.7180327868852459,0.9926255369579252,1.0,5/34,10.57%,TNFAIP3;RAB7B;LYN;NFKBIL1;MFHAS1
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.31553762711140293,0.8312822742544491,0.7120141342756183,0.9920052450031086,1.0,6/22,17.30%,UTP20;RPS21;EXOSC9;WDR12;ERI2;URB1
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.30230200058066864,0.8312435703023261,0.7299270072992701,0.9914061678032756,1.0,4/23,10.98%,PLK2;PRCC;WEE1;CHFR
prerank,postreplication repair (GO:0006301),0.26618518973045174,0.8309498231836911,0.7319932998324958,0.9913637887227814,1.0,7/45,10.17%,RAD18;POLK;UBE2V2;POLD3;TRIM25;SPRTN;UBE2V1
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.3658793885479112,0.8307973208216292,0.6772277227722773,0.9896502989509697,1.0,4/11,16.92%,PANK2;ACAT1;PANK1;PANK4
prerank,coenzyme A biosynthetic process (GO:0015937),0.3658793885479112,0.8307973208216292,0.6772277227722773,0.9896502989509697,1.0,4/11,16.92%,PANK2;ACAT1;PANK1;PANK4
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.3658793885479112,0.8307973208216292,0.6772277227722773,0.9896502989509697,1.0,4/11,16.92%,PANK2;ACAT1;PANK1;PANK4
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.3181561387260311,0.8307034635888685,0.6963087248322147,0.9891988166939166,1.0,2/20,2.89%,GSK3A;BCL2L2
prerank,mesenchymal cell development (GO:0014031),0.3205109560268573,0.8306712951744809,0.7067395264116576,0.9885917638393449,1.0,3/18,8.04%,CDH2;HEY2;NOTCH1
prerank,muscle tissue morphogenesis (GO:0060415),-0.31431503160357865,-0.8306699063514336,0.68762278978389,0.9182999838868242,1.0,2/16,4.74%,TGFBR3;BMP4
prerank,positive regulation of neuron apoptotic process (GO:0043525),-0.27365839497537464,-0.8305721584568007,0.7523148148148148,0.917839322895619,1.0,4/24,9.32%,CTNNB1;EPHA7;NUPR1;BACE1
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.3542499729002543,0.8304189902917759,0.6953125,0.9884500681461598,1.0,3/12,17.51%,ZNF205;CYBA;RAB27A
prerank,positive regulation of protein targeting to membrane (GO:0090314),-0.27019009359393753,-0.8302596521027757,0.7238095238095238,0.9177956575098097,1.0,4/24,7.72%,ANK3;CEMIP;AKT2;FIS1
prerank,positive regulation of exocytosis (GO:0045921),0.28041645770518564,0.8302318210070996,0.7166392092257001,0.9881875949445789,1.0,6/35,10.69%,CLASP2;RAB7A;CADPS;RAB2B;CHMP2A;ATP6AP1
prerank,regulation of protein export from nucleus (GO:0046825),-0.27732927315013706,-0.8302301100368863,0.7155963302752294,0.9171965286723548,1.0,8/23,16.42%,PTPN14;BAG3;ANP32B;GSK3B;TP53;CAMK1;SIRT7;TCF7L2
prerank,"synaptic transmission, glutamatergic (GO:0035249)",0.3220554946089986,0.8302248632285045,0.7044247787610619,0.9875388822597423,1.0,4/18,7.16%,GRIK5;GRIK2;SLC17A6;NAPA
prerank,positive regulation of epidermal cell differentiation (GO:0045606),-0.3220662910532235,-0.8300254238713839,0.6635294117647059,0.9169632385437334,1.0,3/15,8.19%,MED1;BMP4;FOXC1
prerank,positive regulation of isotype switching (GO:0045830),-0.3177714400319321,-0.8295094757567588,0.6978260869565217,0.9172785735399612,1.0,9/15,42.22%,PAXIP1;SHLD1;TGFB1;RIF1;SHLD2;CD40;MAD2L2;CLCF1;TNFSF13
prerank,thymus development (GO:0048538),0.3496936130020424,0.8294307144522235,0.6803921568627451,0.9885007636311449,1.0,2/13,5.97%,SOD1;TBX1
prerank,DNA replication checkpoint signaling (GO:0000076),0.3304823260313112,0.8293221633037455,0.6897746967071057,0.9880776160879765,1.0,3/16,11.27%,CDC45;NAE1;HUS1
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",-0.30121492369272573,-0.8291584942457938,0.6808035714285714,0.9173022103374732,1.0,6/17,16.42%,VCP;RHBDD1;HERPUD1;NPLOC4;SELENOS;HM13
prerank,negative regulation of cellular metabolic process (GO:0031324),-0.25224343920129355,-0.8291131837308056,0.7346938775510204,0.9167372991310669,1.0,14/37,33.36%,DLG4;SIRT2;AATF;OPTN;NFKB1;RIN3;SIRT5;PINK1;PAX2;ITGB3;ANKRD13D;ABCA2;EDN1;ANKRD13B
prerank,toll-like receptor signaling pathway (GO:0002224),0.23786116053269354,0.8288016826572839,0.7839771101573677,0.988516074918906,1.0,11/84,12.87%,PIK3AP1;MAP3K7;TAB2;TIRAP;BIRC2;TAB3;EPG5;TRAF3;TNIP2;IKBKB;CHUK
prerank,regulation of histone H3-K9 acetylation (GO:2000615),-0.3572012286612586,-0.8286853365059141,0.7020408163265306,0.9169123284415498,1.0,3/10,13.63%,KMT2A;SMAD4;CAMK1
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.2719398394109978,0.8286848382769789,0.7217675941080196,0.9881167414701824,1.0,5/40,9.71%,ZRANB3;POLE;RFWD3;EXD2;MSH3
prerank,protein localization to microtubule organizing center (GO:1905508),0.3359539109946,0.8286510953476744,0.7113594040968343,0.9875179579176399,1.0,6/15,21.08%,DCTN2;CEP83;HOOK3;CCDC14;CEP192;BBS4
prerank,keratan sulfate catabolic process (GO:0042340),-0.3497980581969216,-0.8285874694431922,0.7004048582995951,0.9164223591730458,1.0,6/11,20.05%,OGN;HEXA;HEXB;PRELP;GNS;LUM
prerank,polyol metabolic process (GO:0019751),0.26586265807600906,0.8276265726750224,0.7303030303030303,0.9890230106276788,1.0,12/46,18.82%,PPIP5K2;NUDT11;PLCG1;INPP5D;PLCB1;INPP4B;IP6K2;ITPK1;IMPA1;ITPKB;MINPP1;CALM1
prerank,response to hexose (GO:0009746),0.3000190533006494,0.8273071306096403,0.7005163511187608,0.9890437321670804,1.0,4/25,11.50%,SELENOT;IRS2;EIF2B3;ZBED3
prerank,positive regulation of translation (GO:0045727),0.23518200675855275,0.826911023081533,0.7949438202247191,0.9891675750353102,1.0,11/94,10.80%,JMJD4;EIF5AL1;EIF5A;FASTKD2;LARP4B;FXR1;RPL5;PYM1;NGRN;RPS9;DDX3X
prerank,response to amino acid starvation (GO:1990928),0.24724309798201535,0.8267645336163886,0.775112443778111,0.9888179378436746,1.0,20/72,19.34%,MAPK3;EIF2S1;RPTOR;ATP6V1D;ATP6V0D1;CDKN1A;MAPK8;LAMTOR1;ATP6V0E1;LARS1;RRAGC;ATP6V1B2;TFEB;KPTN;SESN3;DAPL1;ATP6V1A;SH3GLB1;SESN1;LARP1
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.2984145081045053,0.8267305875577621,0.7162162162162162,0.988231660498594,1.0,2/25,1.61%,TAL1;ABCB10
prerank,peptidyl-amino acid modification (GO:0018193),0.3709569387798891,0.8262051816216714,0.6830708661417323,0.988654878397722,1.0,2/10,10.71%,METAP2;METAP1
prerank,regulation of protein kinase B signaling (GO:0051896),0.21240619363281227,0.8256819882699483,0.8491547464239272,0.989044659737041,1.0,23/193,11.82%,RAC2;MAZ;PIK3CG;TRIB3;PIK3AP1;PTPRJ;SRC;TEK;FYN;CIB1;RET;SIRT1;TXN;IRS2;DAG1;PHLPP1;PARK7;ESR1;MFHAS1;OTUD3;RHOG;PIK3CD;PIK3R5
prerank,second-messenger-mediated signaling (GO:0019932),-0.20857309803417284,-0.8256583950157234,0.8498498498498499,0.9212392808698198,1.0,10/82,10.84%,MCU;PPP1R9A;NUDT4;PLCE1;P2RX4;CHRM3;CCR9;KSR2;ACKR3;DDAH1
prerank,platelet aggregation (GO:0070527),0.28054745986774055,0.825492701232167,0.7133105802047781,0.988782419072404,1.0,8/33,15.74%,PIK3CG;ACTB;MYL9;METAP1;PLEK;CSRP1;FIBP;MYH9
prerank,phospholipid biosynthetic process (GO:0008654),0.27749500697486756,0.8254637057108105,0.7322314049586777,0.9881855728301108,1.0,6/36,11.31%,GPAM;FITM2;SGMS1;MBOAT1;IDI1;AGPAT3
prerank,positive regulation of macrophage activation (GO:0043032),-0.30566752653886786,-0.8254611059467498,0.7079107505070994,0.9209866419509953,1.0,6/17,27.50%,LBP;THBS1;IL33;HSPD1;TTBK1;KARS1
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.31782493341190027,0.8252866162041652,0.6971830985915493,0.9879139276674659,1.0,7/21,18.20%,PSEN2;SPPL3;DAG1;APH1A;MYH9;ADAM9;SPPL2A
prerank,autophagy of peroxisome (GO:0030242),0.3511253850511155,0.8249392539598256,0.692,0.9879668331823103,1.0,3/12,11.64%,MAP1LC3B;TRAPPC8;NBR1
prerank,gonad development (GO:0008406),-0.23906179453131565,-0.8249305157567326,0.7772277227722773,0.9213336056143794,1.0,6/41,12.96%,NR2F2;KIT;WNT4;SALL1;NCOA4;MSH2
prerank,positive regulation of vasculature development (GO:1904018),0.23760993337100816,0.824778896907019,0.7842857142857143,0.9876313865528025,1.0,16/94,12.62%,PDCL3;HIPK2;PRKD2;RAMP2;TEK;RAPGEF3;SIRT1;PLCG1;WNT5A;TIE1;CYP1B1;FLT1;NOS3;PIK3CD;SP1;CDH5
prerank,folic acid-containing compound metabolic process (GO:0006760),0.31629534055752484,0.8247134497339758,0.6956521739130435,0.9871151070287689,1.0,2/19,6.17%,ALDH1L1;MTHFS
prerank,histone mRNA catabolic process (GO:0071044),-0.31463976617470407,-0.8244227791958652,0.7002237136465325,0.9216416502443655,1.0,6/15,23.79%,EXOSC10;DCP2;ATM;UPF1;ERI1;TUT1
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.2943089727214967,0.8241146248573439,0.7271157167530224,0.987634968163629,1.0,2/27,4.65%,ZC3H12D;RNASE6
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.2300278102955123,0.8236564152865369,0.7939142461964038,0.9878411048720076,1.0,27/100,18.07%,GSK3A;TRIB3;ARIH1;COP1;FOXF2;SMAD7;DESI1;GNA12;MDM2;RAD23A;PARK7;RYBP;CCAR2;PIAS1;ELOB;XPO1;TLK2;GIPC1;RNF180;UCHL5;FBXO22;UBQLN4;TAF1;N4BP1;RAD23B;BBS7;GABARAP
prerank,cellular response to amino acid starvation (GO:0034198),0.24652096651824973,0.8235072525561331,0.7772795216741405,0.9875072384130227,1.0,19/71,19.05%,MAPK3;EIF2S1;RPTOR;ATP6V1D;ATP6V0D1;CDKN1A;MAPK8;LAMTOR1;ATP6V0E1;LARS1;RRAGC;ATP6V1B2;TFEB;KPTN;SESN3;DAPL1;ATP6V1A;SH3GLB1;SESN1
prerank,visual system development (GO:0150063),0.27208568461212146,0.8233459775400773,0.74,0.987161721819072,1.0,4/37,4.88%,ATF6;HIPK2;SOX2;MEIS1
prerank,nucleosome organization (GO:0034728),0.2539188434063255,0.8233070049885657,0.7791601866251944,0.9865894565277573,1.0,14/55,19.08%,DMAP1;NAP1L4;VPS72;RSF1;SMARCD1;ZNHIT1;BRD2;INO80;SMARCA4;SETD2;NPM1;ACTR6;ATRX;SMARCB1
prerank,apoptotic nuclear changes (GO:0030262),-0.27838641163881345,-0.8229110062462317,0.7468982630272953,0.9238596409562193,1.0,17/24,46.63%,DICER1;DFFA;CASP3;ACIN1;EXOG;H1-0;CDK5RAP3;DNASE2;DEDD2;HMGB1;GPER1;HMGB2;ACVR1C;DFFB;TOP2A;FOXL2;BLCAP
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.3629261886297698,0.8229074137487289,0.6761133603238867,0.9867607150795649,1.0,4/10,21.13%,TXN;PARK7;PDE8A;LRRK2
prerank,glial cell development (GO:0021782),-0.26972198339845627,-0.8225074000937707,0.7423887587822015,0.9239887870964922,1.0,17/25,41.94%,CDK6;MXRA8;TPPP;NRROS;PICK1;EIF2B5;CSPG5;MDK;EIF2B2;EIF2B4;MYRF;NSUN5;SOX11;SOX10;MT3;SOX4;EIF2B1
prerank,purine ribonucleotide metabolic process (GO:0009150),0.24770486920744936,0.8219752028794556,0.7650602409638554,0.9880318791982184,1.0,11/68,13.54%,MLYCD;DBI;ACAT1;GPAT4;SULT1A1;RHOQ;BAD;ACOT8;NT5C2;EFL1;GMPR2
prerank,ncRNA export from nucleus (GO:0097064),-0.25014755467505273,-0.8219560213573113,0.7794486215538847,0.924354213126786,1.0,14/36,24.95%,NUP205;NUP155;NUP188;PHAX;NUP88;NUP93;SEH1L;NUP85;AAAS;RAE1;NUP37;NUP214;NCBP2;SEC13
prerank,B cell proliferation (GO:0042100),0.32372424287644436,0.8219527064801052,0.6816479400749064,0.9874173563374129,1.0,1/17,2.03%,PTPRC
prerank,positive regulation of chromatin organization (GO:1905269),0.34412334212117635,0.8219047197998721,0.6869747899159664,0.9868542715690378,1.0,5/12,18.79%,TAL1;ACD;TERF2IP;SIN3A;ATRX
prerank,regulation of microglial cell activation (GO:1903978),0.3306521591306766,0.8218857251804688,0.6910112359550562,0.9862347153705695,1.0,1/15,2.03%,PTPRC
prerank,telomere maintenance (GO:0000723),0.25781214235052563,0.821743094933268,0.7724358974358975,0.985878998949266,1.0,12/50,16.75%,CTC1;ERCC4;DCLRE1B;POLD3;ACD;TERT;HUS1;NBN;LTO1;TERF2IP;ATR;PRKDC
prerank,DNA replication initiation (GO:0006270),0.2752231843445886,0.8216450176462479,0.7305084745762712,0.9854245081121021,1.0,6/37,11.47%,ORC3;POLE;CDC45;ORC4;POLA1;ORC2
prerank,carbohydrate derivative catabolic process (GO:1901136),0.31426365056200806,0.8215985203375039,0.7043010752688172,0.9848744438704918,1.0,3/18,10.86%,BPGM;FUCA1;STT3B
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.36657764218056943,0.8215415161805367,0.6654205607476635,0.9843413238619431,1.0,3/11,14.70%,SIRT1;ING2;CD44
prerank,protein processing (GO:0016485),0.22626064065931178,0.8208007256032172,0.8206896551724138,0.9851793716118302,1.0,10/102,10.03%,PCSK1;PSEN2;MME;SEC11A;METAP2;SPCS3;SPPL3;OMA1;SPRTN;VSIR
prerank,regulation of B cell apoptotic process (GO:0002902),-0.3325924679341626,-0.8207524943816705,0.7131147540983607,0.9259852188952238,1.0,1/12,0.28%,FOXP1
prerank,protein destabilization (GO:0031648),0.2819319468303715,0.8206034536766526,0.7202572347266881,0.9849083076908441,1.0,8/32,12.83%,EP300;CCDC88C;SIRT1;MDM2;RAD23A;CREBBP;PRNP;CUL3
prerank,vasoconstriction (GO:0042310),0.35335739658678134,0.8205790452284445,0.6893203883495146,0.9843036786877848,1.0,3/11,14.60%,EDNRB;ACTA2;PIK3C2A
prerank,organelle transport along microtubule (GO:0072384),0.2868504359439403,0.8204690811281017,0.7467105263157895,0.983890361101311,1.0,8/31,14.53%,DYNC1I1;MAP1S;COPG2;UXT;RAB6A;RAB1A;COPG1;BICD2
prerank,recombinational repair (GO:0000725),0.24053751382779254,0.8200481802484657,0.8064516129032258,0.9840373832429222,1.0,15/77,14.94%,ZSWIM7;ERCC4;YY1;XRCC1;SFPQ;KDM4D;SEM1;RFWD3;EXD2;RAD51B;HUS1;NBN;PSMD14;RMI1;INO80
prerank,polyol biosynthetic process (GO:0046173),0.3303671355166725,0.8193174598920709,0.6963350785340314,0.9848471498522643,1.0,4/16,16.52%,PPIP5K2;ACER3;IP6K2;ITPKB
prerank,positive regulation of lymphocyte differentiation (GO:0045621),-0.2990823411052986,-0.819293748982364,0.7109004739336493,0.9279968303782244,1.0,3/19,5.55%,AXL;MMP14;ZBTB1
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.33162261165414575,0.8191746679257353,0.7118320610687023,0.9845006593980122,1.0,2/15,4.96%,EZH2;PHB2
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.35781887287071057,0.8191514795284695,0.706959706959707,0.983893501299702,1.0,2/11,6.27%,ATL1;LPCAT3
prerank,negative regulation of chemokine production (GO:0032682),0.34166546755064897,0.8188117977704106,0.7063197026022305,0.9839033901934549,1.0,1/14,3.42%,MAP2K5
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.3068655032807819,0.8188000104971723,0.710431654676259,0.9832789199649531,1.0,4/21,9.35%,BIRC2;SOX2;FYN;PCID2
prerank,regulation of response to cytokine stimulus (GO:0060759),-0.28466064353094395,-0.8184864174647849,0.7482517482517482,0.9288425325943859,1.0,4/19,9.34%,CBFB;IRAK1;IFIH1;ELF1
prerank,positive regulation of embryonic development (GO:0040019),-0.2948449603628922,-0.818350906941427,0.7251082251082251,0.9284467266225357,1.0,5/19,14.16%,OSR1;WNT4;NIBAN2;NR2C2;RACK1
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.259566871109622,0.8178211859089399,0.7591125198098256,0.9845803179088939,1.0,15/49,17.79%,BCL2L2;SRC;SGMS1;BCLAF1;BAD;DDX3X;UBQLN1;BMF;PTPMT1;NDUFA13;DDIT3;DNM1L;BECN1;BCAP31;BAX
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.3376447687914695,0.8177246166939682,0.7034220532319392,0.9841296492373997,1.0,4/14,13.20%,MAP2K5;MMRN2;NOTCH1;HDAC5
prerank,regulation of cell size (GO:0008361),0.30698148501574163,0.8176658857957516,0.7023172905525846,0.9836015490815285,1.0,5/23,13.31%,VAV3;RPTOR;AKT1S1;LARS1;PLEK
prerank,protein autoprocessing (GO:0016540),0.3142638330849674,0.817617880034925,0.7142857142857143,0.9830491412422205,1.0,2/17,9.11%,OMA1;SPRTN
prerank,organonitrogen compound catabolic process (GO:1901565),0.24926636261074542,0.8175642724247668,0.761437908496732,0.9825117302801759,1.0,3/57,3.22%,LVRN;AMDHD2;PPT1
prerank,positive regulation of cell death (GO:0010942),0.2518321036203379,0.8175587809747119,0.7596899224806202,0.9818840756008825,1.0,10/59,13.85%,ACER2;EIF2S1;FCGR2B;FYN;SLC6A6;WNT5A;PICALM;PRNP;FAF1;APC
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.2525538865803573,0.817046808725993,0.78125,0.9822682719770139,1.0,20/57,21.15%,RPL35A;RPL5;EMG1;RPS28;RPS24;LTV1;RBIS;WDR12;PAK1IP1;XPO1;LTO1;NPM1;RPL38;RPL26;NVL;RPL7;RPL14;TGS1;GTF3A;SDAD1
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.2825714414776093,-0.8170133719563232,0.7578125,0.9302541314771309,1.0,7/23,19.60%,JAK1;PARP14;IFNGR1;PTPN2;IFNGR2;STAT1;IRGM
prerank,negative regulation of complement activation (GO:0045916),0.3657297665155443,0.8167691628794476,0.6912621359223301,0.9821515299974833,1.0,3/10,18.17%,A2M;CD55;CD46
prerank,extracellular transport (GO:0006858),0.35304148134649166,0.8165546567936693,0.6895910780669146,0.9819109504582888,1.0,1/12,2.17%,CABYR
prerank,regulation of actin nucleation (GO:0051125),-0.3322632334178651,-0.8164862376129639,0.7048832271762208,0.930553935848109,1.0,5/12,28.76%,GSN;WASHC5;ARFIP2;PICK1;ARPIN
prerank,insulin receptor signaling pathway (GO:0008286),0.24322680648856906,0.8164146810171938,0.7820895522388059,0.9815361036459674,1.0,21/69,18.86%,GSK3A;BCAR3;ATP6V1D;ATP6V0D1;AP3S1;IRS2;ATP6V0E1;RHOQ;ATP6AP1;GRB14;APC;PIK3C2A;ATP6V1B2;NAMPT;SHC1;BAIAP2;INSR;C2CD5;ATP6V1A;IRS1;ZNF106
prerank,regulation of long-term synaptic potentiation (GO:1900271),-0.27077186093525235,-0.815986991694539,0.7645631067961165,0.9309049879144371,1.0,6/28,10.62%,ADCY1;RELN;YTHDF1;LGMN;GSK3B;EPHB2
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.2998260088916646,-0.8155119534815768,0.7068965517241379,0.9310958789313135,1.0,9/16,31.78%,PARP14;PIBF1;NF2;PTPN2;HGS;VHL;INPP5F;BCL3;CAV1
prerank,macrophage chemotaxis (GO:0048246),0.3670001456651184,0.8153884390248466,0.6645962732919255,0.9828953411708122,1.0,1/10,8.25%,EDNRB
prerank,regulation of p38MAPK cascade (GO:1900744),-0.2528309844487749,-0.8149409598304708,0.7858942065491183,0.9315429002710371,1.0,8/35,14.82%,SASH1;CYLD;XDH;EZR;ULK4;PER1;DLG1;PTPN22
prerank,RNA biosynthetic process (GO:0032774),-0.2568793921376222,-0.8149316551351976,0.7640449438202247,0.9309057185950271,1.0,14/31,32.64%,NCOA6;POLR2A;SETX;TAF6;TAF12;PRIM2;GTF2B;TAF13;SMN1;PRMT5;POLA2;PRIM1;TAF7;TAF5
prerank,positive regulation of transforming growth factor beta production (GO:0071636),-0.3402531430694475,-0.8146601095081457,0.731404958677686,0.9307593139215224,1.0,4/11,19.91%,THBS1;CD34;BMPR1A;PTGS2
prerank,histone deubiquitination (GO:0016578),0.31502255291094317,0.8145580955084364,0.7035714285714286,0.9838561076378175,1.0,7/18,19.50%,ATXN7L3;USP22;USP15;TRRAP;BRCC3;USP36;UIMC1
prerank,mitotic cytokinetic process (GO:1902410),-0.2909478763674259,-0.8143402591831245,0.7450549450549451,0.9307184684416919,1.0,7/20,25.32%,RHOA;KLHDC8B;MITD1;CHMP2B;CHMP5;VPS4A;CNTROB
prerank,vitamin transport (GO:0051180),0.2865399135902359,0.8141075887761081,0.7416107382550335,0.9841197744946191,1.0,3/29,5.01%,ABCG2;SLC52A2;SLC52A3
prerank,amide transport (GO:0042886),-0.26438335512949795,-0.8140242882692141,0.756152125279642,0.9306634318502189,1.0,9/26,24.93%,PDPN;PLEKHA8;SLC25A32;SLC27A1;SLC19A1;SLC5A6;GLTP;ABCB9;AQP11
prerank,regulation of organelle assembly (GO:1902115),0.24084239108800432,0.8140070396229433,0.8052959501557633,0.9836693686261243,1.0,13/72,13.25%,ALMS1;PLK2;TBC1D8;VPS11;TBC1D10B;USP6NL;PIKFYVE;TBC1D12;IFT140;ADPRH;TBC1D24;TBC1D14;RABGAP1
prerank,telomere maintenance via telomere trimming (GO:0090737),-0.3478391638356363,-0.8136037066363986,0.7190775681341719,0.9294813725962726,1.0,6/10,36.61%,SMARCAL1;BLM;SLX4;TERF1;ERCC1;DNA2
prerank,formation of extrachromosomal circular DNA (GO:0001325),-0.3478391638356363,-0.8136037066363986,0.7190775681341719,0.9294813725962726,1.0,6/10,36.61%,SMARCAL1;BLM;SLX4;TERF1;ERCC1;DNA2
prerank,t-circle formation (GO:0090656),-0.3478391638356363,-0.8136037066363986,0.7190775681341719,0.9294813725962726,1.0,6/10,36.61%,SMARCAL1;BLM;SLX4;TERF1;ERCC1;DNA2
prerank,regulation of mast cell activation (GO:0033003),0.3592170018114978,0.8135489138004055,0.6913827655310621,0.9839351782295408,1.0,2/10,9.52%,LYN;CD84
prerank,cilium-dependent cell motility (GO:0060285),0.30739453521218085,0.8134424067345809,0.7368421052631579,0.9835090986128974,1.0,2/22,5.93%,DNAH3;RFX3
prerank,cellular glucan metabolic process (GO:0006073),-0.3437497254772261,-0.8133470080645766,0.7261410788381742,0.9293026356243128,1.0,4/11,19.40%,PRKAG2;GSK3B;PYGM;PHKG2
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.23670058772979022,0.8132337758619596,0.8166189111747851,0.983271247288177,1.0,10/82,10.48%,ALMS1;HAUS4;HAUS5;CEP41;TUBB;DCTN2;ODF2;CEP164;DCTN3;DYNLL1
prerank,negative regulation of protein-containing complex assembly (GO:0031333),-0.23329571545169187,-0.8132084808792364,0.7803617571059431,0.9288882937101473,1.0,14/49,19.25%,LDLRAD4;PRKCZ;JAM3;SORL1;SMAD6;GSK3B;HSF1;PPM1A;DACT1;RAF1;PEX5;CDC42;CRYAB;RIOK3
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.341341344025325,0.8131725945708741,0.726027397260274,0.982758860095413,1.0,1/13,5.41%,CYRIB
prerank,positive regulation of cellular metabolic process (GO:0031325),0.23003562972664046,0.8131713930554222,0.7988826815642458,0.9821257172791985,1.0,12/98,9.96%,ROMO1;CHCHD2;IFNLR1;GREM1;PAX8;APOE;CDKN1A;PPARD;ACACB;RAB1A;IL10RB;IFNAR1
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.3265706278282835,0.8128476515740596,0.7276190476190476,0.9821595875104646,1.0,3/16,16.59%,TRIB3;ERLIN2;ACADL
prerank,regulation of mononuclear cell migration (GO:0071675),0.29878055923036073,0.812779734019726,0.7215189873417721,0.9816565650008748,1.0,3/23,9.31%,MAPK3;CSF1R;LYN
prerank,cellular response to oxygen levels (GO:0071453),0.3657999379615507,0.8126522231686937,0.6939571150097466,0.9812736111813427,1.0,3/10,10.69%,ATP6V0D1;NDUFS2;ATP6AP1
prerank,positive regulation of protein depolymerization (GO:1901881),-0.33915031576915966,-0.8124258818389709,0.708984375,0.9296301211473881,1.0,4/11,19.13%,STMN2;WDR1;NES;SEMA5A
prerank,translesion synthesis (GO:0019985),-0.2387546899002548,-0.8119757561245281,0.8179419525065963,0.9297966719555848,1.0,30/42,46.52%,RFC1;RCHY1;ZBTB1;VCP;RPA1;UBC;NPLOC4;POLDIP2;USP10;PRIMPOL;RFC2;POLN;PCNA;POLE2;POLI;UBE2L6;ISG15;REV3L;FAAP20;RPA3;RFC3;MAD2L2;UBA52;USP43;POLD2;RPA2;PCLAF;RFC4;POLD4;POLD1
prerank,positive regulation of interferon-beta production (GO:0032728),-0.24773591650207555,-0.8115567027013574,0.7956204379562044,0.9299133992922458,1.0,15/33,37.15%,IFIH1;RNF135;POLR3C;MAVS;RIOK3;FLOT1;TLR3;OAS2;HSP90AA1;POLR3G;TOMM70;TLR7;POLR3D;ISG15;DHX58
prerank,autonomic nervous system development (GO:0048483),-0.2966950543467277,-0.8114817077193677,0.7543478260869565,0.929410112826372,1.0,3/17,11.11%,NRP1;SEMA3A;FN1
prerank,peptidyl-arginine modification (GO:0018195),0.3304173790288928,0.8113468718819952,0.7192307692307692,0.9831651108312393,1.0,2/15,9.76%,NDUFAF5;PARK7
prerank,regulation of neurotransmitter secretion (GO:0046928),0.28057195288974834,0.8109974074902433,0.7474226804123711,0.9832528615875007,1.0,8/32,17.22%,PNKD;PREPL;DTNBP1;MCTP2;MCTP1;SNAPIN;VPS18;SLC30A1
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.26901205725503385,0.8100412788514512,0.7681388012618297,0.9844401975187479,1.0,4/37,9.23%,NCBP1;NUDT5;RNASE6;XRN2
prerank,regulation of cholesterol metabolic process (GO:0090181),0.3056687205095629,0.8100084102569595,0.7213114754098361,0.9838710229332195,1.0,6/20,16.80%,APOE;LPCAT3;MBTPS1;LDLRAP1;ACADL;KPNB1
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.3333225253612578,0.8099936171436205,0.7111517367458866,0.9832615350331734,1.0,3/14,12.57%,SYK;CD81;CD55
prerank,regulation of lipase activity (GO:0060191),-0.323569480609337,-0.8099510667945228,0.7314410480349345,0.931536129716937,1.0,3/13,13.47%,PCSK5;RHOA;PCSK6
prerank,purine nucleotide biosynthetic process (GO:0006164),0.3478718594707446,0.8096998798342046,0.6990291262135923,0.9831690963026049,1.0,2/12,6.35%,PRPS1L1;PRPS1
prerank,PERK-mediated unfolded protein response (GO:0036499),0.3669204750805635,0.8095559244191951,0.6841121495327103,0.9827991917585841,1.0,3/10,16.59%,EIF2S1;DDIT3;QRICH1
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.28990434226477485,0.8088542055559969,0.7486631016042781,0.9835042731850497,1.0,5/24,15.57%,PTPRJ;TEK;TSC1;MAP4K4;ARF6
prerank,cellular response to estrogen stimulus (GO:0071391),0.3220321016463866,0.8088244462627713,0.6989247311827957,0.9829293393265206,1.0,2/14,10.39%,ARID5A;WBP2
prerank,negative regulation of programmed cell death (GO:0043069),0.19912744460861542,0.8086230274099233,0.9341950646298472,0.9826736927937442,1.0,46/355,12.73%,HIGD2A;GCLC;MECOM;CBL;LEF1;PSEN2;PLK2;RPS6KA1;BCL2L2;GREM1;PPT1;SRC;BIRC2;HDAC3;TEK;RAB7A;CIAPIN1;HNRNPK;PHB2;WFS1;CFL1;CIB1;MAPK8;BAG1;PIM1;SIRT1;NAA35;USP47;WNT5A;TJP1;RELA;PCID2;PARK7;TMBIM4;CITED2;PRKAA2;DDX3X;HIGD1A;ANKLE2;PA2G4;BNIP3L;PRKCI;MAP4K4;IKBKB;API5;ERC1
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.303163815643511,0.8082376529684426,0.7073608617594255,0.9827723504490428,1.0,5/22,11.77%,MAP3K4;MINK1;PJA2;MFHAS1;RELL1
prerank,icosanoid metabolic process (GO:0006690),-0.23819470872210474,-0.8078315873342128,0.8090692124105012,0.9347573422150905,1.0,20/40,46.44%,PLA2G4A;EPHX1;PTGIS;GGT5;PTGS2;GPX1;TBXAS1;MAPKAPK2;ABCC10;FADS1;ALOX12;PTGS1;PLA2G4C;DAGLA;FAAH;CYP2S1;LTA4H;PTGR1;MGLL;GGT1
prerank,heart morphogenesis (GO:0003007),-0.2308559801865149,-0.8077478868038389,0.8438356164383561,0.9342517371932187,1.0,11/50,19.72%,TGFBR3;FLRT2;TGFBR1;NIPBL;EPHB4;ACVR1;TBX3;PTK2;MDM4;BMPR1A;OLFM1
prerank,cell junction maintenance (GO:0034331),-0.3113221876099413,-0.8077254715675575,0.7062634989200864,0.9336425061591197,1.0,3/14,15.74%,NLGN2;MYADM;DCTN1
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.2644479179385563,0.807713158459803,0.7487179487179487,0.9831364854810729,1.0,7/38,10.76%,TRIB3;PTPRJ;CIB1;SIRT1;DAG1;PHLPP1;OTUD3
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.3225516891619814,0.807634790653728,0.7054409005628518,0.9826630168835597,1.0,3/15,13.34%,NEK11;HUS1;CHEK2
prerank,organic substance transport (GO:0071702),-0.19392058687880626,-0.8066303990495974,0.9077490774907749,0.9349185731176812,1.0,24/121,15.92%,CALCRL;ABCA9;SLC47A1;SNX4;ARRDC3;LRP1B;ABCA4;ABCA5;TCN2;SLC35F3;PLEKHA8;SLC22A4;SCAMP2;FLVCR1;KIF3A;ABCA1;CHKA;RAMP1;ABCD2;VAMP2;SLC22A6;RCN3;SCAMP5;SLC19A1
prerank,acylglycerol catabolic process (GO:0046464),0.2742907149613662,0.8062275728412005,0.7626016260162601,0.9846573991644785,1.0,29/30,65.44%,FABP7;ABHD12;ABHD16A;FABP2;PNLIPRP2;PNPLA1;PNPLA5;LIPI;ABHD12B;APOC3;FABP6;CPS1;APOA2;LIPG;ABHD6;FABP12;FABP4;ABHD2;LIPC;LIPH;FABP3;MGLL;FAAH;DAGLA;PNPLA3;FABP5;LPL;PNPLA2;LYPLA2
prerank,positive regulation of actin filament polymerization (GO:0030838),0.2606545644653136,0.805660022458185,0.7720706260032103,0.9850796395403966,1.0,10/44,17.44%,VASP;EVL;ARPC4;PFN1;CDC42EP3;LMOD1;WHAMM;ARF6;PTK2B;BAIAP2
prerank,ruffle organization (GO:0031529),-0.296846627576307,-0.8055995586322887,0.7190775681341719,0.9361192352366368,1.0,3/16,6.02%,LIMA1;TPM1;PIP5K1A
prerank,protein localization to lysosome (GO:0061462),-0.25856159004799895,-0.8054825947077532,0.78125,0.9356641871311437,1.0,14/28,27.39%,SORL1;ZFYVE16;NCOA4;M6PR;AP4M1;GGA3;SZT2;NEDD4;MFSD1;VPS4A;HGS;LAMTOR5;LMBRD1;SH3BP4
prerank,negative regulation of phagocytosis (GO:0050765),-0.29506677964970984,-0.8048058593542357,0.762114537444934,0.9362235684503547,1.0,7/17,22.56%,PIP4P2;PLSCR1;SYT11;SIRPA;RACK1;SNX3;APPL1
prerank,visual perception (GO:0007601),0.2307951671540329,0.804663287246597,0.8192252510760402,0.9863048474453531,1.0,8/84,10.37%,RS1;ATF6;WFS1;DRAM2;EYA3;MYO9A;PITPNA;ABLIM1
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.29964046344816175,0.8039877054281467,0.7404021937842779,0.9869338084848646,1.0,5/22,13.85%,CDK5RAP1;CDKN1A;LATS2;TFAP4;APC
prerank,regulation of plasminogen activation (GO:0010755),0.3391504550193143,0.8038601967279674,0.7341772151898734,0.9865338597925317,1.0,1/12,1.93%,PLGRKT
prerank,lipid oxidation (GO:0034440),0.352103098467891,0.8036251186467969,0.7253384912959381,0.9863279402129757,1.0,2/12,11.08%,ADIPOR2;ADIPOR1
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.22596477786078142,0.8034273118851868,0.8375184638109305,0.9860856949989829,1.0,15/88,14.53%,ILF3;PATL2;APOE;FXR1;PAIP2B;EDNRB;CNOT7;TSC1;DDX3X;NANOS3;RPS3;PLAT;YBX1;CNOT1;CAPRIN1
prerank,carboxylic acid catabolic process (GO:0046395),0.3372370536614364,0.8032879966571848,0.7330754352030948,0.985723036142029,1.0,2/12,11.77%,AMDHD2;ACOT8
prerank,protein secretion (GO:0009306),-0.21873498348729636,-0.8030367815685756,0.8440111420612814,0.9387286338460099,1.0,14/56,18.72%,WLS;TANGO2;PCSK5;RAB3C;RAB8B;MON1A;ANXA1;ABCA1;STEAP3;RCN3;OLFM2;RAB8A;SCG2;MTTP
prerank,mitochondrion transport along microtubule (GO:0047497),0.33730426710835204,0.8028068169395643,0.7003676470588235,0.9859820477914175,1.0,2/13,7.04%,MAP1S;UXT
prerank,regulation of sister chromatid cohesion (GO:0007063),-0.3317022747460403,-0.8026829904879241,0.73568281938326,0.9387125230385454,1.0,1/12,3.91%,CTNNB1
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.3138720881490644,0.8026229404183237,0.719626168224299,0.9856987500107977,1.0,2/17,5.79%,ALG6;ALG8
prerank,protein targeting to membrane (GO:0006612),0.2357659797583046,0.8026124056045868,0.8323529411764706,0.9850954660185272,1.0,14/83,14.49%,RTP3;CHM;SGTB;ZDHHC14;PIKFYVE;PXMP2;ZDHHC15;ICMT;VPS37B;SEC62;PRKCI;ZDHHC9;ZDHHC7;PARD3
prerank,protein O-linked mannosylation (GO:0035269),-0.2879473051651529,-0.8021649025961265,0.771551724137931,0.9389969767466522,1.0,6/18,13.05%,TMTC4;TMTC1;DPM1;RXYLT1;LARGE1;FKTN
prerank,protein hydroxylation (GO:0018126),0.32656656612634655,0.8020189295629478,0.7355072463768116,0.9855413739421834,1.0,3/15,10.90%,JMJD4;P3H2;PLOD3
prerank,cellular response to unfolded protein (GO:0034620),0.29073903527712674,0.8016101257022822,0.7625,0.9856806609428972,1.0,2/26,1.88%,ABCB10;HSPA8
prerank,regulation of autophagosome maturation (GO:1901096),0.33905311059915644,0.8011336162758598,0.7269303201506592,0.9859515973140291,1.0,4/13,15.32%,FYCO1;TBC1D25;TMEM39A;UBQLN4
prerank,modulation by host of symbiont process (GO:0051851),0.2789807703531339,0.8010767504864182,0.7541528239202658,0.9854328899138498,1.0,6/31,12.41%,LEF1;EP300;TFAP4;TARDBP;CHD1;SP1
prerank,positive regulation of protein deacetylation (GO:0090312),0.3367351817546828,0.8009353998883987,0.7158469945355191,0.9850851886952819,1.0,3/14,11.22%,AKAP8L;ING2;CTBP1
prerank,hippo signaling (GO:0035329),0.2850853916228618,0.8008456664643541,0.7396551724137931,0.984628858896594,1.0,5/26,9.10%,AMOTL1;YWHAB;TJP1;LATS2;MOB1B
prerank,melanosome organization (GO:0032438),0.2864253673534921,0.8008271887565074,0.7272727272727273,0.9840404613610914,1.0,6/26,16.44%,DTNBP1;AP1G1;PIKFYVE;KIF13A;SNAPIN;BLOC1S5
prerank,cellular response to superoxide (GO:0071451),0.35976758809497855,0.8007659545896016,0.6959847036328872,0.9835225476571949,1.0,3/10,11.15%,SOD1;SOD2;NOS3
prerank,positive regulation of bone resorption (GO:0045780),0.3422788058190648,0.8006040834544235,0.7250922509225092,0.9831705985494646,1.0,2/11,10.69%,SYK;ATP6AP1
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.32350901244959335,0.80056241556879,0.7333333333333333,0.9826245324801888,1.0,1/16,0.61%,IMPDH1
prerank,regulation of superoxide anion generation (GO:0032928),0.33229079100621733,0.8001270421751184,0.6927374301675978,0.9828212459848316,1.0,2/14,6.70%,SOD1;SYK
prerank,steroid biosynthetic process (GO:0006694),0.247032437070993,0.8000894195985178,0.8120184899845917,0.9822668915416681,1.0,9/56,13.79%,EBP;INSIG1;HMGCR;SC5D;OSBPL1A;HSD17B4;ACOT8;LSS;OSBPL2
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),-0.2839456445516524,-0.7998298636660308,0.7775229357798165,0.9423038848543903,1.0,7/20,26.72%,EGFR;PKD1;CCND3;CCNYL1;AKT1;SPDYA;TTBK1
prerank,negative regulation of autophagy (GO:0010507),-0.22393580621366233,-0.7997107633443056,0.8567708333333334,0.9418441124876091,1.0,16/54,20.77%,SNRNP70;LEPR;SIRT2;NUPR1;KDM4A;KLHL22;GOLGA2;NRBP2;CTSA;MTMR9;PTPN22;QSOX1;FOXK1;MET;PINK1;BCL2
prerank,regulation of mRNA polyadenylation (GO:1900363),0.3149573014187641,0.7996840260124429,0.7495495495495496,0.9823808490800392,1.0,5/17,15.81%,NCBP1;CPSF6;ZC3H14;RNF20;ZC3H3
prerank,telomere maintenance via telomerase (GO:0007004),-0.2594555003968769,-0.7994722841800784,0.7991266375545851,0.9416358169021043,1.0,15/28,34.30%,RFC1;RAD50;TNKS1BP1;MRE11;RPA1;PPP6C;PPP6R3;RTEL1;TELO2;HSP90AA1;CDK2;TERF1;TERF2;GAR1;TINF2
prerank,positive regulation of intracellular transport (GO:0032388),0.26513313748652423,0.7991972367504785,0.7698412698412699,0.9826961983963537,1.0,5/38,9.94%,PRR5L;ZFAND1;ICE1;RUFY3;EIPR1
prerank,positive regulation of interleukin-12 production (GO:0032735),0.27960970531012197,0.7991414300983088,0.7653061224489796,0.9821624803315254,1.0,3/31,9.59%,TIRAP;SYK;PLCB1
prerank,regulation of lymphocyte differentiation (GO:0045619),0.30658991609944575,0.7988380227172537,0.7476635514018691,0.982090489880311,1.0,1/18,4.13%,ZFP36L1
prerank,regulation of astrocyte differentiation (GO:0048710),0.338939103096322,0.7988251013413579,0.7320754716981132,0.9814999425656117,1.0,3/12,16.05%,NOTCH1;HES1;ID2
prerank,positive regulation of behavior (GO:0048520),-0.3370487784379844,-0.7988064736671555,0.7349896480331263,0.9420871775514642,1.0,4/10,23.37%,CFAP20;NLGN1;NPAS2;STRA6
prerank,phospholipid translocation (GO:0045332),0.2790063453300544,0.7987603483050283,0.7716666666666666,0.9810097932190657,1.0,6/28,13.90%,ATP8A1;ATP11A;TMEM30B;P2RX7;ATP11C;ATP10A
prerank,regulation of actin filament polymerization (GO:0030833),0.2336972186811032,0.7975655764439554,0.8399412628487518,0.9825578997732635,1.0,16/69,18.87%,VASP;EVL;PFN1;CYRIB;KANK3;SSH2;PAK3;ESAM;CDC42EP3;TWF1;LMOD1;ARF6;PTK2B;BAIAP2;ARFGEF1;PRKCE
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.24188333028542194,0.7972498016461241,0.8197492163009404,0.9825230225506523,1.0,6/66,4.67%,RBM22;TRIM28;DMAP1;CCT2;HDAC3;CCT5
prerank,maturation of 5.8S rRNA (GO:0000460),-0.293281052835759,-0.796084636612779,0.7667386609071274,0.9460829850216042,1.0,8/17,23.72%,NSA2;EXOSC10;LAS1L;MTREX;C1D;RPF1;NOL9;MAK16
prerank,mitotic nuclear membrane reassembly (GO:0007084),-0.22277505762148792,-0.7957527326844941,0.8390501319261213,0.9453400825277443,1.0,19/51,25.22%,SIRT2;PPP2R2A;LMNA;NUP205;IST1;NUP155;NUP188;AHCTF1;NUP93;SEH1L;CHMP2B;NUP85;CC2D1B;NUP37;VPS4A;EMD;LEMD2;SEC13;LBR
prerank,mitotic nuclear membrane organization (GO:0101024),-0.22277505762148792,-0.7957527326844941,0.8390501319261213,0.9453400825277443,1.0,19/51,25.22%,SIRT2;PPP2R2A;LMNA;NUP205;IST1;NUP155;NUP188;AHCTF1;NUP93;SEH1L;CHMP2B;NUP85;CC2D1B;NUP37;VPS4A;EMD;LEMD2;SEC13;LBR
prerank,phosphatidylethanolamine metabolic process (GO:0046337),-0.2589930203650672,-0.7954833544236224,0.8004866180048662,0.9451510598666754,1.0,11/27,27.57%,NAPEPLD;LPIN1;CHKA;SLC27A1;ETNK2;PCYT2;PLA2G6;LPIN2;CHKB;NAAA;LPIN3
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.3133708567076194,0.7951065107492937,0.7574626865671642,0.9857563242203541,1.0,5/18,12.41%,GSK3A;EFNA1;RELA;PICALM;SP1
prerank,positive regulation of supramolecular fiber organization (GO:1902905),-0.20289907516189895,-0.7950892034497931,0.9047619047619048,0.9451640051711588,1.0,21/86,21.72%,NAV3;MAPT;OCLN;FER;CTTN;STMN2;AKAP9;SLAIN2;BIN1;SYNPO2;BAIAP2L1;FCHSD2;WDR1;CDC42EP5;DCTN1;CDC42EP1;SEMA5A;MET;CX3CL1;EFEMP2;PFN2
prerank,endoplasmic reticulum organization (GO:0007029),0.23507069592397517,0.7950354477590387,0.8151382823871907,0.9852664484880852,1.0,10/72,11.92%,REEP1;SMPD4;LMAN2;ATL1;LPCAT3;REEP3;DOP1B;APP;ZBED3;PRNP
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.31348232039348944,0.794829250131976,0.714828897338403,0.985014125170941,1.0,6/17,18.94%,SPRED1;CALM3;SMAD7;PARD3;CALM1;EIF4G1
prerank,mitotic sister chromatid segregation (GO:0000070),0.2226679360280338,0.79456845065682,0.8553370786516854,0.9848762335633193,1.0,15/98,14.94%,KIF18A;NUDC;BOD1;DCTN2;TENT4A;CHMP1A;CDCA8;AKAP8L;CHMP2A;MIS12;CUL3;POGZ;PHF8;CSNK2A2;INO80
prerank,protein monoubiquitination (GO:0006513),0.2656678681250255,0.7944515527525248,0.7949152542372881,0.9844665195639688,1.0,8/36,14.31%,RAD18;TRIM25;ATXN7L3;UBE3D;CUL3;UBE2R2;RNF20;FANCL
prerank,histone H3-K4 trimethylation (GO:0080182),-0.33766864752187464,-0.7943499180715008,0.7550607287449392,0.945717294287978,1.0,2/11,2.13%,OGT;KMT2A
prerank,response to ketone (GO:1901654),-0.2667550056323337,-0.7943180014283596,0.7719298245614035,0.9451201162656202,1.0,9/24,33.82%,TGFBR3;THBS1;TGFB1;CATSPER2;YAP1;TGFB3;CAV1;ABCB4;CATSPER3
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.22640543491167126,0.7939512246216808,0.845925925925926,0.984754831222936,1.0,15/88,13.81%,TAL1;SLF1;TIRAP;PFN1;RAB7A;ICE1;SYK;RGCC;PARK7;CHMP2A;RPS3;BMF;CDH5;PLEK;FAF1
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.2778199861861155,0.7939119892119535,0.7545304777594728,0.9842164275048473,1.0,7/27,15.84%,SPRED1;PTTG1IP;SIRT1;YJU2;MDM2;CD44;ATR
prerank,protein tetramerization (GO:0051262),0.23854333985052767,0.7938543226109199,0.8133748055987559,0.9837105692547149,1.0,11/67,14.95%,THG1L;GLS;B2M;SSBP1;ACACB;SOD2;CPSF6;TRPM4;CUTC;OSBPL2;HOMER1
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.28646659276924097,0.7937899784223016,0.7586206896551724,0.9832104620931393,1.0,9/26,19.35%,TRIB3;ADIPOR2;PRKAA2;ERLIN2;ADIPOR1;ACADL;EIF6;ELOVL5;NR1H3
prerank,regulation of cell death (GO:0010941),0.22453401842709217,0.7929798678762442,0.8641063515509602,0.9840650047461246,1.0,18/94,17.16%,RAD18;SNCG;SLC25A24;TXNDC12;ACER2;TNFRSF1B;TSC1;PARK7;CHMP2A;ACER3;BNIP3L;FAF1;APC;SPEF1;VPS35;BNIP3;BECN1;PDE8A
prerank,negative regulation of cholesterol transport (GO:0032375),-0.33986300482261356,-0.7929195225198993,0.7624190064794817,0.9468138535692372,1.0,2/10,31.27%,NFKB1;ABCA2
prerank,negative regulation of kinase activity (GO:0033673),0.23810536744710525,0.7924410911467382,0.8039816232771823,0.9844304953722351,1.0,8/62,9.76%,TRIB3;PTPRC;GNAQ;SPRED1;AKT1S1;DTNBP1;IRS2;PARK7
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.33620437687005733,0.7923794197192557,0.7282415630550622,0.983922358764422,1.0,4/13,16.35%,SYK;CD81;CD9;CDH13
prerank,synaptic vesicle localization (GO:0097479),-0.3066442220795591,-0.7919979635323942,0.7505112474437627,0.947717669366668,1.0,4/13,15.75%,KIF5C;SYNDIG1;NLGN1;KIF5A
prerank,regulation of histone deacetylation (GO:0031063),0.3351598808783867,0.7918358843453586,0.7339449541284404,0.9842942913633895,1.0,3/13,11.22%,AKAP8L;ING2;CTBP1
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.3522118149039562,0.7918141425362026,0.7373737373737373,0.9837307369088463,1.0,1/10,0.91%,NCBP1
prerank,cellular component disassembly (GO:0022411),0.24616454272438787,0.7916499666291833,0.8141993957703928,0.9834155194669743,1.0,4/53,4.44%,LCP1;BSG;EXOC8;MMP12
prerank,integrated stress response signaling (GO:0140467),0.3350073030739176,0.7910654743486328,0.7319778188539742,0.9838068945440567,1.0,4/14,16.59%,EIF2S1;OMA1;DDIT3;QRICH1
prerank,regulation of receptor recycling (GO:0001919),-0.29163229221175413,-0.7902478700462164,0.7580993520518359,0.9499423227694134,1.0,7/16,30.12%,ANXA2;OPTN;TBC1D16;RAB29;INPP5F;SNCA;SCRIB
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.29937667036578497,0.78987111571821,0.763668430335097,0.9853172669783095,1.0,6/20,18.20%,PSEN2;RELA;MBTPS1;APH1A;ADAM9;SPPL2A
prerank,arachidonic acid secretion (GO:0050482),-0.339261146959169,-0.7897665766018032,0.7569721115537849,0.94943420025634,1.0,4/10,30.46%,ANXA1;ACE;BDKRB2;DRD2
prerank,arachidonate transport (GO:1903963),-0.339261146959169,-0.7897665766018032,0.7569721115537849,0.94943420025634,1.0,4/10,30.46%,ANXA1;ACE;BDKRB2;DRD2
prerank,regulation of centrosome cycle (GO:0046605),0.2939325275303071,0.789460034330017,0.7466666666666667,0.9854298228106801,1.0,5/21,18.09%,CHMP1A;SIRT1;CHMP2A;NPM1;VPS4B
prerank,extracellular matrix disassembly (GO:0022617),0.24597023448626879,0.7893578566480424,0.8121212121212121,0.984993366657932,1.0,4/53,4.44%,LCP1;BSG;EXOC8;MMP12
prerank,synaptic vesicle membrane organization (GO:0048499),-0.29114125658236145,-0.7892720052105424,0.7597402597402597,0.9496208339807427,1.0,9/17,31.85%,SNAP25;STX3;STX1A;SNAP29;SYP;STX1B;AP3D1;SYNGR1;TOR1A
prerank,positive regulation of leukocyte migration (GO:0002687),-0.25142438380837856,-0.7892292159241852,0.785377358490566,0.9490469759037855,1.0,8/27,35.12%,IL6R;JAM3;VEGFA;NCKAP1L;MDK;PTN;THY1;EDN3
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.23856545807750118,0.7889238167885702,0.8184615384615385,0.9851556962296524,1.0,9/72,9.68%,ERCC3;ERCC4;RNASE6;POLK;POLD3;GTF2H1;XRN2;DXO;EXD2
prerank,protein localization to Golgi apparatus (GO:0034067),0.2793077848927484,0.7887491155945613,0.7668308702791461,0.9848413324685857,1.0,6/27,10.13%,ARL5C;RAB6A;TMED10;ARL5B;ZDHHC15;GCC2
prerank,base-excision repair (GO:0006284),0.25196394310915443,0.7887047824441403,0.8247078464106845,0.9843039294084053,1.0,8/48,13.19%,PNKP;XRCC1;TDG;POLE;POLD3;USP47;SMUG1;MPG
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.27497839394785706,0.7886528143541416,0.7777777777777778,0.9837874909991462,1.0,5/28,12.78%,CXCL12;PFN1;PAK3;ESAM;NAA80
prerank,cell-cell junction maintenance (GO:0045217),0.33659233029929436,0.7885371040477178,0.7033398821218074,0.9833765057169035,1.0,2/11,9.17%,TJP1;CSF1R
prerank,regulation of interleukin-10 production (GO:0032653),0.2524682950972895,0.7883747793188387,0.8096,0.9830696515808494,1.0,5/44,13.00%,FCGR2B;SYK;CD47;VSIR;CD274
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.2692807836541139,0.7882690179714217,0.7922297297297297,0.9826511756823214,1.0,4/33,9.19%,TNFAIP3;PRKG1;CDKN1A;SOD2
prerank,cellular response to hormone stimulus (GO:0032870),0.23304729504141503,0.7880869478306093,0.8205128205128205,0.9823552731156715,1.0,9/69,10.75%,ARID5A;GAS2L1;SRC;PAX8;ZFP36L1;RAMP2;LMO2;WBP2;THRB
prerank,mitotic DNA replication (GO:1902969),0.36086302555955946,0.7880167499279981,0.7277882797731569,0.9818787317482154,1.0,2/10,9.29%,CDC45;POLA1
prerank,regulation of monocyte chemotaxis (GO:0090025),0.2860360786819981,0.788010476889315,0.7491103202846975,0.9812870521143303,1.0,3/24,9.31%,CXCL12;GREM1;LYN
prerank,vesicle transport along actin filament (GO:0030050),0.30311538507792524,0.7878895614953517,0.7495652173913043,0.9808869887407816,1.0,4/19,13.12%,MYO5A;ACTN4;MYO1D;MYO1E
prerank,positive regulation of leukocyte activation (GO:0002696),-0.28732744334381444,-0.787489793039993,0.7789256198347108,0.9512577357215083,1.0,6/18,27.50%,LBP;THBS1;IL33;HSPD1;NECTIN2;KARS1
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.3258981893511491,-0.7874052512590087,0.7723404255319148,0.9507374425145962,1.0,6/11,24.50%,LDLR;SLC27A1;GPLD1;SREBF1;CTDNEP1;NR1H2
prerank,positive regulation of MAP kinase activity (GO:0043406),0.23479082672230403,0.7872606173267648,0.838810641627543,0.981384033030349,1.0,9/66,11.82%,MAP3K11;PIK3CG;EZH2;MAP3K7;MAP3K4;PAK1;FLT1;RPS3;PIK3R5
prerank,regulation of endocytic recycling (GO:2001135),-0.3260250408750099,-0.7868471575714222,0.7372708757637475,0.9510788782496027,1.0,4/11,16.53%,ATP9A;SORL1;ACTN2;EHD1
prerank,aminoglycan catabolic process (GO:0006026),0.2766593592590433,0.7866105296313753,0.7861952861952862,0.981936539199413,1.0,6/28,12.34%,SGSH;GLB1;FUCA1;HGSNAT;AGRN;IDS
prerank,microtubule anchoring at centrosome (GO:0034454),-0.3299481730829784,-0.7859505322907865,0.7592954990215264,0.9519211914161455,1.0,3/10,15.74%,NINL;KIF3A;DCTN1
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.3150781960406448,0.7857967248021835,0.7593582887700535,0.9827601569161315,1.0,1/16,0.39%,BCAP29
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.2571491596823018,0.785710892727501,0.781786941580756,0.9822991262557018,1.0,12/39,18.36%,ACER2;NEXMIF;ACTN4;NOTCH1;HOXA7;MAP4K4;AP1AR;CORO2B;SEMA3E;MELTF;CORO1C;CASK
prerank,negative regulation of leukocyte activation (GO:0002695),-0.30103476318356126,-0.7856436719612554,0.7574468085106383,0.9517426817961948,1.0,2/15,7.05%,LRFN5;IL31RA
prerank,response to interleukin-1 (GO:0070555),-0.20499844351811233,-0.7855098404290802,0.8885714285714286,0.9512925840366031,1.0,13/73,16.28%,ADAMTS12;HDAC4;RBMX;IRAK1;PTGIS;IRAK3;NFKB1;ANXA1;SIRPA;CCL14;UPF1;USP10;TANK
prerank,regulation of synapse maturation (GO:0090128),-0.33644011228933995,-0.7852780853182193,0.75,0.9509981054017185,1.0,2/10,5.33%,NRXN1;RELN
prerank,regulation of protein sumoylation (GO:0033233),0.30957421644339067,0.7849850174356066,0.7455830388692579,0.9829659103858553,1.0,4/17,11.39%,SAE1;UBA2;PARK7;PIAS1
prerank,nucleoside catabolic process (GO:0009164),0.3408477383342093,0.7849717043410727,0.7428023032629558,0.982385056825521,1.0,2/11,9.50%,UPP1;UPP2
prerank,proton transmembrane transport (GO:1902600),0.26301801455789264,0.7846617570638504,0.8032258064516129,0.9823320712411446,1.0,5/36,11.55%,UCP2;SLC25A27;ATP6V0D1;ATP6V0E1;COX15
prerank,regulation of erythrocyte differentiation (GO:0045646),0.26581974115494184,0.7844843153136922,0.8076923076923077,0.9820266291374942,1.0,5/35,10.55%,TAL1;ABCB10;ZFP36L1;LYN;ACVR2A
prerank,regulation of nuclear division (GO:0051783),0.29220325670246206,0.7842796161585274,0.7639123102866779,0.9817796282553791,1.0,2/20,7.00%,PIN1;FBXO5
prerank,carbohydrate transport (GO:0008643),-0.333603928094029,-0.7842135665674504,0.7632135306553911,0.9520513663134381,1.0,9/11,61.62%,AQP11;SLC50A1;SLC26A6;SLC2A2;SLC23A1;SLC23A2;AQP1;SLC2A5;AQP9
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),-0.2651107101555364,-0.7834623545973783,0.7845433255269321,0.9525989583850291,1.0,8/23,28.26%,WNT5B;BMP4;SMO;GJA1;SIX1;VEGFA;PAX2;MDK
prerank,linoleic acid metabolic process (GO:0043651),-0.28873201456837516,-0.7832331229742389,0.767337807606264,0.9523286984304243,1.0,6/17,37.60%,ACSL1;FADS2;ELOVL1;FADS1;GSTM2;ALOX12
prerank,P-body assembly (GO:0033962),0.3333101634091511,0.7832330924504466,0.7413793103448276,0.982940184140177,1.0,2/12,9.63%,PATL2;PATL1
prerank,histone lysine methylation (GO:0034968),-0.24288700145881031,-0.7830242950238767,0.8152709359605911,0.9520021741203546,1.0,11/33,19.78%,PRDM5;KMT2A;PAXIP1;RBBP5;EHMT2;SETDB2;KMT2B;SMYD2;KMT2D;DPY30;N6AMT1
prerank,positive regulation of interleukin-10 production (GO:0032733),-0.2471334069774944,-0.7828933234794618,0.822429906542056,0.9515690254732078,1.0,4/30,14.92%,PIBF1;PRKCZ;CD34;HSPD1
prerank,heterochromatin assembly (GO:0031507),-0.2794998993696602,-0.7824908539262775,0.7614107883817427,0.9515858393798233,1.0,10/20,29.77%,HDAC1;SIRT2;ZNFX1;CENPV;HELLS;SMCHD1;NRDE2;BAHD1;HMGA2;SUV39H1
prerank,negative regulation of hemostasis (GO:1900047),-0.32150704493679727,-0.7823485599918587,0.7527593818984547,0.9511772341125307,1.0,3/12,11.71%,TFPI;VTN;CD34
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.30282035672232666,-0.7820910942894692,0.7582417582417582,0.9509508257213586,1.0,5/14,17.76%,DDX1;CSTF2;RTCB;RTRAF;ZBTB8OS
prerank,DNA alkylation (GO:0006305),0.2980002006925628,0.7818286783809937,0.7546816479400749,0.9841229119340983,1.0,2/19,5.83%,DMAP1;BEND3
prerank,DNA methylation or demethylation (GO:0044728),0.2980002006925628,0.7818286783809937,0.7546816479400749,0.9841229119340983,1.0,2/19,5.83%,DMAP1;BEND3
prerank,negative regulation of T cell activation (GO:0050868),0.26027547281895397,0.781733992905312,0.7962962962962963,0.9836869782014337,1.0,4/35,14.50%,FCGR2B;RIPOR2;CD274;PAG1
prerank,catecholamine biosynthetic process (GO:0042423),-0.3263040153612178,-0.7814462541674309,0.7532188841201717,0.9513272529709436,1.0,1/11,2.84%,MOXD1
prerank,sno(s)RNA 3'-end processing (GO:0031126),-0.32679291875128946,-0.7811983824906161,0.763265306122449,0.9510949515882995,1.0,7/11,38.37%,EXOSC10;LARP7;EXOSC2;EXOSC3;EXOSC5;TENT4B;FBL
prerank,negative regulation of Notch signaling pathway (GO:0045746),-0.2530840951111665,-0.7809706636511019,0.829736211031175,0.9507944137157481,1.0,5/28,9.05%,EGFR;MMP14;WWP2;NOTCH3;NIBAN2
prerank,positive regulation of mitochondrion organization (GO:0010822),0.23769343578094726,0.7806283354257967,0.8330827067669173,0.9849492898137316,1.0,13/57,16.49%,GSK3A;RALA;ZNF205;DDHD1;PARK7;FBXO7;BAD;BMF;MIEF1;CAMKK2;VPS35;DNM1L;BNIP3
prerank,protein localization to kinetochore (GO:0034501),0.3211804175563008,0.7801706173373093,0.7430167597765364,0.9851169552577028,1.0,3/14,14.59%,CHAMP1;MIS12;MTBP
prerank,rRNA pseudouridine synthesis (GO:0031118),-0.335765417740765,-0.7801147109409798,0.7469879518072289,0.9514685568970023,1.0,9/10,51.67%,NAF1;RPUSD4;GAR1;NOP10;TSR3;RPUSD1;NHP2;RPUSD2;RPUSD3
prerank,polyamine metabolic process (GO:0006595),0.33250391916177224,0.7799255229951899,0.7384615384615385,0.9849480678169228,1.0,4/13,15.26%,SMOX;DHPS;AMD1;ODC1
prerank,negative regulation of myoblast differentiation (GO:0045662),-0.306875195259004,-0.7798259414655848,0.7780172413793104,0.9512792257490483,1.0,3/13,16.23%,BMP4;TBX3;TGFB1
prerank,negative regulation of interleukin-1 production (GO:0032692),0.2846777579384853,0.7798067449754905,0.7706896551724138,0.9845532539323921,1.0,2/23,6.21%,TNFAIP3;CARD16
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.31565606543239655,0.7797651868526014,0.7763636363636364,0.9840173278323254,1.0,2/15,8.11%,SMAD7;CUEDC2
prerank,regulation of macrophage activation (GO:0043030),-0.24946186719705155,-0.7793365818895721,0.8222748815165877,0.9514572913211615,1.0,6/30,14.92%,LRFN5;LBP;IL31RA;THBS1;IL33;HSPD1
prerank,glycoprotein biosynthetic process (GO:0009101),-0.20262705362976716,-0.7792248665092734,0.9090909090909091,0.9509795683891593,1.0,34/79,35.62%,IGF1;ATP7A;CSGALNACT2;PMM2;GOLGA2;FUT10;CHST11;LARGE1;B3GALT5;ST3GAL4;TNIP1;B3GALNT1;BMPR1B;B3GALT1;ST8SIA2;CHST8;BMPR2;ALG5;ALG10B;CANT1;SERP1;FOXL1;CHST12;B4GALT7;ALG1;B3GALT2;DDOST;CHST10;B4GALT5;GCNT1;TMEM106A;ST8SIA3;ST8SIA5;ST3GAL5
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",-0.26259296480764815,-0.7789943983849934,0.8123515439429929,0.9507097237743385,1.0,5/22,16.35%,MAN1C1;UGGT2;UBC;EDEM1;RNF139
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.32220519390121327,0.7788328492266914,0.7313432835820896,0.9849698249751835,1.0,3/14,9.91%,TIRAP;HNRNPC;TARDBP
prerank,cellular defense response (GO:0006968),-0.2316882076306927,-0.7787846104478957,0.8592964824120602,0.9503924503508241,1.0,6/40,14.57%,DCDC2;LBP;CCR9;LSP1;TCIRG1;RAB23
prerank,reverse cholesterol transport (GO:0043691),0.32562175746640776,0.7785792190071608,0.7366482504604052,0.9848119758257635,1.0,2/13,11.85%,APOE;SCARB1
prerank,positive regulation of organelle assembly (GO:1902117),0.253175502685304,0.7782715921564265,0.7962648556876061,0.984728589062637,1.0,9/44,15.37%,LCP1;RALB;CNOT2;G3BP2;CNOT6;CNOT1;ASAP1;CNOT6L;RAB3GAP1
prerank,tetrahydrofolate metabolic process (GO:0046653),-0.3341710789571102,-0.7782272774780424,0.7841140529531568,0.9506062631580529,1.0,3/10,12.56%,MTHFD2L;MTHFR;MTHFD1
prerank,sulfur compound catabolic process (GO:0044273),0.2575989466011708,0.7778517930383029,0.8215434083601286,0.9847954156229387,1.0,7/38,14.21%,GLB1;MLYCD;FITM2;ACAT1;IDS;GALNS;TXN2
prerank,protein complex oligomerization (GO:0051259),0.22406967823662188,0.7777346151367752,0.8682284040995608,0.9843977059335636,1.0,13/85,12.33%,RS1;EHD4;ATL1;BEND3;LRRC8C;TRMT61B;CPSF6;CHMP2A;MAT2A;HGSNAT;G3BP2;LETM1;CUTC
prerank,histone H3-K4 methylation (GO:0051568),-0.26004716682324364,-0.7775635435852186,0.8102189781021898,0.9509811528773385,1.0,8/26,20.71%,OGT;KMT2A;PAXIP1;RBBP5;KMT2B;KMT2D;DPY30;SETD4
prerank,sister chromatid segregation (GO:0000819),0.271908260944962,0.7773221528540767,0.8056537102473498,0.9844674185443224,1.0,4/31,10.51%,KIF18A;CHAMP1;CDCA8;MIS12
prerank,positive regulation of protein export from nucleus (GO:0046827),-0.29884028615777,-0.7772839115786392,0.7531914893617021,0.9508021223326688,1.0,6/15,16.42%,BAG3;ANP32B;GSK3B;TP53;CAMK1;TCF7L2
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.305180806370112,-0.7772113480863413,0.7689161554192229,0.9502753134764581,1.0,5/13,22.41%,NIBAN2;NEDD4;CADM4;HGS;EMILIN1
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.34571001707563526,0.7770945582933139,0.7405940594059406,0.9842390283255887,1.0,1/10,2.23%,SOD1
prerank,response to amyloid-beta (GO:1904645),0.2509881198426276,0.7769788363811364,0.7959501557632399,0.9838412750881237,1.0,7/44,11.92%,CACNA1A;FCGR2B;MMP12;FYN;ICAM1;APP;PRNP
prerank,negative regulation of histone modification (GO:0031057),0.3169958761686302,0.7769671310397833,0.7816091954022989,0.983264526652726,1.0,1/14,0.92%,AASS
prerank,brain morphogenesis (GO:0048854),-0.31878950107330184,-0.776881723673825,0.7564655172413793,0.9501491633040431,1.0,2/12,5.15%,CTNNA2;FBXW11
prerank,cellular response to leucine (GO:0071233),0.3432530462919188,0.7762321857917912,0.7334630350194552,0.9832708708766129,1.0,4/10,19.05%,RPTOR;LARS1;SESN3;SESN1
prerank,response to leucine (GO:0043201),0.3432530462919188,0.7762321857917912,0.7334630350194552,0.9832708708766129,1.0,4/10,19.05%,RPTOR;LARS1;SESN3;SESN1
prerank,urogenital system development (GO:0001655),-0.32161155466555735,-0.7757708439201362,0.7670682730923695,0.9511874825839285,1.0,3/11,11.85%,OSR1;EPHB2;ANXA1
prerank,regulation of activated T cell proliferation (GO:0046006),0.26703465476919735,0.7757509232451489,0.7878787878787878,0.9834666941966955,1.0,4/30,13.00%,PRKAR1A;RPS3;PRNP;CD274
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.23489264591277695,0.7757046856147818,0.8391167192429022,0.9829444546471294,1.0,6/65,6.54%,CBL;PTPRJ;BCAR3;PTPN12;EPS15L1;ARHGEF7
prerank,glycerolipid metabolic process (GO:0046486),0.3493857499220823,0.7755752926924762,0.7352941176470589,0.982564342923419,1.0,2/11,11.01%,DGKB;PGP
prerank,aromatic amino acid family metabolic process (GO:0009072),-0.3336924022382316,-0.7753519659854069,0.779874213836478,0.9511598017046924,1.0,3/10,20.69%,ATP7A;KYAT1;QDPR
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.2696718401809215,-0.775313727277009,0.7866379310344828,0.9505836082497788,1.0,4/21,13.65%,ZWINT;KLHL22;BUB3;ATM
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.32954259913281736,0.7749858273969186,0.7590579710144928,0.982978131931891,1.0,2/12,10.58%,ESR1;TERT
prerank,response to lipopolysaccharide (GO:0032496),0.21060020774838145,0.7745644820482038,0.910427807486631,0.9830554295616166,1.0,19/138,13.00%,TNFAIP3;TAB2;TIRAP;SBNO2;TNFRSF1B;MAPK8;CARD16;SELP;WNT5A;ERBIN;RELA;IFNAR1;NFKBIL1;NOS3;SCARB1;PLAA;TNIP2;OTUD5;CD274
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.24412003961082832,0.7745181961850418,0.8214285714285714,0.9825346988972848,1.0,9/50,11.52%,IFI35;PHB2;EP300;ACTN4;RELA;DDX3X;APP;NOD1;RPS3
prerank,membrane raft organization (GO:0031579),-0.29675717296355825,-0.7744921479914383,0.7939914163090128,0.9512297206341809,1.0,7/15,28.73%,ANXA2;FLOT2;MYADM;FLOT1;CLN3;EMP2;ABCA7
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.29299077712453425,0.774066407149107,0.7569060773480663,0.9826692918140382,1.0,5/20,10.80%,HEY1;HEY2;NOTCH1;ACVRL1;RBPJ
prerank,negative regulation of telomere maintenance (GO:0032205),0.3103860752630053,0.7726805482942509,0.7523452157598499,0.984258334162698,1.0,6/15,18.15%,ERCC4;TNKS;NBN;TERF2IP;SMG6;TNKS2
prerank,lamellipodium assembly (GO:0030032),-0.25853120902288645,-0.7717607903446013,0.8206388206388207,0.9546916701334881,1.0,9/26,21.63%,KIT;VCL;SPATA13;ABLIM2;ABLIM3;PTPRO;ARFIP2;ARHGEF4;P2RY12
prerank,regulation of cell cycle process (GO:0010564),-0.18932988139385204,-0.7714030130457491,0.9773462783171522,0.9545758801817217,1.0,28/104,25.77%,DYNC1H1;CTNNB1;RPRD1B;CUL9;PIK3C3;AHCTF1;UVRAG;E4F1;OBSL1;SND1;RAB11A;USP19;ENTR1;CAV2;CCP110;TTL;CEP250;CDC42;ATF5;TXLNG;MAP9;MYO19;FLCN;RAB11FIP4;PRMT5;BCL2L1;GIT1;SFRP1
prerank,cellular response to interferon-gamma (GO:0071346),0.22182805818422616,0.7710985164147469,0.8882602545968883,0.9862700624603501,1.0,15/88,15.68%,TRIM8;GBP3;IRF9;B2M;GBP4;ICAM1;TRIM25;CCL25;WNT5A;CD47;IRF2;MID1;MT2A;CD44;CAMK2G
prerank,regulation of mitochondrion organization (GO:0010821),0.24180839394152023,0.7708742006149863,0.8180428134556575,0.9860573147148161,1.0,5/47,7.51%,GSK3A;STOX1;CYRIB;EP300;OMA1
prerank,phospholipid metabolic process (GO:0006644),-0.19986267707393884,-0.7704112169323091,0.9285714285714286,0.955433261412742,1.0,13/71,16.54%,PLA2G4A;PLPPR1;AGPAT4;PLPP3;AGPAT5;PIP5K1A;PLPPR5;PIP4K2B;SMPD3;PLPPR4;PCYT2;FDFT1;PLCD1
prerank,positive regulation of signaling receptor activity (GO:2000273),0.25730281559274326,0.7700199779110757,0.8161512027491409,0.9868508027433373,1.0,4/36,9.86%,SHANK3;GREM1;PARK7;BUD31
prerank,modulation by host of viral genome replication (GO:0044827),0.3262193673015789,0.7700161179406646,0.7601547388781431,0.9862606722851949,1.0,7/13,23.69%,PPIB;IFI27;YTHDC2;EIF2AK4;TBC1D20;VAPA;FMR1
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.25268793091108765,-0.7699091541846073,0.8067415730337079,0.9555209305021717,1.0,1/26,0.15%,ATP1A2
prerank,male gonad development (GO:0008584),0.25725070899720526,0.7692821188688602,0.7976782752902156,0.9868374636753138,1.0,4/34,10.35%,NR5A1;MAMLD1;WNT5A;ING2
prerank,regulation of DNA metabolic process (GO:0051052),0.24927620638806958,0.7686374290401666,0.8157051282051282,0.9872888617229758,1.0,13/44,18.25%,STOX1;SMG1;UBE2V2;UBE2V1;KPNA1;NBN;HELB;TERF2IP;WDR70;SMARCAD1;SMG6;POLH;SMG5
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.2762552326725294,0.7685257357868116,0.7986906710310966,0.9868913888922584,1.0,2/27,3.86%,RRM2B;NME1
prerank,response to estradiol (GO:0032355),-0.24006428338175712,-0.7678817156596118,0.8353510895883777,0.957887105114416,1.0,6/31,16.23%,EGFR;CTNNB1;SOCS2;ANXA1;GGT5;TGFB1
prerank,negative regulation of transport (GO:0051051),0.23860088131874232,0.7678666242105093,0.8521462639109698,0.9873837299850061,1.0,3/51,4.78%,RSC1A1;FCGR2B;RAB7A
prerank,cellular senescence (GO:0090398),-0.2521966728477374,-0.7678449809522004,0.8225419664268585,0.9573076172291638,1.0,5/27,11.62%,MAPK14;PRKCD;PML;SMC6;TBX3
prerank,C-terminal protein amino acid modification (GO:0018410),0.333711073218675,0.7676853756320776,0.7583025830258303,0.9871013260135519,1.0,5/11,19.24%,AGTPBP1;ICMT;ATG7;LCMT1;FOLH1
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.27989069599164634,0.7675203326280019,0.7992766726943942,0.9867865231801529,1.0,4/23,13.31%,GSK3A;EP300;PGP;PLEK
prerank,negative regulation of hormone secretion (GO:0046888),0.34003343879010206,0.7672646327845393,0.7552182163187856,0.9865991509737726,1.0,2/10,17.43%,RAB11FIP5;RAB11FIP1
prerank,covalent chromatin modification (GO:0016569),0.31359693378118336,0.7669147457546706,0.7562862669245648,0.9865318960279262,1.0,4/14,10.39%,SIRT1;SETD5;PARK7;CHD1
prerank,DNA modification (GO:0006304),0.27693884633592714,0.7659695853453159,0.8026070763500931,0.9874657739496029,1.0,5/22,15.22%,TDG;ACD;SMUG1;MPG;TERF2IP
prerank,endothelial cell differentiation (GO:0045446),-0.31015100682791275,-0.7657226078601554,0.7795918367346939,0.9598428286796988,1.0,4/12,22.00%,FSTL1;SCUBE1;BMPR2;KDM6B
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.28576082369912237,-0.765619239376672,0.8004434589800443,0.9593543146191573,1.0,7/16,30.08%,KCNC2;DDAH1;GUCY1A1;GUCY1B1;DDAH2;NDNF;NOS1
prerank,signal transduction by p53 class mediator (GO:0072331),-0.23785792551508472,-0.7654368769915662,0.8600451467268623,0.958959390838615,1.0,5/30,11.55%,DDX5;FHIT;PAXIP1;TP53;STK11
prerank,inositol phosphate-mediated signaling (GO:0048016),-0.2766601245367205,-0.7652602302861536,0.7986870897155361,0.9585619950530389,1.0,5/19,18.39%,NFAT5;PLCE1;NFATC2;PPP3CC;NFATC4
prerank,glycolipid biosynthetic process (GO:0009247),-0.23217287007462162,-0.7651142964362796,0.8552971576227391,0.9581172201197298,1.0,19/38,35.62%,A4GALT;B4GALT6;DPM1;ST6GALNAC5;LARGE1;ST3GAL4;PIGV;PIGG;PIGA;PIGM;PGAP4;PIGF;MPPE1;DPM2;PIGC;DPM3;ST8SIA3;ST8SIA5;ST3GAL5
prerank,regulation of stem cell proliferation (GO:0072091),0.29709763433680325,0.7644671587267995,0.7947761194029851,0.9892874046016772,1.0,3/17,10.58%,PTPRC;ZFP36L1;TERT
prerank,negative regulation of endocytosis (GO:0045806),-0.2593761801922946,-0.7636667286046774,0.8372093023255814,0.9595191931940963,1.0,10/24,32.28%,EPHA3;SYT11;SCAMP5;LRSAM1;PRKD1;NR1H2;ABCA7;PACSIN3;CAV1;CD300A
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.32350401228748454,0.763588606308933,0.7585551330798479,0.9900787148953473,1.0,2/12,10.53%,PPP3CB;TRPM4
prerank,negative regulation of insulin secretion (GO:0046676),-0.28534103517614356,-0.7635511825293324,0.7987679671457906,0.9590489570018308,1.0,8/17,40.79%,PSMD9;CCN3;ADRA2A;SFRP1;SIRT4;PIM3;CHGA;INHBB
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.26957248622597124,0.7634515583286131,0.8184764991896273,0.9896985658248553,1.0,6/28,12.14%,GAS2L1;CLASP2;MAP1S;CAMSAP2;PRUNE1;FKBP4
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.2633061129377346,0.7634494272590481,0.8341793570219966,0.9891113136082847,1.0,3/29,8.79%,ERCC3;CCNH;GTF2H1
prerank,positive regulation of T cell activation (GO:0050870),0.22971243539744957,0.7634475421440887,0.8457943925233645,0.9885253047705111,1.0,14/62,21.75%,PTPRC;CYRIB;CD47;PNP;CD81;CD274;DOCK8;IL7;CD46;TFRC;XBP1;SLC7A1;VCAM1;IL15
prerank,excitatory postsynaptic potential (GO:0060079),-0.27580687692305367,-0.7633807697658576,0.7963386727688787,0.9586540480438871,1.0,7/19,24.53%,GRID2;GRIN2B;GSK3B;GRIN2D;GRIN1;MPP2;AKT1
prerank,positive regulation of neuron migration (GO:2001224),0.33463881257774974,0.7629221952747411,0.7589641434262948,0.9887556646194645,1.0,1/11,0.88%,SEMA6A
prerank,B cell homeostasis (GO:0001782),0.34323018739513567,0.7628997717717442,0.7603143418467584,0.9881976842254699,1.0,2/10,9.31%,TNFAIP3;LYN
prerank,pyrimidine-containing compound catabolic process (GO:0072529),-0.2896811944440246,-0.762898809705232,0.8022727272727272,0.9587292439760133,1.0,2/16,1.62%,DPYD;DPYSL3
prerank,protein autoubiquitination (GO:0051865),0.22877760644937778,0.7627888155261214,0.8606431852986217,0.9877737120729975,1.0,11/61,13.34%,RAD18;UBE3A;NFX1;RNF187;MDM2;KLHL24;UBE3D;RNF13;RNF11;CUL3;RNF146
prerank,protein targeting to lysosome (GO:0006622),-0.26879577458982934,-0.7626363389147548,0.8151658767772512,0.9584827883615723,1.0,10/20,22.03%,SORL1;ZFYVE16;NCOA4;M6PR;AP4M1;GGA3;NEDD4;VPS4A;GNPTAB;HGS
prerank,regulation of defense response to virus by host (GO:0050691),0.26861026063837157,0.7625991042014055,0.7947019867549668,0.9874932600762851,1.0,2/30,2.81%,TNFAIP3;IFNLR1
prerank,endocardial cushion development (GO:0003197),0.2893835022434263,0.7623521322657825,0.7833333333333333,0.987307887283221,1.0,4/21,11.15%,HEY1;NOTCH1;ACVRL1;NOS3
prerank,nucleotide metabolic process (GO:0009117),0.2800922502635607,0.7621877035298362,0.7962648556876061,0.9869717727675937,1.0,4/23,10.60%,REXO2;NUDT5;PARK7;PNP
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.3290469176550438,0.7618447935379714,0.7653429602888087,0.986911845634109,1.0,3/12,13.34%,NAE1;HUS1;CHEK2
prerank,negative regulation of potassium ion transport (GO:0043267),-0.2994353614762656,-0.7617420981768256,0.7978021978021979,0.9590784044647518,1.0,3/13,10.09%,CAB39;BIN1;ACTN2
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.2962902471071337,-0.7616935542997868,0.7846153846153846,0.9585198569889835,1.0,9/15,32.89%,RAB3GAP2;SEC61A1;EDEM1;SRPRB;SRP14;ZFAND2A;SEC61G;SRPRA;SPCS1
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),-0.2376882342399713,-0.7613402006937972,0.8432835820895522,0.9583961390255044,1.0,9/33,15.47%,PKD1;APPL2;CDKN1B;CDC73;DDRGK1;STXBP4;TRIM39;PAF1;MN1
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.290688591365832,0.7613339590285869,0.7838345864661654,0.9870995112618739,1.0,3/18,9.76%,SIRT1;SOD2;PARK7
prerank,negative regulation of histone methylation (GO:0031061),0.338980722203398,0.7611367020709483,0.7528089887640449,0.9867981459476248,1.0,1/10,0.92%,AASS
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.2563306808062231,-0.7603570734977333,0.8277404921700223,0.9591684727028837,1.0,8/24,17.68%,SEC31A;SEC24D;PDIA3;TAPBP;SEC23A;SEC24C;SEC24A;ACE
prerank,negative regulation of cell cycle process (GO:0010948),0.23148465273853355,0.7600222966253491,0.8622291021671826,0.9878909003020154,1.0,8/61,10.41%,EZH2;EED;FBXO5;UXT;BMI1;CHMP2A;RYBP;MGA
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.2862906853473199,0.7592638529495498,0.8071428571428572,0.9884898149169754,1.0,6/21,14.12%,CLASP2;CIB1;FGF13;CAMSAP2;APC;SPEF1
prerank,positive regulation of lamellipodium organization (GO:1902745),0.2562081362050648,0.759100310574675,0.817258883248731,0.9881444897482405,1.0,3/32,6.54%,RAC2;SRC;ARHGEF7
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.2765770345519656,0.7587573245231989,0.8081494057724957,0.9881131788890142,1.0,2/22,8.79%,ERCC3;GTF2H1
prerank,negative regulation of hydrolase activity (GO:0051346),-0.21265555580239245,-0.7586071951739782,0.9190600522193212,0.9609905002546587,1.0,20/49,33.52%,MAP2;CPEB2;WNK1;SLC39A14;GPSM1;GMIP;ECM1;ATP5IF1;SH3RF2;RRP1B;ZCCHC9;CAMK2A;EGLN1;SH3BP4;ARL2;NOS1;TERF2;CHP1;RASA4;MAPK7
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.3260397308738214,-0.7585425364858438,0.7728194726166329,0.9604507426661729,1.0,3/10,13.61%,ITGA5;VTN;GRB10
prerank,ERAD pathway (GO:0036503),0.2194121423434219,0.7581706572515255,0.8880813953488372,0.9884227899024665,1.0,24/83,19.57%,DERL2;YOD1;WFS1;FAM8A1;SGTB;TRIM25;AUP1;RHBDD2;ERLIN2;STT3B;UBQLN1;PSMC6;DNAJC10;UFD1;UBQLN2;DNAJB14;ATXN3;UBXN4;UGGT1;DNAJB9;POMT2;CCDC47;DERL1;SEL1L
prerank,unsaturated fatty acid metabolic process (GO:0033559),-0.2243866313972178,-0.7580137988939968,0.8735362997658079,0.9605228755445803,1.0,3/41,4.84%,PLA2G4A;ACSL1;EPHX1
prerank,double-strand break repair via homologous recombination (GO:0000724),0.21499798994746105,0.7577971778637962,0.9084194977843427,0.9883988864350176,1.0,16/95,14.94%,ZSWIM7;ERCC4;YY1;XRCC1;SFPQ;CDC45;KDM4D;SEM1;RFWD3;EXD2;RAD51B;HUS1;NBN;PSMD14;RMI1;INO80
prerank,synaptic vesicle transport (GO:0048489),0.325654739536878,0.7569799670082289,0.7641129032258065,0.9890688847633805,1.0,5/11,19.66%,TMEM230;SPG11;SNAPIN;RAB27A;KIF5B
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.3164504993786375,0.7564473676731819,0.780114722753346,0.9892902971275158,1.0,5/12,16.45%,APOE;TMED10;PICALM;PRNP;FKBP1A
prerank,mRNA modification (GO:0016556),-0.2643566047716378,-0.7564032360694055,0.8371040723981901,0.9621185200380137,1.0,7/22,24.04%,PUS7;VIRMA;CBLL1;TRUB1;PCIF1;TRMT6;CMTR1
prerank,embryonic heart tube development (GO:0035050),0.3226731481910417,0.7563479865757745,0.7833935018050542,0.9888581500437158,1.0,5/14,19.21%,CITED2;HES1;SOX17;RYR2;IFT122
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),-0.24493644366386258,-0.7562034480682271,0.8498845265588915,0.9617548560319479,1.0,8/27,24.50%,PPARA;ABCA5;NFKB1;ABCA1;IL18;AGTR1;MAPK9;NR1H2
prerank,cochlea morphogenesis (GO:0090103),0.3368987995320937,0.7561862653543425,0.7895752895752896,0.9885172545871905,1.0,1/10,5.97%,TBX1
prerank,transferrin transport (GO:0033572),0.26122411099392073,0.7556055964274182,0.8341880341880342,0.9887874328898562,1.0,5/33,10.69%,ATP6V1D;RAB11B;ATP6V0D1;ATP6V0E1;ATP6AP1
prerank,protein localization to vacuole (GO:0072665),0.317951963443095,0.7553520500307818,0.7765567765567766,0.988587491886792,1.0,5/13,18.85%,GLMP;CD81;KPTN;RNF128;SH3GLB1
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.2887787350969869,-0.7553197635729837,0.8119469026548672,0.9624018734489693,1.0,5/15,17.76%,DDX1;CSTF2;RTCB;RTRAF;ZBTB8OS
prerank,hemidesmosome assembly (GO:0031581),0.330628698954115,0.755263772392687,0.764367816091954,0.9881331924510132,1.0,2/11,8.58%,DST;ITGA6
prerank,nuclear pore organization (GO:0006999),-0.30172865552219885,-0.7550786117204378,0.8322147651006712,0.9620770159019013,1.0,4/14,13.35%,NUP205;AHCTF1;NUP93;SEH1L
prerank,xenobiotic transport (GO:0042908),-0.2769933659509963,-0.7545967249370965,0.8070953436807096,0.9620412585069179,1.0,3/17,10.60%,SLC47A1;SLC22A4;GJA1
prerank,regulation of B cell differentiation (GO:0045577),0.2893297522910749,0.7543154240559483,0.8011049723756906,0.9889725388536796,1.0,2/17,6.70%,ZFP36L1;SYK
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),0.3300581604184629,0.754162370570953,0.7790262172284644,0.9886416792579552,1.0,4/11,20.30%,PARK7;FBXO7;NONO;REST
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.22586244810132267,0.7534352001074249,0.8662519440124417,0.9891292879612165,1.0,6/69,11.27%,PTPRJ;PTPRC;TIRAP;SYK;WNT5A;APP
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.3193885001591232,0.7532560017501728,0.7630057803468208,0.9888249265561649,1.0,1/11,1.77%,AMDHD2
prerank,negative regulation of mitochondrion organization (GO:0010823),-0.23392374843887032,-0.7532514160236133,0.875609756097561,0.9632734022975775,1.0,20/33,40.90%,IGF1;MAPT;MPV17L;HUWE1;GHITM;PINK1;FLCN;AKT1;BCL2L1;GPX1;TMEM14A;FXN;SLC25A5;ADCK1;PRELID1;CLU;HGF;MUL1;OPA1;PPIF
prerank,regulation of gene silencing by miRNA (GO:0060964),0.2271775523775819,0.7527406937804652,0.8851251840942562,0.9889928101276371,1.0,19/62,21.38%,POLR2J;POLR2B;FXR1;NUP54;NUP50;NUP35;IPO8;NDC1;WTIP;NUP160;POM121;STAT3;NUP42;EIF4G1;NUP133;AGO1;TNRC6A;PPARG;DHX9
prerank,regulation of mitotic spindle organization (GO:0060236),-0.23789141485592932,-0.7526889211822219,0.8428246013667426,0.9634564567526671,1.0,8/35,20.58%,DYNC1H1;PARP3;EML3;DCTN1;CHMP2B;CHMP5;RAE1;MAP9
prerank,mitochondrial protein processing (GO:0034982),0.32618070420846396,0.7524720837586899,0.7797619047619048,0.9888160017731089,1.0,4/11,17.39%,IMMP2L;OMA1;YME1L1;MIPEP
prerank,tryptophan catabolic process (GO:0006569),-0.30789027681878095,-0.7519231688261376,0.7762863534675615,0.9638852709525731,1.0,11/11,69.24%,KYAT1;AFMID;KMO;KYNU;IL4I1;HAAO;AADAT;IDO2;TDO2;IDO1;ACMSD
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.24582572648961257,0.7516550922873281,0.8481848184818482,0.9894587648096967,1.0,5/42,8.86%,PTPRJ;TEK;CIB1;CCL25;TSC1
prerank,N-acetylneuraminate metabolic process (GO:0006054),0.32549442487129115,0.750830144171401,0.7760314341846758,0.990031956481662,1.0,1/10,1.77%,AMDHD2
prerank,establishment of protein localization to organelle (GO:0072594),0.22422615627684897,0.7508159278395057,0.8688524590163934,0.9894699068465387,1.0,19/72,19.26%,MMP12;PHB2;RALA;PTTG1IP;SYK;NXT1;NUP50;RANBP17;ZDHHC15;E2F3;TSPAN17;IPO8;HIKESHI;KPNB1;POM121;STAT3;RYR2;LAMP2;NUP133
prerank,positive regulation of lymphocyte activation (GO:0051251),0.2646049569485329,0.7507451872630694,0.8298245614035088,0.9889953696245853,1.0,5/28,17.85%,CYRIB;CD47;TNIP2;PRKDC;SH3KBP1
prerank,signal transduction in response to DNA damage (GO:0042770),0.23531401420125053,0.7507278848386019,0.8605769230769231,0.9884393764002262,1.0,11/49,16.91%,TIPRL;ACER2;RAD1;CLOCK;HUS1;NBN;DOT1L;CHEK2;BRIP1;ATR;USP28
prerank,organic hydroxy compound transport (GO:0015850),-0.22554837592081167,-0.7506277626267452,0.8690176322418136,0.9649580196557093,1.0,7/36,15.66%,RBP4;OSBP;RXRA;RALBP1;NCOA1;STARD5;ATP8B1
prerank,regulation of response to interferon-gamma (GO:0060330),-0.29513492498029636,-0.7505281012615632,0.8045977011494253,0.964457913624729,1.0,5/14,19.51%,JAK1;IFNGR1;PTPN2;IFNGR2;STAT1
prerank,copper ion homeostasis (GO:0055070),-0.28234567013348744,-0.7501881207582177,0.8270509977827051,0.9643094105660271,1.0,6/17,18.71%,ATP7A;XIAP;SLC31A1;COMMD1;SLC31A2;COX19
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.3374093440945693,0.7500572382305163,0.7900207900207901,0.988804787217774,1.0,2/10,8.04%,TNFRSF1B;NOTCH1
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.21427236368977337,0.7495363519058171,0.9271916790490342,0.9890059407346495,1.0,15/84,14.53%,ILF3;PIN1;PATL2;APOE;FXR1;PAIP2B;CNOT7;TSC1;DDX3X;NANOS3;RPS3;PRNP;YBX1;CNOT1;CAPRIN1
prerank,regulation of cellular metabolic process (GO:0031323),0.24134912694224345,0.7493397768970053,0.8730407523510971,0.9887236291544739,1.0,15/45,21.30%,PANK2;LAMTOR1;ACACB;ARF1;CYP1B1;NPC2;VPS35;MBOAT7;ACACA;EIF6;KIF16B;PDK3;ABCG1;FASN;RNF41
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.27336383170909034,0.7490910331763381,0.8454861111111112,0.9885170910632203,1.0,10/25,19.28%,LONP1;OMA1;AUP1;CUL3;UFD1;YME1L1;ATXN3;UGGT1;POMT2;DERL1
prerank,endocardial cushion morphogenesis (GO:0003203),0.2951022048217633,0.7489599821957245,0.782608695652174,0.9881137978495824,1.0,4/18,11.15%,HEY1;NOTCH1;ACVRL1;NOS3
prerank,response to acidic pH (GO:0010447),0.31904359182612235,0.7488629564023505,0.7921348314606742,0.9876918703010438,1.0,2/13,8.00%,RAB11B;RAB11FIP5
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.33403576278705155,0.7487633339052412,0.777120315581854,0.9872539928160017,1.0,3/11,14.51%,TRIM28;PPHLN1;TASOR
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.25108935810359,0.7478311548641494,0.8576158940397351,0.9880781661225518,1.0,6/37,7.73%,RPTOR;STOX1;SPRED1;CALM3;SMAD7;AXIN1
prerank,myelination (GO:0042552),0.2386885861674997,0.7476276631880022,0.8665540540540541,0.9878127424170411,1.0,12/46,14.63%,MAL;MPZ;SCN2A;NFASC;PMP22;MARVELD1;ACER3;SBF2;NF1;ADGRG6;PARD3;ARHGEF10
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.3076908825275807,0.7476180700854396,0.785171102661597,0.9872532570846165,1.0,2/15,11.10%,STOX2;USP22
prerank,regulation of cell communication by electrical coupling (GO:0010649),0.31633471842074923,0.7475818239515434,0.8085501858736059,0.9867298740019628,1.0,2/13,6.88%,PDE4D;CALM3
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.2635860922199479,0.7475288375971721,0.8078902229845626,0.9862324825412537,1.0,4/27,8.56%,CDKN1A;BMI1;CDK4;WNT5A
prerank,positive regulation of vacuole organization (GO:0044090),-0.32279700820557605,-0.7463288733825157,0.8011472275334608,0.9688155172260329,1.0,4/10,16.48%,ANXA2;RAB3GAP2;PIP4K2B;LRSAM1
prerank,establishment of melanosome localization (GO:0032401),0.2846048132648947,0.7452205440050543,0.8044280442804428,0.9889490765596692,1.0,5/19,17.83%,RAB11B;MYO5A;BLOC1S5;RAB27A;BBS7
prerank,negative regulation of GTPase activity (GO:0034260),-0.25756611784956385,-0.7448405387507842,0.8214285714285714,0.9701267114400086,1.0,4/22,11.60%,CPEB2;WNK1;GPSM1;GMIP
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.32346559680948095,0.7448377119337227,0.8015414258188824,0.9889179165023002,1.0,2/12,8.02%,INSIG1;KDELR2
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.24063575857402975,0.7447784275771172,0.8660436137071651,0.9884238169978482,1.0,10/45,15.68%,TRIM8;IRF9;B2M;ICAM1;TRIM25;IRF2;MID1;MT2A;CD44;CAMK2G
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.20942665436719612,0.744415154953433,0.9269662921348315,0.9883734760788051,1.0,11/94,10.48%,ALMS1;HAUS4;HAUS5;CEP41;TUBB;DCTN2;SCLT1;ODF2;CEP164;DCTN3;DYNLL1
prerank,female gonad development (GO:0008585),0.28734481816684,0.7443931644227446,0.8155515370705244,0.9878317527139135,1.0,2/19,4.24%,SOD1;NR5A1
prerank,pre-miRNA processing (GO:0031054),0.3065643903580885,0.7441298579824644,0.7752808988764045,0.9876168642601263,1.0,4/14,15.07%,ADAR;AGO4;TUT7;TUT4
prerank,lymphocyte chemotaxis (GO:0048247),0.2595279338795131,0.7438023678462644,0.8440207972270364,0.9874627933800357,1.0,4/34,15.25%,PIK3CG;CCL25;PIK3CD;GAS6
prerank,positive regulation of fatty acid metabolic process (GO:0045923),-0.2875800730041652,-0.7437571118518231,0.8013856812933026,0.9709527444555965,1.0,3/15,6.59%,LPGAT1;PPARGC1A;PPARA
prerank,mitochondrion disassembly (GO:0061726),-0.23361757083474569,-0.7436749809775841,0.8755868544600939,0.9704209473587432,1.0,4/34,7.72%,AMBRA1;ULK2;WIPI1;FIS1
prerank,regulation of T cell activation (GO:0050863),0.240977919048511,0.7435063756932242,0.862876254180602,0.9873152172071509,1.0,3/42,9.09%,TNFRSF1B;CYRIB;CD47
prerank,regulation of protein targeting to membrane (GO:0090313),-0.2360157529672634,-0.7421726750744391,0.8575063613231552,0.9716829723151972,1.0,4/28,7.72%,ANK3;CEMIP;AKT2;FIS1
prerank,hematopoietic progenitor cell differentiation (GO:0002244),-0.23142388504219655,-0.7416949792166628,0.8654822335025381,0.9716926530577542,1.0,7/30,17.68%,UFL1;BMP4;KIT;TP53;LMBR1L;TGFB1;ACE
prerank,diacylglycerol metabolic process (GO:0046339),0.2748063845452898,0.7413086585032307,0.8297491039426523,0.9897761085330892,1.0,2/23,2.68%,DGKB;GPAM
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.3159145512038042,-0.7411154842462874,0.8358531317494601,0.9718307595813238,1.0,2/11,5.46%,NECAB1;BACE2
prerank,atrioventricular valve morphogenesis (GO:0003181),0.28246476087671113,0.7410216180015388,0.8143100511073254,0.98960160417808,1.0,4/19,8.68%,HEY1;HEY2;NOTCH1;EFNA1
prerank,pigment granule transport (GO:0051904),0.2853044545985488,0.7407428964092184,0.8183520599250936,0.9888446183624503,1.0,5/18,17.83%,RAB11B;MYO5A;BLOC1S5;RAB27A;BBS7
prerank,melanosome transport (GO:0032402),0.2853044545985488,0.7407428964092184,0.8183520599250936,0.9888446183624503,1.0,5/18,17.83%,RAB11B;MYO5A;BLOC1S5;RAB27A;BBS7
prerank,myelin assembly (GO:0032288),-0.32281555382824506,-0.7403657665954816,0.8072033898305084,0.9721513173354687,1.0,6/10,32.27%,EPB41L3;DICER1;TPPP;CNTNAP1;ABCA2;GPC1
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),0.3311093924219949,0.7401652048854945,0.7927063339731286,0.9890918948339006,1.0,3/10,18.42%,PRKG1;CD9;RDX
prerank,amino sugar biosynthetic process (GO:0046349),0.31060569242906294,0.7401140653246946,0.7926356589147286,0.9885877118449999,1.0,1/12,1.77%,AMDHD2
prerank,positive regulation of exosomal secretion (GO:1903543),-0.2775203418380575,-0.7400553893449887,0.8150537634408602,0.971938582043847,1.0,6/15,22.03%,SMPD3;SNF8;TSG101;STAM;VPS4A;HGS
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.23559223949936978,0.7398745552558096,0.8885350318471338,0.9883483370527725,1.0,7/47,13.31%,TRIB3;PRMT3;FYN;EP300;ERLIN2;PGP;PLEK
prerank,cellular biogenic amine biosynthetic process (GO:0042401),-0.27665894775337707,-0.7397773012640119,0.8475991649269311,0.9716594649222373,1.0,2/15,9.88%,MOXD1;SAT1
prerank,positive regulation of mitochondrial fission (GO:0090141),-0.27124682955171575,-0.7397451086578718,0.8371040723981901,0.9710710612600603,1.0,3/18,7.72%,MCU;SPIRE1;FIS1
prerank,mitotic chromosome condensation (GO:0007076),0.26380315011563327,0.7394710827350407,0.8307426597582038,0.9883423997487548,1.0,5/26,14.34%,TENT4A;CHMP1A;AKAP8L;PHF8;CSNK2A2
prerank,lipid transport (GO:0006869),0.21026027962443272,0.739425083902821,0.922316384180791,0.9878416121659995,1.0,16/97,15.55%,ATP8A1;ABCC4;GOT2;APOE;PRELID3B;UGCG;PPARD;PRELID2;PITPNA;SCARB1;GM2A;NPC2;OSBPL2;SPNS2;SLCO1C1;CERT1
prerank,cellular response to amyloid-beta (GO:1904646),0.2504779798627965,0.7389798078243716,0.8599033816425121,0.98791185972507,1.0,7/35,14.37%,CACNA1A;FCGR2B;FYN;ICAM1;APP;PRNP;GRIN2A
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.30958180489376064,0.738751661119466,0.8081936685288641,0.9876572083419268,1.0,1/13,1.17%,CBL
prerank,cellular response to pH (GO:0071467),0.29134232999417675,0.7386717069787713,0.7977941176470589,0.9872104749364654,1.0,2/17,8.00%,RAB11B;RAB11FIP5
prerank,negative regulation of peptide hormone secretion (GO:0090278),-0.26805387902392874,-0.7386243882088762,0.8265524625267666,0.9717899779909303,1.0,7/18,40.79%,PSMD9;CCN3;ADRA2A;SFRP1;SIRT4;CHGA;INHBB
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),-0.26074334766933904,-0.7380249126116627,0.823943661971831,0.9718821577458124,1.0,2/20,3.31%,TGFBR1;DCUN1D5
prerank,zinc ion transmembrane transport (GO:0071577),-0.2531125272876204,-0.7374742210572577,0.863080684596577,0.9718953124803196,1.0,8/22,25.24%,SLC39A14;SLC30A10;SLC39A13;SLC30A4;SLC39A8;SLC39A7;SLC39A6;SLC30A5
prerank,carboxylic acid transmembrane transport (GO:1905039),0.242439567766758,0.7369105637364995,0.8553054662379421,0.9890552262117127,1.0,2/40,1.30%,SLC7A8;SLC36A4
prerank,fatty acid metabolic process (GO:0006631),0.2021981859693804,0.7368126820418613,0.9330655957161981,0.9886280454654692,1.0,12/115,11.77%,CRAT;ACSL5;MLYCD;GPAM;PPARD;ADIPOR2;NUDT19;ALKBH7;ACSL4;ADIPOR1;PNPLA8;ACOT8
prerank,cellular response to acid chemical (GO:0071229),-0.23829565148684811,-0.7366610855663803,0.900990099009901,0.9723494521577322,1.0,3/27,2.38%,CPEB4;CPEB1;CAPN2
prerank,microtubule bundle formation (GO:0001578),0.2414239062983655,0.7365304612814563,0.8513302034428795,0.9884408870411396,1.0,7/42,17.27%,GAS2L1;MAP1S;NAV1;SPEF1;CLIP1;CLASP1;NCKAP5
prerank,melanosome localization (GO:0032400),0.27818724319447896,0.7364321757615201,0.8107606679035251,0.9880166337106455,1.0,6/21,18.03%,RAB11B;MYO5A;BLOC1S5;RAB27A;BBS7;VPS33A
prerank,positive regulation of keratinocyte differentiation (GO:0045618),0.3282726976112068,0.7363632955451149,0.7944444444444444,0.9875485589450692,1.0,1/10,2.74%,PRKCH
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.31297138564028193,0.7360011475086847,0.8003802281368821,0.9874389207196467,1.0,2/12,7.54%,MLYCD;IRS2
prerank,cellular response to fatty acid (GO:0071398),-0.2969271867690329,-0.7358375016436959,0.7982832618025751,0.9727110670824064,1.0,6/12,43.18%,PID1;ZC3H12A;LPL;NR1H4;DGAT2;PDK4
prerank,negative regulation of cyclase activity (GO:0031280),-0.27880822834502306,-0.7352956030402523,0.8259911894273128,0.9727207440826194,1.0,2/14,7.83%,ADGRV1;GABBR2
prerank,positive regulation of protein transport (GO:0051222),-0.19627227451749815,-0.7349317363337451,0.945619335347432,0.9725351111946134,1.0,21/67,26.16%,BMP6;IGF1;EZR;PPID;UNC13B;VAMP2;RACK1;ARHGEF5;OAZ1;EXOC1;TGFB1;CNST;OAZ2;RAB29;CLN3;TGFB3;IER3IP1;RIPOR1;APBB1;SYTL4;PPIA
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.27547408770918147,-0.7346958569805552,0.810989010989011,0.9722040675378493,1.0,6/16,18.89%,A4GALT;B4GALT6;ST6GALNAC5;LARGE1;ST6GALNAC6;ST8SIA2
prerank,regulation of glucose metabolic process (GO:0010906),0.2500575196371277,0.7337084934443457,0.8695652173913043,0.9899780270098932,1.0,5/34,11.08%,SDHAF3;MLYCD;SIRT1;IRS2;ADIPOR1
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.28510389363126504,0.7331394475474171,0.8256880733944955,0.9901595719301514,1.0,3/20,5.51%,ZFP36L1;MEIS1;CIB1
prerank,carnitine metabolic process (GO:0009437),0.3109347475163233,0.7329426775778795,0.810546875,0.9898718067411042,1.0,1/12,1.43%,CRAT
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.30704091864324934,0.7323984608785639,0.8023952095808383,0.9900137023194436,1.0,5/14,13.32%,PPP2R2D;PPP2CA;PPP2CB;PPP3CA;PPP5C
prerank,positive regulation of glial cell differentiation (GO:0045687),0.28654283949183207,0.7320410276192633,0.8330170777988615,0.9899133600916987,1.0,5/17,16.05%,TNFRSF1B;NOTCH1;TENM4;HES1;ID2
prerank,negative regulation of adenylate cyclase activity (GO:0007194),-0.28225021190318067,-0.7318621467042195,0.8275862068965517,0.9751506528282669,1.0,2/13,7.83%,ADGRV1;GABBR2
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.30277548761096507,0.7317286034236217,0.822992700729927,0.9897580991938975,1.0,2/14,9.76%,TXNDC12;PARK7
prerank,regulation of lipid storage (GO:0010883),0.26863182921691486,0.7315498246733285,0.8415672913117547,0.989419330217164,1.0,5/22,15.61%,SIRT1;ALKBH7;MEST;NFKBIA;FTO
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.2706019013711751,-0.7313604377155855,0.8381374722838137,0.9751100030182611,1.0,6/16,27.48%,THBS1;JCAD;AGTR1;VEGFA;GATA2;FGFBP1
prerank,filopodium assembly (GO:0046847),0.2852992875827738,0.7305524354920941,0.8291746641074856,0.9901331636140321,1.0,3/16,14.12%,DNM3;FGD5;SPEF1
prerank,negative regulation of macroautophagy (GO:0016242),0.2628697241853507,0.7297381439893256,0.8621848739495799,0.9906139889305677,1.0,11/26,21.33%,SMG1;TSC1;SCFD1;FEZ2;TMEM39A;UBQLN4;USP36;LZTS1;RUBCN;LRRK2;PIK3CA
prerank,negative regulation of phosphate metabolic process (GO:0045936),-0.2526377070889916,-0.7291366031089447,0.864516129032258,0.9770820384749325,1.0,5/22,11.30%,BMP7;BMP4;ROCK1;CDKN1B;TP53
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),-0.311374781485655,-0.7284612821828382,0.8155737704918032,0.9772007274402464,1.0,8/10,52.68%,AKT1;TICAM1;MYD88;TLR4;CD68;TREM2;CD36;TLR6
prerank,indolalkylamine catabolic process (GO:0046218),-0.30787095154406224,-0.728145210984134,0.8043478260869565,0.9769352574504959,1.0,10/10,69.24%,KYAT1;KMO;KYNU;IL4I1;HAAO;AADAT;IDO2;TDO2;IDO1;ACMSD
prerank,early endosome to late endosome transport (GO:0045022),-0.2563388021586313,-0.7281008666436898,0.8488888888888889,0.9763516590697386,1.0,8/20,23.94%,PIK3C3;EEA1;STX8;SNF8;PTPN23;HOOK2;LMTK2;EMP2
prerank,negative regulation of cell death (GO:0060548),0.2072225143543583,0.7276092548552797,0.943939393939394,0.9927679212059521,1.0,6/88,5.19%,RAD18;MECOM;TXNDC12;FYN;TNFRSF1B;WFS1
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.2665252292350647,-0.7273130264534785,0.8624708624708625,0.9766605325158744,1.0,6/18,27.00%,ROCK1;SLC39A8;ITGA4;ADD2;PODXL2;CX3CR1
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.2564798823968931,0.7270100275255421,0.8355263157894737,0.992973871797376,1.0,8/27,18.81%,RUVBL2;EP300;RUVBL1;CREBBP;TRRAP;TAF6L;NAA50;MSL3
prerank,phosphate ion homeostasis (GO:0055062),0.3225467001388149,0.7268281492131592,0.7813688212927756,0.9926497603925429,1.0,1/10,5.33%,XPR1
prerank,cellular macromolecule catabolic process (GO:0044265),0.231071568685891,0.7266636157327927,0.8841059602649006,0.9923068837837823,1.0,8/49,15.43%,NCBP1;RNASE6;MAGEC2;XRN2;STT3B;CHEK2;UBE2G1;PPP1R8
prerank,protein-DNA complex disassembly (GO:0032986),0.29362196392839757,0.7264591689596175,0.8309352517985612,0.9920114272418888,1.0,4/16,19.08%,RPL23;SMARCD1;SMARCA4;SMARCB1
prerank,regulation of lymphocyte proliferation (GO:0050670),0.28593290159193724,0.7263282337835019,0.8346456692913385,0.9916310784791382,1.0,1/16,5.04%,TNFRSF1B
prerank,miRNA metabolic process (GO:0010586),0.28218403122784036,0.7259716017817294,0.8418181818181818,0.991530445088324,1.0,6/20,19.11%,BCDIN3D;XPO5;TUT7;TUT4;PARN;DIS3L2
prerank,cell proliferation in forebrain (GO:0021846),-0.3088334920161867,-0.7257506243301579,0.803921568627451,0.9779202937945642,1.0,2/10,10.88%,CEP120;NUMBL
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.2561990697777381,0.7257064549662132,0.8277027027027027,0.9912895888616929,1.0,6/26,13.91%,TAL1;MDM2;USP22;APP;CUL3;HES1
prerank,superoxide metabolic process (GO:0006801),-0.2313512513076192,-0.7256444489390279,0.8902743142144638,0.9774320367998641,1.0,10/29,23.37%,ATP7A;SH3PXD2A;CCS;NOX4;PREX1;SOD3;PRDX1;PRDX2;SH3PXD2B;NRROS
prerank,negative regulation of TOR signaling (GO:0032007),0.24467973088174444,0.72532010184446,0.8762886597938144,0.9911964819384452,1.0,9/36,16.18%,GSK3A;EPM2A;AKT1S1;SIRT1;TSC1;PRKAA2;TMEM127;KPTN;SESN3
prerank,macrophage activation (GO:0042116),0.24942954590175312,0.7252690468570587,0.8622950819672132,0.9906932535290786,1.0,6/34,14.77%,IFI35;SBNO2;SYK;APP;CD93;CRTC3
prerank,regulation of cellular protein catabolic process (GO:1903362),-0.25959068250968864,-0.7250913780919633,0.8425531914893617,0.9774371659325813,1.0,9/18,30.97%,NELL1;VGLL4;EZR;DACT1;MSN;AMER1;HSP90AA1;RGP1;CDK5RAP3
prerank,negative regulation of protein ubiquitination (GO:0031397),0.2264607825612549,0.7249611604801893,0.8974358974358975,0.9905238439585827,1.0,8/50,11.52%,TNFAIP3;PRMT3;FBXO5;SMAD7;IVNS1ABP;PARK7;SPOPL;RPS3
prerank,glycerophospholipid metabolic process (GO:0006650),0.2141268526304921,0.7248241853323538,0.9190404797601199,0.9901430522714769,1.0,12/75,14.23%,SERINC1;SMPD4;PLCG1;PIGH;CSF1R;PLCB1;SERINC5;PGP;PIGB;ABHD12;PLEK;PNPLA6
prerank,glucose catabolic process to pyruvate (GO:0061718),-0.23943190790405489,-0.7241096022603778,0.871859296482412,0.977299982526252,1.0,11/24,31.61%,PKM;FOXK1;ALDOA;ENO2;PGK1;HK2;PGAM1;PFKM;GAPDH;ALDOC;PFKL
prerank,canonical glycolysis (GO:0061621),-0.23943190790405489,-0.7241096022603778,0.871859296482412,0.977299982526252,1.0,11/24,31.61%,PKM;FOXK1;ALDOA;ENO2;PGK1;HK2;PGAM1;PFKM;GAPDH;ALDOC;PFKL
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.24125708466271578,0.723849770760805,0.8743362831858407,0.9908374539866276,1.0,5/33,10.58%,CTC1;ANKRD28;DCLRE1B;ACD;TERT
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.32321599244868393,0.7234760502885018,0.7980769230769231,0.9907762312078346,1.0,1/10,1.75%,PDE4D
prerank,negative regulation of bone mineralization (GO:0030502),0.30747750258545936,0.7230064434786543,0.8246628131021194,0.9908034693978193,1.0,3/13,16.33%,GREM1;TRPM4;PTK2B
prerank,response to unfolded protein (GO:0006986),0.22915605573392667,0.7225598002950946,0.9141004862236629,0.990800373496941,1.0,15/48,20.74%,HSPA8;HSPA4L;DNAJB5;STT3B;HSPE1;DDIT3;ERP44;HSPA13;HSPA14;SERPINH1;BAX;DERL1;HSPB8;ERN1;HSP90AB1
prerank,positive regulation of mitotic nuclear division (GO:0045840),-0.2221949104732974,-0.7222346572461633,0.9029126213592233,0.9787697964666584,1.0,2/34,1.84%,IGF1;PDGFRB
prerank,regulation of RIG-I signaling pathway (GO:0039535),-0.2574171377992091,-0.722104295051449,0.8624708624708625,0.978297713620183,1.0,4/18,11.77%,PUM1;PUM2;BIRC3;NPLOC4
prerank,negative regulation of cell division (GO:0051782),-0.302125432552905,-0.7216994663018445,0.854043392504931,0.9781176277318818,1.0,3/11,21.10%,ORC6;BLM;VPS4A
prerank,dorsal/ventral pattern formation (GO:0009953),-0.2558349552278877,-0.7209258252692592,0.8755555555555555,0.9783738624009015,1.0,8/20,28.65%,GLI2;NBL1;ACVR1;BMPR1B;BMPR1A;PTCH1;SFRP1;MDFI
prerank,negative regulation of protein processing (GO:0010955),-0.2942309796865905,-0.7209169753370626,0.8584070796460177,0.9777574251483512,1.0,4/12,25.87%,GAS1;THBS1;CTSZ;SERPINE1
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.3155942549827671,-0.7205994506705384,0.8404669260700389,0.9774837226044835,1.0,2/10,7.24%,DGKH;GAP43
prerank,carbohydrate catabolic process (GO:0016052),0.24087520673884497,0.7202568961031277,0.8848,0.9930892854135213,1.0,2/38,5.68%,ENO4;TPI1
prerank,negative regulation of JUN kinase activity (GO:0043508),-0.31397039443665814,-0.7200735738276695,0.8414376321353065,0.9774628897994554,1.0,5/10,39.33%,HIPK3;PTPN22;DNAJA1;MAPK8IP1;DUSP19
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.2926684185666706,0.71963322772299,0.8300536672629696,0.9932916593857356,1.0,2/16,14.45%,ERCC4;RMI1
prerank,negative regulation of interleukin-6 production (GO:0032715),-0.22981105803809723,-0.7194916265167731,0.891566265060241,0.9775046343046552,1.0,9/27,27.69%,IRAK3;SYT11;SIRPA;PTPN22;SELENOS;CX3CL1;C1QTNF3;NCKAP1L;ZC3H12A
prerank,regulation of cytokinesis (GO:0032465),0.20837736981564134,0.7193312512443009,0.9327217125382263,0.9931071928895981,1.0,20/78,20.21%,PIN1;PLK2;CSPP1;PRPF40A;CALM3;KIF13A;CUL3;GIPC1;PIK3R4;KLHL13;SETD2;BECN1;KLHL9;ZFYVE19;CALM1;SH3GLB1;PRKCE;PKN2;CDC14A;ZFYVE26
prerank,negative regulation of blood coagulation (GO:0030195),0.24144107892161842,0.7192990259584966,0.8780096308186196,0.9925847102646889,1.0,6/38,13.84%,APOE;F8;NOS3;A2M;PLAT;PROC
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.21282206010481267,0.7191708308822213,0.911042944785276,0.9921811270903348,1.0,6/73,11.27%,PTPRJ;PTPRC;TIRAP;SYK;WNT5A;APP
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.27079156668549764,-0.7188889483447359,0.8435374149659864,0.9775844070528135,1.0,5/15,24.84%,BMP4;SMO;SIX1;VEGFA;PAX2
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.29028817735448714,0.7187253659631129,0.8431001890359168,0.9921629344761713,1.0,1/15,2.74%,PRKCH
prerank,protein import into peroxisome matrix (GO:0016558),0.3068810247946925,0.7186697636811293,0.8238532110091743,0.9916664195552574,1.0,2/12,6.57%,PEX1;PEX7
prerank,regulation of hemopoiesis (GO:1903706),-0.3103937873528604,-0.7186251183819395,0.8023715415019763,0.9772540662426167,1.0,5/10,33.70%,CBFB;MYSM1;IL17D;MAFB;PTN
prerank,regulation of transposition (GO:0010528),-0.28396699248193474,-0.7180643215070517,0.8326359832635983,0.9773123687612536,1.0,9/13,58.60%,SIRT7;UBR2;TEX15;SMYD5;PIWIL2;TDRD9;DDX4;PIWIL4;SPOCD1
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.30318915492175796,0.7180600270832428,0.8339622641509434,0.9918280059234961,1.0,5/13,18.22%,TMEM30B;CD81;BCAP31;TMEM30A;EDEM2
prerank,negative regulation of protein secretion (GO:0050709),0.2376850369334212,0.717669914636669,0.8800705467372134,0.9917333887457449,1.0,4/38,10.01%,HMGCR;APOE;RAB11FIP5;RHBDF2
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.19052053109131975,0.7172061595048506,0.9750346740638003,0.9917379604324168,1.0,30/148,16.22%,PIN1;RPL23;HIPK2;RFFL;RAD1;EP300;RPL5;MDM2;TTC5;TAF15;PRKAA2;ING2;HUS1;TOP3A;PAK1IP1;TAF4B;NBN;CHD3;TBP;ING5;CHEK2;MAP2K6;CSNK2A2;RMI1;BRIP1;DYRK2;TAF1;ATR;RBBP4;TAF3
prerank,cell projection assembly (GO:0030031),0.26327568320578776,0.7170495535815371,0.8589743589743589,0.9913877646300183,1.0,3/22,11.04%,RAC2;RHOQ;RHOG
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.26042950929123443,0.7163738656007715,0.8568872987477638,0.9916399541082973,1.0,2/25,3.34%,GSK3A;INSYN2A
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.3150128611718961,-0.7160698924683196,0.8269617706237424,0.9788715864124475,1.0,7/10,46.57%,SIRT2;CDC42;RCC2;RACGAP1;ECT2;KNSTRN;SPAG5
prerank,ceramide transport (GO:0035627),-0.2928140172180285,-0.7159284782384491,0.8434959349593496,0.9783927023369885,1.0,2/12,8.49%,PSAP;PLEKHA8
prerank,negative regulation of gluconeogenesis (GO:0045721),0.3087205704709962,0.7156358799915936,0.8090551181102362,0.9919581452977688,1.0,2/11,11.01%,EP300;PGP
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.29044899648074396,-0.7154658048164385,0.8203463203463204,0.9783019102937545,1.0,4/12,35.41%,BMP7;FLOT1;THY1;SKAP1
prerank,DNA unwinding involved in DNA replication (GO:0006268),-0.2697609277967448,-0.7145472152856555,0.8654708520179372,0.9786514399391328,1.0,5/16,22.64%,RPA1;PURA;BLM;RECQL;MCM6
prerank,positive regulation of keratinocyte migration (GO:0051549),-0.30404081119754495,-0.7145020829015319,0.8196392785571143,0.9780813283074051,1.0,6/10,33.10%,EPB41L4B;IQSEC1;MAPRE2;FGF10;FGF7;MTOR
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),-0.2941444033861558,-0.7144162360802785,0.8382352941176471,0.977562695015211,1.0,3/11,11.96%,PUM1;PUM2;LIMD1
prerank,positive regulation of sodium ion transport (GO:0010765),0.3082776590502617,0.7141450985591838,0.8346007604562737,0.9931825454382796,1.0,2/12,6.92%,AHCYL1;CNKSR3
prerank,glycoprotein metabolic process (GO:0009100),-0.1963666755121647,-0.7134577237071982,0.9468085106382979,0.9779498933220073,1.0,12/53,18.89%,MAN1C1;NGLY1;FUT8;ADAMTS9;GANC;MAN2A2;LARGE1;PCSK6;ST3GAL4;TNIP1;ST6GALNAC6;ST8SIA2
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.27936974477350984,0.7133493177711506,0.8303249097472925,0.9935366974098174,1.0,4/17,10.80%,HEY1;HEY2;NOTCH1;RBPJ
prerank,positive regulation of cardiocyte differentiation (GO:1905209),0.31537072897903723,0.7132567366537076,0.8264014466546112,0.9930943417832929,1.0,1/11,3.08%,GREM1
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.27381042926741106,0.712792961580225,0.8380952380952381,0.9930889779909686,1.0,3/18,9.18%,CLASP2;RGCC;COLGALT1
prerank,cellular response to virus (GO:0098586),0.2523306466477236,0.7123259284825888,0.8638743455497382,0.9930836201883623,1.0,5/30,14.22%,EIF5A;ARF1;DDX3X;CHUK;LGALS8
prerank,regulation of glycogen metabolic process (GO:0070873),-0.2846788119700708,-0.7118881048911849,0.8459958932238193,0.9789441920158476,1.0,9/12,56.67%,PPP1R3B;AKT1;INPP5K;PPP1R3C;RUBCNL;KHK;PPP1R3E;PPP1R3D;GCGR
prerank,mitochondrial membrane organization (GO:0007006),0.24393245143114925,0.7116173262569401,0.9003496503496503,0.9933658929546152,1.0,9/32,17.58%,IMMT;BAD;MAIP1;CHCHD6;CHCHD3;DNAJC11;MICOS10;BNIP3;RCC1L
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.2296607793435471,-0.7115417167482334,0.9121447028423773,0.9786792966569446,1.0,17/32,32.20%,TAOK3;MRE11;BRSK1;TAOK1;ATM;TRIM39;RINT1;FOXN3;BABAM1;BLM;NOP53;CDC14B;TOPBP1;TAOK2;HMGA2;CDK5RAP3;CLSPN
prerank,regulation of cell-substrate adhesion (GO:0010810),0.23173970325659765,0.7114586348820412,0.8980582524271845,0.9929835343592027,1.0,10/42,17.73%,RAC2;NOTCH1;MINK1;TSC1;NPNT;NF1;CORO2B;ATXN3;CORO1C;FBLN2
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.2084617511927333,0.7107088123432176,0.93026706231454,0.9933203694753158,1.0,10/76,11.60%,GSK3A;TRIB3;ARIH1;COP1;SMAD7;AXIN1;MDM2;RAD23A;PIAS1;ELOB
prerank,cellular response to misfolded protein (GO:0071218),0.27183913312639846,0.7102714596964438,0.8686131386861314,0.9932545234635042,1.0,9/20,20.98%,AUP1;CUL3;UFD1;DNAJB14;ATXN3;UGGT1;POMT2;DERL1;KLHL15
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.29350570598294673,-0.7101540443104716,0.8592436974789915,0.9795335427801257,1.0,6/12,24.36%,TET1;MPHOSPH8;SETDB2;RESF1;DNMT1;ATF7IP
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.2791616387996809,-0.7099419238906135,0.8423236514522822,0.9791317868157279,1.0,7/13,35.79%,UFL1;DDRGK1;RACK1;PPP1R15B;ABCA7;NCK1;ATF6B
prerank,cholesterol transport (GO:0030301),0.22912443906449792,0.7087372924931142,0.8980582524271845,0.9944781506208722,1.0,9/45,15.93%,APOE;SOAT1;SCARB1;LDLRAP1;NPC2;NPC1;OSBPL2;SERAC1;STARD3
prerank,response to organic cyclic compound (GO:0014070),-0.1981742385684901,-0.7085270404831029,0.9544235924932976,0.9799690017983957,1.0,10/52,17.44%,IGFBP5;CTNNB1;HLCS;SOCS2;ANXA1;IL18;GGT5;SPP1;TGFB1;ALPL
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.2169110204852604,0.708221810098187,0.919558359621451,0.9945242335976169,1.0,13/58,17.41%,ABRAXAS1;ERCC4;KDM2A;DCLRE1B;UBE2V2;POLA1;NBN;PSMD14;BRCC3;NSD2;XRCC4;PRKDC;DCLRE1C
prerank,regulation of spindle assembly (GO:0090169),-0.24374779657137352,-0.7082217736984161,0.8955555555555555,0.9796528844388663,1.0,5/25,18.87%,DYNC1H1;RNF4;EML3;CHMP2B;CHMP5
prerank,DNA double-strand break processing (GO:0000729),-0.2586918718916541,-0.7081154205492656,0.8779956427015251,0.9791515232862529,1.0,10/18,36.61%,UBE2N;RAD50;MRE11;ATM;BLM;SLX4;KAT5;BARD1;SETMAR;DNA2
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.23700171673940162,0.707905638070515,0.8984509466437177,0.994320066730363,1.0,7/36,14.25%,SPR;APOE;TERT;NOSTRIN;NOS3;SCARB1;GCH1
prerank,microtubule depolymerization (GO:0007019),0.28000193179079635,0.7073296600154579,0.8444846292947559,0.9944137685219859,1.0,4/17,18.21%,KIF18A;KIF2A;NCKAP5;KIF24
prerank,pancreas development (GO:0031016),0.3098564883146694,0.705920341580524,0.8356435643564356,0.99539574787622,1.0,1/12,4.00%,SELENOT
prerank,coenzyme A metabolic process (GO:0015936),0.29016743812876106,0.7053907188600904,0.8346007604562737,0.995426050073716,1.0,2/14,5.63%,PANK2;ACAT1
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.2246337440832531,-0.7048676375486852,0.9129411764705883,0.9818431077599805,1.0,8/28,20.64%,NUPR1;DDRGK1;PTK2;RNF139;ATP5IF1;OSBPL7;PSMC5;PSMC3
prerank,release of cytochrome c from mitochondria (GO:0001836),0.2728448647267221,0.7046555343624686,0.8462929475587704,0.9956786729102157,1.0,5/17,17.79%,SOD2;FZD9;BAD;DNM1L;BAX
prerank,adipose tissue development (GO:0060612),-0.28809028649634066,-0.7044310116291089,0.8516949152542372,0.981674876688399,1.0,6/11,41.47%,LRP5;PGRMC2;SH3PXD2B;DYRK1B;DGAT2;SOX8
prerank,quinone biosynthetic process (GO:1901663),0.2839323987733995,0.7043414258386688,0.8602540834845736,0.9954698863084883,1.0,6/14,19.46%,COQ2;PDSS2;COQ5;PDSS1;COQ3;COQ10A
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.2692126419938533,0.7037642195976769,0.8691756272401434,0.9955616814414894,1.0,7/20,20.58%,IMPDH1;NT5C2;GMPR2;HPRT1;GART;ATIC;PPAT
prerank,positive regulation of secretion by cell (GO:1903532),-0.18703074231683214,-0.7023099398324631,0.9823529411764705,0.983269615115346,1.0,13/70,16.64%,BMP6;IGF1;P2RX4;SLC12A2;RAB27B;EZR;STXBP5;PPID;RAB9A;UNC13B;EXOC1;TGFB1;STX1A
prerank,bile acid and bile salt transport (GO:0015721),0.2536228535576288,0.7019212179990375,0.8774774774774775,0.9970100041277559,1.0,1/24,1.40%,ABCC4
prerank,calcineurin-mediated signaling (GO:0097720),-0.3102375509227058,-0.701503180859382,0.8577405857740585,0.9828653452660044,1.0,4/10,18.39%,NFAT5;NFATC2;PPP3CC;NFATC4
prerank,calcineurin-NFAT signaling cascade (GO:0033173),-0.3102375509227058,-0.701503180859382,0.8577405857740585,0.9828653452660044,1.0,4/10,18.39%,NFAT5;NFATC2;PPP3CC;NFATC4
prerank,histone H2A monoubiquitination (GO:0035518),-0.2584379584336445,-0.7012915461811158,0.8758169934640523,0.9824715621131873,1.0,6/17,19.08%,DDB1;DDB2;RNF168;PCGF2;BCOR;PCGF6
prerank,vesicle organization (GO:0016050),0.220968486306673,0.7008588626380918,0.9143780290791599,0.9976222200371865,1.0,12/46,19.19%,SORT1;EXOC8;VPS11;LAMTOR1;AKTIP;RAB22A;LAPTM4B;HOOK3;VPS18;FNBP1L;ALS2;PI4K2B
prerank,negative regulation of anoikis (GO:2000811),0.29201133091031484,0.7008344208958313,0.8563327032136105,0.9970933142835443,1.0,2/14,8.04%,SRC;NOTCH1
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.22496539329812149,-0.7006303942061456,0.9081364829396326,0.9824797936249856,1.0,9/28,21.13%,ERCC6;SHLD1;HSF1;PARP3;SIRT7;ACTR2;RIF1;SMCHD1;DTX3L
prerank,steroid metabolic process (GO:0008202),-0.18279304124292045,-0.7005979826827984,0.976271186440678,0.9818942501561488,1.0,18/72,30.38%,CYP27A1;CYP7B1;LGMN;MSMO1;CYP26B1;FDX1;FDFT1;CYP51A1;PIAS4;ARV1;PRLR;DHRS4;LIPA;CUBN;GBA2;AMACR;DHCR24;DHRS11
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.31521396029349824,0.700534072668003,0.8330170777988615,0.9968571242713961,1.0,4/10,19.11%,CHFR;TUT7;TUT4;DIS3L2
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.25098848679195573,0.7003150793427961,0.8556876061120543,0.9965270604957187,1.0,6/26,14.59%,RPTOR;RGCC;PLCB1;DDX3X;ANKRD17;MTBP
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.2574721252637054,0.7002406487179103,0.8807829181494662,0.9960554824313477,1.0,6/24,16.33%,APOE;UBE3A;EFNA1;PSMD14;UCHL5;PTK2B
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),-0.27533684675600206,-0.6998414302952903,0.8540305010893247,0.981995484369074,1.0,6/14,36.48%,ACE;ENPEP;AGTR1;EDN1;EDN3;ACE2
prerank,Golgi ribbon formation (GO:0090161),0.2946764007377038,0.6993703286147106,0.8295454545454546,0.9964387489773079,1.0,3/13,10.13%,TRIP11;TMED5;GCC2
prerank,regulation of ceramide biosynthetic process (GO:2000303),-0.27159281635602306,-0.6985299128631329,0.8633405639913232,0.9826797173958053,1.0,10/15,39.85%,PRKCD;SMPD3;RACK1;PLA2G6;ORMDL3;SMPD2;SPHK1;ORMDL1;ORMDL2;SPHK2
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.2767587091630206,0.6976126107990769,0.8609154929577465,0.9972321416070209,1.0,3/16,8.88%,SRC;CLASP2;ACVRL1
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.2767587091630206,0.6976126107990769,0.8609154929577465,0.9972321416070209,1.0,3/16,8.88%,SRC;CLASP2;ACVRL1
prerank,regulation of gene silencing by RNA (GO:0060966),0.21998830538770017,0.6969179557891392,0.918918918918919,0.9968291641445503,1.0,13/50,20.07%,POLR2J;POLR2B;NUP54;NUP50;NUP35;IPO8;NDC1;NUP160;POM121;NUP42;EIF4G1;NUP133;AGO1
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.21998830538770017,0.6969179557891392,0.918918918918919,0.9968291641445503,1.0,13/50,20.07%,POLR2J;POLR2B;NUP54;NUP50;NUP35;IPO8;NDC1;NUP160;POM121;NUP42;EIF4G1;NUP133;AGO1
prerank,regulation of microtubule nucleation (GO:0010968),-0.300940102461867,-0.6968929540881063,0.8407643312101911,0.9836562403445956,1.0,3/10,15.74%,EML2;CKAP5;DCTN1
prerank,cellular copper ion homeostasis (GO:0006878),0.28981488906910907,0.696737593191928,0.8658088235294118,0.9964883531239085,1.0,4/14,14.68%,ARF1;APP;PRNP;MT2A
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.27907080250563,0.6963886108948099,0.8499095840867993,0.9963097979790453,1.0,3/15,14.50%,TENT4A;CNOT7;CNOT1
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.22397294459719833,0.6963128468944528,0.9072,0.9958374091534965,1.0,7/43,13.29%,ABRAXAS1;CDKN1A;NAE1;CHFR;HUS1;NBN;BRCC3
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.27977596807775945,-0.6945723897262789,0.885593220338983,0.9852930028082665,1.0,8/13,36.63%,TOB1;PABPC1;BTG2;POLR2G;TNRC6C;TNRC6B;EIF4ENIF1;ZFP36
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.2290944459396726,-0.693896940327637,0.8913043478260869,0.9853184883791124,1.0,13/26,35.43%,FBN1;CDK6;RARA;PTPN2;TCTA;TLR3;INHBA;GPR137B;CEACAM1;TMEM178A;MAFB;ZFPM1;GPR137
prerank,DNA replication (GO:0006260),0.19176612472279705,0.6936790997907575,0.9717912552891397,0.9980564136759659,1.0,19/105,15.84%,PNKP;ING4;ORC3;RAD1;POLE;CDC45;ORC4;CDK2AP1;POLA1;HUS1;ORC2;TOP3A;NBN;HELB;ING5;RMI1;BRIP1;TOP1;ATR
prerank,regulation of exocytosis (GO:0017157),0.22164807700825914,0.6935809155174171,0.9132492113564669,0.9975990952119708,1.0,6/46,10.69%,CLASP2;STXBP5L;RALA;CADPS;RAB2B;ATP6AP1
prerank,regulation of macrophage migration (GO:1905521),0.31073286842866144,0.6920087361811763,0.8403193612774451,0.9986510139660592,1.0,3/10,16.33%,CD81;MTUS1;PTK2B
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.2745712770616259,0.6916755420389583,0.8738738738738738,0.9984397744299323,1.0,4/16,16.75%,PNKP;KDM4D;KMT5B;PRKDC
prerank,RNA methylation (GO:0001510),0.21186799168101866,0.6916120992088796,0.9296,0.9979655147324372,1.0,15/60,20.59%,TRMO;BCDIN3D;THUMPD2;TRMT61B;METTL2A;METTL2B;NSUN6;ZC3H13;NSUN2;TFB1M;FTSJ1;TFB2M;METTL14;TGS1;ALKBH8
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.2775641137844394,0.6913725921806969,0.8640595903165735,0.9976605233741829,1.0,6/15,21.07%,PPARD;IRS2;LDLRAP1;IRS1;PRKCE;PPARG
prerank,cobalamin metabolic process (GO:0009235),0.26775608227801423,0.6911034422080652,0.8568840579710145,0.9973897970163208,1.0,1/17,2.94%,MTR
prerank,histone mRNA metabolic process (GO:0008334),0.2448225336586895,0.690529717231287,0.8986710963455149,0.9974185923112552,1.0,7/27,18.64%,NCBP1;TUT7;SSB;TUT4;SLBP;LSM1;SNRPD3
prerank,phosphate ion transport (GO:0006817),0.27944400016165305,0.6905280400350909,0.8812615955473099,0.9968741551646297,1.0,2/16,9.67%,XPR1;SLC37A3
prerank,endodermal cell fate commitment (GO:0001711),0.30623851533433877,0.6903148421153077,0.84,0.996541036595369,1.0,1/10,4.86%,SOX2
prerank,neuron apoptotic process (GO:0051402),-0.2460827304183747,-0.6901313790701823,0.8824833702882483,0.988262156308637,1.0,9/19,29.69%,TRPC5;CIT;FAM162A;TNFRSF21;ATN1;BCL2;GAPDH;BID;CDK5
prerank,regulation of steroid biosynthetic process (GO:0050810),0.30230036417949446,0.6900833621528919,0.875,0.9962346704881127,1.0,2/11,7.30%,NR5A1;SIRT1
prerank,hydrogen peroxide metabolic process (GO:0042743),0.2665222033891351,0.6899212729818048,0.8584229390681004,0.995846532158867,1.0,3/19,14.46%,SOD1;PARK7;CYBA
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),-0.2756940537528327,-0.6896497156216791,0.8950749464668094,0.9880905788984757,1.0,7/13,34.23%,RAB23;ENTPD7;AK3;GTPBP1;MFN1;RAN;AK4
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.20375444147668212,0.6878767132889925,0.9692982456140351,0.9973427670947547,1.0,17/78,18.07%,GSK3A;TRIB3;ARIH1;COP1;SMAD7;MDM2;RAD23A;UBQLN1;PIAS1;ELOB;RNF180;FBXO22;TAF1;UBQLN2;BCAP31;BBS7;GABARAP
prerank,mRNA methylation (GO:0080009),-0.26619147946524563,-0.6878216856517545,0.8702928870292888,0.9891437729131368,1.0,5/15,24.04%,VIRMA;CBLL1;PCIF1;TRMT6;CMTR1
prerank,positive regulation of vasculogenesis (GO:2001214),-0.29484424631623374,-0.6875799923952206,0.8814655172413793,0.9887354050851861,1.0,6/10,35.72%,CD34;RAPGEF2;HIF1AN;CEACAM1;RRAS;RIN2
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.23495595179237763,0.6873994054633414,0.9215017064846417,0.9972586576776533,1.0,3/31,13.00%,FCGR2B;LYN;CD274
prerank,sterol transport (GO:0015918),0.2637256075942337,0.6873470564757413,0.8803738317757009,0.9967603054620142,1.0,5/19,15.93%,LDLRAP1;NPC2;NPC1;OSBPL2;STARD3
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.284947119886932,0.686713695750107,0.8667953667953668,0.9968017317135546,1.0,2/15,7.11%,SORT1;BDNF
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),-0.23862274611236642,-0.6862567136939532,0.9103139013452914,0.9893571712033211,1.0,7/20,23.61%,MCU;MICU2;AFG3L2;MCUR1;SPG7;MCUB;STOML2
prerank,lysosome localization (GO:0032418),0.2299341436561463,0.6862086189549039,0.9136212624584718,0.9967766136300079,1.0,10/37,19.66%,PIK3CG;LAMTOR1;PIK3CD;SNAPIN;S100A13;TFEB;MYH9;VPS33A;PLEKHM2;KIF5B
prerank,positive regulation of type I interferon production (GO:0032481),0.20481244751029362,0.686170087691164,0.963302752293578,0.9962609865525868,1.0,16/73,19.12%,LRRFIP1;POLR1C;EP300;RELA;DDX3X;CREBBP;POLR3F;CHUK;POLR3B;SETD2;PRKDC;PTPN11;POLR3K;POLR3GL;TRIM56;DHX36
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.2834186650720846,0.6859253202497863,0.8524271844660194,0.9959665172645391,1.0,1/13,1.77%,AMDHD2
prerank,B cell activation involved in immune response (GO:0002312),0.2861323318387434,0.6855706595441362,0.8522727272727273,0.9957432181164461,1.0,1/13,2.51%,FCGR2B
prerank,negative regulation of interleukin-8 production (GO:0032717),-0.25329683868314784,-0.6846003511895261,0.8932714617169374,0.9903169405250553,1.0,6/17,28.78%,ANXA4;ANXA1;PTPN22;SSC5D;OTUD7B;BCL3
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",-0.2356195061404027,-0.683341543465741,0.9047619047619048,0.9907718798432127,1.0,11/23,36.14%,DICER1;DNASE1L1;DFFA;CASP3;EXOG;H1-0;DNASE2;HMGB1;HMGB2;SETMAR;MUS81
prerank,development of primary male sexual characteristics (GO:0046546),-0.20748056234011192,-0.6830543152555102,0.9432989690721649,0.990404932389516,1.0,5/34,12.96%,KIT;LHFPL2;WNT4;NCOA4;MSH2
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),-0.2771967807150605,-0.6821140797072432,0.870020964360587,0.9906340548077046,1.0,4/12,26.40%,BTRC;GOLGA2;CDC14B;UBE2S
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),-0.25001263219582337,-0.6817942252790417,0.8953229398663697,0.9902858776983546,1.0,9/18,31.24%,USP13;BCL2L11;TMEM259;RNFT1;PIK3R1;BAG6;RNF185;NCK1;BOK
prerank,cellular lipid catabolic process (GO:0044242),0.2410817008465041,0.6809703672145786,0.8900709219858156,0.9996653399470954,1.0,5/27,12.52%,PPARD;NUDT19;CYP1B1;ACOT8;ABHD12
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.28211963119615213,-0.6809580287949619,0.875,0.9903893684827911,1.0,5/11,28.52%,NBL1;RIN3;CCN3;DUSP1;PADI2
prerank,protein localization to centrosome (GO:0071539),-0.24972302466696503,-0.6809547547511346,0.9187358916478555,0.9897770837438816,1.0,3/17,10.50%,PIBF1;NUDCD3;GOLGB1
prerank,mesoderm development (GO:0007498),0.26440804779629407,0.6799686442799238,0.8865248226950354,1.0,1.0,3/18,10.46%,TBX1;TIE1;MEST
prerank,regulation of T cell differentiation (GO:0045580),-0.20614526353278062,-0.6798388313406106,0.9320388349514563,0.9901047000981555,1.0,3/33,6.99%,CBFB;ZBTB1;CAMK4
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.2913775916439283,-0.6797762157019636,0.8917322834645669,0.9895402085151163,1.0,3/10,15.31%,DNAJC19;MTMR9;MTMR4
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.29536343704084905,0.6797173591298423,0.8513513513513513,0.999226690746321,1.0,3/11,18.82%,CALM3;FKBP1A;CALM1
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.29536343704084905,0.6797173591298423,0.8513513513513513,0.999226690746321,1.0,3/11,18.82%,CALM3;FKBP1A;CALM1
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.285253934592545,0.6795898376346837,0.8660377358490566,0.9988011263275117,1.0,3/12,13.62%,SGTB;SEC62;SEC61A2
prerank,regulation of protein localization to cell periphery (GO:1904375),-0.246874416560789,-0.6789174635715344,0.8944954128440367,0.9896655718626705,1.0,10/18,33.32%,MMP14;STX8;VPS4A;APPL1;CLN3;VAMP8;SPTBN1;CDK5;ABCA2;VTI1B
prerank,purine-containing compound biosynthetic process (GO:0072522),-0.2252483250561678,-0.6785941169135549,0.9144893111638955,0.9893507196827792,1.0,6/25,15.84%,AMPD3;DGUOK;ADK;GMPS;MTHFD1;PRPSAP2
prerank,protein catabolic process (GO:0030163),0.20393864636822553,0.6783262064826263,0.9492868462757528,0.9994476572741968,1.0,8/59,15.10%,HSPA8;PPT1;APOE;MAGEC2;TPP1;STT3B;CHEK2;UBE2G1
prerank,inhibitory synapse assembly (GO:1904862),-0.28273784818162545,-0.6779068928165083,0.8681102362204725,0.9893517875325564,1.0,5/11,24.48%,GABRA2;GABRG2;LGI2;GABRA1;PLXNB1
prerank,phasic smooth muscle contraction (GO:0014821),0.3046698468491086,0.6761979157104264,0.8661257606490872,1.0,1.0,10/10,69.55%,EDNRB;EDN2;HTR1D;TIFAB;GDNF;HTR2B;EDN3;PTGER3;EDN1;DRD2
prerank,cytoplasmic sequestering of protein (GO:0051220),-0.26966239545303927,-0.6760550869687894,0.902,0.9902667691554804,1.0,7/13,28.65%,PKD1;FLNA;KEAP1;SUFU;DBN1;GET4;MDFI
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),-0.2548218829837003,-0.675514947858876,0.9069264069264069,0.9900971496098648,1.0,8/16,31.79%,PIGV;PIGG;PIGX;PIGA;PIGM;PIGF;DPM2;PIGC
prerank,tetrapyrrole metabolic process (GO:0033013),0.2597613532588763,0.6751386542630218,0.8878676470588235,1.0,1.0,1/18,2.94%,MTR
prerank,positive regulation of vasoconstriction (GO:0045907),-0.2695667305913542,-0.6750792203370776,0.8610526315789474,0.9898385511422655,1.0,4/13,32.25%,ADRA1B;ADRA1A;CAV1;TBXA2R
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.2561868818021455,0.6746146855541231,0.8911070780399274,1.0,1.0,4/20,13.85%,CDK5RAP1;LATS2;TFAP4;APC
prerank,regulation of myelination (GO:0031641),-0.2227532155389484,-0.6740190364393158,0.9242105263157895,0.9901672981325138,1.0,12/25,35.79%,SIRT2;TNFRSF21;DICER1;TPPP;RNF10;EIF2AK3;LGI4;MYRF;PTN;NSUN5;ZPR1;TMEM98
prerank,positive regulation of TOR signaling (GO:0032008),0.22183451885383415,0.6739743521551483,0.9420289855072463,1.0,1.0,7/40,15.25%,RPTOR;HDAC3;LAMTOR1;SIK3;LARS1;RRAGC;GAS6
prerank,Golgi to endosome transport (GO:0006895),0.27171904482291526,0.6735735701311665,0.8998144712430427,1.0,1.0,6/16,17.75%,SORT1;RAB14;DOP1B;AP1AR;CORO7;KIF16B
prerank,regulation of cholesterol storage (GO:0010885),-0.2576008730335841,-0.6732121240994623,0.8601694915254238,0.9902172699016258,1.0,4/15,16.53%,PPARA;ABCA1;TTC39B;EHD1
prerank,alpha-linolenic acid metabolic process (GO:0036109),-0.27112663142961163,-0.6729379380239439,0.879746835443038,0.9898331906722939,1.0,1/12,1.66%,ACSL1
prerank,rRNA 3'-end processing (GO:0031125),0.3060021900300778,0.6726701003431852,0.8571428571428571,1.0,1.0,2/10,8.81%,RPS21;EXOSC9
prerank,phosphate ion transmembrane transport (GO:0035435),0.29325079187585235,0.6719478233046264,0.858252427184466,1.0,1.0,2/12,9.67%,XPR1;SLC37A3
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),-0.2865056903349726,-0.6710744284942527,0.891170431211499,0.9901243868724648,1.0,4/10,21.48%,PRKCD;SMPD3;RACK1;PLA2G6
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.2865056903349726,-0.6710744284942527,0.891170431211499,0.9901243868724648,1.0,4/10,21.48%,PRKCD;SMPD3;RACK1;PLA2G6
prerank,long-chain fatty acid metabolic process (GO:0001676),0.20297125996591217,0.6705422808487901,0.9448698315467075,1.0,1.0,12/64,18.12%,ACSL5;ELOVL6;ACSL4;CYP1B1;PNPLA8;HSD17B4;ACOT8;DAGLB;HPGD;ACADL;AIG1;ELOVL5
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.26201583720857047,-0.6703636115826954,0.8665207877461707,0.9900555517354565,1.0,2/13,15.93%,IL33;SELENOS
prerank,mitochondrial transcription (GO:0006390),-0.2862086452787129,-0.6698088427988983,0.8806584362139918,0.9898730203140262,1.0,7/10,41.27%,SLC25A33;FOXO3;MTERF2;MRPL12;TEFM;POLRMT;TWNK
prerank,positive regulation of cell development (GO:0010720),0.23128072711619183,0.6695593419743089,0.9358752166377816,1.0,1.0,5/31,13.61%,MME;RFX3;BAD;ATP6AP1;FAIM
prerank,regulation of interferon-beta production (GO:0032648),0.2162642021458136,0.6692783960593194,0.9434571890145396,1.0,1.0,8/46,13.47%,TIRAP;YY1;NLRC3;TRAF3;DDX3X;POLR3F;RNF216;POLR3B
prerank,rRNA modification (GO:0000154),0.24991977487120803,0.6691623103804399,0.893048128342246,1.0,1.0,1/21,1.09%,THUMPD1
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),-0.22025568218143535,-0.6686532591012132,0.9402985074626866,0.9901691314083856,1.0,11/25,31.61%,PKM;FOXK1;ALDOA;ENO2;PGK1;HK2;PGAM1;PFKM;GAPDH;ALDOC;PFKL
prerank,cellular biogenic amine metabolic process (GO:0006576),-0.26971180366361047,-0.6685549303840453,0.8710359408033826,0.9896402872735063,1.0,4/12,22.92%,ATP7A;HNMT;SMS;OAZ2
prerank,regulation of cell aging (GO:0090342),0.2925348402672812,0.6677591745881731,0.8715953307392996,1.0,1.0,4/11,18.90%,ING2;NEK6;RSL1D1;NUAK1
prerank,establishment of protein localization to extracellular region (GO:0035592),0.21753647612583288,0.6676132851359826,0.9409888357256778,1.0,1.0,10/39,19.57%,MIA2;ARL4D;COPG2;PPY;COPG1;TANGO6;TVP23B;MIA3;PDIA4;SEL1L
prerank,regulation of triglyceride biosynthetic process (GO:0010866),0.27274907548257293,0.6672697967377127,0.8963636363636364,1.0,1.0,3/15,11.85%,FITM2;CNEP1R1;SCARB1
prerank,regulation of T cell proliferation (GO:0042129),0.2020975851068687,0.6671485219504468,0.9663461538461539,1.0,1.0,4/61,13.00%,PTPRC;TNFRSF1B;PNP;CD274
prerank,protein localization to chromatin (GO:0071168),0.2625665247195158,0.6663421311226414,0.8904847396768402,1.0,1.0,4/18,14.51%,RUVBL2;ESR1;PPHLN1;TASOR
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.20782314963858772,0.6654129693418465,0.9570063694267515,1.0,1.0,8/54,11.52%,TNFAIP3;PRMT3;RPL5;SMAD7;IVNS1ABP;PARK7;SPOPL;RPS3
prerank,regulation of membrane depolarization (GO:0003254),0.2526422998452496,0.6653088779939614,0.8881118881118881,1.0,1.0,2/18,7.28%,NEDD4L;SMAD7
prerank,monocarboxylic acid catabolic process (GO:0072329),-0.231645154809419,-0.6650434794785761,0.9282608695652174,0.9917761744256965,1.0,7/21,27.57%,ACBD5;LPIN1;CYP26B1;LPIN2;FAH;HOGA1;LPIN3
prerank,negative regulation of neurogenesis (GO:0050768),0.22486638160309064,0.6649148240741853,0.9444444444444444,1.0,1.0,8/34,17.53%,B2M;RUFY3;NOTCH1;NF1;YWHAH;HOOK3;LRP4;LINGO1
prerank,respiratory chain complex IV assembly (GO:0008535),-0.22992081884131033,-0.6646790910161867,0.9193548387096774,0.9914511583915812,1.0,14/21,43.68%,COX16;COX19;COX17;COX18;PET100;COX20;COX14;BCS1L;COA5;SCO1;COA3;SURF1;COA6;FASTKD3
prerank,high-density lipoprotein particle assembly (GO:0034380),0.3010100972312113,0.6642233791538386,0.8662900188323918,1.0,1.0,1/10,4.59%,APOE
prerank,intracellular cholesterol transport (GO:0032367),0.26895981636409083,0.6633505724932103,0.8936170212765957,1.0,1.0,5/15,13.98%,LDLRAP1;NPC2;NPC1;OSBPL2;SERAC1
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.20013057578154278,0.662947051439757,0.955177743431221,1.0,1.0,13/67,15.63%,TBC1D8;PPP1R16B;TBC1D10B;FXR1;USP6NL;PODXL;IFT140;TBC1D24;TBC1D14;RABGAP1;TWF1;ARF6;CDKL5
prerank,positive regulation of response to cytokine stimulus (GO:0060760),-0.2597621823015946,-0.6624462617836866,0.9098901098901099,0.9925140114409843,1.0,3/13,17.65%,AXL;IFIH1;MAVS
prerank,GPI anchor metabolic process (GO:0006505),-0.21765166010890447,-0.6616393950119528,0.9445727482678984,0.9924951595652193,1.0,12/26,33.86%,DPM1;GPLD1;PIGV;PIGG;PIGA;PIGM;PGAP4;PIGF;MPPE1;DPM2;PIGC;DPM3
prerank,nucleotide-sugar biosynthetic process (GO:0009226),-0.23359250770438847,-0.6614468797120401,0.9235955056179775,0.992017630385504,1.0,12/19,37.45%,PMM2;RENBP;UGDH;NAGK;GFPT1;GNPDA2;GFPT2;GNPDA1;GNPNAT1;PMM1;UAP1;NANS
prerank,positive regulation of macrophage migration (GO:1905523),0.25301840218233,0.6613050221635398,0.8894830659536542,1.0,1.0,2/19,9.17%,MAPK3;CSF1R
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.25827272991352274,0.6612271740277509,0.8957952468007313,1.0,1.0,1/17,2.58%,CXCL12
prerank,piRNA metabolic process (GO:0034587),0.2574263643785719,0.6607107833610155,0.9005424954792043,1.0,1.0,19/19,74.29%,MYBL1;PLD6;PIWIL1;TDRD1;BTBD18;GPAT2;ASZ1;HENMT1;MOV10L1;MAEL;FKBP6;PIWIL4;TDRD12;DDX4;TDRD9;PIWIL2;EXD1;TEX15;TDRKH
prerank,NAD biosynthetic process (GO:0009435),0.252457587971704,0.6604834522372925,0.9173838209982789,1.0,1.0,5/20,16.87%,NUDT12;NADSYN1;NAMPT;NAXD;NMNAT1
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.21054897229231143,0.6600041032472531,0.9427244582043344,1.0,1.0,10/49,18.08%,RAB7B;MYL9;CIB1;EP300;MTURN;AGO4;PITHD1;MOV10;EIF6;SIN3A
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.23385767849733083,0.6599224816095969,0.9321739130434783,1.0,1.0,5/29,11.27%,GRIK2;NETO1;APOE;MCTP1;APP
prerank,regulation of fatty acid beta-oxidation (GO:0031998),-0.2576392819327131,-0.6596476723205121,0.8874734607218684,0.9927350623002525,1.0,8/14,40.71%,PPARA;AKT2;ABCD2;AKT1;MFSD2A;TWIST1;TYSND1;MTLN
prerank,positive regulation of pseudopodium assembly (GO:0031274),-0.28190893769448666,-0.6594450358036439,0.8884120171673819,0.9916718229961143,1.0,5/10,33.57%,CDC42EP5;CDC42EP1;CDC42;CDC42EP2;WASHC1
prerank,regulation of pseudopodium assembly (GO:0031272),-0.28190893769448666,-0.6594450358036439,0.8884120171673819,0.9916718229961143,1.0,5/10,33.57%,CDC42EP5;CDC42EP1;CDC42;CDC42EP2;WASHC1
prerank,positive regulation of protein localization to cell surface (GO:2000010),0.27167948398855624,0.6564918851585981,0.8719851576994434,1.0,1.0,2/13,8.20%,RIC3;TMEM35A
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),-0.19995201632648496,-0.656360141736715,0.9623655913978495,0.9932929756078449,1.0,4/35,8.39%,CDH10;CDH11;CDH7;NLGN1
prerank,cellular response to interleukin-15 (GO:0071350),-0.2636773511710456,-0.655696190175337,0.9040816326530612,0.992575832385696,1.0,2/13,12.24%,JAK1;GRB2
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.2636773511710456,-0.655696190175337,0.9040816326530612,0.992575832385696,1.0,2/13,12.24%,JAK1;GRB2
prerank,ncRNA 3'-end processing (GO:0043628),0.26874164769851544,0.6556237042268331,0.8867562380038387,1.0,1.0,6/14,20.27%,PTCD1;INTS14;SSB;INTS6;TRNT1;INTS2
prerank,glial cell differentiation (GO:0010001),-0.21517148112776618,-0.655411217639208,0.9487179487179487,0.9921697656068947,1.0,18/28,41.74%,NFIB;RELN;TPPP;PAX2;PICK1;EIF2B5;CDK5;MYRF;FGF10;GPC1;SOX11;ERBB3;GPR157;SOX10;METRN;SOX4;SOX8;PTPRZ1
prerank,positive regulation of endopeptidase activity (GO:0010950),-0.218996870008197,-0.6537543869738441,0.9344262295081968,0.992774054693077,1.0,5/26,12.91%,GRIN2B;MBP;ROCK2;AIM2;USP50
prerank,negative regulation of interferon-gamma production (GO:0032689),0.24112269444920453,0.6524431137014928,0.9322033898305084,1.0,1.0,5/23,15.25%,VSIR;PRNP;CD274;DDIT3;GAS6
prerank,mRNA polyadenylation (GO:0006378),0.23670584796073849,0.6519608263019073,0.9204946996466431,1.0,1.0,9/26,21.52%,AHCYL1;PAPOLA;APP;SCAF8;WDR33;CLP1;PAPOLG;TENT2;MTPAP
prerank,RNA polyadenylation (GO:0043631),0.23670584796073849,0.6519608263019073,0.9204946996466431,1.0,1.0,9/26,21.52%,AHCYL1;PAPOLA;APP;SCAF8;WDR33;CLP1;PAPOLG;TENT2;MTPAP
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.2358953743360883,0.6511356730093818,0.9387040280210157,1.0,1.0,4/25,12.73%,HEY1;HEY2;PARK7;DOT1L
prerank,positive regulation of cholesterol transport (GO:0032376),0.23212673685537172,0.6510665801383185,0.9152542372881356,1.0,1.0,3/27,7.30%,APOE;LPCAT3;SIRT1
prerank,glycerophospholipid catabolic process (GO:0046475),0.23157088041603696,0.6510258660868213,0.9302325581395349,1.0,1.0,4/27,14.23%,SMPD4;PNPLA8;ABHD12;PNPLA6
prerank,potassium ion export across plasma membrane (GO:0097623),-0.26208112259311933,-0.6509093123896025,0.9050632911392406,0.9941601350080748,1.0,5/13,45.90%,KCNK5;KCNQ1;KCNIP2;KCNE4;KCNH2
prerank,regulation of keratinocyte migration (GO:0051547),-0.2626070633527756,-0.6504067606772563,0.8825995807127882,0.993902840298276,1.0,6/12,33.10%,EPB41L4B;IQSEC1;MAPRE2;FGF10;FGF7;MTOR
prerank,steroid hormone biosynthetic process (GO:0120178),0.22998607028989612,0.6501417126445651,0.9415584415584416,1.0,1.0,4/29,15.93%,TSPO;HSD17B11;STARD3NL;STARD3
prerank,mesoderm formation (GO:0001707),0.2594394146068476,0.649991415866051,0.8950381679389313,1.0,1.0,2/17,12.25%,ITGA2;ITGA3
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.269396660399868,0.6485975747716164,0.8972972972972973,1.0,1.0,2/15,6.97%,RIPOR2;RAPGEF3
prerank,regulation of stem cell population maintenance (GO:2000036),0.2518663590825543,0.6474346618739173,0.9084507042253521,1.0,1.0,5/18,20.30%,CNOT2;CNOT1;TAF6L;ZC3H13;REST
prerank,histone H3-K36 demethylation (GO:0070544),-0.2761632647771401,-0.6468446026089459,0.9170212765957447,0.9957092449673204,1.0,2/10,5.28%,KDM4A;KDM7A
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.21883314282563654,0.6468334893047559,0.9359190556492412,1.0,1.0,6/32,16.60%,LPCAT3;GPAT4;SLC44A1;CEPT1;CSNK2A2;SLC44A2
prerank,positive regulation of T cell proliferation (GO:0042102),-0.17894596079662378,-0.6463652678097774,0.9812834224598931,0.9954149755435254,1.0,6/55,14.13%,IGF1;IGFBP2;ANXA1;IL18;IL6ST;IGF2
prerank,lymphocyte migration (GO:0072676),0.2216576218834869,0.6456087898843325,0.9337748344370861,1.0,1.0,2/32,8.51%,RET;CCL25
prerank,negative regulation of autophagosome assembly (GO:1902902),-0.2532047700090012,-0.6453932456728669,0.9189765458422174,0.995395893274155,1.0,4/13,22.02%,NUPR1;FEZ1;PINK1;PHF23
prerank,cellular response to interleukin-2 (GO:0071352),0.27907143519265704,0.6450841558080357,0.8780487804878049,1.0,1.0,3/11,16.70%,SYK;PTK2B;SHC1
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.27907143519265704,0.6450841558080357,0.8780487804878049,1.0,1.0,3/11,16.70%,SYK;PTK2B;SHC1
prerank,macrophage migration (GO:1905517),-0.2557099379890825,-0.6447356677342891,0.9043659043659044,0.9952350504942747,1.0,3/13,24.21%,P2RX4;P2RY12;CKLF
prerank,negative regulation of organelle assembly (GO:1902116),-0.19557485398508748,-0.6436463575785705,0.9612403100775194,0.9953687506457864,1.0,17/35,32.81%,SMAD4;NUPR1;FEZ1;CCP110;LIMK2;PINK1;PHF23;RBM14;YAP1;MDM1;CDK10;TBC1D7;CEP97;KAT2B;TCHP;TRIM37;SMCR8
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),0.28645578891660517,0.6435259894317349,0.8909090909090909,1.0,1.0,1/10,6.88%,CALM3
prerank,ubiquinone metabolic process (GO:0006743),0.2560839392997263,0.6431950727199526,0.8976234003656307,1.0,1.0,6/15,19.46%,COQ2;PDSS2;COQ5;PDSS1;COQ3;COQ10A
prerank,cell projection organization (GO:0030030),0.2212380801213184,0.6424117744559709,0.9594356261022927,1.0,1.0,6/30,16.84%,RAC2;RHOQ;RHOG;PLEK;PACSIN2;CYFIP1
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.2030574887234473,0.642217119244453,0.9758064516129032,1.0,1.0,2/51,2.58%,MAPK3;CXCL12
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),-0.2705969357892068,-0.6417026313877149,0.9241803278688525,0.9960803659303323,1.0,4/11,20.49%,EFNB2;TGFB1;SOX6;FZD7
prerank,ganglioside biosynthetic process (GO:0001574),0.26035470440489106,0.6415006505642463,0.9001919385796545,1.0,1.0,3/15,14.61%,ST6GALNAC3;ST3GAL1;ST8SIA6
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.24044051856089116,-0.6404642398082162,0.9102564102564102,0.9962598837618927,1.0,6/15,26.99%,ALDH4A1;GGT5;PRODH;SARDH;HOGA1;CHAC2
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.19502178018116637,0.6402747765755474,0.9768875192604006,1.0,1.0,8/57,13.34%,ABRAXAS1;NEK11;CDKN1A;RFWD3;HUS1;NBN;BRCC3;CHEK2
prerank,regulation of cilium assembly (GO:1902017),0.1949192642835908,0.6394636437349973,0.9735973597359736,1.0,1.0,9/62,13.25%,EVI5L;TBC1D30;TBC1D8;TBC1D10B;USP6NL;IFT140;TBC1D24;TBC1D14;RABGAP1
prerank,regulation of telomere maintenance (GO:0032204),0.22732306242653239,0.6386086935555427,0.9440559440559441,1.0,1.0,8/26,19.12%,ERCC4;SMG1;NBN;TERF2IP;SMG6;SMG5;ATRX;DHX36
prerank,regulation of mitochondrial fusion (GO:0010635),0.2775794447485146,0.6383705701255031,0.9036608863198459,1.0,1.0,4/11,19.06%,OMA1;VAT1;BNIP3;TFRC
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.24769167000138434,-0.6381748720498742,0.9341825902335457,0.9970835237080102,1.0,9/14,38.48%,ZNHIT6;NOL9;RPF2;FTSJ3;BOP1;NIFK;RPL7L1;PES1;DDX18
prerank,intracellular sterol transport (GO:0032366),0.26549015141920884,0.6381183700530332,0.9255725190839694,1.0,1.0,4/13,13.98%,NPC2;NPC1;OSBPL2;SERAC1
prerank,negative regulation by host of viral transcription (GO:0043922),-0.25705966634342814,-0.6373636216389945,0.9148471615720524,0.9969836051049441,1.0,5/12,29.17%,HDAC1;JUN;PSMC3;INPP5K;HMGA2
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.25670896517947933,0.63720015010073,0.9122486288848263,1.0,1.0,5/15,19.57%,DERL2;AUP1;UFD1;DERL1;SEL1L
prerank,DNA methylation (GO:0006306),0.23249654290710348,0.6368183111421454,0.9226618705035972,1.0,1.0,2/23,5.83%,DMAP1;BEND3
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.24482111784831964,0.6365091733691124,0.9226713532513181,1.0,1.0,1/18,2.43%,DERL2
prerank,toll-like receptor 3 signaling pathway (GO:0034138),-0.2663272858189286,-0.636392488815345,0.9036402569593148,0.9969984606986018,1.0,1/11,3.95%,SCARA3
prerank,neuromuscular process (GO:0050905),0.2548735775186054,0.6355644741618417,0.9113043478260869,1.0,1.0,5/16,17.78%,AGTPBP1;TPP1;MYCBP2;GCH1;PAFAH1B1
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.2833291488827516,0.6350804820968448,0.9090909090909091,1.0,1.0,10/10,71.68%,ETFBKMT;OXA1L;GZMA;DRD5;PRKN;HP;AOC3;MT3;SNCA;HDAC6
prerank,striated muscle cell differentiation (GO:0051146),0.25257936476156007,0.6347968793622165,0.9175824175824175,1.0,1.0,2/16,5.81%,SORT1;MYEF2
prerank,glycerolipid catabolic process (GO:0046503),0.24693044555310995,0.634017872987806,0.9318600368324125,1.0,1.0,3/19,14.23%,SMPD4;ABHD12;PNPLA6
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.27240055230953963,-0.6336692372051707,0.9147286821705426,0.9980090887257806,1.0,4/10,23.59%,EMC7;EMC1;EMC8;EMC9
prerank,chromosome organization (GO:0051276),0.17671126388018796,0.6334767821305556,0.9912152269399708,1.0,1.0,16/99,16.09%,EZH2;HDAC3;SOX2;FAM50A;SIRT1;CDCA8;RFWD3;MSH3;COPS7B;PWWP3A;DOT1L;HDAC5;COPS8;EZH1;SMARCA4;TCF7L1
prerank,myelin maintenance (GO:0043217),0.2840116616182693,0.6332826174215939,0.8978723404255319,1.0,1.0,1/10,2.23%,SOD1
prerank,neural crest cell differentiation (GO:0014033),-0.22507959597177668,-0.6332051962742463,0.9449152542372882,0.9976709011343169,1.0,13/18,50.33%,TAPT1;LRP6;PEF1;TCOF1;NOLC1;FBXL17;SOX11;SOX8;KBTBD8;HTR2B;SNAI2;NRG1;MEF2C
prerank,protein alkylation (GO:0008213),-0.2199154065066061,-0.6324829220146143,0.9507042253521126,0.9975143275793408,1.0,8/22,28.30%,CAMKMT;FAM98A;EEF1AKMT1;PRMT2;METTL21A;PRMT8;PRMT1;EEF2KMT
prerank,hexose transmembrane transport (GO:0008645),0.23941552533817628,0.6312382186561584,0.9246935201401051,1.0,1.0,2/21,8.35%,PPARD;SLC2A1
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.2645310549805336,0.6310402425927001,0.9054054054054054,1.0,1.0,2/13,12.41%,PLCG1;SP1
prerank,regulation of DNA recombination (GO:0000018),0.2178426877383103,0.6306555048353025,0.9549393414211439,1.0,1.0,6/32,16.84%,ZRANB3;MSH3;KPNA1;TERF2IP;SETD2;SMARCAD1
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.2647254873179613,0.6300647470448212,0.9292364990689013,1.0,1.0,1/13,3.56%,EXTL2
prerank,regulation of store-operated calcium entry (GO:2001256),-0.2700402866497341,-0.6293996234046552,0.9350393700787402,0.9987624623942013,1.0,1/10,3.09%,STIM1
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.27057095080739263,0.6287616426072544,0.9284403669724771,1.0,1.0,3/13,15.95%,NUDT12;NAMPT;NAXD
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.27742328468883565,0.6286078319691893,0.9026717557251909,1.0,1.0,2/11,13.00%,VSIR;CD274
prerank,negative regulation of secretion (GO:0051048),-0.27006992018601694,-0.627122710517744,0.9053763440860215,0.9995001505362928,1.0,6/10,50.18%,VAMP8;PTGER3;EGF;ERBB3;SPX;NRG1
prerank,purine nucleotide metabolic process (GO:0006163),0.22836152121607806,0.6251383747059236,0.9389179755671903,1.0,1.0,4/24,12.02%,PRPS1L1;PRPS1;PNP;NT5C2
prerank,GPI anchor biosynthetic process (GO:0006506),-0.19915437082057214,-0.6248627309583821,0.9783653846153846,1.0,1.0,14/30,33.86%,DPM1;PIGV;PIGG;PIGX;PIGA;PIGM;PGAP4;PIGS;PIGF;GPAA1;MPPE1;DPM2;PIGC;DPM3
prerank,amyloid precursor protein catabolic process (GO:0042987),0.2587163818164939,0.6247837567514383,0.9253731343283582,1.0,1.0,1/14,2.47%,PSEN2
prerank,actin filament-based transport (GO:0099515),0.23495225155386412,0.6241848782660769,0.9406631762652705,1.0,1.0,4/21,13.12%,MYO5A;ACTN4;MYO1D;MYO1E
prerank,negative regulation of intracellular protein transport (GO:0090317),-0.2117325618610223,-0.6240843123189763,0.9502369668246445,0.9998916432084455,1.0,12/22,34.59%,LMAN1;GDI1;RAB23;APOD;CABP1;ITGB1BP1;DMTN;SUFU;INPP5K;CHP1;SIAH3;BARD1
prerank,muscle tissue development (GO:0060537),0.255380864532751,0.6234095272277529,0.9213051823416507,1.0,1.0,3/13,13.39%,PGM5;NF1;CSRP1
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.2628625116317672,0.6227751789085565,0.9191729323308271,1.0,1.0,1/12,3.46%,PAX8
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.2263395644679429,0.6215671964584315,0.9413735343383585,1.0,1.0,3/24,10.98%,PDE4D;CALM3;DMD
prerank,cardiac cell development (GO:0055006),-0.2623426071138991,-0.62155776265685,0.9229166666666667,1.0,1.0,3/11,24.78%,CXADR;VEGFA;MYH11
prerank,defense response to fungus (GO:0050832),0.24340021082356833,0.621491220055361,0.9314285714285714,1.0,1.0,1/17,6.03%,FAM3A
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.23864488461478742,0.6199559071513832,0.9247706422018349,1.0,1.0,6/19,18.52%,POLD3;TERT;PNP;GMPR2;GMPR;HPRT1
prerank,negative regulation of translational initiation (GO:0045947),0.25608722632463043,0.6198610838525985,0.9179389312977099,1.0,1.0,7/13,23.69%,PAIP2B;EIF3E;LARP1;EIF2AK4;PAIP2;AGO2;FMR1
prerank,positive regulation of innate immune response (GO:0045089),0.2127406241428401,0.6192303307200125,0.9616055846422339,1.0,1.0,5/30,13.47%,IFI35;WNT5A;POLR3F;NLRC5;POLR3B
prerank,macromolecule catabolic process (GO:0009057),-0.2053139488164847,-0.6191871894033135,0.9641148325358851,1.0,1.0,12/26,33.10%,LGMN;UVRAG;SNX25;UCHL3;TGFB1;LRSAM1;NEDD4;CLPX;CLN5;SMURF1;MVB12A;MTOR
prerank,regulation of RNA export from nucleus (GO:0046831),0.26927223659985633,0.617841139338422,0.9172932330827067,1.0,1.0,5/11,21.38%,AKAP8L;CPSF6;SETD2;NSUN2;DHX9
prerank,ubiquinone biosynthetic process (GO:0006744),0.24730532933377058,0.6175987782656089,0.9343065693430657,1.0,1.0,6/15,19.46%,COQ2;PDSS2;COQ5;PDSS1;COQ3;COQ10A
prerank,mitochondrial genome maintenance (GO:0000002),-0.25403313374027714,-0.6172441949492741,0.9340425531914893,1.0,1.0,4/11,19.83%,SLC25A36;MPV17;PARP1;SLC25A33
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.26395717917059036,-0.6170579750692428,0.9493670886075949,1.0,1.0,1/10,3.61%,TGFBR2
prerank,RNA interference (GO:0016246),-0.23041810407560526,-0.6163259763886192,0.9344978165938864,1.0,1.0,6/17,28.60%,TSN;AGO3;DICER1;NRDE2;CELF1;DROSHA
prerank,snRNA 3'-end processing (GO:0034472),0.2324965004043737,0.615961714639388,0.9297597042513863,1.0,1.0,6/19,20.27%,USB1;EXOSC9;INTS14;INTS6;EXOSC7;INTS2
prerank,negative regulation of receptor internalization (GO:0002091),-0.25006402656211707,-0.6158978723730024,0.9253112033195021,1.0,1.0,2/12,15.61%,DLG4;RIN3
prerank,regulation of acrosome reaction (GO:0060046),-0.26561080277334964,-0.6143633951674524,0.9213250517598344,1.0,1.0,1/10,7.73%,GLRA1
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.20389264229592863,0.6139313939508481,0.9786184210526315,1.0,1.0,5/35,12.83%,RIPOR2;SCAI;RASIP1;ITGA3;CUL3
prerank,regulation of ruffle assembly (GO:1900027),0.22710656299810644,0.6138205843431112,0.9401088929219601,1.0,1.0,2/23,4.76%,EVL;PFN1
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.26319338507644163,0.6125256270469054,0.9412878787878788,1.0,1.0,3/13,17.67%,CRLF1;TYK2;STAT3
prerank,cellular response to interferon-beta (GO:0035458),0.2600589391210383,0.6124502909659736,0.9281553398058252,1.0,1.0,2/14,13.08%,IFITM2;NDUFA13
prerank,positive regulation of ruffle assembly (GO:1900029),-0.24410097915903717,-0.6123931423448525,0.9517102615694165,1.0,1.0,5/13,24.18%,NLGN1;FAM98A;PLEKHM1;P2RY12;EPS8L2
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.22695774813783506,-0.6122094899675123,0.9342105263157895,1.0,1.0,6/17,36.26%,PRKCZ;RARA;CEBPB;CD86;HAVCR2;FCER1G
prerank,organophosphate catabolic process (GO:0046434),0.2685958194714708,0.6118597615373639,0.9194756554307116,1.0,1.0,11/11,73.16%,ABHD12;ENPP2;PNLIPRP2;APOA2;LIPG;PON1;PDXP;NUDT15;PLBD1;ANGPTL3;PLBD2
prerank,cellular response to leucine starvation (GO:1990253),-0.2655103070708936,-0.6118506316917796,0.9336016096579477,1.0,1.0,5/10,33.65%,GCN1;IMPACT;SESN2;MTOR;RRAGD
prerank,maintenance of gastrointestinal epithelium (GO:0030277),-0.2536434959581348,-0.6113244885354375,0.9417879417879418,0.9998188024846985,1.0,1/12,7.87%,RBP4
prerank,regulation of interleukin-6 production (GO:0032675),0.1726100945052959,0.6106906244248558,0.9942528735632183,1.0,1.0,7/96,9.09%,TNFAIP3;TIRAP;RAB7B;SYK;NLRC3;WNT5A;CD47
prerank,fatty acid biosynthetic process (GO:0006633),-0.16021080670857213,-0.6105635367894151,0.9943502824858758,0.9995956461960943,1.0,24/63,39.25%,HACD3;HACD1;HACD4;TECR;ACLY;ABHD3;ACOT7;PTGS2;DEGS1;EPHX2;ABCD3;ELOVL4;FADS3;DECR2;CBR4;SCD;ELOVL1;LIAS;FADS1;ACSBG1;LPL;ALOX12;HSD17B8;OXSM
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.22624519396253773,0.6102180641364171,0.9445407279029463,1.0,1.0,4/22,14.04%,ZDHHC14;ZDHHC15;ZDHHC9;ZDHHC7
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.22624519396253773,0.6102180641364171,0.9445407279029463,1.0,1.0,4/22,14.04%,ZDHHC14;ZDHHC15;ZDHHC9;ZDHHC7
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.26759272594287575,0.6096981805136159,0.9136276391554703,1.0,1.0,2/11,11.08%,PTPRT;ADIPOR1
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.20216970157338532,-0.6089076341373074,0.9676674364896074,0.9998036386448348,1.0,4/25,13.07%,FAM162A;BCL2L11;TP53;PDCD5
prerank,chromatin assembly (GO:0031497),0.19666187108641067,0.6079072597543465,0.9744027303754266,1.0,1.0,8/38,18.79%,NAP1L4;SIRT1;RSF1;BRD2;EZH1;RBBP4;NPM1;ATRX
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),-0.21687403761452304,-0.6077999754601776,0.9587852494577006,0.9997108214041477,1.0,8/18,43.79%,GPLD1;SPG21;BAG6;CMKLR1;SH2B2;FCER1G;BCAR1;C3AR1
prerank,ureteric bud morphogenesis (GO:0060675),0.24269016021351436,0.6066080822635395,0.9540441176470589,1.0,1.0,2/16,11.08%,PAX8;NPNT
prerank,negative regulation of histone acetylation (GO:0035067),0.25863973070090596,0.6065479022839284,0.9252525252525252,1.0,1.0,2/11,11.22%,SIRT1;CTBP1
prerank,peptidyl-lysine monomethylation (GO:0018026),-0.2579550174185588,-0.6062328275641098,0.9266247379454927,0.9998545142169409,1.0,3/10,20.71%,SETD7;SMYD2;SETD4
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.26665915091932635,0.6059337310659527,0.9260780287474333,0.9999889672891848,1.0,2/10,11.22%,SIRT1;CTBP1
prerank,ESCRT complex disassembly (GO:1904896),0.26880727325387654,0.6044196251452459,0.9235412474849095,0.999730352060399,1.0,2/10,10.22%,CHMP1A;CHMP2A
prerank,ESCRT III complex disassembly (GO:1904903),0.26880727325387654,0.6044196251452459,0.9235412474849095,0.999730352060399,1.0,2/10,10.22%,CHMP1A;CHMP2A
prerank,apoptotic mitochondrial changes (GO:0008637),-0.19311267581655928,-0.6043998032084787,0.9816091954022989,1.0,1.0,9/32,25.53%,ERBB4;FIS1;HSPD1;THEM4;BCL2;HK2;CAMK2A;AIFM2;BCL2L1
prerank,modulation by symbiont of entry into host (GO:0052372),-0.22660684091754704,-0.6025313373621873,0.9491150442477876,1.0,1.0,9/16,35.44%,HS3ST5;EXOC7;TRIM5;NECTIN2;TRIM62;FUCA2;CAV1;TRIM21;TRIM68
prerank,positive regulation of interleukin-17 production (GO:0032740),-0.20645105898982946,-0.601911710901037,0.9617224880382775,0.9999948048579143,1.0,18/22,66.03%,IL18;TGFB1;SPHK1;ZBTB7B;NR1H4;NOD2;MYD88;LY9;SLAMF6;PRKCQ;CARD9;IL23A;IL6;IL23R;CCL1;IL12B;IL2;OSM
prerank,fibrinolysis (GO:0042730),0.25877330654780595,0.6016401358510898,0.9260700389105059,1.0,1.0,13/13,74.14%,PLAT;FGG;SERPINF2;KRT1;F2;GP1BA;CPB2;SERPINB2;PLG;HRG;PLAU;PLAUR;SERPINE1
prerank,homologous chromosome segregation (GO:0045143),-0.2088295985231536,-0.6014372931782298,0.9531615925058547,0.9995950923716573,1.0,11/20,53.29%,FMN2;SIRT7;PTTG1;PRDM9;TERB1;MEI4;FANCD2;ZCWPW1;SGO1;MAJIN;MEIOB
prerank,iron-sulfur cluster assembly (GO:0016226),0.21799129503698453,0.6005320204828088,0.9511784511784511,1.0,1.0,4/24,13.46%,CIAPIN1;ISCU;GLRX3;HSCB
prerank,regulation of alcohol biosynthetic process (GO:1902930),-0.24304842016267392,-0.6003527111025122,0.9524838012958964,0.9994711700326595,1.0,7/12,31.28%,CLCN2;MBTPS2;SREBF1;DGKQ;H6PD;ABCA2;RAN
prerank,positive regulation of oxidoreductase activity (GO:0051353),-0.21964477221460343,-0.5994407855676368,0.9668141592920354,0.9992735740718632,1.0,13/18,45.30%,ATP7A;ABL2;AGTR1;RFK;PDP1;POR;FXN;EDN1;EDN3;AGT;NOD2;GDNF;PDP2
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.19412871639690107,0.5983389402429137,0.9776714513556619,1.0,1.0,12/44,20.81%,PRR5L;ZFP36L1;CNOT7;NANOS3;CNOT1;MOV10;FTO;RC3H1;DHX36;METTL14;CNOT8;TNRC6A
prerank,RNA stabilization (GO:0043489),0.20163214706860133,0.5982747030388923,0.9499165275459098,1.0,1.0,10/33,19.34%,TAF15;YBX1;FUS;NOCT;DKC1;ZCCHC17;PARN;NSUN2;DHX36;LARP1
prerank,ovarian follicle development (GO:0001541),0.25610318332241516,0.5981763489131063,0.9545454545454546,1.0,1.0,1/13,2.23%,SOD1
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.23762555687791614,0.5973471783054721,0.9475587703435805,1.0,1.0,3/18,12.41%,PLCG1;FLT1;SP1
prerank,peptidyl-lysine methylation (GO:0018022),-0.19886939356169273,-0.5972884344905726,0.9717223650385605,0.9995993597067839,1.0,17/26,43.88%,SETD7;EHMT2;ATPSCKMT;EEF1AKMT1;SMYD2;N6AMT1;SETD4;METTL21A;EEF2KMT;SUV39H1;EEF1AKMT2;SMYD1;ANTKMT;SUV39H2;VCPKMT;SETD6;TRMT112
prerank,negative regulation of centrosome duplication (GO:0010826),-0.25185834893980047,-0.5972622108044738,0.9490196078431372,0.9990164982322479,1.0,7/11,43.95%,RBM14;MDM1;KAT2B;TRIM37;KAT2A;CCNF;BRCA1
prerank,modulation by symbiont of host process (GO:0044003),0.2693973379487403,0.5970672556779859,0.908411214953271,0.9997028582049673,1.0,1/10,5.45%,B2M
prerank,negative regulation of DNA replication (GO:0008156),-0.23432157535188344,-0.5969366623469526,0.9521829521829522,0.9985890766174685,1.0,9/13,54.19%,S100A11;TSPYL2;CDAN1;TERF1;PDS5A;GMNC;RAD17;GMNN;CDC6
prerank,protein localization to mitochondrion (GO:0070585),0.261605810372731,0.5962082804652504,0.9453860640301318,0.9995856754209054,1.0,2/11,10.66%,RALA;MAIP1
prerank,negative regulation of leukocyte migration (GO:0002686),-0.25511996836910655,-0.5952843474070907,0.9448979591836735,0.9986763438517156,1.0,1/10,3.66%,BMP5
prerank,fatty acid oxidation (GO:0019395),0.1826102402703263,0.5947830390587391,0.9826224328593997,0.9997399373837621,1.0,11/57,17.50%,ACAT1;PPARD;ADIPOR2;ADIPOR1;HSD17B4;BDH2;ECHDC1;ECHS1;ACAA2;ACADL;PEX13
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.21290052520576316,0.5943107210331215,0.9539249146757679,0.9994202834266415,1.0,4/29,12.87%,BIRC2;TRAF3;IKBKB;CHUK
prerank,regulation of interferon-alpha production (GO:0032647),-0.1984340865718606,-0.5942105943706725,0.9607390300230947,0.9985246350999872,1.0,5/23,19.51%,PTPRS;IFIH1;HSPD1;MAVS;STAT1
prerank,eye photoreceptor cell development (GO:0042462),-0.2245837067295351,-0.5939426210851748,0.945031712473573,0.9980461047912561,1.0,8/15,49.39%,TOPORS;VEGFA;RP1;THY1;RPGRIP1;TULP1;MYO7A;RORB
prerank,production of siRNA involved in RNA interference (GO:0030422),-0.2588356637640291,-0.5916258290886364,0.9571428571428572,0.9983654449835423,1.0,2/10,14.25%,TSN;DICER1
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.2239583371305613,-0.5914205105640529,0.9697624190064795,0.9978394847257506,1.0,10/16,44.30%,SHLD1;RIF1;SMCHD1;SHLD2;POLQ;FANCB;CGAS;MAD2L2;RMI2;PARPBP
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.2100012363314282,0.5913770465838504,0.9714285714285714,1.0,1.0,4/30,12.87%,BIRC2;TRAF3;IKBKB;CHUK
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.21084044181678216,0.590754049470021,0.9571428571428572,0.9999630408608272,1.0,1/26,1.17%,CBL
prerank,cGMP biosynthetic process (GO:0006182),0.2657506864076139,0.5906969929483895,0.9247104247104247,0.9994769212388334,1.0,2/10,14.18%,NPPC;NPR2
prerank,electron transport chain (GO:0022900),0.24284499561972311,0.5887055109145206,0.9431818181818182,0.9998525657824394,1.0,3/15,13.86%,ETFA;SDHA;PDIA5
prerank,negative regulation of biosynthetic process (GO:0009890),-0.2147094416317127,-0.5869678328819854,0.9535864978902954,0.9990016572304877,1.0,3/16,13.86%,SLC30A10;PPARA;ABCD2
prerank,plasma membrane tubulation (GO:0097320),-0.23394478601286672,-0.5859411072819198,0.9576612903225806,0.9988028380505798,1.0,5/13,32.61%,BIN3;PACSIN1;PACSIN3;CAVIN2;MICALL1
prerank,positive regulation of cholesterol efflux (GO:0010875),0.21885097049915442,0.5855929889522964,0.9437819420783645,1.0,1.0,7/21,21.07%,APOE;SIRT1;NFKBIA;PLTP;EEPD1;NR1H3;PPARG
prerank,oligodendrocyte differentiation (GO:0048709),-0.2093734875983681,-0.5853305924346245,0.9614512471655329,0.9984442362891823,1.0,12/19,41.94%,SOX6;TPPP;EIF2B5;EIF2B2;CDK5;EIF2B4;MYRF;NSUN5;SOX10;SOX8;PTPRZ1;EIF2B1
prerank,pyrimidine-containing compound metabolic process (GO:0072527),-0.2423387696859881,-0.5845134292339051,0.9568788501026694,0.9981866761224265,1.0,5/11,32.14%,ENPP3;NT5C3A;SLC19A2;DCK;SLC25A19
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.24956511494215003,-0.5836727296984193,0.9520958083832335,0.9979121050918819,1.0,7/10,46.96%,NPLOC4;RIOK3;GPATCH3;DHX58;C1QBP;TKFC;TSPAN6
prerank,respiratory electron transport chain (GO:0022904),0.2400511971988185,0.5835403545261628,0.9143389199255121,1.0,1.0,3/14,12.49%,ETFA;SDHA;SLC25A12
prerank,leukocyte tethering or rolling (GO:0050901),-0.21612573164065882,-0.5830373080879403,0.9604651162790697,0.9975313682454056,1.0,5/17,27.00%,ROCK1;ITGA4;ADD2;PODXL2;CX3CR1
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),-0.22140760522728553,-0.5824634886855751,0.9483146067415731,0.9971510801164855,1.0,4/16,20.40%,TMEM50A;SNF8;CHMP5;STAM
prerank,ncRNA metabolic process (GO:0034660),0.1977166078987923,0.5824033608102923,0.9787234042553191,1.0,1.0,6/37,16.46%,BCDIN3D;XPO5;TUT7;TUT4;DTD1;PARN
prerank,negative regulation of transposition (GO:0010529),0.23189633284251374,0.5816263445441766,0.9476534296028881,1.0,1.0,4/16,19.14%,TUT7;TUT4;MOV10;MYBL1
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.23958556800959954,0.5816034077613165,0.9444444444444444,1.0,1.0,2/13,9.76%,TXN;PARK7
prerank,regulation of tau-protein kinase activity (GO:1902947),-0.24617149481503284,-0.5813940696339978,0.9279835390946503,0.9969281270676199,1.0,3/10,27.41%,SORL1;HSP90AA1;EGR1
prerank,regulation of cholesterol efflux (GO:0010874),0.2042677470477804,0.5802617133878019,0.9759450171821306,1.0,1.0,3/30,7.30%,APOE;LAMTOR1;SIRT1
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),-0.2478179201379161,-0.5800394745920686,0.9506437768240343,0.9968070873462832,1.0,5/10,30.05%,AKT2;GPLD1;AKT1;SNCA;SLC45A3
prerank,regulation of mitotic spindle assembly (GO:1901673),0.22248697923290334,0.5797112999442257,0.9445506692160612,0.9999376179909548,1.0,2/19,10.22%,CHMP1A;CHMP2A
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.17533403724442945,-0.5792818396530427,0.9801980198019802,0.9964710559711425,1.0,18/36,49.18%,AXL;PARP14;UBE2K;MAVS;IRGM;AGPAT1;PARP9;EDN1;LAPTM5;AGPAT2;TRIM6;HSPA1A;ZBP1;TXK;CASP1;HSPA1B;CXCR4;CD300LF
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.23321082691733147,0.578549137709996,0.9611829944547134,0.9998768197286705,1.0,6/16,19.12%,ERCC4;TNKS;SMG6;TNKS2;SMG5;DHX36
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.21849113794005576,0.5781614795009883,0.9605734767025089,0.9995230458927362,1.0,3/21,13.40%,TXNDC12;PARK7;DDIT3
prerank,apoptotic DNA fragmentation (GO:0006309),-0.2202506350697399,-0.5780555894756437,0.971830985915493,0.9963358279930336,1.0,8/16,35.83%,DICER1;DFFA;CASP3;EXOG;H1-0;DNASE2;HMGB1;HMGB2
prerank,low-density lipoprotein particle remodeling (GO:0034374),-0.2466975136901213,-0.5779379996393184,0.9285714285714286,0.9957875767592295,1.0,5/11,52.63%,AGTR1;PLA2G7;AGT;LIPC;PLA2G5
prerank,actin-myosin filament sliding (GO:0033275),-0.17397787333610232,-0.5778177126688603,0.9870466321243523,0.9946605454229895,1.0,3/38,10.09%,TPM1;VIM;ACTN2
prerank,muscle filament sliding (GO:0030049),-0.17397787333610232,-0.5778177126688603,0.9870466321243523,0.9946605454229895,1.0,3/38,10.09%,TPM1;VIM;ACTN2
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),-0.22264171070676694,-0.5775334360399657,0.9720430107526882,0.9941824322444976,1.0,1/14,1.93%,PKD1
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),-0.24114667816462312,-0.5761679011893615,0.9381898454746137,0.9940568820161299,1.0,6/11,33.10%,NOL11;SIRT7;NOP53;PIH1D1;DDX11;MTOR
prerank,mRNA stabilization (GO:0048255),0.18748038800484523,0.57517164816782,0.983633387888707,1.0,1.0,7/40,15.50%,TIRAP;HNRNPC;TARDBP;TAF15;YBX1;FUS;NOCT
prerank,regulation of anoikis (GO:2000209),0.22256517510061818,0.5735083318288703,0.9608540925266904,1.0,1.0,2/19,8.04%,SRC;NOTCH1
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),0.25353192983299755,0.5719086979592377,0.9387351778656127,1.0,1.0,1/10,7.28%,SMAD7
prerank,maturation of LSU-rRNA (GO:0000470),0.2058688780099072,0.5714557113842752,0.9773123909249564,0.9999194104188003,1.0,7/26,17.53%,RRP15;SNU13;WDR12;RPL35;RSL1D1;URB1;EIF6
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.20692531115050553,0.5711940712325386,0.9621993127147767,0.9995068521669962,1.0,9/25,22.03%,APP;PICALM;ARF6;MTMR2;UBQLN2;RAC1;ANKRD13A;PSEN1;ATXN2
prerank,negative regulation of cell activation (GO:0050866),0.23758781903142845,0.5688429998370792,0.946257197696737,0.9998481879582762,1.0,2/14,11.15%,APOE;NOS3
prerank,sulfur amino acid catabolic process (GO:0000098),0.2595405473261363,0.5677435179233773,0.9508840864440079,0.9997054422450337,1.0,10/10,74.06%,TXN2;BLMH;MAT1A;GADL1;TST;MPST;ADO;CTH;CBS;MTRR
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),-0.22387423273905732,-0.5662170287456306,0.9746835443037974,0.9966988984884262,1.0,7/13,34.59%,RAB23;APOD;CABP1;SUFU;NUP153;CHP1;BARD1
prerank,regulation of transferase activity (GO:0051338),0.22512858620667475,0.5660241462387796,0.975925925925926,0.9998075878350869,1.0,1/17,1.41%,JMJD8
prerank,regulation of chromosome organization (GO:0033044),-0.19212472440065828,-0.5644454731305402,0.9833729216152018,0.996637449444544,1.0,4/22,17.70%,MAPT;CENPV;UPF1;YLPM1
prerank,calcium ion import across plasma membrane (GO:0098703),-0.2209030564162463,-0.5636367308282402,0.9688796680497925,0.9962933794933219,1.0,6/14,37.05%,SLC24A2;CACNA2D1;TRPV2;SLC8A2;TRPM2;ATP2B4
prerank,regulation of sensory perception of pain (GO:0051930),0.24009639504027408,0.5628656758357973,0.94106463878327,1.0,1.0,1/11,7.31%,TMEM100
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.25106703489831783,0.5627842173843721,0.9718875502008032,0.9998648694059007,1.0,10/10,74.91%,FBXW7;ADAM17;AREG;EPGN;TGFA;NCF1;BTC;EGF;HBEGF;ADRA2A
prerank,secretory granule organization (GO:0033363),0.2590990160499846,0.5609859689301463,0.9410569105691057,0.9999603239330405,1.0,1/10,6.05%,DTNBP1
prerank,ganglioside metabolic process (GO:0001573),-0.1979342865501933,-0.5596899399093578,0.962877030162413,0.9968474629046096,1.0,10/20,35.62%,HEXA;HEXB;ST6GALNAC5;ST6GALNAC6;ST8SIA2;ST6GALNAC4;ABCA2;NEU1;ST8SIA3;ST3GAL5
prerank,replication fork processing (GO:0031297),0.1867308199367462,0.5591765732600427,0.9885433715220949,1.0,1.0,3/38,9.68%,ZRANB3;RFWD3;EXD2
prerank,phospholipid catabolic process (GO:0009395),0.2037573329232479,0.5584277338259047,0.9666666666666667,0.9997571148923771,1.0,3/24,14.23%,SMPD4;ABHD12;PNPLA6
prerank,inositol phosphate dephosphorylation (GO:0046855),0.2481325717155234,0.5581760104999145,0.9641509433962264,0.9988341779110181,1.0,11/11,75.20%,SYNJ2;IMPA1;INPP5B;SYNJ1;INPP5J;PTEN;IMPA2;INPP1;INPP5K;OCRL;INPP5A
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.2481325717155234,0.5581760104999145,0.9641509433962264,0.9988341779110181,1.0,11/11,75.20%,SYNJ2;IMPA1;INPP5B;SYNJ1;INPP5J;PTEN;IMPA2;INPP1;INPP5K;OCRL;INPP5A
prerank,tyrosine metabolic process (GO:0006570),0.24860897040360552,0.5563313381515981,0.9397590361445783,0.9988710421691329,1.0,1/11,9.16%,THAP4
prerank,ribosomal subunit export from nucleus (GO:0000054),0.23598793046094255,0.556095358259843,0.9650485436893204,0.9984440440781244,1.0,6/13,21.76%,LTV1;XPO1;NPM1;EIF6;SDAD1;NMD3
prerank,midbody abscission (GO:0061952),0.21833253815775366,0.5549422829538678,0.9589552238805971,0.9983032585003684,1.0,2/17,10.22%,CHMP1A;CHMP2A
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.23143028121470932,0.554066822788308,0.9648148148148148,0.9980519418561629,1.0,1/14,3.76%,NUDT5
prerank,negative regulation of cation channel activity (GO:2001258),0.197164849246176,0.5533815982864491,0.9828473413379074,0.9977545202777827,1.0,5/26,18.82%,CALM3;KCNAB1;UBQLN1;FKBP1A;CALM1
prerank,prostanoid metabolic process (GO:0006692),0.23006169616998068,0.552698070010554,0.9659090909090909,0.9974491406594017,1.0,3/13,15.79%,PLAA;PTGR2;HPGD
prerank,negative regulation of transforming growth factor beta production (GO:0071635),-0.23288634646580614,-0.5524361364790962,0.9711340206185567,0.9982281940223673,1.0,6/10,43.18%,FN1;GATA6;CD24;TSKU;TYROBP;CDH3
prerank,lymphocyte mediated immunity (GO:0002449),0.22884126848403874,0.5518896056300914,0.9615384615384616,0.9971825851453398,1.0,3/12,20.22%,CD55;CD46;BTN3A3
prerank,oxoacid metabolic process (GO:0043436),-0.17593368519602795,-0.5516137451237768,0.9824120603015075,0.9978554462115922,1.0,2/27,5.42%,DDO;ENPP1
prerank,female gamete generation (GO:0007292),-0.17389666993369468,-0.5515820176926,0.9900990099009901,0.9972828113024209,1.0,2/29,5.66%,DIAPH2;FMN2
prerank,response to fatty acid (GO:0070542),-0.20133928525436653,-0.5514628526840141,0.9861751152073732,0.9967240159880884,1.0,1/17,3.56%,PID1
prerank,positive regulation of immune system process (GO:0002684),-0.20388328012865986,-0.5508379949474264,0.9890350877192983,0.996306066047055,1.0,6/16,41.21%,ANXA1;VEGFA;NCKAP1L;RSAD2;PIK3CB;TGFB2
prerank,protein deneddylation (GO:0000338),-0.23361910559724847,-0.5498647295837717,0.9777327935222672,0.9959741176049495,1.0,6/10,38.80%,COPS2;COPS5;COPS7A;TOR1A;COPS6;GPS1
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.23086003005722744,-0.5490060227923477,0.9744094488188977,0.9950373955458695,1.0,5/11,36.63%,AGO3;RBM4;NOTCH4;TNRC6C;ZFP36
prerank,miRNA mediated inhibition of translation (GO:0035278),-0.23086003005722744,-0.5490060227923477,0.9744094488188977,0.9950373955458695,1.0,5/11,36.63%,AGO3;RBM4;NOTCH4;TNRC6C;ZFP36
prerank,cGMP metabolic process (GO:0046068),-0.2231780886612048,-0.5426845972795494,0.9810924369747899,0.996043057186299,1.0,4/12,26.26%,GUCY1A1;NPR1;GUCY1B1;PDE2A
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.21402657140362824,0.5423610562876982,0.975609756097561,0.999287999672374,1.0,2/15,10.80%,NLRC3;DDX3X
prerank,positive regulation of interferon-alpha production (GO:0032727),-0.1896184855086862,-0.5408574322007685,0.9822222222222222,0.9958623201766333,1.0,5/19,25.13%,IFIH1;HSPD1;MAVS;STAT1;TLR3
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.20402530852618522,0.5390864190835755,0.9821428571428571,0.999658877906651,1.0,3/20,11.27%,TXN;P2RX7;APP
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.22186532469569412,0.5389458676470809,0.9652650822669104,0.9991851280605216,1.0,1/15,4.13%,ZFP36L1
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.22537510201519242,0.5361169882575538,0.963531669865643,0.9993740144943176,1.0,13/13,77.48%,PCID2;LCMT1;CDK5RAP2;USP44;TPR;CCNB1;XRCC3;NDC80;GEN1;MAD2L1;DYNC1LI1;ANAPC15;DUSP1
prerank,neutrophil activation (GO:0042119),0.22967032316981045,0.5336264271691974,0.9671814671814671,0.9994501959266887,1.0,1/12,6.70%,SYK
prerank,calcium ion import into cytosol (GO:1902656),-0.20396178234140405,-0.5329617608468101,0.9771309771309772,0.9970237478257262,1.0,6/15,37.05%,SLC24A2;CACNA2D1;TRPV2;SLC8A2;TRPM2;ATP2B4
prerank,L-serine metabolic process (GO:0006563),0.23994331390644974,0.5327814839494215,0.9752066115702479,0.9991496096816853,1.0,2/10,11.35%,SERINC5;SERINC3
prerank,double-strand break repair via break-induced replication (GO:0000727),0.22642812303829268,0.5327465692838601,0.9633204633204633,0.9986565047859888,1.0,12/12,77.37%,CDC45;MCM2;GINS2;MCM5;MCM7;MCM3;GINS4;MCMDC2;MUS81;MCM4;CDC7;MCM6
prerank,ER-associated misfolded protein catabolic process (GO:0071712),-0.22078182025247056,-0.53085468512018,0.9706498951781971,0.9968688716609213,1.0,5/11,31.85%,VCP;UGGT2;BAG6;RNF185;TOR1A
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),-0.20575707499120685,-0.5302480394270308,0.9818548387096774,0.9964036434319299,1.0,4/14,33.41%,IL18;IL17D;CD80;PAEP
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),-0.23208517319761104,-0.5290848457804512,0.9710144927536232,0.9960528814902668,1.0,5/10,37.76%,SRI;PDE4B;CACNA2D1;NIPSNAP2;CACNB3
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.2318403589683073,0.5262993396094441,0.9633401221995926,0.9996463133914022,1.0,1/11,7.28%,SMAD7
prerank,androgen metabolic process (GO:0008209),0.20777686394772288,0.5261234917278527,0.988155668358714,0.9991781028133788,1.0,2/18,11.73%,HSD17B11;HSD17B4
prerank,positive regulation of interleukin-1 beta production (GO:0032731),-0.15052138292297407,-0.5258752279821679,0.9973958333333334,0.9960912225382945,1.0,21/45,47.58%,MALT1;AIM2;USP50;GBP5;GSDMD;HSPB1;PANX1;TRIM16;EGR1;TMEM106A;LPL;TYROBP;CASP8;CCL19;NOD2;PYCARD;MYD88;TLR4;CASP1;FZD5;AGER
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.226651352671914,-0.5251204431323195,0.979381443298969,0.9956540671453789,1.0,1/10,4.76%,KIT
prerank,regulation of interleukin-17 production (GO:0032660),0.18178152627825733,0.5223107890735796,0.9930795847750865,0.9994800270813631,1.0,4/31,17.21%,VSIR;PRNP;DDIT3;SLC7A5
prerank,endoderm development (GO:0007492),0.2253751020151925,0.5221784082392008,0.9862306368330465,0.9990105446656986,1.0,13/13,77.48%,SOX17;KIF16B;APELA;EOMES;GATA4;DUSP2;DUSP5;TBX20;DUSP4;LHX1;LAMC1;SOX7;DUSP1
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.18338153150912026,0.5209902020451256,0.9845094664371773,0.998773522533077,1.0,1/29,2.58%,CXCL12
prerank,mitotic sister chromatid cohesion (GO:0007064),0.20785956649410142,0.5174539825623754,0.9699115044247788,0.9989394425731717,1.0,1/16,3.93%,BOD1
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),-0.2070006664344891,-0.516963295804288,0.9909502262443439,0.996582162120462,1.0,3/13,24.34%,ENPP1;BPNT1;ABHD14B
prerank,regulation of multicellular organismal development (GO:2000026),0.18867616662118725,0.5163651954660973,0.9894736842105263,0.9986562502814793,1.0,5/25,19.12%,TDG;RAB14;SOX17;INSR;DHX36
prerank,oogenesis (GO:0048477),0.2066925376271621,0.514367394328341,0.9752212389380531,0.9985412704895554,1.0,2/15,11.15%,MARF1;NANOS3
prerank,inositol phosphate catabolic process (GO:0071545),-0.21230862404514872,-0.5105491401988937,0.9807692307692307,0.9970787011583794,1.0,6/12,36.35%,NUDT3;INPP5A;OCRL;INPP5K;INPP1;IMPA2
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.1985054006531023,0.5089523160536776,0.9853747714808044,0.9989890748520228,1.0,18/18,80.17%,ALKBH7;BAD;BNIP3;SLC25A4;TMEM102;SLC25A31;HEBP2;NAIF1;PMAIP1;PPIF;BAK1;MUL1;SLC25A5;BCL2L1;CAMK2A;BCL2;THEM4;SPG7
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),-0.16544655723207735,-0.5075660630794974,0.9912087912087912,0.9969466173779414,1.0,7/26,29.10%,SLC30A10;PPARA;ABCD2;SLC25A33;GRIN1;SLC5A3;SNCA
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.18965471295856814,0.5074132799032534,0.9860383944153578,0.998776750970197,1.0,5/22,18.09%,UBAP1;VPS37B;PLAA;VPS37C;VPS4B
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.20720179611401404,-0.5034125942758138,0.9852631578947368,0.9970365293749939,1.0,3/11,27.27%,BMP4;BMPR1A;ZFPM2
prerank,zymogen activation (GO:0031638),0.16425490278909485,0.4969822407780225,0.9984202211690363,0.9999892208600311,1.0,5/39,14.37%,OMA1;VSIR;BAD;PLAT;GRIN2A
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),-0.21415108978500935,-0.4965431205618353,0.9842209072978304,0.9973910911868522,1.0,7/10,41.69%,ACAD11;ETFB;ACADS;ACADVL;IVD;ACADM;GCDH
prerank,outer dynein arm assembly (GO:0036158),0.20608696308457636,0.49587780986545377,0.9791271347248577,0.9996707847389541,1.0,1/14,6.62%,DNAL1
prerank,positive regulation of interleukin-6 production (GO:0032755),0.1468452738538344,0.4923802482722543,1.0,0.9996963130852334,1.0,5/68,11.27%,TIRAP;RAB7B;SYK;WNT5A;APP
prerank,defense response to protozoan (GO:0042832),0.20808425899137317,0.49236686608503977,0.9785330948121646,0.9991995694939735,1.0,1/12,6.26%,GBP4
prerank,serine family amino acid biosynthetic process (GO:0009070),-0.2003457482553461,-0.48901853434201614,0.993963782696177,0.9977537160146482,1.0,9/12,46.44%,SRR;MTHFD1;PSPH;PSAT1;CBS;PHGDH;SEPHS2;CTH;GGT1
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),-0.16792527992462164,-0.48584153494192833,0.9976190476190476,0.997517982923288,1.0,9/22,33.10%,NOL11;WDR43;ATF4;UTP15;EIF2AK3;ERBB2;PIH1D1;DDX11;MTOR
prerank,metallo-sulfur cluster assembly (GO:0031163),0.17845745762009715,0.482793107336643,0.9879518072289156,1.0,1.0,2/22,7.13%,CIAPIN1;ISCU
prerank,mitochondrial RNA metabolic process (GO:0000959),0.19619537920642904,0.4786414138580416,0.9910394265232975,1.0,1.0,14/14,80.40%,EARS2;TFAM;TFB1M;TFB2M;PNPT1;FASTKD5;TWNK;POLRMT;TEFM;MRPL12;MTERF2;FOXO3;SLC25A33;FASTKD1
prerank,response to glucocorticoid (GO:0051384),0.17267779001747502,0.47857999580209304,0.9918032786885246,0.9995458204731186,1.0,1/26,4.13%,ZFP36L1
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.20277380300317607,-0.47547902972989686,0.9853249475890985,0.9979823193169022,1.0,1/10,13.42%,IL33
prerank,lipoxygenase pathway (GO:0019372),0.19914615770969357,0.4732900538303129,0.9848484848484849,0.9996732343139372,1.0,14/14,80.10%,HPGD;ALOX12B;ALOX15;GPX4;PON3;PON1;LTC4S;PON2;ALOX5;ALOXE3;ALOX5AP;ALOX12;GPX1;PTGS2
prerank,meiosis I (GO:0007127),0.1759170825435581,0.47319061119643707,0.9965095986038395,0.9991854309351411,1.0,21/23,57.77%,ING2;FOXJ3;ZSCAN21;MYBL1;BRDT;BTBD18;MEIOC;DNMT3L;MEI1;CCNA1;MEIKIN;MOV10L1;FOXJ2;SLC25A31;MEIOB;DDX4;TDRD9;SGO1;SYCP3;ZCWPW1;HSF2BP
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.191103988015979,-0.4718756664940702,0.9956803455723542,0.9977239552286219,1.0,4/13,22.98%,NFU1;MMS19;ISCA1;CIAO1
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.17136754821282751,0.46111381722276595,0.9947826086956522,0.9999190869943759,1.0,23/23,82.89%,ELOVL6;HPGD;ALOX12B;ALOX15;GPX4;ACSBG2;GSTP1;LTC4S;CYP1A1;GSTM4;CYP2E1;ALOX5;ALOXE3;ASAH2;LTA4H;ALOX12;ACSBG1;GSTM2;FADS1;EPHX2;GSTM1;PTGS2;ACOT7
prerank,regulation of mitotic sister chromatid separation (GO:0010965),-0.17730252164537488,-0.4569387499385562,0.9978494623655914,0.9983957098749261,1.0,4/15,25.09%,RIOK2;PTTG1;HECW2;CDC27
prerank,negative regulation of immune effector process (GO:0002698),0.18749237885367315,0.451730023657843,0.9885931558935361,1.0,1.0,4/13,20.44%,CD47;CD55;RC3H1;GRN
prerank,sensory perception of pain (GO:0019233),0.17368948001102724,0.44538546148457087,0.9983221476510067,1.0,1.0,2/21,10.95%,MME;P2RX7
prerank,DNA catabolic process (GO:0006308),0.19493015011234865,0.4442666463742379,0.9944954128440368,0.9998160465801156,1.0,2/11,18.51%,XRN2;FBH1
prerank,superoxide anion generation (GO:0042554),-0.17573867083757388,-0.43874670299271723,0.991869918699187,0.9989445192194439,1.0,9/13,60.93%,NOX4;NCF2;ALOX12;CYBB;TAFA4;NCF1;NOX3;NCF4;DUOX1
prerank,purine nucleotide catabolic process (GO:0006195),0.17787165585533343,0.43546711305149727,0.996316758747698,0.999913601012543,1.0,2/13,12.02%,PNP;NT5C2
prerank,regulation of phosphate metabolic process (GO:0019220),0.1687092601280695,0.42283042245585567,0.9945155393053017,1.0,1.0,6/16,21.48%,IKBKB;SMG6;SMG5;IGBP1;SMG7;PSEN1
prerank,toxin transport (GO:1901998),0.18477067243844386,0.42268506546557344,0.9980732177263969,0.9996100251199248,1.0,2/10,15.84%,RAB40B;ANTXR1
prerank,pseudouridine synthesis (GO:0001522),-0.1671641389154388,-0.4159837608440278,0.9978813559322034,0.9993472143344322,1.0,10/13,50.83%,PUS7;TRUB1;PUS3;GAR1;NOP10;PUS1;PUS7L;NHP2;PUSL1;RPUSD2
prerank,inorganic ion transmembrane transport (GO:0098660),0.16998032752262277,0.40408853335938416,0.9981785063752276,0.999860813004412,1.0,1/12,10.53%,TRPM4
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.1293100550851124,0.3748293480748054,1.0,1.0,1.0,4/29,15.50%,TAF15;YBX1;FUS;NOCT
prerank,positive regulation of interleukin-1 production (GO:0032732),0.11391942202832794,0.3681367709013355,1.0,0.9996752854875581,1.0,4/51,11.27%,TMED10;WNT5A;P2RX7;APP
prerank,regulation of regulatory T cell differentiation (GO:0045589),-0.11601828924660444,-0.34232533982090374,1.0,0.9999565101117236,1.0,1/22,5.12%,CBFB
